data_2n67_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n67 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 79.1 mmm . . . . . 0 N--CA 1.45 -0.456 0 CA-C-O 120.978 0.418 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -58.4 -23.59 57.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.745 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 13.3 m -65.7 -29.88 70.48 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.932 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 9.6 mm -62.74 -41.66 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 121.856 0.836 . . . . 0.0 109.436 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -70.72 -34.49 71.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.877 -174.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.574 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 17.6 m -67.73 -45.95 73.55 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.216 177.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.48 -44.59 96.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.968 0.413 . . . . 0.0 110.329 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . 0.51 ' ND2' HD21 ' B' ' 29' ' ' LEU . 2.1 t-20 -52.29 -49.98 63.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.953 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -18.07 47.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.24 -174.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -78.55 -49.86 12.58 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 120.984 0.421 . . . . 0.0 111.859 176.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.414 HD23 HG12 ' B' ' 72' ' ' VAL . 67.5 mt -72.89 -43.41 62.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.295 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -85.56 74.4 10.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.641 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -131.38 -77.4 0.52 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.672 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.35 46.13 1.13 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.414 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -117.19 -140.74 0.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.679 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -85.7 170.78 44.43 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.848 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.516 ' HE2' ' HB2' ' B' ' 41' ' ' SER . 4.9 ttpt -61.84 127.09 29.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 11.6 tp -158.04 115.46 2.96 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 120.957 0.408 . . . . 0.0 110.693 -169.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 69.3 m -107.74 114.14 27.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.054 177.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.51 HD21 ' ND2' ' B' ' 17' ' ' ASN . 3.1 mm? -86.4 154.94 20.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.542 0.687 . . . . 0.0 111.166 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.97 154.47 41.3 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.545 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 54.1 mtt -119.88 144.73 47.24 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.118 0.485 . . . . 0.0 111.898 -171.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -154.42 108.32 2.95 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.09 -111.66 4.18 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -168.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.504 ' HB2' ' HA2' ' B' ' 86' ' ' GLY . 13.8 m120 -123.48 19.58 9.63 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 168.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -72.55 154.71 40.67 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.401 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 20.3 tp -112.44 92.03 3.87 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.172 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -89.52 151.75 21.8 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -170.65 155.53 4.91 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -171.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 11.0 p -123.27 140.18 53.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.207 168.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 27.1 t -142.18 153.13 43.8 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.767 0.794 . . . . 0.0 112.753 -172.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.516 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . 10.2 m -133.0 168.39 18.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.754 176.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -112.07 36.46 3.33 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.478 0.656 . . . . 0.0 109.94 -170.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.7 22.28 0.1 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.86 -1.064 . . . . 0.0 113.376 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.46 -44.11 0.53 Allowed Glycine 0 C--O 1.229 -0.186 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.532 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.679 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 44.4 p90 46.98 -152.51 0.08 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.22 1.008 . . . . 0.0 113.469 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.42 ' H ' HG21 ' B' ' 71' ' ' THR . . . -81.75 99.74 2.02 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.444 -173.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.407 ' H ' HD13 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -112.52 -54.53 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.509 0.671 . . . . 0.0 109.266 172.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -42.87 -55.7 3.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.154 -1.384 . . . . 0.0 111.939 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -79.21 121.12 24.65 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.96 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -65.76 -83.92 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.814 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -146.63 112.37 5.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.508 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 79.6 mttt -139.21 136.23 34.79 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -125.41 128.14 47.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.51 0.671 . . . . 0.0 111.934 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.565 ' HA ' HG12 ' B' ' 94' ' ' ILE . 30.5 p-90 -147.73 177.15 9.54 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.266 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.26 151.16 22.05 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.973 -174.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.469 HD12 ' CD2' ' B' ' 64' ' ' TYR . 19.0 mt -110.26 141.61 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 174.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 60.9 m-85 -125.36 139.45 53.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.795 -173.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.576 HG11 ' ND2' ' B' ' 59' ' ' ASN . 7.4 p -126.37 137.38 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.616 ' HA ' ' CG ' ' B' ' 87' ' ' MET . 2.9 m-80 63.11 6.24 2.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.33 0.652 . . . . 0.0 110.171 -175.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.3 -5.45 55.41 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.94 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' B' ' 58' ' ' VAL . 22.1 mt-10 -100.2 174.45 6.14 Favored 'General case' 0 C--O 1.193 -1.873 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.504 ' HA ' ' CD1' ' B' ' 57' ' ' PHE . 10.7 tttt -80.88 169.97 16.87 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.02 -3.22 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.717 165.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.754 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -158.16 130.83 7.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.437 -172.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 25.3 m -137.68 125.68 22.78 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.448 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.406 ' HB3' ' CD1' ' B' ' 75' ' ' ILE . 0.1 OUTLIER -160.91 154.2 21.68 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 122.709 1.242 . . . . 0.0 113.239 -175.219 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 19.1 t-20 -107.93 152.1 24.9 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.364 -2.198 . . . . 0.0 107.777 166.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -64.27 -24.29 67.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.572 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.565 ' O ' HG23 ' B' ' 71' ' ' THR . 4.4 ttmp? -82.8 -26.09 32.1 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.027 0.441 . . . . 0.0 110.948 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 6.6 t -69.93 -22.3 63.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.565 HG23 ' O ' ' B' ' 69' ' ' LYS . 11.9 p 60.28 115.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.326 1.05 . . . . 0.0 112.558 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.414 HG12 HD23 ' B' ' 20' ' ' LEU . 10.0 m -61.52 -11.74 5.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.82 -172.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.56 -52.6 51.52 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.192 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -72.01 -32.57 67.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.584 0.707 . . . . 0.0 110.213 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.497 HG13 ' O ' ' B' ' 71' ' ' THR . 2.9 mt -73.19 -48.35 43.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.606 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.8 t -50.87 -36.75 39.59 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.239 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -51.21 -55.81 16.11 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.838 0.828 . . . . 0.0 109.744 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.759 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 24.2 m-20 -69.68 -39.7 76.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.046 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.754 HG13 ' CE1' ' B' ' 64' ' ' TYR . 42.6 mm -57.88 -30.91 39.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.378 0.609 . . . . 0.0 111.881 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -73.53 2.4 7.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.618 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.759 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 45.3 pttt -109.49 8.06 25.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.259 0.552 . . . . 0.0 109.937 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -77.36 -6.82 54.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.606 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 56.2 65.03 1.53 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -167.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 54.1 mt -67.75 149.56 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.092 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.589 ' HB2' HD22 ' B' ' 59' ' ' ASN . 63.2 mttm -129.68 -159.71 0.98 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.932 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -160.29 126.77 1.67 Allowed Glycine 0 C--N 1.318 -0.426 0 C-N-CA 120.005 -1.093 . . . . 0.0 114.434 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.616 ' CG ' ' HA ' ' B' ' 59' ' ' ASN . 21.1 ptp -176.72 -52.11 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 122.782 0.433 . . . . 0.0 111.166 168.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . 0.506 ' N ' ' HG3' ' B' ' 87' ' ' MET . 60.7 t80 -127.37 99.08 5.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.917 -0.49 . . . . 0.0 109.883 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 41.1 mm -96.53 137.18 25.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.233 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 6.5 mm-40 -128.88 153.93 47.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.035 0.445 . . . . 0.0 111.494 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.512 HG21 ' CZ3' ' B' ' 54' ' ' TRP . 51.5 mt -131.9 114.29 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.323 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 62.6 pttt -166.7 162.24 16.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.06 0.457 . . . . 0.0 112.157 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.445 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -80.82 163.97 23.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.106 175.277 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.565 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.3 pt . . . . . 0 C--O 1.245 0.85 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.892 -172.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 121.4 0.619 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -56.35 -24.66 45.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.943 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.535 ' O ' HG22 ' B' ' 16' ' ' VAL . 5.4 m -63.52 -33.02 74.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.569 -178.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 12.6 mm -62.74 -43.28 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.624 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -71.93 -39.94 69.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.834 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.6 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 23.8 m -61.33 -49.39 77.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.705 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.535 HG22 ' O ' ' B' ' 12' ' ' SER . 61.2 t -65.2 -38.93 83.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 110.436 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -49.97 -45.96 51.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.905 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.2 OUTLIER -82.75 -41.54 19.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.384 -179.322 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.6 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -58.55 -52.66 64.7 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 123.419 0.688 . . . . 0.0 112.761 -175.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 70.2 mt -73.54 -28.39 61.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.74 0.305 . . . . 0.0 110.945 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -89.46 61.32 5.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.45 0.643 . . . . 0.0 110.279 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 30.7 mtpp -129.36 -84.27 0.56 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.835 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.65 44.95 1.39 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.616 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -126.24 -159.05 0.89 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.575 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -67.96 159.04 51.41 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.434 ' HG2' ' HB2' ' B' ' 41' ' ' SER . 0.0 OUTLIER -82.07 111.01 17.82 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.708 -177.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' B' ' 39' ' ' THR . 2.3 pt? -131.57 148.74 52.64 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.604 -176.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 60.7 m -102.67 117.08 33.89 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.404 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.446 HD23 ' N ' ' B' ' 29' ' ' LEU . 2.8 mm? -88.51 152.6 21.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.51 0.672 . . . . 0.0 110.787 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.1 p -150.07 151.02 32.55 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.237 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 50.7 mtt -120.13 146.21 46.19 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.858 0.361 . . . . 0.0 110.92 -175.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -154.05 116.65 4.4 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.96 -111.49 4.16 Favored Glycine 0 CA--C 1.507 -0.41 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -169.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.54 ' HB2' ' CA ' ' B' ' 86' ' ' GLY . 43.1 m-20 -130.45 37.75 3.82 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 168.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.416 ' HG2' ' CG2' ' B' ' 84' ' ' ILE . 48.1 mt-30 -92.17 161.25 14.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.241 175.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 27.4 tp -127.44 110.53 12.87 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 171.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.414 ' HA ' ' ND2' ' B' ' 80' ' ' ASN . 32.2 mtmt -113.36 148.06 36.49 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -177.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -156.89 158.16 36.18 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -172.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 4.6 p -133.35 134.68 44.07 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.929 171.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -131.1 147.82 52.66 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -167.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.434 ' HB2' ' HG2' ' B' ' 26' ' ' LYS . 2.4 m -99.75 141.7 32.21 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 167.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -103.92 32.06 4.15 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.339 -169.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.71 22.52 1.6 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.135 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.69 -36.52 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.798 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.575 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 6.8 p90 38.13 -142.02 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.475 1.11 . . . . 0.0 113.646 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.49 112.05 3.41 Favored Glycine 0 C--N 1.339 0.729 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.076 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.21 -57.41 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.005 0.431 . . . . 0.0 109.846 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.4 m -43.2 -54.81 4.29 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.346 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -97.32 120.38 37.59 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.067 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -94.98 -84.17 0.34 Allowed 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.641 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -103.96 108.35 19.66 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.749 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.509 ' HB2' ' CG ' ' B' ' 68' ' ' GLU . 93.2 mttt -150.15 134.29 17.09 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 169.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.96 126.51 51.05 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.127 0.489 . . . . 0.0 110.805 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.557 ' CZ3' HG22 ' B' ' 91' ' ' ILE . 25.1 p-90 -145.02 159.34 43.09 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.721 176.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -122.09 147.82 17.09 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.166 -175.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.546 HD11 ' CD2' ' B' ' 64' ' ' TYR . 16.4 mt -105.11 148.76 9.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 169.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.681 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 88.9 m-85 -128.35 141.28 51.47 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -169.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.539 HG11 ' ND2' ' B' ' 59' ' ' ASN . 7.9 p -128.12 136.57 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.539 ' ND2' HG11 ' B' ' 58' ' ' VAL . 3.3 m-80 62.43 12.82 5.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.276 -171.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.94 78.92 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.075 -174.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 17.2 mt-10 -98.25 175.31 6.12 Favored 'General case' 0 C--O 1.202 -1.429 0 C-N-CA 123.517 0.727 . . . . 0.0 109.357 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.0 tppp? -63.4 160.56 15.9 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 118.681 0.673 . . . . 0.0 109.956 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.445 ' N ' ' HG3' ' B' ' 62' ' ' LYS . 7.2 p -151.47 -16.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.965 0.412 . . . . 0.0 110.168 167.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.662 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.9 OUTLIER -161.5 125.74 3.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.148 -171.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 22.7 m -131.36 129.44 41.39 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.642 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.441 ' CD1' ' CD1' ' B' ' 64' ' ' TYR . 7.7 p90 -167.83 153.66 7.34 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 122.186 0.993 . . . . 0.0 112.567 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.49 ' O ' ' HB3' ' B' ' 70' ' ' SER . 16.6 t-20 -99.81 153.14 19.37 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.151 -1.84 . . . . 0.0 108.962 171.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . 0.509 ' CG ' ' HB2' ' B' ' 52' ' ' LYS . 6.7 mm-40 -62.03 -45.67 92.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.969 0.349 . . . . 0.0 111.423 -176.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.514 ' O ' HG22 ' B' ' 71' ' ' THR . 86.4 tttt -64.71 -22.22 66.93 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.454 0.702 . . . . 0.0 111.547 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 6.2 t -69.44 -16.74 63.55 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.514 HG22 ' O ' ' B' ' 69' ' ' LYS . 30.2 p 59.18 107.78 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.888 1.275 . . . . 0.0 112.915 172.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.4 HG13 ' CD2' ' B' ' 66' ' ' PHE . 2.3 m -58.34 -17.85 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 114.266 -1.333 . . . . 0.0 112.635 -171.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.37 -48.97 80.75 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.682 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -74.5 -34.21 63.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.465 0.65 . . . . 0.0 110.191 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.477 ' HB ' ' OH ' ' B' ' 64' ' ' TYR . 1.9 mt -74.68 -48.45 34.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.085 -173.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 77.7 p -50.62 -48.75 57.89 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.583 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -41.62 -52.57 3.76 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.751 -1.568 . . . . 0.0 111.216 173.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.688 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 22.7 m-20 -74.28 -28.83 61.38 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.429 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.662 HG13 ' CE1' ' B' ' 64' ' ' TYR . 48.8 mm -71.88 -38.12 63.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.142 0.496 . . . . 0.0 111.199 177.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' B' ' 37' ' ' LYS . 11.3 m120 -62.88 -28.37 70.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.373 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 61.1 pttt -81.59 3.41 25.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.446 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' B' ' 79' ' ' ILE . 36.8 mt -84.77 3.89 35.45 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.726 0.298 . . . . 0.0 110.862 -177.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 58.9 t30 54.15 58.03 5.38 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -170.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.416 ' CG2' ' HG2' ' B' ' 35' ' ' GLN . 61.7 mt -52.31 149.88 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.726 -173.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -109.22 175.14 5.56 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.573 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.54 ' CA ' ' HB2' ' B' ' 34' ' ' ASN . . . -141.97 112.94 0.78 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.472 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.547 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 0.2 OUTLIER -146.1 -81.21 0.15 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 117.021 0.41 . . . . 0.0 110.595 175.536 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . 0.547 ' N ' ' HG3' ' B' ' 87' ' ' MET . 46.8 t80 -120.16 106.24 11.75 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.681 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 22.0 mm -101.11 130.55 50.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.092 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -122.89 178.58 4.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.188 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.557 HG22 ' CZ3' ' B' ' 54' ' ' TRP . 95.8 mt -149.98 127.76 2.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.29 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -174.36 154.2 2.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.98 0.419 . . . . 0.0 111.615 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.536 ' H ' ' NE2' ' B' ' 93' ' ' GLN . 0.7 OUTLIER -82.68 146.43 29.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.087 177.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.503 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.2 pt . . . . . 0 C--O 1.249 1.064 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.95 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' MET . . . . . 0.612 ' HG2' ' H ' ' B' ' 89' ' ' ILE . 15.1 tpt . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -54.04 -28.63 39.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.22 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.536 ' O ' HG23 ' B' ' 16' ' ' VAL . 6.2 m -75.2 -16.63 60.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.397 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.517 HG21 ' SD ' ' B' ' 31' ' ' MET . 6.3 mm -57.45 -44.06 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 122.313 1.054 . . . . 0.0 109.03 175.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -70.32 -30.67 67.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.536 -1.666 . . . . 0.0 109.792 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.48 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 10.7 t -70.96 -38.04 72.81 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.903 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.536 HG23 ' O ' ' B' ' 12' ' ' SER . 93.3 t -51.01 -50.55 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.397 0.618 . . . . 0.0 109.816 174.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -59.02 -49.46 77.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.871 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -30.86 68.32 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -174.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' B' ' 15' ' ' SER . 10.0 mmmm -76.85 -23.65 52.7 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.464 0.649 . . . . 0.0 111.381 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 92.0 mt -97.36 -42.11 7.92 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.181 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -84.95 73.46 10.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.395 0.616 . . . . 0.0 110.184 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -116.72 -74.38 0.61 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.504 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.49 40.65 0.82 Allowed Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.723 ' HG2' ' CE1' ' B' ' 49' ' ' TYR . 44.4 mttt -110.7 -145.48 0.4 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.489 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -70.09 154.2 52.51 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' B' ' 40' ' ' SER . 0.3 OUTLIER -61.91 121.67 13.52 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.452 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 28.8 tp -148.23 97.46 2.78 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.481 0.658 . . . . 0.0 109.256 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 43.0 m -99.12 116.24 30.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.788 -175.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.452 ' CD1' ' HG ' ' B' ' 27' ' ' LEU . 10.2 mp -101.67 167.27 10.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.555 0.693 . . . . 0.0 111.838 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.488 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 1.3 p -149.38 146.26 27.4 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.802 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' MET . . . . . 0.517 ' SD ' HG21 ' B' ' 13' ' ' ILE . 5.7 mmt -105.8 118.26 36.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.562 -169.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . 0.425 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 4.0 t30 -133.5 60.76 1.69 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.882 0.373 . . . . 0.0 110.009 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.88 -104.11 0.12 Allowed Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.606 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.481 ' HA ' ' N ' ' B' ' 86' ' ' GLY . 17.9 m120 -85.02 23.19 1.26 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.687 -0.257 . . . . 0.0 111.07 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 35.3 mt-30 -138.73 150.84 46.58 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.437 0.636 . . . . 0.0 110.595 172.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -123.94 114.65 20.09 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.162 172.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.488 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 6.7 mmmm -110.73 137.78 47.96 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -176.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -162.28 154.2 18.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.28 0.562 . . . . 0.0 112.329 -172.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.33 146.15 51.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.389 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 33.6 p -135.67 154.98 51.11 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.004 0.431 . . . . 0.0 112.031 -175.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 28.1 t -152.95 159.37 42.94 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.152 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . 0.47 ' C ' ' H ' ' B' ' 44' ' ' GLY . 51.3 m-80 -85.76 52.82 2.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.114 -174.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.21 23.22 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.856 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' B' ' 42' ' ' ASN . . . 117.39 -13.19 13.74 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.784 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.489 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 35.7 p90 45.2 -156.98 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.403 1.081 . . . . 0.0 113.136 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.63 89.97 0.55 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.91 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.462 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -91.68 -70.85 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.541 0.686 . . . . 0.0 110.509 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 m -50.34 -55.88 13.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.987 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.723 ' CE1' ' HG2' ' B' ' 24' ' ' LYS . 4.3 m-85 -61.48 109.69 1.24 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.605 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.29 -64.44 0.95 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.543 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -173.05 113.09 0.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.734 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 54.1 mtmt -138.31 145.34 41.09 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.505 ' HB3' ' OD1' ' B' ' 67' ' ' ASN . 0.5 OUTLIER -121.82 121.96 38.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.226 0.536 . . . . 0.0 111.623 -178.194 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.57 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 33.4 p-90 -140.23 173.74 11.21 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.229 174.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.98 151.79 21.12 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.907 -1.14 . . . . 0.0 113.372 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.504 HD11 ' CD2' ' B' ' 64' ' ' TYR . 18.2 mt -110.12 145.92 16.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 174.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.753 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 72.8 m-85 -128.88 143.66 50.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.282 -171.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.541 HG12 ' ND2' ' B' ' 59' ' ' ASN . 9.6 p -128.47 137.34 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.541 ' ND2' HG12 ' B' ' 58' ' ' VAL . 1.4 m-80 60.27 9.02 1.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.277 0.631 . . . . 0.0 110.494 -176.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.77 7.87 57.45 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.232 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 12.1 mt-10 -114.62 177.02 4.8 Favored 'General case' 0 C--O 1.199 -1.592 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.569 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 18.6 ttmt -78.89 169.21 18.58 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 119.303 0.956 . . . . 0.0 109.924 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.53 -14.96 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.798 164.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.647 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.5 OUTLIER -158.4 130.07 6.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.601 -167.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.2 m -137.96 133.3 33.54 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.218 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.458 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.0 OUTLIER -159.35 160.97 35.63 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.953 0.882 . . . . 0.0 111.21 -174.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.505 ' OD1' ' HB3' ' B' ' 53' ' ' ASN . 2.9 m120 -115.96 146.78 41.81 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.624 -1.626 . . . . 0.0 109.787 170.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . 0.487 ' CD ' ' HZ1' ' B' ' 24' ' ' LYS . 13.4 mm-40 -56.35 -44.27 79.92 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.614 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.527 ' O ' HG21 ' B' ' 71' ' ' THR . 35.0 ttpt -64.01 -30.09 71.19 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.611 0.72 . . . . 0.0 110.621 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 23.7 m -81.27 -3.35 52.18 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.091 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.527 HG21 ' O ' ' B' ' 69' ' ' LYS . 23.6 p 55.21 102.01 0.01 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.304 1.442 . . . . 0.0 113.474 165.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 4.2 m -62.94 -18.88 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.425 -173.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.42 -49.58 75.09 Favored Glycine 0 C--O 1.236 0.241 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.974 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -69.62 -37.52 76.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.023 0.439 . . . . 0.0 110.268 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.552 ' O ' HG12 ' B' ' 79' ' ' ILE . 2.7 mt -68.21 -46.61 80.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.609 -176.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 45.6 m -57.02 -35.5 69.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.933 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -54.74 -49.17 71.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.169 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 7.3 m-20 -70.51 -37.49 74.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.558 -1.201 . . . . 0.0 112.122 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.647 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 43.7 mm -59.02 -24.4 26.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.482 0.658 . . . . 0.0 111.443 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -59.95 -18.66 47.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.508 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 6.0 ptpp? -87.11 1.32 53.36 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.172 0.51 . . . . 0.0 110.851 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 2.4 mm? -81.38 -1.66 46.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.156 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 49.54 62.35 2.68 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.798 -168.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.466 HD13 HG23 ' B' ' 79' ' ' ILE . 49.0 mt -58.71 140.77 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.71 -177.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -127.37 -176.76 3.84 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.796 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.481 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -136.89 115.53 1.27 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.872 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 32.7 ttm -157.79 -74.99 0.09 Allowed 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -130.77 82.51 2.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.415 0.626 . . . . 0.0 109.503 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.753 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.2 mp -87.67 136.68 22.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.518 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -122.08 171.78 8.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.888 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.483 HG22 ' CZ3' ' B' ' 54' ' ' TRP . 32.9 mm -144.93 110.1 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.33 -174.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 16.6 pttp -161.04 173.18 15.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.291 0.567 . . . . 0.0 112.042 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.497 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.0 OUTLIER -105.49 145.79 30.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.882 -175.03 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.525 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.7 pt . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.95 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -60.28 -33.36 72.23 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.967 0.413 . . . . 0.0 111.805 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.417 ' O ' HG23 ' B' ' 16' ' ' VAL . 23.2 t -67.84 -8.45 36.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.031 -169.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 10.2 mm -55.41 -55.11 18.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.935 0.874 . . . . 0.0 110.12 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -77.56 -27.7 51.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.355 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 10.1 m -57.6 -47.05 83.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.116 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 12' ' ' SER . 76.1 t -66.46 -43.91 90.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.085 0.469 . . . . 0.0 109.978 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . 0.485 HD21 HD11 ' B' ' 29' ' ' LEU . 3.8 t-20 -54.08 -50.77 66.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.986 178.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.38 -43.21 64.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.648 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -57.24 -50.89 71.45 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 123.204 0.602 . . . . 0.0 111.593 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -70.69 -45.24 65.38 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.827 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -85.97 59.78 5.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.389 0.614 . . . . 0.0 111.369 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -105.23 -17.34 14.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.328 0.585 . . . . 0.0 109.914 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.83 -95.16 0.1 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.51 ' HE3' ' OE2' ' B' ' 68' ' ' GLU . 51.3 mttp 41.65 -135.1 0.29 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.688 0.795 . . . . 0.0 111.197 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.602 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -84.42 168.15 43.85 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.785 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.414 ' HE3' ' CB ' ' B' ' 41' ' ' SER . 14.7 ttpt -86.27 109.84 19.23 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -145.52 168.31 20.91 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.161 -176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 43.9 m -125.66 107.11 10.25 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.759 -176.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.485 HD11 HD21 ' B' ' 17' ' ' ASN . 33.1 mt -86.87 144.91 26.78 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.556 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 9.0 p -134.78 156.69 48.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.964 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 55.0 mtm -110.04 127.99 55.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.991 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -148.89 108.33 3.96 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.04 -114.62 6.92 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.54 ' HB2' ' HA2' ' B' ' 86' ' ' GLY . 1.7 m-20 -123.9 20.03 9.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -74.69 158.78 32.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.528 -176.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tt -115.93 104.01 11.18 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.391 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.556 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 4.7 mtmp? -115.59 142.63 46.47 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -158.91 156.61 29.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -175.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -130.56 134.65 47.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 170.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 44.6 t -126.33 160.07 31.41 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -164.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.414 ' CB ' ' HE3' ' B' ' 26' ' ' LYS . 35.2 t -134.4 159.97 39.41 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.007 174.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -109.25 29.63 7.35 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.276 0.56 . . . . 0.0 110.727 -171.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.03 22.4 0.09 Allowed 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.961 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.75 -38.3 0.57 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.409 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.602 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 14.4 p90 45.56 -159.48 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.471 1.108 . . . . 0.0 113.758 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.17 114.83 6.03 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.974 -0.632 . . . . 0.0 113.118 -175.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.11 -60.81 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.837 0.351 . . . . 0.0 110.815 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 m -40.66 -57.23 1.93 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.077 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.81 106.15 10.61 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.784 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -60.0 -49.22 78.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.651 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -165.32 110.77 0.91 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.985 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 71.8 mmtt -133.51 131.93 40.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -112.73 125.77 54.68 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.501 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 16.7 p-90 -152.7 166.74 31.2 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.886 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.33 142.6 13.88 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.846 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.554 HD12 ' CD2' ' B' ' 64' ' ' TYR . 23.7 mt -106.59 151.37 8.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.667 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 76.0 m-85 -132.59 140.29 48.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.277 -170.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.457 ' HA ' HD12 ' B' ' 89' ' ' ILE . 11.9 p -124.85 131.42 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.447 ' ND2' HG13 ' B' ' 58' ' ' VAL . 2.8 m-80 64.25 11.49 6.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.51 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.96 -3.74 62.55 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.348 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -103.01 177.15 4.92 Favored 'General case' 0 C--O 1.207 -1.152 0 C-N-CA 123.303 0.641 . . . . 0.0 109.642 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.464 ' HD2' ' HG1' ' B' ' 65' ' ' THR . 5.2 tppp? -63.87 158.76 21.22 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.014 175.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.419 ' N ' ' HG3' ' B' ' 62' ' ' LYS . 9.8 p -153.23 -11.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.122 0.487 . . . . 0.0 110.245 165.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.796 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -161.21 136.25 7.52 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.061 0.458 . . . . 0.0 110.53 -174.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.464 ' HG1' ' HD2' ' B' ' 62' ' ' LYS . 84.8 m -149.25 118.47 6.81 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.49 ' N ' ' HD1' ' B' ' 66' ' ' PHE . 0.0 OUTLIER -167.74 159.76 12.04 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.717 0.77 . . . . 0.0 111.462 -164.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 18.1 t-20 -114.04 158.8 20.74 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.915 -1.493 . . . . 0.0 109.591 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . 0.51 ' OE2' ' HE3' ' B' ' 24' ' ' LYS . 8.5 mm-40 -74.06 -34.14 63.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.004 0.43 . . . . 0.0 110.898 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.54 ' O ' HG21 ' B' ' 71' ' ' THR . 53.0 tttm -68.94 -31.69 70.76 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.049 0.928 . . . . 0.0 109.319 176.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 30.4 m -79.62 0.3 30.74 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.843 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.54 HG21 ' O ' ' B' ' 69' ' ' LYS . 20.1 p 53.64 100.58 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.436 1.494 . . . . 0.0 113.678 165.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 m -56.68 -21.77 14.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.069 -176.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.67 -54.64 35.73 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.544 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -69.4 -31.93 70.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.202 0.525 . . . . 0.0 110.172 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.513 HG13 ' O ' ' B' ' 71' ' ' THR . 2.9 mt -70.11 -42.61 79.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.239 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -58.02 -30.25 65.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.752 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -52.6 -53.32 48.31 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.767 0.794 . . . . 0.0 109.633 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.666 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 4.9 m-20 -65.1 -40.67 94.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.461 177.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.796 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 44.5 mm -54.31 -32.33 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.314 0.578 . . . . 0.0 111.817 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.458 ' OD1' ' HA ' ' B' ' 37' ' ' LYS . 90.5 m-20 -58.43 -31.22 67.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.816 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.666 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 4.6 ptpp? -83.43 -4.48 58.54 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.163 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.8 mm? -70.32 -15.83 62.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.717 0.294 . . . . 0.0 110.667 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 44.01 61.66 2.25 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.813 -171.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.434 HG22 ' O ' ' B' ' 85' ' ' LYS . 73.0 mt -60.04 146.37 10.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.362 -1.29 . . . . 0.0 112.6 -172.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.434 ' O ' HG22 ' B' ' 84' ' ' ILE . 30.0 mmmt -92.11 -166.07 1.48 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.132 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.54 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -148.55 114.16 0.66 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.808 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.48 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 6.2 tpt -152.42 -68.89 0.16 Allowed 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 122.531 0.333 . . . . 0.0 110.124 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . 0.48 ' N ' ' HG3' ' B' ' 87' ' ' MET . 5.1 t80 -143.41 106.57 4.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.072 0.463 . . . . 0.0 109.835 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.667 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 37.0 mm -91.85 130.28 41.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.04 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -121.65 169.47 10.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.793 0.33 . . . . 0.0 110.154 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.404 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 70.5 mt -146.72 130.28 9.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.24 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 39.9 pttt -165.03 159.57 18.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.124 0.488 . . . . 0.0 111.42 174.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.485 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -106.69 138.78 42.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.863 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.49 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.2 pt . . . . . 0 C--O 1.246 0.88 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.042 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' MET . . . . . 0.406 ' O ' HG12 ' B' ' 13' ' ' ILE . 90.3 mmm . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 121.672 0.748 . . . . 0.0 112.108 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -51.11 -27.52 8.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.865 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 5.1 m -66.6 -31.07 71.53 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.288 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.406 HG12 ' O ' ' B' ' 10' ' ' MET . 11.4 mm -63.77 -31.0 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.647 0.737 . . . . 0.0 109.888 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -92.09 -44.36 8.87 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.812 -172.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 14.5 p -70.89 -45.24 64.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.095 -178.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 91.4 t -68.51 -30.14 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.585 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -53.79 -47.17 71.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.258 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.1 OUTLIER -78.95 -42.63 26.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.619 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -58.65 -43.05 89.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.401 -176.101 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.452 ' HB3' HG23 ' B' ' 72' ' ' VAL . 19.7 mt -80.24 -24.24 40.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -105.62 70.93 0.89 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.818 0.342 . . . . 0.0 111.249 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 33.6 mtmt -138.31 -91.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.817 175.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.432 ' O ' ' HA2' ' B' ' 46' ' ' GLY . . . -92.93 32.42 5.64 Favored Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.554 ' HD2' ' N ' ' B' ' 24' ' ' LYS . 0.0 OUTLIER -124.27 -163.08 1.12 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 174.119 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.636 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -67.96 144.97 44.16 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.184 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' B' ' 40' ' ' SER . 44.7 mttm -62.2 144.5 55.41 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.41 ' CD2' ' HB3' ' B' ' 40' ' ' SER . 4.0 mt -150.07 118.45 6.45 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.118 0.485 . . . . 0.0 110.91 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 14.4 m -99.06 97.97 9.04 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.338 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 10.4 mp -86.14 163.0 18.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.797 0.808 . . . . 0.0 112.094 -172.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.1 p -146.69 148.82 32.41 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.111 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 58.0 mtt -96.49 139.7 32.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.106 0.479 . . . . 0.0 111.68 -173.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' B' ' 35' ' ' GLN . 8.6 t30 -157.15 91.92 1.22 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.833 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.98 -97.55 0.51 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -172.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -142.1 21.61 2.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.551 ' CG ' ' HG2' ' B' ' 37' ' ' LYS . 0.0 OUTLIER -85.71 158.27 20.09 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.893 -176.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.407 ' H ' ' NE2' ' B' ' 35' ' ' GLN . 2.8 tt -111.85 98.06 7.12 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.887 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.551 ' HG2' ' CG ' ' B' ' 35' ' ' GLN . 11.1 mtmt -112.1 137.17 50.53 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.4 169.96 4.3 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -170.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 5.8 p -128.17 140.34 51.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.591 170.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 74.1 p -123.66 165.41 17.26 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -169.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.431 ' HB3' ' HB2' ' B' ' 26' ' ' LYS . 32.3 t -131.62 157.98 42.26 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.481 176.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -117.04 18.31 14.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.331 -172.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.64 -21.86 66.59 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.549 ' O ' HD11 ' B' ' 47' ' ' ILE . . . -143.14 -48.6 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.099 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.636 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 3.4 p90 52.93 -164.55 0.08 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.966 1.306 . . . . 0.0 113.852 -176.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.519 ' N ' ' HD1' ' B' ' 45' ' ' TYR . . . -57.87 100.12 0.13 Allowed Glycine 0 C--N 1.342 0.88 0 N-CA-C 114.601 0.6 . . . . 0.0 114.601 -174.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.549 HD11 ' O ' ' B' ' 44' ' ' GLY . 3.8 mm -108.53 -67.81 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-O 121.59 0.71 . . . . 0.0 110.777 173.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -51.16 -62.62 1.51 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.579 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -83.48 127.01 33.37 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.772 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.69 -171.97 1.73 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.18 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -65.53 107.07 1.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.368 0.604 . . . . 0.0 109.706 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 6.4 mtmp? -145.4 128.83 16.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.621 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -102.73 124.85 49.02 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.532 0.682 . . . . 0.0 112.357 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.591 ' CZ3' HG22 ' B' ' 91' ' ' ILE . 51.4 p-90 -141.15 163.7 32.26 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.368 169.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.82 156.8 23.02 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 119.772 -1.204 . . . . 0.0 113.317 -172.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.432 HD13 ' CD2' ' B' ' 64' ' ' TYR . 22.1 mt -111.82 137.74 43.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 174.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.713 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 46.0 m-85 -124.77 132.12 53.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.014 -174.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.535 HG12 ' ND2' ' B' ' 59' ' ' ASN . 13.4 p -112.48 136.27 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.916 177.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.535 ' ND2' HG12 ' B' ' 58' ' ' VAL . 9.9 m-80 71.04 -7.93 1.05 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.538 0.735 . . . . 0.0 110.905 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.25 5.9 39.76 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -169.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' B' ' 58' ' ' VAL . 25.9 mt-10 -106.55 165.76 11.05 Favored 'General case' 0 C--O 1.198 -1.642 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 174.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.476 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 27.8 ttmt -78.5 168.93 19.05 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.403 HG12 ' O ' ' B' ' 62' ' ' LYS . 0.0 OUTLIER -155.82 -10.08 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.326 165.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.614 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.5 OUTLIER -158.1 125.79 5.2 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.413 -170.169 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -134.42 132.2 39.07 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.178 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.439 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.0 OUTLIER -163.76 165.97 22.53 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 122.161 0.981 . . . . 0.0 111.162 -175.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.613 ' HB2' ' OG ' ' B' ' 70' ' ' SER . 12.0 m120 -116.72 144.63 44.21 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.493 169.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -64.67 -15.8 61.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.824 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -92.82 -25.28 18.2 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.252 0.549 . . . . 0.0 109.846 177.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.613 ' OG ' ' HB2' ' B' ' 67' ' ' ASN . 38.2 m -76.98 -5.57 49.17 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.458 -175.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' THR . . . . . . . . . . . . . 3.3 p 66.27 99.84 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.741 169.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' B' ' 20' ' ' LEU . 7.8 m -65.67 -13.11 14.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.45 -176.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.55 -51.95 51.28 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.1 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -67.94 -42.68 80.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.312 0.577 . . . . 0.0 110.263 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.482 ' O ' HG12 ' B' ' 79' ' ' ILE . 2.6 mt -64.97 -42.03 93.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.54 -174.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 55.7 m -59.13 -30.29 68.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.229 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' B' ' 80' ' ' ASN . 46.9 t-20 -52.39 -54.6 29.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.607 0.718 . . . . 0.0 109.388 174.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.66 -39.49 94.46 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.634 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.614 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 48.4 mm -58.67 -33.54 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 123.021 0.528 . . . . 0.0 112.085 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' B' ' 77' ' ' ASN . 5.7 m-80 -54.81 -35.89 64.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.558 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -78.46 -14.07 59.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.782 0.325 . . . . 0.0 111.111 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 3.7 mm? -65.56 -22.58 66.71 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.558 -173.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 55.9 t30 46.01 57.58 5.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.938 -172.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' B' ' 35' ' ' GLN . 88.6 mt -59.38 141.98 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.203 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -87.44 -164.13 1.04 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.273 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -150.35 115.26 0.7 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.027 -1.082 . . . . 0.0 113.322 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 28.4 ttp -154.06 -75.2 0.12 Allowed 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.565 0.183 . . . . 0.0 110.591 172.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . 0.441 ' H ' ' HA ' ' B' ' 59' ' ' ASN . 44.7 t80 -121.49 93.45 4.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.192 0.52 . . . . 0.0 109.925 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.713 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.0 mp -95.32 128.95 46.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.795 -177.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.52 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 43.3 mt-10 -114.15 144.36 43.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.29 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.591 HG22 ' CZ3' ' B' ' 54' ' ' TRP . 50.0 mm -126.23 112.4 29.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.99 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -166.49 158.39 13.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.477 0.656 . . . . 0.0 112.424 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.522 ' CD ' ' H ' ' B' ' 93' ' ' GLN . 4.5 pm0 -79.27 145.99 33.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.78 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.487 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.9 pt . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.254 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' MET . . . . . 0.428 ' O ' HG13 ' B' ' 13' ' ' ILE . 98.5 mmm . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -37.96 -24.93 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.887 1.675 . . . . 0.0 114.848 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.518 ' O ' HG23 ' B' ' 16' ' ' VAL . 8.8 m -61.87 -9.14 6.05 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.428 HG13 ' O ' ' B' ' 10' ' ' MET . 0.1 OUTLIER -51.27 -58.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 CA-C-O 122.008 0.909 . . . . 0.0 110.112 -177.312 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -79.39 -27.74 41.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.204 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.618 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 15.1 m -61.11 -39.14 88.86 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 12' ' ' SER . 99.0 t -69.06 -45.4 80.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.27 0.557 . . . . 0.0 109.866 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -52.43 -49.02 65.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.699 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.3 -31.86 60.8 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.78 -176.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.618 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.3 OUTLIER -61.82 -44.97 95.79 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 122.812 0.445 . . . . 0.0 111.406 177.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 72.5 mt -81.53 -39.27 24.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.659 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -81.48 70.82 8.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.037 0.446 . . . . 0.0 111.33 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -144.33 -72.26 0.27 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.264 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.405 ' O ' ' HA2' ' B' ' 46' ' ' GLY . . . -119.01 44.75 1.35 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.072 -176.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -111.92 -158.05 0.64 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.662 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -83.27 -166.66 40.17 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.347 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.819 ' O ' ' HA ' ' B' ' 40' ' ' SER . 44.7 mtmt -67.84 98.57 0.74 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' B' ' 39' ' ' THR . 21.0 tp -124.88 115.7 21.05 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.23 -163.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 51.4 m -105.61 105.86 16.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.387 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.424 HD23 ' N ' ' B' ' 29' ' ' LEU . 2.5 mm? -83.31 149.57 26.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.313 0.578 . . . . 0.0 110.376 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p -146.27 147.47 31.44 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.36 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 62.0 mtt -116.42 145.34 43.33 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.103 0.478 . . . . 0.0 111.796 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -160.3 105.78 1.51 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.66 -122.81 18.09 Favored Glycine 0 CA--C 1.503 -0.681 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -167.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.477 HD21 ' CG1' ' B' ' 89' ' ' ILE . 2.0 m-20 -119.31 25.2 10.27 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.48 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 48.7 mt-30 -79.42 156.34 27.95 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.74 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -114.77 88.2 2.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.127 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.473 ' HA ' ' ND2' ' B' ' 80' ' ' ASN . 27.4 mtpt -96.37 141.05 30.16 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -171.45 160.64 6.07 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -171.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 2.1 p -134.85 143.73 47.18 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.713 171.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.819 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 9.9 t -144.87 149.19 34.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.438 0.637 . . . . 0.0 111.965 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.463 ' CB ' ' HE3' ' B' ' 26' ' ' LYS . 6.8 m -111.98 163.83 13.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.561 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -113.08 33.78 4.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.02 -173.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.45 -1.53 30.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.032 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.63 -43.67 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.662 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 31.2 p90 43.75 -154.62 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.884 1.274 . . . . 0.0 114.281 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' B' ' 23' ' ' GLY . . . -77.11 107.94 2.48 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.681 -173.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.71 -54.92 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.338 0.589 . . . . 0.0 110.276 176.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.1 m -34.36 -57.8 0.49 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.098 -1.41 . . . . 0.0 114.323 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -75.06 -5.8 46.04 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.136 -173.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' B' ' 69' ' ' LYS . 46.3 mt-10 54.99 -92.39 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 123.498 0.499 . . . . 0.0 110.297 -168.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -136.31 110.09 8.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.589 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 33.7 mmtp -131.92 138.89 48.54 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -114.0 130.62 56.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.912 0.387 . . . . 0.0 110.053 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.506 ' HA ' HG12 ' B' ' 94' ' ' ILE . 18.5 p-90 -146.07 168.58 20.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.895 175.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -133.25 144.0 15.83 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.776 -174.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.448 HD12 ' CD2' ' B' ' 64' ' ' TYR . 15.6 mt -107.82 148.01 12.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 171.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.687 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 71.5 m-85 -129.57 136.76 50.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.51 -171.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' B' ' 61' ' ' GLU . 10.6 p -122.44 135.82 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.461 ' ND2' HG12 ' B' ' 58' ' ' VAL . 2.1 m-80 60.7 14.24 4.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.389 -172.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.65 -18.3 57.52 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.458 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' B' ' 58' ' ' VAL . 0.6 OUTLIER -87.92 165.61 15.12 Favored 'General case' 0 C--O 1.194 -1.821 0 C-N-CA 123.795 0.838 . . . . 0.0 108.831 -179.026 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.621 ' HA ' ' CD1' ' B' ' 57' ' ' PHE . 2.2 tttt -65.23 164.8 12.63 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 120.529 -0.469 . . . . 0.0 109.827 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.453 ' HB ' HG13 ' B' ' 58' ' ' VAL . 7.5 p -154.5 -13.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.084 0.468 . . . . 0.0 110.481 172.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.766 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.7 OUTLIER -159.65 124.56 4.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.215 0.531 . . . . 0.0 110.913 -171.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 21.3 m -131.9 127.92 37.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.102 176.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' B' ' 66' ' ' PHE . 0.0 OUTLIER -168.31 149.42 4.97 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.171 0.986 . . . . 0.0 111.872 -171.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.492 ' O ' ' HB3' ' B' ' 70' ' ' SER . 26.4 t-20 -103.39 146.82 27.92 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.165 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -67.59 -21.7 65.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.775 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.479 ' O ' HG22 ' B' ' 71' ' ' THR . 1.5 tmtp? -88.05 -23.28 23.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.361 0.601 . . . . 0.0 109.526 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 5.2 t -65.7 -27.31 68.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.979 172.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.489 ' O ' HG13 ' B' ' 75' ' ' ILE . 23.5 p 61.24 123.24 0.01 OUTLIER 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.004 1.322 . . . . 0.0 113.057 174.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.417 ' HB ' ' OG ' ' B' ' 76' ' ' SER . 12.3 m -62.93 -11.2 6.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 114.405 -1.271 . . . . 0.0 113.239 -170.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' B' ' 40' ' ' SER . . . -56.24 -54.21 37.39 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.267 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -73.41 -35.21 65.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.263 0.554 . . . . 0.0 110.127 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.489 HG13 ' O ' ' B' ' 71' ' ' THR . 1.6 mt -74.6 -55.74 11.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.723 -172.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.438 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 49.3 m -60.48 -30.64 69.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.863 -174.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -49.5 -52.19 31.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.83 0.824 . . . . 0.0 109.658 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.732 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 5.0 m-20 -67.31 -44.66 78.66 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.363 -1.289 . . . . 0.0 111.286 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.766 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 49.3 mm -50.82 -33.12 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.28 0.562 . . . . 0.0 112.26 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.473 ' ND2' ' HA ' ' B' ' 37' ' ' LYS . 0.9 OUTLIER -64.34 -29.27 70.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.919 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 49.7 pttt -81.39 -6.23 58.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.076 0.465 . . . . 0.0 110.549 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 4.2 mm? -73.57 -10.27 59.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.014 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 33.58 64.96 0.3 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.265 1.031 . . . . 0.0 111.113 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.48 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 60.3 mt -60.46 150.55 6.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 113.866 -1.516 . . . . 0.0 112.518 -170.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.419 ' O ' HG22 ' B' ' 84' ' ' ILE . 65.8 mttm -89.38 -177.16 5.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.286 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.76 112.87 0.72 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.898 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.486 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 7.6 tpt -151.87 -74.58 0.14 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.575 0.226 . . . . 0.0 110.575 176.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . 0.486 ' N ' ' HG3' ' B' ' 87' ' ' MET . 35.5 t80 -124.64 100.2 6.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.687 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 29.1 mm -100.98 120.31 50.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.732 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -111.61 -179.53 3.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.514 0.673 . . . . 0.0 110.959 174.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.429 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 83.9 mt -153.56 131.17 2.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.033 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.582 ' HE2' ' CE2' ' B' ' 57' ' ' PHE . 42.8 pttt -171.05 150.03 3.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.038 0.447 . . . . 0.0 111.3 176.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.476 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.8 OUTLIER -84.67 153.01 23.39 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.552 172.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.506 HG12 ' HA ' ' B' ' 54' ' ' TRP . 7.5 pt . . . . . 0 C--N 1.314 -0.957 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.089 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' MET . . . . . 0.481 ' O ' HG12 ' B' ' 13' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . 0.503 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 21.4 t-20 -50.87 -24.95 3.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -176.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.499 ' HA ' ' CG2' ' B' ' 16' ' ' VAL . 20.1 m -66.72 -14.83 63.02 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.276 -0.265 . . . . 0.0 111.69 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.481 HG12 ' O ' ' B' ' 10' ' ' MET . 16.0 mm -61.44 -52.64 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.015 0.436 . . . . 0.0 110.987 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -106.74 -63.02 1.32 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.024 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.46 ' HB3' ' OD1' ' B' ' 11' ' ' ASN . 32.6 t -59.61 -60.34 4.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.071 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.499 ' CG2' ' HA ' ' B' ' 12' ' ' SER . 47.4 t -57.78 -40.52 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.872 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.26 -51.23 70.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.07 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.55 -34.03 58.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.59 0.233 . . . . 0.0 111.518 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 13.1 tppt? -64.01 -47.74 79.07 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.465 0.65 . . . . 0.0 110.86 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.418 HD21 ' CZ ' ' B' ' 66' ' ' PHE . 28.3 mt -67.35 -46.68 72.67 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.774 176.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -88.12 53.9 2.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.191 0.52 . . . . 0.0 111.116 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' B' ' 19' ' ' LYS . 30.5 mtpp -83.9 -25.3 30.31 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 166.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.46 ' HA3' ' OH ' ' B' ' 49' ' ' TYR . . . 165.47 -93.94 0.11 Allowed Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 114.317 -1.311 . . . . 0.0 110.356 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.57 -125.12 0.38 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.511 0.724 . . . . 0.0 110.553 -176.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.59 137.37 15.23 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.758 ' O ' ' HA ' ' B' ' 40' ' ' SER . 41.0 mtmt -61.64 100.59 0.15 Allowed 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -177.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 43.9 tp -128.46 124.03 35.16 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 120.877 0.37 . . . . 0.0 110.06 -171.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.669 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 5.2 p -105.41 100.49 10.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.445 -176.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.441 HD22 ' N ' ' B' ' 29' ' ' LEU . 2.1 mm? -87.96 147.95 24.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.736 0.779 . . . . 0.0 111.439 -175.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.9 p -142.67 141.32 31.84 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.939 168.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.78 131.34 54.01 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.359 -173.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -140.2 68.35 1.36 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.97 -102.4 0.51 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.498 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' B' ' 84' ' ' ILE . 5.3 m-20 -79.28 -24.17 43.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.756 0.312 . . . . 0.0 111.043 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -94.96 147.1 23.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.958 0.885 . . . . 0.0 111.819 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 33.4 tp -128.59 99.49 5.39 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 113.973 -1.467 . . . . 0.0 107.674 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -95.82 137.81 34.36 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.983 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -160.97 156.73 25.23 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.143 -170.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.47 147.12 47.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 171.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.758 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 6.9 t -138.62 162.87 33.52 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 47.3 t -136.29 162.17 33.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.8 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -113.68 30.68 7.06 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.534 0.683 . . . . 0.0 109.619 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.18 21.45 0.13 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.112 -173.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.51 -32.66 0.58 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.731 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.535 ' CD1' HG23 ' B' ' 71' ' ' THR . 19.0 p90 44.22 -157.27 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.578 1.151 . . . . 0.0 113.365 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.426 ' N ' ' HD1' ' B' ' 45' ' ' TYR . . . -67.07 96.12 0.31 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.748 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.448 ' H ' HD13 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -91.2 -71.28 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.274 0.559 . . . . 0.0 110.593 -177.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.4 m -62.86 -48.61 78.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.202 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.46 ' OH ' ' HA3' ' B' ' 23' ' ' GLY . 11.5 m-85 -39.52 119.45 0.95 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.699 -1.591 . . . . 0.0 112.365 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -74.58 -171.15 1.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.22 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.5 109.39 13.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.731 0.777 . . . . 0.0 109.348 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.597 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 76.4 mttt -131.87 123.61 27.85 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.409 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.412 HD21 HG13 ' B' ' 94' ' ' ILE . 1.2 p-10 -111.18 118.48 36.08 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.454 0.645 . . . . 0.0 110.777 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.653 ' CZ3' HG22 ' B' ' 91' ' ' ILE . 40.5 p-90 -143.19 166.46 24.62 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.375 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.63 147.79 18.75 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.595 -174.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.455 HD11 ' CD2' ' B' ' 64' ' ' TYR . 18.4 mt -103.9 144.82 13.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 170.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 68.4 m-85 -125.15 141.06 52.34 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.493 -174.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.589 HG12 ' ND2' ' B' ' 59' ' ' ASN . 7.3 p -126.55 134.66 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.589 ' ND2' HG12 ' B' ' 58' ' ' VAL . 6.3 m-80 68.24 0.85 2.62 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.461 0.705 . . . . 0.0 109.297 -174.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.26 -0.9 50.47 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.588 -173.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 17.8 mt-10 -104.48 178.13 4.65 Favored 'General case' 0 C--O 1.203 -1.342 0 C-N-CA 124.018 0.927 . . . . 0.0 109.396 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.5 tppp? -65.98 161.07 22.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 118.765 0.711 . . . . 0.0 109.8 174.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.496 ' HB ' ' CG1' ' B' ' 58' ' ' VAL . 11.2 p -152.87 -18.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.094 0.473 . . . . 0.0 110.229 167.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.729 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.3 OUTLIER -160.66 127.95 4.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.94 0.4 . . . . 0.0 110.235 -171.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 6.1 m -135.16 129.09 33.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.527 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.455 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.1 OUTLIER -162.66 -176.47 5.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 122.357 1.075 . . . . 0.0 112.191 -174.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.9 t-20 -138.79 148.53 43.92 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 112.831 -1.986 . . . . 0.0 108.044 176.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -43.79 70.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.253 0.478 . . . . 0.0 111.79 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.475 ' O ' HG21 ' B' ' 71' ' ' THR . 58.4 mtpt -78.88 -16.26 57.27 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.853 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 3.2 t -73.28 -20.17 60.89 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.535 HG23 ' CD1' ' B' ' 45' ' ' TYR . 19.3 p 58.64 109.55 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.594 1.157 . . . . 0.0 112.533 170.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 m -61.43 -10.88 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.431 -169.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.75 -56.93 21.49 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.193 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -69.32 -31.31 69.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.307 0.575 . . . . 0.0 110.313 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.481 HG13 ' O ' ' B' ' 71' ' ' THR . 3.2 mt -70.5 -48.79 57.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.93 -177.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 34.2 t -56.38 -33.74 66.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.095 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -50.63 -54.74 20.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.695 0.76 . . . . 0.0 110.162 175.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.564 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 34.7 m-20 -64.79 -44.55 89.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.405 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.729 HG13 ' CE1' ' B' ' 64' ' ' TYR . 42.5 mm -55.47 -30.46 25.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -176.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -59.37 -25.24 64.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.7 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 16.4 ptmt -85.65 -3.36 58.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.727 0.298 . . . . 0.0 111.304 -175.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.2 mm? -73.8 -11.9 60.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.55 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 52.26 65.84 1.39 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.812 0.815 . . . . 0.0 109.068 -169.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' B' ' 34' ' ' ASN . 65.5 mt -57.49 156.54 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.504 -1.226 . . . . 0.0 111.484 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.438 ' HB2' HD22 ' B' ' 59' ' ' ASN . 86.7 mttt -113.66 -178.09 3.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.269 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.31 112.14 0.72 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.76 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.601 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 5.6 tpt -154.79 -72.7 0.12 Allowed 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 120.491 0.186 . . . . 0.0 110.873 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . 0.601 ' N ' ' HG3' ' B' ' 87' ' ' MET . 75.9 t80 -134.48 116.73 15.45 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.668 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 21.3 mm -104.96 145.21 13.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.458 -177.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 33.4 mm-40 -135.97 156.29 48.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.38 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.653 HG22 ' CZ3' ' B' ' 54' ' ' TRP . 67.8 mt -135.13 126.21 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.738 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -175.24 153.13 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.699 0.285 . . . . 0.0 111.533 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -75.71 150.92 37.76 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.325 0.583 . . . . 0.0 111.209 175.555 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.7 pt . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.459 -0.781 . . . . 0.0 111.634 -172.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' MET . . . . . 0.42 ' C ' HD13 ' B' ' 13' ' ' ILE . 77.4 mmm . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 121.544 0.687 . . . . 0.0 111.643 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -109.61 -18.59 13.45 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.512 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -59.39 -21.12 59.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.829 0.823 . . . . 0.0 109.668 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.494 ' CD1' ' H ' ' B' ' 13' ' ' ILE . 1.4 mp -61.91 -34.41 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.354 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -106.7 -62.92 1.33 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.709 -173.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 49.8 m -66.12 -59.93 3.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.555 -172.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 70.6 t -55.82 -46.25 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.928 0.394 . . . . 0.0 111.359 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -56.28 -46.4 79.76 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.719 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.43 -42.72 58.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.786 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -61.89 -47.47 84.84 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 123.458 0.703 . . . . 0.0 111.936 -175.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.435 HD23 HG11 ' B' ' 72' ' ' VAL . 64.0 mt -75.53 -19.48 59.32 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.778 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -104.29 79.1 1.56 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.01 0.434 . . . . 0.0 110.323 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -130.17 19.86 5.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.572 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.49 25.63 7.65 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.389 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.622 ' HG2' ' CZ ' ' B' ' 49' ' ' TYR . 43.3 mttt -98.35 -140.02 0.3 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.606 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -65.52 142.66 44.44 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 172.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' B' ' 40' ' ' SER . 47.3 mttm -61.82 132.5 53.31 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 18.0 tp -152.5 104.87 2.95 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 -174.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 20.3 m -103.52 110.91 23.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.065 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.4 ' N ' HD23 ' B' ' 29' ' ' LEU . 2.6 mm? -90.87 152.91 20.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.746 0.784 . . . . 0.0 111.894 -173.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.7 p -145.92 147.11 31.39 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.326 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 57.6 mtt -122.32 140.49 52.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.515 0.674 . . . . 0.0 112.168 -172.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . 0.496 ' O ' ' HG3' ' B' ' 35' ' ' GLN . 6.7 t30 -130.37 101.34 5.71 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 173.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.19 -99.87 1.0 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -166.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.46 ' HB2' ' HA2' ' B' ' 86' ' ' GLY . 15.3 m120 -130.6 19.26 5.18 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 171.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' B' ' 32' ' ' ASN . 24.7 mt-30 -69.75 156.0 39.68 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.243 0.544 . . . . 0.0 110.714 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 15.4 tp -118.2 106.59 12.98 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.842 175.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.428 ' HA ' ' OD1' ' B' ' 80' ' ' ASN . 24.0 mtmt -116.07 139.86 49.86 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -156.35 150.82 25.65 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -168.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 8.8 p -115.46 142.42 46.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.32 170.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 32.1 p -138.09 173.07 12.02 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -170.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 30.7 t -155.19 158.61 39.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.768 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -116.26 28.45 8.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.785 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.73 -18.52 65.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.691 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.67 -41.01 0.05 OUTLIER Glycine 0 C--N 1.318 -0.445 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.619 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.606 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 23.1 p90 45.04 -163.49 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.957 1.303 . . . . 0.0 114.264 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.472 ' H ' HG22 ' B' ' 71' ' ' THR . . . -81.11 85.49 1.4 Allowed Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.402 ' H ' HD12 ' B' ' 47' ' ' ILE . 1.0 OUTLIER -59.42 -69.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.4 0.619 . . . . 0.0 110.293 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.1 t -115.37 -92.97 0.5 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.389 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.622 ' CZ ' ' HG2' ' B' ' 24' ' ' LYS . 72.0 m-85 55.18 41.91 31.07 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.651 0.594 . . . . 0.0 110.154 -175.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 35.64 -95.35 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.285 -1.325 . . . . 0.0 112.988 -169.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -171.14 110.74 0.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 74.6 mttt -134.37 126.29 29.3 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -175.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -114.21 126.51 55.14 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.238 0.542 . . . . 0.0 110.578 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.528 ' HA ' HG12 ' B' ' 94' ' ' ILE . 34.3 p-90 -146.64 163.58 35.4 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.734 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -126.96 148.03 17.14 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.944 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.563 HD11 ' CD2' ' B' ' 64' ' ' TYR . 30.1 mt -107.1 148.86 11.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.741 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 89.5 m-85 -128.24 146.62 50.68 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -169.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.516 HG12 ' ND2' ' B' ' 59' ' ' ASN . 8.7 p -130.85 135.9 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.516 ' ND2' HG12 ' B' ' 58' ' ' VAL . 1.7 m-80 60.73 17.58 7.74 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -173.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.39 -3.27 83.82 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.407 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -103.34 176.09 5.26 Favored 'General case' 0 C--O 1.2 -1.53 0 C-N-CA 123.459 0.703 . . . . 0.0 109.711 -177.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.412 ' HB2' ' HE3' ' B' ' 62' ' ' LYS . 4.8 tppp? -60.67 156.75 16.04 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 118.541 0.61 . . . . 0.0 110.616 176.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 8.0 p -150.75 -12.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.007 0.432 . . . . 0.0 110.368 166.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.563 ' CD2' HD11 ' B' ' 56' ' ' ILE . 0.9 OUTLIER -162.4 125.26 2.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.239 -173.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 14.2 m -132.03 127.89 37.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.68 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.427 ' CD1' ' CE1' ' B' ' 64' ' ' TYR . 21.2 p90 -165.45 -175.03 3.39 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 122.017 0.913 . . . . 0.0 112.166 -176.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 18.5 t-20 -138.25 163.42 31.8 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.614 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -67.01 -51.65 52.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.298 0.57 . . . . 0.0 110.847 -176.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.443 ' O ' HG21 ' B' ' 71' ' ' THR . 40.3 ttmt -70.24 -17.75 63.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.23 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 3.2 t -69.06 -10.39 57.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.1 0.476 . . . . 0.0 109.902 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.481 ' O ' HG13 ' B' ' 75' ' ' ILE . 21.2 p 60.44 94.74 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.661 1.184 . . . . 0.0 112.157 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.45 ' HA ' ' CD1' ' B' ' 75' ' ' ILE . 2.4 m -59.37 -21.38 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.371 -172.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.42 -47.33 76.6 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.606 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -78.61 -36.0 44.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.282 0.563 . . . . 0.0 110.169 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.481 HG13 ' O ' ' B' ' 71' ' ' THR . 2.4 mt -65.41 -45.63 92.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.293 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.542 ' N ' ' HH ' ' B' ' 64' ' ' TYR . 32.2 t -64.21 -27.52 69.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.624 -176.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -55.37 -44.23 75.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.835 0.826 . . . . 0.0 109.865 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.727 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 10.7 m-20 -69.95 -40.46 75.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.442 -1.253 . . . . 0.0 111.022 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.465 HG13 ' CE1' ' B' ' 64' ' ' TYR . 48.3 mm -58.01 -28.87 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.333 0.587 . . . . 0.0 111.832 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.428 ' OD1' ' HA ' ' B' ' 37' ' ' LYS . 83.8 m-20 -60.38 -23.16 64.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.737 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.727 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 17.0 ptmt -96.73 6.38 48.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.808 0.337 . . . . 0.0 111.245 -174.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' B' ' 79' ' ' ILE . 3.4 mm? -78.78 -5.08 52.42 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -175.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 41.9 52.22 4.19 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 123.871 0.732 . . . . 0.0 110.95 -171.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.437 ' O ' ' HG2' ' B' ' 35' ' ' GLN . 82.8 mt -52.22 147.45 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.768 -171.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.6 -164.27 1.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.119 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -154.23 113.87 0.59 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.819 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.442 ' CG ' ' HA ' ' B' ' 59' ' ' ASN . 24.6 ptp -173.47 -54.85 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.197 0.199 . . . . 0.0 111.242 175.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . 0.413 ' N ' ' HG3' ' B' ' 87' ' ' MET . 1.3 t80 -135.73 84.44 2.09 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.842 -0.536 . . . . 0.0 110.226 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.741 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.1 mp -99.4 114.1 36.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.003 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -98.73 -179.22 4.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.366 0.603 . . . . 0.0 111.355 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 41.7 mt -151.51 114.93 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.573 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -174.64 160.85 3.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.333 0.587 . . . . 0.0 112.309 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.501 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 1.5 pp0? -72.26 158.47 35.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.617 174.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.528 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.5 pt . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.899 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' MET . . . . . 0.459 ' HE3' ' O ' ' B' ' 87' ' ' MET . 26.3 mmt . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 121.261 0.553 . . . . 0.0 111.46 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -62.44 -24.71 67.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.776 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.661 ' O ' HG23 ' B' ' 16' ' ' VAL . 15.9 t -66.75 -25.85 66.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.045 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 11.2 mm -58.55 -38.37 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-O 121.703 0.763 . . . . 0.0 109.98 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -71.14 -41.4 70.52 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.959 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.569 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 0.6 OUTLIER -65.36 -34.12 77.56 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.143 177.116 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.661 HG23 ' O ' ' B' ' 12' ' ' SER . 54.5 t -63.29 -42.26 95.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.218 0.533 . . . . 0.0 109.991 175.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . 0.548 HD21 HD21 ' B' ' 29' ' ' LEU . 2.5 t-20 -61.94 -42.12 98.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.867 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.76 -40.93 63.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.451 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' B' ' 15' ' ' SER . 4.5 tmtm? -53.4 -73.04 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.54 0.736 . . . . 0.0 112.186 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.424 HD22 HG12 ' B' ' 72' ' ' VAL . 17.4 mt -52.29 -29.87 25.37 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -84.41 74.23 10.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.193 0.52 . . . . 0.0 111.023 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -133.24 -79.48 0.48 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.203 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.21 34.83 2.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.943 -176.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.484 ' HA ' ' HA2' ' B' ' 46' ' ' GLY . 0.9 OUTLIER -122.79 -168.98 1.84 Allowed 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 173.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' B' ' 45' ' ' TYR . . . -54.26 137.24 41.79 Favored Glycine 0 N--CA 1.45 -0.41 0 O-C-N 123.961 0.788 . . . . 0.0 111.619 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.49 112.12 21.88 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 121.397 0.618 . . . . 0.0 109.911 -170.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.453 HD13 ' O ' ' B' ' 27' ' ' LEU . 0.0 OUTLIER -134.29 143.52 47.79 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.267 177.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 49.3 m -104.03 111.55 24.17 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.879 -173.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.548 HD21 HD21 ' B' ' 17' ' ' ASN . 3.1 mm? -77.5 152.79 33.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.596 0.713 . . . . 0.0 109.932 176.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 0.3 OUTLIER -144.27 145.48 32.05 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.29 175.303 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 43.6 mtt -112.86 133.1 55.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.072 0.463 . . . . 0.0 111.864 -165.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . 0.48 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 4.3 t30 -146.11 59.22 1.23 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 47.73 -99.58 0.02 OUTLIER Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.895 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.687 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 8.1 p30 -83.39 16.57 2.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.41 -0.395 . . . . 0.0 111.493 -176.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 19.5 mt-30 -134.87 146.38 49.18 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.393 0.616 . . . . 0.0 110.735 171.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.475 ' HB3' ' HB ' ' B' ' 84' ' ' ILE . 3.2 tm? -122.39 127.96 50.36 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.558 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.47 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 16.7 mtmt -126.33 146.6 49.97 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -174.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -161.63 151.19 16.46 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -176.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 11.8 p -126.88 142.2 51.61 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 58.9 p -136.75 150.29 48.31 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -167.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 22.7 t -139.56 153.46 47.43 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.707 171.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -115.36 9.39 15.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -170.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.72 -59.84 4.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.814 0.816 . . . . 0.0 110.451 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.68 61.28 2.77 Favored Glycine 0 C--N 1.309 -0.927 0 CA-C-N 114.59 -1.187 . . . . 0.0 110.89 175.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.548 ' HA ' ' HA2' ' B' ' 25' ' ' GLY . 0.1 OUTLIER -70.1 -161.91 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.079 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' B' ' 24' ' ' LYS . . . -62.14 107.44 1.58 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.27 -0.49 . . . . 0.0 112.23 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 22.2 mm -85.46 -69.74 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 CA-C-O 122.307 1.051 . . . . 0.0 109.817 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.438 ' C ' ' H ' ' B' ' 50' ' ' GLU . 6.8 m -104.62 -153.82 0.49 Allowed 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 113.634 -1.621 . . . . 0.0 109.391 -176.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 67.76 -12.53 0.29 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.992 0.917 . . . . 0.0 112.432 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.438 ' H ' ' C ' ' B' ' 48' ' ' SER . 44.7 mt-10 49.77 -105.2 0.16 Allowed 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.839 0.856 . . . . 0.0 111.994 -175.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -129.65 110.71 12.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.582 ' HB2' ' OE1' ' B' ' 68' ' ' GLU . 66.2 mttm -118.19 134.82 54.67 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 170.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -98.17 110.58 23.14 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.553 ' HA ' HG12 ' B' ' 94' ' ' ILE . 37.5 p-90 -149.38 168.18 24.11 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.444 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.9 156.86 25.68 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.408 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.415 HD11 ' CD2' ' B' ' 64' ' ' TYR . 21.8 mt -108.42 147.68 13.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.673 ' CE1' ' HD3' ' B' ' 62' ' ' LYS . 71.5 m-85 -130.46 139.9 50.54 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -169.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 13.6 t -131.35 138.34 53.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 64.54 5.26 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.99 0.806 . . . . 0.0 109.238 -174.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.91 17.49 47.64 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.737 -172.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 7.8 mt-10 -120.5 174.56 6.47 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.673 ' HD3' ' CE1' ' B' ' 57' ' ' PHE . 0.0 OUTLIER -67.6 167.82 12.31 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.26 173.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.425 ' N ' ' HG3' ' B' ' 62' ' ' LYS . 8.6 p -153.77 -15.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.781 164.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.626 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.5 OUTLIER -160.05 124.2 3.74 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.049 -170.29 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 28.1 m -131.94 131.11 42.35 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.797 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.458 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.1 OUTLIER -160.94 -176.55 5.57 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 122.531 1.158 . . . . 0.0 112.312 -174.113 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -133.21 149.67 52.0 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 112.272 -2.24 . . . . 0.0 108.626 173.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . 0.582 ' OE1' ' HB2' ' B' ' 52' ' ' LYS . 1.3 mp0 -52.04 -51.03 60.14 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.941 0.401 . . . . 0.0 111.57 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.546 ' O ' HG22 ' B' ' 71' ' ' THR . 88.8 tttt -69.13 -22.95 63.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.602 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.6 t -68.74 -17.06 63.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 174.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.546 HG22 ' O ' ' B' ' 69' ' ' LYS . 30.2 p 56.26 106.15 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.344 1.058 . . . . 0.0 112.865 172.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.503 ' HB ' ' HH ' ' B' ' 64' ' ' TYR . 9.5 m -62.7 -10.3 5.24 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.861 -171.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.46 -55.21 31.33 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.463 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -67.79 -36.9 81.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.416 0.627 . . . . 0.0 110.9 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.446 ' O ' HG12 ' B' ' 79' ' ' ILE . 1.9 mt -68.53 -49.19 67.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.75 -177.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.419 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 22.9 t -58.81 -29.75 67.09 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.979 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -49.66 -52.23 32.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.893 0.854 . . . . 0.0 109.614 173.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.689 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 0.4 OUTLIER -72.7 -39.66 66.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.945 178.041 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.626 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.1 mm -56.96 -33.25 41.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.12 0.486 . . . . 0.0 112.26 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.469 HD22 ' HB2' ' B' ' 38' ' ' ALA . 7.3 m-80 -61.85 -16.93 54.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.689 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 20.7 pttm -85.05 -7.31 59.17 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.906 0.384 . . . . 0.0 110.469 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 2.5 mm? -69.61 -16.09 63.32 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -174.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 51.7 58.72 5.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.336 -171.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' B' ' 36' ' ' LEU . 5.2 mp -55.99 148.29 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.517 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.687 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 67.5 mttm -116.8 -167.73 1.34 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.269 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.544 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -142.35 111.24 0.66 Allowed Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.131 -177.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.459 ' O ' ' HE3' ' B' ' 10' ' ' MET . 16.6 tpp -151.22 -73.43 0.15 Allowed 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . 0.449 ' N ' ' HG3' ' B' ' 87' ' ' MET . 32.8 t80 -125.77 97.15 5.03 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 22.9 mm -96.35 126.35 49.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.834 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -121.67 169.77 10.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.115 0.484 . . . . 0.0 110.784 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.424 HD12 HG21 ' B' ' 16' ' ' VAL . 23.6 mm -149.14 121.72 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.768 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.536 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 48.2 pttt -168.83 173.53 7.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.251 0.548 . . . . 0.0 111.452 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.518 ' H ' ' NE2' ' B' ' 93' ' ' GLN . 0.5 OUTLIER -95.8 149.81 21.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.281 175.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.553 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.7 pt . . . . . 0 C--N 1.313 -0.999 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.255 -175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' MET . . . . . 0.632 ' O ' HG12 ' B' ' 13' ' ' ILE . 86.8 mmm . . . . . 0 C--O 1.222 -0.351 0 CA-C-O 121.236 0.541 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -52.51 -23.26 5.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.794 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.534 ' O ' HG23 ' B' ' 16' ' ' VAL . 5.3 m -68.39 -17.07 64.14 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.909 -174.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.632 HG12 ' O ' ' B' ' 10' ' ' MET . 14.2 mm -49.21 -65.08 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.449 0.642 . . . . 0.0 111.26 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -78.3 -25.63 46.66 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.555 -177.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.405 ' HB2' ' HA ' ' B' ' 12' ' ' SER . 23.7 m -67.7 -33.33 74.68 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.003 -176.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.534 HG23 ' O ' ' B' ' 12' ' ' SER . 71.5 t -67.84 -42.47 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.5 0.667 . . . . 0.0 109.478 176.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . 0.72 ' ND2' HD21 ' B' ' 29' ' ' LEU . 12.4 t-20 -59.08 -58.71 7.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.264 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.39 -12.15 60.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.857 -177.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' B' ' 16' ' ' VAL . 14.2 tppt? -78.24 -50.19 12.34 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.5 0.667 . . . . 0.0 111.059 173.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.1 -22.81 41.78 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.202 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -116.14 93.14 4.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.433 0.635 . . . . 0.0 110.643 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -138.59 -70.41 0.42 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.222 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.56 49.14 0.77 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.533 ' HZ2' ' CD ' ' B' ' 68' ' ' GLU . 27.0 mttt -127.96 -138.47 0.24 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -176.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.412 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -76.31 163.36 52.95 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.668 ' HE3' ' OG ' ' B' ' 41' ' ' SER . 0.0 OUTLIER -70.26 150.6 46.23 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.221 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' B' ' 39' ' ' THR . 16.5 tp -149.06 123.76 9.84 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -173.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.596 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 16.1 m -106.85 96.74 6.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.298 0.57 . . . . 0.0 111.468 -177.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.72 HD21 ' ND2' ' B' ' 17' ' ' ASN . 0.2 OUTLIER -68.5 147.92 51.31 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.266 1.426 . . . . 0.0 114.496 -167.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 11.4 p -155.18 152.97 30.03 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.138 171.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 61.3 mtt -115.01 149.16 37.86 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -166.67 120.28 1.05 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.181 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.1 -116.78 9.55 Favored Glycine 0 CA--C 1.506 -0.481 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.879 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.43 ' HA ' ' CD1' ' B' ' 13' ' ' ILE . 20.6 m120 -121.33 22.98 10.63 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 172.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.572 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 49.6 mt-30 -86.35 160.96 18.94 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.311 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -128.69 98.96 5.16 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 169.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.578 ' HA ' ' ND2' ' B' ' 80' ' ' ASN . 6.0 mtmp? -97.2 146.37 25.15 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.531 -177.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -173.36 142.91 1.03 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -93.02 159.12 15.44 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 177.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.478 ' OG ' ' HA2' ' B' ' 73' ' ' GLY . 11.6 p -149.92 151.06 32.8 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.592 -170.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.668 ' OG ' ' HE3' ' B' ' 26' ' ' LYS . 0.1 OUTLIER -129.83 140.79 50.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.986 177.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -94.5 41.49 1.09 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.905 -170.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.7 -60.08 3.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.244 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.68 -35.87 3.66 Favored Glycine 0 C--N 1.316 -0.572 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.737 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.412 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 23.7 p90 49.21 -166.35 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.871 1.268 . . . . 0.0 113.98 177.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.7 97.57 1.49 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.602 -175.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.421 ' H ' HD13 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -108.92 -55.92 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.386 0.612 . . . . 0.0 109.74 175.079 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.9 m -39.31 -57.09 1.43 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.523 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -80.38 4.67 17.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.985 -173.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 50.47 -98.03 0.05 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.694 0.797 . . . . 0.0 112.331 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -142.46 113.37 7.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.395 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 94.6 mttt -138.13 143.36 40.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.284 175.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.41 ' HB3' ' OD1' ' B' ' 67' ' ' ASN . 0.4 OUTLIER -112.87 117.9 33.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.176 0.513 . . . . 0.0 110.715 177.108 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.603 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 48.9 p-90 -131.45 164.43 25.76 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -125.19 148.69 16.88 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.472 -173.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.444 ' C ' HG11 ' B' ' 63' ' ' VAL . 7.7 mt -100.41 150.33 5.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 170.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.777 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 74.9 m-85 -129.97 138.65 50.95 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.202 -174.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' B' ' 61' ' ' GLU . 13.5 p -121.9 131.72 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 63.33 7.98 3.2 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.251 0.548 . . . . 0.0 109.697 -174.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.57 -17.09 40.06 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.242 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 0.6 OUTLIER -91.5 170.21 10.14 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 123.185 0.594 . . . . 0.0 110.105 -177.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.431 ' HB2' ' HE3' ' B' ' 62' ' ' LYS . 5.4 tppp? -55.74 158.24 3.71 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.915 0.388 . . . . 0.0 110.007 172.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.444 HG11 ' C ' ' B' ' 56' ' ' ILE . 10.0 p -144.91 -18.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 168.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.485 ' CE2' HG21 ' B' ' 75' ' ' ILE . 1.6 t80 -171.08 153.04 3.63 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.71 -175.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.522 HG22 ' CD1' ' B' ' 94' ' ' ILE . 80.0 m -138.6 135.76 35.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.521 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.697 ' CD2' HD11 ' B' ' 75' ' ' ILE . 23.8 p90 -168.55 158.53 9.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.795 0.807 . . . . 0.0 111.521 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 5.6 m120 -113.61 151.58 31.51 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.02 -1.445 . . . . 0.0 112.001 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . 0.533 ' CD ' ' HZ2' ' B' ' 24' ' ' LYS . 21.1 mm-40 -61.91 -42.5 99.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.529 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.461 ' O ' HG22 ' B' ' 71' ' ' THR . 22.0 tptp -59.98 -36.12 76.46 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.02 0.914 . . . . 0.0 110.175 176.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' B' ' 67' ' ' ASN . 58.5 m -70.37 -10.33 58.75 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.264 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.461 HG22 ' O ' ' B' ' 69' ' ' LYS . 8.2 p 65.08 124.02 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 126.134 1.774 . . . . 0.0 113.209 170.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.446 ' HA ' ' HB ' ' B' ' 75' ' ' ILE . 3.6 m -64.57 -5.56 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.097 -173.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . 0.478 ' HA2' ' OG ' ' B' ' 40' ' ' SER . . . -67.28 -55.16 16.81 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.432 -0.413 . . . . 0.0 113.228 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -73.17 -23.38 60.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 122.048 0.928 . . . . 0.0 109.09 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.697 HD11 ' CD2' ' B' ' 66' ' ' PHE . 68.0 mt -68.79 -54.84 18.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 113.904 -1.498 . . . . 0.0 112.745 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 18.2 t -54.57 -37.82 65.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.901 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -50.85 -49.43 58.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.982 0.896 . . . . 0.0 110.599 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.522 ' HA ' ' HG2' ' B' ' 81' ' ' LYS . 72.1 m-20 -64.9 -46.89 79.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.912 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.448 HG12 ' CD2' ' B' ' 64' ' ' TYR . 66.3 mt -51.96 -37.53 21.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.325 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.578 ' ND2' ' HA ' ' B' ' 37' ' ' LYS . 7.3 m120 -75.07 -38.49 61.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.383 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' B' ' 78' ' ' ASP . 6.4 ptpp? -75.47 -21.31 58.18 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.222 -176.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.447 HD22 ' O ' ' B' ' 78' ' ' ASP . 1.7 mm? -63.9 -22.01 66.73 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.869 0.366 . . . . 0.0 110.154 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 45.35 64.79 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.697 -171.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.572 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 55.6 mt -62.89 149.89 9.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.21 -175.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.443 ' NZ ' ' HB3' ' B' ' 85' ' ' LYS . 7.7 mtpm? -90.18 179.42 5.92 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.827 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -133.68 113.25 1.18 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 119.693 -1.241 . . . . 0.0 112.466 -176.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.409 ' HG2' ' N ' ' B' ' 88' ' ' TYR . 17.8 ttt -154.31 -77.09 0.11 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 123.076 0.55 . . . . 0.0 109.909 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . 0.409 ' N ' ' HG2' ' B' ' 87' ' ' MET . 34.1 t80 -132.34 81.86 1.98 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.217 0.532 . . . . 0.0 109.668 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.777 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.1 mp -87.72 125.51 41.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.853 178.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -108.83 177.97 4.61 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.356 0.598 . . . . 0.0 110.7 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.603 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 57.5 mt -149.74 110.04 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.632 -178.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -167.87 166.67 13.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.273 0.559 . . . . 0.0 112.102 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -84.63 148.84 26.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.467 -174.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.522 ' CD1' HG22 ' B' ' 65' ' ' THR . 4.2 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.408 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' MET . . . . . 0.591 ' SD ' ' HA ' ' B' ' 88' ' ' TYR . 82.5 mtp . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.82 0.343 . . . . 0.0 111.585 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -57.38 -30.55 64.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.168 0.508 . . . . 0.0 110.888 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.573 ' O ' HG23 ' B' ' 16' ' ' VAL . 1.3 p -63.94 -30.94 71.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.909 -174.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mm -53.79 -45.49 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.858 0.837 . . . . 0.0 110.113 177.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -82.89 -29.99 28.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.976 -177.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 21.8 t -71.5 -27.38 63.18 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.602 -175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.573 HG23 ' O ' ' B' ' 12' ' ' SER . 87.4 t -58.44 -42.89 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.446 0.641 . . . . 0.0 109.704 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . 0.407 ' OD1' HD12 ' B' ' 29' ' ' LEU . 55.9 t30 -63.87 -45.54 88.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.866 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.8 -28.5 62.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.619 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.477 ' HZ1' ' CD ' ' B' ' 68' ' ' GLU . 6.7 tptp -68.37 -53.08 26.38 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.167 0.508 . . . . 0.0 111.398 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 94.3 mt -73.0 -27.82 62.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.655 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -90.41 75.97 6.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.369 0.604 . . . . 0.0 110.593 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -135.89 62.95 1.61 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.491 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.91 54.48 4.14 Favored Glycine 0 C--N 1.317 -0.5 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.621 ' HB3' ' CD2' ' B' ' 45' ' ' TYR . 33.2 mmtp -137.15 -152.51 0.44 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.223 -0.488 . . . . 0.0 110.396 -174.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.47 ' HA3' ' HB2' ' B' ' 45' ' ' TYR . . . -78.69 -177.27 48.87 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 176.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.445 ' HE2' ' HB2' ' B' ' 41' ' ' SER . 4.3 mppt? -88.57 127.9 35.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 117.292 0.546 . . . . 0.0 111.02 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.4 tp -156.03 110.93 2.9 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 19.5 m -108.7 108.86 19.87 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.535 -176.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.488 HD23 HD12 ' B' ' 36' ' ' LEU . 10.2 mp -86.04 158.73 19.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.606 0.717 . . . . 0.0 110.738 176.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.528 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 20.3 m -135.81 140.29 44.12 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.919 173.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -100.59 125.65 46.99 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.792 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.59 58.66 1.61 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.43 -95.61 0.01 OUTLIER Glycine 0 C--N 1.335 0.506 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.028 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 14.2 m120 -88.09 15.72 7.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.481 -0.359 . . . . 0.0 111.044 -176.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 16.8 mt-30 -139.95 142.97 36.34 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.558 0.694 . . . . 0.0 110.931 173.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.488 HD12 HD23 ' B' ' 29' ' ' LEU . 32.4 tp -113.58 120.78 42.12 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.818 173.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.528 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 6.6 mmmm -114.48 150.31 35.0 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -174.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' B' ' 29' ' ' LEU . . . -163.55 143.35 8.49 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 2.8 p -120.86 151.79 39.22 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.4 t -142.89 150.07 39.32 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.126 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.445 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . 5.7 m -126.12 149.77 48.7 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.424 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -82.76 47.9 1.26 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.266 -170.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.49 -3.71 29.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.786 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.37 70.34 1.35 Allowed Glycine 0 CA--C 1.485 -1.808 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.262 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.621 ' CD2' ' HB3' ' B' ' 24' ' ' LYS . 0.8 OUTLIER -65.59 148.86 51.04 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 161.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.583 ' N ' ' CD1' ' B' ' 45' ' ' TYR . . . 109.17 58.86 0.53 Allowed Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -176.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 3.9 mm -85.84 -69.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.521 0.677 . . . . 0.0 109.702 -172.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.2 m -151.8 -130.32 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.021 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.46 ' O ' ' HE2' ' B' ' 52' ' ' LYS . 84.5 m-85 64.23 27.63 13.9 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.004 0.522 . . . . 0.0 111.503 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 43.63 -106.47 0.09 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.593 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.46 ' HB3' HD22 ' B' ' 67' ' ' ASN . 6.9 m-20 -144.48 119.4 9.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.089 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.46 ' HE2' ' O ' ' B' ' 49' ' ' TYR . 65.7 mmtt -119.26 122.74 42.62 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -107.64 127.24 53.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.149 0.499 . . . . 0.0 111.058 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.683 ' CZ3' HG21 ' B' ' 91' ' ' ILE . 37.2 p-90 -142.41 161.38 38.2 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.891 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.1 151.94 16.89 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.899 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.481 ' O ' HG12 ' B' ' 63' ' ' VAL . 7.5 mt -102.74 141.03 19.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 172.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.686 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 64.0 m-85 -121.81 140.85 51.86 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.507 HG12 ' ND2' ' B' ' 59' ' ' ASN . 8.4 p -131.72 142.5 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.507 ' ND2' HG12 ' B' ' 58' ' ' VAL . 14.3 m-80 68.72 -2.81 1.57 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -169.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' B' ' 58' ' ' VAL . . . 96.76 -1.75 61.74 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -170.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 58' ' ' VAL . 16.5 mt-10 -100.36 172.0 7.41 Favored 'General case' 0 C--O 1.199 -1.587 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.592 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 11.1 ttmt -67.09 168.3 10.4 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 119.009 0.822 . . . . 0.0 109.948 175.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.481 HG12 ' O ' ' B' ' 56' ' ' ILE . 7.6 p -148.49 -20.33 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.618 170.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.409 ' CD2' HG12 ' B' ' 79' ' ' ILE . 4.5 t80 -169.1 146.14 3.58 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.997 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.507 HG22 ' CD1' ' B' ' 94' ' ' ILE . 54.9 m -130.17 134.07 47.04 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.257 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.649 ' CD2' HG21 ' B' ' 75' ' ' ILE . 9.0 p90 -165.48 153.04 10.77 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.672 0.749 . . . . 0.0 109.939 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.489 ' O ' ' HB3' ' B' ' 70' ' ' SER . 23.2 t-20 -99.2 159.73 14.78 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.885 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . 0.477 ' CD ' ' HZ1' ' B' ' 19' ' ' LYS . 10.2 mm-40 -60.92 -63.15 1.4 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.278 0.561 . . . . 0.0 109.954 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -66.37 -5.17 9.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.184 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 1.4 t -68.37 -3.14 10.11 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.417 0.627 . . . . 0.0 109.762 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.422 ' O ' HG13 ' B' ' 75' ' ' ILE . 31.9 p 62.17 102.97 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.308 1.443 . . . . 0.0 111.55 174.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.532 ' HA ' ' CG1' ' B' ' 75' ' ' ILE . 5.4 m -66.79 -4.43 2.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.151 -168.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.68 -48.12 80.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.443 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -78.78 -25.9 44.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.496 0.665 . . . . 0.0 109.777 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.649 HG21 ' CD2' ' B' ' 66' ' ' PHE . 24.5 mt -66.29 -44.97 90.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.299 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 28.9 t -53.73 -36.52 62.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.351 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -50.04 -54.61 19.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.792 0.806 . . . . 0.0 110.54 174.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 27.3 m-20 -63.89 -48.07 78.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.904 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.409 HG12 ' CD2' ' B' ' 64' ' ' TYR . 43.7 mt -54.69 -37.29 39.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.104 0.478 . . . . 0.0 111.48 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.98 -43.29 96.17 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.106 176.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 59.1 pttt -76.05 -31.1 58.64 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.054 -176.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.58 -26.31 67.89 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 65.6 t30 40.44 72.19 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 O-C-N 124.583 1.177 . . . . 0.0 110.839 -172.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' B' ' 35' ' ' GLN . 3.1 mp -57.18 137.16 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.908 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 30.4 mmtp -90.61 -169.41 2.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.409 -177.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.477 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -136.65 113.92 1.1 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.256 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 3.1 ptp -167.43 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.637 0.375 . . . . 0.0 110.604 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . 0.591 ' HA ' ' SD ' ' B' ' 10' ' ' MET . 21.7 t80 -124.8 88.32 2.87 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.686 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 34.1 mm -93.75 133.35 35.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.29 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.562 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 24.1 mt-10 -125.38 155.61 40.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.142 0.496 . . . . 0.0 111.636 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.683 HG21 ' CZ3' ' B' ' 54' ' ' TRP . 86.8 mt -131.15 118.21 40.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.453 176.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -171.69 154.19 3.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.12 0.486 . . . . 0.0 111.894 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 5.1 pm0 -64.76 149.48 49.19 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.268 175.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.507 ' CD1' HG22 ' B' ' 65' ' ' THR . 3.3 pt . . . . . 0 C--N 1.312 -1.026 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.304 -173.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' MET . . . . . 0.464 ' SD ' HG12 ' B' ' 89' ' ' ILE . 62.1 mtm . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.941 0.4 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -70.56 -26.88 63.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.692 0.758 . . . . 0.0 109.966 171.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 14.8 m -68.4 -10.14 53.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.642 -174.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.426 HG21 ' HG2' ' B' ' 31' ' ' MET . 28.5 mm -49.58 -52.34 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-O 121.089 0.471 . . . . 0.0 111.579 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -102.65 -38.3 7.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.865 -174.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.646 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 16.0 m -57.94 -41.86 83.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.945 -174.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.67 -45.13 75.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.964 0.411 . . . . 0.0 110.448 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -43.61 98.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.161 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.12 -26.19 52.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.24 -176.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.646 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -64.79 -46.29 82.68 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 121.092 0.472 . . . . 0.0 111.715 178.325 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 9.1 mt -87.05 -31.77 20.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.058 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -92.35 81.02 4.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.277 0.56 . . . . 0.0 110.176 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -122.35 -83.22 0.66 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.315 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.32 34.34 2.32 Favored Glycine 0 CA--C 1.508 -0.378 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -114.29 -147.26 0.41 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.072 -0.564 . . . . 0.0 109.591 -175.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.441 ' HA3' ' HB2' ' B' ' 45' ' ' TYR . . . -72.45 167.69 53.22 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.673 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.451 ' HE2' ' HB2' ' B' ' 41' ' ' SER . 2.1 mppt? -80.04 130.03 34.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.781 0.324 . . . . 0.0 110.943 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.455 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 26.6 tp -149.84 92.75 1.94 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 20.3 m -88.61 107.7 19.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.974 -175.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.455 ' CD1' ' HG ' ' B' ' 27' ' ' LEU . 9.3 mp -90.26 162.68 15.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.751 0.786 . . . . 0.0 111.548 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.6 p -156.0 144.68 20.26 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.718 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' MET . . . . . 0.426 ' HG2' HG21 ' B' ' 13' ' ' ILE . 0.6 OUTLIER -106.91 139.45 41.29 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.924 0.392 . . . . 0.0 111.232 -173.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . 0.495 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 2.5 t30 -142.29 57.4 1.46 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 170.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . 0.483 ' O ' ' HA3' ' B' ' 86' ' ' GLY . . . 45.44 -95.01 0.01 OUTLIER Glycine 0 C--N 1.333 0.403 0 O-C-N 123.806 0.691 . . . . 0.0 113.075 -175.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.701 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 4.6 p30 -80.61 10.82 4.31 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.814 0.446 . . . . 0.0 112.17 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.66 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 21.0 mt-30 -132.98 147.81 52.27 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.366 0.603 . . . . 0.0 110.544 165.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.47 116.05 19.82 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -116.99 138.78 51.34 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.614 -172.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -158.66 139.12 12.53 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.115 0.484 . . . . 0.0 111.521 -177.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 13.8 p -115.9 138.35 51.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.612 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.3 p -123.43 142.47 50.95 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.172 0.51 . . . . 0.0 111.551 -174.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.451 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . 2.5 m -117.82 143.97 45.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.618 175.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -99.5 44.0 1.04 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.823 -168.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.42 -32.19 68.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.103 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.72 63.72 0.03 OUTLIER Glycine 0 CA--C 1.49 -1.482 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.287 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.763 ' CD1' ' HA ' ' B' ' 71' ' ' THR . 2.5 t80 -69.42 152.87 44.39 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 161.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.586 ' N ' ' CD1' ' B' ' 45' ' ' TYR . . . 106.38 57.18 0.63 Allowed Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 5.6 mm -79.33 -69.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.606 -0.797 . . . . 0.0 110.3 -171.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 69.1 m -152.46 -106.19 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.202 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.449 ' O ' ' HG2' ' B' ' 52' ' ' LYS . 64.9 m-85 58.94 20.66 8.37 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.083 0.553 . . . . 0.0 112.15 177.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 46.57 -95.12 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.83 0.706 . . . . 0.0 110.503 -171.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.45 ' HB3' HD22 ' B' ' 67' ' ' ASN . 9.3 m-20 -149.38 110.51 4.38 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 169.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' B' ' 49' ' ' TYR . 72.3 mmtt -121.13 122.29 39.7 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -113.52 130.58 56.31 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.298 0.571 . . . . 0.0 110.988 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.507 ' HA ' HG12 ' B' ' 94' ' ' ILE . 26.7 p-90 -141.0 168.45 19.76 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.695 176.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.56 145.13 16.79 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.706 -174.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.508 HD12 ' CD2' ' B' ' 64' ' ' TYR . 26.4 mt -106.76 141.73 21.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 171.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.708 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 63.5 m-85 -123.33 143.04 50.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.722 -174.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.519 HG11 ' ND2' ' B' ' 59' ' ' ASN . 10.4 p -128.0 136.89 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.519 ' ND2' HG11 ' B' ' 58' ' ' VAL . 3.3 m-80 61.69 11.04 3.71 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.989 0.515 . . . . 0.0 109.626 -172.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.51 0.64 66.96 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.278 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' B' ' 58' ' ' VAL . 15.7 mt-10 -106.8 176.27 5.23 Favored 'General case' 0 C--O 1.199 -1.597 0 C-N-CA 123.521 0.728 . . . . 0.0 109.139 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.51 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.4 tppp? -66.08 162.42 19.61 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 119.092 0.86 . . . . 0.0 109.949 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.51 ' N ' ' HG3' ' B' ' 62' ' ' LYS . 7.8 p -153.42 -18.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.918 0.389 . . . . 0.0 110.371 167.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.661 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.8 OUTLIER -160.78 126.41 3.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 110.359 -172.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.3 m -134.23 126.64 30.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.48 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.465 ' HB2' HD12 ' B' ' 75' ' ' ILE . 0.7 OUTLIER -169.38 152.35 4.83 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.124 0.964 . . . . 0.0 112.467 -174.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.45 HD22 ' HB3' ' B' ' 51' ' ' ASP . 17.3 t-20 -92.61 153.98 18.67 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.233 -1.803 . . . . 0.0 109.956 174.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . 0.406 ' HA ' ' OH ' ' B' ' 45' ' ' TYR . 22.6 mm-40 -75.86 -3.68 36.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.192 0.52 . . . . 0.0 111.782 -174.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -111.43 -7.5 14.35 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.896 0.379 . . . . 0.0 111.431 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 1.3 t -73.92 -3.63 30.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.396 0.617 . . . . 0.0 111.688 -173.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.763 ' HA ' ' CD1' ' B' ' 45' ' ' TYR . 13.3 p 64.75 98.5 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.742 1.217 . . . . 0.0 111.444 173.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.406 ' HA ' ' CD1' ' B' ' 75' ' ' ILE . 7.7 m -66.64 -12.37 14.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.63 -169.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.24 -41.42 98.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.933 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -82.8 -30.76 28.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.206 0.527 . . . . 0.0 110.523 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' B' ' 66' ' ' PHE . 1.3 mt -75.62 -53.44 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.657 -176.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 22.5 t -58.38 -29.13 65.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.3 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -48.12 -54.74 12.23 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.778 0.799 . . . . 0.0 110.391 172.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.736 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 10.3 m-20 -69.36 -49.51 54.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.262 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.661 HG13 ' CE1' ' B' ' 64' ' ' TYR . 46.7 mm -52.29 -37.11 22.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -70.06 -20.78 63.21 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.736 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 46.9 pttt -83.26 -1.54 53.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.192 0.52 . . . . 0.0 109.986 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 3.7 mm? -77.46 -5.31 49.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.832 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 55.9 t30 51.38 63.51 2.21 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.427 -171.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.66 ' O ' ' HA ' ' B' ' 35' ' ' GLN . 48.2 mt -55.23 145.3 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.069 -172.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 50.3 mtmt -114.78 -176.94 3.01 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.779 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.483 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -142.0 113.11 0.79 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.844 -0.694 . . . . 0.0 111.725 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 12.2 tpp -150.25 -70.74 0.18 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 120.832 0.348 . . . . 0.0 110.221 178.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -129.29 87.16 2.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 46.1 mm -85.9 132.51 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.213 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 33.9 mt-10 -119.2 145.06 46.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.495 173.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.48 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 44.8 mm -129.14 112.06 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.502 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.499 ' HE2' ' CE2' ' B' ' 57' ' ' PHE . 45.3 pttt -166.83 166.83 15.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.041 0.448 . . . . 0.0 111.819 -174.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -94.11 149.17 21.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.157 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.7 pt . . . . . 0 C--O 1.25 1.13 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.061 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 21.8 mmt . . . . . 0 N--CA 1.443 -0.782 0 CA-C-O 122.074 0.94 . . . . 0.0 113.359 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.07 -26.43 67.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.963 175.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.428 ' O ' HG21 ' B' ' 16' ' ' VAL . 49.1 m -67.16 -22.56 65.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.922 -174.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mm -60.41 -43.46 94.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.925 0.869 . . . . 0.0 109.61 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -66.51 -33.72 76.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.978 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 4.2 m -65.22 -44.43 88.29 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.941 176.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.428 HG21 ' O ' ' B' ' 12' ' ' SER . 91.9 t -61.0 -43.59 96.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.152 0.501 . . . . 0.0 110.111 176.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . 0.455 ' OD1' ' HB2' ' B' ' 29' ' ' LEU . 0.2 OUTLIER -56.02 -41.66 75.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.233 -179.454 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.39 -37.48 37.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.149 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -59.88 -43.64 94.65 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 122.86 0.464 . . . . 0.0 111.688 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.45 HD23 ' HE1' ' B' ' 54' ' ' TRP . 81.1 mt -83.66 28.6 0.56 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.896 -175.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -104.01 29.64 5.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.804 0.812 . . . . 0.0 108.954 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -119.33 57.52 0.89 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.317 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' B' ' 25' ' ' GLY . . . 163.28 47.2 0.02 OUTLIER Glycine 0 CA--C 1.503 -0.667 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.717 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 57.06 -63.27 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.517 ' H ' ' HA ' ' B' ' 45' ' ' TYR . . . -36.87 105.64 0.04 OUTLIER Glycine 0 C--N 1.33 0.248 0 O-C-N 124.006 0.816 . . . . 0.0 113.158 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' B' ' 40' ' ' SER . 34.3 pttt -63.67 132.34 50.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.941 0.401 . . . . 0.0 111.327 -176.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.459 HD11 ' OG ' ' B' ' 40' ' ' SER . 8.7 tp -146.09 104.7 3.85 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.073 -173.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -98.84 115.38 28.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.486 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.455 ' HB2' ' OD1' ' B' ' 17' ' ' ASN . 11.1 mp -89.05 165.93 14.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.817 0.818 . . . . 0.0 111.547 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 68.4 m -147.55 142.24 26.67 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.186 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.54 117.72 33.11 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.885 -171.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . 0.455 HD21 ' NE2' ' B' ' 35' ' ' GLN . 59.9 t30 -140.88 59.53 1.53 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.258 172.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 49.75 -87.09 0.01 OUTLIER Glycine 0 C--N 1.339 0.71 0 O-C-N 124.305 1.003 . . . . 0.0 115.133 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -66.35 -15.33 63.19 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.853 0.461 . . . . 0.0 111.6 -174.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.455 ' NE2' HD21 ' B' ' 32' ' ' ASN . 14.1 pt20 -132.56 149.01 52.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.057 0.932 . . . . 0.0 112.505 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.431 ' HB3' ' HB ' ' B' ' 84' ' ' ILE . 19.0 tp -112.45 101.67 9.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.604 -1.634 . . . . 0.0 107.964 170.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.4 ' HD3' ' CD ' ' B' ' 35' ' ' GLN . 35.5 mtmt -102.58 152.41 21.21 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.008 -1.451 . . . . 0.0 108.753 -172.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.86 156.93 2.91 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 1.3 p -126.27 144.94 50.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.982 175.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 16.2 m -144.02 151.31 39.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -175.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.528 ' HB2' ' CE ' ' B' ' 26' ' ' LYS . 20.1 m -138.02 158.49 44.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.288 170.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . 0.484 ' C ' ' H ' ' B' ' 44' ' ' GLY . 48.7 m-80 -109.63 46.01 1.04 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.896 -173.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.67 22.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.658 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.531 ' O ' HD13 ' B' ' 47' ' ' ILE . . . 165.9 -49.82 0.27 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.517 ' HA ' ' H ' ' B' ' 25' ' ' GLY . 7.3 p90 53.25 -177.75 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.0 1.32 . . . . 0.0 113.856 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.5 ' C ' HD11 ' B' ' 47' ' ' ILE . . . -70.74 105.76 1.69 Allowed Glycine 0 C--N 1.337 0.604 0 CA-C-N 116.014 -0.539 . . . . 0.0 113.934 -170.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.531 HD13 ' O ' ' B' ' 44' ' ' GLY . 3.4 mm -113.13 -70.0 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.988 0.423 . . . . 0.0 110.748 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.0 m -61.85 -51.75 66.96 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.816 0.817 . . . . 0.0 110.404 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -59.86 108.81 0.81 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.929 -1.487 . . . . 0.0 109.111 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.486 ' HB2' ' H ' ' B' ' 51' ' ' ASP . 0.0 OUTLIER -81.02 -157.8 0.18 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.849 0.357 . . . . 0.0 111.195 -176.67 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.486 ' H ' ' HB2' ' B' ' 50' ' ' GLU . 9.6 p-10 -74.88 108.9 7.92 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.228 1.013 . . . . 0.0 111.152 -173.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 44.3 mttm -122.51 125.57 46.03 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.724 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -108.16 136.02 48.53 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.899 0.38 . . . . 0.0 110.848 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.655 ' CZ3' HG22 ' B' ' 91' ' ' ILE . 21.9 p-90 -147.89 158.87 44.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.251 171.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.44 143.77 15.22 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.224 -174.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.47 ' O ' HG12 ' B' ' 63' ' ' VAL . 6.0 mt -102.84 143.1 15.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 173.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.582 ' HB2' ' HB2' ' B' ' 90' ' ' GLU . 55.4 m-85 -124.4 140.95 52.47 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.534 -176.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.47 HG13 ' ND2' ' B' ' 59' ' ' ASN . 9.1 p -128.49 134.87 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.47 ' ND2' HG13 ' B' ' 58' ' ' VAL . 2.1 m-80 60.91 13.32 4.42 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.95 -174.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.4 -0.88 63.88 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.631 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 23.1 mt-10 -104.81 172.95 6.52 Favored 'General case' 0 C--O 1.207 -1.16 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.408 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 12.0 tppt? -61.28 164.71 5.15 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.47 HG12 ' O ' ' B' ' 56' ' ' ILE . 8.8 p -146.91 -22.66 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 167.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.431 ' CE2' ' CG1' ' B' ' 79' ' ' ILE . 2.2 t80 -171.68 144.66 1.87 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.989 -173.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 78.2 m -133.31 128.46 35.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.649 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.691 ' CD2' HG22 ' B' ' 75' ' ' ILE . 14.3 p90 -158.96 -171.39 3.38 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.221 0.534 . . . . 0.0 110.799 -176.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.7 t-20 -151.57 144.15 24.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.317 -166.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . 0.452 ' OE1' ' HB2' ' B' ' 52' ' ' LYS . 2.4 mp0 -63.99 -34.25 77.57 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -78.93 -18.25 54.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.235 0.541 . . . . 0.0 110.125 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.446 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 3.1 t -71.64 -8.12 52.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.679 ' O ' HG13 ' B' ' 75' ' ' ILE . 7.5 p 65.08 112.28 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.687 -1.597 . . . . 0.0 112.372 173.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.415 ' HA ' ' CD1' ' B' ' 75' ' ' ILE . 2.9 m -61.02 -15.14 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.449 -170.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' B' ' 40' ' ' SER . . . -67.06 -50.49 45.89 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.288 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -75.2 -19.17 59.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.491 0.662 . . . . 0.0 109.506 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.691 HG22 ' CD2' ' B' ' 66' ' ' PHE . 49.6 mt -73.64 -53.61 17.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.015 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.404 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 43.5 t -55.87 -33.05 64.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.12 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -52.0 -48.19 64.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.126 173.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.67 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 5.7 m-20 -70.54 -41.45 72.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.131 177.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.431 ' CG1' ' CE2' ' B' ' 64' ' ' TYR . 58.2 mt -54.55 -37.74 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.0 0.429 . . . . 0.0 111.381 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -58.12 -34.57 70.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.396 177.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.67 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 18.8 pttp -85.07 -31.0 23.62 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.663 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.01 -26.75 68.42 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.778 0.323 . . . . 0.0 110.23 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 4.8 t30 42.54 69.84 0.34 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.456 -172.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.448 ' H ' ' CD1' ' B' ' 84' ' ' ILE . 2.6 mp -59.13 131.18 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.017 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -86.47 -170.74 3.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.842 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.95 111.66 0.67 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.348 -0.929 . . . . 0.0 112.607 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 19.3 tpp -150.08 -68.58 0.2 Allowed 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -127.96 84.83 2.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 45.5 mm -85.73 130.77 35.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.983 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.582 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 27.7 mt-10 -123.7 150.19 44.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.034 0.445 . . . . 0.0 111.526 175.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.655 HG22 ' CZ3' ' B' ' 54' ' ' TRP . 83.6 mt -129.74 125.61 61.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.491 176.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.487 ' HE3' ' CE2' ' B' ' 57' ' ' PHE . 14.9 pttp -167.57 164.97 14.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.131 0.491 . . . . 0.0 111.504 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -95.47 134.59 38.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.125 -174.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.554 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.2 pt . . . . . 0 C--O 1.247 0.938 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.682 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' MET . . . . . 0.674 ' SD ' ' HA ' ' B' ' 34' ' ' ASN . 75.2 mtm . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -56.75 -32.31 65.45 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.994 0.902 . . . . 0.0 110.044 173.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.549 ' O ' HG23 ' B' ' 16' ' ' VAL . 3.4 m -69.76 -30.75 68.41 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.253 -175.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' B' ' 10' ' ' MET . 11.3 mm -68.97 -35.86 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.914 -172.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . 0.64 ' N ' HD21 ' B' ' 14' ' ' ASN . 0.7 OUTLIER -69.02 -32.17 71.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.085 -178.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 32.8 t -69.48 -35.13 75.29 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.016 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.549 HG23 ' O ' ' B' ' 12' ' ' SER . 15.7 t -64.22 -42.47 95.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.691 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . 0.443 ' ND2' HD23 ' B' ' 29' ' ' LEU . 5.2 t-20 -57.59 -38.18 74.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.227 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.13 -40.05 32.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.216 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -65.13 -57.04 9.59 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.439 0.696 . . . . 0.0 112.455 -176.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 43.6 mt -68.75 -31.39 70.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.703 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.84 61.05 5.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.284 0.564 . . . . 0.0 110.529 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -121.59 -86.73 0.65 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.082 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.82 51.06 0.84 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.75 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.523 ' HE2' ' O ' ' B' ' 68' ' ' GLU . 31.5 mmtp -114.16 -161.43 0.77 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.01 -175.48 29.05 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.139 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.812 ' O ' ' HA ' ' B' ' 40' ' ' SER . 16.4 ptpt -67.76 105.15 1.84 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 174.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' B' ' 39' ' ' THR . 17.8 tp -119.24 128.17 53.93 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.442 -162.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 67.3 m -117.87 126.05 51.65 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.164 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.447 ' N ' HD21 ' B' ' 29' ' ' LEU . 1.7 mm? -104.83 147.88 27.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.117 0.484 . . . . 0.0 110.343 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 11.3 p -142.67 150.2 39.87 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.199 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 73.7 mtp -114.39 136.33 53.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.093 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -144.34 115.98 8.17 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.15 -107.28 2.05 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.674 ' HA ' ' SD ' ' B' ' 10' ' ' MET . 2.6 m-20 -123.67 14.83 9.44 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.468 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 75.1 mt-30 -78.48 162.07 26.62 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.304 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.422 HD21 HD12 ' B' ' 29' ' ' LEU . 6.1 tt -133.15 123.15 25.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.347 168.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -118.59 143.88 46.49 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -139.81 143.96 37.09 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.062 -0.655 . . . . 0.0 112.333 -170.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 8.6 p -128.02 141.63 51.46 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.105 175.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.812 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 21.2 p -153.13 145.25 23.81 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.713 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.446 ' HB2' ' CG ' ' B' ' 26' ' ' LYS . 16.9 m -113.18 167.16 10.78 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.367 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -78.88 47.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.194 -172.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.62 -59.82 2.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.015 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.494 ' O ' HD13 ' B' ' 47' ' ' ILE . . . -154.7 55.26 0.42 Allowed Glycine 0 C--N 1.313 -0.746 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.764 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.593 ' O ' HG13 ' B' ' 47' ' ' ILE . 41.4 p90 -77.63 160.16 28.71 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -172.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' B' ' 69' ' ' LYS . . . 14.87 76.5 0.01 OUTLIER Glycine 0 C--N 1.337 0.636 0 O-C-N 125.269 1.606 . . . . 0.0 116.498 168.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.593 HG13 ' O ' ' B' ' 45' ' ' TYR . 1.3 mp -106.75 -72.34 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-O 122.204 1.002 . . . . 0.0 111.684 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -88.33 -152.99 0.23 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.56 -1.655 . . . . 0.0 111.374 -170.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.508 ' O ' ' HE3' ' B' ' 52' ' ' LYS . 64.5 m-85 70.85 6.98 6.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.746 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 56.47 -81.36 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 124.245 0.966 . . . . 0.0 111.674 -175.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -167.28 110.43 0.68 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.508 ' HE3' ' O ' ' B' ' 49' ' ' TYR . 31.9 mmtp -129.61 124.09 32.89 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -104.34 128.13 52.1 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.547 ' HA ' HG12 ' B' ' 94' ' ' ILE . 50.0 p-90 -144.7 157.28 44.25 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -126.34 150.6 17.75 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.334 -170.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.621 HD11 ' CD2' ' B' ' 64' ' ' TYR . 28.6 mt -106.57 149.93 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 169.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.705 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 84.3 m-85 -131.52 142.69 50.0 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -169.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.555 HG12 ' ND2' ' B' ' 59' ' ' ASN . 7.9 p -131.67 140.51 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.555 ' ND2' HG12 ' B' ' 58' ' ' VAL . 8.7 m-80 66.76 0.11 1.79 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -170.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' B' ' 58' ' ' VAL . . . 97.22 0.24 59.88 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.37 -172.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' B' ' 58' ' ' VAL . 12.5 mt-10 -102.78 176.1 5.27 Favored 'General case' 0 C--O 1.201 -1.491 0 C-N-CA 123.716 0.806 . . . . 0.0 109.254 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.444 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.1 tppp? -62.37 160.37 13.5 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 118.633 0.651 . . . . 0.0 110.395 175.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.444 ' N ' ' HG3' ' B' ' 62' ' ' LYS . 8.5 p -152.97 -15.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.507 168.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.621 ' CD2' HD11 ' B' ' 56' ' ' ILE . 0.8 OUTLIER -160.43 126.19 4.01 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -172.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 23.9 m -134.51 126.32 29.12 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.189 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.428 ' CB ' HD12 ' B' ' 75' ' ' ILE . 3.9 p90 -166.96 -175.16 2.93 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.533 0.682 . . . . 0.0 110.424 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 10.0 t-20 -128.77 168.27 16.11 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.093 -170.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . 0.523 ' O ' ' HE2' ' B' ' 24' ' ' LYS . 8.9 mm-40 -85.81 -11.08 54.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.871 0.367 . . . . 0.0 110.955 -177.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.471 ' O ' ' HA3' ' B' ' 46' ' ' GLY . 51.1 tttm -100.78 -26.1 13.9 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 21.5 t -63.88 152.07 40.76 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.811 0.815 . . . . 0.0 108.989 174.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.445 ' O ' HG13 ' B' ' 75' ' ' ILE . 0.1 OUTLIER -99.26 109.59 22.22 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.113 -173.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.481 ' HA ' ' CD1' ' B' ' 75' ' ' ILE . 3.6 m -67.33 -14.47 18.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.425 -167.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.54 -47.96 88.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.675 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -74.42 -32.84 62.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.045 0.45 . . . . 0.0 110.609 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.516 ' O ' HG12 ' B' ' 79' ' ' ILE . 1.4 mt -70.33 -51.33 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.127 0.489 . . . . 0.0 110.274 -177.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.455 ' N ' ' HH ' ' B' ' 64' ' ' TYR . 16.6 t -61.94 -28.77 69.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.563 -176.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -50.67 -53.5 30.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.527 0.679 . . . . 0.0 110.268 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.744 ' O ' ' HG3' ' B' ' 81' ' ' LYS . 0.8 OUTLIER -69.29 -43.07 74.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.099 179.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.53 HG13 ' CE1' ' B' ' 64' ' ' TYR . 42.8 mm -51.77 -37.98 21.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.266 0.555 . . . . 0.0 111.718 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -66.27 -28.42 68.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.326 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.744 ' HG3' ' O ' ' B' ' 78' ' ' ASP . 0.0 OUTLIER -84.6 -0.43 53.23 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.758 -176.582 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 3.1 mm? -72.78 -11.84 60.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.232 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 62.6 t30 50.61 58.97 4.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.634 -172.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.468 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 68.9 mt -61.59 150.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.375 -173.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.425 ' O ' HG21 ' B' ' 84' ' ' ILE . 64.8 mttm -103.26 -178.53 3.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.381 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.471 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -139.62 115.3 1.08 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.795 -1.193 . . . . 0.0 113.805 -177.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.423 ' HG2' ' N ' ' B' ' 88' ' ' TYR . 1.7 pmm? -165.25 -57.64 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 175.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . 0.423 ' N ' ' HG2' ' B' ' 87' ' ' MET . 15.7 t80 -129.31 83.23 2.13 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 121.611 -0.681 . . . . 0.0 109.778 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.705 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 23.4 mm -92.21 121.9 43.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.222 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -109.14 171.54 7.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.985 0.421 . . . . 0.0 109.933 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.467 ' CG1' ' HB3' ' B' ' 12' ' ' SER . 30.4 mm -152.94 115.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.677 -175.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -169.18 165.79 10.93 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.177 0.513 . . . . 0.0 111.875 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.482 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 3.1 pp0? -82.76 143.61 30.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.854 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.547 HG12 ' HA ' ' B' ' 54' ' ' TRP . 6.2 pt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.868 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.455 -0.183 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -47.44 -32.47 5.11 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.504 ' CB ' ' HB ' ' B' ' 89' ' ' ILE . 12.2 m -65.49 -27.23 68.34 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.99 -173.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mm -67.4 -47.06 82.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 122.079 0.942 . . . . 0.0 109.392 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -59.23 -32.6 70.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.285 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.471 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 9.9 t -68.51 -42.28 78.79 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.801 177.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.471 HG23 ' O ' ' B' ' 12' ' ' SER . 97.7 t -55.26 -42.75 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.128 0.49 . . . . 0.0 110.379 177.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . 0.489 ' ND2' ' HB2' ' B' ' 29' ' ' LEU . 2.3 t-20 -56.73 -45.66 81.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.758 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.92 -38.9 52.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.237 -175.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' B' ' 15' ' ' SER . 24.1 mmmt -78.5 -8.26 58.36 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -172.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.427 HD22 ' CZ ' ' B' ' 66' ' ' PHE . 15.6 mt -91.63 23.43 3.54 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . 0.531 ' CG ' ' H ' ' B' ' 22' ' ' LYS . 20.3 p-10 -88.73 -79.34 0.31 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 171.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.531 ' H ' ' CG ' ' B' ' 21' ' ' ASN . 28.7 mtpp 48.61 34.01 4.65 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 169.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 146.8 -92.38 0.15 Allowed Glycine 0 N--CA 1.439 -1.167 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.472 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.569 ' HD2' ' CD1' ' B' ' 47' ' ' ILE . 58.0 mttm -152.84 -141.75 0.11 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -171.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.662 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . 68.05 111.75 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.8 -173.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' B' ' 40' ' ' SER . 0.3 OUTLIER -63.0 115.44 4.41 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 173.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.491 HD21 ' CG2' ' B' ' 72' ' ' VAL . 4.0 tp -152.85 105.08 2.91 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 72.4 m -97.76 113.92 25.81 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.344 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.489 ' HB2' ' ND2' ' B' ' 17' ' ' ASN . 2.8 mm? -86.75 159.85 19.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.477 0.656 . . . . 0.0 110.59 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.541 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 0.1 OUTLIER -151.11 147.66 27.34 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.313 173.52 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 58.8 mtm -118.81 141.09 48.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.149 0.5 . . . . 0.0 111.839 -168.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . 0.501 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 49.6 t30 -150.55 60.48 0.95 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.405 173.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.78 -92.83 0.01 OUTLIER Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.2 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.35 -18.17 57.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.774 -0.213 . . . . 0.0 111.328 -177.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 68.5 mt-30 -101.53 147.0 26.9 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.666 0.746 . . . . 0.0 111.422 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.19 104.81 9.4 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.506 174.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.541 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 8.1 mmmm -102.56 142.73 33.25 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -172.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -162.92 145.1 10.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -174.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 7.9 p -122.13 143.18 49.7 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 172.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 20.3 m -137.15 155.45 49.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.45 0.643 . . . . 0.0 112.256 -173.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.409 ' HB3' ' CB ' ' B' ' 26' ' ' LYS . 32.5 t -137.87 154.53 49.47 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.618 176.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -105.93 37.05 2.35 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.924 -170.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.23 23.12 0.29 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.591 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.45 -56.71 0.41 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.728 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.662 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 14.8 p90 47.58 -161.88 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.48 1.112 . . . . 0.0 113.784 175.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.592 ' HA2' ' OH ' ' B' ' 49' ' ' TYR . . . -69.07 104.7 1.31 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 116.34 -0.391 . . . . 0.0 113.358 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.569 ' CD1' ' HD2' ' B' ' 24' ' ' LYS . 2.1 mp -100.28 -71.33 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 122.11 0.957 . . . . 0.0 110.685 179.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 18.4 m -99.75 -118.65 0.15 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.036 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.592 ' OH ' ' HA2' ' B' ' 46' ' ' GLY . 0.1 OUTLIER 38.46 45.86 0.89 Allowed 'General case' 0 N--CA 1.472 0.625 0 O-C-N 123.693 0.621 . . . . 0.0 111.226 -171.315 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 48.55 -94.5 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.836 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.412 ' CG ' HD22 ' B' ' 67' ' ' ASN . 18.1 t70 -174.41 109.85 0.14 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -177.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.625 ' HB2' ' OE2' ' B' ' 68' ' ' GLU . 47.4 mmtt -123.26 136.84 54.9 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -174.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.41 ' CG ' HD21 ' B' ' 67' ' ' ASN . 47.2 m-80 -120.1 140.32 51.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.799 0.333 . . . . 0.0 111.344 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.602 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 22.2 p-90 -156.23 172.02 19.19 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.505 172.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.7 147.07 19.0 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.661 -173.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 25.0 mt -107.14 146.32 13.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 170.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 60.3 m-85 -126.63 143.89 51.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.426 -174.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.563 HG12 ' ND2' ' B' ' 59' ' ' ASN . 7.1 p -129.68 136.43 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.563 ' ND2' HG12 ' B' ' 58' ' ' VAL . 1.6 m-80 59.13 14.93 3.77 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.118 0.567 . . . . 0.0 109.842 -174.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.37 -1.5 66.95 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.496 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 14.6 mt-10 -105.86 177.5 4.83 Favored 'General case' 0 C--O 1.205 -1.266 0 C-N-CA 123.644 0.778 . . . . 0.0 109.162 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.486 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.2 tppp? -66.14 163.04 18.43 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 172.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.491 ' HB ' ' CG1' ' B' ' 58' ' ' VAL . 11.3 p -151.48 -21.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.104 0.478 . . . . 0.0 109.877 167.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.671 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.6 OUTLIER -161.31 123.46 3.02 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.163 0.506 . . . . 0.0 110.845 -171.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 8.6 m -129.48 129.4 44.55 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.421 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.475 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.0 OUTLIER -153.01 -176.7 5.88 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 122.261 1.029 . . . . 0.0 111.875 -176.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.412 HD22 ' CG ' ' B' ' 51' ' ' ASP . 23.9 t-20 -147.28 149.09 32.19 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 112.897 -1.956 . . . . 0.0 108.365 -176.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . 0.625 ' OE2' ' HB2' ' B' ' 52' ' ' LYS . 0.4 OUTLIER -66.48 -21.1 66.18 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -172.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.434 ' O ' HG23 ' B' ' 71' ' ' THR . 85.4 tttt -95.88 -20.91 18.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.226 0.536 . . . . 0.0 110.011 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 6.7 t -69.88 -23.63 63.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.674 174.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.568 HG22 ' CD1' ' B' ' 45' ' ' TYR . 19.2 p 61.87 107.13 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.313 1.045 . . . . 0.0 111.878 174.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.491 ' CG2' HD21 ' B' ' 27' ' ' LEU . 6.0 m -64.41 -16.47 19.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.606 -169.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.07 -48.5 82.48 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.269 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -75.43 -28.91 59.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.285 0.564 . . . . 0.0 110.572 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.504 ' O ' HG12 ' B' ' 79' ' ' ILE . 2.9 mt -73.0 -47.83 46.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.595 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 42.1 m -52.08 -35.43 47.61 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.041 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -48.51 -58.26 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.788 0.804 . . . . 0.0 110.336 172.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.553 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 7.1 m-20 -70.31 -35.9 73.97 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.572 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.671 HG13 ' CE1' ' B' ' 64' ' ' TYR . 41.5 mm -58.81 -25.54 29.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.571 0.7 . . . . 0.0 111.729 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -69.18 4.54 1.59 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.406 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 0.1 OUTLIER -105.17 -0.61 26.36 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.132 0.492 . . . . 0.0 110.446 176.134 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.56 -4.46 51.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.999 -169.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . 0.416 HD21 ' C ' ' B' ' 83' ' ' ASN . 0.2 OUTLIER 53.13 58.85 4.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -170.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.4 HD13 HG23 ' B' ' 79' ' ' ILE . 59.8 mt -56.84 155.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.121 -175.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -134.86 -171.69 2.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.882 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -149.47 112.7 0.57 Allowed Glycine 0 C--N 1.309 -0.945 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.463 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.468 ' HG2' ' N ' ' B' ' 88' ' ' TYR . 16.0 ttt -160.29 -76.3 0.06 Allowed 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . 0.468 ' N ' ' HG2' ' B' ' 87' ' ' MET . 49.7 t80 -120.11 94.05 4.26 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.644 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 22.3 mm -96.32 130.52 44.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.672 -177.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 51.3 mm-40 -123.94 154.99 38.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.4 . . . . 0.0 111.528 177.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.5 HG22 ' CZ3' ' B' ' 54' ' ' TRP . 72.2 mt -137.54 126.25 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.646 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.602 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 49.6 pttt -172.62 167.27 5.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.064 0.459 . . . . 0.0 111.262 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.657 ' H ' ' NE2' ' B' ' 93' ' ' GLN . 0.6 OUTLIER -96.77 151.67 19.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.427 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.546 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.9 pt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.038 -0.982 . . . . 0.0 111.038 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' MET . . . . . 0.439 ' O ' HG13 ' B' ' 13' ' ' ILE . 25.8 mmt . . . . . 0 C--O 1.226 -0.183 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -40.25 -19.89 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.42 1.488 . . . . 0.0 114.092 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.428 ' O ' HG22 ' B' ' 16' ' ' VAL . 39.1 t -60.09 -7.3 1.76 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.569 0.747 . . . . 0.0 112.325 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.439 HG13 ' O ' ' B' ' 10' ' ' MET . 0.6 OUTLIER -47.91 -62.27 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.347 0 CA-C-O 121.224 0.535 . . . . 0.0 111.916 -176.064 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -106.67 -20.77 13.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.792 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 30.9 t -53.61 -38.35 63.93 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.164 -175.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.428 HG22 ' O ' ' B' ' 12' ' ' SER . 90.1 t -57.19 -41.93 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 111.211 -176.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . 0.417 ' HA ' HD21 ' B' ' 29' ' ' LEU . 4.9 t-20 -67.05 -41.53 86.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.668 -176.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.07 -38.9 56.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.0 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 6.4 mmpt? -57.88 -66.22 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.484 HD23 ' CZ ' ' B' ' 66' ' ' PHE . 75.3 mt -59.1 -23.02 61.72 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.269 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -86.74 79.8 8.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.713 0.768 . . . . 0.0 110.711 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' B' ' 19' ' ' LYS . 29.7 mtpp -119.14 37.3 4.17 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.97 177.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.65 59.5 3.48 Favored Glycine 0 CA--C 1.505 -0.59 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -125.45 -163.44 1.2 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.437 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -53.54 139.94 34.26 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.175 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' B' ' 40' ' ' SER . 43.1 mtmt -61.76 107.9 0.91 Allowed 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 117.036 0.418 . . . . 0.0 109.96 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.572 ' HA ' ' O ' ' B' ' 39' ' ' THR . 36.7 tp -125.41 122.58 37.14 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.853 -167.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 18.2 m -101.61 101.9 12.52 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.542 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.479 HD11 ' N ' ' B' ' 29' ' ' LEU . 4.9 mp -90.69 150.94 21.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 122.02 0.914 . . . . 0.0 112.485 -170.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 34.3 p -146.65 149.8 34.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.778 -1.555 . . . . 0.0 107.893 173.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 78.3 mtp -120.74 160.85 22.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.244 0.545 . . . . 0.0 111.811 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -159.09 104.94 1.72 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.599 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.91 -97.59 0.74 Allowed Glycine 0 CA--C 1.504 -0.604 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -169.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -137.17 19.77 2.98 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 168.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -77.68 155.14 31.52 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.927 175.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.468 ' O ' HG21 ' B' ' 79' ' ' ILE . 2.0 tm? -126.45 116.99 21.99 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.18 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -120.97 133.01 55.26 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.726 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -162.82 150.44 13.56 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -170.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 18.4 p -112.14 148.11 34.69 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.699 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 7.7 p -134.34 146.47 49.97 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -170.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 47.3 t -118.82 165.26 14.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.399 167.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -113.93 18.72 17.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.165 0.507 . . . . 0.0 111.238 -172.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.75 -61.45 2.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.181 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.54 53.94 0.56 Allowed Glycine 0 C--N 1.311 -0.807 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.985 -176.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.437 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 0.1 OUTLIER -63.65 -165.69 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.03 0.532 . . . . 0.0 112.192 -177.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.45 ' H ' ' CG2' ' B' ' 71' ' ' THR . . . -70.33 106.66 1.9 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.154 175.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 4.7 mm -64.0 -68.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.974 0.416 . . . . 0.0 110.173 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.0 m -123.28 -90.79 0.56 Allowed 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.18 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 56.15 33.91 22.91 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 122.761 0.424 . . . . 0.0 111.332 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 34.02 -109.62 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.727 -1.124 . . . . 0.0 113.111 -175.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -150.65 110.52 4.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.828 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -131.53 135.16 46.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.521 HD21 ' N ' ' B' ' 53' ' ' ASN . 0.8 OUTLIER -111.5 136.09 51.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.846 0.355 . . . . 0.0 110.156 -179.446 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.656 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 48.0 p-90 -151.2 166.99 29.19 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 172.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.71 159.4 26.86 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 119.989 -1.1 . . . . 0.0 113.711 -170.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 13.3 mt -105.7 142.85 17.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 171.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.577 ' CE1' ' HG3' ' B' ' 62' ' ' LYS . 48.8 m-85 -126.23 131.29 51.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.998 -0.092 . . . . 0.0 110.756 -177.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.481 HG13 ' ND2' ' B' ' 59' ' ' ASN . 12.2 p -116.26 133.86 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.276 -177.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.481 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.8 m-80 65.78 5.01 3.15 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.719 0.808 . . . . 0.0 110.263 -177.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.61 11.9 56.4 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.829 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 14.8 mt-10 -110.25 173.7 6.21 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 171.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.577 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 24.9 ttmt -76.49 168.77 19.48 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 119.427 1.012 . . . . 0.0 108.971 173.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.426 ' HB ' HG11 ' B' ' 58' ' ' VAL . 8.4 p -151.47 -19.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.804 171.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.645 ' CD2' HD12 ' B' ' 79' ' ' ILE . 0.0 OUTLIER -163.33 153.21 15.4 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.588 -175.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 27.6 m -149.97 130.03 13.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.308 177.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.484 ' CZ ' HD23 ' B' ' 20' ' ' LEU . 0.0 OUTLIER -145.11 -176.76 5.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.724 0.773 . . . . 0.0 110.769 -178.803 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.403 HD21 ' ND2' ' B' ' 53' ' ' ASN . 24.6 t-20 -136.22 160.2 39.41 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.156 -1.384 . . . . 0.0 110.219 -175.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -61.15 -44.25 97.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.865 0.364 . . . . 0.0 111.724 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.554 ' O ' HG22 ' B' ' 71' ' ' THR . 50.3 tptt -80.86 -19.76 43.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.838 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 8.7 t -69.1 -18.38 63.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.402 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.554 HG22 ' O ' ' B' ' 69' ' ' LYS . 41.0 p 56.27 105.93 0.01 OUTLIER 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.304 1.041 . . . . 0.0 113.332 170.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.1 m -57.65 -15.12 3.67 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-N 114.556 -1.202 . . . . 0.0 113.265 -171.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.58 -52.3 46.26 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.979 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -76.45 -32.68 58.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.354 0.597 . . . . 0.0 109.976 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.595 HG21 ' CE2' ' B' ' 64' ' ' TYR . 1.9 mt -72.03 -53.93 18.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.604 -173.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.8 m -69.75 -14.08 62.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.52 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -61.93 -42.24 98.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.768 0.794 . . . . 0.0 109.459 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 4.3 m-20 -68.95 -32.46 72.07 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.529 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.645 HD12 ' CD2' ' B' ' 64' ' ' TYR . 17.7 mm -55.67 -26.35 19.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -54.85 -27.26 40.96 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.296 173.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 19.8 pttm -104.11 -6.14 21.37 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -172.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' B' ' 79' ' ' ILE . 2.8 mm? -70.97 -18.3 62.62 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 122.126 -0.359 . . . . 0.0 111.815 -173.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 61.0 t30 45.97 55.69 6.8 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.972 0.795 . . . . 0.0 110.63 -171.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.479 HG23 ' O ' ' B' ' 85' ' ' LYS . 83.1 mt -59.81 145.5 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.171 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.479 ' O ' HG23 ' B' ' 84' ' ' ILE . 62.3 mttp -89.88 178.27 6.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.32 176.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -134.33 112.58 1.06 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.474 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.24 -79.73 0.09 Allowed 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -122.33 88.07 2.87 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 28.0 mm -90.83 128.66 42.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.912 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 33.8 mt-10 -117.52 144.73 44.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.588 173.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 2.5 mt -134.75 102.81 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.656 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 48.0 pttt -154.65 178.01 10.59 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -169.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.431 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 21.1 mm-40 -99.01 146.8 25.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.163 -176.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.611 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.9 pt . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.305 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 15.0 mmt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.362 0.601 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -66.5 -28.26 68.43 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.956 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 24.2 m -71.45 -21.12 62.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.712 -175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mm -61.93 -47.4 93.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 122.07 0.938 . . . . 0.0 109.196 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -63.69 -38.39 90.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.405 -177.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -62.2 -44.27 96.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.934 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.96 -48.0 91.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.096 0.474 . . . . 0.0 110.329 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -60.11 -37.05 78.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.882 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . 0.667 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.2 OUTLIER -71.32 -57.47 4.43 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.377 176.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -55.59 -49.96 71.38 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.059 0.944 . . . . 0.0 112.85 -173.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.441 HD22 ' CZ ' ' B' ' 66' ' ' PHE . 47.2 mt -71.17 -21.06 62.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.963 -175.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -91.94 -99.55 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.667 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 30.6 mtpp 49.9 25.79 1.74 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.67 11.22 60.84 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.933 178.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -96.25 -129.08 0.16 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 175.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.538 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -66.87 107.29 1.94 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 173.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.733 ' O ' ' HA ' ' B' ' 40' ' ' SER . 34.9 mtmt -66.97 90.08 0.18 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.846 0.314 . . . . 0.0 111.846 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 47.1 tp -108.47 93.14 4.37 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 21.0 m -81.24 105.47 12.46 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.264 -176.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.41 165.24 22.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.946 0.879 . . . . 0.0 111.601 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 49.1 m -146.49 144.35 29.58 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.363 174.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 33.9 mtt -114.26 124.1 51.19 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.817 0.341 . . . . 0.0 110.945 -170.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.83 60.04 1.32 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.662 176.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . 0.407 ' O ' ' HA3' ' B' ' 86' ' ' GLY . . . 49.55 -102.9 0.07 OUTLIER Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.248 -0.887 . . . . 0.0 113.861 178.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.441 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 4.6 m-20 -79.44 19.37 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.271 0.229 . . . . 0.0 111.435 -176.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 42.9 mt-30 -139.13 146.28 40.45 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.317 0.58 . . . . 0.0 110.472 172.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -129.05 116.66 19.64 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 176.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.46 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 16.1 mtpt -118.09 148.87 41.86 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -172.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -170.58 145.6 2.58 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -176.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 19.5 p -122.68 141.62 51.57 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.548 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.733 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 24.1 t -122.53 147.51 46.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.363 0.601 . . . . 0.0 112.163 -174.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.532 ' HB3' ' HB2' ' B' ' 26' ' ' LYS . 46.8 t -131.67 160.85 34.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.813 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' B' ' 44' ' ' GLY . 51.1 m-80 -114.1 32.84 5.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.115 -171.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.425 ' HB3' ' HE2' ' B' ' 26' ' ' LYS . . . -72.96 22.46 0.07 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.306 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' B' ' 42' ' ' ASN . . . 165.34 -43.97 0.29 Allowed Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.538 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 37.1 p90 46.04 -160.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.355 1.062 . . . . 0.0 113.013 -175.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.55 99.39 0.73 Allowed Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.842 -0.694 . . . . 0.0 114.17 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.06 -54.73 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.1 0.476 . . . . 0.0 109.782 170.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -37.93 -57.97 0.98 Allowed 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.285 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -103.81 112.91 26.08 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' B' ' 69' ' ' LYS . 30.5 mt-10 -67.75 -48.38 66.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.616 -170.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -167.22 111.93 0.72 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.443 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -132.39 142.18 49.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.848 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.59 113.87 26.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.522 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 29.1 p-90 -154.12 165.7 35.38 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.345 176.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.12 150.45 20.19 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.844 -174.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.429 HD13 ' CD2' ' B' ' 64' ' ' TYR . 24.3 mt -106.35 150.41 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 172.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.563 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 70.7 m-85 -131.9 139.43 48.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.128 -172.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.502 HG12 ' ND2' ' B' ' 59' ' ' ASN . 8.6 p -125.17 133.39 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.502 ' ND2' HG12 ' B' ' 58' ' ' VAL . 5.4 m-80 64.12 5.88 2.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.859 -175.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.87 -12.21 38.16 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.435 -176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' B' ' 58' ' ' VAL . 0.2 OUTLIER -100.17 177.22 5.13 Favored 'General case' 0 C--O 1.202 -1.421 0 C-N-CA 123.713 0.805 . . . . 0.0 109.938 -176.708 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.473 ' HD2' ' OG1' ' B' ' 65' ' ' THR . 13.1 tppt? -61.44 159.45 12.74 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 118.279 0.491 . . . . 0.0 110.485 174.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.439 ' HB ' ' CG1' ' B' ' 58' ' ' VAL . 8.1 p -153.7 -14.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.262 0.553 . . . . 0.0 110.389 167.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.758 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -161.14 133.99 6.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.184 -173.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.473 ' OG1' ' HD2' ' B' ' 62' ' ' LYS . 16.4 m -142.18 126.0 17.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.02 177.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.441 ' CZ ' HD22 ' B' ' 20' ' ' LEU . 0.0 OUTLIER -166.16 -177.8 4.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 122.567 1.175 . . . . 0.0 112.29 -174.26 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -136.83 145.9 45.0 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 112.349 -2.205 . . . . 0.0 108.736 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.3 -29.3 65.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.186 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.431 ' O ' HG23 ' B' ' 71' ' ' THR . 28.2 ttpp -80.99 -25.94 36.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.99 0.424 . . . . 0.0 110.599 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 9.8 t -68.05 -31.64 71.42 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 174.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.474 ' O ' HG13 ' B' ' 75' ' ' ILE . 11.1 p 62.77 125.08 0.01 OUTLIER 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.548 1.139 . . . . 0.0 112.614 174.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 m -63.92 -10.75 8.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.356 -168.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.92 -56.31 23.57 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.663 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -76.48 -31.28 57.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.39 0.614 . . . . 0.0 110.265 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.474 HG13 ' O ' ' B' ' 71' ' ' THR . 2.8 mt -67.93 -46.24 82.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.649 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.401 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 38.2 t -59.16 -32.71 70.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.693 -178.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -49.04 -52.42 25.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.66 0.743 . . . . 0.0 110.286 176.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.459 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 30.3 m-20 -67.7 -47.32 69.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.018 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.758 HG13 ' CE1' ' B' ' 64' ' ' TYR . 46.2 mm -55.16 -30.75 24.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.262 0.553 . . . . 0.0 112.065 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -58.6 -20.01 43.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.269 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.566 ' HZ3' ' HB2' ' B' ' 81' ' ' LYS . 0.0 OUTLIER -94.56 -4.0 48.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 0.0 111.058 -175.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.447 HD21 ' HA ' ' B' ' 79' ' ' ILE . 3.1 mm? -70.5 -16.26 62.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.99 -173.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 58.9 t30 50.84 57.64 6.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.461 -171.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' B' ' 35' ' ' GLN . 48.9 mt -57.63 144.08 10.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.94 -174.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 30.3 mtmm -109.03 -168.58 1.36 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.112 175.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' B' ' 33' ' ' GLY . . . -146.25 113.58 0.69 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.925 -177.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 37.4 ttp -157.34 -74.09 0.09 Allowed 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 116.639 0.22 . . . . 0.0 110.458 173.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -117.32 94.24 4.48 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.181 0.515 . . . . 0.0 109.694 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 20.4 mm -93.57 134.66 30.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.384 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -122.89 173.49 7.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.369 0.604 . . . . 0.0 110.937 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.522 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 92.1 mt -152.22 118.85 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.759 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 30.7 pttt -171.26 168.3 6.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.175 0.512 . . . . 0.0 111.768 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.459 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 2.4 pt20 -99.39 150.51 22.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.154 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.2 pt . . . . . 0 C--N 1.308 -1.203 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.972 -174.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' MET . . . . . 0.455 ' O ' ' HE3' ' B' ' 31' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.277 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -36.83 -22.97 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.638 1.975 . . . . 0.0 115.825 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 15.2 m -60.33 -12.5 9.31 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 122.441 0.296 . . . . 0.0 111.792 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.52 -50.36 49.87 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-O 121.732 0.777 . . . . 0.0 109.849 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' B' ' 18' ' ' ASP . 40.0 m-80 -106.82 -60.6 1.65 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.274 -175.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 5.5 m -58.24 -64.49 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.393 -170.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 67.9 t -62.94 -40.5 89.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.449 . . . . 0.0 110.701 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -56.83 -47.14 81.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.827 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . 0.757 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.1 OUTLIER -75.02 -40.54 60.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.273 -178.039 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -52.49 -35.18 52.27 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.016 0.527 . . . . 0.0 112.027 -176.764 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.22 -42.24 11.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.273 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . 0.454 ' OD1' ' HA ' ' B' ' 18' ' ' ASP . 4.3 p-10 -80.45 -2.41 45.7 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.757 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 29.2 mtpp -73.37 -74.29 0.18 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.753 0.311 . . . . 0.0 111.565 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.17 15.93 59.83 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.822 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.563 ' NZ ' ' HA ' ' B' ' 68' ' ' GLU . 26.0 mtpt -129.29 -160.23 1.02 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.168 0.509 . . . . 0.0 110.224 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.483 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -66.03 139.24 38.03 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 173.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' B' ' 40' ' ' SER . 60.3 mttt -62.28 133.91 55.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -175.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.483 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 29.6 tp -141.56 96.57 3.0 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 41.9 m -86.63 126.83 34.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.789 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.483 ' CD1' ' HG ' ' B' ' 27' ' ' LEU . 10.4 mp -107.07 163.75 12.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 122.327 1.06 . . . . 0.0 112.758 -174.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.444 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 3.1 p -160.22 146.06 15.33 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 112.878 -1.965 . . . . 0.0 107.073 171.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' MET . . . . . 0.455 ' HE3' ' O ' ' B' ' 10' ' ' MET . 52.9 mtm -128.67 145.61 51.11 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.582 -172.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . 0.446 ' C ' HD21 ' B' ' 32' ' ' ASN . 0.2 OUTLIER -138.02 61.21 1.6 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.47 -96.82 0.12 Allowed Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.54 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -87.19 25.77 1.31 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.913 0.387 . . . . 0.0 110.791 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.417 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 14.8 mt-30 -137.31 144.82 42.8 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 121.465 0.65 . . . . 0.0 110.627 172.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tt -126.25 105.17 8.64 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.248 -1.342 . . . . 0.0 107.645 175.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.444 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 6.0 mmmm -102.62 138.27 39.74 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -173.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -156.56 147.47 21.95 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -172.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -124.27 155.22 39.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.09 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 6.7 p -135.85 157.52 46.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -172.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 22.8 t -136.43 154.45 50.78 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.776 174.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -115.96 30.39 7.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.812 -171.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.61 23.2 0.12 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.59 -24.26 0.36 Allowed Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.777 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.513 ' HB2' ' HB ' ' B' ' 71' ' ' THR . 52.6 p90 45.37 -156.6 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.167 0.987 . . . . 0.0 113.032 -176.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' B' ' 24' ' ' LYS . . . -69.52 102.98 1.02 Allowed Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.666 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.79 -64.19 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.037 0.446 . . . . 0.0 110.619 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 60.1 m -48.5 -53.66 17.24 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.152 -175.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.532 ' CB ' ' HB3' ' B' ' 68' ' ' GLU . 4.4 m-30 -78.39 127.25 31.93 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.768 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -84.25 -168.62 2.23 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.942 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -60.71 108.63 0.87 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.716 0.77 . . . . 0.0 111.325 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 54.3 mtmt -150.24 140.78 22.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.443 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.54 123.93 40.19 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.993 0.425 . . . . 0.0 111.485 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.517 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 28.1 p-90 -143.33 169.7 17.16 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.085 177.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.16 148.59 20.0 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.126 -173.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 13.5 mt -105.66 150.66 8.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 171.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.677 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 84.3 m-85 -130.56 139.48 50.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -171.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.531 HG11 ' ND2' ' B' ' 59' ' ' ASN . 7.2 p -126.58 134.32 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.531 ' ND2' HG11 ' B' ' 58' ' ' VAL . 4.5 m-80 66.86 -2.32 1.15 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.641 -173.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' B' ' 58' ' ' VAL . . . 108.18 -6.3 34.4 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.552 -172.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 1.9 mp0 -94.47 176.45 6.29 Favored 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 123.896 0.878 . . . . 0.0 109.193 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.432 ' HD3' ' CE1' ' B' ' 57' ' ' PHE . 7.8 tppt? -66.91 161.99 22.81 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.409 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.8 p -153.48 -11.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.08 0.467 . . . . 0.0 110.219 168.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.65 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -160.58 132.39 5.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.547 -175.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 54.9 m -139.01 124.39 19.26 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.288 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.414 ' HB3' HD11 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -164.84 155.6 14.43 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.505 1.145 . . . . 0.0 111.869 -174.667 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 10.7 t-20 -93.41 153.49 18.47 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.038 -1.892 . . . . 0.0 108.352 169.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . 0.563 ' HA ' ' NZ ' ' B' ' 24' ' ' LYS . 7.1 mm-40 -80.63 -4.48 54.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.025 0.44 . . . . 0.0 111.229 -177.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -97.23 -30.66 12.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -60.57 152.49 26.03 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.062 172.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' B' ' 45' ' ' TYR . 0.1 OUTLIER -103.22 115.79 31.24 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.112 -174.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.507 ' HA ' ' CD1' ' B' ' 75' ' ' ILE . 14.3 m -68.98 -12.48 16.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.246 -167.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.29 -46.05 94.72 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.485 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -69.13 -31.78 70.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.439 0.638 . . . . 0.0 110.271 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.576 ' O ' HG12 ' B' ' 79' ' ' ILE . 3.8 mt -74.64 -45.89 43.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.294 -176.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 22.6 t -54.13 -34.45 60.35 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.533 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -51.89 -57.0 10.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.232 173.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.769 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 11.3 m-20 -65.9 -36.53 83.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.676 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.65 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.4 mm -61.98 -33.07 56.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.38 0.609 . . . . 0.0 111.519 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -74.66 1.77 11.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.553 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.769 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 56.6 pttt -110.44 5.62 21.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.39 . . . . 0.0 110.864 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 32.8 mt -86.75 9.35 19.2 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.149 -174.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 63.7 t30 53.15 57.44 6.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -170.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -45.23 146.12 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.597 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.408 ' HB2' HD22 ' B' ' 59' ' ' ASN . 38.5 mtpt -127.63 -171.77 2.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.387 177.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -157.0 113.61 0.57 Allowed Glycine 0 N--CA 1.45 -0.396 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.482 ' HG2' ' N ' ' B' ' 88' ' ' TYR . 15.9 ttt -156.4 -75.7 0.1 Allowed 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 117.057 0.429 . . . . 0.0 110.967 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . 0.482 ' N ' ' HG2' ' B' ' 87' ' ' MET . 60.8 t80 -122.31 101.81 7.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.677 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 28.3 mm -96.25 126.28 48.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.402 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -109.9 171.92 7.16 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 62.2 mt -149.48 107.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.148 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 47.7 pttt -157.45 179.81 8.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.098 0.475 . . . . 0.0 111.687 -177.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 1.5 pt20 -105.13 145.25 30.82 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.93 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.481 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.1 pt . . . . . 0 C--O 1.247 0.926 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.135 -174.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' MET . . . . . 0.514 ' O ' HG12 ' B' ' 13' ' ' ILE . 39.7 tpp . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -35.39 -41.85 0.19 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 5.4 m -65.52 -19.29 65.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.174 -169.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.514 HG12 ' O ' ' B' ' 10' ' ' MET . 7.7 mm -59.85 -39.59 80.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 122.198 0.999 . . . . 0.0 109.423 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -76.7 -28.01 55.7 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.22 -175.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.64 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 12.1 m -63.11 -41.93 99.45 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.821 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 63.9 t -52.7 -44.07 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.508 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -65.25 -41.56 94.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.477 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.49 -29.15 62.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.634 -178.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' B' ' 15' ' ' SER . 27.4 mmmt -71.16 -20.16 62.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.661 0.743 . . . . 0.0 111.387 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 67.1 mt -108.39 -28.15 9.55 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.416 -175.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -80.43 69.96 7.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.372 0.606 . . . . 0.0 110.104 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -133.45 33.87 3.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.954 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.28 48.85 5.49 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -130.94 -152.37 0.51 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' B' ' 45' ' ' TYR . . . -60.3 125.94 40.06 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 171.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.478 ' CB ' ' HB3' ' B' ' 41' ' ' SER . 29.7 mtpp -80.63 130.71 35.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.598 0.714 . . . . 0.0 111.276 -171.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 21.9 tp -150.26 101.57 3.0 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.11 -173.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 15.4 p -85.8 104.09 15.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.933 -174.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 60.0 mt -88.64 151.34 22.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.593 0.711 . . . . 0.0 111.31 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 71.2 m -140.49 143.9 35.73 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.748 175.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' MET . . . . . 0.469 ' SD ' HG23 ' B' ' 13' ' ' ILE . 5.1 mmt -106.79 120.46 42.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.795 0.331 . . . . 0.0 110.845 -167.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 18.3 t-20 -134.29 58.97 1.75 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.267 0.556 . . . . 0.0 109.513 177.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.45 -99.76 0.03 OUTLIER Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.301 -0.863 . . . . 0.0 114.016 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -78.92 4.77 13.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.36 -0.42 . . . . 0.0 111.104 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 37.7 mt-30 -129.98 147.71 51.76 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.673 0.749 . . . . 0.0 110.579 174.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' B' ' 84' ' ' ILE . 1.4 tt -124.11 106.62 10.49 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.354 -1.294 . . . . 0.0 107.615 174.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.434 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 12.2 mmmm -96.92 153.15 18.07 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.505 -170.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -164.93 152.49 11.36 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.774 -171.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.25 171.71 12.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 169.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 16.3 p -131.78 149.95 52.31 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.189 -0.605 . . . . 0.0 111.381 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.478 ' HB3' ' CB ' ' B' ' 26' ' ' LYS . 31.1 t -130.1 155.96 45.33 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.449 0.642 . . . . 0.0 110.791 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -114.61 33.23 5.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.8 -162.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.31 -33.34 67.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.047 0.927 . . . . 0.0 110.181 172.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.33 -121.62 1.03 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 113.923 -1.489 . . . . 0.0 110.37 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.452 ' HB2' ' CG2' ' B' ' 71' ' ' THR . 9.2 p90 -177.92 -166.63 0.12 Allowed 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 120.774 0.321 . . . . 0.0 111.743 -178.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.75 122.76 6.4 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.053 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.04 -61.25 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 CA-C-O 122.36 1.076 . . . . 0.0 109.058 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 2.4 m -57.32 167.67 0.9 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 112.483 -2.144 . . . . 0.0 112.05 -174.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 74.49 10.29 4.2 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.391 -1.731 . . . . 0.0 111.46 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 48.65 -108.95 0.29 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.507 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -130.79 111.66 12.33 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.787 0.803 . . . . 0.0 110.42 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 94.1 mttt -134.07 138.12 45.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.121 176.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -112.47 132.84 54.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.078 0.466 . . . . 0.0 110.665 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.518 ' HA ' HG12 ' B' ' 94' ' ' ILE . 27.6 p-90 -141.88 173.05 11.87 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.016 176.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.65 139.35 10.87 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.567 -173.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.498 HD12 ' CD2' ' B' ' 64' ' ' TYR . 28.3 mt -104.86 151.34 7.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 169.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.715 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 74.9 m-85 -130.45 145.34 51.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -172.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.591 HG12 ' ND2' ' B' ' 59' ' ' ASN . 7.1 p -135.98 140.98 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.591 ' ND2' HG12 ' B' ' 58' ' ' VAL . 8.6 m-80 66.52 3.17 2.76 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -172.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.9 4.11 65.38 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.352 -172.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 3.9 mm-40 -105.84 176.51 5.14 Favored 'General case' 0 C--O 1.202 -1.433 0 C-N-CA 123.618 0.767 . . . . 0.0 109.209 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.51 ' HE3' ' CE1' ' B' ' 57' ' ' PHE . 0.0 OUTLIER -68.26 161.59 26.92 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.493 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.427 ' HB ' HG13 ' B' ' 58' ' ' VAL . 9.6 p -153.79 -12.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.909 0.385 . . . . 0.0 110.698 170.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.791 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.2 OUTLIER -159.52 128.76 5.3 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.207 -173.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 26.5 m -137.72 124.81 21.52 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.546 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' B' ' 66' ' ' PHE . 0.0 OUTLIER -173.47 151.77 2.02 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 122.042 0.925 . . . . 0.0 112.078 -167.404 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 5.4 m120 -97.97 153.04 18.64 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.562 -1.653 . . . . 0.0 110.58 174.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -58.24 -48.06 81.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.806 0.336 . . . . 0.0 111.125 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.58 ' O ' HG21 ' B' ' 71' ' ' THR . 41.4 ttmt -72.59 -16.74 61.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.298 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.6 t -72.31 -15.08 61.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.58 HG21 ' O ' ' B' ' 69' ' ' LYS . 21.4 p 56.17 113.11 0.01 OUTLIER 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.653 1.181 . . . . 0.0 113.756 169.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 5.4 m -62.33 -14.54 12.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.16 -171.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.67 -48.96 63.27 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.404 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 77.0 m-20 -83.81 -36.29 23.62 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.451 0.643 . . . . 0.0 110.578 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.499 HG13 ' O ' ' B' ' 71' ' ' THR . 2.8 mt -64.89 -48.37 84.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.176 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.508 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 14.4 t -66.69 -21.13 66.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.153 -177.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' B' ' 74' ' ' ASN . 0.9 OUTLIER -52.58 -41.32 63.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 171.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.671 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 4.7 m-20 -72.6 -52.77 14.06 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.794 172.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.791 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 51.5 mm -47.42 -38.09 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -59.31 -30.51 68.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.671 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 45.2 pttt -73.86 -20.97 60.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.978 0.418 . . . . 0.0 110.062 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 4.3 mm? -68.66 -18.51 64.29 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.845 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 66.0 t30 39.77 69.07 0.33 Allowed 'General case' 0 C--O 1.235 0.321 0 O-C-N 124.154 0.909 . . . . 0.0 110.21 -171.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.474 HD13 ' H ' ' B' ' 84' ' ' ILE . 3.9 mp -50.23 143.91 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.614 -174.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -98.1 -178.19 3.98 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.841 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -136.75 113.68 1.07 Allowed Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.315 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.456 ' SD ' ' HA ' ' B' ' 59' ' ' ASN . 1.7 pmm? -170.21 -58.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.406 0.282 . . . . 0.0 110.907 171.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . 0.415 ' N ' ' HG2' ' B' ' 87' ' ' MET . 14.2 t80 -130.27 81.25 2.0 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.38 0.536 . . . . 0.0 109.85 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.715 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.3 mp -99.41 120.5 48.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.731 178.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -106.35 176.44 5.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.372 0.606 . . . . 0.0 110.442 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.404 HG22 ' CZ3' ' B' ' 54' ' ' TRP . 30.4 mm -151.87 116.3 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.569 -174.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 40.6 pttt -168.05 159.48 11.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.094 0.473 . . . . 0.0 111.943 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.569 ' H ' ' NE2' ' B' ' 93' ' ' GLN . 0.7 OUTLIER -83.27 152.31 25.22 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.014 172.297 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.518 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.4 pt . . . . . 0 C--N 1.311 -1.066 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.179 -171.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.565 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -41.58 -40.48 1.89 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.536 ' O ' HG21 ' B' ' 16' ' ' VAL . 31.8 m -74.02 -20.95 60.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.212 -172.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.464 HG21 ' SD ' ' B' ' 31' ' ' MET . 10.7 mm -58.85 -44.31 90.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 121.933 0.873 . . . . 0.0 109.284 175.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.9 -36.07 72.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.051 -176.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 19.4 t -63.81 -44.9 91.92 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.098 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.536 HG21 ' O ' ' B' ' 12' ' ' SER . 70.3 t -57.29 -47.62 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.802 0.334 . . . . 0.0 110.457 176.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . 0.405 ' ND2' ' HB2' ' B' ' 29' ' ' LEU . 2.4 t-20 -54.21 -50.56 66.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.864 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.09 -38.74 72.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.215 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -60.17 -52.13 66.65 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.514 0.673 . . . . 0.0 111.496 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 77.3 mt -75.5 -12.75 60.3 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.026 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -118.32 79.48 1.38 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.204 0.526 . . . . 0.0 111.253 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.483 ' HD3' ' OH ' ' B' ' 49' ' ' TYR . 30.1 mtpp -134.76 30.46 3.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.141 0.496 . . . . 0.0 110.667 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.17 45.18 1.91 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.1 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.528 ' HD2' ' OG ' ' B' ' 48' ' ' SER . 12.7 mmtp -90.4 -145.55 0.18 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' B' ' 45' ' ' TYR . . . -74.96 -146.24 1.28 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.74 173.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.494 ' HE3' ' HB3' ' B' ' 41' ' ' SER . 2.6 mtmp? -90.35 110.69 21.76 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -177.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.5 tp -158.75 134.33 8.72 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 74.0 p -131.24 98.77 4.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.041 0.448 . . . . 0.0 111.195 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.405 ' HB2' ' ND2' ' B' ' 17' ' ' ASN . 31.6 mt -83.47 151.39 25.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.416 0.627 . . . . 0.0 111.043 -177.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 54.3 m -148.43 144.69 27.6 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.624 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' MET . . . . . 0.464 ' SD ' HG21 ' B' ' 13' ' ' ILE . 57.8 mtm -109.0 130.45 55.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.92 0.391 . . . . 0.0 111.094 -173.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -137.97 60.12 1.63 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.362 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 51.96 -96.95 0.02 OUTLIER Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.232 -0.894 . . . . 0.0 113.433 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -78.92 -0.58 31.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.726 0.298 . . . . 0.0 111.415 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -125.32 148.9 48.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.805 0.812 . . . . 0.0 111.441 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -128.7 106.84 9.21 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.383 -1.28 . . . . 0.0 107.612 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -107.38 149.21 28.13 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.521 -170.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -170.23 151.61 3.92 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.067 0.229 . . . . 0.0 111.461 -177.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 3.3 p -120.9 138.18 54.23 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 168.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.6 ' CB ' ' HA3' ' B' ' 73' ' ' GLY . 29.6 t -148.26 154.54 40.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.272 0.558 . . . . 0.0 111.431 -170.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.494 ' HB3' ' HE3' ' B' ' 26' ' ' LYS . 47.5 t -144.0 155.51 44.05 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.086 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -90.32 -6.3 55.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.845 -169.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.1 -20.47 65.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.222 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.429 ' O ' ' HA2' ' B' ' 25' ' ' GLY . . . -106.27 -4.21 38.12 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.471 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.642 ' O ' ' HA3' ' B' ' 25' ' ' GLY . 0.0 OUTLIER 78.48 -168.83 0.05 OUTLIER 'General case' 0 C--N 1.342 0.248 0 C-N-CA 123.65 0.78 . . . . 0.0 112.506 179.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.47 46.56 0.83 Allowed Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 167.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -44.73 -69.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.252 0.621 . . . . 0.0 110.567 -174.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.528 ' OG ' ' HD2' ' B' ' 24' ' ' LYS . 9.5 m 60.95 -88.58 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.666 172.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.483 ' OH ' ' HD3' ' B' ' 22' ' ' LYS . 59.3 m-85 -140.56 69.42 1.35 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -173.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 51.95 -94.82 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.369 -176.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -156.28 109.82 2.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.522 -0.763 . . . . 0.0 108.942 171.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 59.3 mttm -141.43 142.9 33.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.072 -175.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.521 HD21 HG13 ' B' ' 94' ' ' ILE . 1.0 OUTLIER -114.27 124.32 51.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.307 0.575 . . . . 0.0 111.856 -176.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.611 ' CZ3' HG22 ' B' ' 91' ' ' ILE . 17.0 p-90 -133.88 171.68 13.84 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.948 174.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.5 143.04 14.35 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.585 -175.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.626 HD11 ' CD2' ' B' ' 64' ' ' TYR . 22.3 mt -108.49 143.33 19.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 173.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.639 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 46.8 m-85 -125.58 143.06 51.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.65 -174.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.574 HG11 ' ND2' ' B' ' 59' ' ' ASN . 9.6 p -128.79 143.41 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.574 ' ND2' HG11 ' B' ' 58' ' ' VAL . 2.0 m-80 59.07 14.4 3.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -171.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.35 -1.56 82.33 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.628 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' B' ' 58' ' ' VAL . 13.5 mt-10 -105.12 160.03 15.38 Favored 'General case' 0 C--O 1.192 -1.973 0 C-N-CA 123.887 0.875 . . . . 0.0 109.268 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.623 ' HA ' ' CD2' ' B' ' 57' ' ' PHE . 1.2 tttm -61.89 164.08 6.86 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 118.233 0.469 . . . . 0.0 110.766 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.53 0.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.17 164.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.682 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -157.67 131.96 8.29 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.209 -0.597 . . . . 0.0 111.101 -173.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 29.6 m -142.85 119.0 10.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.208 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.478 ' CD1' ' CD1' ' B' ' 64' ' ' TYR . 25.4 p90 -171.29 156.41 4.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.058 0.933 . . . . 0.0 112.646 -172.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.542 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 8.2 m120 -100.76 150.78 22.43 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.214 167.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' B' ' 48' ' ' SER . 36.3 mm-40 -58.73 -40.15 82.93 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.153 0.501 . . . . 0.0 110.92 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -65.01 -17.64 64.61 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.63 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 4.9 t -78.74 -0.59 30.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.603 178.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.439 ' O ' HG13 ' B' ' 75' ' ' ILE . 32.5 p 56.69 97.57 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.721 1.208 . . . . 0.0 112.093 176.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.449 ' HA ' ' CD1' ' B' ' 75' ' ' ILE . 2.5 m -57.96 -22.42 18.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.716 -170.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . 0.6 ' HA3' ' CB ' ' B' ' 40' ' ' SER . . . -62.03 -47.94 86.63 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.477 -178.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 77.2 m-20 -66.8 -37.73 85.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.451 0.643 . . . . 0.0 109.825 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.449 ' CD1' ' HA ' ' B' ' 72' ' ' VAL . 3.0 mt -67.06 -42.42 88.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.131 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 30.8 t -51.02 -39.93 56.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.54 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' B' ' 74' ' ' ASN . 0.7 OUTLIER -56.77 -40.67 76.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.887 176.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.77 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 24.0 m-20 -75.47 -40.67 57.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.124 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.682 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.9 mm -63.32 -32.14 55.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.325 0.583 . . . . 0.0 111.261 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.22 -11.03 56.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.593 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.77 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 20.4 pttp -95.93 3.12 53.82 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.543 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' B' ' 79' ' ' ILE . 24.2 mt -85.94 2.72 45.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.173 -176.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 52.66 62.21 2.8 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -169.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 62.1 mt -53.57 151.3 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.18 -174.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -125.08 176.19 6.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.403 176.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -139.36 112.75 0.86 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 173.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.428 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 8.2 tpt -153.7 -82.58 0.08 Allowed 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 117.024 0.412 . . . . 0.0 110.365 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . 0.428 ' N ' ' HG3' ' B' ' 87' ' ' MET . 23.2 t80 -109.08 94.68 5.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.639 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 34.0 mm -98.94 122.63 50.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.037 -173.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.558 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 54.1 mm-40 -116.54 148.21 41.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.428 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.611 HG22 ' CZ3' ' B' ' 54' ' ' TRP . 77.9 mt -127.89 127.74 68.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.592 176.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.51 ' HE3' ' CE1' ' B' ' 57' ' ' PHE . 14.3 pttp -174.53 152.46 1.69 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.03 0.443 . . . . 0.0 111.476 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.483 ' H ' ' NE2' ' B' ' 93' ' ' GLN . 0.5 OUTLIER -80.09 144.44 33.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.234 -179.47 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.521 HG13 HD21 ' B' ' 53' ' ' ASN . 4.4 pt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.197 -174.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 85.1 mmm . . . . . 0 CA--C 1.522 -0.109 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -46.12 -10.81 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.046 1.738 . . . . 0.0 114.956 -178.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -56.58 -15.49 4.47 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 122.842 0.457 . . . . 0.0 111.596 177.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -50.68 -59.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 121.411 0.624 . . . . 0.0 111.27 -176.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -106.44 -49.11 3.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.015 -176.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 5.9 m -55.93 -53.45 56.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.825 -173.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 80.2 t -72.8 -33.11 42.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.918 -177.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . 0.469 ' HA ' HD12 ' B' ' 29' ' ' LEU . 0.2 OUTLIER -59.79 -42.82 94.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.953 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.14 -37.88 61.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.056 178.406 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.1 OUTLIER -61.36 -40.83 95.74 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 122.9 0.48 . . . . 0.0 111.606 -179.717 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -80.03 -31.7 39.55 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.845 178.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -96.47 53.19 1.28 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.356 0.598 . . . . 0.0 110.44 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' B' ' 19' ' ' LYS . 30.6 mtpp -89.91 -51.95 5.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.139 0.495 . . . . 0.0 110.358 177.197 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.42 68.14 0.22 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 -178.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -124.28 -156.82 0.74 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.467 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -72.56 -171.08 17.68 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 175.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.706 ' O ' ' HA ' ' B' ' 40' ' ' SER . 0.0 OUTLIER -72.97 88.74 1.39 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 117.702 0.751 . . . . 0.0 109.345 176.236 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' B' ' 39' ' ' THR . 15.9 tp -105.94 127.4 53.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.035 -172.091 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 63.4 m -125.89 114.67 18.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.048 178.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' B' ' 17' ' ' ASN . 24.7 mt -89.26 156.18 18.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.439 0.638 . . . . 0.0 110.776 178.119 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 63.7 m -145.33 153.74 41.58 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.691 172.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 80.8 mtp -120.79 141.29 50.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.195 0.522 . . . . 0.0 111.857 -176.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -145.12 113.15 6.45 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.56 -104.55 1.09 Allowed Glycine 0 CA--C 1.507 -0.419 0 C-N-CA 119.465 -1.35 . . . . 0.0 109.769 -169.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -132.86 25.0 4.32 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.558 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 22.5 mt-30 -80.01 156.71 27.03 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.227 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tt -110.31 110.31 21.08 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.977 -1.011 . . . . 0.0 108.514 173.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.54 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 22.4 mmmt -106.22 148.36 28.01 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.393 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -161.64 146.04 12.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.306 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 10.4 p -129.22 144.29 51.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.146 172.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.706 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 46.8 m -154.84 152.85 30.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.404 0.621 . . . . 0.0 112.292 -177.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.609 ' HB2' ' CD ' ' B' ' 26' ' ' LYS . 1.3 m -118.89 152.2 36.72 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 167.306 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . 0.485 ' HA ' ' HB3' ' B' ' 45' ' ' TYR . 15.0 m120 -112.56 35.16 3.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.134 0.493 . . . . 0.0 111.821 -165.353 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.81 -61.37 1.8 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.801 0.81 . . . . 0.0 110.414 173.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.96 62.23 0.43 Allowed Glycine 0 C--N 1.311 -0.812 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 174.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.485 ' HB3' ' HA ' ' B' ' 42' ' ' ASN . 41.6 p90 -71.54 -149.68 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -173.112 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.23 92.16 1.37 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.563 -177.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.32 -57.2 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.029 0.442 . . . . 0.0 110.28 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -39.37 -58.72 1.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.318 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -91.3 101.3 14.0 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.081 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -76.7 -82.08 0.08 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.351 -176.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -110.99 108.75 18.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.876 0.846 . . . . 0.0 112.068 -176.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 55.4 mttm -141.23 121.59 14.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 165.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -110.12 121.3 44.93 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.61 0.719 . . . . 0.0 111.556 -174.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.541 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 28.7 p-90 -141.68 162.06 36.4 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.492 175.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.15 147.14 16.82 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.864 -173.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.579 HD13 ' CD2' ' B' ' 64' ' ' TYR . 29.0 mt -107.08 148.31 11.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 170.157 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.726 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 75.7 m-85 -127.61 144.46 51.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.263 -171.255 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.58 HG13 ' ND2' ' B' ' 59' ' ' ASN . 7.9 p -131.41 135.37 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.58 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.0 m-80 61.85 10.13 3.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.016 -176.061 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.87 -2.43 55.57 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 -177.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 7.7 mt-10 -107.43 176.93 4.99 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.4 tppp? -63.27 161.22 14.21 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 173.076 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.474 ' N ' ' HG3' ' B' ' 62' ' ' LYS . 9.8 p -153.17 -13.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.946 0.403 . . . . 0.0 110.376 168.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.685 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.2 OUTLIER -160.07 128.71 4.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.016 0.436 . . . . 0.0 110.536 -172.66 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 55.0 m -139.74 123.99 17.93 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.391 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.448 ' CD1' ' CD1' ' B' ' 64' ' ' TYR . 19.9 p90 -171.46 157.49 4.88 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 122.012 0.91 . . . . 0.0 112.023 -172.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 11.4 m120 -105.4 162.46 13.43 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 113.474 -1.694 . . . . 0.0 110.193 172.226 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -61.38 -48.11 82.73 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -174.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.583 ' O ' HG23 ' B' ' 71' ' ' THR . 41.7 ttmt -61.88 -24.52 66.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.951 0.405 . . . . 0.0 112.036 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 11.5 t -67.09 -20.46 65.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.285 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.583 HG23 ' O ' ' B' ' 69' ' ' LYS . 9.9 p 60.56 111.72 0.02 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.633 1.173 . . . . 0.0 112.113 175.231 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.434 HG11 ' CE2' ' B' ' 66' ' ' PHE . 1.7 m -61.18 -28.42 43.74 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.961 -167.252 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.11 -49.08 57.29 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.179 -176.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 58.1 m-80 -67.72 -42.79 81.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.622 0.725 . . . . 0.0 110.221 179.037 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.52 ' HB ' ' HH ' ' B' ' 64' ' ' TYR . 1.8 mt -64.21 -41.75 93.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.601 -176.099 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.456 ' N ' ' HH ' ' B' ' 64' ' ' TYR . 74.5 m -53.69 -36.01 61.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.344 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' B' ' 74' ' ' ASN . 39.0 m-20 -57.69 -38.01 74.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.989 0.423 . . . . 0.0 111.066 177.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.567 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 13.9 m-20 -73.83 -51.3 16.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.741 174.572 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.685 HG13 ' CE1' ' B' ' 64' ' ' TYR . 44.5 mm -56.08 -35.52 41.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.469 -178.373 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -11.28 59.68 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 15.5 ptmt -92.19 4.58 52.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.373 0.606 . . . . 0.0 110.135 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -81.47 -1.51 46.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.411 -175.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 52.07 47.28 25.08 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.702 0.763 . . . . 0.0 109.66 -173.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.558 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 94.2 mt -55.12 127.69 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.682 -1.144 . . . . 0.0 113.233 -171.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -92.1 -164.35 1.17 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.582 178.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -151.16 119.69 1.02 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.13 -178.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 22.8 ptm -176.76 -56.73 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.616 0.208 . . . . 0.0 111.472 177.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -128.1 80.58 1.97 Allowed 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.816 -0.552 . . . . 0.0 110.013 177.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.726 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.3 mp -98.53 128.86 49.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.37 175.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -114.66 171.37 7.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.082 0.467 . . . . 0.0 110.058 175.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.541 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 38.9 mm -142.15 109.55 2.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.594 -178.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -168.27 151.87 5.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.426 0.632 . . . . 0.0 112.344 -174.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 2.0 pp0? -61.95 148.21 44.44 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.637 172.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.518 HG12 ' HA ' ' B' ' 54' ' ' TRP . 2.0 pt . . . . . 0 C--N 1.311 -1.075 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.028 -176.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 10' ' ' MET . . . . . 0.468 ' HG3' HD22 ' B' ' 34' ' ' ASN . 85.8 mmm . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.46 0.648 . . . . 0.0 111.94 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -77.02 -15.77 59.52 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.254 175.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 11.6 m -65.94 -10.28 37.55 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.35 -176.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.415 HG12 ' O ' ' B' ' 10' ' ' MET . 27.9 mm -58.48 -59.81 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.508 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -106.74 -36.36 6.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.644 -175.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.588 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 22.5 t -56.98 -41.83 79.1 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.907 -171.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.57 -38.95 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.85 0.357 . . . . 0.0 111.089 -176.251 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . 0.434 ' ND2' HD12 ' B' ' 29' ' ' LEU . 34.0 t-20 -59.13 -55.14 38.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.102 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.12 -40.11 82.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.516 -178.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' B' ' 15' ' ' SER . 8.5 tmtm? -49.21 -67.33 0.27 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.652 0.781 . . . . 0.0 111.71 177.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.596 ' C ' ' H ' ' B' ' 22' ' ' LYS . 16.2 mt -51.88 -67.01 0.29 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.729 175.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . 0.451 ' OD1' ' HE2' ' B' ' 49' ' ' TYR . 2.8 t-20 65.25 -19.4 0.09 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.935 0.894 . . . . 0.0 110.609 -168.301 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.596 ' H ' ' C ' ' B' ' 20' ' ' LEU . 31.0 mtpp 83.37 -34.62 0.07 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 159.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.663 ' HA2' ' CE1' ' B' ' 49' ' ' TYR . . . 95.93 79.72 1.48 Allowed Glycine 0 C--O 1.208 -1.521 0 C-N-CA 119.074 -1.536 . . . . 0.0 110.078 -166.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 64.62 -59.75 0.22 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 173.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' B' ' 23' ' ' GLY . . . -33.05 108.27 0.03 OUTLIER Glycine 0 CA--C 1.52 0.354 0 O-C-N 124.071 0.857 . . . . 0.0 113.892 179.08 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.466 ' HE3' ' HB2' ' B' ' 41' ' ' SER . 0.1 OUTLIER -77.84 153.18 32.97 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.825 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.416 HD23 ' CD ' ' B' ' 22' ' ' LYS . 1.3 pt? -163.45 170.28 17.61 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 118.291 0.496 . . . . 0.0 111.5 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 20.7 m -127.87 114.0 16.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.694 178.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.434 HD12 ' ND2' ' B' ' 17' ' ' ASN . 9.7 mp -83.87 158.63 21.57 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 122.038 0.923 . . . . 0.0 112.408 -179.003 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.9 p -150.4 154.8 38.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.409 178.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 29.7 mtt -122.82 138.55 54.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.654 0.264 . . . . 0.0 111.628 -168.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -152.09 108.09 3.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.458 177.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.45 -92.87 0.52 Allowed Glycine 0 CA--C 1.505 -0.534 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -176.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.47 ' HB2' ' CA ' ' B' ' 86' ' ' GLY . 0.4 OUTLIER -135.7 8.09 3.29 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.574 0.702 . . . . 0.0 109.311 171.585 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.531 ' OE1' ' HA ' ' B' ' 83' ' ' ASN . 49.6 mt-30 -77.94 149.82 34.11 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.23 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.8 tp -125.84 93.28 3.79 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.206 177.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -96.52 150.61 20.44 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.695 -171.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -165.52 158.34 15.66 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.249 -0.58 . . . . 0.0 112.219 -174.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 14.3 p -124.84 137.62 54.29 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 18.2 t -121.16 154.68 35.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.078 0.466 . . . . 0.0 111.484 -170.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.466 ' HB2' ' HE3' ' B' ' 26' ' ' LYS . 14.9 m -121.92 158.53 28.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.606 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -82.59 54.24 2.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.623 -172.223 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.75 22.44 0.6 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.973 177.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.442 ' O ' HD12 ' B' ' 47' ' ' ILE . . . 132.56 -47.73 1.0 Allowed Glycine 0 C--O 1.222 -0.615 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.992 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.457 ' O ' HG12 ' B' ' 47' ' ' ILE . 1.2 p90 59.15 177.38 0.08 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.455 1.102 . . . . 0.0 113.224 177.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.414 ' C ' HD13 ' B' ' 47' ' ' ILE . . . -47.64 92.03 0.01 OUTLIER Glycine 0 C--N 1.336 0.533 0 N-CA-C 114.864 0.706 . . . . 0.0 114.864 -176.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.457 HG12 ' O ' ' B' ' 45' ' ' TYR . 6.5 mm -109.8 -71.8 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.575 0.702 . . . . 0.0 110.625 175.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.2 p -97.45 -126.9 0.15 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.543 -178.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.663 ' CE1' ' HA2' ' B' ' 23' ' ' GLY . 7.1 m-85 63.91 20.29 12.14 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.206 0.526 . . . . 0.0 110.32 178.074 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 52.7 -161.17 0.11 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.621 -176.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -109.21 108.94 19.75 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.748 0.785 . . . . 0.0 109.435 173.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.5 ' HE3' ' O ' ' B' ' 49' ' ' TYR . 43.8 mttt -105.13 120.79 42.39 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -115.15 113.93 24.61 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.554 ' HA ' HG12 ' B' ' 94' ' ' ILE . 36.1 p-90 -148.04 164.93 32.32 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.3 -176.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -126.55 152.75 18.5 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.835 -176.019 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.424 ' O ' HG12 ' B' ' 63' ' ' VAL . 10.3 mt -102.18 146.81 9.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 169.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.686 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 83.0 m-85 -125.94 143.75 50.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.482 -172.011 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.543 HG13 ' ND2' ' B' ' 59' ' ' ASN . 10.3 p -130.7 135.24 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.543 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.7 m-80 65.74 4.62 2.97 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.72 -176.179 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.03 -0.17 51.44 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.019 -176.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -108.47 176.06 5.25 Favored 'General case' 0 C--O 1.203 -1.355 0 C-N-CA 123.346 0.658 . . . . 0.0 109.46 -179.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.5 tppp? -62.44 161.2 12.13 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 173.121 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.504 ' N ' ' HG3' ' B' ' 62' ' ' LYS . 9.3 p -146.58 -22.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 166.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.49 ' HH ' HG22 ' B' ' 75' ' ' ILE . 0.8 OUTLIER -162.21 142.5 10.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.475 -175.457 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.434 HG23 ' CD1' ' B' ' 94' ' ' ILE . 28.1 m -136.07 127.25 28.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.775 179.325 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.606 ' CD2' HG21 ' B' ' 75' ' ' ILE . 21.5 p90 -163.04 -166.95 1.37 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.07 0.462 . . . . 0.0 111.032 -177.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.736 ' O ' ' HB3' ' B' ' 70' ' ' SER . 22.9 t-20 -153.95 158.52 40.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.816 -173.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . 0.451 ' CD ' ' HD2' ' B' ' 52' ' ' LYS . 8.0 mm-40 -60.28 -56.62 19.24 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.385 0.612 . . . . 0.0 111.234 -178.328 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.578 ' C ' ' H ' ' B' ' 71' ' ' THR . 37.2 ttpt -65.8 -11.69 48.13 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.687 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 70' ' ' SER . . . . . 0.736 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 9.7 t -67.22 2.22 1.72 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.227 1.013 . . . . 0.0 109.283 170.253 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.578 ' H ' ' C ' ' B' ' 69' ' ' LYS . 37.6 p 59.61 80.28 0.2 Allowed 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.02 -1.9 . . . . 0.0 110.56 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.781 ' HA ' ' CG1' ' B' ' 75' ' ' ILE . 17.9 m -68.24 -4.67 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.772 -170.202 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.43 -37.18 94.22 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 119.806 -1.188 . . . . 0.0 110.201 174.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 42.7 m-20 -80.28 -36.21 34.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.219 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.781 ' CG1' ' HA ' ' B' ' 72' ' ' VAL . 24.2 mm -51.64 -54.27 13.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.458 176.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 58.8 m -55.55 -37.44 67.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.124 177.512 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . 0.448 ' HA ' ' ND2' ' B' ' 80' ' ' ASN . 49.0 m-20 -64.76 -38.67 91.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.205 0.526 . . . . 0.0 111.044 177.342 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.693 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 5.9 m-20 -65.78 -40.58 92.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.899 176.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.522 HG13 ' O ' ' B' ' 75' ' ' ILE . 63.8 mt -57.68 -30.75 37.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.121 0.486 . . . . 0.0 110.869 178.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.448 ' ND2' ' HA ' ' B' ' 77' ' ' ASN . 82.0 m-20 -62.02 -22.48 65.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.46 176.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.693 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 12.1 ptmm? -105.44 -11.47 16.41 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -175.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.24 -23.87 67.46 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.801 0.334 . . . . 0.0 110.863 -175.136 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . 0.531 ' HA ' ' OE1' ' B' ' 35' ' ' GLN . 23.6 t-20 45.75 62.79 2.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.059 -170.334 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.443 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 72.7 mt -64.5 142.66 16.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.125 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -86.64 178.37 7.07 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.822 178.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.47 ' CA ' ' HB2' ' B' ' 34' ' ' ASN . . . -135.02 114.44 1.25 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 119.73 -1.224 . . . . 0.0 113.318 -175.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.467 ' HG3' ' HA ' ' B' ' 59' ' ' ASN . 22.8 ptp -175.07 -55.2 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.49 0.316 . . . . 0.0 110.795 177.001 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -139.6 80.7 1.79 Allowed 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.557 -0.714 . . . . 0.0 110.123 174.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.686 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.0 mp -94.63 126.67 47.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.061 174.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -109.32 175.63 5.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.26 0.552 . . . . 0.0 110.433 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 mt -147.75 102.0 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.676 -177.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 45.1 pttt -164.42 165.77 21.21 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.266 -173.48 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.4 OUTLIER -73.84 159.49 32.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.781 178.998 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.554 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.0 pt . . . . . 0 C--N 1.31 -1.124 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.714 -177.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 10' ' ' MET . . . . . 0.454 ' SD ' ' HA ' ' B' ' 88' ' ' TYR . 80.6 mtp . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.811 0.339 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -64.16 -32.03 73.45 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.128 0.49 . . . . 0.0 110.53 176.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.538 ' O ' HG21 ' B' ' 16' ' ' VAL . 13.3 m -68.81 -20.89 64.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.847 -171.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 mm -51.22 -52.4 19.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 121.901 0.857 . . . . 0.0 110.672 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -75.75 -33.76 60.24 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.5 -175.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -64.59 -41.08 96.48 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.878 179.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.538 HG21 ' O ' ' B' ' 12' ' ' SER . 94.4 t -61.49 -45.22 99.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.963 0.411 . . . . 0.0 110.163 178.142 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -42.14 99.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.524 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -33.9 68.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.866 0.365 . . . . 0.0 111.359 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -68.17 -48.79 64.34 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 123.348 0.659 . . . . 0.0 111.952 -178.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 63.6 mt -77.81 -7.95 57.34 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.383 -176.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . 0.453 ' CG ' ' H ' ' B' ' 22' ' ' LYS . 61.2 t30 -99.73 -161.87 0.9 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.217 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.453 ' H ' ' CG ' ' B' ' 21' ' ' ASN . 53.4 mtpt 52.2 37.03 20.79 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.749 -175.014 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -134.17 41.28 1.48 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.55 -174.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 71.2 -67.05 0.27 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.04 0.536 . . . . 0.0 111.843 174.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' B' ' 45' ' ' TYR . . . -55.92 121.66 24.27 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 174.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' B' ' 40' ' ' SER . 43.2 mttm -61.5 135.41 57.66 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.194 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' B' ' 39' ' ' THR . 22.2 tp -158.94 110.93 2.17 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 121.175 0.512 . . . . 0.0 110.499 -176.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 55.2 m -116.32 114.08 23.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.772 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 9.2 mp -95.55 163.42 13.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.85 0.833 . . . . 0.0 111.701 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.406 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 1.4 p -157.81 147.38 19.98 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.104 171.133 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 66.0 mtp -130.02 117.06 19.46 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.512 0.673 . . . . 0.0 110.943 -177.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -98.83 61.57 1.3 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.316 -178.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.41 -88.61 0.13 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.471 -178.071 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' B' ' 84' ' ' ILE . 2.9 m-20 -94.0 16.48 14.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.786 0.327 . . . . 0.0 111.008 -177.397 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -132.12 151.24 51.89 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.261 0.553 . . . . 0.0 111.501 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tt -124.75 112.68 17.01 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.681 176.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.498 ' HB3' ' HZ2' ' B' ' 37' ' ' LYS . 1.5 mtpm? -112.31 149.11 32.86 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -176.24 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -167.73 142.05 3.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.924 0.392 . . . . 0.0 111.759 -178.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 1.7 p -119.55 142.2 48.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.354 173.377 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 3.5 p -140.86 156.14 46.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.235 0.541 . . . . 0.0 112.39 -172.174 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 15.7 m -141.27 158.69 43.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.06 176.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' B' ' 44' ' ' GLY . 51.4 m-80 -95.25 46.47 1.11 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.531 0.681 . . . . 0.0 110.768 -167.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.61 23.85 0.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.759 -1.11 . . . . 0.0 112.533 178.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' B' ' 42' ' ' ASN . . . 133.31 -41.01 1.53 Allowed Glycine 0 CA--C 1.51 -0.252 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.573 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.502 ' HA ' ' HA3' ' B' ' 25' ' ' GLY . 21.8 p90 51.26 -165.31 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.92 1.288 . . . . 0.0 114.138 173.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' B' ' 68' ' ' GLU . . . -75.95 110.43 3.04 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.867 -175.179 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.65 -69.19 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-O 121.243 0.544 . . . . 0.0 111.233 177.315 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 66.9 m -119.78 -75.26 0.59 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.81 -170.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.455 ' O ' ' HE3' ' B' ' 52' ' ' LYS . 0.1 OUTLIER -68.17 -22.27 64.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.522 0.677 . . . . 0.0 109.875 -176.899 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' B' ' 50' ' ' GLU . 22.1 mp0 -73.25 -62.6 1.42 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.996 174.171 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . 0.423 ' HA ' ' HB2' ' B' ' 68' ' ' GLU . 6.9 t70 -44.92 108.23 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.242 -1.799 . . . . 0.0 112.497 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 98.7 mttt -150.12 161.15 42.93 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.047 176.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -109.45 119.64 40.05 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.452 0.644 . . . . 0.0 111.277 -178.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.545 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 6.4 p-90 -154.62 171.62 19.18 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.647 176.43 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.5 141.58 12.82 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.666 -178.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.651 HD12 ' CD2' ' B' ' 64' ' ' TYR . 17.7 mt -104.72 147.64 10.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 172.286 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.741 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 71.7 m-85 -127.05 143.62 51.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 -171.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.528 HG13 ' ND2' ' B' ' 59' ' ' ASN . 8.9 p -129.94 134.73 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.528 ' ND2' HG13 ' B' ' 58' ' ' VAL . 2.0 m-80 63.06 10.27 4.37 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.034 0.534 . . . . 0.0 109.885 -174.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.3 -1.7 64.79 Favored Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.099 -174.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -102.8 176.89 5.01 Favored 'General case' 0 C--O 1.207 -1.144 0 C-N-CA 123.558 0.743 . . . . 0.0 109.042 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 4.9 tppp? -66.69 161.24 23.86 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.395 0.543 . . . . 0.0 109.537 174.05 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.433 ' HB ' ' CG1' ' B' ' 58' ' ' VAL . 8.7 p -153.87 -13.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.196 0.522 . . . . 0.0 110.284 166.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.761 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -160.87 140.12 10.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.247 -171.128 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 96.1 m -157.33 121.23 4.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.522 ' CB ' HD13 ' B' ' 75' ' ' ILE . 15.6 p90 -174.9 161.27 2.98 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.938 0.875 . . . . 0.0 111.855 -168.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.693 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 2.2 m120 -109.09 138.2 45.81 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.184 -1.826 . . . . 0.0 108.215 166.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . 0.437 ' O ' ' HA3' ' B' ' 46' ' ' GLY . 20.2 mp0 -61.91 -12.81 19.8 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.627 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -69.12 -29.79 67.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.394 0.616 . . . . 0.0 109.863 172.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 39.1 t -70.58 -16.46 62.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.822 173.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 71' ' ' THR . . . . . . . . . . . . . 13.5 p 61.74 116.03 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.216 1.407 . . . . 0.0 112.095 178.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.486 ' HA ' ' CD1' ' B' ' 75' ' ' ILE . 3.0 m -59.85 -24.92 30.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.628 -169.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.93 -46.08 69.61 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.738 -178.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -72.66 -34.35 67.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.313 0.578 . . . . 0.0 110.436 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.522 HD13 ' CB ' ' B' ' 66' ' ' PHE . 1.7 mt -72.24 -45.85 59.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.968 -176.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 48.3 m -54.37 -33.08 58.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.53 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -53.13 -53.65 47.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.066 174.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' B' ' 81' ' ' LYS . 10.9 m-20 -69.57 -44.34 71.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.747 -179.407 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.761 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.2 mm -57.96 -32.19 42.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.348 0.594 . . . . 0.0 112.024 -178.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -65.15 -17.23 64.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.047 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' B' ' 78' ' ' ASP . 13.2 tppt? -91.63 -5.32 54.07 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.769 0.795 . . . . 0.0 109.917 -176.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 3.2 mm? -72.69 -12.59 61.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.354 -176.21 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 55.92 71.27 0.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.964 -168.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.457 ' O ' ' HB3' ' B' ' 34' ' ' ASN . 59.6 mt -64.52 157.8 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.437 -175.397 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -121.18 -175.51 3.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.183 175.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.02 113.44 0.75 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.661 175.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.82 -63.48 0.09 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.607 0.241 . . . . 0.0 111.02 -178.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . 0.454 ' HA ' ' SD ' ' B' ' 10' ' ' MET . 25.3 t80 -141.34 90.95 2.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.19 0.519 . . . . 0.0 109.892 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.741 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.1 mp -90.8 132.4 35.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.494 178.02 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -118.28 175.12 5.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.11 0.481 . . . . 0.0 110.496 177.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.545 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 82.1 mt -147.76 124.76 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.664 -176.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 41.5 pttt -177.57 160.46 1.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 0.0 111.209 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.9 OUTLIER -80.82 164.54 22.62 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.539 0.685 . . . . 0.0 110.958 177.45 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.537 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.4 pt . . . . . 0 C--N 1.309 -1.17 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.243 -173.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 8.2 tmm? . . . . . 0 CA--C 1.545 0.774 0 CA-C-O 121.744 0.783 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . 0.537 ' HA ' ' SD ' ' B' ' 31' ' ' MET . 9.1 t30 -61.62 -43.4 98.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.815 -175.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 9.9 m -69.16 -15.45 63.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.216 0.532 . . . . 0.0 110.387 -172.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -75.19 -43.49 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.57 0.7 . . . . 0.0 110.448 178.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -71.66 -14.74 62.13 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.935 -175.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 15' ' ' SER . . . . . 0.636 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 78.4 p -48.29 -40.53 25.25 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 123.444 0.465 . . . . 0.0 110.875 -179.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 49.8 t -69.61 -40.24 79.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.399 0.619 . . . . 0.0 110.166 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . 0.65 HD22 HD11 ' B' ' 29' ' ' LEU . 7.6 t30 -64.83 -37.12 86.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.281 176.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.03 -29.27 69.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.275 174.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' B' ' 15' ' ' SER . 24.6 mmmt -73.15 -11.6 60.59 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.183 0.516 . . . . 0.0 111.388 176.599 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.519 ' O ' ' HD3' ' B' ' 24' ' ' LYS . 39.7 mt -80.39 -18.59 48.49 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.663 0.744 . . . . 0.0 109.342 176.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' B' ' 26' ' ' LYS . 62.9 t30 -92.39 58.19 3.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.985 -176.738 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -123.45 -91.85 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.492 178.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.16 34.64 5.24 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 177.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.603 ' HA ' ' C ' ' B' ' 45' ' ' TYR . 27.6 mtpt -133.07 -164.63 1.5 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.434 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.582 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -64.07 145.14 49.51 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.329 -0.939 . . . . 0.0 110.996 178.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.548 ' CE ' ' HB2' ' B' ' 41' ' ' SER . 13.9 ttpt -80.5 136.34 36.28 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -174.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.497 ' HG ' HD11 ' B' ' 29' ' ' LEU . 19.3 tp -154.03 107.67 2.96 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.869 -178.079 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -110.18 103.89 12.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.213 -176.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.65 HD11 HD22 ' B' ' 17' ' ' ASN . 0.0 OUTLIER -82.02 156.92 24.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.827 0.822 . . . . 0.0 112.516 -177.702 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 53.9 m -129.8 144.11 51.14 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.355 -1.293 . . . . 0.0 107.517 164.34 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 31' ' ' MET . . . . . 0.537 ' SD ' ' HA ' ' B' ' 11' ' ' ASN . 40.7 mtt -111.24 127.53 55.64 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.675 -167.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -137.16 59.47 1.68 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.736 175.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 47.97 -93.68 0.01 OUTLIER Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.99 178.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.651 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 8.1 p30 -79.76 4.89 14.98 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 122.592 0.357 . . . . 0.0 111.299 -176.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 18.5 mt-30 -129.82 144.56 51.37 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.592 0.711 . . . . 0.0 111.017 172.584 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.436 ' CB ' ' HB ' ' B' ' 84' ' ' ILE . 0.9 OUTLIER -118.34 105.22 11.51 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.184 175.549 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . 0.504 ' HB3' ' HZ2' ' B' ' 37' ' ' LYS . 0.0 OUTLIER -99.91 151.92 20.76 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -175.702 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.04 164.21 4.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.456 0.571 . . . . 0.0 112.498 -177.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -128.35 141.03 51.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.211 168.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -142.58 147.5 35.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.091 0.472 . . . . 0.0 111.615 -175.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.548 ' HB2' ' CE ' ' B' ' 26' ' ' LYS . 24.1 m -159.31 169.57 23.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.53 178.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . 0.469 ' C ' ' H ' ' B' ' 44' ' ' GLY . 44.6 m-80 -91.73 49.18 1.53 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.102 -176.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.422 ' HB1' ' HE2' ' B' ' 26' ' ' LYS . . . -68.96 22.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.025 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.494 ' O ' ' HD1' ' B' ' 45' ' ' TYR . . . 161.43 -63.37 0.28 Allowed Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.006 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.735 ' CD2' HG22 ' B' ' 71' ' ' THR . 0.0 OUTLIER 70.29 161.86 0.23 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.955 0.902 . . . . 0.0 111.852 -179.489 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.523 ' H ' ' CG2' ' B' ' 71' ' ' THR . . . -63.18 113.1 5.56 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 116.157 -0.474 . . . . 0.0 114.043 -166.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 11.4 mm -95.76 -67.61 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.273 0.558 . . . . 0.0 110.604 177.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 59.3 m -67.12 -52.67 38.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.073 -176.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -42.27 124.41 2.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.334 -178.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -74.91 -172.68 1.67 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.282 177.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.66 108.09 14.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 50.0 mttm -139.69 130.57 26.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.442 -178.214 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -108.79 135.6 49.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.999 0.428 . . . . 0.0 111.551 -177.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.613 ' HA ' HG12 ' B' ' 94' ' ' ILE . 37.5 p-90 -154.49 169.26 24.21 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.947 175.43 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.8 152.81 21.44 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.702 -172.44 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.51 HD11 ' CD2' ' B' ' 64' ' ' TYR . 30.0 mt -113.31 142.63 25.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 173.302 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.614 ' CE1' ' HG3' ' B' ' 62' ' ' LYS . 58.9 m-85 -127.68 140.73 51.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.408 -171.427 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.468 HG11 ' ND2' ' B' ' 59' ' ' ASN . 10.8 p -123.77 134.47 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.468 ' ND2' HG11 ' B' ' 58' ' ' VAL . 3.4 m-80 63.46 4.57 1.79 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.254 0.622 . . . . 0.0 110.263 -176.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.56 -7.58 39.55 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.09 -174.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 33.1 mt-10 -98.54 175.87 5.86 Favored 'General case' 0 C--O 1.197 -1.708 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.043 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.614 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 14.4 ttmt -79.96 169.84 17.31 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 119.282 0.946 . . . . 0.0 109.929 176.323 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.2 -12.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.046 165.409 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.537 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.7 OUTLIER -159.67 123.93 3.84 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.791 -168.808 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.1 m -134.2 120.86 20.57 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.437 179.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.458 ' HB2' HD13 ' B' ' 75' ' ' ILE . 2.2 p90 -160.65 -178.63 7.0 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.563 1.173 . . . . 0.0 112.795 -174.529 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 16.3 t-20 -130.25 156.24 44.95 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.652 -176.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -70.41 -27.87 64.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.857 0.36 . . . . 0.0 110.985 -177.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.535 ' O ' HG23 ' B' ' 71' ' ' THR . 40.7 ttmt -86.6 -22.27 26.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.97 177.144 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 8.8 t -71.71 -20.29 61.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.397 173.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 71' ' ' THR . . . . . 0.735 HG22 ' CD2' ' B' ' 45' ' ' TYR . 35.6 p 58.46 113.69 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.4 1.08 . . . . 0.0 113.759 168.073 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.421 HG13 ' CE2' ' B' ' 66' ' ' PHE . 1.8 m -59.53 -15.99 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.21 -168.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.03 -50.66 64.06 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.506 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -75.69 -35.1 60.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.553 0.692 . . . . 0.0 110.461 179.463 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.492 HG13 ' O ' ' B' ' 71' ' ' THR . 1.5 mt -74.66 -51.08 23.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.184 -171.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 8.5 t -64.14 -26.8 68.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.256 -175.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -48.61 -48.93 38.91 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.925 0.869 . . . . 0.0 109.636 171.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.657 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 0.3 OUTLIER -71.63 -42.15 67.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.315 177.514 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.537 HG13 ' CE1' ' B' ' 64' ' ' TYR . 36.0 mm -57.92 -33.75 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.029 0.442 . . . . 0.0 111.898 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.04 -21.91 61.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.067 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.657 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 21.4 pttm -86.5 -7.79 58.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.839 0.352 . . . . 0.0 110.633 -178.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 3.4 mm? -71.11 -16.2 62.55 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.699 -176.184 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 t30 46.67 61.55 2.74 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 124.148 0.905 . . . . 0.0 109.624 -170.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' B' ' 35' ' ' GLN . 3.6 mp -57.09 141.08 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.079 -176.373 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.651 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 51.5 mtpt -95.91 -175.01 3.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.846 178.203 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . 0.4 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -139.47 114.54 1.01 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 178.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.14 -74.76 0.08 Allowed 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -121.21 84.7 2.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 25.7 mm -86.64 129.77 37.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.63 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.582 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 12.9 mm-40 -123.38 146.34 48.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.742 177.108 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.549 HG21 ' CZ3' ' B' ' 54' ' ' TRP . 47.2 mt -135.01 120.5 30.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.394 177.114 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 26.8 pttt -172.76 171.21 4.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.969 0.414 . . . . 0.0 111.921 -174.174 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.411 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 15.7 mm-40 -84.62 151.52 24.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.842 179.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.613 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.8 pt . . . . . 0 C--N 1.313 -1.017 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.327 -174.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 10' ' ' MET . . . . . 0.413 ' O ' HG13 ' B' ' 13' ' ' ILE . 46.1 tpp . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.388 0.137 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -41.16 -20.41 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.165 1.786 . . . . 0.0 114.239 -176.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -63.75 -5.2 3.83 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.992 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.457 ' HA ' ' HB2' ' B' ' 31' ' ' MET . 0.2 OUTLIER -49.03 -52.99 8.79 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-O 122.003 0.906 . . . . 0.0 110.007 179.361 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 14' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' B' ' 18' ' ' ASP . 35.0 m-80 -88.41 -32.53 18.28 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.616 -175.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 3.1 m -59.51 -43.62 93.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.769 0.319 . . . . 0.0 111.424 -177.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.88 -41.18 60.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.27 0.557 . . . . 0.0 109.765 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 17' ' ' ASN . . . . . 0.559 ' O ' ' HB2' ' B' ' 21' ' ' ASN . 3.0 t-20 -65.69 -45.88 81.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.972 -177.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' B' ' 14' ' ' ASN . 0.2 OUTLIER -67.85 -34.46 76.73 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.173 0.511 . . . . 0.0 110.729 -176.36 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -57.75 -59.91 4.5 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.192 178.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 49.1 mt -94.37 26.52 3.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.292 -177.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' B' ' 17' ' ' ASN . 27.5 t-20 -91.87 -37.86 12.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.264 0.554 . . . . 0.0 110.375 177.029 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -91.61 42.64 1.11 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.952 -178.033 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' B' ' 24' ' ' LYS . . . -85.82 -6.94 82.0 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.811 -177.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.464 ' HE3' ' CE1' ' B' ' 49' ' ' TYR . 86.7 mttt 72.53 -55.88 0.66 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.443 0.697 . . . . 0.0 110.801 -177.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.611 ' HA3' ' O ' ' B' ' 45' ' ' TYR . . . -61.76 147.49 48.26 Favored Glycine 0 C--N 1.314 -0.678 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 167.234 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.519 ' CB ' ' HB3' ' B' ' 41' ' ' SER . 82.1 mttt -83.97 119.41 24.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.456 1.128 . . . . 0.0 111.105 -168.275 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 20.1 tp -158.06 118.79 3.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 28' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 57.8 m -114.55 112.27 22.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.31 -175.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 9.5 mp -98.09 165.65 11.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.659 0.742 . . . . 0.0 111.842 -178.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.3 p -160.47 141.44 11.97 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.808 171.485 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 31' ' ' MET . . . . . 0.693 ' SD ' HD22 ' B' ' 36' ' ' LEU . 82.0 mmm -108.47 136.38 48.19 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.65 0.262 . . . . 0.0 110.528 -175.136 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -137.08 61.33 1.63 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 55.43 -100.09 0.08 OUTLIER Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.194 177.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 34' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 20.9 m120 -75.81 -0.56 21.51 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.636 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -133.66 150.99 51.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.833 0.825 . . . . 0.0 112.253 175.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.693 HD22 ' SD ' ' B' ' 31' ' ' MET . 2.3 tm? -118.73 132.18 56.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.833 170.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -127.63 136.62 51.89 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -162.92 157.54 21.27 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.03 0.443 . . . . 0.0 111.761 -175.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.98 152.96 46.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.508 177.328 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 24.1 p -127.82 150.37 49.86 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.76 0.314 . . . . 0.0 110.702 -178.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.519 ' HB3' ' CB ' ' B' ' 26' ' ' LYS . 41.9 t -126.69 163.98 22.3 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.594 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -72.02 55.18 0.29 Allowed 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 125.243 1.589 . . . . 0.0 113.48 -154.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.438 ' CB ' ' HA2' ' B' ' 25' ' ' GLY . . . -97.68 -18.32 18.93 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.911 169.247 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.12 -52.74 2.17 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.198 -0.91 . . . . 0.0 113.358 177.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.611 ' O ' ' HA3' ' B' ' 25' ' ' GLY . 5.4 m-85 -75.85 173.52 11.07 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.823 0.82 . . . . 0.0 112.638 -175.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.83 33.44 0.44 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 176.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.36 -45.09 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-N 114.178 -1.011 . . . . 0.0 111.803 -173.506 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.2 t 71.24 -91.33 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.168 -172.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.531 ' HB2' ' CE ' ' B' ' 52' ' ' LYS . 29.4 m-85 -140.78 126.93 19.61 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.457 0.473 . . . . 0.0 110.757 174.104 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 35.96 -109.97 0.06 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.287 1.035 . . . . 0.0 112.89 -174.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -132.85 132.63 42.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.19 0.519 . . . . 0.0 109.955 176.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.531 ' CE ' ' HB2' ' B' ' 49' ' ' TYR . 75.4 mttt -137.84 130.6 29.86 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.458 179.481 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -117.28 118.75 33.14 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.173 0.511 . . . . 0.0 109.782 175.271 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 54' ' ' TRP . . . . . 0.634 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 37.5 p-90 -143.95 170.52 15.76 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.374 -177.118 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.37 150.89 20.63 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.292 -175.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 11.4 mt -102.81 142.7 16.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 173.159 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 57' ' ' PHE . . . . . 0.578 ' HB2' ' HB2' ' B' ' 90' ' ' GLU . 46.7 m-85 -124.81 134.17 52.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.978 -177.322 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.529 HG12 ' ND2' ' B' ' 59' ' ' ASN . 9.3 p -126.43 137.89 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -178.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.529 ' ND2' HG12 ' B' ' 58' ' ' VAL . 6.0 m-80 65.86 3.09 2.41 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -172.141 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . 0.409 ' N ' ' HB3' ' B' ' 88' ' ' TYR . . . 103.36 -12.63 54.85 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.912 -174.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 1.4 mp0 -91.01 170.28 10.18 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 123.663 0.785 . . . . 0.0 108.885 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 62' ' ' LYS . . . . . 0.561 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 17.4 ttmt -68.2 169.28 10.65 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 172.505 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.418 ' HB ' HG13 ' B' ' 58' ' ' VAL . 8.7 p -153.53 -13.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.297 170.722 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.489 ' CE2' HG22 ' B' ' 75' ' ' ILE . 0.3 OUTLIER -164.58 136.43 4.5 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.863 -176.347 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -128.43 127.19 42.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.515 173.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 66' ' ' PHE . . . . . 0.653 ' CE2' HG21 ' B' ' 75' ' ' ILE . 27.2 p90 -166.88 154.83 9.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.676 0.75 . . . . 0.0 111.074 -176.311 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -101.76 161.01 13.97 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.386 173.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 68' ' ' GLU . . . . . 0.495 ' CG ' ' HB2' ' B' ' 52' ' ' LYS . 4.7 mm-40 -73.37 -36.83 66.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.491 0.662 . . . . 0.0 109.952 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -59.72 -25.58 64.93 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.781 177.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.4 t -68.17 -10.4 53.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.343 -178.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 71' ' ' THR . . . . . . . . . . . . . 31.6 p 75.47 94.38 0.07 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 112.479 -2.146 . . . . 0.0 110.763 177.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.743 ' HA ' ' CG1' ' B' ' 75' ' ' ILE . 19.7 m -67.86 -8.56 9.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.328 -171.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.99 -37.14 94.47 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.236 176.517 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -82.14 -29.13 31.79 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 75' ' ' ILE . . . . . 0.743 ' CG1' ' HA ' ' B' ' 72' ' ' VAL . 30.2 mm -57.92 -60.56 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.959 174.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 76' ' ' SER . . . . . 0.44 ' HA ' HD12 ' B' ' 79' ' ' ILE . 18.9 t -61.77 -32.55 72.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.377 -177.462 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' B' ' 80' ' ' ASN . 64.8 t30 -51.96 -49.94 62.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.947 174.681 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 78' ' ' ASP . . . . . 0.669 ' O ' ' HG3' ' B' ' 81' ' ' LYS . 0.4 OUTLIER -73.47 -34.8 65.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.188 178.471 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.568 HG13 ' O ' ' B' ' 75' ' ' ILE . 57.0 mt -56.13 -34.79 39.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.253 0.549 . . . . 0.0 110.453 176.53 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 80' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' B' ' 77' ' ' ASN . 10.1 m-80 -56.91 -28.08 61.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.156 177.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 81' ' ' LYS . . . . . 0.669 ' HG3' ' O ' ' B' ' 78' ' ' ASP . 1.1 pptp? -97.44 -5.59 35.81 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -171.212 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 31.0 mt -68.45 -21.69 64.63 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 122.0 -0.438 . . . . 0.0 110.392 -174.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 50.59 64.73 1.7 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.505 -166.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.501 HD12 ' HB2' ' B' ' 36' ' ' LEU . 70.2 mt -59.82 157.5 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.592 -172.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.457 ' O ' HG21 ' B' ' 84' ' ' ILE . 22.0 mmmt -100.82 -169.35 1.69 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.211 0.529 . . . . 0.0 110.14 175.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -151.53 113.27 0.57 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.192 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 87' ' ' MET . . . . . 0.413 ' HG3' ' HA ' ' B' ' 59' ' ' ASN . 18.0 ptp -174.42 -54.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 122.53 0.332 . . . . 0.0 110.248 177.636 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 88' ' ' TYR . . . . . 0.409 ' HB3' ' N ' ' B' ' 60' ' ' GLY . 6.8 t80 -134.03 79.56 1.82 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 34.1 mm -94.49 114.92 32.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.171 177.373 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.578 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 31.7 mm-40 -110.17 146.53 35.37 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.051 0.453 . . . . 0.0 111.432 179.232 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.634 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 5.2 mp -131.68 107.24 12.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.839 178.198 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 92' ' ' LYS . . . . . 0.551 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 16.4 pttp -167.9 172.65 8.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.943 0.401 . . . . 0.0 111.433 -172.364 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.47 165.03 21.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.528 174.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 94' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' B' ' 54' ' ' TRP . 2.3 pt . . . . . 0 C--O 1.25 1.131 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.401 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 p30 . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -126.12 152.99 45.18 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.967 0.413 . . . . 0.0 110.762 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -67.47 -2.73 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.51 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -78.18 -13.3 59.92 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.297 0.57 . . . . 0.0 110.231 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.6 -169.57 0.88 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.184 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.37 22.22 0.44 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.086 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -63.74 -69.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.793 0.33 . . . . 0.0 110.356 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -81.87 -24.32 35.83 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.805 0.812 . . . . 0.0 110.09 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.96 65.5 3.5 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.474 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 79.1 mmm -81.5 117.78 22.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.994 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -58.4 -23.59 57.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.745 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 13.3 m -65.7 -29.88 70.48 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.932 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 9.6 mm -62.74 -41.66 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 121.856 0.836 . . . . 0.0 109.436 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -70.72 -34.49 71.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.877 -174.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.574 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 17.6 m -67.73 -45.95 73.55 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.216 177.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.48 -44.59 96.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.968 0.413 . . . . 0.0 110.329 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . 0.51 ' ND2' HD21 ' B' ' 29' ' ' LEU . 2.1 t-20 -52.29 -49.98 63.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.953 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -18.07 47.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.24 -174.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -78.55 -49.86 12.58 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 120.984 0.421 . . . . 0.0 111.859 176.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.414 HD23 HG12 ' B' ' 72' ' ' VAL . 67.5 mt -72.89 -43.41 62.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.295 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -85.56 74.4 10.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.641 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -131.38 -77.4 0.52 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.672 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.35 46.13 1.13 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.414 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -117.19 -140.74 0.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.679 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -85.7 170.78 44.43 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.848 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.516 ' HE2' ' HB2' ' B' ' 41' ' ' SER . 4.9 ttpt -61.84 127.09 29.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 11.6 tp -158.04 115.46 2.96 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 120.957 0.408 . . . . 0.0 110.693 -169.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 69.3 m -107.74 114.14 27.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.054 177.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.51 HD21 ' ND2' ' B' ' 17' ' ' ASN . 3.1 mm? -86.4 154.94 20.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.542 0.687 . . . . 0.0 111.166 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.97 154.47 41.3 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.545 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 54.1 mtt -119.88 144.73 47.24 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.118 0.485 . . . . 0.0 111.898 -171.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -154.42 108.32 2.95 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.09 -111.66 4.18 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -168.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.504 ' HB2' ' HA2' ' B' ' 86' ' ' GLY . 13.8 m120 -123.48 19.58 9.63 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 168.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -72.55 154.71 40.67 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.401 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 20.3 tp -112.44 92.03 3.87 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.172 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -89.52 151.75 21.8 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -170.65 155.53 4.91 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -171.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 11.0 p -123.27 140.18 53.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.207 168.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 27.1 t -142.18 153.13 43.8 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.767 0.794 . . . . 0.0 112.753 -172.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.516 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . 10.2 m -133.0 168.39 18.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.754 176.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -112.07 36.46 3.33 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.478 0.656 . . . . 0.0 109.94 -170.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.7 22.28 0.1 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.86 -1.064 . . . . 0.0 113.376 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.46 -44.11 0.53 Allowed Glycine 0 C--O 1.229 -0.186 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.532 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.679 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 44.4 p90 46.98 -152.51 0.08 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.22 1.008 . . . . 0.0 113.469 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.42 ' H ' HG21 ' B' ' 71' ' ' THR . . . -81.75 99.74 2.02 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.444 -173.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.407 ' H ' HD13 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -112.52 -54.53 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.509 0.671 . . . . 0.0 109.266 172.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -42.87 -55.7 3.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.154 -1.384 . . . . 0.0 111.939 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -79.21 121.12 24.65 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.96 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -65.76 -83.92 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.814 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -146.63 112.37 5.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.508 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 79.6 mttt -139.21 136.23 34.79 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -125.41 128.14 47.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.51 0.671 . . . . 0.0 111.934 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.565 ' HA ' HG12 ' B' ' 94' ' ' ILE . 30.5 p-90 -147.73 177.15 9.54 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.266 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.26 151.16 22.05 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.973 -174.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.469 HD12 ' CD2' ' B' ' 64' ' ' TYR . 19.0 mt -110.26 141.61 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 174.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 60.9 m-85 -125.36 139.45 53.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.795 -173.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.576 HG11 ' ND2' ' B' ' 59' ' ' ASN . 7.4 p -126.37 137.38 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.616 ' HA ' ' CG ' ' B' ' 87' ' ' MET . 2.9 m-80 63.11 6.24 2.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.33 0.652 . . . . 0.0 110.171 -175.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.3 -5.45 55.41 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.94 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' B' ' 58' ' ' VAL . 22.1 mt-10 -100.2 174.45 6.14 Favored 'General case' 0 C--O 1.193 -1.873 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.504 ' HA ' ' CD1' ' B' ' 57' ' ' PHE . 10.7 tttt -80.88 169.97 16.87 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.02 -3.22 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.717 165.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.754 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -158.16 130.83 7.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.437 -172.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 25.3 m -137.68 125.68 22.78 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.448 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.406 ' HB3' ' CD1' ' B' ' 75' ' ' ILE . 0.1 OUTLIER -160.91 154.2 21.68 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 122.709 1.242 . . . . 0.0 113.239 -175.219 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 19.1 t-20 -107.93 152.1 24.9 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.364 -2.198 . . . . 0.0 107.777 166.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -64.27 -24.29 67.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.572 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.565 ' O ' HG23 ' B' ' 71' ' ' THR . 4.4 ttmp? -82.8 -26.09 32.1 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.027 0.441 . . . . 0.0 110.948 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 6.6 t -69.93 -22.3 63.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.565 HG23 ' O ' ' B' ' 69' ' ' LYS . 11.9 p 60.28 115.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.326 1.05 . . . . 0.0 112.558 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.414 HG12 HD23 ' B' ' 20' ' ' LEU . 10.0 m -61.52 -11.74 5.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.82 -172.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.56 -52.6 51.52 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.192 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -72.01 -32.57 67.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.584 0.707 . . . . 0.0 110.213 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.497 HG13 ' O ' ' B' ' 71' ' ' THR . 2.9 mt -73.19 -48.35 43.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.606 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.8 t -50.87 -36.75 39.59 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.239 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -51.21 -55.81 16.11 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.838 0.828 . . . . 0.0 109.744 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.759 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 24.2 m-20 -69.68 -39.7 76.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.046 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.754 HG13 ' CE1' ' B' ' 64' ' ' TYR . 42.6 mm -57.88 -30.91 39.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.378 0.609 . . . . 0.0 111.881 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -73.53 2.4 7.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.618 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.759 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 45.3 pttt -109.49 8.06 25.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.259 0.552 . . . . 0.0 109.937 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -77.36 -6.82 54.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.606 -175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 56.2 65.03 1.53 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -167.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 54.1 mt -67.75 149.56 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.092 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.589 ' HB2' HD22 ' B' ' 59' ' ' ASN . 63.2 mttm -129.68 -159.71 0.98 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.932 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -160.29 126.77 1.67 Allowed Glycine 0 C--N 1.318 -0.426 0 C-N-CA 120.005 -1.093 . . . . 0.0 114.434 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.616 ' CG ' ' HA ' ' B' ' 59' ' ' ASN . 21.1 ptp -176.72 -52.11 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 122.782 0.433 . . . . 0.0 111.166 168.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . 0.506 ' N ' ' HG3' ' B' ' 87' ' ' MET . 60.7 t80 -127.37 99.08 5.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.917 -0.49 . . . . 0.0 109.883 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 41.1 mm -96.53 137.18 25.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.233 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 6.5 mm-40 -128.88 153.93 47.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.035 0.445 . . . . 0.0 111.494 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.512 HG21 ' CZ3' ' B' ' 54' ' ' TRP . 51.5 mt -131.9 114.29 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.323 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 62.6 pttt -166.7 162.24 16.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.06 0.457 . . . . 0.0 112.157 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.445 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -80.82 163.97 23.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.106 175.277 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.565 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.3 pt . . . . . 0 C--O 1.245 0.85 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.892 -172.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.966 0.412 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.517 ' HB3' ' OE1' ' B' ' 8' ' ' GLU . 3.9 m-20 -80.25 -25.51 39.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.177 -175.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -75.16 -17.58 60.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.892 0.377 . . . . 0.0 110.877 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -99.84 -20.42 16.19 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.143 0.497 . . . . 0.0 110.323 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.43 125.11 25.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.977 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 61.2 mt -71.69 -3.43 21.75 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.761 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -62.8 -49.2 75.9 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.95 172.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.517 ' OE1' ' HB3' ' B' ' 2' ' ' ASN . 26.0 mt-10 -92.42 -33.65 14.46 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.393 0.616 . . . . 0.0 110.714 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -85.95 107.1 17.59 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.184 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -62.91 135.8 57.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.4 0.619 . . . . 0.0 110.678 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -56.35 -24.66 45.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.943 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.535 ' O ' HG22 ' B' ' 16' ' ' VAL . 5.4 m -63.52 -33.02 74.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.569 -178.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 12.6 mm -62.74 -43.28 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.624 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -71.93 -39.94 69.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.834 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.6 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 23.8 m -61.33 -49.39 77.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.705 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.535 HG22 ' O ' ' B' ' 12' ' ' SER . 61.2 t -65.2 -38.93 83.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 110.436 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -49.97 -45.96 51.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.905 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.2 OUTLIER -82.75 -41.54 19.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.384 -179.322 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.6 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -58.55 -52.66 64.7 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 123.419 0.688 . . . . 0.0 112.761 -175.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 70.2 mt -73.54 -28.39 61.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.74 0.305 . . . . 0.0 110.945 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -89.46 61.32 5.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.45 0.643 . . . . 0.0 110.279 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 30.7 mtpp -129.36 -84.27 0.56 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.835 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.65 44.95 1.39 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.616 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -126.24 -159.05 0.89 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.575 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -67.96 159.04 51.41 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.434 ' HG2' ' HB2' ' B' ' 41' ' ' SER . 0.0 OUTLIER -82.07 111.01 17.82 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.708 -177.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' B' ' 39' ' ' THR . 2.3 pt? -131.57 148.74 52.64 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.604 -176.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 60.7 m -102.67 117.08 33.89 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.404 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.446 HD23 ' N ' ' B' ' 29' ' ' LEU . 2.8 mm? -88.51 152.6 21.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.51 0.672 . . . . 0.0 110.787 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.1 p -150.07 151.02 32.55 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.237 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 50.7 mtt -120.13 146.21 46.19 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.858 0.361 . . . . 0.0 110.92 -175.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -154.05 116.65 4.4 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.96 -111.49 4.16 Favored Glycine 0 CA--C 1.507 -0.41 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -169.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.54 ' HB2' ' CA ' ' B' ' 86' ' ' GLY . 43.1 m-20 -130.45 37.75 3.82 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 168.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.416 ' HG2' ' CG2' ' B' ' 84' ' ' ILE . 48.1 mt-30 -92.17 161.25 14.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.241 175.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 27.4 tp -127.44 110.53 12.87 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 171.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.414 ' HA ' ' ND2' ' B' ' 80' ' ' ASN . 32.2 mtmt -113.36 148.06 36.49 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -177.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -156.89 158.16 36.18 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -172.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 4.6 p -133.35 134.68 44.07 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.929 171.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -131.1 147.82 52.66 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -167.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.434 ' HB2' ' HG2' ' B' ' 26' ' ' LYS . 2.4 m -99.75 141.7 32.21 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 167.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -103.92 32.06 4.15 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.339 -169.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.71 22.52 1.6 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.135 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.69 -36.52 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.798 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.575 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 6.8 p90 38.13 -142.02 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.475 1.11 . . . . 0.0 113.646 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.49 112.05 3.41 Favored Glycine 0 C--N 1.339 0.729 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.076 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.21 -57.41 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.005 0.431 . . . . 0.0 109.846 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.4 m -43.2 -54.81 4.29 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.346 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -97.32 120.38 37.59 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.067 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -94.98 -84.17 0.34 Allowed 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.641 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -103.96 108.35 19.66 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.749 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.509 ' HB2' ' CG ' ' B' ' 68' ' ' GLU . 93.2 mttt -150.15 134.29 17.09 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 169.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.96 126.51 51.05 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.127 0.489 . . . . 0.0 110.805 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.557 ' CZ3' HG22 ' B' ' 91' ' ' ILE . 25.1 p-90 -145.02 159.34 43.09 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.721 176.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -122.09 147.82 17.09 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.166 -175.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.546 HD11 ' CD2' ' B' ' 64' ' ' TYR . 16.4 mt -105.11 148.76 9.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 169.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.681 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 88.9 m-85 -128.35 141.28 51.47 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -169.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.539 HG11 ' ND2' ' B' ' 59' ' ' ASN . 7.9 p -128.12 136.57 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.539 ' ND2' HG11 ' B' ' 58' ' ' VAL . 3.3 m-80 62.43 12.82 5.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.276 -171.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.94 78.92 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.075 -174.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 17.2 mt-10 -98.25 175.31 6.12 Favored 'General case' 0 C--O 1.202 -1.429 0 C-N-CA 123.517 0.727 . . . . 0.0 109.357 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.0 tppp? -63.4 160.56 15.9 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 118.681 0.673 . . . . 0.0 109.956 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.445 ' N ' ' HG3' ' B' ' 62' ' ' LYS . 7.2 p -151.47 -16.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.965 0.412 . . . . 0.0 110.168 167.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.662 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.9 OUTLIER -161.5 125.74 3.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.148 -171.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 22.7 m -131.36 129.44 41.39 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.642 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.441 ' CD1' ' CD1' ' B' ' 64' ' ' TYR . 7.7 p90 -167.83 153.66 7.34 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 122.186 0.993 . . . . 0.0 112.567 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.49 ' O ' ' HB3' ' B' ' 70' ' ' SER . 16.6 t-20 -99.81 153.14 19.37 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.151 -1.84 . . . . 0.0 108.962 171.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . 0.509 ' CG ' ' HB2' ' B' ' 52' ' ' LYS . 6.7 mm-40 -62.03 -45.67 92.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.969 0.349 . . . . 0.0 111.423 -176.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.514 ' O ' HG22 ' B' ' 71' ' ' THR . 86.4 tttt -64.71 -22.22 66.93 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.454 0.702 . . . . 0.0 111.547 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 6.2 t -69.44 -16.74 63.55 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.514 HG22 ' O ' ' B' ' 69' ' ' LYS . 30.2 p 59.18 107.78 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.888 1.275 . . . . 0.0 112.915 172.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.4 HG13 ' CD2' ' B' ' 66' ' ' PHE . 2.3 m -58.34 -17.85 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 114.266 -1.333 . . . . 0.0 112.635 -171.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.37 -48.97 80.75 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.682 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -74.5 -34.21 63.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.465 0.65 . . . . 0.0 110.191 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.477 ' HB ' ' OH ' ' B' ' 64' ' ' TYR . 1.9 mt -74.68 -48.45 34.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.085 -173.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 77.7 p -50.62 -48.75 57.89 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.583 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -41.62 -52.57 3.76 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.751 -1.568 . . . . 0.0 111.216 173.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.688 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 22.7 m-20 -74.28 -28.83 61.38 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.429 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.662 HG13 ' CE1' ' B' ' 64' ' ' TYR . 48.8 mm -71.88 -38.12 63.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.142 0.496 . . . . 0.0 111.199 177.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' B' ' 37' ' ' LYS . 11.3 m120 -62.88 -28.37 70.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.373 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 61.1 pttt -81.59 3.41 25.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.446 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' B' ' 79' ' ' ILE . 36.8 mt -84.77 3.89 35.45 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.726 0.298 . . . . 0.0 110.862 -177.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 58.9 t30 54.15 58.03 5.38 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -170.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.416 ' CG2' ' HG2' ' B' ' 35' ' ' GLN . 61.7 mt -52.31 149.88 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.726 -173.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -109.22 175.14 5.56 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.573 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.54 ' CA ' ' HB2' ' B' ' 34' ' ' ASN . . . -141.97 112.94 0.78 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.472 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.547 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 0.2 OUTLIER -146.1 -81.21 0.15 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 117.021 0.41 . . . . 0.0 110.595 175.536 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . 0.547 ' N ' ' HG3' ' B' ' 87' ' ' MET . 46.8 t80 -120.16 106.24 11.75 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.681 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 22.0 mm -101.11 130.55 50.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.092 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -122.89 178.58 4.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.188 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.557 HG22 ' CZ3' ' B' ' 54' ' ' TRP . 95.8 mt -149.98 127.76 2.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.29 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -174.36 154.2 2.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.98 0.419 . . . . 0.0 111.615 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.536 ' H ' ' NE2' ' B' ' 93' ' ' GLN . 0.7 OUTLIER -82.68 146.43 29.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.087 177.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.503 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.2 pt . . . . . 0 C--O 1.249 1.064 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.95 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 14.8 t70 . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.702 0.286 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -127.96 37.99 4.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.712 0.291 . . . . 0.0 110.955 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -90.64 -70.09 0.69 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.028 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -97.1 -61.93 1.33 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.095 0.474 . . . . 0.0 111.116 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.49 85.89 6.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.204 -175.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.4 -21.51 63.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.866 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' B' ' 87' ' ' MET . 31.6 mt-10 -67.13 -10.83 54.24 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -175.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -70.11 -21.57 63.1 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 122.417 1.104 . . . . 0.0 109.351 174.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . 0.602 ' HG2' ' H ' ' B' ' 10' ' ' MET . 17.8 tt0 -128.87 -163.59 1.3 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.085 -1.87 . . . . 0.0 107.314 174.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' MET . . . . . 0.612 ' HG2' ' H ' ' B' ' 89' ' ' ILE . 15.1 tpt -158.58 138.39 12.01 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.765 -0.585 . . . . 0.0 109.736 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -54.04 -28.63 39.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.22 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.536 ' O ' HG23 ' B' ' 16' ' ' VAL . 6.2 m -75.2 -16.63 60.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.397 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.517 HG21 ' SD ' ' B' ' 31' ' ' MET . 6.3 mm -57.45 -44.06 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 122.313 1.054 . . . . 0.0 109.03 175.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -70.32 -30.67 67.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.536 -1.666 . . . . 0.0 109.792 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.48 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 10.7 t -70.96 -38.04 72.81 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.903 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.536 HG23 ' O ' ' B' ' 12' ' ' SER . 93.3 t -51.01 -50.55 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.397 0.618 . . . . 0.0 109.816 174.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -59.02 -49.46 77.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.871 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -30.86 68.32 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -174.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' B' ' 15' ' ' SER . 10.0 mmmm -76.85 -23.65 52.7 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.464 0.649 . . . . 0.0 111.381 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 92.0 mt -97.36 -42.11 7.92 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.181 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -84.95 73.46 10.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.395 0.616 . . . . 0.0 110.184 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -116.72 -74.38 0.61 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.504 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.49 40.65 0.82 Allowed Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.723 ' HG2' ' CE1' ' B' ' 49' ' ' TYR . 44.4 mttt -110.7 -145.48 0.4 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.489 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -70.09 154.2 52.51 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' B' ' 40' ' ' SER . 0.3 OUTLIER -61.91 121.67 13.52 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.452 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 28.8 tp -148.23 97.46 2.78 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.481 0.658 . . . . 0.0 109.256 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 43.0 m -99.12 116.24 30.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.788 -175.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.452 ' CD1' ' HG ' ' B' ' 27' ' ' LEU . 10.2 mp -101.67 167.27 10.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.555 0.693 . . . . 0.0 111.838 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.488 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 1.3 p -149.38 146.26 27.4 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.802 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' MET . . . . . 0.517 ' SD ' HG21 ' B' ' 13' ' ' ILE . 5.7 mmt -105.8 118.26 36.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.562 -169.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . 0.425 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 4.0 t30 -133.5 60.76 1.69 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.882 0.373 . . . . 0.0 110.009 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.88 -104.11 0.12 Allowed Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.606 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.481 ' HA ' ' N ' ' B' ' 86' ' ' GLY . 17.9 m120 -85.02 23.19 1.26 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.687 -0.257 . . . . 0.0 111.07 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 35.3 mt-30 -138.73 150.84 46.58 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.437 0.636 . . . . 0.0 110.595 172.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -123.94 114.65 20.09 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.162 172.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.488 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 6.7 mmmm -110.73 137.78 47.96 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -176.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -162.28 154.2 18.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.28 0.562 . . . . 0.0 112.329 -172.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.33 146.15 51.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.389 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 33.6 p -135.67 154.98 51.11 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.004 0.431 . . . . 0.0 112.031 -175.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 28.1 t -152.95 159.37 42.94 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.152 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . 0.47 ' C ' ' H ' ' B' ' 44' ' ' GLY . 51.3 m-80 -85.76 52.82 2.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.114 -174.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.21 23.22 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.856 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' B' ' 42' ' ' ASN . . . 117.39 -13.19 13.74 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.784 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.489 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 35.7 p90 45.2 -156.98 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.403 1.081 . . . . 0.0 113.136 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.63 89.97 0.55 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.91 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.462 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -91.68 -70.85 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.541 0.686 . . . . 0.0 110.509 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 m -50.34 -55.88 13.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.987 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.723 ' CE1' ' HG2' ' B' ' 24' ' ' LYS . 4.3 m-85 -61.48 109.69 1.24 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.605 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.29 -64.44 0.95 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.543 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -173.05 113.09 0.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.734 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 54.1 mtmt -138.31 145.34 41.09 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.505 ' HB3' ' OD1' ' B' ' 67' ' ' ASN . 0.5 OUTLIER -121.82 121.96 38.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.226 0.536 . . . . 0.0 111.623 -178.194 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.57 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 33.4 p-90 -140.23 173.74 11.21 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.229 174.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.98 151.79 21.12 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.907 -1.14 . . . . 0.0 113.372 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.504 HD11 ' CD2' ' B' ' 64' ' ' TYR . 18.2 mt -110.12 145.92 16.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 174.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.753 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 72.8 m-85 -128.88 143.66 50.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.282 -171.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.541 HG12 ' ND2' ' B' ' 59' ' ' ASN . 9.6 p -128.47 137.34 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.541 ' ND2' HG12 ' B' ' 58' ' ' VAL . 1.4 m-80 60.27 9.02 1.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.277 0.631 . . . . 0.0 110.494 -176.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.77 7.87 57.45 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.232 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 12.1 mt-10 -114.62 177.02 4.8 Favored 'General case' 0 C--O 1.199 -1.592 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.569 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 18.6 ttmt -78.89 169.21 18.58 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 119.303 0.956 . . . . 0.0 109.924 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.53 -14.96 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.798 164.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.647 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.5 OUTLIER -158.4 130.07 6.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.601 -167.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.2 m -137.96 133.3 33.54 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.218 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.458 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.0 OUTLIER -159.35 160.97 35.63 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.953 0.882 . . . . 0.0 111.21 -174.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.505 ' OD1' ' HB3' ' B' ' 53' ' ' ASN . 2.9 m120 -115.96 146.78 41.81 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.624 -1.626 . . . . 0.0 109.787 170.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . 0.487 ' CD ' ' HZ1' ' B' ' 24' ' ' LYS . 13.4 mm-40 -56.35 -44.27 79.92 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.614 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.527 ' O ' HG21 ' B' ' 71' ' ' THR . 35.0 ttpt -64.01 -30.09 71.19 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.611 0.72 . . . . 0.0 110.621 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 23.7 m -81.27 -3.35 52.18 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.091 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.527 HG21 ' O ' ' B' ' 69' ' ' LYS . 23.6 p 55.21 102.01 0.01 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.304 1.442 . . . . 0.0 113.474 165.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 4.2 m -62.94 -18.88 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.425 -173.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.42 -49.58 75.09 Favored Glycine 0 C--O 1.236 0.241 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.974 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -69.62 -37.52 76.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.023 0.439 . . . . 0.0 110.268 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.552 ' O ' HG12 ' B' ' 79' ' ' ILE . 2.7 mt -68.21 -46.61 80.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.609 -176.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 45.6 m -57.02 -35.5 69.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.933 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -54.74 -49.17 71.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.169 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 7.3 m-20 -70.51 -37.49 74.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.558 -1.201 . . . . 0.0 112.122 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.647 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 43.7 mm -59.02 -24.4 26.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.482 0.658 . . . . 0.0 111.443 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -59.95 -18.66 47.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.508 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 6.0 ptpp? -87.11 1.32 53.36 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.172 0.51 . . . . 0.0 110.851 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 2.4 mm? -81.38 -1.66 46.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.156 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 49.54 62.35 2.68 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.798 -168.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.466 HD13 HG23 ' B' ' 79' ' ' ILE . 49.0 mt -58.71 140.77 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.71 -177.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -127.37 -176.76 3.84 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.796 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.481 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -136.89 115.53 1.27 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.872 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' B' ' 7' ' ' GLU . 32.7 ttm -157.79 -74.99 0.09 Allowed 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -130.77 82.51 2.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.415 0.626 . . . . 0.0 109.503 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.753 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.2 mp -87.67 136.68 22.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.518 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -122.08 171.78 8.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.888 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.483 HG22 ' CZ3' ' B' ' 54' ' ' TRP . 32.9 mm -144.93 110.1 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.33 -174.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 16.6 pttp -161.04 173.18 15.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.291 0.567 . . . . 0.0 112.042 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.497 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.0 OUTLIER -105.49 145.79 30.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.882 -175.03 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.525 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.7 pt . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.95 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -100.89 -25.09 14.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.727 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -55.22 -42.67 73.65 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -173.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -70.62 -26.15 63.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.143 0.497 . . . . 0.0 110.775 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -107.77 26.68 10.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.24 -175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' B' ' 9' ' ' GLN . 74.9 mt -75.24 11.47 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.24 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -68.17 -62.66 1.3 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.205 0.526 . . . . 0.0 109.639 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -89.32 -33.22 16.99 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.03 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' B' ' 6' ' ' LEU . 50.6 mt-30 -85.75 119.35 25.99 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.361 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.15 174.09 7.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.958 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -60.28 -33.36 72.23 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.967 0.413 . . . . 0.0 111.805 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.417 ' O ' HG23 ' B' ' 16' ' ' VAL . 23.2 t -67.84 -8.45 36.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.031 -169.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 10.2 mm -55.41 -55.11 18.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.935 0.874 . . . . 0.0 110.12 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -77.56 -27.7 51.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.355 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 10.1 m -57.6 -47.05 83.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.116 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 12' ' ' SER . 76.1 t -66.46 -43.91 90.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.085 0.469 . . . . 0.0 109.978 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . 0.485 HD21 HD11 ' B' ' 29' ' ' LEU . 3.8 t-20 -54.08 -50.77 66.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.986 178.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.38 -43.21 64.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.648 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -57.24 -50.89 71.45 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 123.204 0.602 . . . . 0.0 111.593 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -70.69 -45.24 65.38 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.827 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -85.97 59.78 5.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.389 0.614 . . . . 0.0 111.369 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -105.23 -17.34 14.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.328 0.585 . . . . 0.0 109.914 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.83 -95.16 0.1 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.51 ' HE3' ' OE2' ' B' ' 68' ' ' GLU . 51.3 mttp 41.65 -135.1 0.29 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.688 0.795 . . . . 0.0 111.197 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.602 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -84.42 168.15 43.85 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.785 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.414 ' HE3' ' CB ' ' B' ' 41' ' ' SER . 14.7 ttpt -86.27 109.84 19.23 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -145.52 168.31 20.91 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.161 -176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 43.9 m -125.66 107.11 10.25 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.759 -176.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.485 HD11 HD21 ' B' ' 17' ' ' ASN . 33.1 mt -86.87 144.91 26.78 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.556 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 9.0 p -134.78 156.69 48.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.964 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 55.0 mtm -110.04 127.99 55.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.991 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -148.89 108.33 3.96 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.04 -114.62 6.92 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.54 ' HB2' ' HA2' ' B' ' 86' ' ' GLY . 1.7 m-20 -123.9 20.03 9.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -74.69 158.78 32.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.528 -176.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tt -115.93 104.01 11.18 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.391 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.556 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 4.7 mtmp? -115.59 142.63 46.47 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -158.91 156.61 29.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -175.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -130.56 134.65 47.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 170.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 44.6 t -126.33 160.07 31.41 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -164.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.414 ' CB ' ' HE3' ' B' ' 26' ' ' LYS . 35.2 t -134.4 159.97 39.41 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.007 174.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -109.25 29.63 7.35 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.276 0.56 . . . . 0.0 110.727 -171.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.03 22.4 0.09 Allowed 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.961 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.75 -38.3 0.57 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.409 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.602 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 14.4 p90 45.56 -159.48 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.471 1.108 . . . . 0.0 113.758 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.17 114.83 6.03 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.974 -0.632 . . . . 0.0 113.118 -175.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.11 -60.81 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.837 0.351 . . . . 0.0 110.815 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 m -40.66 -57.23 1.93 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.077 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.81 106.15 10.61 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.784 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -60.0 -49.22 78.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.651 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -165.32 110.77 0.91 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.985 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 71.8 mmtt -133.51 131.93 40.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -112.73 125.77 54.68 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.501 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 16.7 p-90 -152.7 166.74 31.2 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.886 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.33 142.6 13.88 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.846 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.554 HD12 ' CD2' ' B' ' 64' ' ' TYR . 23.7 mt -106.59 151.37 8.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.667 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 76.0 m-85 -132.59 140.29 48.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.277 -170.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.457 ' HA ' HD12 ' B' ' 89' ' ' ILE . 11.9 p -124.85 131.42 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.447 ' ND2' HG13 ' B' ' 58' ' ' VAL . 2.8 m-80 64.25 11.49 6.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.51 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.96 -3.74 62.55 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.348 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -103.01 177.15 4.92 Favored 'General case' 0 C--O 1.207 -1.152 0 C-N-CA 123.303 0.641 . . . . 0.0 109.642 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.464 ' HD2' ' HG1' ' B' ' 65' ' ' THR . 5.2 tppp? -63.87 158.76 21.22 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.014 175.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.419 ' N ' ' HG3' ' B' ' 62' ' ' LYS . 9.8 p -153.23 -11.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.122 0.487 . . . . 0.0 110.245 165.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.796 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -161.21 136.25 7.52 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.061 0.458 . . . . 0.0 110.53 -174.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.464 ' HG1' ' HD2' ' B' ' 62' ' ' LYS . 84.8 m -149.25 118.47 6.81 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.49 ' N ' ' HD1' ' B' ' 66' ' ' PHE . 0.0 OUTLIER -167.74 159.76 12.04 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.717 0.77 . . . . 0.0 111.462 -164.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 18.1 t-20 -114.04 158.8 20.74 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.915 -1.493 . . . . 0.0 109.591 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . 0.51 ' OE2' ' HE3' ' B' ' 24' ' ' LYS . 8.5 mm-40 -74.06 -34.14 63.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.004 0.43 . . . . 0.0 110.898 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.54 ' O ' HG21 ' B' ' 71' ' ' THR . 53.0 tttm -68.94 -31.69 70.76 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.049 0.928 . . . . 0.0 109.319 176.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 30.4 m -79.62 0.3 30.74 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.843 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.54 HG21 ' O ' ' B' ' 69' ' ' LYS . 20.1 p 53.64 100.58 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.436 1.494 . . . . 0.0 113.678 165.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 m -56.68 -21.77 14.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.069 -176.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.67 -54.64 35.73 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.544 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -69.4 -31.93 70.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.202 0.525 . . . . 0.0 110.172 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.513 HG13 ' O ' ' B' ' 71' ' ' THR . 2.9 mt -70.11 -42.61 79.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.239 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -58.02 -30.25 65.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.752 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -52.6 -53.32 48.31 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.767 0.794 . . . . 0.0 109.633 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.666 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 4.9 m-20 -65.1 -40.67 94.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.461 177.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.796 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 44.5 mm -54.31 -32.33 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.314 0.578 . . . . 0.0 111.817 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.458 ' OD1' ' HA ' ' B' ' 37' ' ' LYS . 90.5 m-20 -58.43 -31.22 67.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.816 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.666 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 4.6 ptpp? -83.43 -4.48 58.54 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.163 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.8 mm? -70.32 -15.83 62.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.717 0.294 . . . . 0.0 110.667 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 44.01 61.66 2.25 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.813 -171.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.434 HG22 ' O ' ' B' ' 85' ' ' LYS . 73.0 mt -60.04 146.37 10.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.362 -1.29 . . . . 0.0 112.6 -172.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.434 ' O ' HG22 ' B' ' 84' ' ' ILE . 30.0 mmmt -92.11 -166.07 1.48 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.132 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.54 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -148.55 114.16 0.66 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.808 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.48 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 6.2 tpt -152.42 -68.89 0.16 Allowed 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 122.531 0.333 . . . . 0.0 110.124 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . 0.48 ' N ' ' HG3' ' B' ' 87' ' ' MET . 5.1 t80 -143.41 106.57 4.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.072 0.463 . . . . 0.0 109.835 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.667 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 37.0 mm -91.85 130.28 41.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.04 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -121.65 169.47 10.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.793 0.33 . . . . 0.0 110.154 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.404 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 70.5 mt -146.72 130.28 9.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.24 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 39.9 pttt -165.03 159.57 18.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.124 0.488 . . . . 0.0 111.42 174.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.485 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -106.69 138.78 42.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.863 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.49 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.2 pt . . . . . 0 C--O 1.246 0.88 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.042 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -143.92 95.55 2.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.825 0.345 . . . . 0.0 110.277 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -20.21 64.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.479 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -68.7 -29.36 67.77 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.32 0.581 . . . . 0.0 109.8 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.21 -22.09 27.11 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.413 0.625 . . . . 0.0 109.937 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 80.9 mt -87.91 8.64 25.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.367 -176.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.54 -33.29 75.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.309 0.576 . . . . 0.0 109.919 174.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -86.52 -63.55 1.3 Allowed 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.833 0.825 . . . . 0.0 109.897 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -82.5 74.31 9.48 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.436 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' MET . . . . . 0.406 ' O ' HG12 ' B' ' 13' ' ' ILE . 90.3 mmm -45.86 145.49 1.44 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.108 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -51.11 -27.52 8.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.865 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 5.1 m -66.6 -31.07 71.53 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.288 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.406 HG12 ' O ' ' B' ' 10' ' ' MET . 11.4 mm -63.77 -31.0 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.647 0.737 . . . . 0.0 109.888 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -92.09 -44.36 8.87 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.812 -172.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 14.5 p -70.89 -45.24 64.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.095 -178.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 91.4 t -68.51 -30.14 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.585 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -53.79 -47.17 71.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.258 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.1 OUTLIER -78.95 -42.63 26.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.619 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -58.65 -43.05 89.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.401 -176.101 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.452 ' HB3' HG23 ' B' ' 72' ' ' VAL . 19.7 mt -80.24 -24.24 40.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -105.62 70.93 0.89 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.818 0.342 . . . . 0.0 111.249 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 33.6 mtmt -138.31 -91.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.817 175.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.432 ' O ' ' HA2' ' B' ' 46' ' ' GLY . . . -92.93 32.42 5.64 Favored Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.554 ' HD2' ' N ' ' B' ' 24' ' ' LYS . 0.0 OUTLIER -124.27 -163.08 1.12 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 174.119 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.636 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -67.96 144.97 44.16 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.184 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' B' ' 40' ' ' SER . 44.7 mttm -62.2 144.5 55.41 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.41 ' CD2' ' HB3' ' B' ' 40' ' ' SER . 4.0 mt -150.07 118.45 6.45 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.118 0.485 . . . . 0.0 110.91 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 14.4 m -99.06 97.97 9.04 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.338 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 10.4 mp -86.14 163.0 18.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.797 0.808 . . . . 0.0 112.094 -172.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.1 p -146.69 148.82 32.41 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.111 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 58.0 mtt -96.49 139.7 32.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.106 0.479 . . . . 0.0 111.68 -173.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' B' ' 35' ' ' GLN . 8.6 t30 -157.15 91.92 1.22 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.833 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.98 -97.55 0.51 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -172.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -142.1 21.61 2.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.551 ' CG ' ' HG2' ' B' ' 37' ' ' LYS . 0.0 OUTLIER -85.71 158.27 20.09 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.893 -176.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.407 ' H ' ' NE2' ' B' ' 35' ' ' GLN . 2.8 tt -111.85 98.06 7.12 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.887 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.551 ' HG2' ' CG ' ' B' ' 35' ' ' GLN . 11.1 mtmt -112.1 137.17 50.53 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.4 169.96 4.3 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -170.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 5.8 p -128.17 140.34 51.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.591 170.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 74.1 p -123.66 165.41 17.26 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -169.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.431 ' HB3' ' HB2' ' B' ' 26' ' ' LYS . 32.3 t -131.62 157.98 42.26 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.481 176.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -117.04 18.31 14.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.331 -172.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.64 -21.86 66.59 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.549 ' O ' HD11 ' B' ' 47' ' ' ILE . . . -143.14 -48.6 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.099 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.636 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 3.4 p90 52.93 -164.55 0.08 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.966 1.306 . . . . 0.0 113.852 -176.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.519 ' N ' ' HD1' ' B' ' 45' ' ' TYR . . . -57.87 100.12 0.13 Allowed Glycine 0 C--N 1.342 0.88 0 N-CA-C 114.601 0.6 . . . . 0.0 114.601 -174.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.549 HD11 ' O ' ' B' ' 44' ' ' GLY . 3.8 mm -108.53 -67.81 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-O 121.59 0.71 . . . . 0.0 110.777 173.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -51.16 -62.62 1.51 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.579 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -83.48 127.01 33.37 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.772 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.69 -171.97 1.73 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.18 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -65.53 107.07 1.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.368 0.604 . . . . 0.0 109.706 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 6.4 mtmp? -145.4 128.83 16.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.621 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -102.73 124.85 49.02 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.532 0.682 . . . . 0.0 112.357 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.591 ' CZ3' HG22 ' B' ' 91' ' ' ILE . 51.4 p-90 -141.15 163.7 32.26 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.368 169.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.82 156.8 23.02 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 119.772 -1.204 . . . . 0.0 113.317 -172.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.432 HD13 ' CD2' ' B' ' 64' ' ' TYR . 22.1 mt -111.82 137.74 43.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 174.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.713 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 46.0 m-85 -124.77 132.12 53.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.014 -174.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.535 HG12 ' ND2' ' B' ' 59' ' ' ASN . 13.4 p -112.48 136.27 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.916 177.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.535 ' ND2' HG12 ' B' ' 58' ' ' VAL . 9.9 m-80 71.04 -7.93 1.05 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.538 0.735 . . . . 0.0 110.905 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.25 5.9 39.76 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -169.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' B' ' 58' ' ' VAL . 25.9 mt-10 -106.55 165.76 11.05 Favored 'General case' 0 C--O 1.198 -1.642 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 174.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.476 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 27.8 ttmt -78.5 168.93 19.05 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.403 HG12 ' O ' ' B' ' 62' ' ' LYS . 0.0 OUTLIER -155.82 -10.08 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.326 165.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.614 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.5 OUTLIER -158.1 125.79 5.2 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.413 -170.169 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -134.42 132.2 39.07 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.178 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.439 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.0 OUTLIER -163.76 165.97 22.53 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 122.161 0.981 . . . . 0.0 111.162 -175.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.613 ' HB2' ' OG ' ' B' ' 70' ' ' SER . 12.0 m120 -116.72 144.63 44.21 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.493 169.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -64.67 -15.8 61.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.824 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -92.82 -25.28 18.2 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.252 0.549 . . . . 0.0 109.846 177.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.613 ' OG ' ' HB2' ' B' ' 67' ' ' ASN . 38.2 m -76.98 -5.57 49.17 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.458 -175.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' THR . . . . . . . . . . . . . 3.3 p 66.27 99.84 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.741 169.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' B' ' 20' ' ' LEU . 7.8 m -65.67 -13.11 14.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.45 -176.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.55 -51.95 51.28 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.1 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -67.94 -42.68 80.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.312 0.577 . . . . 0.0 110.263 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.482 ' O ' HG12 ' B' ' 79' ' ' ILE . 2.6 mt -64.97 -42.03 93.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.54 -174.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 55.7 m -59.13 -30.29 68.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.229 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' B' ' 80' ' ' ASN . 46.9 t-20 -52.39 -54.6 29.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.607 0.718 . . . . 0.0 109.388 174.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.66 -39.49 94.46 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.634 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.614 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 48.4 mm -58.67 -33.54 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 123.021 0.528 . . . . 0.0 112.085 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' B' ' 77' ' ' ASN . 5.7 m-80 -54.81 -35.89 64.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.558 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -78.46 -14.07 59.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.782 0.325 . . . . 0.0 111.111 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 3.7 mm? -65.56 -22.58 66.71 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.558 -173.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 55.9 t30 46.01 57.58 5.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.938 -172.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' B' ' 35' ' ' GLN . 88.6 mt -59.38 141.98 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.203 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -87.44 -164.13 1.04 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.273 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -150.35 115.26 0.7 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.027 -1.082 . . . . 0.0 113.322 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 28.4 ttp -154.06 -75.2 0.12 Allowed 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.565 0.183 . . . . 0.0 110.591 172.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . 0.441 ' H ' ' HA ' ' B' ' 59' ' ' ASN . 44.7 t80 -121.49 93.45 4.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.192 0.52 . . . . 0.0 109.925 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.713 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.0 mp -95.32 128.95 46.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.795 -177.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.52 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 43.3 mt-10 -114.15 144.36 43.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.29 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.591 HG22 ' CZ3' ' B' ' 54' ' ' TRP . 50.0 mm -126.23 112.4 29.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.99 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -166.49 158.39 13.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.477 0.656 . . . . 0.0 112.424 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.522 ' CD ' ' H ' ' B' ' 93' ' ' GLN . 4.5 pm0 -79.27 145.99 33.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.78 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.487 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.9 pt . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.254 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . 0.402 ' OD1' ' HG2' ' B' ' 3' ' ' GLN . 27.5 t70 . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -119.34 7.97 11.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . 0.402 ' HG2' ' OD1' ' B' ' 1' ' ' ASP . 10.9 pt20 -91.23 -34.65 14.89 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.185 177.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -82.68 -38.01 24.01 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' B' ' 7' ' ' GLU . . . -74.98 96.92 3.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.848 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 98.6 mt -79.77 21.03 0.56 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.323 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.401 ' H ' ' C ' ' B' ' 5' ' ' ALA . 25.9 mt-10 -70.98 -62.05 1.54 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.138 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -86.4 -9.61 55.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.445 0.64 . . . . 0.0 110.591 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -108.75 102.78 11.79 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.777 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' MET . . . . . 0.428 ' O ' HG13 ' B' ' 13' ' ' ILE . 98.5 mmm -95.57 137.78 34.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.964 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -37.96 -24.93 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.887 1.675 . . . . 0.0 114.848 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.518 ' O ' HG23 ' B' ' 16' ' ' VAL . 8.8 m -61.87 -9.14 6.05 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.428 HG13 ' O ' ' B' ' 10' ' ' MET . 0.1 OUTLIER -51.27 -58.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 CA-C-O 122.008 0.909 . . . . 0.0 110.112 -177.312 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -79.39 -27.74 41.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.204 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.618 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 15.1 m -61.11 -39.14 88.86 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 12' ' ' SER . 99.0 t -69.06 -45.4 80.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.27 0.557 . . . . 0.0 109.866 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -52.43 -49.02 65.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.699 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.3 -31.86 60.8 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.78 -176.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.618 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.3 OUTLIER -61.82 -44.97 95.79 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 122.812 0.445 . . . . 0.0 111.406 177.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 72.5 mt -81.53 -39.27 24.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.659 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -81.48 70.82 8.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.037 0.446 . . . . 0.0 111.33 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -144.33 -72.26 0.27 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.264 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.405 ' O ' ' HA2' ' B' ' 46' ' ' GLY . . . -119.01 44.75 1.35 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.072 -176.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -111.92 -158.05 0.64 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.662 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -83.27 -166.66 40.17 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.347 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.819 ' O ' ' HA ' ' B' ' 40' ' ' SER . 44.7 mtmt -67.84 98.57 0.74 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' B' ' 39' ' ' THR . 21.0 tp -124.88 115.7 21.05 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.23 -163.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 51.4 m -105.61 105.86 16.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.387 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.424 HD23 ' N ' ' B' ' 29' ' ' LEU . 2.5 mm? -83.31 149.57 26.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.313 0.578 . . . . 0.0 110.376 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p -146.27 147.47 31.44 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.36 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 62.0 mtt -116.42 145.34 43.33 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.103 0.478 . . . . 0.0 111.796 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -160.3 105.78 1.51 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.66 -122.81 18.09 Favored Glycine 0 CA--C 1.503 -0.681 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -167.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.477 HD21 ' CG1' ' B' ' 89' ' ' ILE . 2.0 m-20 -119.31 25.2 10.27 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.48 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 48.7 mt-30 -79.42 156.34 27.95 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.74 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -114.77 88.2 2.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.127 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.473 ' HA ' ' ND2' ' B' ' 80' ' ' ASN . 27.4 mtpt -96.37 141.05 30.16 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -171.45 160.64 6.07 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -171.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 2.1 p -134.85 143.73 47.18 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.713 171.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.819 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 9.9 t -144.87 149.19 34.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.438 0.637 . . . . 0.0 111.965 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.463 ' CB ' ' HE3' ' B' ' 26' ' ' LYS . 6.8 m -111.98 163.83 13.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.561 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -113.08 33.78 4.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.02 -173.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.45 -1.53 30.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.032 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.63 -43.67 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.662 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 31.2 p90 43.75 -154.62 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.884 1.274 . . . . 0.0 114.281 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' B' ' 23' ' ' GLY . . . -77.11 107.94 2.48 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.681 -173.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.71 -54.92 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.338 0.589 . . . . 0.0 110.276 176.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.1 m -34.36 -57.8 0.49 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.098 -1.41 . . . . 0.0 114.323 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -75.06 -5.8 46.04 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.136 -173.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' B' ' 69' ' ' LYS . 46.3 mt-10 54.99 -92.39 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 123.498 0.499 . . . . 0.0 110.297 -168.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -136.31 110.09 8.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.589 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 33.7 mmtp -131.92 138.89 48.54 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -114.0 130.62 56.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.912 0.387 . . . . 0.0 110.053 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.506 ' HA ' HG12 ' B' ' 94' ' ' ILE . 18.5 p-90 -146.07 168.58 20.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.895 175.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -133.25 144.0 15.83 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.776 -174.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.448 HD12 ' CD2' ' B' ' 64' ' ' TYR . 15.6 mt -107.82 148.01 12.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 171.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.687 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 71.5 m-85 -129.57 136.76 50.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.51 -171.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' B' ' 61' ' ' GLU . 10.6 p -122.44 135.82 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.461 ' ND2' HG12 ' B' ' 58' ' ' VAL . 2.1 m-80 60.7 14.24 4.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.389 -172.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.65 -18.3 57.52 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.458 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' B' ' 58' ' ' VAL . 0.6 OUTLIER -87.92 165.61 15.12 Favored 'General case' 0 C--O 1.194 -1.821 0 C-N-CA 123.795 0.838 . . . . 0.0 108.831 -179.026 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.621 ' HA ' ' CD1' ' B' ' 57' ' ' PHE . 2.2 tttt -65.23 164.8 12.63 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 120.529 -0.469 . . . . 0.0 109.827 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.453 ' HB ' HG13 ' B' ' 58' ' ' VAL . 7.5 p -154.5 -13.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.084 0.468 . . . . 0.0 110.481 172.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.766 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.7 OUTLIER -159.65 124.56 4.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.215 0.531 . . . . 0.0 110.913 -171.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 21.3 m -131.9 127.92 37.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.102 176.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' B' ' 66' ' ' PHE . 0.0 OUTLIER -168.31 149.42 4.97 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.171 0.986 . . . . 0.0 111.872 -171.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.492 ' O ' ' HB3' ' B' ' 70' ' ' SER . 26.4 t-20 -103.39 146.82 27.92 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.165 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -67.59 -21.7 65.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.775 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.479 ' O ' HG22 ' B' ' 71' ' ' THR . 1.5 tmtp? -88.05 -23.28 23.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.361 0.601 . . . . 0.0 109.526 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 5.2 t -65.7 -27.31 68.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.979 172.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.489 ' O ' HG13 ' B' ' 75' ' ' ILE . 23.5 p 61.24 123.24 0.01 OUTLIER 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.004 1.322 . . . . 0.0 113.057 174.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.417 ' HB ' ' OG ' ' B' ' 76' ' ' SER . 12.3 m -62.93 -11.2 6.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 114.405 -1.271 . . . . 0.0 113.239 -170.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' B' ' 40' ' ' SER . . . -56.24 -54.21 37.39 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.267 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -73.41 -35.21 65.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.263 0.554 . . . . 0.0 110.127 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.489 HG13 ' O ' ' B' ' 71' ' ' THR . 1.6 mt -74.6 -55.74 11.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.723 -172.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.438 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 49.3 m -60.48 -30.64 69.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.863 -174.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -49.5 -52.19 31.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.83 0.824 . . . . 0.0 109.658 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.732 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 5.0 m-20 -67.31 -44.66 78.66 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.363 -1.289 . . . . 0.0 111.286 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.766 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 49.3 mm -50.82 -33.12 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.28 0.562 . . . . 0.0 112.26 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.473 ' ND2' ' HA ' ' B' ' 37' ' ' LYS . 0.9 OUTLIER -64.34 -29.27 70.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.919 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.732 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 49.7 pttt -81.39 -6.23 58.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.076 0.465 . . . . 0.0 110.549 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 4.2 mm? -73.57 -10.27 59.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.014 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 33.58 64.96 0.3 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.265 1.031 . . . . 0.0 111.113 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.48 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 60.3 mt -60.46 150.55 6.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 113.866 -1.516 . . . . 0.0 112.518 -170.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.419 ' O ' HG22 ' B' ' 84' ' ' ILE . 65.8 mttm -89.38 -177.16 5.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.286 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.76 112.87 0.72 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.898 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.486 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 7.6 tpt -151.87 -74.58 0.14 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.575 0.226 . . . . 0.0 110.575 176.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . 0.486 ' N ' ' HG3' ' B' ' 87' ' ' MET . 35.5 t80 -124.64 100.2 6.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.687 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 29.1 mm -100.98 120.31 50.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.732 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -111.61 -179.53 3.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.514 0.673 . . . . 0.0 110.959 174.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.429 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 83.9 mt -153.56 131.17 2.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.033 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.582 ' HE2' ' CE2' ' B' ' 57' ' ' PHE . 42.8 pttt -171.05 150.03 3.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.038 0.447 . . . . 0.0 111.3 176.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.476 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.8 OUTLIER -84.67 153.01 23.39 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.552 172.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.506 HG12 ' HA ' ' B' ' 54' ' ' TRP . 7.5 pt . . . . . 0 C--N 1.314 -0.957 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.089 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 120.616 0.246 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -68.47 -25.14 64.84 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -172.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -72.88 -17.11 61.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 110.424 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -90.51 -18.06 25.96 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.371 0.605 . . . . 0.0 109.521 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.9 136.82 36.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.983 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' B' ' 9' ' ' GLN . 79.8 mt -69.48 -8.45 47.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.799 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -67.62 -60.9 2.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.511 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -90.92 -6.82 53.61 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.194 0.521 . . . . 0.0 111.504 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' B' ' 6' ' ' LEU . 29.8 tt0 -123.76 83.74 2.18 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' MET . . . . . 0.481 ' O ' HG12 ' B' ' 13' ' ' ILE . 0.0 OUTLIER -108.88 -169.11 1.43 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.749 -170.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . 0.503 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 21.4 t-20 -50.87 -24.95 3.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -176.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.499 ' HA ' ' CG2' ' B' ' 16' ' ' VAL . 20.1 m -66.72 -14.83 63.02 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.276 -0.265 . . . . 0.0 111.69 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.481 HG12 ' O ' ' B' ' 10' ' ' MET . 16.0 mm -61.44 -52.64 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.015 0.436 . . . . 0.0 110.987 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -106.74 -63.02 1.32 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.024 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.46 ' HB3' ' OD1' ' B' ' 11' ' ' ASN . 32.6 t -59.61 -60.34 4.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.071 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.499 ' CG2' ' HA ' ' B' ' 12' ' ' SER . 47.4 t -57.78 -40.52 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.872 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.26 -51.23 70.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.07 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.55 -34.03 58.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.59 0.233 . . . . 0.0 111.518 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 13.1 tppt? -64.01 -47.74 79.07 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.465 0.65 . . . . 0.0 110.86 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.418 HD21 ' CZ ' ' B' ' 66' ' ' PHE . 28.3 mt -67.35 -46.68 72.67 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.774 176.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -88.12 53.9 2.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.191 0.52 . . . . 0.0 111.116 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' B' ' 19' ' ' LYS . 30.5 mtpp -83.9 -25.3 30.31 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 166.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.46 ' HA3' ' OH ' ' B' ' 49' ' ' TYR . . . 165.47 -93.94 0.11 Allowed Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 114.317 -1.311 . . . . 0.0 110.356 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.57 -125.12 0.38 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.511 0.724 . . . . 0.0 110.553 -176.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.59 137.37 15.23 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.758 ' O ' ' HA ' ' B' ' 40' ' ' SER . 41.0 mtmt -61.64 100.59 0.15 Allowed 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -177.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 43.9 tp -128.46 124.03 35.16 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 120.877 0.37 . . . . 0.0 110.06 -171.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.669 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 5.2 p -105.41 100.49 10.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.445 -176.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.441 HD22 ' N ' ' B' ' 29' ' ' LEU . 2.1 mm? -87.96 147.95 24.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.736 0.779 . . . . 0.0 111.439 -175.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.9 p -142.67 141.32 31.84 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.939 168.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.78 131.34 54.01 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.359 -173.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -140.2 68.35 1.36 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.97 -102.4 0.51 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.498 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' B' ' 84' ' ' ILE . 5.3 m-20 -79.28 -24.17 43.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.756 0.312 . . . . 0.0 111.043 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -94.96 147.1 23.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.958 0.885 . . . . 0.0 111.819 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 33.4 tp -128.59 99.49 5.39 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 113.973 -1.467 . . . . 0.0 107.674 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -95.82 137.81 34.36 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.983 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -160.97 156.73 25.23 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.143 -170.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.47 147.12 47.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 171.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.758 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 6.9 t -138.62 162.87 33.52 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 47.3 t -136.29 162.17 33.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.8 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -113.68 30.68 7.06 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.534 0.683 . . . . 0.0 109.619 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.18 21.45 0.13 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.112 -173.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.51 -32.66 0.58 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.731 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.535 ' CD1' HG23 ' B' ' 71' ' ' THR . 19.0 p90 44.22 -157.27 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.578 1.151 . . . . 0.0 113.365 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.426 ' N ' ' HD1' ' B' ' 45' ' ' TYR . . . -67.07 96.12 0.31 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.748 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.448 ' H ' HD13 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -91.2 -71.28 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.274 0.559 . . . . 0.0 110.593 -177.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.4 m -62.86 -48.61 78.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.202 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.46 ' OH ' ' HA3' ' B' ' 23' ' ' GLY . 11.5 m-85 -39.52 119.45 0.95 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.699 -1.591 . . . . 0.0 112.365 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -74.58 -171.15 1.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.22 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.5 109.39 13.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.731 0.777 . . . . 0.0 109.348 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.597 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 76.4 mttt -131.87 123.61 27.85 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.409 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.412 HD21 HG13 ' B' ' 94' ' ' ILE . 1.2 p-10 -111.18 118.48 36.08 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.454 0.645 . . . . 0.0 110.777 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.653 ' CZ3' HG22 ' B' ' 91' ' ' ILE . 40.5 p-90 -143.19 166.46 24.62 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.375 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.63 147.79 18.75 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.595 -174.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.455 HD11 ' CD2' ' B' ' 64' ' ' TYR . 18.4 mt -103.9 144.82 13.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 170.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.668 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 68.4 m-85 -125.15 141.06 52.34 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.493 -174.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.589 HG12 ' ND2' ' B' ' 59' ' ' ASN . 7.3 p -126.55 134.66 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.589 ' ND2' HG12 ' B' ' 58' ' ' VAL . 6.3 m-80 68.24 0.85 2.62 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.461 0.705 . . . . 0.0 109.297 -174.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.26 -0.9 50.47 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.588 -173.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 17.8 mt-10 -104.48 178.13 4.65 Favored 'General case' 0 C--O 1.203 -1.342 0 C-N-CA 124.018 0.927 . . . . 0.0 109.396 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.5 tppp? -65.98 161.07 22.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 118.765 0.711 . . . . 0.0 109.8 174.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.496 ' HB ' ' CG1' ' B' ' 58' ' ' VAL . 11.2 p -152.87 -18.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.094 0.473 . . . . 0.0 110.229 167.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.729 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.3 OUTLIER -160.66 127.95 4.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.94 0.4 . . . . 0.0 110.235 -171.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 6.1 m -135.16 129.09 33.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.527 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.455 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.1 OUTLIER -162.66 -176.47 5.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 122.357 1.075 . . . . 0.0 112.191 -174.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.9 t-20 -138.79 148.53 43.92 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 112.831 -1.986 . . . . 0.0 108.044 176.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -43.79 70.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.253 0.478 . . . . 0.0 111.79 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.475 ' O ' HG21 ' B' ' 71' ' ' THR . 58.4 mtpt -78.88 -16.26 57.27 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.853 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 3.2 t -73.28 -20.17 60.89 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.535 HG23 ' CD1' ' B' ' 45' ' ' TYR . 19.3 p 58.64 109.55 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.594 1.157 . . . . 0.0 112.533 170.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 m -61.43 -10.88 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.431 -169.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.75 -56.93 21.49 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.193 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -69.32 -31.31 69.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.307 0.575 . . . . 0.0 110.313 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.481 HG13 ' O ' ' B' ' 71' ' ' THR . 3.2 mt -70.5 -48.79 57.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.93 -177.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 34.2 t -56.38 -33.74 66.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.095 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -50.63 -54.74 20.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.695 0.76 . . . . 0.0 110.162 175.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.564 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 34.7 m-20 -64.79 -44.55 89.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.405 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.729 HG13 ' CE1' ' B' ' 64' ' ' TYR . 42.5 mm -55.47 -30.46 25.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -176.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -59.37 -25.24 64.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.7 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 16.4 ptmt -85.65 -3.36 58.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.727 0.298 . . . . 0.0 111.304 -175.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.2 mm? -73.8 -11.9 60.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.55 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 52.26 65.84 1.39 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.812 0.815 . . . . 0.0 109.068 -169.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' B' ' 34' ' ' ASN . 65.5 mt -57.49 156.54 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.504 -1.226 . . . . 0.0 111.484 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.438 ' HB2' HD22 ' B' ' 59' ' ' ASN . 86.7 mttt -113.66 -178.09 3.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.269 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.31 112.14 0.72 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.76 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.601 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 5.6 tpt -154.79 -72.7 0.12 Allowed 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 120.491 0.186 . . . . 0.0 110.873 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . 0.601 ' N ' ' HG3' ' B' ' 87' ' ' MET . 75.9 t80 -134.48 116.73 15.45 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.668 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 21.3 mm -104.96 145.21 13.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.458 -177.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 33.4 mm-40 -135.97 156.29 48.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.38 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.653 HG22 ' CZ3' ' B' ' 54' ' ' TRP . 67.8 mt -135.13 126.21 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.738 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -175.24 153.13 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.699 0.285 . . . . 0.0 111.533 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -75.71 150.92 37.76 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.325 0.583 . . . . 0.0 111.209 175.555 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.7 pt . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.459 -0.781 . . . . 0.0 111.634 -172.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.974 0.416 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -162.6 -39.84 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.695 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -68.21 -21.47 64.85 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -172.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -76.2 -18.41 59.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.111 0.481 . . . . 0.0 110.378 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.36 20.07 11.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.212 0.529 . . . . 0.0 110.469 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 81.0 mt -107.94 22.94 15.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.691 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -59.22 -64.85 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.599 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -88.87 -26.12 21.78 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 122.206 1.003 . . . . 0.0 110.127 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -100.16 93.72 5.86 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.375 -1.739 . . . . 0.0 110.076 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' MET . . . . . 0.42 ' C ' HD13 ' B' ' 13' ' ' ILE . 77.4 mmm -75.65 -165.24 0.42 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.544 0.687 . . . . 0.0 111.643 -175.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -109.61 -18.59 13.45 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.512 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -59.39 -21.12 59.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.829 0.823 . . . . 0.0 109.668 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.494 ' CD1' ' H ' ' B' ' 13' ' ' ILE . 1.4 mp -61.91 -34.41 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.354 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -106.7 -62.92 1.33 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.709 -173.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 49.8 m -66.12 -59.93 3.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.555 -172.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 70.6 t -55.82 -46.25 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.928 0.394 . . . . 0.0 111.359 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -56.28 -46.4 79.76 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.719 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.43 -42.72 58.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.786 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -61.89 -47.47 84.84 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 123.458 0.703 . . . . 0.0 111.936 -175.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.435 HD23 HG11 ' B' ' 72' ' ' VAL . 64.0 mt -75.53 -19.48 59.32 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.778 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -104.29 79.1 1.56 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.01 0.434 . . . . 0.0 110.323 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -130.17 19.86 5.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.572 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.49 25.63 7.65 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.389 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.622 ' HG2' ' CZ ' ' B' ' 49' ' ' TYR . 43.3 mttt -98.35 -140.02 0.3 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.606 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -65.52 142.66 44.44 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 172.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' B' ' 40' ' ' SER . 47.3 mttm -61.82 132.5 53.31 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 18.0 tp -152.5 104.87 2.95 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 -174.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 20.3 m -103.52 110.91 23.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.065 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.4 ' N ' HD23 ' B' ' 29' ' ' LEU . 2.6 mm? -90.87 152.91 20.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.746 0.784 . . . . 0.0 111.894 -173.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.7 p -145.92 147.11 31.39 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.326 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 57.6 mtt -122.32 140.49 52.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.515 0.674 . . . . 0.0 112.168 -172.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . 0.496 ' O ' ' HG3' ' B' ' 35' ' ' GLN . 6.7 t30 -130.37 101.34 5.71 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 173.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.19 -99.87 1.0 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -166.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.46 ' HB2' ' HA2' ' B' ' 86' ' ' GLY . 15.3 m120 -130.6 19.26 5.18 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 171.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' B' ' 32' ' ' ASN . 24.7 mt-30 -69.75 156.0 39.68 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.243 0.544 . . . . 0.0 110.714 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 15.4 tp -118.2 106.59 12.98 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.842 175.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.428 ' HA ' ' OD1' ' B' ' 80' ' ' ASN . 24.0 mtmt -116.07 139.86 49.86 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -156.35 150.82 25.65 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -168.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 8.8 p -115.46 142.42 46.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.32 170.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 32.1 p -138.09 173.07 12.02 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -170.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 30.7 t -155.19 158.61 39.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.768 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -116.26 28.45 8.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.785 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.73 -18.52 65.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.691 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.67 -41.01 0.05 OUTLIER Glycine 0 C--N 1.318 -0.445 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.619 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.606 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 23.1 p90 45.04 -163.49 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.957 1.303 . . . . 0.0 114.264 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.472 ' H ' HG22 ' B' ' 71' ' ' THR . . . -81.11 85.49 1.4 Allowed Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.402 ' H ' HD12 ' B' ' 47' ' ' ILE . 1.0 OUTLIER -59.42 -69.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.4 0.619 . . . . 0.0 110.293 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.1 t -115.37 -92.97 0.5 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.389 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.622 ' CZ ' ' HG2' ' B' ' 24' ' ' LYS . 72.0 m-85 55.18 41.91 31.07 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.651 0.594 . . . . 0.0 110.154 -175.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 35.64 -95.35 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.285 -1.325 . . . . 0.0 112.988 -169.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -171.14 110.74 0.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 74.6 mttt -134.37 126.29 29.3 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -175.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -114.21 126.51 55.14 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.238 0.542 . . . . 0.0 110.578 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.528 ' HA ' HG12 ' B' ' 94' ' ' ILE . 34.3 p-90 -146.64 163.58 35.4 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.734 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -126.96 148.03 17.14 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.944 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.563 HD11 ' CD2' ' B' ' 64' ' ' TYR . 30.1 mt -107.1 148.86 11.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.741 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 89.5 m-85 -128.24 146.62 50.68 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -169.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.516 HG12 ' ND2' ' B' ' 59' ' ' ASN . 8.7 p -130.85 135.9 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.516 ' ND2' HG12 ' B' ' 58' ' ' VAL . 1.7 m-80 60.73 17.58 7.74 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -173.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.39 -3.27 83.82 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.407 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -103.34 176.09 5.26 Favored 'General case' 0 C--O 1.2 -1.53 0 C-N-CA 123.459 0.703 . . . . 0.0 109.711 -177.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.412 ' HB2' ' HE3' ' B' ' 62' ' ' LYS . 4.8 tppp? -60.67 156.75 16.04 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 118.541 0.61 . . . . 0.0 110.616 176.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 8.0 p -150.75 -12.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.007 0.432 . . . . 0.0 110.368 166.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.563 ' CD2' HD11 ' B' ' 56' ' ' ILE . 0.9 OUTLIER -162.4 125.26 2.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.239 -173.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 14.2 m -132.03 127.89 37.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.68 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.427 ' CD1' ' CE1' ' B' ' 64' ' ' TYR . 21.2 p90 -165.45 -175.03 3.39 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 122.017 0.913 . . . . 0.0 112.166 -176.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 18.5 t-20 -138.25 163.42 31.8 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.614 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -67.01 -51.65 52.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.298 0.57 . . . . 0.0 110.847 -176.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.443 ' O ' HG21 ' B' ' 71' ' ' THR . 40.3 ttmt -70.24 -17.75 63.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.23 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 3.2 t -69.06 -10.39 57.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.1 0.476 . . . . 0.0 109.902 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.481 ' O ' HG13 ' B' ' 75' ' ' ILE . 21.2 p 60.44 94.74 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.661 1.184 . . . . 0.0 112.157 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.45 ' HA ' ' CD1' ' B' ' 75' ' ' ILE . 2.4 m -59.37 -21.38 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.371 -172.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.42 -47.33 76.6 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.606 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -78.61 -36.0 44.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.282 0.563 . . . . 0.0 110.169 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.481 HG13 ' O ' ' B' ' 71' ' ' THR . 2.4 mt -65.41 -45.63 92.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.293 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.542 ' N ' ' HH ' ' B' ' 64' ' ' TYR . 32.2 t -64.21 -27.52 69.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.624 -176.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -55.37 -44.23 75.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.835 0.826 . . . . 0.0 109.865 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.727 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 10.7 m-20 -69.95 -40.46 75.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.442 -1.253 . . . . 0.0 111.022 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.465 HG13 ' CE1' ' B' ' 64' ' ' TYR . 48.3 mm -58.01 -28.87 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.333 0.587 . . . . 0.0 111.832 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.428 ' OD1' ' HA ' ' B' ' 37' ' ' LYS . 83.8 m-20 -60.38 -23.16 64.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.737 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.727 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 17.0 ptmt -96.73 6.38 48.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.808 0.337 . . . . 0.0 111.245 -174.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' B' ' 79' ' ' ILE . 3.4 mm? -78.78 -5.08 52.42 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -175.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 41.9 52.22 4.19 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 123.871 0.732 . . . . 0.0 110.95 -171.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.437 ' O ' ' HG2' ' B' ' 35' ' ' GLN . 82.8 mt -52.22 147.45 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.768 -171.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.6 -164.27 1.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.119 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -154.23 113.87 0.59 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.819 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.442 ' CG ' ' HA ' ' B' ' 59' ' ' ASN . 24.6 ptp -173.47 -54.85 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.197 0.199 . . . . 0.0 111.242 175.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . 0.413 ' N ' ' HG3' ' B' ' 87' ' ' MET . 1.3 t80 -135.73 84.44 2.09 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.842 -0.536 . . . . 0.0 110.226 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.741 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.1 mp -99.4 114.1 36.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.003 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -98.73 -179.22 4.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.366 0.603 . . . . 0.0 111.355 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 41.7 mt -151.51 114.93 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.573 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -174.64 160.85 3.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.333 0.587 . . . . 0.0 112.309 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.501 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 1.5 pp0? -72.26 158.47 35.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.617 174.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.528 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.5 pt . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.899 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -143.56 -56.43 0.39 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.867 0.365 . . . . 0.0 110.955 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -76.39 -8.86 58.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.373 -174.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -83.83 -22.12 31.84 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 120.98 0.419 . . . . 0.0 110.413 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.6 83.39 4.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.875 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.3 mt -80.31 11.36 3.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.625 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -68.14 -65.84 0.64 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.838 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -81.95 -30.05 31.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.215 1.007 . . . . 0.0 110.38 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -77.47 99.67 5.74 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 113.532 -1.667 . . . . 0.0 109.952 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' MET . . . . . 0.459 ' HE3' ' O ' ' B' ' 87' ' ' MET . 26.3 mmt -83.64 151.19 25.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.46 -175.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -62.44 -24.71 67.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.776 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.661 ' O ' HG23 ' B' ' 16' ' ' VAL . 15.9 t -66.75 -25.85 66.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.045 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 11.2 mm -58.55 -38.37 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-O 121.703 0.763 . . . . 0.0 109.98 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -71.14 -41.4 70.52 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.959 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.569 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 0.6 OUTLIER -65.36 -34.12 77.56 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.143 177.116 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.661 HG23 ' O ' ' B' ' 12' ' ' SER . 54.5 t -63.29 -42.26 95.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.218 0.533 . . . . 0.0 109.991 175.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . 0.548 HD21 HD21 ' B' ' 29' ' ' LEU . 2.5 t-20 -61.94 -42.12 98.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.867 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.76 -40.93 63.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.451 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' B' ' 15' ' ' SER . 4.5 tmtm? -53.4 -73.04 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.54 0.736 . . . . 0.0 112.186 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.424 HD22 HG12 ' B' ' 72' ' ' VAL . 17.4 mt -52.29 -29.87 25.37 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -84.41 74.23 10.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.193 0.52 . . . . 0.0 111.023 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -133.24 -79.48 0.48 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.203 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.21 34.83 2.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.943 -176.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.484 ' HA ' ' HA2' ' B' ' 46' ' ' GLY . 0.9 OUTLIER -122.79 -168.98 1.84 Allowed 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 173.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' B' ' 45' ' ' TYR . . . -54.26 137.24 41.79 Favored Glycine 0 N--CA 1.45 -0.41 0 O-C-N 123.961 0.788 . . . . 0.0 111.619 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.49 112.12 21.88 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 121.397 0.618 . . . . 0.0 109.911 -170.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.453 HD13 ' O ' ' B' ' 27' ' ' LEU . 0.0 OUTLIER -134.29 143.52 47.79 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.267 177.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 49.3 m -104.03 111.55 24.17 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.879 -173.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.548 HD21 HD21 ' B' ' 17' ' ' ASN . 3.1 mm? -77.5 152.79 33.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.596 0.713 . . . . 0.0 109.932 176.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 0.3 OUTLIER -144.27 145.48 32.05 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.29 175.303 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 43.6 mtt -112.86 133.1 55.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.072 0.463 . . . . 0.0 111.864 -165.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . 0.48 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 4.3 t30 -146.11 59.22 1.23 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 47.73 -99.58 0.02 OUTLIER Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.895 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.687 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 8.1 p30 -83.39 16.57 2.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.41 -0.395 . . . . 0.0 111.493 -176.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 19.5 mt-30 -134.87 146.38 49.18 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.393 0.616 . . . . 0.0 110.735 171.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.475 ' HB3' ' HB ' ' B' ' 84' ' ' ILE . 3.2 tm? -122.39 127.96 50.36 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.558 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.47 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 16.7 mtmt -126.33 146.6 49.97 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -174.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -161.63 151.19 16.46 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -176.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 11.8 p -126.88 142.2 51.61 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 58.9 p -136.75 150.29 48.31 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -167.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 22.7 t -139.56 153.46 47.43 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.707 171.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -115.36 9.39 15.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -170.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.72 -59.84 4.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.814 0.816 . . . . 0.0 110.451 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.68 61.28 2.77 Favored Glycine 0 C--N 1.309 -0.927 0 CA-C-N 114.59 -1.187 . . . . 0.0 110.89 175.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.548 ' HA ' ' HA2' ' B' ' 25' ' ' GLY . 0.1 OUTLIER -70.1 -161.91 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.079 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' B' ' 24' ' ' LYS . . . -62.14 107.44 1.58 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.27 -0.49 . . . . 0.0 112.23 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 22.2 mm -85.46 -69.74 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 CA-C-O 122.307 1.051 . . . . 0.0 109.817 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.438 ' C ' ' H ' ' B' ' 50' ' ' GLU . 6.8 m -104.62 -153.82 0.49 Allowed 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 113.634 -1.621 . . . . 0.0 109.391 -176.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 67.76 -12.53 0.29 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.992 0.917 . . . . 0.0 112.432 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.438 ' H ' ' C ' ' B' ' 48' ' ' SER . 44.7 mt-10 49.77 -105.2 0.16 Allowed 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.839 0.856 . . . . 0.0 111.994 -175.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -129.65 110.71 12.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.582 ' HB2' ' OE1' ' B' ' 68' ' ' GLU . 66.2 mttm -118.19 134.82 54.67 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 170.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -98.17 110.58 23.14 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.553 ' HA ' HG12 ' B' ' 94' ' ' ILE . 37.5 p-90 -149.38 168.18 24.11 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.444 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.9 156.86 25.68 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.408 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.415 HD11 ' CD2' ' B' ' 64' ' ' TYR . 21.8 mt -108.42 147.68 13.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.673 ' CE1' ' HD3' ' B' ' 62' ' ' LYS . 71.5 m-85 -130.46 139.9 50.54 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -169.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 13.6 t -131.35 138.34 53.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 64.54 5.26 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.99 0.806 . . . . 0.0 109.238 -174.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.91 17.49 47.64 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.737 -172.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 7.8 mt-10 -120.5 174.56 6.47 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.673 ' HD3' ' CE1' ' B' ' 57' ' ' PHE . 0.0 OUTLIER -67.6 167.82 12.31 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.26 173.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.425 ' N ' ' HG3' ' B' ' 62' ' ' LYS . 8.6 p -153.77 -15.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.781 164.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.626 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.5 OUTLIER -160.05 124.2 3.74 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.049 -170.29 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 28.1 m -131.94 131.11 42.35 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.797 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.458 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.1 OUTLIER -160.94 -176.55 5.57 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 122.531 1.158 . . . . 0.0 112.312 -174.113 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -133.21 149.67 52.0 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 112.272 -2.24 . . . . 0.0 108.626 173.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . 0.582 ' OE1' ' HB2' ' B' ' 52' ' ' LYS . 1.3 mp0 -52.04 -51.03 60.14 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.941 0.401 . . . . 0.0 111.57 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.546 ' O ' HG22 ' B' ' 71' ' ' THR . 88.8 tttt -69.13 -22.95 63.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.602 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.6 t -68.74 -17.06 63.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 174.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.546 HG22 ' O ' ' B' ' 69' ' ' LYS . 30.2 p 56.26 106.15 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.344 1.058 . . . . 0.0 112.865 172.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.503 ' HB ' ' HH ' ' B' ' 64' ' ' TYR . 9.5 m -62.7 -10.3 5.24 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.861 -171.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.46 -55.21 31.33 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.463 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -67.79 -36.9 81.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.416 0.627 . . . . 0.0 110.9 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.446 ' O ' HG12 ' B' ' 79' ' ' ILE . 1.9 mt -68.53 -49.19 67.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.75 -177.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.419 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 22.9 t -58.81 -29.75 67.09 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.979 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -49.66 -52.23 32.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.893 0.854 . . . . 0.0 109.614 173.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.689 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 0.4 OUTLIER -72.7 -39.66 66.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.945 178.041 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.626 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.1 mm -56.96 -33.25 41.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.12 0.486 . . . . 0.0 112.26 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.469 HD22 ' HB2' ' B' ' 38' ' ' ALA . 7.3 m-80 -61.85 -16.93 54.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.689 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 20.7 pttm -85.05 -7.31 59.17 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.906 0.384 . . . . 0.0 110.469 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 2.5 mm? -69.61 -16.09 63.32 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -174.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 51.7 58.72 5.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.336 -171.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' B' ' 36' ' ' LEU . 5.2 mp -55.99 148.29 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.517 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.687 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 67.5 mttm -116.8 -167.73 1.34 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.269 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.544 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -142.35 111.24 0.66 Allowed Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.131 -177.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.459 ' O ' ' HE3' ' B' ' 10' ' ' MET . 16.6 tpp -151.22 -73.43 0.15 Allowed 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . 0.449 ' N ' ' HG3' ' B' ' 87' ' ' MET . 32.8 t80 -125.77 97.15 5.03 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 22.9 mm -96.35 126.35 49.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.834 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -121.67 169.77 10.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.115 0.484 . . . . 0.0 110.784 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.424 HD12 HG21 ' B' ' 16' ' ' VAL . 23.6 mm -149.14 121.72 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.768 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.536 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 48.2 pttt -168.83 173.53 7.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.251 0.548 . . . . 0.0 111.452 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.518 ' H ' ' NE2' ' B' ' 93' ' ' GLN . 0.5 OUTLIER -95.8 149.81 21.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.281 175.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.553 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.7 pt . . . . . 0 C--N 1.313 -0.999 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.255 -175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 17.3 t70 . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -131.85 35.89 3.74 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.599 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -67.61 -16.7 64.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.399 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' B' ' 4' ' ' LYS . 22.6 tptm -76.86 -3.41 38.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.95 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.06 114.71 1.54 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.44 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 93.7 mt -71.67 -17.17 62.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.553 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -64.11 -44.76 91.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.102 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -75.48 -46.98 29.16 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.649 0.738 . . . . 0.0 110.392 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -93.14 61.81 3.44 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.625 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' MET . . . . . 0.632 ' O ' HG12 ' B' ' 13' ' ' ILE . 86.8 mmm -53.75 130.71 37.66 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.252 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -52.51 -23.26 5.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.794 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.534 ' O ' HG23 ' B' ' 16' ' ' VAL . 5.3 m -68.39 -17.07 64.14 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.909 -174.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.632 HG12 ' O ' ' B' ' 10' ' ' MET . 14.2 mm -49.21 -65.08 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.449 0.642 . . . . 0.0 111.26 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -78.3 -25.63 46.66 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.555 -177.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.405 ' HB2' ' HA ' ' B' ' 12' ' ' SER . 23.7 m -67.7 -33.33 74.68 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.003 -176.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.534 HG23 ' O ' ' B' ' 12' ' ' SER . 71.5 t -67.84 -42.47 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.5 0.667 . . . . 0.0 109.478 176.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . 0.72 ' ND2' HD21 ' B' ' 29' ' ' LEU . 12.4 t-20 -59.08 -58.71 7.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.264 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.39 -12.15 60.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.857 -177.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' B' ' 16' ' ' VAL . 14.2 tppt? -78.24 -50.19 12.34 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.5 0.667 . . . . 0.0 111.059 173.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.1 -22.81 41.78 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.202 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -116.14 93.14 4.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.433 0.635 . . . . 0.0 110.643 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -138.59 -70.41 0.42 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.222 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.56 49.14 0.77 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.533 ' HZ2' ' CD ' ' B' ' 68' ' ' GLU . 27.0 mttt -127.96 -138.47 0.24 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -176.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.412 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -76.31 163.36 52.95 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.668 ' HE3' ' OG ' ' B' ' 41' ' ' SER . 0.0 OUTLIER -70.26 150.6 46.23 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.221 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' B' ' 39' ' ' THR . 16.5 tp -149.06 123.76 9.84 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -173.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.596 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 16.1 m -106.85 96.74 6.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.298 0.57 . . . . 0.0 111.468 -177.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.72 HD21 ' ND2' ' B' ' 17' ' ' ASN . 0.2 OUTLIER -68.5 147.92 51.31 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.266 1.426 . . . . 0.0 114.496 -167.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 11.4 p -155.18 152.97 30.03 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.138 171.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 61.3 mtt -115.01 149.16 37.86 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -166.67 120.28 1.05 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.181 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.1 -116.78 9.55 Favored Glycine 0 CA--C 1.506 -0.481 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.879 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.43 ' HA ' ' CD1' ' B' ' 13' ' ' ILE . 20.6 m120 -121.33 22.98 10.63 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 172.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.572 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 49.6 mt-30 -86.35 160.96 18.94 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.311 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -128.69 98.96 5.16 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 169.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.578 ' HA ' ' ND2' ' B' ' 80' ' ' ASN . 6.0 mtmp? -97.2 146.37 25.15 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.531 -177.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -173.36 142.91 1.03 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -93.02 159.12 15.44 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 177.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.478 ' OG ' ' HA2' ' B' ' 73' ' ' GLY . 11.6 p -149.92 151.06 32.8 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.592 -170.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.668 ' OG ' ' HE3' ' B' ' 26' ' ' LYS . 0.1 OUTLIER -129.83 140.79 50.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.986 177.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -94.5 41.49 1.09 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.905 -170.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.7 -60.08 3.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.244 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.68 -35.87 3.66 Favored Glycine 0 C--N 1.316 -0.572 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.737 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.412 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 23.7 p90 49.21 -166.35 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.871 1.268 . . . . 0.0 113.98 177.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.7 97.57 1.49 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.602 -175.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.421 ' H ' HD13 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -108.92 -55.92 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.386 0.612 . . . . 0.0 109.74 175.079 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.9 m -39.31 -57.09 1.43 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.523 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -80.38 4.67 17.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.985 -173.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 50.47 -98.03 0.05 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.694 0.797 . . . . 0.0 112.331 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -142.46 113.37 7.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.395 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 94.6 mttt -138.13 143.36 40.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.284 175.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.41 ' HB3' ' OD1' ' B' ' 67' ' ' ASN . 0.4 OUTLIER -112.87 117.9 33.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.176 0.513 . . . . 0.0 110.715 177.108 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.603 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 48.9 p-90 -131.45 164.43 25.76 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -125.19 148.69 16.88 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.472 -173.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.444 ' C ' HG11 ' B' ' 63' ' ' VAL . 7.7 mt -100.41 150.33 5.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 170.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.777 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 74.9 m-85 -129.97 138.65 50.95 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.202 -174.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' B' ' 61' ' ' GLU . 13.5 p -121.9 131.72 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 63.33 7.98 3.2 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.251 0.548 . . . . 0.0 109.697 -174.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.57 -17.09 40.06 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.242 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 0.6 OUTLIER -91.5 170.21 10.14 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 123.185 0.594 . . . . 0.0 110.105 -177.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.431 ' HB2' ' HE3' ' B' ' 62' ' ' LYS . 5.4 tppp? -55.74 158.24 3.71 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.915 0.388 . . . . 0.0 110.007 172.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.444 HG11 ' C ' ' B' ' 56' ' ' ILE . 10.0 p -144.91 -18.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 168.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.485 ' CE2' HG21 ' B' ' 75' ' ' ILE . 1.6 t80 -171.08 153.04 3.63 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.71 -175.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.522 HG22 ' CD1' ' B' ' 94' ' ' ILE . 80.0 m -138.6 135.76 35.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.521 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.697 ' CD2' HD11 ' B' ' 75' ' ' ILE . 23.8 p90 -168.55 158.53 9.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.795 0.807 . . . . 0.0 111.521 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 5.6 m120 -113.61 151.58 31.51 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.02 -1.445 . . . . 0.0 112.001 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . 0.533 ' CD ' ' HZ2' ' B' ' 24' ' ' LYS . 21.1 mm-40 -61.91 -42.5 99.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.529 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.461 ' O ' HG22 ' B' ' 71' ' ' THR . 22.0 tptp -59.98 -36.12 76.46 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.02 0.914 . . . . 0.0 110.175 176.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' B' ' 67' ' ' ASN . 58.5 m -70.37 -10.33 58.75 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.264 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.461 HG22 ' O ' ' B' ' 69' ' ' LYS . 8.2 p 65.08 124.02 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 126.134 1.774 . . . . 0.0 113.209 170.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.446 ' HA ' ' HB ' ' B' ' 75' ' ' ILE . 3.6 m -64.57 -5.56 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.097 -173.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . 0.478 ' HA2' ' OG ' ' B' ' 40' ' ' SER . . . -67.28 -55.16 16.81 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.432 -0.413 . . . . 0.0 113.228 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -73.17 -23.38 60.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 122.048 0.928 . . . . 0.0 109.09 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.697 HD11 ' CD2' ' B' ' 66' ' ' PHE . 68.0 mt -68.79 -54.84 18.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 113.904 -1.498 . . . . 0.0 112.745 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 18.2 t -54.57 -37.82 65.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.901 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -50.85 -49.43 58.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.982 0.896 . . . . 0.0 110.599 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.522 ' HA ' ' HG2' ' B' ' 81' ' ' LYS . 72.1 m-20 -64.9 -46.89 79.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.912 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.448 HG12 ' CD2' ' B' ' 64' ' ' TYR . 66.3 mt -51.96 -37.53 21.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.325 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.578 ' ND2' ' HA ' ' B' ' 37' ' ' LYS . 7.3 m120 -75.07 -38.49 61.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.383 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' B' ' 78' ' ' ASP . 6.4 ptpp? -75.47 -21.31 58.18 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.222 -176.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.447 HD22 ' O ' ' B' ' 78' ' ' ASP . 1.7 mm? -63.9 -22.01 66.73 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.869 0.366 . . . . 0.0 110.154 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 45.35 64.79 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.697 -171.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.572 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 55.6 mt -62.89 149.89 9.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.21 -175.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.443 ' NZ ' ' HB3' ' B' ' 85' ' ' LYS . 7.7 mtpm? -90.18 179.42 5.92 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.827 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -133.68 113.25 1.18 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 119.693 -1.241 . . . . 0.0 112.466 -176.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.409 ' HG2' ' N ' ' B' ' 88' ' ' TYR . 17.8 ttt -154.31 -77.09 0.11 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 123.076 0.55 . . . . 0.0 109.909 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . 0.409 ' N ' ' HG2' ' B' ' 87' ' ' MET . 34.1 t80 -132.34 81.86 1.98 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.217 0.532 . . . . 0.0 109.668 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.777 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.1 mp -87.72 125.51 41.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.853 178.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -108.83 177.97 4.61 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.356 0.598 . . . . 0.0 110.7 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.603 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 57.5 mt -149.74 110.04 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.632 -178.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -167.87 166.67 13.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.273 0.559 . . . . 0.0 112.102 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -84.63 148.84 26.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.467 -174.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.522 ' CD1' HG22 ' B' ' 65' ' ' THR . 4.2 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.408 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 121.009 0.433 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -73.63 -32.43 64.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.884 0.373 . . . . 0.0 110.537 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -66.3 -18.38 65.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.817 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -76.06 -21.61 56.58 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.314 0.578 . . . . 0.0 110.255 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.24 -7.99 54.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.565 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' B' ' 9' ' ' GLN . 98.8 mt -78.4 -6.73 56.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.197 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.91 -43.31 79.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.998 0.428 . . . . 0.0 110.351 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.483 ' HG3' ' N ' ' B' ' 9' ' ' GLN . 10.3 pt-20 -90.9 -51.36 5.39 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.846 0.831 . . . . 0.0 110.451 175.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' B' ' 6' ' ' LEU . 24.5 tt0 -99.61 87.35 3.55 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.665 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' MET . . . . . 0.591 ' SD ' ' HA ' ' B' ' 88' ' ' TYR . 82.5 mtp -71.66 171.32 11.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.585 -176.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -57.38 -30.55 64.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.168 0.508 . . . . 0.0 110.888 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.573 ' O ' HG23 ' B' ' 16' ' ' VAL . 1.3 p -63.94 -30.94 71.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.909 -174.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mm -53.79 -45.49 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.858 0.837 . . . . 0.0 110.113 177.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -82.89 -29.99 28.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.976 -177.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 21.8 t -71.5 -27.38 63.18 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.602 -175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.573 HG23 ' O ' ' B' ' 12' ' ' SER . 87.4 t -58.44 -42.89 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.446 0.641 . . . . 0.0 109.704 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . 0.407 ' OD1' HD12 ' B' ' 29' ' ' LEU . 55.9 t30 -63.87 -45.54 88.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.866 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.8 -28.5 62.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.619 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.477 ' HZ1' ' CD ' ' B' ' 68' ' ' GLU . 6.7 tptp -68.37 -53.08 26.38 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.167 0.508 . . . . 0.0 111.398 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 94.3 mt -73.0 -27.82 62.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.655 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -90.41 75.97 6.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.369 0.604 . . . . 0.0 110.593 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -135.89 62.95 1.61 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.491 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.91 54.48 4.14 Favored Glycine 0 C--N 1.317 -0.5 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.621 ' HB3' ' CD2' ' B' ' 45' ' ' TYR . 33.2 mmtp -137.15 -152.51 0.44 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.223 -0.488 . . . . 0.0 110.396 -174.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.47 ' HA3' ' HB2' ' B' ' 45' ' ' TYR . . . -78.69 -177.27 48.87 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 176.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.445 ' HE2' ' HB2' ' B' ' 41' ' ' SER . 4.3 mppt? -88.57 127.9 35.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 117.292 0.546 . . . . 0.0 111.02 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 13.4 tp -156.03 110.93 2.9 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 19.5 m -108.7 108.86 19.87 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.535 -176.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.488 HD23 HD12 ' B' ' 36' ' ' LEU . 10.2 mp -86.04 158.73 19.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.606 0.717 . . . . 0.0 110.738 176.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.528 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 20.3 m -135.81 140.29 44.12 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.919 173.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -100.59 125.65 46.99 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.792 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.59 58.66 1.61 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' B' ' 9' ' ' GLN . . . 50.43 -95.61 0.01 OUTLIER Glycine 0 C--N 1.335 0.506 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.028 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 14.2 m120 -88.09 15.72 7.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.481 -0.359 . . . . 0.0 111.044 -176.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 16.8 mt-30 -139.95 142.97 36.34 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.558 0.694 . . . . 0.0 110.931 173.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.488 HD12 HD23 ' B' ' 29' ' ' LEU . 32.4 tp -113.58 120.78 42.12 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.818 173.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.528 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 6.6 mmmm -114.48 150.31 35.0 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -174.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' B' ' 29' ' ' LEU . . . -163.55 143.35 8.49 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 2.8 p -120.86 151.79 39.22 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.4 t -142.89 150.07 39.32 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.126 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.445 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . 5.7 m -126.12 149.77 48.7 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.424 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -82.76 47.9 1.26 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.266 -170.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.49 -3.71 29.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.786 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.37 70.34 1.35 Allowed Glycine 0 CA--C 1.485 -1.808 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.262 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.621 ' CD2' ' HB3' ' B' ' 24' ' ' LYS . 0.8 OUTLIER -65.59 148.86 51.04 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 161.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.583 ' N ' ' CD1' ' B' ' 45' ' ' TYR . . . 109.17 58.86 0.53 Allowed Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -176.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 3.9 mm -85.84 -69.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.521 0.677 . . . . 0.0 109.702 -172.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.2 m -151.8 -130.32 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.021 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.46 ' O ' ' HE2' ' B' ' 52' ' ' LYS . 84.5 m-85 64.23 27.63 13.9 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.004 0.522 . . . . 0.0 111.503 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 43.63 -106.47 0.09 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.593 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.46 ' HB3' HD22 ' B' ' 67' ' ' ASN . 6.9 m-20 -144.48 119.4 9.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.089 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.46 ' HE2' ' O ' ' B' ' 49' ' ' TYR . 65.7 mmtt -119.26 122.74 42.62 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -107.64 127.24 53.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.149 0.499 . . . . 0.0 111.058 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.683 ' CZ3' HG21 ' B' ' 91' ' ' ILE . 37.2 p-90 -142.41 161.38 38.2 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.891 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.1 151.94 16.89 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.899 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.481 ' O ' HG12 ' B' ' 63' ' ' VAL . 7.5 mt -102.74 141.03 19.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 172.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.686 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 64.0 m-85 -121.81 140.85 51.86 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.507 HG12 ' ND2' ' B' ' 59' ' ' ASN . 8.4 p -131.72 142.5 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.507 ' ND2' HG12 ' B' ' 58' ' ' VAL . 14.3 m-80 68.72 -2.81 1.57 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -169.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' B' ' 58' ' ' VAL . . . 96.76 -1.75 61.74 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -170.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 58' ' ' VAL . 16.5 mt-10 -100.36 172.0 7.41 Favored 'General case' 0 C--O 1.199 -1.587 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.592 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 11.1 ttmt -67.09 168.3 10.4 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 119.009 0.822 . . . . 0.0 109.948 175.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.481 HG12 ' O ' ' B' ' 56' ' ' ILE . 7.6 p -148.49 -20.33 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.618 170.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.409 ' CD2' HG12 ' B' ' 79' ' ' ILE . 4.5 t80 -169.1 146.14 3.58 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.997 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.507 HG22 ' CD1' ' B' ' 94' ' ' ILE . 54.9 m -130.17 134.07 47.04 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.257 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.649 ' CD2' HG21 ' B' ' 75' ' ' ILE . 9.0 p90 -165.48 153.04 10.77 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.672 0.749 . . . . 0.0 109.939 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.489 ' O ' ' HB3' ' B' ' 70' ' ' SER . 23.2 t-20 -99.2 159.73 14.78 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.885 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . 0.477 ' CD ' ' HZ1' ' B' ' 19' ' ' LYS . 10.2 mm-40 -60.92 -63.15 1.4 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.278 0.561 . . . . 0.0 109.954 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -66.37 -5.17 9.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.184 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 1.4 t -68.37 -3.14 10.11 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.417 0.627 . . . . 0.0 109.762 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.422 ' O ' HG13 ' B' ' 75' ' ' ILE . 31.9 p 62.17 102.97 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.308 1.443 . . . . 0.0 111.55 174.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.532 ' HA ' ' CG1' ' B' ' 75' ' ' ILE . 5.4 m -66.79 -4.43 2.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.151 -168.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.68 -48.12 80.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.443 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -78.78 -25.9 44.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.496 0.665 . . . . 0.0 109.777 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.649 HG21 ' CD2' ' B' ' 66' ' ' PHE . 24.5 mt -66.29 -44.97 90.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.299 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 28.9 t -53.73 -36.52 62.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.351 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -50.04 -54.61 19.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.792 0.806 . . . . 0.0 110.54 174.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 27.3 m-20 -63.89 -48.07 78.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.904 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.409 HG12 ' CD2' ' B' ' 64' ' ' TYR . 43.7 mt -54.69 -37.29 39.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.104 0.478 . . . . 0.0 111.48 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.98 -43.29 96.17 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.106 176.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 59.1 pttt -76.05 -31.1 58.64 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.054 -176.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.58 -26.31 67.89 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 65.6 t30 40.44 72.19 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 O-C-N 124.583 1.177 . . . . 0.0 110.839 -172.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' B' ' 35' ' ' GLN . 3.1 mp -57.18 137.16 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.908 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 30.4 mmtp -90.61 -169.41 2.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.409 -177.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.477 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -136.65 113.92 1.1 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.256 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 3.1 ptp -167.43 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.637 0.375 . . . . 0.0 110.604 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . 0.591 ' HA ' ' SD ' ' B' ' 10' ' ' MET . 21.7 t80 -124.8 88.32 2.87 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.686 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 34.1 mm -93.75 133.35 35.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.29 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.562 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 24.1 mt-10 -125.38 155.61 40.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.142 0.496 . . . . 0.0 111.636 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.683 HG21 ' CZ3' ' B' ' 54' ' ' TRP . 86.8 mt -131.15 118.21 40.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.453 176.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -171.69 154.19 3.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.12 0.486 . . . . 0.0 111.894 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 5.1 pm0 -64.76 149.48 49.19 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.268 175.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.507 ' CD1' HG22 ' B' ' 65' ' ' THR . 3.3 pt . . . . . 0 C--N 1.312 -1.026 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.304 -173.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -162.86 108.24 1.14 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -77.18 -29.45 54.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -174.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' B' ' 4' ' ' LYS . 25.3 tptp -87.0 5.8 35.53 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.5 0.667 . . . . 0.0 110.574 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 0.409 ' HB2' ' CG ' ' B' ' 7' ' ' GLU . . . -53.84 129.7 34.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.616 -175.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 83.0 mt -98.98 10.48 41.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.827 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' B' ' 87' ' ' MET . 0.0 OUTLIER -70.3 -30.58 67.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.154 173.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.466 ' HG3' ' HG2' ' B' ' 9' ' ' GLN . 15.2 pt-20 -96.03 -37.71 10.52 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.926 0.87 . . . . 0.0 109.928 175.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . 0.466 ' HG2' ' HG3' ' B' ' 8' ' ' GLU . 16.8 mm100 -93.98 71.28 4.02 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.338 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' MET . . . . . 0.464 ' SD ' HG12 ' B' ' 89' ' ' ILE . 62.1 mtm -94.18 168.93 10.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.101 -177.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -70.56 -26.88 63.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.692 0.758 . . . . 0.0 109.966 171.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 14.8 m -68.4 -10.14 53.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.642 -174.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.426 HG21 ' HG2' ' B' ' 31' ' ' MET . 28.5 mm -49.58 -52.34 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-O 121.089 0.471 . . . . 0.0 111.579 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -102.65 -38.3 7.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.865 -174.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.646 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 16.0 m -57.94 -41.86 83.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.945 -174.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.67 -45.13 75.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.964 0.411 . . . . 0.0 110.448 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -43.61 98.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.161 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.12 -26.19 52.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.24 -176.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.646 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -64.79 -46.29 82.68 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 121.092 0.472 . . . . 0.0 111.715 178.325 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 9.1 mt -87.05 -31.77 20.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.058 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -92.35 81.02 4.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.277 0.56 . . . . 0.0 110.176 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -122.35 -83.22 0.66 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.315 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.32 34.34 2.32 Favored Glycine 0 CA--C 1.508 -0.378 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -114.29 -147.26 0.41 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.072 -0.564 . . . . 0.0 109.591 -175.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.441 ' HA3' ' HB2' ' B' ' 45' ' ' TYR . . . -72.45 167.69 53.22 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.673 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.451 ' HE2' ' HB2' ' B' ' 41' ' ' SER . 2.1 mppt? -80.04 130.03 34.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.781 0.324 . . . . 0.0 110.943 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.455 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 26.6 tp -149.84 92.75 1.94 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 20.3 m -88.61 107.7 19.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.974 -175.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.455 ' CD1' ' HG ' ' B' ' 27' ' ' LEU . 9.3 mp -90.26 162.68 15.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.751 0.786 . . . . 0.0 111.548 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.6 p -156.0 144.68 20.26 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.718 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' MET . . . . . 0.426 ' HG2' HG21 ' B' ' 13' ' ' ILE . 0.6 OUTLIER -106.91 139.45 41.29 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.924 0.392 . . . . 0.0 111.232 -173.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . 0.495 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 2.5 t30 -142.29 57.4 1.46 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 170.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . 0.483 ' O ' ' HA3' ' B' ' 86' ' ' GLY . . . 45.44 -95.01 0.01 OUTLIER Glycine 0 C--N 1.333 0.403 0 O-C-N 123.806 0.691 . . . . 0.0 113.075 -175.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.701 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 4.6 p30 -80.61 10.82 4.31 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.814 0.446 . . . . 0.0 112.17 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.66 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 21.0 mt-30 -132.98 147.81 52.27 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.366 0.603 . . . . 0.0 110.544 165.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.47 116.05 19.82 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -116.99 138.78 51.34 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.614 -172.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -158.66 139.12 12.53 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.115 0.484 . . . . 0.0 111.521 -177.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 13.8 p -115.9 138.35 51.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.612 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.3 p -123.43 142.47 50.95 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.172 0.51 . . . . 0.0 111.551 -174.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.451 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . 2.5 m -117.82 143.97 45.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.618 175.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -99.5 44.0 1.04 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.823 -168.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.42 -32.19 68.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.103 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.72 63.72 0.03 OUTLIER Glycine 0 CA--C 1.49 -1.482 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.287 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.763 ' CD1' ' HA ' ' B' ' 71' ' ' THR . 2.5 t80 -69.42 152.87 44.39 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 161.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.586 ' N ' ' CD1' ' B' ' 45' ' ' TYR . . . 106.38 57.18 0.63 Allowed Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 5.6 mm -79.33 -69.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.606 -0.797 . . . . 0.0 110.3 -171.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 69.1 m -152.46 -106.19 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.202 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.449 ' O ' ' HG2' ' B' ' 52' ' ' LYS . 64.9 m-85 58.94 20.66 8.37 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.083 0.553 . . . . 0.0 112.15 177.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 46.57 -95.12 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.83 0.706 . . . . 0.0 110.503 -171.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.45 ' HB3' HD22 ' B' ' 67' ' ' ASN . 9.3 m-20 -149.38 110.51 4.38 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 169.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' B' ' 49' ' ' TYR . 72.3 mmtt -121.13 122.29 39.7 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -113.52 130.58 56.31 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.298 0.571 . . . . 0.0 110.988 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.507 ' HA ' HG12 ' B' ' 94' ' ' ILE . 26.7 p-90 -141.0 168.45 19.76 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.695 176.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.56 145.13 16.79 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.706 -174.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.508 HD12 ' CD2' ' B' ' 64' ' ' TYR . 26.4 mt -106.76 141.73 21.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 171.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.708 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 63.5 m-85 -123.33 143.04 50.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.722 -174.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.519 HG11 ' ND2' ' B' ' 59' ' ' ASN . 10.4 p -128.0 136.89 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.519 ' ND2' HG11 ' B' ' 58' ' ' VAL . 3.3 m-80 61.69 11.04 3.71 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.989 0.515 . . . . 0.0 109.626 -172.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.51 0.64 66.96 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.278 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' B' ' 58' ' ' VAL . 15.7 mt-10 -106.8 176.27 5.23 Favored 'General case' 0 C--O 1.199 -1.597 0 C-N-CA 123.521 0.728 . . . . 0.0 109.139 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.51 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.4 tppp? -66.08 162.42 19.61 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 119.092 0.86 . . . . 0.0 109.949 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.51 ' N ' ' HG3' ' B' ' 62' ' ' LYS . 7.8 p -153.42 -18.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.918 0.389 . . . . 0.0 110.371 167.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.661 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.8 OUTLIER -160.78 126.41 3.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 110.359 -172.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.3 m -134.23 126.64 30.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.48 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.465 ' HB2' HD12 ' B' ' 75' ' ' ILE . 0.7 OUTLIER -169.38 152.35 4.83 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.124 0.964 . . . . 0.0 112.467 -174.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.45 HD22 ' HB3' ' B' ' 51' ' ' ASP . 17.3 t-20 -92.61 153.98 18.67 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.233 -1.803 . . . . 0.0 109.956 174.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . 0.406 ' HA ' ' OH ' ' B' ' 45' ' ' TYR . 22.6 mm-40 -75.86 -3.68 36.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.192 0.52 . . . . 0.0 111.782 -174.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -111.43 -7.5 14.35 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.896 0.379 . . . . 0.0 111.431 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 1.3 t -73.92 -3.63 30.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.396 0.617 . . . . 0.0 111.688 -173.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.763 ' HA ' ' CD1' ' B' ' 45' ' ' TYR . 13.3 p 64.75 98.5 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.742 1.217 . . . . 0.0 111.444 173.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.406 ' HA ' ' CD1' ' B' ' 75' ' ' ILE . 7.7 m -66.64 -12.37 14.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.63 -169.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.24 -41.42 98.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.933 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -82.8 -30.76 28.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.206 0.527 . . . . 0.0 110.523 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' B' ' 66' ' ' PHE . 1.3 mt -75.62 -53.44 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.657 -176.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 22.5 t -58.38 -29.13 65.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.3 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -48.12 -54.74 12.23 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.778 0.799 . . . . 0.0 110.391 172.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.736 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 10.3 m-20 -69.36 -49.51 54.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.262 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.661 HG13 ' CE1' ' B' ' 64' ' ' TYR . 46.7 mm -52.29 -37.11 22.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -70.06 -20.78 63.21 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.736 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 46.9 pttt -83.26 -1.54 53.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.192 0.52 . . . . 0.0 109.986 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 3.7 mm? -77.46 -5.31 49.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.832 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 55.9 t30 51.38 63.51 2.21 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.427 -171.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.66 ' O ' ' HA ' ' B' ' 35' ' ' GLN . 48.2 mt -55.23 145.3 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.069 -172.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 50.3 mtmt -114.78 -176.94 3.01 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.779 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.483 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -142.0 113.11 0.79 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.844 -0.694 . . . . 0.0 111.725 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.477 ' HA ' ' HB2' ' B' ' 7' ' ' GLU . 12.2 tpp -150.25 -70.74 0.18 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 120.832 0.348 . . . . 0.0 110.221 178.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -129.29 87.16 2.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 46.1 mm -85.9 132.51 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.213 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 33.9 mt-10 -119.2 145.06 46.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.495 173.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.48 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 44.8 mm -129.14 112.06 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.502 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.499 ' HE2' ' CE2' ' B' ' 57' ' ' PHE . 45.3 pttt -166.83 166.83 15.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.041 0.448 . . . . 0.0 111.819 -174.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -94.11 149.17 21.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.157 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.7 pt . . . . . 0 C--O 1.25 1.13 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.061 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . 0.424 ' OD1' ' HB2' ' B' ' 4' ' ' LYS . 11.1 t70 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.777 0.322 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 10.4 t30 73.33 -45.25 0.61 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.986 0.915 . . . . 0.0 112.998 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -72.44 -13.01 61.34 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.424 ' HB2' ' OD1' ' B' ' 1' ' ' ASP . 14.1 tptp -73.84 -8.15 54.95 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 120.931 0.396 . . . . 0.0 110.885 173.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 0.484 ' HA ' HE22 ' B' ' 9' ' ' GLN . . . -81.44 96.58 7.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.589 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.408 HD11 ' H ' ' B' ' 6' ' ' LEU . 5.1 mp -71.68 -95.65 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.44 177.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -116.44 -76.19 0.57 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.449 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 21.6 mt-10 -121.6 3.32 10.15 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -173.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . 0.619 ' O ' HG13 ' B' ' 13' ' ' ILE . 2.1 pm0 -75.47 -14.73 60.45 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.26 -175.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 21.8 mmt 63.54 113.75 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.547 1.139 . . . . 0.0 113.359 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . 0.445 ' HB2' ' HB3' ' B' ' 5' ' ' ALA . 0.2 OUTLIER -61.07 -26.43 67.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.963 175.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.428 ' O ' HG21 ' B' ' 16' ' ' VAL . 49.1 m -67.16 -22.56 65.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.922 -174.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.619 HG13 ' O ' ' B' ' 9' ' ' GLN . 2.1 mm -60.41 -43.46 94.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.925 0.869 . . . . 0.0 109.61 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -66.51 -33.72 76.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.978 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 4.2 m -65.22 -44.43 88.29 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.941 176.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.428 HG21 ' O ' ' B' ' 12' ' ' SER . 91.9 t -61.0 -43.59 96.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.152 0.501 . . . . 0.0 110.111 176.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . 0.455 ' OD1' ' HB2' ' B' ' 29' ' ' LEU . 0.2 OUTLIER -56.02 -41.66 75.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.233 -179.454 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.39 -37.48 37.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.149 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -59.88 -43.64 94.65 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 122.86 0.464 . . . . 0.0 111.688 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.45 HD23 ' HE1' ' B' ' 54' ' ' TRP . 81.1 mt -83.66 28.6 0.56 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.896 -175.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -104.01 29.64 5.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.804 0.812 . . . . 0.0 108.954 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -119.33 57.52 0.89 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.317 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' B' ' 25' ' ' GLY . . . 163.28 47.2 0.02 OUTLIER Glycine 0 CA--C 1.503 -0.667 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.717 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 57.06 -63.27 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.517 ' H ' ' HA ' ' B' ' 45' ' ' TYR . . . -36.87 105.64 0.04 OUTLIER Glycine 0 C--N 1.33 0.248 0 O-C-N 124.006 0.816 . . . . 0.0 113.158 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' B' ' 40' ' ' SER . 34.3 pttt -63.67 132.34 50.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.941 0.401 . . . . 0.0 111.327 -176.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.459 HD11 ' OG ' ' B' ' 40' ' ' SER . 8.7 tp -146.09 104.7 3.85 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.073 -173.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -98.84 115.38 28.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.486 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.455 ' HB2' ' OD1' ' B' ' 17' ' ' ASN . 11.1 mp -89.05 165.93 14.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.817 0.818 . . . . 0.0 111.547 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 68.4 m -147.55 142.24 26.67 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.186 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.54 117.72 33.11 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.885 -171.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . 0.455 HD21 ' NE2' ' B' ' 35' ' ' GLN . 59.9 t30 -140.88 59.53 1.53 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.258 172.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' B' ' 8' ' ' GLU . . . 49.75 -87.09 0.01 OUTLIER Glycine 0 C--N 1.339 0.71 0 O-C-N 124.305 1.003 . . . . 0.0 115.133 173.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -66.35 -15.33 63.19 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.853 0.461 . . . . 0.0 111.6 -174.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.455 ' NE2' HD21 ' B' ' 32' ' ' ASN . 14.1 pt20 -132.56 149.01 52.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.057 0.932 . . . . 0.0 112.505 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.431 ' HB3' ' HB ' ' B' ' 84' ' ' ILE . 19.0 tp -112.45 101.67 9.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.604 -1.634 . . . . 0.0 107.964 170.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.4 ' HD3' ' CD ' ' B' ' 35' ' ' GLN . 35.5 mtmt -102.58 152.41 21.21 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.008 -1.451 . . . . 0.0 108.753 -172.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.86 156.93 2.91 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 1.3 p -126.27 144.94 50.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.982 175.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 16.2 m -144.02 151.31 39.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -175.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.528 ' HB2' ' CE ' ' B' ' 26' ' ' LYS . 20.1 m -138.02 158.49 44.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.288 170.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . 0.484 ' C ' ' H ' ' B' ' 44' ' ' GLY . 48.7 m-80 -109.63 46.01 1.04 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.896 -173.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.67 22.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.658 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.531 ' O ' HD13 ' B' ' 47' ' ' ILE . . . 165.9 -49.82 0.27 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.517 ' HA ' ' H ' ' B' ' 25' ' ' GLY . 7.3 p90 53.25 -177.75 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.0 1.32 . . . . 0.0 113.856 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.5 ' C ' HD11 ' B' ' 47' ' ' ILE . . . -70.74 105.76 1.69 Allowed Glycine 0 C--N 1.337 0.604 0 CA-C-N 116.014 -0.539 . . . . 0.0 113.934 -170.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.531 HD13 ' O ' ' B' ' 44' ' ' GLY . 3.4 mm -113.13 -70.0 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.988 0.423 . . . . 0.0 110.748 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.0 m -61.85 -51.75 66.96 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.816 0.817 . . . . 0.0 110.404 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -59.86 108.81 0.81 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.929 -1.487 . . . . 0.0 109.111 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.486 ' HB2' ' H ' ' B' ' 51' ' ' ASP . 0.0 OUTLIER -81.02 -157.8 0.18 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.849 0.357 . . . . 0.0 111.195 -176.67 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.486 ' H ' ' HB2' ' B' ' 50' ' ' GLU . 9.6 p-10 -74.88 108.9 7.92 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.228 1.013 . . . . 0.0 111.152 -173.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 44.3 mttm -122.51 125.57 46.03 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.724 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -108.16 136.02 48.53 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.899 0.38 . . . . 0.0 110.848 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.655 ' CZ3' HG22 ' B' ' 91' ' ' ILE . 21.9 p-90 -147.89 158.87 44.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.251 171.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.44 143.77 15.22 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.224 -174.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.47 ' O ' HG12 ' B' ' 63' ' ' VAL . 6.0 mt -102.84 143.1 15.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 173.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.582 ' HB2' ' HB2' ' B' ' 90' ' ' GLU . 55.4 m-85 -124.4 140.95 52.47 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.534 -176.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.47 HG13 ' ND2' ' B' ' 59' ' ' ASN . 9.1 p -128.49 134.87 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.47 ' ND2' HG13 ' B' ' 58' ' ' VAL . 2.1 m-80 60.91 13.32 4.42 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.95 -174.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.4 -0.88 63.88 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.631 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 23.1 mt-10 -104.81 172.95 6.52 Favored 'General case' 0 C--O 1.207 -1.16 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.408 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 12.0 tppt? -61.28 164.71 5.15 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.47 HG12 ' O ' ' B' ' 56' ' ' ILE . 8.8 p -146.91 -22.66 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 167.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.431 ' CE2' ' CG1' ' B' ' 79' ' ' ILE . 2.2 t80 -171.68 144.66 1.87 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.989 -173.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 78.2 m -133.31 128.46 35.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.649 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.691 ' CD2' HG22 ' B' ' 75' ' ' ILE . 14.3 p90 -158.96 -171.39 3.38 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.221 0.534 . . . . 0.0 110.799 -176.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.7 t-20 -151.57 144.15 24.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.317 -166.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . 0.452 ' OE1' ' HB2' ' B' ' 52' ' ' LYS . 2.4 mp0 -63.99 -34.25 77.57 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -78.93 -18.25 54.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.235 0.541 . . . . 0.0 110.125 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.446 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 3.1 t -71.64 -8.12 52.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.679 ' O ' HG13 ' B' ' 75' ' ' ILE . 7.5 p 65.08 112.28 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.687 -1.597 . . . . 0.0 112.372 173.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.415 ' HA ' ' CD1' ' B' ' 75' ' ' ILE . 2.9 m -61.02 -15.14 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.449 -170.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' B' ' 40' ' ' SER . . . -67.06 -50.49 45.89 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.288 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -75.2 -19.17 59.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.491 0.662 . . . . 0.0 109.506 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.691 HG22 ' CD2' ' B' ' 66' ' ' PHE . 49.6 mt -73.64 -53.61 17.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.015 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.404 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 43.5 t -55.87 -33.05 64.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.12 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -52.0 -48.19 64.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.126 173.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.67 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 5.7 m-20 -70.54 -41.45 72.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.131 177.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.431 ' CG1' ' CE2' ' B' ' 64' ' ' TYR . 58.2 mt -54.55 -37.74 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.0 0.429 . . . . 0.0 111.381 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -58.12 -34.57 70.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.396 177.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.67 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 18.8 pttp -85.07 -31.0 23.62 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.663 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.01 -26.75 68.42 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.778 0.323 . . . . 0.0 110.23 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 4.8 t30 42.54 69.84 0.34 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.456 -172.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.448 ' H ' ' CD1' ' B' ' 84' ' ' ILE . 2.6 mp -59.13 131.18 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.017 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -86.47 -170.74 3.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.842 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.95 111.66 0.67 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.348 -0.929 . . . . 0.0 112.607 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 19.3 tpp -150.08 -68.58 0.2 Allowed 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -127.96 84.83 2.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 45.5 mm -85.73 130.77 35.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.983 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.582 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 27.7 mt-10 -123.7 150.19 44.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.034 0.445 . . . . 0.0 111.526 175.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.655 HG22 ' CZ3' ' B' ' 54' ' ' TRP . 83.6 mt -129.74 125.61 61.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.491 176.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.487 ' HE3' ' CE2' ' B' ' 57' ' ' PHE . 14.9 pttp -167.57 164.97 14.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.131 0.491 . . . . 0.0 111.504 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -95.47 134.59 38.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.125 -174.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.554 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.2 pt . . . . . 0 C--O 1.247 0.938 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.682 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 t30 68.45 94.27 0.07 Allowed 'General case' 0 C--O 1.227 -0.104 0 O-C-N 123.588 0.555 . . . . 0.0 109.872 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -60.92 -18.96 59.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.186 -175.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.579 ' O ' ' HD3' ' B' ' 4' ' ' LYS . 4.3 tmtp? -70.8 -17.45 62.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.404 0.621 . . . . 0.0 109.698 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.2 168.54 19.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.274 0.559 . . . . 0.0 110.524 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' B' ' 11' ' ' ASN . 70.3 mt -84.31 -4.16 58.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.59 -173.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -53.62 -54.67 34.3 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.241 0.543 . . . . 0.0 110.159 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -74.59 -38.0 62.74 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.543 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . 0.448 HE21 ' HB2' ' B' ' 10' ' ' MET . 0.9 OUTLIER -89.25 73.2 8.09 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.297 -174.246 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' MET . . . . . 0.674 ' SD ' ' HA ' ' B' ' 34' ' ' ASN . 75.2 mtm 43.72 31.95 0.52 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 161.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' B' ' 6' ' ' LEU . 21.8 t-20 -56.75 -32.31 65.45 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.994 0.902 . . . . 0.0 110.044 173.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.549 ' O ' HG23 ' B' ' 16' ' ' VAL . 3.4 m -69.76 -30.75 68.41 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.253 -175.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' B' ' 10' ' ' MET . 11.3 mm -68.97 -35.86 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.914 -172.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . 0.64 ' N ' HD21 ' B' ' 14' ' ' ASN . 0.7 OUTLIER -69.02 -32.17 71.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.085 -178.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 32.8 t -69.48 -35.13 75.29 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.016 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.549 HG23 ' O ' ' B' ' 12' ' ' SER . 15.7 t -64.22 -42.47 95.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.691 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . 0.443 ' ND2' HD23 ' B' ' 29' ' ' LEU . 5.2 t-20 -57.59 -38.18 74.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.227 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.13 -40.05 32.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.216 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -65.13 -57.04 9.59 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.439 0.696 . . . . 0.0 112.455 -176.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 43.6 mt -68.75 -31.39 70.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.703 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.84 61.05 5.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.284 0.564 . . . . 0.0 110.529 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -121.59 -86.73 0.65 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.082 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.82 51.06 0.84 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.75 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.523 ' HE2' ' O ' ' B' ' 68' ' ' GLU . 31.5 mmtp -114.16 -161.43 0.77 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.01 -175.48 29.05 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.139 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.812 ' O ' ' HA ' ' B' ' 40' ' ' SER . 16.4 ptpt -67.76 105.15 1.84 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 174.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' B' ' 39' ' ' THR . 17.8 tp -119.24 128.17 53.93 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.442 -162.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 67.3 m -117.87 126.05 51.65 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.164 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.447 ' N ' HD21 ' B' ' 29' ' ' LEU . 1.7 mm? -104.83 147.88 27.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.117 0.484 . . . . 0.0 110.343 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 11.3 p -142.67 150.2 39.87 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.199 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 73.7 mtp -114.39 136.33 53.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.093 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -144.34 115.98 8.17 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.15 -107.28 2.05 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.674 ' HA ' ' SD ' ' B' ' 10' ' ' MET . 2.6 m-20 -123.67 14.83 9.44 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.468 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 75.1 mt-30 -78.48 162.07 26.62 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.304 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.422 HD21 HD12 ' B' ' 29' ' ' LEU . 6.1 tt -133.15 123.15 25.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.347 168.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -118.59 143.88 46.49 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -139.81 143.96 37.09 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.062 -0.655 . . . . 0.0 112.333 -170.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 8.6 p -128.02 141.63 51.46 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.105 175.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.812 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 21.2 p -153.13 145.25 23.81 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.713 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.446 ' HB2' ' CG ' ' B' ' 26' ' ' LYS . 16.9 m -113.18 167.16 10.78 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.367 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -78.88 47.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.194 -172.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.62 -59.82 2.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.015 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.494 ' O ' HD13 ' B' ' 47' ' ' ILE . . . -154.7 55.26 0.42 Allowed Glycine 0 C--N 1.313 -0.746 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.764 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.593 ' O ' HG13 ' B' ' 47' ' ' ILE . 41.4 p90 -77.63 160.16 28.71 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -172.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' B' ' 69' ' ' LYS . . . 14.87 76.5 0.01 OUTLIER Glycine 0 C--N 1.337 0.636 0 O-C-N 125.269 1.606 . . . . 0.0 116.498 168.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.593 HG13 ' O ' ' B' ' 45' ' ' TYR . 1.3 mp -106.75 -72.34 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-O 122.204 1.002 . . . . 0.0 111.684 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -88.33 -152.99 0.23 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.56 -1.655 . . . . 0.0 111.374 -170.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.508 ' O ' ' HE3' ' B' ' 52' ' ' LYS . 64.5 m-85 70.85 6.98 6.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.746 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 56.47 -81.36 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 124.245 0.966 . . . . 0.0 111.674 -175.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -167.28 110.43 0.68 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.508 ' HE3' ' O ' ' B' ' 49' ' ' TYR . 31.9 mmtp -129.61 124.09 32.89 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -104.34 128.13 52.1 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.547 ' HA ' HG12 ' B' ' 94' ' ' ILE . 50.0 p-90 -144.7 157.28 44.25 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -126.34 150.6 17.75 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.334 -170.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.621 HD11 ' CD2' ' B' ' 64' ' ' TYR . 28.6 mt -106.57 149.93 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 169.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.705 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 84.3 m-85 -131.52 142.69 50.0 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -169.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.555 HG12 ' ND2' ' B' ' 59' ' ' ASN . 7.9 p -131.67 140.51 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.555 ' ND2' HG12 ' B' ' 58' ' ' VAL . 8.7 m-80 66.76 0.11 1.79 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -170.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' B' ' 58' ' ' VAL . . . 97.22 0.24 59.88 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.37 -172.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' B' ' 58' ' ' VAL . 12.5 mt-10 -102.78 176.1 5.27 Favored 'General case' 0 C--O 1.201 -1.491 0 C-N-CA 123.716 0.806 . . . . 0.0 109.254 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.444 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.1 tppp? -62.37 160.37 13.5 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 118.633 0.651 . . . . 0.0 110.395 175.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.444 ' N ' ' HG3' ' B' ' 62' ' ' LYS . 8.5 p -152.97 -15.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.507 168.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.621 ' CD2' HD11 ' B' ' 56' ' ' ILE . 0.8 OUTLIER -160.43 126.19 4.01 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -172.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 23.9 m -134.51 126.32 29.12 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.189 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.428 ' CB ' HD12 ' B' ' 75' ' ' ILE . 3.9 p90 -166.96 -175.16 2.93 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.533 0.682 . . . . 0.0 110.424 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 10.0 t-20 -128.77 168.27 16.11 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.093 -170.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . 0.523 ' O ' ' HE2' ' B' ' 24' ' ' LYS . 8.9 mm-40 -85.81 -11.08 54.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.871 0.367 . . . . 0.0 110.955 -177.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.471 ' O ' ' HA3' ' B' ' 46' ' ' GLY . 51.1 tttm -100.78 -26.1 13.9 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 21.5 t -63.88 152.07 40.76 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.811 0.815 . . . . 0.0 108.989 174.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.445 ' O ' HG13 ' B' ' 75' ' ' ILE . 0.1 OUTLIER -99.26 109.59 22.22 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.113 -173.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.481 ' HA ' ' CD1' ' B' ' 75' ' ' ILE . 3.6 m -67.33 -14.47 18.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.425 -167.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.54 -47.96 88.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.675 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -74.42 -32.84 62.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.045 0.45 . . . . 0.0 110.609 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.516 ' O ' HG12 ' B' ' 79' ' ' ILE . 1.4 mt -70.33 -51.33 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.127 0.489 . . . . 0.0 110.274 -177.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.455 ' N ' ' HH ' ' B' ' 64' ' ' TYR . 16.6 t -61.94 -28.77 69.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.563 -176.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -50.67 -53.5 30.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.527 0.679 . . . . 0.0 110.268 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.744 ' O ' ' HG3' ' B' ' 81' ' ' LYS . 0.8 OUTLIER -69.29 -43.07 74.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.099 179.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.53 HG13 ' CE1' ' B' ' 64' ' ' TYR . 42.8 mm -51.77 -37.98 21.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.266 0.555 . . . . 0.0 111.718 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -66.27 -28.42 68.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.326 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.744 ' HG3' ' O ' ' B' ' 78' ' ' ASP . 0.0 OUTLIER -84.6 -0.43 53.23 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.758 -176.582 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 3.1 mm? -72.78 -11.84 60.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.232 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 62.6 t30 50.61 58.97 4.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.634 -172.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.468 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 68.9 mt -61.59 150.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.375 -173.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.425 ' O ' HG21 ' B' ' 84' ' ' ILE . 64.8 mttm -103.26 -178.53 3.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.381 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.471 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -139.62 115.3 1.08 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.795 -1.193 . . . . 0.0 113.805 -177.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.423 ' HG2' ' N ' ' B' ' 88' ' ' TYR . 1.7 pmm? -165.25 -57.64 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 175.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . 0.423 ' N ' ' HG2' ' B' ' 87' ' ' MET . 15.7 t80 -129.31 83.23 2.13 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 121.611 -0.681 . . . . 0.0 109.778 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.705 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 23.4 mm -92.21 121.9 43.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.222 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -109.14 171.54 7.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.985 0.421 . . . . 0.0 109.933 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.467 ' CG1' ' HB3' ' B' ' 12' ' ' SER . 30.4 mm -152.94 115.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.677 -175.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -169.18 165.79 10.93 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.177 0.513 . . . . 0.0 111.875 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.482 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 3.1 pp0? -82.76 143.61 30.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.854 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.547 HG12 ' HA ' ' B' ' 54' ' ' TRP . 6.2 pt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.868 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -149.65 106.06 3.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.927 0.394 . . . . 0.0 111.138 -175.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . 0.449 ' HB3' ' O ' ' B' ' 31' ' ' MET . 8.6 pt20 -95.53 -1.58 50.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.544 175.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.95 -29.43 58.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.817 -177.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.88 98.72 0.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.337 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 91.0 mt -68.56 -15.15 63.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.051 -173.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -71.93 -44.93 62.82 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.325 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -81.5 -32.26 32.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.597 0.713 . . . . 0.0 110.885 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . 0.615 ' OE1' ' HB ' ' B' ' 13' ' ' ILE . 0.4 OUTLIER -119.07 84.72 2.24 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.753 -177.801 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -83.35 166.67 18.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.555 -174.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -47.44 -32.47 5.11 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.504 ' CB ' ' HB ' ' B' ' 89' ' ' ILE . 12.2 m -65.49 -27.23 68.34 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.99 -173.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.615 ' HB ' ' OE1' ' B' ' 9' ' ' GLN . 3.3 mm -67.4 -47.06 82.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 122.079 0.942 . . . . 0.0 109.392 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -59.23 -32.6 70.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.285 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.471 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 9.9 t -68.51 -42.28 78.79 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.801 177.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.471 HG23 ' O ' ' B' ' 12' ' ' SER . 97.7 t -55.26 -42.75 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.128 0.49 . . . . 0.0 110.379 177.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . 0.489 ' ND2' ' HB2' ' B' ' 29' ' ' LEU . 2.3 t-20 -56.73 -45.66 81.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.758 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.92 -38.9 52.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.237 -175.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' B' ' 15' ' ' SER . 24.1 mmmt -78.5 -8.26 58.36 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -172.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.427 HD22 ' CZ ' ' B' ' 66' ' ' PHE . 15.6 mt -91.63 23.43 3.54 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . 0.531 ' CG ' ' H ' ' B' ' 22' ' ' LYS . 20.3 p-10 -88.73 -79.34 0.31 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 171.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.531 ' H ' ' CG ' ' B' ' 21' ' ' ASN . 28.7 mtpp 48.61 34.01 4.65 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 169.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 146.8 -92.38 0.15 Allowed Glycine 0 N--CA 1.439 -1.167 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.472 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.569 ' HD2' ' CD1' ' B' ' 47' ' ' ILE . 58.0 mttm -152.84 -141.75 0.11 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -171.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.662 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . 68.05 111.75 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.8 -173.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' B' ' 40' ' ' SER . 0.3 OUTLIER -63.0 115.44 4.41 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 173.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.491 HD21 ' CG2' ' B' ' 72' ' ' VAL . 4.0 tp -152.85 105.08 2.91 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 72.4 m -97.76 113.92 25.81 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.344 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.489 ' HB2' ' ND2' ' B' ' 17' ' ' ASN . 2.8 mm? -86.75 159.85 19.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.477 0.656 . . . . 0.0 110.59 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.541 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 0.1 OUTLIER -151.11 147.66 27.34 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.313 173.52 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' MET . . . . . 0.449 ' O ' ' HB3' ' B' ' 3' ' ' GLN . 58.8 mtm -118.81 141.09 48.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.149 0.5 . . . . 0.0 111.839 -168.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . 0.501 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 49.6 t30 -150.55 60.48 0.95 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.405 173.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.78 -92.83 0.01 OUTLIER Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.2 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.35 -18.17 57.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.774 -0.213 . . . . 0.0 111.328 -177.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.501 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 68.5 mt-30 -101.53 147.0 26.9 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.666 0.746 . . . . 0.0 111.422 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.19 104.81 9.4 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.506 174.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.541 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 8.1 mmmm -102.56 142.73 33.25 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -172.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -162.92 145.1 10.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -174.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 7.9 p -122.13 143.18 49.7 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 172.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 20.3 m -137.15 155.45 49.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.45 0.643 . . . . 0.0 112.256 -173.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.409 ' HB3' ' CB ' ' B' ' 26' ' ' LYS . 32.5 t -137.87 154.53 49.47 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.618 176.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -105.93 37.05 2.35 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.924 -170.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.23 23.12 0.29 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.591 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.45 -56.71 0.41 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.728 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.662 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 14.8 p90 47.58 -161.88 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.48 1.112 . . . . 0.0 113.784 175.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.592 ' HA2' ' OH ' ' B' ' 49' ' ' TYR . . . -69.07 104.7 1.31 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 116.34 -0.391 . . . . 0.0 113.358 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.569 ' CD1' ' HD2' ' B' ' 24' ' ' LYS . 2.1 mp -100.28 -71.33 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 122.11 0.957 . . . . 0.0 110.685 179.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 18.4 m -99.75 -118.65 0.15 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.036 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.592 ' OH ' ' HA2' ' B' ' 46' ' ' GLY . 0.1 OUTLIER 38.46 45.86 0.89 Allowed 'General case' 0 N--CA 1.472 0.625 0 O-C-N 123.693 0.621 . . . . 0.0 111.226 -171.315 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 48.55 -94.5 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.836 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.412 ' CG ' HD22 ' B' ' 67' ' ' ASN . 18.1 t70 -174.41 109.85 0.14 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -177.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.625 ' HB2' ' OE2' ' B' ' 68' ' ' GLU . 47.4 mmtt -123.26 136.84 54.9 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -174.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.41 ' CG ' HD21 ' B' ' 67' ' ' ASN . 47.2 m-80 -120.1 140.32 51.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.799 0.333 . . . . 0.0 111.344 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.602 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 22.2 p-90 -156.23 172.02 19.19 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.505 172.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.7 147.07 19.0 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.661 -173.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 25.0 mt -107.14 146.32 13.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 170.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 60.3 m-85 -126.63 143.89 51.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.426 -174.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.563 HG12 ' ND2' ' B' ' 59' ' ' ASN . 7.1 p -129.68 136.43 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.563 ' ND2' HG12 ' B' ' 58' ' ' VAL . 1.6 m-80 59.13 14.93 3.77 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.118 0.567 . . . . 0.0 109.842 -174.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.37 -1.5 66.95 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.496 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 14.6 mt-10 -105.86 177.5 4.83 Favored 'General case' 0 C--O 1.205 -1.266 0 C-N-CA 123.644 0.778 . . . . 0.0 109.162 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.486 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.2 tppp? -66.14 163.04 18.43 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 172.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.491 ' HB ' ' CG1' ' B' ' 58' ' ' VAL . 11.3 p -151.48 -21.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.104 0.478 . . . . 0.0 109.877 167.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.671 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.6 OUTLIER -161.31 123.46 3.02 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.163 0.506 . . . . 0.0 110.845 -171.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 8.6 m -129.48 129.4 44.55 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.421 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.475 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.0 OUTLIER -153.01 -176.7 5.88 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 122.261 1.029 . . . . 0.0 111.875 -176.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.412 HD22 ' CG ' ' B' ' 51' ' ' ASP . 23.9 t-20 -147.28 149.09 32.19 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 112.897 -1.956 . . . . 0.0 108.365 -176.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . 0.625 ' OE2' ' HB2' ' B' ' 52' ' ' LYS . 0.4 OUTLIER -66.48 -21.1 66.18 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -172.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.434 ' O ' HG23 ' B' ' 71' ' ' THR . 85.4 tttt -95.88 -20.91 18.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.226 0.536 . . . . 0.0 110.011 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 6.7 t -69.88 -23.63 63.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.674 174.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.568 HG22 ' CD1' ' B' ' 45' ' ' TYR . 19.2 p 61.87 107.13 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.313 1.045 . . . . 0.0 111.878 174.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.491 ' CG2' HD21 ' B' ' 27' ' ' LEU . 6.0 m -64.41 -16.47 19.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.606 -169.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.07 -48.5 82.48 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.269 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -75.43 -28.91 59.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.285 0.564 . . . . 0.0 110.572 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.504 ' O ' HG12 ' B' ' 79' ' ' ILE . 2.9 mt -73.0 -47.83 46.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.595 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 42.1 m -52.08 -35.43 47.61 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.041 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -48.51 -58.26 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.788 0.804 . . . . 0.0 110.336 172.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.553 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 7.1 m-20 -70.31 -35.9 73.97 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.572 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.671 HG13 ' CE1' ' B' ' 64' ' ' TYR . 41.5 mm -58.81 -25.54 29.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.571 0.7 . . . . 0.0 111.729 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -69.18 4.54 1.59 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.406 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 0.1 OUTLIER -105.17 -0.61 26.36 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.132 0.492 . . . . 0.0 110.446 176.134 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.56 -4.46 51.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.999 -169.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . 0.416 HD21 ' C ' ' B' ' 83' ' ' ASN . 0.2 OUTLIER 53.13 58.85 4.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -170.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.4 HD13 HG23 ' B' ' 79' ' ' ILE . 59.8 mt -56.84 155.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.121 -175.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -134.86 -171.69 2.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.882 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -149.47 112.7 0.57 Allowed Glycine 0 C--N 1.309 -0.945 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.463 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.468 ' HG2' ' N ' ' B' ' 88' ' ' TYR . 16.0 ttt -160.29 -76.3 0.06 Allowed 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . 0.468 ' N ' ' HG2' ' B' ' 87' ' ' MET . 49.7 t80 -120.11 94.05 4.26 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.644 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 22.3 mm -96.32 130.52 44.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.672 -177.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 51.3 mm-40 -123.94 154.99 38.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.4 . . . . 0.0 111.528 177.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.5 HG22 ' CZ3' ' B' ' 54' ' ' TRP . 72.2 mt -137.54 126.25 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.646 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.602 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 49.6 pttt -172.62 167.27 5.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.064 0.459 . . . . 0.0 111.262 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.657 ' H ' ' NE2' ' B' ' 93' ' ' GLN . 0.6 OUTLIER -96.77 151.67 19.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.427 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.546 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.9 pt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.038 -0.982 . . . . 0.0 111.038 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.545 0.212 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -76.74 -30.55 56.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.848 0.356 . . . . 0.0 111.484 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -63.41 -15.61 58.11 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.768 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -72.76 -18.98 61.45 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.032 0.444 . . . . 0.0 110.946 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.82 11.08 30.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.063 0.459 . . . . 0.0 110.587 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 75.2 mt -118.42 21.9 12.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.46 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -40.33 75.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.418 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -87.48 -30.44 20.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 122.098 0.952 . . . . 0.0 110.149 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -81.27 68.97 7.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.772 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' MET . . . . . 0.439 ' O ' HG13 ' B' ' 13' ' ' ILE . 25.8 mmt -66.12 138.04 57.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.884 176.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -40.25 -19.89 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.42 1.488 . . . . 0.0 114.092 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.428 ' O ' HG22 ' B' ' 16' ' ' VAL . 39.1 t -60.09 -7.3 1.76 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.569 0.747 . . . . 0.0 112.325 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.439 HG13 ' O ' ' B' ' 10' ' ' MET . 0.6 OUTLIER -47.91 -62.27 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.347 0 CA-C-O 121.224 0.535 . . . . 0.0 111.916 -176.064 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -106.67 -20.77 13.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.792 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 30.9 t -53.61 -38.35 63.93 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.164 -175.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.428 HG22 ' O ' ' B' ' 12' ' ' SER . 90.1 t -57.19 -41.93 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 111.211 -176.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . 0.417 ' HA ' HD21 ' B' ' 29' ' ' LEU . 4.9 t-20 -67.05 -41.53 86.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.668 -176.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.07 -38.9 56.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.0 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 6.4 mmpt? -57.88 -66.22 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.484 HD23 ' CZ ' ' B' ' 66' ' ' PHE . 75.3 mt -59.1 -23.02 61.72 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.269 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -86.74 79.8 8.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.713 0.768 . . . . 0.0 110.711 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' B' ' 19' ' ' LYS . 29.7 mtpp -119.14 37.3 4.17 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.97 177.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.65 59.5 3.48 Favored Glycine 0 CA--C 1.505 -0.59 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -125.45 -163.44 1.2 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.437 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -53.54 139.94 34.26 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.175 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' B' ' 40' ' ' SER . 43.1 mtmt -61.76 107.9 0.91 Allowed 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 117.036 0.418 . . . . 0.0 109.96 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.572 ' HA ' ' O ' ' B' ' 39' ' ' THR . 36.7 tp -125.41 122.58 37.14 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.853 -167.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 18.2 m -101.61 101.9 12.52 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.542 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.479 HD11 ' N ' ' B' ' 29' ' ' LEU . 4.9 mp -90.69 150.94 21.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 122.02 0.914 . . . . 0.0 112.485 -170.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 34.3 p -146.65 149.8 34.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.778 -1.555 . . . . 0.0 107.893 173.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 78.3 mtp -120.74 160.85 22.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.244 0.545 . . . . 0.0 111.811 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -159.09 104.94 1.72 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.599 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.91 -97.59 0.74 Allowed Glycine 0 CA--C 1.504 -0.604 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -169.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -137.17 19.77 2.98 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 168.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -77.68 155.14 31.52 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.927 175.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.468 ' O ' HG21 ' B' ' 79' ' ' ILE . 2.0 tm? -126.45 116.99 21.99 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.18 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -120.97 133.01 55.26 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.726 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -162.82 150.44 13.56 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -170.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 18.4 p -112.14 148.11 34.69 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.699 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 7.7 p -134.34 146.47 49.97 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -170.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 47.3 t -118.82 165.26 14.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.399 167.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -113.93 18.72 17.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.165 0.507 . . . . 0.0 111.238 -172.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.75 -61.45 2.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.181 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.54 53.94 0.56 Allowed Glycine 0 C--N 1.311 -0.807 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.985 -176.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.437 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 0.1 OUTLIER -63.65 -165.69 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.03 0.532 . . . . 0.0 112.192 -177.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.45 ' H ' ' CG2' ' B' ' 71' ' ' THR . . . -70.33 106.66 1.9 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.154 175.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 4.7 mm -64.0 -68.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.974 0.416 . . . . 0.0 110.173 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.0 m -123.28 -90.79 0.56 Allowed 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.18 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 56.15 33.91 22.91 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 122.761 0.424 . . . . 0.0 111.332 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 34.02 -109.62 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.727 -1.124 . . . . 0.0 113.111 -175.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -150.65 110.52 4.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.828 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -131.53 135.16 46.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.521 HD21 ' N ' ' B' ' 53' ' ' ASN . 0.8 OUTLIER -111.5 136.09 51.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.846 0.355 . . . . 0.0 110.156 -179.446 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.656 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 48.0 p-90 -151.2 166.99 29.19 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 172.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.71 159.4 26.86 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 119.989 -1.1 . . . . 0.0 113.711 -170.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 13.3 mt -105.7 142.85 17.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 171.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.577 ' CE1' ' HG3' ' B' ' 62' ' ' LYS . 48.8 m-85 -126.23 131.29 51.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.998 -0.092 . . . . 0.0 110.756 -177.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.481 HG13 ' ND2' ' B' ' 59' ' ' ASN . 12.2 p -116.26 133.86 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.276 -177.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.481 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.8 m-80 65.78 5.01 3.15 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.719 0.808 . . . . 0.0 110.263 -177.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.61 11.9 56.4 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.829 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 14.8 mt-10 -110.25 173.7 6.21 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 171.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.577 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 24.9 ttmt -76.49 168.77 19.48 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 119.427 1.012 . . . . 0.0 108.971 173.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.426 ' HB ' HG11 ' B' ' 58' ' ' VAL . 8.4 p -151.47 -19.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.804 171.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.645 ' CD2' HD12 ' B' ' 79' ' ' ILE . 0.0 OUTLIER -163.33 153.21 15.4 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.588 -175.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 27.6 m -149.97 130.03 13.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.308 177.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.484 ' CZ ' HD23 ' B' ' 20' ' ' LEU . 0.0 OUTLIER -145.11 -176.76 5.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.724 0.773 . . . . 0.0 110.769 -178.803 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.403 HD21 ' ND2' ' B' ' 53' ' ' ASN . 24.6 t-20 -136.22 160.2 39.41 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.156 -1.384 . . . . 0.0 110.219 -175.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -61.15 -44.25 97.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.865 0.364 . . . . 0.0 111.724 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.554 ' O ' HG22 ' B' ' 71' ' ' THR . 50.3 tptt -80.86 -19.76 43.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.838 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 8.7 t -69.1 -18.38 63.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.402 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.554 HG22 ' O ' ' B' ' 69' ' ' LYS . 41.0 p 56.27 105.93 0.01 OUTLIER 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.304 1.041 . . . . 0.0 113.332 170.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.1 m -57.65 -15.12 3.67 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-N 114.556 -1.202 . . . . 0.0 113.265 -171.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.58 -52.3 46.26 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.979 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -76.45 -32.68 58.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.354 0.597 . . . . 0.0 109.976 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.595 HG21 ' CE2' ' B' ' 64' ' ' TYR . 1.9 mt -72.03 -53.93 18.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.604 -173.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.8 m -69.75 -14.08 62.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.52 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -61.93 -42.24 98.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.768 0.794 . . . . 0.0 109.459 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 4.3 m-20 -68.95 -32.46 72.07 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.529 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.645 HD12 ' CD2' ' B' ' 64' ' ' TYR . 17.7 mm -55.67 -26.35 19.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -54.85 -27.26 40.96 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.296 173.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 19.8 pttm -104.11 -6.14 21.37 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -172.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' B' ' 79' ' ' ILE . 2.8 mm? -70.97 -18.3 62.62 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 122.126 -0.359 . . . . 0.0 111.815 -173.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 61.0 t30 45.97 55.69 6.8 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.972 0.795 . . . . 0.0 110.63 -171.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.479 HG23 ' O ' ' B' ' 85' ' ' LYS . 83.1 mt -59.81 145.5 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.171 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.479 ' O ' HG23 ' B' ' 84' ' ' ILE . 62.3 mttp -89.88 178.27 6.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.32 176.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -134.33 112.58 1.06 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.474 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.24 -79.73 0.09 Allowed 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -122.33 88.07 2.87 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 28.0 mm -90.83 128.66 42.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.912 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 33.8 mt-10 -117.52 144.73 44.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.588 173.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 2.5 mt -134.75 102.81 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.656 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 48.0 pttt -154.65 178.01 10.59 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -169.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.431 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 21.1 mm-40 -99.01 146.8 25.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.163 -176.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.611 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.9 pt . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.305 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.635 0.255 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -78.27 -39.54 39.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.761 0.315 . . . . 0.0 111.007 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -83.54 -19.44 35.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.319 0.58 . . . . 0.0 110.214 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -93.64 9.4 37.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.023 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.04 83.71 0.33 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.825 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.89 21.22 14.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.498 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.56 -63.74 1.2 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.733 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -98.22 1.23 47.09 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 121.413 0.625 . . . . 0.0 110.512 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -130.26 76.92 1.75 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.367 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 15.0 mmt -71.64 150.52 44.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.362 0.601 . . . . 0.0 111.283 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -66.5 -28.26 68.43 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.956 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 24.2 m -71.45 -21.12 62.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.712 -175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mm -61.93 -47.4 93.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 122.07 0.938 . . . . 0.0 109.196 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -63.69 -38.39 90.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.405 -177.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -62.2 -44.27 96.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.934 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.96 -48.0 91.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.096 0.474 . . . . 0.0 110.329 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -60.11 -37.05 78.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.882 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . 0.667 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.2 OUTLIER -71.32 -57.47 4.43 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.377 176.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -55.59 -49.96 71.38 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.059 0.944 . . . . 0.0 112.85 -173.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.441 HD22 ' CZ ' ' B' ' 66' ' ' PHE . 47.2 mt -71.17 -21.06 62.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.963 -175.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -91.94 -99.55 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.667 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 30.6 mtpp 49.9 25.79 1.74 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.67 11.22 60.84 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.933 178.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -96.25 -129.08 0.16 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 175.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.538 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -66.87 107.29 1.94 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 173.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.733 ' O ' ' HA ' ' B' ' 40' ' ' SER . 34.9 mtmt -66.97 90.08 0.18 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.846 0.314 . . . . 0.0 111.846 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 47.1 tp -108.47 93.14 4.37 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 21.0 m -81.24 105.47 12.46 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.264 -176.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.41 165.24 22.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.946 0.879 . . . . 0.0 111.601 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 49.1 m -146.49 144.35 29.58 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.363 174.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 33.9 mtt -114.26 124.1 51.19 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.817 0.341 . . . . 0.0 110.945 -170.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.83 60.04 1.32 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.662 176.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . 0.407 ' O ' ' HA3' ' B' ' 86' ' ' GLY . . . 49.55 -102.9 0.07 OUTLIER Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.248 -0.887 . . . . 0.0 113.861 178.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.441 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 4.6 m-20 -79.44 19.37 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.271 0.229 . . . . 0.0 111.435 -176.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 42.9 mt-30 -139.13 146.28 40.45 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.317 0.58 . . . . 0.0 110.472 172.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -129.05 116.66 19.64 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 176.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.46 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 16.1 mtpt -118.09 148.87 41.86 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -172.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -170.58 145.6 2.58 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -176.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 19.5 p -122.68 141.62 51.57 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.548 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.733 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 24.1 t -122.53 147.51 46.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.363 0.601 . . . . 0.0 112.163 -174.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.532 ' HB3' ' HB2' ' B' ' 26' ' ' LYS . 46.8 t -131.67 160.85 34.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.813 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' B' ' 44' ' ' GLY . 51.1 m-80 -114.1 32.84 5.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.115 -171.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.425 ' HB3' ' HE2' ' B' ' 26' ' ' LYS . . . -72.96 22.46 0.07 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.306 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' B' ' 42' ' ' ASN . . . 165.34 -43.97 0.29 Allowed Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.538 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 37.1 p90 46.04 -160.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.355 1.062 . . . . 0.0 113.013 -175.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.55 99.39 0.73 Allowed Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.842 -0.694 . . . . 0.0 114.17 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.06 -54.73 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.1 0.476 . . . . 0.0 109.782 170.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -37.93 -57.97 0.98 Allowed 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.285 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -103.81 112.91 26.08 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' B' ' 69' ' ' LYS . 30.5 mt-10 -67.75 -48.38 66.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.616 -170.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -167.22 111.93 0.72 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.443 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -132.39 142.18 49.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.848 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.59 113.87 26.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.522 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 29.1 p-90 -154.12 165.7 35.38 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.345 176.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.12 150.45 20.19 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.844 -174.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.429 HD13 ' CD2' ' B' ' 64' ' ' TYR . 24.3 mt -106.35 150.41 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 172.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.563 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 70.7 m-85 -131.9 139.43 48.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.128 -172.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.502 HG12 ' ND2' ' B' ' 59' ' ' ASN . 8.6 p -125.17 133.39 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.502 ' ND2' HG12 ' B' ' 58' ' ' VAL . 5.4 m-80 64.12 5.88 2.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.859 -175.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.87 -12.21 38.16 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.435 -176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' B' ' 58' ' ' VAL . 0.2 OUTLIER -100.17 177.22 5.13 Favored 'General case' 0 C--O 1.202 -1.421 0 C-N-CA 123.713 0.805 . . . . 0.0 109.938 -176.708 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.473 ' HD2' ' OG1' ' B' ' 65' ' ' THR . 13.1 tppt? -61.44 159.45 12.74 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 118.279 0.491 . . . . 0.0 110.485 174.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.439 ' HB ' ' CG1' ' B' ' 58' ' ' VAL . 8.1 p -153.7 -14.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.262 0.553 . . . . 0.0 110.389 167.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.758 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -161.14 133.99 6.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.184 -173.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.473 ' OG1' ' HD2' ' B' ' 62' ' ' LYS . 16.4 m -142.18 126.0 17.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.02 177.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.441 ' CZ ' HD22 ' B' ' 20' ' ' LEU . 0.0 OUTLIER -166.16 -177.8 4.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 122.567 1.175 . . . . 0.0 112.29 -174.26 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -136.83 145.9 45.0 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 112.349 -2.205 . . . . 0.0 108.736 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.3 -29.3 65.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.186 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.431 ' O ' HG23 ' B' ' 71' ' ' THR . 28.2 ttpp -80.99 -25.94 36.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.99 0.424 . . . . 0.0 110.599 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 9.8 t -68.05 -31.64 71.42 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 174.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.474 ' O ' HG13 ' B' ' 75' ' ' ILE . 11.1 p 62.77 125.08 0.01 OUTLIER 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.548 1.139 . . . . 0.0 112.614 174.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 m -63.92 -10.75 8.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.356 -168.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.92 -56.31 23.57 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.663 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -76.48 -31.28 57.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.39 0.614 . . . . 0.0 110.265 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.474 HG13 ' O ' ' B' ' 71' ' ' THR . 2.8 mt -67.93 -46.24 82.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.649 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.401 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 38.2 t -59.16 -32.71 70.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.693 -178.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -49.04 -52.42 25.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.66 0.743 . . . . 0.0 110.286 176.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.459 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 30.3 m-20 -67.7 -47.32 69.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.018 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.758 HG13 ' CE1' ' B' ' 64' ' ' TYR . 46.2 mm -55.16 -30.75 24.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.262 0.553 . . . . 0.0 112.065 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -58.6 -20.01 43.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.269 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.566 ' HZ3' ' HB2' ' B' ' 81' ' ' LYS . 0.0 OUTLIER -94.56 -4.0 48.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 0.0 111.058 -175.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.447 HD21 ' HA ' ' B' ' 79' ' ' ILE . 3.1 mm? -70.5 -16.26 62.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.99 -173.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 58.9 t30 50.84 57.64 6.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.461 -171.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' B' ' 35' ' ' GLN . 48.9 mt -57.63 144.08 10.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.94 -174.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 30.3 mtmm -109.03 -168.58 1.36 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.112 175.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' B' ' 33' ' ' GLY . . . -146.25 113.58 0.69 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.925 -177.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 37.4 ttp -157.34 -74.09 0.09 Allowed 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 116.639 0.22 . . . . 0.0 110.458 173.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -117.32 94.24 4.48 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.181 0.515 . . . . 0.0 109.694 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 20.4 mm -93.57 134.66 30.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.384 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -122.89 173.49 7.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.369 0.604 . . . . 0.0 110.937 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.522 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 92.1 mt -152.22 118.85 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.759 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 30.7 pttt -171.26 168.3 6.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.175 0.512 . . . . 0.0 111.768 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.459 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 2.4 pt20 -99.39 150.51 22.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.154 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.2 pt . . . . . 0 C--N 1.308 -1.203 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.972 -174.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . 0.433 ' HB3' ' HB3' ' B' ' 4' ' ' LYS . 3.6 m-20 . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -61.64 -53.66 53.17 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -170.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . 0.406 ' O ' ' HG ' ' B' ' 6' ' ' LEU . 11.9 pt20 -74.15 -15.59 61.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.848 0.356 . . . . 0.0 111.793 -176.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.433 ' HB3' ' HB3' ' B' ' 1' ' ' ASP . 55.3 tptt -85.93 -21.75 27.77 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.248 0.547 . . . . 0.0 110.44 175.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 0.437 ' O ' ' HG2' ' B' ' 9' ' ' GLN . . . -108.5 42.84 1.32 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.085 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 3' ' ' GLN . 67.4 mt -71.84 -3.41 22.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.855 0.36 . . . . 0.0 111.465 -176.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -82.5 -37.02 25.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.005 0.431 . . . . 0.0 110.212 171.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.88 -20.47 49.4 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.714 0.769 . . . . 0.0 110.713 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' B' ' 5' ' ' ALA . 17.7 pt20 -128.4 68.05 1.37 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.439 172.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' MET . . . . . 0.455 ' O ' ' HE3' ' B' ' 31' ' ' MET . 0.0 OUTLIER -81.75 171.02 15.05 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.625 -1.171 . . . . 0.0 112.115 -173.472 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -36.83 -22.97 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.638 1.975 . . . . 0.0 115.825 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 15.2 m -60.33 -12.5 9.31 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 122.441 0.296 . . . . 0.0 111.792 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.52 -50.36 49.87 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-O 121.732 0.777 . . . . 0.0 109.849 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' B' ' 18' ' ' ASP . 40.0 m-80 -106.82 -60.6 1.65 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.274 -175.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 5.5 m -58.24 -64.49 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.393 -170.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 67.9 t -62.94 -40.5 89.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.449 . . . . 0.0 110.701 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -56.83 -47.14 81.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.827 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . 0.757 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.1 OUTLIER -75.02 -40.54 60.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.273 -178.039 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -52.49 -35.18 52.27 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.016 0.527 . . . . 0.0 112.027 -176.764 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.22 -42.24 11.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.273 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . 0.454 ' OD1' ' HA ' ' B' ' 18' ' ' ASP . 4.3 p-10 -80.45 -2.41 45.7 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.757 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 29.2 mtpp -73.37 -74.29 0.18 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.753 0.311 . . . . 0.0 111.565 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.17 15.93 59.83 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.822 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.563 ' NZ ' ' HA ' ' B' ' 68' ' ' GLU . 26.0 mtpt -129.29 -160.23 1.02 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.168 0.509 . . . . 0.0 110.224 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.483 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -66.03 139.24 38.03 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 173.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' B' ' 40' ' ' SER . 60.3 mttt -62.28 133.91 55.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -175.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.483 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 29.6 tp -141.56 96.57 3.0 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 41.9 m -86.63 126.83 34.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.789 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.483 ' CD1' ' HG ' ' B' ' 27' ' ' LEU . 10.4 mp -107.07 163.75 12.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 122.327 1.06 . . . . 0.0 112.758 -174.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.444 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 3.1 p -160.22 146.06 15.33 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 112.878 -1.965 . . . . 0.0 107.073 171.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' MET . . . . . 0.455 ' HE3' ' O ' ' B' ' 10' ' ' MET . 52.9 mtm -128.67 145.61 51.11 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.582 -172.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . 0.446 ' C ' HD21 ' B' ' 32' ' ' ASN . 0.2 OUTLIER -138.02 61.21 1.6 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.47 -96.82 0.12 Allowed Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.54 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -87.19 25.77 1.31 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.913 0.387 . . . . 0.0 110.791 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.417 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 14.8 mt-30 -137.31 144.82 42.8 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 121.465 0.65 . . . . 0.0 110.627 172.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tt -126.25 105.17 8.64 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.248 -1.342 . . . . 0.0 107.645 175.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.444 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 6.0 mmmm -102.62 138.27 39.74 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -173.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -156.56 147.47 21.95 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -172.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -124.27 155.22 39.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.09 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 6.7 p -135.85 157.52 46.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -172.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 22.8 t -136.43 154.45 50.78 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.776 174.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -115.96 30.39 7.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.812 -171.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.61 23.2 0.12 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.59 -24.26 0.36 Allowed Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.777 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.513 ' HB2' ' HB ' ' B' ' 71' ' ' THR . 52.6 p90 45.37 -156.6 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.167 0.987 . . . . 0.0 113.032 -176.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' B' ' 24' ' ' LYS . . . -69.52 102.98 1.02 Allowed Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.666 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.79 -64.19 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.037 0.446 . . . . 0.0 110.619 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 60.1 m -48.5 -53.66 17.24 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.152 -175.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.532 ' CB ' ' HB3' ' B' ' 68' ' ' GLU . 4.4 m-30 -78.39 127.25 31.93 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.768 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -84.25 -168.62 2.23 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.942 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -60.71 108.63 0.87 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.716 0.77 . . . . 0.0 111.325 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 54.3 mtmt -150.24 140.78 22.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.443 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.54 123.93 40.19 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.993 0.425 . . . . 0.0 111.485 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.517 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 28.1 p-90 -143.33 169.7 17.16 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.085 177.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.16 148.59 20.0 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.126 -173.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 13.5 mt -105.66 150.66 8.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 171.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.677 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 84.3 m-85 -130.56 139.48 50.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -171.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.531 HG11 ' ND2' ' B' ' 59' ' ' ASN . 7.2 p -126.58 134.32 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.531 ' ND2' HG11 ' B' ' 58' ' ' VAL . 4.5 m-80 66.86 -2.32 1.15 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.641 -173.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' B' ' 58' ' ' VAL . . . 108.18 -6.3 34.4 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.552 -172.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 1.9 mp0 -94.47 176.45 6.29 Favored 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 123.896 0.878 . . . . 0.0 109.193 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.432 ' HD3' ' CE1' ' B' ' 57' ' ' PHE . 7.8 tppt? -66.91 161.99 22.81 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.409 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.8 p -153.48 -11.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.08 0.467 . . . . 0.0 110.219 168.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.65 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -160.58 132.39 5.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.547 -175.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 54.9 m -139.01 124.39 19.26 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.288 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.414 ' HB3' HD11 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -164.84 155.6 14.43 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.505 1.145 . . . . 0.0 111.869 -174.667 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 10.7 t-20 -93.41 153.49 18.47 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.038 -1.892 . . . . 0.0 108.352 169.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . 0.563 ' HA ' ' NZ ' ' B' ' 24' ' ' LYS . 7.1 mm-40 -80.63 -4.48 54.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.025 0.44 . . . . 0.0 111.229 -177.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -97.23 -30.66 12.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -60.57 152.49 26.03 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.062 172.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' B' ' 45' ' ' TYR . 0.1 OUTLIER -103.22 115.79 31.24 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.112 -174.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.507 ' HA ' ' CD1' ' B' ' 75' ' ' ILE . 14.3 m -68.98 -12.48 16.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.246 -167.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.29 -46.05 94.72 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.485 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -69.13 -31.78 70.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.439 0.638 . . . . 0.0 110.271 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.576 ' O ' HG12 ' B' ' 79' ' ' ILE . 3.8 mt -74.64 -45.89 43.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.294 -176.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 22.6 t -54.13 -34.45 60.35 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.533 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -51.89 -57.0 10.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.232 173.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.769 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 11.3 m-20 -65.9 -36.53 83.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.676 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.65 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.4 mm -61.98 -33.07 56.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.38 0.609 . . . . 0.0 111.519 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -74.66 1.77 11.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.553 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.769 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 56.6 pttt -110.44 5.62 21.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.39 . . . . 0.0 110.864 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 32.8 mt -86.75 9.35 19.2 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.149 -174.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 63.7 t30 53.15 57.44 6.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -170.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -45.23 146.12 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.597 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.408 ' HB2' HD22 ' B' ' 59' ' ' ASN . 38.5 mtpt -127.63 -171.77 2.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.387 177.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -157.0 113.61 0.57 Allowed Glycine 0 N--CA 1.45 -0.396 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.482 ' HG2' ' N ' ' B' ' 88' ' ' TYR . 15.9 ttt -156.4 -75.7 0.1 Allowed 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 117.057 0.429 . . . . 0.0 110.967 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . 0.482 ' N ' ' HG2' ' B' ' 87' ' ' MET . 60.8 t80 -122.31 101.81 7.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.677 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 28.3 mm -96.25 126.28 48.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.402 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -109.9 171.92 7.16 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 62.2 mt -149.48 107.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.148 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 47.7 pttt -157.45 179.81 8.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.098 0.475 . . . . 0.0 111.687 -177.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 1.5 pt20 -105.13 145.25 30.82 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.93 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.481 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.1 pt . . . . . 0 C--O 1.247 0.926 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.135 -174.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.465 ' O ' ' HG ' ' B' ' 6' ' ' LEU . 24.4 t-20 -92.38 113.32 25.57 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.19 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -87.5 10.09 18.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.927 -176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.597 ' HB3' ' OD1' ' B' ' 11' ' ' ASN . 11.5 mmtp -98.26 -65.71 0.95 Allowed 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.033 0.444 . . . . 0.0 110.318 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.0 80.47 1.32 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.838 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.485 ' H ' HD12 ' B' ' 6' ' ' LEU . 4.8 mp -74.36 -98.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.074 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -87.98 -76.26 0.39 Allowed 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.692 -175.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -114.25 4.17 15.38 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.018 0.437 . . . . 0.0 111.252 -176.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . 0.546 ' HB3' ' HA2' ' B' ' 33' ' ' GLY . 16.6 pt20 -98.4 155.06 17.42 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.501 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' MET . . . . . 0.514 ' O ' HG12 ' B' ' 13' ' ' ILE . 39.7 tpp -119.12 146.92 44.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.943 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . 0.597 ' OD1' ' HB3' ' B' ' 4' ' ' LYS . 42.2 m-20 -35.39 -41.85 0.19 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 5.4 m -65.52 -19.29 65.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.174 -169.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.514 HG12 ' O ' ' B' ' 10' ' ' MET . 7.7 mm -59.85 -39.59 80.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 122.198 0.999 . . . . 0.0 109.423 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -76.7 -28.01 55.7 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.22 -175.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.64 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 12.1 m -63.11 -41.93 99.45 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.821 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 63.9 t -52.7 -44.07 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.508 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -65.25 -41.56 94.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.477 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.49 -29.15 62.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.634 -178.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' B' ' 15' ' ' SER . 27.4 mmmt -71.16 -20.16 62.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.661 0.743 . . . . 0.0 111.387 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 67.1 mt -108.39 -28.15 9.55 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.416 -175.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -80.43 69.96 7.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.372 0.606 . . . . 0.0 110.104 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -133.45 33.87 3.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.954 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.28 48.85 5.49 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -130.94 -152.37 0.51 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' B' ' 45' ' ' TYR . . . -60.3 125.94 40.06 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 171.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.478 ' CB ' ' HB3' ' B' ' 41' ' ' SER . 29.7 mtpp -80.63 130.71 35.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.598 0.714 . . . . 0.0 111.276 -171.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 21.9 tp -150.26 101.57 3.0 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.11 -173.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 15.4 p -85.8 104.09 15.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.933 -174.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 60.0 mt -88.64 151.34 22.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.593 0.711 . . . . 0.0 111.31 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 71.2 m -140.49 143.9 35.73 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.748 175.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' MET . . . . . 0.469 ' SD ' HG23 ' B' ' 13' ' ' ILE . 5.1 mmt -106.79 120.46 42.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.795 0.331 . . . . 0.0 110.845 -167.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 18.3 t-20 -134.29 58.97 1.75 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.267 0.556 . . . . 0.0 109.513 177.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' B' ' 9' ' ' GLN . . . 50.45 -99.76 0.03 OUTLIER Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.301 -0.863 . . . . 0.0 114.016 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -78.92 4.77 13.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.36 -0.42 . . . . 0.0 111.104 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 37.7 mt-30 -129.98 147.71 51.76 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.673 0.749 . . . . 0.0 110.579 174.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' B' ' 84' ' ' ILE . 1.4 tt -124.11 106.62 10.49 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.354 -1.294 . . . . 0.0 107.615 174.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.434 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 12.2 mmmm -96.92 153.15 18.07 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.505 -170.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -164.93 152.49 11.36 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.774 -171.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.25 171.71 12.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 169.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 16.3 p -131.78 149.95 52.31 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.189 -0.605 . . . . 0.0 111.381 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.478 ' HB3' ' CB ' ' B' ' 26' ' ' LYS . 31.1 t -130.1 155.96 45.33 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.449 0.642 . . . . 0.0 110.791 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -114.61 33.23 5.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.8 -162.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.31 -33.34 67.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.047 0.927 . . . . 0.0 110.181 172.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.33 -121.62 1.03 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 113.923 -1.489 . . . . 0.0 110.37 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.452 ' HB2' ' CG2' ' B' ' 71' ' ' THR . 9.2 p90 -177.92 -166.63 0.12 Allowed 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 120.774 0.321 . . . . 0.0 111.743 -178.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.75 122.76 6.4 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.053 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.04 -61.25 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 CA-C-O 122.36 1.076 . . . . 0.0 109.058 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 2.4 m -57.32 167.67 0.9 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 112.483 -2.144 . . . . 0.0 112.05 -174.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 74.49 10.29 4.2 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.391 -1.731 . . . . 0.0 111.46 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 48.65 -108.95 0.29 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.507 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -130.79 111.66 12.33 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.787 0.803 . . . . 0.0 110.42 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 94.1 mttt -134.07 138.12 45.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.121 176.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -112.47 132.84 54.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.078 0.466 . . . . 0.0 110.665 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.518 ' HA ' HG12 ' B' ' 94' ' ' ILE . 27.6 p-90 -141.88 173.05 11.87 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.016 176.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.65 139.35 10.87 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.567 -173.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.498 HD12 ' CD2' ' B' ' 64' ' ' TYR . 28.3 mt -104.86 151.34 7.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 169.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.715 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 74.9 m-85 -130.45 145.34 51.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -172.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.591 HG12 ' ND2' ' B' ' 59' ' ' ASN . 7.1 p -135.98 140.98 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.591 ' ND2' HG12 ' B' ' 58' ' ' VAL . 8.6 m-80 66.52 3.17 2.76 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -172.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.9 4.11 65.38 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.352 -172.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 3.9 mm-40 -105.84 176.51 5.14 Favored 'General case' 0 C--O 1.202 -1.433 0 C-N-CA 123.618 0.767 . . . . 0.0 109.209 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.51 ' HE3' ' CE1' ' B' ' 57' ' ' PHE . 0.0 OUTLIER -68.26 161.59 26.92 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.493 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.427 ' HB ' HG13 ' B' ' 58' ' ' VAL . 9.6 p -153.79 -12.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.909 0.385 . . . . 0.0 110.698 170.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.791 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.2 OUTLIER -159.52 128.76 5.3 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.207 -173.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 26.5 m -137.72 124.81 21.52 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.546 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' B' ' 66' ' ' PHE . 0.0 OUTLIER -173.47 151.77 2.02 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 122.042 0.925 . . . . 0.0 112.078 -167.404 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 5.4 m120 -97.97 153.04 18.64 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.562 -1.653 . . . . 0.0 110.58 174.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -58.24 -48.06 81.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.806 0.336 . . . . 0.0 111.125 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.58 ' O ' HG21 ' B' ' 71' ' ' THR . 41.4 ttmt -72.59 -16.74 61.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.298 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.6 t -72.31 -15.08 61.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.58 HG21 ' O ' ' B' ' 69' ' ' LYS . 21.4 p 56.17 113.11 0.01 OUTLIER 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.653 1.181 . . . . 0.0 113.756 169.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 5.4 m -62.33 -14.54 12.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.16 -171.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.67 -48.96 63.27 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.404 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 77.0 m-20 -83.81 -36.29 23.62 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.451 0.643 . . . . 0.0 110.578 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.499 HG13 ' O ' ' B' ' 71' ' ' THR . 2.8 mt -64.89 -48.37 84.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.176 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.508 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 14.4 t -66.69 -21.13 66.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.153 -177.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' B' ' 74' ' ' ASN . 0.9 OUTLIER -52.58 -41.32 63.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 171.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.671 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 4.7 m-20 -72.6 -52.77 14.06 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.794 172.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.791 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 51.5 mm -47.42 -38.09 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -59.31 -30.51 68.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.671 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 45.2 pttt -73.86 -20.97 60.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.978 0.418 . . . . 0.0 110.062 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 4.3 mm? -68.66 -18.51 64.29 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.845 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 66.0 t30 39.77 69.07 0.33 Allowed 'General case' 0 C--O 1.235 0.321 0 O-C-N 124.154 0.909 . . . . 0.0 110.21 -171.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.474 HD13 ' H ' ' B' ' 84' ' ' ILE . 3.9 mp -50.23 143.91 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.614 -174.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -98.1 -178.19 3.98 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.841 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -136.75 113.68 1.07 Allowed Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.315 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.456 ' SD ' ' HA ' ' B' ' 59' ' ' ASN . 1.7 pmm? -170.21 -58.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.406 0.282 . . . . 0.0 110.907 171.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . 0.415 ' N ' ' HG2' ' B' ' 87' ' ' MET . 14.2 t80 -130.27 81.25 2.0 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.38 0.536 . . . . 0.0 109.85 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.715 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.3 mp -99.41 120.5 48.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.731 178.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -106.35 176.44 5.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.372 0.606 . . . . 0.0 110.442 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.404 HG22 ' CZ3' ' B' ' 54' ' ' TRP . 30.4 mm -151.87 116.3 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.569 -174.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 40.6 pttt -168.05 159.48 11.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.094 0.473 . . . . 0.0 111.943 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.569 ' H ' ' NE2' ' B' ' 93' ' ' GLN . 0.7 OUTLIER -83.27 152.31 25.22 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.014 172.297 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.518 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.4 pt . . . . . 0 C--N 1.311 -1.066 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.179 -171.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 121.276 0.56 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -85.39 98.67 10.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.112 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . 0.403 ' HA ' ' HG ' ' B' ' 6' ' ' LEU . 0.5 OUTLIER -66.8 -26.44 66.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.339 -175.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -76.2 -19.16 58.66 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.016 0.436 . . . . 0.0 110.607 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.2 17.14 23.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.531 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.403 ' HG ' ' HA ' ' B' ' 3' ' ' GLN . 78.4 mt -64.17 -8.32 11.96 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -56.52 -55.14 37.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.984 174.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -94.99 -27.69 15.52 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.404 0.621 . . . . 0.0 110.881 176.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -80.37 67.4 6.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.827 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -68.61 142.63 55.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.497 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -41.58 -40.48 1.89 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.536 ' O ' HG21 ' B' ' 16' ' ' VAL . 31.8 m -74.02 -20.95 60.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.212 -172.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.464 HG21 ' SD ' ' B' ' 31' ' ' MET . 10.7 mm -58.85 -44.31 90.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 121.933 0.873 . . . . 0.0 109.284 175.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.9 -36.07 72.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.051 -176.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 19.4 t -63.81 -44.9 91.92 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.098 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.536 HG21 ' O ' ' B' ' 12' ' ' SER . 70.3 t -57.29 -47.62 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.802 0.334 . . . . 0.0 110.457 176.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . 0.405 ' ND2' ' HB2' ' B' ' 29' ' ' LEU . 2.4 t-20 -54.21 -50.56 66.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.864 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.09 -38.74 72.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.215 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -60.17 -52.13 66.65 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.514 0.673 . . . . 0.0 111.496 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 77.3 mt -75.5 -12.75 60.3 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.026 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -118.32 79.48 1.38 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.204 0.526 . . . . 0.0 111.253 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.483 ' HD3' ' OH ' ' B' ' 49' ' ' TYR . 30.1 mtpp -134.76 30.46 3.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.141 0.496 . . . . 0.0 110.667 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.17 45.18 1.91 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.1 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.528 ' HD2' ' OG ' ' B' ' 48' ' ' SER . 12.7 mmtp -90.4 -145.55 0.18 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' B' ' 45' ' ' TYR . . . -74.96 -146.24 1.28 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.74 173.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.494 ' HE3' ' HB3' ' B' ' 41' ' ' SER . 2.6 mtmp? -90.35 110.69 21.76 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -177.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.5 tp -158.75 134.33 8.72 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 74.0 p -131.24 98.77 4.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.041 0.448 . . . . 0.0 111.195 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.405 ' HB2' ' ND2' ' B' ' 17' ' ' ASN . 31.6 mt -83.47 151.39 25.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.416 0.627 . . . . 0.0 111.043 -177.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 54.3 m -148.43 144.69 27.6 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.624 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' MET . . . . . 0.464 ' SD ' HG21 ' B' ' 13' ' ' ILE . 57.8 mtm -109.0 130.45 55.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.92 0.391 . . . . 0.0 111.094 -173.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -137.97 60.12 1.63 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.362 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 51.96 -96.95 0.02 OUTLIER Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.232 -0.894 . . . . 0.0 113.433 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -78.92 -0.58 31.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.726 0.298 . . . . 0.0 111.415 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -125.32 148.9 48.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.805 0.812 . . . . 0.0 111.441 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -128.7 106.84 9.21 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.383 -1.28 . . . . 0.0 107.612 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -107.38 149.21 28.13 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.521 -170.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -170.23 151.61 3.92 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.067 0.229 . . . . 0.0 111.461 -177.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 3.3 p -120.9 138.18 54.23 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 168.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.6 ' CB ' ' HA3' ' B' ' 73' ' ' GLY . 29.6 t -148.26 154.54 40.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.272 0.558 . . . . 0.0 111.431 -170.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.494 ' HB3' ' HE3' ' B' ' 26' ' ' LYS . 47.5 t -144.0 155.51 44.05 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.086 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -90.32 -6.3 55.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.845 -169.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.1 -20.47 65.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.222 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.429 ' O ' ' HA2' ' B' ' 25' ' ' GLY . . . -106.27 -4.21 38.12 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.471 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.642 ' O ' ' HA3' ' B' ' 25' ' ' GLY . 0.0 OUTLIER 78.48 -168.83 0.05 OUTLIER 'General case' 0 C--N 1.342 0.248 0 C-N-CA 123.65 0.78 . . . . 0.0 112.506 179.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.47 46.56 0.83 Allowed Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 167.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -44.73 -69.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.252 0.621 . . . . 0.0 110.567 -174.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.528 ' OG ' ' HD2' ' B' ' 24' ' ' LYS . 9.5 m 60.95 -88.58 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.666 172.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.483 ' OH ' ' HD3' ' B' ' 22' ' ' LYS . 59.3 m-85 -140.56 69.42 1.35 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -173.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 51.95 -94.82 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.369 -176.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -156.28 109.82 2.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.522 -0.763 . . . . 0.0 108.942 171.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 59.3 mttm -141.43 142.9 33.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.072 -175.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.521 HD21 HG13 ' B' ' 94' ' ' ILE . 1.0 OUTLIER -114.27 124.32 51.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.307 0.575 . . . . 0.0 111.856 -176.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.611 ' CZ3' HG22 ' B' ' 91' ' ' ILE . 17.0 p-90 -133.88 171.68 13.84 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.948 174.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.5 143.04 14.35 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.585 -175.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.626 HD11 ' CD2' ' B' ' 64' ' ' TYR . 22.3 mt -108.49 143.33 19.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 173.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.639 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 46.8 m-85 -125.58 143.06 51.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.65 -174.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.574 HG11 ' ND2' ' B' ' 59' ' ' ASN . 9.6 p -128.79 143.41 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.574 ' ND2' HG11 ' B' ' 58' ' ' VAL . 2.0 m-80 59.07 14.4 3.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -171.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.35 -1.56 82.33 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.628 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' B' ' 58' ' ' VAL . 13.5 mt-10 -105.12 160.03 15.38 Favored 'General case' 0 C--O 1.192 -1.973 0 C-N-CA 123.887 0.875 . . . . 0.0 109.268 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.623 ' HA ' ' CD2' ' B' ' 57' ' ' PHE . 1.2 tttm -61.89 164.08 6.86 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 118.233 0.469 . . . . 0.0 110.766 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.53 0.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.17 164.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.682 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -157.67 131.96 8.29 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.209 -0.597 . . . . 0.0 111.101 -173.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 29.6 m -142.85 119.0 10.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.208 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.478 ' CD1' ' CD1' ' B' ' 64' ' ' TYR . 25.4 p90 -171.29 156.41 4.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.058 0.933 . . . . 0.0 112.646 -172.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.542 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 8.2 m120 -100.76 150.78 22.43 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.214 167.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' B' ' 48' ' ' SER . 36.3 mm-40 -58.73 -40.15 82.93 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.153 0.501 . . . . 0.0 110.92 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -65.01 -17.64 64.61 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.63 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 4.9 t -78.74 -0.59 30.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.603 178.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.439 ' O ' HG13 ' B' ' 75' ' ' ILE . 32.5 p 56.69 97.57 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.721 1.208 . . . . 0.0 112.093 176.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.449 ' HA ' ' CD1' ' B' ' 75' ' ' ILE . 2.5 m -57.96 -22.42 18.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.716 -170.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . 0.6 ' HA3' ' CB ' ' B' ' 40' ' ' SER . . . -62.03 -47.94 86.63 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.477 -178.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 77.2 m-20 -66.8 -37.73 85.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.451 0.643 . . . . 0.0 109.825 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.449 ' CD1' ' HA ' ' B' ' 72' ' ' VAL . 3.0 mt -67.06 -42.42 88.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.131 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 30.8 t -51.02 -39.93 56.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.54 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' B' ' 74' ' ' ASN . 0.7 OUTLIER -56.77 -40.67 76.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.887 176.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.77 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 24.0 m-20 -75.47 -40.67 57.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.124 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.682 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.9 mm -63.32 -32.14 55.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.325 0.583 . . . . 0.0 111.261 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.22 -11.03 56.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.593 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.77 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 20.4 pttp -95.93 3.12 53.82 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.543 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' B' ' 79' ' ' ILE . 24.2 mt -85.94 2.72 45.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.173 -176.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 52.66 62.21 2.8 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -169.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 62.1 mt -53.57 151.3 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.18 -174.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -125.08 176.19 6.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.403 176.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -139.36 112.75 0.86 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 173.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.428 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 8.2 tpt -153.7 -82.58 0.08 Allowed 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 117.024 0.412 . . . . 0.0 110.365 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . 0.428 ' N ' ' HG3' ' B' ' 87' ' ' MET . 23.2 t80 -109.08 94.68 5.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.639 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 34.0 mm -98.94 122.63 50.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.037 -173.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.558 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 54.1 mm-40 -116.54 148.21 41.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.428 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.611 HG22 ' CZ3' ' B' ' 54' ' ' TRP . 77.9 mt -127.89 127.74 68.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.592 176.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.51 ' HE3' ' CE1' ' B' ' 57' ' ' PHE . 14.3 pttp -174.53 152.46 1.69 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.03 0.443 . . . . 0.0 111.476 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.483 ' H ' ' NE2' ' B' ' 93' ' ' GLN . 0.5 OUTLIER -80.09 144.44 33.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.234 -179.47 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.521 HG13 HD21 ' B' ' 53' ' ' ASN . 4.4 pt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.197 -174.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 47.7 t30 70.39 -58.97 0.53 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.525 0.73 . . . . 0.0 111.755 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -72.85 -2.92 22.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.813 0.34 . . . . 0.0 111.712 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -84.95 -36.63 21.26 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.07 0.462 . . . . 0.0 109.781 177.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.93 60.37 4.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.414 -177.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 92.8 mt -96.68 21.06 9.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.379 177.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' B' ' 10' ' ' MET . 29.9 mt-10 -65.24 -56.65 11.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.968 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -80.4 -1.77 42.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.219 0.533 . . . . 0.0 111.213 -178.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -128.86 57.84 1.61 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.705 177.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 10' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' B' ' 7' ' ' GLU . 85.1 mmm -59.26 139.26 57.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.182 -175.287 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -46.12 -10.81 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.046 1.738 . . . . 0.0 114.956 -178.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -56.58 -15.49 4.47 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 122.842 0.457 . . . . 0.0 111.596 177.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -50.68 -59.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 121.411 0.624 . . . . 0.0 111.27 -176.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -106.44 -49.11 3.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.015 -176.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 5.9 m -55.93 -53.45 56.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.825 -173.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 80.2 t -72.8 -33.11 42.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.918 -177.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . 0.469 ' HA ' HD12 ' B' ' 29' ' ' LEU . 0.2 OUTLIER -59.79 -42.82 94.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.953 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.14 -37.88 61.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.056 178.406 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.1 OUTLIER -61.36 -40.83 95.74 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 122.9 0.48 . . . . 0.0 111.606 -179.717 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -80.03 -31.7 39.55 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.845 178.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -96.47 53.19 1.28 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.356 0.598 . . . . 0.0 110.44 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' B' ' 19' ' ' LYS . 30.6 mtpp -89.91 -51.95 5.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.139 0.495 . . . . 0.0 110.358 177.197 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.42 68.14 0.22 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 -178.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -124.28 -156.82 0.74 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.467 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -72.56 -171.08 17.68 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 175.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.706 ' O ' ' HA ' ' B' ' 40' ' ' SER . 0.0 OUTLIER -72.97 88.74 1.39 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 117.702 0.751 . . . . 0.0 109.345 176.236 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' B' ' 39' ' ' THR . 15.9 tp -105.94 127.4 53.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.035 -172.091 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 63.4 m -125.89 114.67 18.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.048 178.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' B' ' 17' ' ' ASN . 24.7 mt -89.26 156.18 18.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.439 0.638 . . . . 0.0 110.776 178.119 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 63.7 m -145.33 153.74 41.58 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.691 172.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 80.8 mtp -120.79 141.29 50.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.195 0.522 . . . . 0.0 111.857 -176.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -145.12 113.15 6.45 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.56 -104.55 1.09 Allowed Glycine 0 CA--C 1.507 -0.419 0 C-N-CA 119.465 -1.35 . . . . 0.0 109.769 -169.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -132.86 25.0 4.32 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.558 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 22.5 mt-30 -80.01 156.71 27.03 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.227 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tt -110.31 110.31 21.08 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.977 -1.011 . . . . 0.0 108.514 173.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.54 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 22.4 mmmt -106.22 148.36 28.01 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.393 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -161.64 146.04 12.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.306 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 10.4 p -129.22 144.29 51.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.146 172.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.706 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 46.8 m -154.84 152.85 30.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.404 0.621 . . . . 0.0 112.292 -177.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.609 ' HB2' ' CD ' ' B' ' 26' ' ' LYS . 1.3 m -118.89 152.2 36.72 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 167.306 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . 0.485 ' HA ' ' HB3' ' B' ' 45' ' ' TYR . 15.0 m120 -112.56 35.16 3.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.134 0.493 . . . . 0.0 111.821 -165.353 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.81 -61.37 1.8 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.801 0.81 . . . . 0.0 110.414 173.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.96 62.23 0.43 Allowed Glycine 0 C--N 1.311 -0.812 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 174.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.485 ' HB3' ' HA ' ' B' ' 42' ' ' ASN . 41.6 p90 -71.54 -149.68 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -173.112 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.23 92.16 1.37 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.563 -177.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.32 -57.2 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.029 0.442 . . . . 0.0 110.28 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -39.37 -58.72 1.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.318 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -91.3 101.3 14.0 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.081 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -76.7 -82.08 0.08 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.351 -176.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -110.99 108.75 18.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.876 0.846 . . . . 0.0 112.068 -176.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 55.4 mttm -141.23 121.59 14.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 165.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -110.12 121.3 44.93 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.61 0.719 . . . . 0.0 111.556 -174.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.541 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 28.7 p-90 -141.68 162.06 36.4 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.492 175.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.15 147.14 16.82 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.864 -173.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.579 HD13 ' CD2' ' B' ' 64' ' ' TYR . 29.0 mt -107.08 148.31 11.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 170.157 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.726 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 75.7 m-85 -127.61 144.46 51.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.263 -171.255 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.58 HG13 ' ND2' ' B' ' 59' ' ' ASN . 7.9 p -131.41 135.37 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.58 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.0 m-80 61.85 10.13 3.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.016 -176.061 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.87 -2.43 55.57 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 -177.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 7.7 mt-10 -107.43 176.93 4.99 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.4 tppp? -63.27 161.22 14.21 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 173.076 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.474 ' N ' ' HG3' ' B' ' 62' ' ' LYS . 9.8 p -153.17 -13.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.946 0.403 . . . . 0.0 110.376 168.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.685 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.2 OUTLIER -160.07 128.71 4.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.016 0.436 . . . . 0.0 110.536 -172.66 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 55.0 m -139.74 123.99 17.93 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.391 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.448 ' CD1' ' CD1' ' B' ' 64' ' ' TYR . 19.9 p90 -171.46 157.49 4.88 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 122.012 0.91 . . . . 0.0 112.023 -172.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 11.4 m120 -105.4 162.46 13.43 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 113.474 -1.694 . . . . 0.0 110.193 172.226 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -61.38 -48.11 82.73 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -174.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.583 ' O ' HG23 ' B' ' 71' ' ' THR . 41.7 ttmt -61.88 -24.52 66.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.951 0.405 . . . . 0.0 112.036 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 11.5 t -67.09 -20.46 65.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.285 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.583 HG23 ' O ' ' B' ' 69' ' ' LYS . 9.9 p 60.56 111.72 0.02 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.633 1.173 . . . . 0.0 112.113 175.231 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.434 HG11 ' CE2' ' B' ' 66' ' ' PHE . 1.7 m -61.18 -28.42 43.74 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.961 -167.252 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.11 -49.08 57.29 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.179 -176.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 58.1 m-80 -67.72 -42.79 81.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.622 0.725 . . . . 0.0 110.221 179.037 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.52 ' HB ' ' HH ' ' B' ' 64' ' ' TYR . 1.8 mt -64.21 -41.75 93.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.601 -176.099 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.456 ' N ' ' HH ' ' B' ' 64' ' ' TYR . 74.5 m -53.69 -36.01 61.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.344 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' B' ' 74' ' ' ASN . 39.0 m-20 -57.69 -38.01 74.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.989 0.423 . . . . 0.0 111.066 177.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.567 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 13.9 m-20 -73.83 -51.3 16.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.741 174.572 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.685 HG13 ' CE1' ' B' ' 64' ' ' TYR . 44.5 mm -56.08 -35.52 41.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.469 -178.373 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -11.28 59.68 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 15.5 ptmt -92.19 4.58 52.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.373 0.606 . . . . 0.0 110.135 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -81.47 -1.51 46.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.411 -175.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 52.07 47.28 25.08 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.702 0.763 . . . . 0.0 109.66 -173.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.558 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 94.2 mt -55.12 127.69 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.682 -1.144 . . . . 0.0 113.233 -171.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -92.1 -164.35 1.17 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.582 178.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -151.16 119.69 1.02 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.13 -178.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 22.8 ptm -176.76 -56.73 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.616 0.208 . . . . 0.0 111.472 177.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -128.1 80.58 1.97 Allowed 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.816 -0.552 . . . . 0.0 110.013 177.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.726 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.3 mp -98.53 128.86 49.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.37 175.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -114.66 171.37 7.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.082 0.467 . . . . 0.0 110.058 175.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.541 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 38.9 mm -142.15 109.55 2.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.594 -178.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -168.27 151.87 5.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.426 0.632 . . . . 0.0 112.344 -174.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 2.0 pp0? -61.95 148.21 44.44 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.637 172.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.518 HG12 ' HA ' ' B' ' 54' ' ' TRP . 2.0 pt . . . . . 0 C--N 1.311 -1.075 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.028 -176.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 34.7 t70 . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 121.252 0.548 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -147.19 158.11 43.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.205 0.526 . . . . 0.0 110.488 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -66.55 -22.33 66.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.542 -172.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' B' ' 7' ' ' GLU . 28.2 tptp -68.72 -27.69 66.17 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 120.902 0.382 . . . . 0.0 111.225 -177.498 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.22 2.24 56.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.253 0.549 . . . . 0.0 110.288 178.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt -117.96 23.28 11.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.043 -178.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' B' ' 4' ' ' LYS . 32.7 mt-10 -61.28 -52.44 64.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.862 178.368 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -87.61 -21.06 25.56 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.238 0.542 . . . . 0.0 111.508 -179.418 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -105.17 93.26 4.59 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.569 177.111 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 10' ' ' MET . . . . . 0.468 ' HG3' HD22 ' B' ' 34' ' ' ASN . 85.8 mmm -62.41 129.67 41.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.46 0.648 . . . . 0.0 111.94 -174.074 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -77.02 -15.77 59.52 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.254 175.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 11.6 m -65.94 -10.28 37.55 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.35 -176.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.415 HG12 ' O ' ' B' ' 10' ' ' MET . 27.9 mm -58.48 -59.81 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.508 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -106.74 -36.36 6.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.644 -175.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.588 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 22.5 t -56.98 -41.83 79.1 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.907 -171.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.57 -38.95 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.85 0.357 . . . . 0.0 111.089 -176.251 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . 0.434 ' ND2' HD12 ' B' ' 29' ' ' LEU . 34.0 t-20 -59.13 -55.14 38.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.102 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.12 -40.11 82.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.516 -178.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' B' ' 15' ' ' SER . 8.5 tmtm? -49.21 -67.33 0.27 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.652 0.781 . . . . 0.0 111.71 177.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.596 ' C ' ' H ' ' B' ' 22' ' ' LYS . 16.2 mt -51.88 -67.01 0.29 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.729 175.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . 0.451 ' OD1' ' HE2' ' B' ' 49' ' ' TYR . 2.8 t-20 65.25 -19.4 0.09 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.935 0.894 . . . . 0.0 110.609 -168.301 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.596 ' H ' ' C ' ' B' ' 20' ' ' LEU . 31.0 mtpp 83.37 -34.62 0.07 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 159.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.663 ' HA2' ' CE1' ' B' ' 49' ' ' TYR . . . 95.93 79.72 1.48 Allowed Glycine 0 C--O 1.208 -1.521 0 C-N-CA 119.074 -1.536 . . . . 0.0 110.078 -166.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 64.62 -59.75 0.22 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 173.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' B' ' 23' ' ' GLY . . . -33.05 108.27 0.03 OUTLIER Glycine 0 CA--C 1.52 0.354 0 O-C-N 124.071 0.857 . . . . 0.0 113.892 179.08 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.466 ' HE3' ' HB2' ' B' ' 41' ' ' SER . 0.1 OUTLIER -77.84 153.18 32.97 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.825 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.416 HD23 ' CD ' ' B' ' 22' ' ' LYS . 1.3 pt? -163.45 170.28 17.61 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 118.291 0.496 . . . . 0.0 111.5 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 20.7 m -127.87 114.0 16.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.694 178.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.434 HD12 ' ND2' ' B' ' 17' ' ' ASN . 9.7 mp -83.87 158.63 21.57 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 122.038 0.923 . . . . 0.0 112.408 -179.003 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.9 p -150.4 154.8 38.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.409 178.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 29.7 mtt -122.82 138.55 54.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.654 0.264 . . . . 0.0 111.628 -168.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -152.09 108.09 3.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.458 177.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.45 -92.87 0.52 Allowed Glycine 0 CA--C 1.505 -0.534 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -176.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.47 ' HB2' ' CA ' ' B' ' 86' ' ' GLY . 0.4 OUTLIER -135.7 8.09 3.29 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.574 0.702 . . . . 0.0 109.311 171.585 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.531 ' OE1' ' HA ' ' B' ' 83' ' ' ASN . 49.6 mt-30 -77.94 149.82 34.11 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.23 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.8 tp -125.84 93.28 3.79 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.206 177.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -96.52 150.61 20.44 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.695 -171.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -165.52 158.34 15.66 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.249 -0.58 . . . . 0.0 112.219 -174.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 14.3 p -124.84 137.62 54.29 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 18.2 t -121.16 154.68 35.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.078 0.466 . . . . 0.0 111.484 -170.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.466 ' HB2' ' HE3' ' B' ' 26' ' ' LYS . 14.9 m -121.92 158.53 28.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.606 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -82.59 54.24 2.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.623 -172.223 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.75 22.44 0.6 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.973 177.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.442 ' O ' HD12 ' B' ' 47' ' ' ILE . . . 132.56 -47.73 1.0 Allowed Glycine 0 C--O 1.222 -0.615 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.992 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.457 ' O ' HG12 ' B' ' 47' ' ' ILE . 1.2 p90 59.15 177.38 0.08 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.455 1.102 . . . . 0.0 113.224 177.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.414 ' C ' HD13 ' B' ' 47' ' ' ILE . . . -47.64 92.03 0.01 OUTLIER Glycine 0 C--N 1.336 0.533 0 N-CA-C 114.864 0.706 . . . . 0.0 114.864 -176.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.457 HG12 ' O ' ' B' ' 45' ' ' TYR . 6.5 mm -109.8 -71.8 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.575 0.702 . . . . 0.0 110.625 175.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.2 p -97.45 -126.9 0.15 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.543 -178.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.663 ' CE1' ' HA2' ' B' ' 23' ' ' GLY . 7.1 m-85 63.91 20.29 12.14 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.206 0.526 . . . . 0.0 110.32 178.074 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 52.7 -161.17 0.11 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.621 -176.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -109.21 108.94 19.75 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.748 0.785 . . . . 0.0 109.435 173.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.5 ' HE3' ' O ' ' B' ' 49' ' ' TYR . 43.8 mttt -105.13 120.79 42.39 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -115.15 113.93 24.61 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.554 ' HA ' HG12 ' B' ' 94' ' ' ILE . 36.1 p-90 -148.04 164.93 32.32 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.3 -176.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -126.55 152.75 18.5 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.835 -176.019 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.424 ' O ' HG12 ' B' ' 63' ' ' VAL . 10.3 mt -102.18 146.81 9.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 169.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.686 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 83.0 m-85 -125.94 143.75 50.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.482 -172.011 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.543 HG13 ' ND2' ' B' ' 59' ' ' ASN . 10.3 p -130.7 135.24 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.543 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.7 m-80 65.74 4.62 2.97 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.72 -176.179 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.03 -0.17 51.44 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.019 -176.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -108.47 176.06 5.25 Favored 'General case' 0 C--O 1.203 -1.355 0 C-N-CA 123.346 0.658 . . . . 0.0 109.46 -179.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.5 tppp? -62.44 161.2 12.13 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 173.121 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.504 ' N ' ' HG3' ' B' ' 62' ' ' LYS . 9.3 p -146.58 -22.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 166.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.49 ' HH ' HG22 ' B' ' 75' ' ' ILE . 0.8 OUTLIER -162.21 142.5 10.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.475 -175.457 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.434 HG23 ' CD1' ' B' ' 94' ' ' ILE . 28.1 m -136.07 127.25 28.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.775 179.325 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.606 ' CD2' HG21 ' B' ' 75' ' ' ILE . 21.5 p90 -163.04 -166.95 1.37 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.07 0.462 . . . . 0.0 111.032 -177.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.736 ' O ' ' HB3' ' B' ' 70' ' ' SER . 22.9 t-20 -153.95 158.52 40.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.816 -173.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . 0.451 ' CD ' ' HD2' ' B' ' 52' ' ' LYS . 8.0 mm-40 -60.28 -56.62 19.24 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.385 0.612 . . . . 0.0 111.234 -178.328 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.578 ' C ' ' H ' ' B' ' 71' ' ' THR . 37.2 ttpt -65.8 -11.69 48.13 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.687 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 70' ' ' SER . . . . . 0.736 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 9.7 t -67.22 2.22 1.72 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.227 1.013 . . . . 0.0 109.283 170.253 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.578 ' H ' ' C ' ' B' ' 69' ' ' LYS . 37.6 p 59.61 80.28 0.2 Allowed 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.02 -1.9 . . . . 0.0 110.56 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.781 ' HA ' ' CG1' ' B' ' 75' ' ' ILE . 17.9 m -68.24 -4.67 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.772 -170.202 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.43 -37.18 94.22 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 119.806 -1.188 . . . . 0.0 110.201 174.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 42.7 m-20 -80.28 -36.21 34.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.219 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.781 ' CG1' ' HA ' ' B' ' 72' ' ' VAL . 24.2 mm -51.64 -54.27 13.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.458 176.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 58.8 m -55.55 -37.44 67.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.124 177.512 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . 0.448 ' HA ' ' ND2' ' B' ' 80' ' ' ASN . 49.0 m-20 -64.76 -38.67 91.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.205 0.526 . . . . 0.0 111.044 177.342 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.693 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 5.9 m-20 -65.78 -40.58 92.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.899 176.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.522 HG13 ' O ' ' B' ' 75' ' ' ILE . 63.8 mt -57.68 -30.75 37.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.121 0.486 . . . . 0.0 110.869 178.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.448 ' ND2' ' HA ' ' B' ' 77' ' ' ASN . 82.0 m-20 -62.02 -22.48 65.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.46 176.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.693 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 12.1 ptmm? -105.44 -11.47 16.41 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -175.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.24 -23.87 67.46 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.801 0.334 . . . . 0.0 110.863 -175.136 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . 0.531 ' HA ' ' OE1' ' B' ' 35' ' ' GLN . 23.6 t-20 45.75 62.79 2.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.059 -170.334 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.443 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 72.7 mt -64.5 142.66 16.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.125 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -86.64 178.37 7.07 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.822 178.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.47 ' CA ' ' HB2' ' B' ' 34' ' ' ASN . . . -135.02 114.44 1.25 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 119.73 -1.224 . . . . 0.0 113.318 -175.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.467 ' HG3' ' HA ' ' B' ' 59' ' ' ASN . 22.8 ptp -175.07 -55.2 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.49 0.316 . . . . 0.0 110.795 177.001 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -139.6 80.7 1.79 Allowed 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.557 -0.714 . . . . 0.0 110.123 174.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.686 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.0 mp -94.63 126.67 47.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.061 174.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -109.32 175.63 5.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.26 0.552 . . . . 0.0 110.433 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 mt -147.75 102.0 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.676 -177.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 45.1 pttt -164.42 165.77 21.21 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.266 -173.48 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.4 OUTLIER -73.84 159.49 32.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.781 178.998 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.554 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.0 pt . . . . . 0 C--N 1.31 -1.124 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.714 -177.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -70.49 -24.54 62.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.863 178.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -70.86 -11.93 61.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.301 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.474 ' O ' ' HD3' ' B' ' 4' ' ' LYS . 6.5 tmtm? -73.22 -27.16 61.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.36 91.61 6.84 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.534 178.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.47 -5.15 43.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.105 -178.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -72.85 -43.08 63.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.493 174.491 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -81.76 -55.02 4.9 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.815 0.817 . . . . 0.0 110.222 175.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -88.69 75.31 8.25 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.577 178.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 10' ' ' MET . . . . . 0.454 ' SD ' ' HA ' ' B' ' 88' ' ' TYR . 80.6 mtp -74.01 179.68 4.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.219 -178.15 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -64.16 -32.03 73.45 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.128 0.49 . . . . 0.0 110.53 176.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.538 ' O ' HG21 ' B' ' 16' ' ' VAL . 13.3 m -68.81 -20.89 64.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.847 -171.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 mm -51.22 -52.4 19.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 121.901 0.857 . . . . 0.0 110.672 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -75.75 -33.76 60.24 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.5 -175.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -64.59 -41.08 96.48 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.878 179.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.538 HG21 ' O ' ' B' ' 12' ' ' SER . 94.4 t -61.49 -45.22 99.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.963 0.411 . . . . 0.0 110.163 178.142 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -42.14 99.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.524 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -33.9 68.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.866 0.365 . . . . 0.0 111.359 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -68.17 -48.79 64.34 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 123.348 0.659 . . . . 0.0 111.952 -178.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 63.6 mt -77.81 -7.95 57.34 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.383 -176.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . 0.453 ' CG ' ' H ' ' B' ' 22' ' ' LYS . 61.2 t30 -99.73 -161.87 0.9 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.217 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.453 ' H ' ' CG ' ' B' ' 21' ' ' ASN . 53.4 mtpt 52.2 37.03 20.79 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.749 -175.014 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -134.17 41.28 1.48 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.55 -174.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 71.2 -67.05 0.27 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.04 0.536 . . . . 0.0 111.843 174.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' B' ' 45' ' ' TYR . . . -55.92 121.66 24.27 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 174.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' B' ' 40' ' ' SER . 43.2 mttm -61.5 135.41 57.66 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.194 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' B' ' 39' ' ' THR . 22.2 tp -158.94 110.93 2.17 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 121.175 0.512 . . . . 0.0 110.499 -176.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 55.2 m -116.32 114.08 23.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.772 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 9.2 mp -95.55 163.42 13.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.85 0.833 . . . . 0.0 111.701 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.406 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 1.4 p -157.81 147.38 19.98 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.104 171.133 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 66.0 mtp -130.02 117.06 19.46 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.512 0.673 . . . . 0.0 110.943 -177.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -98.83 61.57 1.3 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.316 -178.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.41 -88.61 0.13 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.471 -178.071 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' B' ' 84' ' ' ILE . 2.9 m-20 -94.0 16.48 14.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.786 0.327 . . . . 0.0 111.008 -177.397 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -132.12 151.24 51.89 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.261 0.553 . . . . 0.0 111.501 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tt -124.75 112.68 17.01 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.681 176.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.498 ' HB3' ' HZ2' ' B' ' 37' ' ' LYS . 1.5 mtpm? -112.31 149.11 32.86 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -176.24 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -167.73 142.05 3.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.924 0.392 . . . . 0.0 111.759 -178.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 1.7 p -119.55 142.2 48.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.354 173.377 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 3.5 p -140.86 156.14 46.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.235 0.541 . . . . 0.0 112.39 -172.174 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 15.7 m -141.27 158.69 43.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.06 176.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' B' ' 44' ' ' GLY . 51.4 m-80 -95.25 46.47 1.11 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.531 0.681 . . . . 0.0 110.768 -167.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.61 23.85 0.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.759 -1.11 . . . . 0.0 112.533 178.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' B' ' 42' ' ' ASN . . . 133.31 -41.01 1.53 Allowed Glycine 0 CA--C 1.51 -0.252 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.573 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.502 ' HA ' ' HA3' ' B' ' 25' ' ' GLY . 21.8 p90 51.26 -165.31 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.92 1.288 . . . . 0.0 114.138 173.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' B' ' 68' ' ' GLU . . . -75.95 110.43 3.04 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.867 -175.179 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.65 -69.19 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-O 121.243 0.544 . . . . 0.0 111.233 177.315 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 66.9 m -119.78 -75.26 0.59 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.81 -170.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.455 ' O ' ' HE3' ' B' ' 52' ' ' LYS . 0.1 OUTLIER -68.17 -22.27 64.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.522 0.677 . . . . 0.0 109.875 -176.899 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' B' ' 50' ' ' GLU . 22.1 mp0 -73.25 -62.6 1.42 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.996 174.171 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.423 ' HA ' ' HB2' ' B' ' 68' ' ' GLU . 6.9 t70 -44.92 108.23 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.242 -1.799 . . . . 0.0 112.497 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 98.7 mttt -150.12 161.15 42.93 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.047 176.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -109.45 119.64 40.05 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.452 0.644 . . . . 0.0 111.277 -178.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.545 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 6.4 p-90 -154.62 171.62 19.18 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.647 176.43 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.5 141.58 12.82 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.666 -178.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.651 HD12 ' CD2' ' B' ' 64' ' ' TYR . 17.7 mt -104.72 147.64 10.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 172.286 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.741 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 71.7 m-85 -127.05 143.62 51.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 -171.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.528 HG13 ' ND2' ' B' ' 59' ' ' ASN . 8.9 p -129.94 134.73 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.528 ' ND2' HG13 ' B' ' 58' ' ' VAL . 2.0 m-80 63.06 10.27 4.37 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.034 0.534 . . . . 0.0 109.885 -174.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.3 -1.7 64.79 Favored Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.099 -174.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -102.8 176.89 5.01 Favored 'General case' 0 C--O 1.207 -1.144 0 C-N-CA 123.558 0.743 . . . . 0.0 109.042 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 4.9 tppp? -66.69 161.24 23.86 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.395 0.543 . . . . 0.0 109.537 174.05 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.433 ' HB ' ' CG1' ' B' ' 58' ' ' VAL . 8.7 p -153.87 -13.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.196 0.522 . . . . 0.0 110.284 166.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.761 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -160.87 140.12 10.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.247 -171.128 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 96.1 m -157.33 121.23 4.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.522 ' CB ' HD13 ' B' ' 75' ' ' ILE . 15.6 p90 -174.9 161.27 2.98 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.938 0.875 . . . . 0.0 111.855 -168.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.693 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 2.2 m120 -109.09 138.2 45.81 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.184 -1.826 . . . . 0.0 108.215 166.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . 0.437 ' O ' ' HA3' ' B' ' 46' ' ' GLY . 20.2 mp0 -61.91 -12.81 19.8 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.627 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -69.12 -29.79 67.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.394 0.616 . . . . 0.0 109.863 172.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 39.1 t -70.58 -16.46 62.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.822 173.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 71' ' ' THR . . . . . . . . . . . . . 13.5 p 61.74 116.03 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.216 1.407 . . . . 0.0 112.095 178.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.486 ' HA ' ' CD1' ' B' ' 75' ' ' ILE . 3.0 m -59.85 -24.92 30.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.628 -169.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.93 -46.08 69.61 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.738 -178.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -72.66 -34.35 67.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.313 0.578 . . . . 0.0 110.436 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.522 HD13 ' CB ' ' B' ' 66' ' ' PHE . 1.7 mt -72.24 -45.85 59.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.968 -176.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 48.3 m -54.37 -33.08 58.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.53 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -53.13 -53.65 47.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.066 174.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' B' ' 81' ' ' LYS . 10.9 m-20 -69.57 -44.34 71.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.747 -179.407 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.761 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.2 mm -57.96 -32.19 42.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.348 0.594 . . . . 0.0 112.024 -178.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -65.15 -17.23 64.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.047 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' B' ' 78' ' ' ASP . 13.2 tppt? -91.63 -5.32 54.07 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.769 0.795 . . . . 0.0 109.917 -176.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 3.2 mm? -72.69 -12.59 61.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.354 -176.21 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 55.92 71.27 0.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.964 -168.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.457 ' O ' ' HB3' ' B' ' 34' ' ' ASN . 59.6 mt -64.52 157.8 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.437 -175.397 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -121.18 -175.51 3.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.183 175.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.02 113.44 0.75 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.661 175.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.82 -63.48 0.09 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.607 0.241 . . . . 0.0 111.02 -178.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . 0.454 ' HA ' ' SD ' ' B' ' 10' ' ' MET . 25.3 t80 -141.34 90.95 2.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.19 0.519 . . . . 0.0 109.892 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.741 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.1 mp -90.8 132.4 35.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.494 178.02 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -118.28 175.12 5.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.11 0.481 . . . . 0.0 110.496 177.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.545 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 82.1 mt -147.76 124.76 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.664 -176.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 41.5 pttt -177.57 160.46 1.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 0.0 111.209 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.9 OUTLIER -80.82 164.54 22.62 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.539 0.685 . . . . 0.0 110.958 177.45 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.537 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.4 pt . . . . . 0 C--N 1.309 -1.17 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.243 -173.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.752 0.311 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -94.86 148.26 22.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.831 -176.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -81.35 4.85 19.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -173.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -72.14 -61.49 1.77 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.384 0.611 . . . . 0.0 109.737 174.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.97 96.23 10.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.151 178.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.91 -21.68 66.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.712 -178.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -62.93 -49.16 75.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.552 175.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.99 -2.1 42.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.279 0.562 . . . . 0.0 110.796 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . 0.518 ' HG2' ' H ' ' B' ' 11' ' ' ASN . 20.6 tt0 -92.47 -72.51 0.59 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.239 175.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 8.2 tmm? 61.53 6.73 1.58 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.744 0.783 . . . . 0.0 111.414 176.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . 0.537 ' HA ' ' SD ' ' B' ' 31' ' ' MET . 9.1 t30 -61.62 -43.4 98.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.815 -175.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 9.9 m -69.16 -15.45 63.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.216 0.532 . . . . 0.0 110.387 -172.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -75.19 -43.49 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.57 0.7 . . . . 0.0 110.448 178.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -71.66 -14.74 62.13 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.935 -175.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.636 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 78.4 p -48.29 -40.53 25.25 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 123.444 0.465 . . . . 0.0 110.875 -179.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 49.8 t -69.61 -40.24 79.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.399 0.619 . . . . 0.0 110.166 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . 0.65 HD22 HD11 ' B' ' 29' ' ' LEU . 7.6 t30 -64.83 -37.12 86.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.281 176.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.03 -29.27 69.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.275 174.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' B' ' 15' ' ' SER . 24.6 mmmt -73.15 -11.6 60.59 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.183 0.516 . . . . 0.0 111.388 176.599 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.519 ' O ' ' HD3' ' B' ' 24' ' ' LYS . 39.7 mt -80.39 -18.59 48.49 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.663 0.744 . . . . 0.0 109.342 176.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' B' ' 26' ' ' LYS . 62.9 t30 -92.39 58.19 3.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.985 -176.738 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -123.45 -91.85 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.492 178.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.16 34.64 5.24 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 177.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.603 ' HA ' ' C ' ' B' ' 45' ' ' TYR . 27.6 mtpt -133.07 -164.63 1.5 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.434 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.582 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -64.07 145.14 49.51 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.329 -0.939 . . . . 0.0 110.996 178.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.548 ' CE ' ' HB2' ' B' ' 41' ' ' SER . 13.9 ttpt -80.5 136.34 36.28 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -174.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.497 ' HG ' HD11 ' B' ' 29' ' ' LEU . 19.3 tp -154.03 107.67 2.96 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.869 -178.079 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -110.18 103.89 12.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.213 -176.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.65 HD11 HD22 ' B' ' 17' ' ' ASN . 0.0 OUTLIER -82.02 156.92 24.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.827 0.822 . . . . 0.0 112.516 -177.702 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 53.9 m -129.8 144.11 51.14 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.355 -1.293 . . . . 0.0 107.517 164.34 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 31' ' ' MET . . . . . 0.537 ' SD ' ' HA ' ' B' ' 11' ' ' ASN . 40.7 mtt -111.24 127.53 55.64 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.675 -167.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -137.16 59.47 1.68 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.736 175.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 47.97 -93.68 0.01 OUTLIER Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.99 178.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.651 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 8.1 p30 -79.76 4.89 14.98 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 122.592 0.357 . . . . 0.0 111.299 -176.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 18.5 mt-30 -129.82 144.56 51.37 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.592 0.711 . . . . 0.0 111.017 172.584 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.436 ' CB ' ' HB ' ' B' ' 84' ' ' ILE . 0.9 OUTLIER -118.34 105.22 11.51 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.184 175.549 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . 0.504 ' HB3' ' HZ2' ' B' ' 37' ' ' LYS . 0.0 OUTLIER -99.91 151.92 20.76 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -175.702 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.04 164.21 4.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.456 0.571 . . . . 0.0 112.498 -177.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -128.35 141.03 51.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.211 168.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -142.58 147.5 35.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.091 0.472 . . . . 0.0 111.615 -175.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.548 ' HB2' ' CE ' ' B' ' 26' ' ' LYS . 24.1 m -159.31 169.57 23.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.53 178.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . 0.469 ' C ' ' H ' ' B' ' 44' ' ' GLY . 44.6 m-80 -91.73 49.18 1.53 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.102 -176.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.422 ' HB1' ' HE2' ' B' ' 26' ' ' LYS . . . -68.96 22.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.025 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.494 ' O ' ' HD1' ' B' ' 45' ' ' TYR . . . 161.43 -63.37 0.28 Allowed Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.006 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.735 ' CD2' HG22 ' B' ' 71' ' ' THR . 0.0 OUTLIER 70.29 161.86 0.23 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.955 0.902 . . . . 0.0 111.852 -179.489 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.523 ' H ' ' CG2' ' B' ' 71' ' ' THR . . . -63.18 113.1 5.56 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 116.157 -0.474 . . . . 0.0 114.043 -166.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 11.4 mm -95.76 -67.61 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.273 0.558 . . . . 0.0 110.604 177.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 59.3 m -67.12 -52.67 38.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.073 -176.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -42.27 124.41 2.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.334 -178.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -74.91 -172.68 1.67 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.282 177.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.66 108.09 14.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 50.0 mttm -139.69 130.57 26.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.442 -178.214 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -108.79 135.6 49.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.999 0.428 . . . . 0.0 111.551 -177.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.613 ' HA ' HG12 ' B' ' 94' ' ' ILE . 37.5 p-90 -154.49 169.26 24.21 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.947 175.43 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.8 152.81 21.44 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.702 -172.44 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.51 HD11 ' CD2' ' B' ' 64' ' ' TYR . 30.0 mt -113.31 142.63 25.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 173.302 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.614 ' CE1' ' HG3' ' B' ' 62' ' ' LYS . 58.9 m-85 -127.68 140.73 51.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.408 -171.427 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.468 HG11 ' ND2' ' B' ' 59' ' ' ASN . 10.8 p -123.77 134.47 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.468 ' ND2' HG11 ' B' ' 58' ' ' VAL . 3.4 m-80 63.46 4.57 1.79 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.254 0.622 . . . . 0.0 110.263 -176.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.56 -7.58 39.55 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.09 -174.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 33.1 mt-10 -98.54 175.87 5.86 Favored 'General case' 0 C--O 1.197 -1.708 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.043 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.614 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 14.4 ttmt -79.96 169.84 17.31 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 119.282 0.946 . . . . 0.0 109.929 176.323 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.2 -12.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.046 165.409 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.537 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.7 OUTLIER -159.67 123.93 3.84 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.791 -168.808 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.1 m -134.2 120.86 20.57 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.437 179.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.458 ' HB2' HD13 ' B' ' 75' ' ' ILE . 2.2 p90 -160.65 -178.63 7.0 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.563 1.173 . . . . 0.0 112.795 -174.529 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 16.3 t-20 -130.25 156.24 44.95 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.652 -176.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -70.41 -27.87 64.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.857 0.36 . . . . 0.0 110.985 -177.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.535 ' O ' HG23 ' B' ' 71' ' ' THR . 40.7 ttmt -86.6 -22.27 26.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.97 177.144 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 8.8 t -71.71 -20.29 61.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.397 173.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 71' ' ' THR . . . . . 0.735 HG22 ' CD2' ' B' ' 45' ' ' TYR . 35.6 p 58.46 113.69 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.4 1.08 . . . . 0.0 113.759 168.073 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.421 HG13 ' CE2' ' B' ' 66' ' ' PHE . 1.8 m -59.53 -15.99 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.21 -168.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.03 -50.66 64.06 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.506 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -75.69 -35.1 60.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.553 0.692 . . . . 0.0 110.461 179.463 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.492 HG13 ' O ' ' B' ' 71' ' ' THR . 1.5 mt -74.66 -51.08 23.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.184 -171.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 8.5 t -64.14 -26.8 68.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.256 -175.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -48.61 -48.93 38.91 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.925 0.869 . . . . 0.0 109.636 171.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.657 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 0.3 OUTLIER -71.63 -42.15 67.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.315 177.514 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.537 HG13 ' CE1' ' B' ' 64' ' ' TYR . 36.0 mm -57.92 -33.75 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.029 0.442 . . . . 0.0 111.898 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.04 -21.91 61.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.067 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.657 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 21.4 pttm -86.5 -7.79 58.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.839 0.352 . . . . 0.0 110.633 -178.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 3.4 mm? -71.11 -16.2 62.55 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.699 -176.184 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 t30 46.67 61.55 2.74 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 124.148 0.905 . . . . 0.0 109.624 -170.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' B' ' 35' ' ' GLN . 3.6 mp -57.09 141.08 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.079 -176.373 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.651 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 51.5 mtpt -95.91 -175.01 3.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.846 178.203 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . 0.4 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -139.47 114.54 1.01 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 178.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.14 -74.76 0.08 Allowed 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -121.21 84.7 2.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 25.7 mm -86.64 129.77 37.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.63 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.582 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 12.9 mm-40 -123.38 146.34 48.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.742 177.108 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.549 HG21 ' CZ3' ' B' ' 54' ' ' TRP . 47.2 mt -135.01 120.5 30.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.394 177.114 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 26.8 pttt -172.76 171.21 4.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.969 0.414 . . . . 0.0 111.921 -174.174 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.411 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 15.7 mm-40 -84.62 151.52 24.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.842 179.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.613 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.8 pt . . . . . 0 C--N 1.313 -1.017 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.327 -174.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.851 0.358 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -140.49 82.78 1.87 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.183 0.516 . . . . 0.0 109.958 -178.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -80.43 -4.71 54.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.99 -176.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.517 ' HZ3' ' HB2' ' B' ' 4' ' ' LYS . 0.0 OUTLIER -69.3 -29.03 66.8 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.471 0.653 . . . . 0.0 109.408 173.52 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.32 113.95 20.46 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.19 177.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 82.9 mt -98.06 24.74 6.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.232 -176.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -53.07 -57.84 9.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.674 -176.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -95.26 -26.35 15.98 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.601 0.715 . . . . 0.0 110.425 176.032 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -93.8 69.99 4.04 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.012 -178.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 10' ' ' MET . . . . . 0.413 ' O ' HG13 ' B' ' 13' ' ' ILE . 46.1 tpp -59.97 143.58 51.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.19 -178.239 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -41.16 -20.41 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.165 1.786 . . . . 0.0 114.239 -176.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -63.75 -5.2 3.83 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.992 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.457 ' HA ' ' HB2' ' B' ' 31' ' ' MET . 0.2 OUTLIER -49.03 -52.99 8.79 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-O 122.003 0.906 . . . . 0.0 110.007 179.361 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 14' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' B' ' 18' ' ' ASP . 35.0 m-80 -88.41 -32.53 18.28 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.616 -175.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 3.1 m -59.51 -43.62 93.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.769 0.319 . . . . 0.0 111.424 -177.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.88 -41.18 60.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.27 0.557 . . . . 0.0 109.765 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . 0.559 ' O ' ' HB2' ' B' ' 21' ' ' ASN . 3.0 t-20 -65.69 -45.88 81.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.972 -177.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' B' ' 14' ' ' ASN . 0.2 OUTLIER -67.85 -34.46 76.73 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.173 0.511 . . . . 0.0 110.729 -176.36 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -57.75 -59.91 4.5 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.192 178.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 49.1 mt -94.37 26.52 3.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.292 -177.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' B' ' 17' ' ' ASN . 27.5 t-20 -91.87 -37.86 12.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.264 0.554 . . . . 0.0 110.375 177.029 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -91.61 42.64 1.11 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.952 -178.033 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' B' ' 24' ' ' LYS . . . -85.82 -6.94 82.0 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.811 -177.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.464 ' HE3' ' CE1' ' B' ' 49' ' ' TYR . 86.7 mttt 72.53 -55.88 0.66 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.443 0.697 . . . . 0.0 110.801 -177.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.611 ' HA3' ' O ' ' B' ' 45' ' ' TYR . . . -61.76 147.49 48.26 Favored Glycine 0 C--N 1.314 -0.678 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 167.234 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.519 ' CB ' ' HB3' ' B' ' 41' ' ' SER . 82.1 mttt -83.97 119.41 24.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.456 1.128 . . . . 0.0 111.105 -168.275 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 20.1 tp -158.06 118.79 3.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 28' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 57.8 m -114.55 112.27 22.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.31 -175.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 9.5 mp -98.09 165.65 11.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.659 0.742 . . . . 0.0 111.842 -178.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.3 p -160.47 141.44 11.97 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.808 171.485 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 31' ' ' MET . . . . . 0.693 ' SD ' HD22 ' B' ' 36' ' ' LEU . 82.0 mmm -108.47 136.38 48.19 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.65 0.262 . . . . 0.0 110.528 -175.136 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -137.08 61.33 1.63 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 55.43 -100.09 0.08 OUTLIER Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.194 177.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 34' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 20.9 m120 -75.81 -0.56 21.51 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.636 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -133.66 150.99 51.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.833 0.825 . . . . 0.0 112.253 175.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.693 HD22 ' SD ' ' B' ' 31' ' ' MET . 2.3 tm? -118.73 132.18 56.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.833 170.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -127.63 136.62 51.89 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -162.92 157.54 21.27 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.03 0.443 . . . . 0.0 111.761 -175.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.98 152.96 46.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.508 177.328 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 24.1 p -127.82 150.37 49.86 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.76 0.314 . . . . 0.0 110.702 -178.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.519 ' HB3' ' CB ' ' B' ' 26' ' ' LYS . 41.9 t -126.69 163.98 22.3 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.594 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -72.02 55.18 0.29 Allowed 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 125.243 1.589 . . . . 0.0 113.48 -154.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.438 ' CB ' ' HA2' ' B' ' 25' ' ' GLY . . . -97.68 -18.32 18.93 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.911 169.247 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.12 -52.74 2.17 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.198 -0.91 . . . . 0.0 113.358 177.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.611 ' O ' ' HA3' ' B' ' 25' ' ' GLY . 5.4 m-85 -75.85 173.52 11.07 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.823 0.82 . . . . 0.0 112.638 -175.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.83 33.44 0.44 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 176.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.36 -45.09 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-N 114.178 -1.011 . . . . 0.0 111.803 -173.506 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.2 t 71.24 -91.33 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.168 -172.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.531 ' HB2' ' CE ' ' B' ' 52' ' ' LYS . 29.4 m-85 -140.78 126.93 19.61 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.457 0.473 . . . . 0.0 110.757 174.104 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 35.96 -109.97 0.06 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.287 1.035 . . . . 0.0 112.89 -174.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -132.85 132.63 42.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.19 0.519 . . . . 0.0 109.955 176.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.531 ' CE ' ' HB2' ' B' ' 49' ' ' TYR . 75.4 mttt -137.84 130.6 29.86 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.458 179.481 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -117.28 118.75 33.14 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.173 0.511 . . . . 0.0 109.782 175.271 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 0.634 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 37.5 p-90 -143.95 170.52 15.76 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.374 -177.118 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.37 150.89 20.63 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.292 -175.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 11.4 mt -102.81 142.7 16.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 173.159 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 57' ' ' PHE . . . . . 0.578 ' HB2' ' HB2' ' B' ' 90' ' ' GLU . 46.7 m-85 -124.81 134.17 52.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.978 -177.322 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.529 HG12 ' ND2' ' B' ' 59' ' ' ASN . 9.3 p -126.43 137.89 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -178.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.529 ' ND2' HG12 ' B' ' 58' ' ' VAL . 6.0 m-80 65.86 3.09 2.41 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -172.141 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.409 ' N ' ' HB3' ' B' ' 88' ' ' TYR . . . 103.36 -12.63 54.85 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.912 -174.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 1.4 mp0 -91.01 170.28 10.18 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 123.663 0.785 . . . . 0.0 108.885 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.561 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 17.4 ttmt -68.2 169.28 10.65 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 172.505 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.418 ' HB ' HG13 ' B' ' 58' ' ' VAL . 8.7 p -153.53 -13.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.297 170.722 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.489 ' CE2' HG22 ' B' ' 75' ' ' ILE . 0.3 OUTLIER -164.58 136.43 4.5 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.863 -176.347 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -128.43 127.19 42.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.515 173.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 66' ' ' PHE . . . . . 0.653 ' CE2' HG21 ' B' ' 75' ' ' ILE . 27.2 p90 -166.88 154.83 9.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.676 0.75 . . . . 0.0 111.074 -176.311 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -101.76 161.01 13.97 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.386 173.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . 0.495 ' CG ' ' HB2' ' B' ' 52' ' ' LYS . 4.7 mm-40 -73.37 -36.83 66.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.491 0.662 . . . . 0.0 109.952 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -59.72 -25.58 64.93 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.781 177.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.4 t -68.17 -10.4 53.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.343 -178.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 71' ' ' THR . . . . . . . . . . . . . 31.6 p 75.47 94.38 0.07 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 112.479 -2.146 . . . . 0.0 110.763 177.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.743 ' HA ' ' CG1' ' B' ' 75' ' ' ILE . 19.7 m -67.86 -8.56 9.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.328 -171.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.99 -37.14 94.47 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.236 176.517 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -82.14 -29.13 31.79 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 75' ' ' ILE . . . . . 0.743 ' CG1' ' HA ' ' B' ' 72' ' ' VAL . 30.2 mm -57.92 -60.56 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.959 174.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 76' ' ' SER . . . . . 0.44 ' HA ' HD12 ' B' ' 79' ' ' ILE . 18.9 t -61.77 -32.55 72.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.377 -177.462 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' B' ' 80' ' ' ASN . 64.8 t30 -51.96 -49.94 62.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.947 174.681 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 78' ' ' ASP . . . . . 0.669 ' O ' ' HG3' ' B' ' 81' ' ' LYS . 0.4 OUTLIER -73.47 -34.8 65.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.188 178.471 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.568 HG13 ' O ' ' B' ' 75' ' ' ILE . 57.0 mt -56.13 -34.79 39.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.253 0.549 . . . . 0.0 110.453 176.53 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 80' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' B' ' 77' ' ' ASN . 10.1 m-80 -56.91 -28.08 61.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.156 177.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . 0.669 ' HG3' ' O ' ' B' ' 78' ' ' ASP . 1.1 pptp? -97.44 -5.59 35.81 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -171.212 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 31.0 mt -68.45 -21.69 64.63 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 122.0 -0.438 . . . . 0.0 110.392 -174.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 50.59 64.73 1.7 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.505 -166.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.501 HD12 ' HB2' ' B' ' 36' ' ' LEU . 70.2 mt -59.82 157.5 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.592 -172.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.457 ' O ' HG21 ' B' ' 84' ' ' ILE . 22.0 mmmt -100.82 -169.35 1.69 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.211 0.529 . . . . 0.0 110.14 175.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -151.53 113.27 0.57 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.192 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 87' ' ' MET . . . . . 0.413 ' HG3' ' HA ' ' B' ' 59' ' ' ASN . 18.0 ptp -174.42 -54.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 122.53 0.332 . . . . 0.0 110.248 177.636 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 88' ' ' TYR . . . . . 0.409 ' HB3' ' N ' ' B' ' 60' ' ' GLY . 6.8 t80 -134.03 79.56 1.82 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 34.1 mm -94.49 114.92 32.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.171 177.373 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.578 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 31.7 mm-40 -110.17 146.53 35.37 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.051 0.453 . . . . 0.0 111.432 179.232 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.634 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 5.2 mp -131.68 107.24 12.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.839 178.198 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 92' ' ' LYS . . . . . 0.551 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 16.4 pttp -167.9 172.65 8.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.943 0.401 . . . . 0.0 111.433 -172.364 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.47 165.03 21.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.528 174.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 94' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' B' ' 54' ' ' TRP . 2.3 pt . . . . . 0 C--O 1.25 1.131 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.401 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 79.1 mmm . . . . . 0 N--CA 1.45 -0.456 0 CA-C-O 120.978 0.418 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -58.4 -23.59 57.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.745 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 13.3 m -65.7 -29.88 70.48 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.932 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 9.6 mm -62.74 -41.66 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 121.856 0.836 . . . . 0.0 109.436 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -70.72 -34.49 71.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.877 -174.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.573 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 17.6 m -67.73 -45.95 73.55 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.216 177.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.48 -44.59 96.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.968 0.413 . . . . 0.0 110.329 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -52.29 -49.98 63.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.953 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -18.07 47.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.24 -174.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -78.55 -49.86 12.58 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 120.984 0.421 . . . . 0.0 111.859 176.812 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.563 HD22 HG11 ' B' ' 72' ' ' VAL . 67.5 mt -72.89 -43.41 62.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.295 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -85.56 74.4 10.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.641 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -131.38 -77.4 0.52 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.672 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.35 46.13 1.13 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.414 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -117.19 -140.74 0.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.687 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -85.7 170.78 44.43 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.848 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.529 ' HE2' ' HB2' ' B' ' 41' ' ' SER . 4.9 ttpt -61.84 127.09 29.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' B' ' 39' ' ' THR . 11.6 tp -158.04 115.46 2.96 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 120.957 0.408 . . . . 0.0 110.693 -169.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 69.3 m -107.74 114.14 27.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.054 177.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.459 HD13 ' HB2' ' B' ' 38' ' ' ALA . 3.1 mm? -86.4 154.94 20.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.542 0.687 . . . . 0.0 111.166 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.97 154.47 41.3 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.545 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 54.1 mtt -119.88 144.73 47.24 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.118 0.485 . . . . 0.0 111.898 -171.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -154.42 108.32 2.95 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.09 -111.66 4.18 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -168.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.539 ' HB2' ' HA2' ' B' ' 86' ' ' GLY . 13.8 m120 -123.48 19.58 9.63 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 168.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -72.55 154.71 40.67 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.401 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 20.3 tp -112.44 92.03 3.87 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.172 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -89.52 151.75 21.8 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.459 ' HB2' HD13 ' B' ' 29' ' ' LEU . . . -170.65 155.53 4.91 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -171.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 11.0 p -123.27 140.18 53.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.207 168.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 27.1 t -142.18 153.13 43.8 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.767 0.794 . . . . 0.0 112.753 -172.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.529 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . 10.2 m -133.0 168.39 18.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.754 176.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -112.07 36.46 3.33 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.478 0.656 . . . . 0.0 109.94 -170.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.7 22.28 0.1 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.86 -1.064 . . . . 0.0 113.376 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.46 -44.11 0.53 Allowed Glycine 0 C--O 1.229 -0.186 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.532 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.687 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 44.4 p90 46.98 -152.51 0.08 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.22 1.008 . . . . 0.0 113.469 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.474 ' H ' ' CG2' ' B' ' 71' ' ' THR . . . -81.75 99.74 2.02 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.444 -173.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.463 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -112.52 -54.53 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.509 0.671 . . . . 0.0 109.266 172.786 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -42.87 -55.7 3.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.154 -1.384 . . . . 0.0 111.939 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -79.21 121.12 24.65 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.96 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -65.76 -83.92 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.814 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -146.63 112.37 5.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.508 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 79.6 mttt -139.21 136.23 34.79 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -125.41 128.14 47.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.51 0.671 . . . . 0.0 111.934 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.553 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 30.5 p-90 -147.73 177.15 9.54 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.266 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.26 151.16 22.05 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.973 -174.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' B' ' 64' ' ' TYR . 19.0 mt -110.26 141.61 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 174.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 60.9 m-85 -125.36 139.45 53.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.795 -173.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.574 HG13 ' ND2' ' B' ' 59' ' ' ASN . 7.4 p -126.37 137.38 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.642 ' HA ' ' CG ' ' B' ' 87' ' ' MET . 2.9 m-80 63.11 6.24 2.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.33 0.652 . . . . 0.0 110.171 -175.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.3 -5.45 55.41 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.94 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' B' ' 58' ' ' VAL . 22.1 mt-10 -100.2 174.45 6.14 Favored 'General case' 0 C--O 1.193 -1.873 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.504 ' HE3' ' CE1' ' B' ' 57' ' ' PHE . 10.7 tttt -80.88 169.97 16.87 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.02 -3.22 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.717 165.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.781 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -158.16 130.83 7.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.437 -172.434 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 25.3 m -137.68 125.68 22.78 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.448 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.549 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.1 OUTLIER -160.91 154.2 21.68 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 122.709 1.242 . . . . 0.0 113.239 -175.219 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 19.1 t-20 -107.93 152.1 24.9 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.364 -2.198 . . . . 0.0 107.777 166.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -64.27 -24.29 67.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.572 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.573 ' O ' HG23 ' B' ' 71' ' ' THR . 4.4 ttmp? -82.8 -26.09 32.1 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.027 0.441 . . . . 0.0 110.948 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 6.6 t -69.93 -22.3 63.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.573 HG23 ' O ' ' B' ' 69' ' ' LYS . 11.9 p 60.28 115.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.326 1.05 . . . . 0.0 112.558 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.563 HG11 HD22 ' B' ' 20' ' ' LEU . 10.0 m -61.52 -11.74 5.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.82 -172.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.56 -52.6 51.52 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.192 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -72.01 -32.57 67.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.584 0.707 . . . . 0.0 110.213 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.549 HD13 ' HB3' ' B' ' 66' ' ' PHE . 2.9 mt -73.19 -48.35 43.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.606 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.8 t -50.87 -36.75 39.59 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.239 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -51.21 -55.81 16.11 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.838 0.828 . . . . 0.0 109.744 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.748 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 24.2 m-20 -69.68 -39.7 76.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.046 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.781 HG13 ' CE1' ' B' ' 64' ' ' TYR . 42.6 mm -57.88 -30.91 39.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.378 0.609 . . . . 0.0 111.881 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -73.53 2.4 7.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.618 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.748 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 45.3 pttt -109.49 8.06 25.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.259 0.552 . . . . 0.0 109.937 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' B' ' 79' ' ' ILE . 2.3 mm? -77.36 -6.82 54.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.606 -175.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 56.2 65.03 1.53 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -167.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 54.1 mt -67.75 149.56 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.092 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.614 ' HB2' HD21 ' B' ' 59' ' ' ASN . 63.2 mttm -129.68 -159.71 0.98 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.932 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.539 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -160.29 126.77 1.67 Allowed Glycine 0 C--N 1.318 -0.426 0 C-N-CA 120.005 -1.093 . . . . 0.0 114.434 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.642 ' CG ' ' HA ' ' B' ' 59' ' ' ASN . 21.1 ptp -176.72 -52.11 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 122.782 0.433 . . . . 0.0 111.166 168.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' TYR . . . . . 0.51 ' N ' ' HG3' ' B' ' 87' ' ' MET . 60.7 t80 -127.37 99.08 5.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.917 -0.49 . . . . 0.0 109.883 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 41.1 mm -96.53 137.18 25.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.233 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 6.5 mm-40 -128.88 153.93 47.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.035 0.445 . . . . 0.0 111.494 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.553 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 51.5 mt -131.9 114.29 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.323 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 62.6 pttt -166.7 162.24 16.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.06 0.457 . . . . 0.0 112.157 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.45 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -80.82 163.97 23.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.106 175.277 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.55 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.3 pt . . . . . 0 C--O 1.245 0.85 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.892 -172.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 121.4 0.619 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -56.35 -24.66 45.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.943 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.507 ' O ' HG23 ' B' ' 16' ' ' VAL . 5.4 m -63.52 -33.02 74.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.569 -178.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.448 HD11 HG13 ' B' ' 89' ' ' ILE . 12.6 mm -62.74 -43.28 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.624 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' B' ' 17' ' ' ASN . 1.3 m120 -71.93 -39.94 69.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.834 -175.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.603 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 23.8 m -61.33 -49.39 77.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.705 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.507 HG23 ' O ' ' B' ' 12' ' ' SER . 61.2 t -65.2 -38.93 83.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 110.436 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' B' ' 14' ' ' ASN . 12.2 t30 -49.97 -45.96 51.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.905 175.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.2 OUTLIER -82.75 -41.54 19.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.384 -179.322 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.603 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -58.55 -52.66 64.7 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 123.419 0.688 . . . . 0.0 112.761 -175.472 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.426 HD21 ' HZ2' ' B' ' 54' ' ' TRP . 70.2 mt -73.54 -28.39 61.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.74 0.305 . . . . 0.0 110.945 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -89.46 61.32 5.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.45 0.643 . . . . 0.0 110.279 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 30.7 mtpp -129.36 -84.27 0.56 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.835 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.65 44.95 1.39 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.616 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -126.24 -159.05 0.89 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.584 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -67.96 159.04 51.41 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.466 ' HG2' ' HB2' ' B' ' 41' ' ' SER . 0.0 OUTLIER -82.07 111.01 17.82 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.708 -177.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' B' ' 39' ' ' THR . 2.3 pt? -131.57 148.74 52.64 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.604 -176.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 60.7 m -102.67 117.08 33.89 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.404 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' B' ' 38' ' ' ALA . 2.8 mm? -88.51 152.6 21.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.51 0.672 . . . . 0.0 110.787 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.1 p -150.07 151.02 32.55 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.237 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 50.7 mtt -120.13 146.21 46.19 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.858 0.361 . . . . 0.0 110.92 -175.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -154.05 116.65 4.4 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.96 -111.49 4.16 Favored Glycine 0 CA--C 1.507 -0.41 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -169.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.56 ' HB2' ' CA ' ' B' ' 86' ' ' GLY . 43.1 m-20 -130.45 37.75 3.82 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 168.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.426 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 48.1 mt-30 -92.17 161.25 14.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.241 175.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 27.4 tp -127.44 110.53 12.87 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 171.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.427 ' HA ' ' ND2' ' B' ' 80' ' ' ASN . 32.2 mtmt -113.36 148.06 36.49 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -177.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.485 ' HB2' HD13 ' B' ' 29' ' ' LEU . . . -156.89 158.16 36.18 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -172.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 4.6 p -133.35 134.68 44.07 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.929 171.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -131.1 147.82 52.66 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -167.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.466 ' HB2' ' HG2' ' B' ' 26' ' ' LYS . 2.4 m -99.75 141.7 32.21 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 167.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -103.92 32.06 4.15 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.339 -169.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.71 22.52 1.6 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.135 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.69 -36.52 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.798 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.584 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 6.8 p90 38.13 -142.02 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.475 1.11 . . . . 0.0 113.646 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.49 112.05 3.41 Favored Glycine 0 C--N 1.339 0.729 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.076 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.21 -57.41 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.005 0.431 . . . . 0.0 109.846 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.4 m -43.2 -54.81 4.29 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.346 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -97.32 120.38 37.59 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.067 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -94.98 -84.17 0.34 Allowed 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.641 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -103.96 108.35 19.66 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.749 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.52 ' HB2' ' CG ' ' B' ' 68' ' ' GLU . 93.2 mttt -150.15 134.29 17.09 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 169.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.96 126.51 51.05 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.127 0.489 . . . . 0.0 110.805 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.566 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 25.1 p-90 -145.02 159.34 43.09 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.721 176.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -122.09 147.82 17.09 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.166 -175.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.548 HD12 ' CD2' ' B' ' 64' ' ' TYR . 16.4 mt -105.11 148.76 9.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 169.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.69 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 88.9 m-85 -128.35 141.28 51.47 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -169.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.565 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.9 p -128.12 136.57 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 3.2 m120 62.43 12.82 5.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.276 -171.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.94 78.92 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.075 -174.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 17.2 mt-10 -98.25 175.31 6.12 Favored 'General case' 0 C--O 1.202 -1.429 0 C-N-CA 123.517 0.727 . . . . 0.0 109.357 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.0 tppp? -63.4 160.56 15.9 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 118.681 0.673 . . . . 0.0 109.956 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.565 ' HB ' HG12 ' B' ' 58' ' ' VAL . 7.2 p -151.47 -16.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.965 0.412 . . . . 0.0 110.168 167.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.691 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.9 OUTLIER -161.5 125.74 3.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.148 -171.83 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 22.7 m -131.36 129.44 41.39 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.642 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.511 ' CB ' HD13 ' B' ' 75' ' ' ILE . 7.7 p90 -167.83 153.66 7.34 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 122.186 0.993 . . . . 0.0 112.567 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.496 ' O ' ' HB3' ' B' ' 70' ' ' SER . 16.6 t-20 -99.81 153.14 19.37 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.151 -1.84 . . . . 0.0 108.962 171.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' GLU . . . . . 0.52 ' CG ' ' HB2' ' B' ' 52' ' ' LYS . 6.7 mm-40 -62.03 -45.67 92.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.969 0.349 . . . . 0.0 111.423 -176.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.522 ' O ' HG23 ' B' ' 71' ' ' THR . 86.4 tttt -64.71 -22.22 66.93 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.454 0.702 . . . . 0.0 111.547 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 6.2 t -69.44 -16.74 63.55 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.522 HG23 ' O ' ' B' ' 69' ' ' LYS . 30.2 p 59.18 107.78 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.888 1.275 . . . . 0.0 112.915 172.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.547 ' HA ' HD12 ' B' ' 75' ' ' ILE . 2.3 m -58.34 -17.85 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 114.266 -1.333 . . . . 0.0 112.635 -171.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.37 -48.97 80.75 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.682 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -74.5 -34.21 63.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.465 0.65 . . . . 0.0 110.191 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' B' ' 72' ' ' VAL . 1.9 mt -74.68 -48.45 34.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.085 -173.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 77.7 p -50.62 -48.75 57.89 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.583 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -41.62 -52.57 3.76 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.751 -1.568 . . . . 0.0 111.216 173.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.705 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 22.7 m-20 -74.28 -28.83 61.38 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.429 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.691 HG13 ' CE1' ' B' ' 64' ' ' TYR . 48.8 mm -71.88 -38.12 63.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.142 0.496 . . . . 0.0 111.199 177.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.427 ' ND2' ' HA ' ' B' ' 37' ' ' LYS . 11.3 m120 -62.88 -28.37 70.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.373 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.705 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 61.1 pttt -81.59 3.41 25.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.446 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' B' ' 79' ' ' ILE . 36.8 mt -84.77 3.89 35.45 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.726 0.298 . . . . 0.0 110.862 -177.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 58.9 t30 54.15 58.03 5.38 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -170.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.443 HD11 HG22 ' B' ' 79' ' ' ILE . 61.7 mt -52.31 149.88 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.726 -173.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -109.22 175.14 5.56 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.573 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.56 ' CA ' ' HB2' ' B' ' 34' ' ' ASN . . . -141.97 112.94 0.78 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.472 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.536 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 0.2 OUTLIER -146.1 -81.21 0.15 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 117.021 0.41 . . . . 0.0 110.595 175.536 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 88' ' ' TYR . . . . . 0.536 ' N ' ' HG3' ' B' ' 87' ' ' MET . 46.8 t80 -120.16 106.24 11.75 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.69 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 22.0 mm -101.11 130.55 50.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.092 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -122.89 178.58 4.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.188 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.566 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 95.8 mt -149.98 127.76 2.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.29 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -174.36 154.2 2.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.98 0.419 . . . . 0.0 111.615 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.3 OUTLIER -82.68 146.43 29.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.087 177.201 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.49 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.2 pt . . . . . 0 C--O 1.249 1.064 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.95 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' MET . . . . . 0.684 ' HG2' ' H ' ' B' ' 89' ' ' ILE . 15.1 tpt . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -54.04 -28.63 39.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.22 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.585 ' H ' ' HG3' ' B' ' 10' ' ' MET . 6.2 m -75.2 -16.63 60.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.397 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.523 HG22 ' SD ' ' B' ' 31' ' ' MET . 6.3 mm -57.45 -44.06 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 122.313 1.054 . . . . 0.0 109.03 175.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -70.32 -30.67 67.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.536 -1.666 . . . . 0.0 109.792 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.477 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 10.7 t -70.96 -38.04 72.81 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.903 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.545 HG23 ' O ' ' B' ' 12' ' ' SER . 93.3 t -51.01 -50.55 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.397 0.618 . . . . 0.0 109.816 174.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -59.02 -49.46 77.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.871 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -30.86 68.32 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -174.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' B' ' 15' ' ' SER . 10.0 mmmm -76.85 -23.65 52.7 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.464 0.649 . . . . 0.0 111.381 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.41 HD22 HG11 ' B' ' 72' ' ' VAL . 92.0 mt -97.36 -42.11 7.92 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.181 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -84.95 73.46 10.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.395 0.616 . . . . 0.0 110.184 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -116.72 -74.38 0.61 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.504 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.49 40.65 0.82 Allowed Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.741 ' HG2' ' CE1' ' B' ' 49' ' ' TYR . 44.4 mttt -110.7 -145.48 0.4 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -70.09 154.2 52.51 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' B' ' 40' ' ' SER . 0.3 OUTLIER -61.91 121.67 13.52 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.487 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.476 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 28.8 tp -148.23 97.46 2.78 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.481 0.658 . . . . 0.0 109.256 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 43.0 m -99.12 116.24 30.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.788 -175.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.476 ' CD1' ' HG ' ' B' ' 27' ' ' LEU . 10.2 mp -101.67 167.27 10.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.555 0.693 . . . . 0.0 111.838 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.5 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 1.3 p -149.38 146.26 27.4 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.802 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' MET . . . . . 0.523 ' SD ' HG22 ' B' ' 13' ' ' ILE . 5.7 mmt -105.8 118.26 36.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.562 -169.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 14.0 t-20 -133.5 60.76 1.69 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.882 0.373 . . . . 0.0 110.009 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.88 -104.11 0.12 Allowed Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.606 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.491 ' HA ' ' N ' ' B' ' 86' ' ' GLY . 17.9 m120 -85.02 23.19 1.26 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.687 -0.257 . . . . 0.0 111.07 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 35.3 mt-30 -138.73 150.84 46.58 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.437 0.636 . . . . 0.0 110.595 172.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -123.94 114.65 20.09 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.162 172.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.5 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 6.7 mmmm -110.73 137.78 47.96 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -176.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -162.28 154.2 18.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.28 0.562 . . . . 0.0 112.329 -172.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.33 146.15 51.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.389 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 33.6 p -135.67 154.98 51.11 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.004 0.431 . . . . 0.0 112.031 -175.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 28.1 t -152.95 159.37 42.94 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.152 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' B' ' 44' ' ' GLY . 51.3 m-80 -85.76 52.82 2.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.114 -174.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.21 23.22 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.856 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' B' ' 42' ' ' ASN . . . 117.39 -13.19 13.74 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.784 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.49 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 35.7 p90 45.2 -156.98 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.403 1.081 . . . . 0.0 113.136 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.424 ' H ' HG22 ' B' ' 71' ' ' THR . . . -72.63 89.97 0.55 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.91 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.55 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -91.68 -70.85 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.541 0.686 . . . . 0.0 110.509 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 m -50.34 -55.88 13.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.987 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.741 ' CE1' ' HG2' ' B' ' 24' ' ' LYS . 4.3 m-85 -61.48 109.69 1.24 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.605 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.29 -64.44 0.95 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.543 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -173.05 113.09 0.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.734 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 54.1 mtmt -138.31 145.34 41.09 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.513 ' HB3' ' OD1' ' B' ' 67' ' ' ASN . 0.5 OUTLIER -121.82 121.96 38.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.226 0.536 . . . . 0.0 111.623 -178.194 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.584 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 33.4 p-90 -140.23 173.74 11.21 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.229 174.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.98 151.79 21.12 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.907 -1.14 . . . . 0.0 113.372 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.523 HD12 ' CD2' ' B' ' 64' ' ' TYR . 18.2 mt -110.12 145.92 16.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 174.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.76 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 72.8 m-85 -128.88 143.66 50.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.282 -171.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.536 HG13 ' ND2' ' B' ' 59' ' ' ASN . 9.6 p -128.47 137.34 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.536 ' ND2' HG13 ' B' ' 58' ' ' VAL . 1.4 m-80 60.27 9.02 1.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.277 0.631 . . . . 0.0 110.494 -176.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.77 7.87 57.45 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.232 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 12.1 mt-10 -114.62 177.02 4.8 Favored 'General case' 0 C--O 1.199 -1.592 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.571 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 18.6 ttmt -78.89 169.21 18.58 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 119.303 0.956 . . . . 0.0 109.924 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.53 -14.96 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.798 164.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.679 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.5 OUTLIER -158.4 130.07 6.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.601 -167.054 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.2 m -137.96 133.3 33.54 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.218 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.458 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.0 OUTLIER -159.35 160.97 35.63 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.953 0.882 . . . . 0.0 111.21 -174.5 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.513 ' OD1' ' HB3' ' B' ' 53' ' ' ASN . 2.9 m120 -115.96 146.78 41.81 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.624 -1.626 . . . . 0.0 109.787 170.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' GLU . . . . . 0.465 ' CD ' ' HZ3' ' B' ' 24' ' ' LYS . 13.4 mm-40 -56.35 -44.27 79.92 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.614 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.538 ' O ' HG23 ' B' ' 71' ' ' THR . 35.0 ttpt -64.01 -30.09 71.19 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.611 0.72 . . . . 0.0 110.621 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 23.7 m -81.27 -3.35 52.18 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.091 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.538 HG23 ' O ' ' B' ' 69' ' ' LYS . 23.6 p 55.21 102.01 0.01 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.304 1.442 . . . . 0.0 113.474 165.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.41 HG11 HD22 ' B' ' 20' ' ' LEU . 4.2 m -62.94 -18.88 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.425 -173.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.42 -49.58 75.09 Favored Glycine 0 C--O 1.236 0.241 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.974 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -69.62 -37.52 76.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.023 0.439 . . . . 0.0 110.268 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.569 ' O ' HG12 ' B' ' 79' ' ' ILE . 2.7 mt -68.21 -46.61 80.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.609 -176.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 45.6 m -57.02 -35.5 69.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.933 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -54.74 -49.17 71.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.169 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 7.3 m-20 -70.51 -37.49 74.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.558 -1.201 . . . . 0.0 112.122 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.679 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 43.7 mm -59.02 -24.4 26.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.482 0.658 . . . . 0.0 111.443 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -59.95 -18.66 47.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.508 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 6.0 ptpp? -87.11 1.32 53.36 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.172 0.51 . . . . 0.0 110.851 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.577 HD23 ' HA ' ' B' ' 79' ' ' ILE . 2.4 mm? -81.38 -1.66 46.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.156 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 49.54 62.35 2.68 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.798 -168.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.584 HD11 HG22 ' B' ' 79' ' ' ILE . 49.0 mt -58.71 140.77 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.71 -177.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -127.37 -176.76 3.84 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.796 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.491 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -136.89 115.53 1.27 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.872 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 32.7 ttm -157.79 -74.99 0.09 Allowed 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -130.77 82.51 2.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.415 0.626 . . . . 0.0 109.503 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.76 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.2 mp -87.67 136.68 22.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.518 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -122.08 171.78 8.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.888 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.509 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 32.9 mm -144.93 110.1 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.33 -174.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.584 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 16.6 pttp -161.04 173.18 15.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.291 0.567 . . . . 0.0 112.042 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.509 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 5.1 pm0 -105.49 145.79 30.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.882 -175.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.7 pt . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.95 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -60.28 -33.36 72.23 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.967 0.413 . . . . 0.0 111.805 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.431 ' O ' HG23 ' B' ' 16' ' ' VAL . 23.2 t -67.84 -8.45 36.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.031 -169.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 10.2 mm -55.41 -55.11 18.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.935 0.874 . . . . 0.0 110.12 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -77.56 -27.7 51.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.355 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 10.1 m -57.6 -47.05 83.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.116 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.431 HG23 ' O ' ' B' ' 12' ' ' SER . 76.1 t -66.46 -43.91 90.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.085 0.469 . . . . 0.0 109.978 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -54.08 -50.77 66.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.986 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.38 -43.21 64.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.648 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -57.24 -50.89 71.45 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 123.204 0.602 . . . . 0.0 111.593 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -70.69 -45.24 65.38 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.827 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -85.97 59.78 5.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.389 0.614 . . . . 0.0 111.369 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -105.23 -17.34 14.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.328 0.585 . . . . 0.0 109.914 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.83 -95.16 0.1 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.521 ' HE3' ' OE2' ' B' ' 68' ' ' GLU . 51.3 mttp 41.65 -135.1 0.29 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.688 0.795 . . . . 0.0 111.197 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.608 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -84.42 168.15 43.85 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.785 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.425 ' HE3' ' CB ' ' B' ' 41' ' ' SER . 14.7 ttpt -86.27 109.84 19.23 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -145.52 168.31 20.91 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.161 -176.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.6 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 43.9 m -125.66 107.11 10.25 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.759 -176.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.503 HD23 ' HB2' ' B' ' 38' ' ' ALA . 33.1 mt -86.87 144.91 26.78 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.569 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 9.0 p -134.78 156.69 48.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.964 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 55.0 mtm -110.04 127.99 55.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.991 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -148.89 108.33 3.96 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.04 -114.62 6.92 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.581 ' HB2' ' HA2' ' B' ' 86' ' ' GLY . 1.7 m-20 -123.9 20.03 9.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' B' ' 84' ' ' ILE . 74.5 mt-30 -74.69 158.78 32.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.528 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tt -115.93 104.01 11.18 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.391 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.569 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 4.7 mtmp? -115.59 142.63 46.47 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -158.91 156.61 29.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -175.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -130.56 134.65 47.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 170.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 44.6 t -126.33 160.07 31.41 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -164.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.425 ' CB ' ' HE3' ' B' ' 26' ' ' LYS . 35.2 t -134.4 159.97 39.41 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.007 174.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -109.25 29.63 7.35 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.276 0.56 . . . . 0.0 110.727 -171.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.03 22.4 0.09 Allowed 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.961 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.75 -38.3 0.57 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.409 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.608 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 14.4 p90 45.56 -159.48 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.471 1.108 . . . . 0.0 113.758 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.17 114.83 6.03 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.974 -0.632 . . . . 0.0 113.118 -175.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.11 -60.81 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.837 0.351 . . . . 0.0 110.815 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 m -40.66 -57.23 1.93 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.077 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.81 106.15 10.61 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.784 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -60.0 -49.22 78.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.651 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -165.32 110.77 0.91 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.985 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 71.8 mmtt -133.51 131.93 40.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -112.73 125.77 54.68 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.522 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 16.7 p-90 -152.7 166.74 31.2 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.886 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.33 142.6 13.88 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.846 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.589 HD12 ' CD2' ' B' ' 64' ' ' TYR . 23.7 mt -106.59 151.37 8.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.669 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 76.0 m-85 -132.59 140.29 48.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.277 -170.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.544 HG12 ' HB ' ' B' ' 63' ' ' VAL . 11.9 p -124.85 131.42 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.407 ' ND2' HG13 ' B' ' 58' ' ' VAL . 2.8 m-80 64.25 11.49 6.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.51 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.96 -3.74 62.55 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.348 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -103.01 177.15 4.92 Favored 'General case' 0 C--O 1.207 -1.152 0 C-N-CA 123.303 0.641 . . . . 0.0 109.642 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.438 ' HD2' ' OG1' ' B' ' 65' ' ' THR . 5.2 tppp? -63.87 158.76 21.22 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.014 175.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.544 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.8 p -153.23 -11.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.122 0.487 . . . . 0.0 110.245 165.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.819 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -161.21 136.25 7.52 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.061 0.458 . . . . 0.0 110.53 -174.329 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.438 ' OG1' ' HD2' ' B' ' 62' ' ' LYS . 84.8 m -149.25 118.47 6.81 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' B' ' 66' ' ' PHE . 0.0 OUTLIER -167.74 159.76 12.04 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.717 0.77 . . . . 0.0 111.462 -164.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 18.1 t-20 -114.04 158.8 20.74 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.915 -1.493 . . . . 0.0 109.591 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' GLU . . . . . 0.521 ' OE2' ' HE3' ' B' ' 24' ' ' LYS . 8.5 mm-40 -74.06 -34.14 63.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.004 0.43 . . . . 0.0 110.898 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.548 ' O ' HG23 ' B' ' 71' ' ' THR . 53.0 tttm -68.94 -31.69 70.76 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.049 0.928 . . . . 0.0 109.319 176.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 30.4 m -79.62 0.3 30.74 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.843 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.548 HG23 ' O ' ' B' ' 69' ' ' LYS . 20.1 p 53.64 100.58 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.436 1.494 . . . . 0.0 113.678 165.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 m -56.68 -21.77 14.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.069 -176.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.67 -54.64 35.73 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.544 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -69.4 -31.93 70.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.202 0.525 . . . . 0.0 110.172 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.513 HG13 ' O ' ' B' ' 71' ' ' THR . 2.9 mt -70.11 -42.61 79.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.239 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -58.02 -30.25 65.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.752 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -52.6 -53.32 48.31 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.767 0.794 . . . . 0.0 109.633 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.684 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 4.9 m-20 -65.1 -40.67 94.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.461 177.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.819 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 44.5 mm -54.31 -32.33 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.314 0.578 . . . . 0.0 111.817 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.461 ' OD1' ' HA ' ' B' ' 37' ' ' LYS . 90.5 m-20 -58.43 -31.22 67.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.816 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 4.6 ptpp? -83.43 -4.48 58.54 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.163 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.8 mm? -70.32 -15.83 62.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.717 0.294 . . . . 0.0 110.667 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 44.01 61.66 2.25 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.813 -171.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.442 HG22 ' O ' ' B' ' 85' ' ' LYS . 73.0 mt -60.04 146.37 10.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.362 -1.29 . . . . 0.0 112.6 -172.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.442 ' O ' HG22 ' B' ' 84' ' ' ILE . 30.0 mmmt -92.11 -166.07 1.48 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.132 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.581 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -148.55 114.16 0.66 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.808 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.464 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 6.2 tpt -152.42 -68.89 0.16 Allowed 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 122.531 0.333 . . . . 0.0 110.124 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' TYR . . . . . 0.464 ' N ' ' HG3' ' B' ' 87' ' ' MET . 5.1 t80 -143.41 106.57 4.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.072 0.463 . . . . 0.0 109.835 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.669 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 37.0 mm -91.85 130.28 41.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.04 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -121.65 169.47 10.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.793 0.33 . . . . 0.0 110.154 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.436 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 70.5 mt -146.72 130.28 9.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.24 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 39.9 pttt -165.03 159.57 18.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.124 0.488 . . . . 0.0 111.42 174.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.502 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.6 OUTLIER -106.69 138.78 42.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.863 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.2 pt . . . . . 0 C--O 1.246 0.88 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.042 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' MET . . . . . 0.426 ' O ' HG12 ' B' ' 13' ' ' ILE . 90.3 mmm . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 121.672 0.748 . . . . 0.0 112.108 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -51.11 -27.52 8.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.865 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 5.1 m -66.6 -31.07 71.53 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.288 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.426 HG12 ' O ' ' B' ' 10' ' ' MET . 11.4 mm -63.77 -31.0 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.647 0.737 . . . . 0.0 109.888 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -92.09 -44.36 8.87 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.812 -172.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 14.5 p -70.89 -45.24 64.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.095 -178.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 91.4 t -68.51 -30.14 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.585 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -53.79 -47.17 71.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.258 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.1 OUTLIER -78.95 -42.63 26.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.619 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -58.65 -43.05 89.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.401 -176.101 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.656 HD22 HG11 ' B' ' 72' ' ' VAL . 19.7 mt -80.24 -24.24 40.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -105.62 70.93 0.89 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.818 0.342 . . . . 0.0 111.249 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 33.6 mtmt -138.31 -91.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.817 175.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.434 ' O ' ' HA2' ' B' ' 46' ' ' GLY . . . -92.93 32.42 5.64 Favored Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.567 ' N ' ' HD2' ' B' ' 24' ' ' LYS . 0.0 OUTLIER -124.27 -163.08 1.12 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 174.119 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.648 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -67.96 144.97 44.16 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.184 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.546 ' HE2' ' HB3' ' B' ' 43' ' ' ALA . 44.7 mttm -62.2 144.5 55.41 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.424 ' CD2' ' HB3' ' B' ' 40' ' ' SER . 4.0 mt -150.07 118.45 6.45 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.118 0.485 . . . . 0.0 110.91 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 14.4 m -99.06 97.97 9.04 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.338 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.496 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 10.4 mp -86.14 163.0 18.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.797 0.808 . . . . 0.0 112.094 -172.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.1 p -146.69 148.82 32.41 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.111 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 58.0 mtt -96.49 139.7 32.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.106 0.479 . . . . 0.0 111.68 -173.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ASN . . . . . 0.524 ' O ' ' HB3' ' B' ' 35' ' ' GLN . 8.6 t30 -157.15 91.92 1.22 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.833 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.98 -97.55 0.51 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -172.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -142.1 21.61 2.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.563 ' CG ' ' HG2' ' B' ' 37' ' ' LYS . 0.1 OUTLIER -85.71 158.27 20.09 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.893 -176.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tt -111.85 98.06 7.12 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.887 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.563 ' HG2' ' CG ' ' B' ' 35' ' ' GLN . 11.1 mtmt -112.1 137.17 50.53 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' B' ' 29' ' ' LEU . . . -173.4 169.96 4.3 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -170.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 5.8 p -128.17 140.34 51.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.591 170.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 74.1 p -123.66 165.41 17.26 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -169.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' B' ' 26' ' ' LYS . 32.3 t -131.62 157.98 42.26 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.481 176.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -117.04 18.31 14.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.331 -172.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.546 ' HB3' ' HE2' ' B' ' 26' ' ' LYS . . . -63.64 -21.86 66.59 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.585 ' O ' HD11 ' B' ' 47' ' ' ILE . . . -143.14 -48.6 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.099 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.648 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 3.4 p90 52.93 -164.55 0.08 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.966 1.306 . . . . 0.0 113.852 -176.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.514 ' N ' ' HD1' ' B' ' 45' ' ' TYR . . . -57.87 100.12 0.13 Allowed Glycine 0 C--N 1.342 0.88 0 N-CA-C 114.601 0.6 . . . . 0.0 114.601 -174.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.585 HD11 ' O ' ' B' ' 44' ' ' GLY . 3.8 mm -108.53 -67.81 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-O 121.59 0.71 . . . . 0.0 110.777 173.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -51.16 -62.62 1.51 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.579 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -83.48 127.01 33.37 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.772 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.69 -171.97 1.73 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.18 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -65.53 107.07 1.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.368 0.604 . . . . 0.0 109.706 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 6.4 mtmp? -145.4 128.83 16.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.621 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -102.73 124.85 49.02 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.532 0.682 . . . . 0.0 112.357 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.61 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 51.4 p-90 -141.15 163.7 32.26 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.368 169.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.82 156.8 23.02 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 119.772 -1.204 . . . . 0.0 113.317 -172.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.45 HD12 ' CD2' ' B' ' 64' ' ' TYR . 22.1 mt -111.82 137.74 43.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 174.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.726 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 46.0 m-85 -124.77 132.12 53.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.014 -174.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.531 HG13 ' ND2' ' B' ' 59' ' ' ASN . 13.4 p -112.48 136.27 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.916 177.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.531 ' ND2' HG13 ' B' ' 58' ' ' VAL . 9.9 m-80 71.04 -7.93 1.05 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.538 0.735 . . . . 0.0 110.905 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.25 5.9 39.76 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -169.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' B' ' 58' ' ' VAL . 25.9 mt-10 -106.55 165.76 11.05 Favored 'General case' 0 C--O 1.198 -1.642 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 174.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.475 ' HA ' ' CD1' ' B' ' 57' ' ' PHE . 27.8 ttmt -78.5 168.93 19.05 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.82 -10.08 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.326 165.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.649 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.5 OUTLIER -158.1 125.79 5.2 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.413 -170.169 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -134.42 132.2 39.07 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.178 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.439 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.0 OUTLIER -163.76 165.97 22.53 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 122.161 0.981 . . . . 0.0 111.162 -175.882 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.627 ' HB2' ' OG ' ' B' ' 70' ' ' SER . 24.5 m-80 -116.72 144.63 44.21 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.493 169.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -64.67 -15.8 61.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.824 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -92.82 -25.28 18.2 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.252 0.549 . . . . 0.0 109.846 177.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.627 ' OG ' ' HB2' ' B' ' 67' ' ' ASN . 38.2 m -76.98 -5.57 49.17 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.458 -175.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.495 HG22 ' H ' ' B' ' 46' ' ' GLY . 3.3 p 66.27 99.84 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.741 169.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.656 HG11 HD22 ' B' ' 20' ' ' LEU . 7.8 m -65.67 -13.11 14.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.45 -176.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.55 -51.95 51.28 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.1 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -67.94 -42.68 80.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.312 0.577 . . . . 0.0 110.263 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.499 ' O ' HG12 ' B' ' 79' ' ' ILE . 2.6 mt -64.97 -42.03 93.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.54 -174.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 55.7 m -59.13 -30.29 68.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.229 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' B' ' 80' ' ' ASN . 46.9 t-20 -52.39 -54.6 29.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.607 0.718 . . . . 0.0 109.388 174.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.66 -39.49 94.46 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.634 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.649 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 48.4 mm -58.67 -33.54 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 123.021 0.528 . . . . 0.0 112.085 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' B' ' 77' ' ' ASN . 5.7 m-80 -54.81 -35.89 64.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.558 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -78.46 -14.07 59.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.782 0.325 . . . . 0.0 111.111 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.7 mm? -65.56 -22.58 66.71 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.558 -173.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 55.9 t30 46.01 57.58 5.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.938 -172.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.546 ' HB ' ' HA ' ' B' ' 35' ' ' GLN . 88.6 mt -59.38 141.98 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.203 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -87.44 -164.13 1.04 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.273 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -150.35 115.26 0.7 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.027 -1.082 . . . . 0.0 113.322 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 28.4 ttp -154.06 -75.2 0.12 Allowed 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.565 0.183 . . . . 0.0 110.591 172.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' TYR . . . . . 0.53 ' H ' ' HA ' ' B' ' 59' ' ' ASN . 44.7 t80 -121.49 93.45 4.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.192 0.52 . . . . 0.0 109.925 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.726 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.0 mp -95.32 128.95 46.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.795 -177.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 43.3 mt-10 -114.15 144.36 43.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.29 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.61 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 50.0 mm -126.23 112.4 29.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.99 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -166.49 158.39 13.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.477 0.656 . . . . 0.0 112.424 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.607 ' H ' ' CD ' ' B' ' 93' ' ' GLN . 4.5 pm0 -79.27 145.99 33.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.78 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.9 pt . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.254 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' MET . . . . . 0.412 ' O ' HG13 ' B' ' 13' ' ' ILE . 98.5 mmm . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -37.96 -24.93 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.887 1.675 . . . . 0.0 114.848 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.52 ' O ' HG23 ' B' ' 16' ' ' VAL . 8.8 m -61.87 -9.14 6.05 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.475 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.1 OUTLIER -51.27 -58.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 CA-C-O 122.008 0.909 . . . . 0.0 110.112 -177.312 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -79.39 -27.74 41.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.204 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.62 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 15.1 m -61.11 -39.14 88.86 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.52 HG23 ' O ' ' B' ' 12' ' ' SER . 99.0 t -69.06 -45.4 80.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.27 0.557 . . . . 0.0 109.866 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -52.43 -49.02 65.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.699 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.3 -31.86 60.8 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.78 -176.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.3 OUTLIER -61.82 -44.97 95.79 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 122.812 0.445 . . . . 0.0 111.406 177.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.423 HD21 ' HZ2' ' B' ' 54' ' ' TRP . 72.5 mt -81.53 -39.27 24.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.659 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -81.48 70.82 8.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.037 0.446 . . . . 0.0 111.33 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -144.33 -72.26 0.27 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.264 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.414 ' O ' ' HA2' ' B' ' 46' ' ' GLY . . . -119.01 44.75 1.35 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.072 -176.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -111.92 -158.05 0.64 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.685 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -83.27 -166.66 40.17 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.347 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.83 ' O ' ' HA ' ' B' ' 40' ' ' SER . 44.7 mtmt -67.84 98.57 0.74 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' B' ' 39' ' ' THR . 21.0 tp -124.88 115.7 21.05 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.23 -163.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 51.4 m -105.61 105.86 16.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.387 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.422 ' N ' HD22 ' B' ' 29' ' ' LEU . 2.5 mm? -83.31 149.57 26.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.313 0.578 . . . . 0.0 110.376 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p -146.27 147.47 31.44 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.36 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 62.0 mtt -116.42 145.34 43.33 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.103 0.478 . . . . 0.0 111.796 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -160.3 105.78 1.51 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.66 -122.81 18.09 Favored Glycine 0 CA--C 1.503 -0.681 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -167.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.523 HD22 ' CG1' ' B' ' 89' ' ' ILE . 2.0 m-20 -119.31 25.2 10.27 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.497 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 48.7 mt-30 -79.42 156.34 27.95 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.74 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.404 HD21 HD12 ' B' ' 29' ' ' LEU . 1.2 tt -114.77 88.2 2.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.127 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -96.37 141.05 30.16 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -171.45 160.64 6.07 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -171.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 2.1 p -134.85 143.73 47.18 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.713 171.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.83 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 9.9 t -144.87 149.19 34.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.438 0.637 . . . . 0.0 111.965 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.473 ' CB ' ' HE3' ' B' ' 26' ' ' LYS . 6.8 m -111.98 163.83 13.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.561 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -113.08 33.78 4.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.02 -173.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.45 -1.53 30.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.032 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.63 -43.67 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.685 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 31.2 p90 43.75 -154.62 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.884 1.274 . . . . 0.0 114.281 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' B' ' 23' ' ' GLY . . . -77.11 107.94 2.48 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.681 -173.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.71 -54.92 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.338 0.589 . . . . 0.0 110.276 176.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.1 m -34.36 -57.8 0.49 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.098 -1.41 . . . . 0.0 114.323 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -75.06 -5.8 46.04 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.136 -173.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' B' ' 69' ' ' LYS . 46.3 mt-10 54.99 -92.39 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 123.498 0.499 . . . . 0.0 110.297 -168.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -136.31 110.09 8.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.589 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 33.7 mmtp -131.92 138.89 48.54 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -114.0 130.62 56.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.912 0.387 . . . . 0.0 110.053 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.51 ' HA ' HG12 ' B' ' 94' ' ' ILE . 18.5 p-90 -146.07 168.58 20.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.895 175.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -133.25 144.0 15.83 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.776 -174.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.445 HD12 ' CD2' ' B' ' 64' ' ' TYR . 15.6 mt -107.82 148.01 12.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 171.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.69 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 71.5 m-85 -129.57 136.76 50.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.51 -171.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.634 HG12 ' HB ' ' B' ' 63' ' ' VAL . 10.6 p -122.44 135.82 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 2.4 m120 60.7 14.24 4.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.389 -172.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.65 -18.3 57.52 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.458 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' B' ' 58' ' ' VAL . 0.6 OUTLIER -87.92 165.61 15.12 Favored 'General case' 0 C--O 1.194 -1.821 0 C-N-CA 123.795 0.838 . . . . 0.0 108.831 -179.026 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.607 ' HA ' ' CD1' ' B' ' 57' ' ' PHE . 2.2 tttt -65.23 164.8 12.63 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 120.529 -0.469 . . . . 0.0 109.827 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.634 ' HB ' HG12 ' B' ' 58' ' ' VAL . 7.5 p -154.5 -13.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.084 0.468 . . . . 0.0 110.481 172.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.786 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.7 OUTLIER -159.65 124.56 4.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.215 0.531 . . . . 0.0 110.913 -171.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 21.3 m -131.9 127.92 37.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.102 176.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.527 ' HB2' HD13 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -168.31 149.42 4.97 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.171 0.986 . . . . 0.0 111.872 -171.535 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.495 ' O ' ' HB3' ' B' ' 70' ' ' SER . 26.4 t-20 -103.39 146.82 27.92 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.165 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -67.59 -21.7 65.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.775 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.494 ' O ' HG23 ' B' ' 71' ' ' THR . 1.5 tmtp? -88.05 -23.28 23.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.361 0.601 . . . . 0.0 109.526 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 5.2 t -65.7 -27.31 68.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.979 172.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.494 HG23 ' O ' ' B' ' 69' ' ' LYS . 23.5 p 61.24 123.24 0.01 OUTLIER 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.004 1.322 . . . . 0.0 113.057 174.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.425 ' HB ' ' OG ' ' B' ' 76' ' ' SER . 12.3 m -62.93 -11.2 6.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 114.405 -1.271 . . . . 0.0 113.239 -170.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' GLY . . . . . 0.537 ' HA2' ' HB3' ' B' ' 40' ' ' SER . . . -56.24 -54.21 37.39 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.267 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -73.41 -35.21 65.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.263 0.554 . . . . 0.0 110.127 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' B' ' 66' ' ' PHE . 1.6 mt -74.6 -55.74 11.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.723 -172.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.433 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 49.3 m -60.48 -30.64 69.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.863 -174.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -49.5 -52.19 31.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.83 0.824 . . . . 0.0 109.658 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 5.0 m-20 -67.31 -44.66 78.66 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.363 -1.289 . . . . 0.0 111.286 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.786 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 49.3 mm -50.82 -33.12 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.28 0.562 . . . . 0.0 112.26 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.417 HD22 ' H ' ' B' ' 38' ' ' ALA . 5.1 m-20 -64.34 -29.27 70.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.919 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 49.7 pttt -81.39 -6.23 58.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.076 0.465 . . . . 0.0 110.549 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 4.2 mm? -73.57 -10.27 59.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.014 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 33.58 64.96 0.3 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.265 1.031 . . . . 0.0 111.113 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.497 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 60.3 mt -60.46 150.55 6.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 113.866 -1.516 . . . . 0.0 112.518 -170.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.426 ' O ' HG22 ' B' ' 84' ' ' ILE . 65.8 mttm -89.38 -177.16 5.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.286 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.76 112.87 0.72 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.898 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.477 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 7.6 tpt -151.87 -74.58 0.14 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.575 0.226 . . . . 0.0 110.575 176.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 88' ' ' TYR . . . . . 0.477 ' N ' ' HG3' ' B' ' 87' ' ' MET . 35.5 t80 -124.64 100.2 6.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.69 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 29.1 mm -100.98 120.31 50.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.732 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -111.61 -179.53 3.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.514 0.673 . . . . 0.0 110.959 174.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.472 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 83.9 mt -153.56 131.17 2.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.033 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.585 ' HE2' ' CE2' ' B' ' 57' ' ' PHE . 42.8 pttt -171.05 150.03 3.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.038 0.447 . . . . 0.0 111.3 176.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.484 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.8 OUTLIER -84.67 153.01 23.39 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.552 172.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' B' ' 54' ' ' TRP . 7.5 pt . . . . . 0 C--N 1.314 -0.957 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.089 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' MET . . . . . 0.511 ' O ' HG12 ' B' ' 13' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ASN . . . . . 0.548 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 21.4 t-20 -50.87 -24.95 3.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -176.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.505 ' HA ' ' CG2' ' B' ' 16' ' ' VAL . 20.1 m -66.72 -14.83 63.02 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.276 -0.265 . . . . 0.0 111.69 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.511 HG12 ' O ' ' B' ' 10' ' ' MET . 16.0 mm -61.44 -52.64 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.015 0.436 . . . . 0.0 110.987 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -106.74 -63.02 1.32 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.024 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.467 ' HB3' ' OD1' ' B' ' 11' ' ' ASN . 32.6 t -59.61 -60.34 4.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.071 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.505 ' CG2' ' HA ' ' B' ' 12' ' ' SER . 47.4 t -57.78 -40.52 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.872 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -58.26 -51.23 70.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.07 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.55 -34.03 58.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.59 0.233 . . . . 0.0 111.518 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 13.1 tppt? -64.01 -47.74 79.07 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.465 0.65 . . . . 0.0 110.86 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.429 HD21 ' CZ ' ' B' ' 66' ' ' PHE . 28.3 mt -67.35 -46.68 72.67 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.774 176.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -88.12 53.9 2.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.191 0.52 . . . . 0.0 111.116 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' B' ' 19' ' ' LYS . 30.5 mtpp -83.9 -25.3 30.31 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 166.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.452 ' HA3' ' OH ' ' B' ' 49' ' ' TYR . . . 165.47 -93.94 0.11 Allowed Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 114.317 -1.311 . . . . 0.0 110.356 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.57 -125.12 0.38 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.511 0.724 . . . . 0.0 110.553 -176.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.59 137.37 15.23 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.768 ' O ' ' HA ' ' B' ' 40' ' ' SER . 41.0 mtmt -61.64 100.59 0.15 Allowed 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -177.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.465 HD21 HD11 ' B' ' 29' ' ' LEU . 43.9 tp -128.46 124.03 35.16 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 120.877 0.37 . . . . 0.0 110.06 -171.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.662 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 5.2 p -105.41 100.49 10.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.445 -176.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.465 HD11 HD21 ' B' ' 27' ' ' LEU . 2.1 mm? -87.96 147.95 24.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.736 0.779 . . . . 0.0 111.439 -175.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.9 p -142.67 141.32 31.84 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.939 168.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.78 131.34 54.01 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.359 -173.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -140.2 68.35 1.36 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.97 -102.4 0.51 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.498 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' B' ' 84' ' ' ILE . 5.3 m-20 -79.28 -24.17 43.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.756 0.312 . . . . 0.0 111.043 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -94.96 147.1 23.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.958 0.885 . . . . 0.0 111.819 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 33.4 tp -128.59 99.49 5.39 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 113.973 -1.467 . . . . 0.0 107.674 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -95.82 137.81 34.36 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.983 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.662 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -160.97 156.73 25.23 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.143 -170.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.47 147.12 47.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 171.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.768 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 6.9 t -138.62 162.87 33.52 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 47.3 t -136.29 162.17 33.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.8 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -113.68 30.68 7.06 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.534 0.683 . . . . 0.0 109.619 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.18 21.45 0.13 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.112 -173.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.51 -32.66 0.58 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.731 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.555 ' CD1' HG21 ' B' ' 71' ' ' THR . 19.0 p90 44.22 -157.27 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.578 1.151 . . . . 0.0 113.365 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.422 ' N ' ' HD1' ' B' ' 45' ' ' TYR . . . -67.07 96.12 0.31 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.748 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.562 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -91.2 -71.28 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.274 0.559 . . . . 0.0 110.593 -177.311 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.4 m -62.86 -48.61 78.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.202 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.452 ' OH ' ' HA3' ' B' ' 23' ' ' GLY . 11.5 m-85 -39.52 119.45 0.95 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.699 -1.591 . . . . 0.0 112.365 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -74.58 -171.15 1.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.22 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.5 109.39 13.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.731 0.777 . . . . 0.0 109.348 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.611 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 76.4 mttt -131.87 123.61 27.85 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.409 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -111.18 118.48 36.08 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.454 0.645 . . . . 0.0 110.777 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.664 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 40.5 p-90 -143.19 166.46 24.62 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.375 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.63 147.79 18.75 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.595 -174.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.47 HD12 ' CD2' ' B' ' 64' ' ' TYR . 18.4 mt -103.9 144.82 13.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 170.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.672 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 68.4 m-85 -125.15 141.06 52.34 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.493 -174.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.61 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.3 p -126.55 134.66 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.413 ' OD1' HG13 ' B' ' 58' ' ' VAL . 5.7 m120 68.24 0.85 2.62 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.461 0.705 . . . . 0.0 109.297 -174.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.26 -0.9 50.47 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.588 -173.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -104.48 178.13 4.65 Favored 'General case' 0 C--O 1.203 -1.342 0 C-N-CA 124.018 0.927 . . . . 0.0 109.396 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.466 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.5 tppp? -65.98 161.07 22.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 118.765 0.711 . . . . 0.0 109.8 174.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.61 ' HB ' HG12 ' B' ' 58' ' ' VAL . 11.2 p -152.87 -18.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.094 0.473 . . . . 0.0 110.229 167.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.756 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.3 OUTLIER -160.66 127.95 4.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.94 0.4 . . . . 0.0 110.235 -171.396 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 6.1 m -135.16 129.09 33.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.527 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.614 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.1 OUTLIER -162.66 -176.47 5.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 122.357 1.075 . . . . 0.0 112.191 -174.773 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.9 t-20 -138.79 148.53 43.92 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 112.831 -1.986 . . . . 0.0 108.044 176.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -43.79 70.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.253 0.478 . . . . 0.0 111.79 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.489 ' O ' HG23 ' B' ' 71' ' ' THR . 58.4 mtpt -78.88 -16.26 57.27 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.853 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 3.2 t -73.28 -20.17 60.89 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.555 HG21 ' CD1' ' B' ' 45' ' ' TYR . 19.3 p 58.64 109.55 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.594 1.157 . . . . 0.0 112.533 170.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.609 ' HA ' HD12 ' B' ' 75' ' ' ILE . 11.4 m -61.43 -10.88 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.431 -169.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.75 -56.93 21.49 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.193 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -69.32 -31.31 69.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.307 0.575 . . . . 0.0 110.313 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.614 HD13 ' HB3' ' B' ' 66' ' ' PHE . 3.2 mt -70.5 -48.79 57.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.93 -177.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 34.2 t -56.38 -33.74 66.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.095 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -50.63 -54.74 20.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.695 0.76 . . . . 0.0 110.162 175.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 34.7 m-20 -64.79 -44.55 89.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.405 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.756 HG13 ' CE1' ' B' ' 64' ' ' TYR . 42.5 mm -55.47 -30.46 25.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -176.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -59.37 -25.24 64.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.7 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 16.4 ptmt -85.65 -3.36 58.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.727 0.298 . . . . 0.0 111.304 -175.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.2 mm? -73.8 -11.9 60.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.55 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 52.26 65.84 1.39 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.812 0.815 . . . . 0.0 109.068 -169.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.423 HG23 HG21 ' B' ' 63' ' ' VAL . 65.5 mt -57.49 156.54 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.504 -1.226 . . . . 0.0 111.484 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -113.66 -178.09 3.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.269 177.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.31 112.14 0.72 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.76 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.584 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 5.6 tpt -154.79 -72.7 0.12 Allowed 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 120.491 0.186 . . . . 0.0 110.873 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 88' ' ' TYR . . . . . 0.584 ' N ' ' HG3' ' B' ' 87' ' ' MET . 75.9 t80 -134.48 116.73 15.45 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 21.3 mm -104.96 145.21 13.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.458 -177.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.541 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 33.4 mm-40 -135.97 156.29 48.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.38 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.664 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 67.8 mt -135.13 126.21 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.738 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.418 ' HE2' ' CE2' ' B' ' 57' ' ' PHE . 49.3 pttt -175.24 153.13 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.699 0.285 . . . . 0.0 111.533 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -75.71 150.92 37.76 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.325 0.583 . . . . 0.0 111.209 175.555 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.424 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.7 pt . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.459 -0.781 . . . . 0.0 111.634 -172.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' MET . . . . . 0.465 ' C ' HD13 ' B' ' 13' ' ' ILE . 77.4 mmm . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 121.544 0.687 . . . . 0.0 111.643 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -109.61 -18.59 13.45 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.512 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -59.39 -21.12 59.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.829 0.823 . . . . 0.0 109.668 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.555 ' H ' ' CD1' ' B' ' 13' ' ' ILE . 1.4 mp -61.91 -34.41 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.354 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -106.7 -62.92 1.33 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.709 -173.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 49.8 m -66.12 -59.93 3.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.555 -172.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 70.6 t -55.82 -46.25 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.928 0.394 . . . . 0.0 111.359 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -56.28 -46.4 79.76 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.719 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.43 -42.72 58.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.786 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -61.89 -47.47 84.84 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 123.458 0.703 . . . . 0.0 111.936 -175.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.649 HD22 HG11 ' B' ' 72' ' ' VAL . 64.0 mt -75.53 -19.48 59.32 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.778 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -104.29 79.1 1.56 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.01 0.434 . . . . 0.0 110.323 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -130.17 19.86 5.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.572 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.49 25.63 7.65 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.389 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.635 ' HG2' ' CZ ' ' B' ' 49' ' ' TYR . 43.3 mttt -98.35 -140.02 0.3 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.617 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -65.52 142.66 44.44 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 172.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' B' ' 40' ' ' SER . 47.3 mttm -61.82 132.5 53.31 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 18.0 tp -152.5 104.87 2.95 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 -174.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 20.3 m -103.52 110.91 23.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.065 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.421 ' N ' HD22 ' B' ' 29' ' ' LEU . 2.6 mm? -90.87 152.91 20.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.746 0.784 . . . . 0.0 111.894 -173.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.7 p -145.92 147.11 31.39 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.326 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 57.6 mtt -122.32 140.49 52.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.515 0.674 . . . . 0.0 112.168 -172.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ASN . . . . . 0.492 ' O ' ' HG3' ' B' ' 35' ' ' GLN . 27.1 t-20 -130.37 101.34 5.71 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 173.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.19 -99.87 1.0 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -166.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.488 ' HB2' ' HA2' ' B' ' 86' ' ' GLY . 15.3 m120 -130.6 19.26 5.18 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 171.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' B' ' 32' ' ' ASN . 76.6 mt-30 -69.75 156.0 39.68 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.243 0.544 . . . . 0.0 110.714 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.515 ' H ' HD12 ' B' ' 84' ' ' ILE . 15.4 tp -118.2 106.59 12.98 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.842 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.409 ' HA ' ' OD1' ' B' ' 80' ' ' ASN . 24.0 mtmt -116.07 139.86 49.86 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -156.35 150.82 25.65 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -168.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 8.8 p -115.46 142.42 46.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.32 170.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 32.1 p -138.09 173.07 12.02 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -170.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' B' ' 26' ' ' LYS . 30.7 t -155.19 158.61 39.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.768 174.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -116.26 28.45 8.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.785 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.73 -18.52 65.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.691 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.67 -41.01 0.05 OUTLIER Glycine 0 C--N 1.318 -0.445 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.619 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.617 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 23.1 p90 45.04 -163.49 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.957 1.303 . . . . 0.0 114.264 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.59 ' H ' HG22 ' B' ' 71' ' ' THR . . . -81.11 85.49 1.4 Allowed Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.472 ' H ' HD12 ' B' ' 47' ' ' ILE . 1.0 OUTLIER -59.42 -69.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.4 0.619 . . . . 0.0 110.293 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.1 t -115.37 -92.97 0.5 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.389 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.635 ' CZ ' ' HG2' ' B' ' 24' ' ' LYS . 72.0 m-85 55.18 41.91 31.07 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.651 0.594 . . . . 0.0 110.154 -175.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 35.64 -95.35 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.285 -1.325 . . . . 0.0 112.988 -169.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -171.14 110.74 0.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 74.6 mttt -134.37 126.29 29.3 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -175.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -114.21 126.51 55.14 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.238 0.542 . . . . 0.0 110.578 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.516 ' HA ' HG12 ' B' ' 94' ' ' ILE . 34.3 p-90 -146.64 163.58 35.4 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.734 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -126.96 148.03 17.14 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.944 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.591 HD12 ' CD2' ' B' ' 64' ' ' TYR . 30.1 mt -107.1 148.86 11.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.753 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 89.5 m-85 -128.24 146.62 50.68 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -169.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.495 HG13 ' ND2' ' B' ' 59' ' ' ASN . 8.7 p -130.85 135.9 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.495 ' ND2' HG13 ' B' ' 58' ' ' VAL . 1.7 m-80 60.73 17.58 7.74 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -173.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.39 -3.27 83.82 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.407 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' B' ' 58' ' ' VAL . 24.4 mt-10 -103.34 176.09 5.26 Favored 'General case' 0 C--O 1.2 -1.53 0 C-N-CA 123.459 0.703 . . . . 0.0 109.711 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -60.67 156.75 16.04 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 118.541 0.61 . . . . 0.0 110.616 176.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.466 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.0 p -150.75 -12.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.007 0.432 . . . . 0.0 110.368 166.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.591 ' CD2' HD12 ' B' ' 56' ' ' ILE . 0.9 OUTLIER -162.4 125.26 2.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.239 -173.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 14.2 m -132.03 127.89 37.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.68 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.485 ' HB2' HD13 ' B' ' 75' ' ' ILE . 21.2 p90 -165.45 -175.03 3.39 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 122.017 0.913 . . . . 0.0 112.166 -176.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 18.5 t-20 -138.25 163.42 31.8 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.614 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -67.01 -51.65 52.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.298 0.57 . . . . 0.0 110.847 -176.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.471 ' O ' HG23 ' B' ' 71' ' ' THR . 40.3 ttmt -70.24 -17.75 63.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.23 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 3.2 t -69.06 -10.39 57.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.1 0.476 . . . . 0.0 109.902 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.59 HG22 ' H ' ' B' ' 46' ' ' GLY . 21.2 p 60.44 94.74 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.661 1.184 . . . . 0.0 112.157 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.656 ' HA ' HD12 ' B' ' 75' ' ' ILE . 2.4 m -59.37 -21.38 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.371 -172.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.42 -47.33 76.6 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.606 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -78.61 -36.0 44.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.282 0.563 . . . . 0.0 110.169 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.656 HD12 ' HA ' ' B' ' 72' ' ' VAL . 2.4 mt -65.41 -45.63 92.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.293 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 32.2 t -64.21 -27.52 69.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.624 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -55.37 -44.23 75.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.835 0.826 . . . . 0.0 109.865 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.721 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 10.7 m-20 -69.95 -40.46 75.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.442 -1.253 . . . . 0.0 111.022 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.586 ' HA ' HD23 ' B' ' 82' ' ' LEU . 48.3 mm -58.01 -28.87 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.333 0.587 . . . . 0.0 111.832 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.409 ' OD1' ' HA ' ' B' ' 37' ' ' LYS . 83.8 m-20 -60.38 -23.16 64.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.737 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 17.0 ptmt -96.73 6.38 48.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.808 0.337 . . . . 0.0 111.245 -174.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.4 mm? -78.78 -5.08 52.42 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -175.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 41.9 52.22 4.19 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 123.871 0.732 . . . . 0.0 110.95 -171.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.515 HD12 ' H ' ' B' ' 36' ' ' LEU . 82.8 mt -52.22 147.45 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.768 -171.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.6 -164.27 1.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.119 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.488 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -154.23 113.87 0.59 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.819 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.468 ' CG ' ' HA ' ' B' ' 59' ' ' ASN . 24.6 ptp -173.47 -54.85 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.197 0.199 . . . . 0.0 111.242 175.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' TYR . . . . . 0.43 ' N ' ' HG3' ' B' ' 87' ' ' MET . 1.3 t80 -135.73 84.44 2.09 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.842 -0.536 . . . . 0.0 110.226 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.753 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.1 mp -99.4 114.1 36.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.003 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -98.73 -179.22 4.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.366 0.603 . . . . 0.0 111.355 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 41.7 mt -151.51 114.93 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.573 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -174.64 160.85 3.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.333 0.587 . . . . 0.0 112.309 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.503 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 1.5 pp0? -72.26 158.47 35.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.617 174.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.5 pt . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.899 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 121.261 0.553 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -62.44 -24.71 67.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.776 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.679 ' O ' HG23 ' B' ' 16' ' ' VAL . 15.9 t -66.75 -25.85 66.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.045 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 11.2 mm -58.55 -38.37 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-O 121.703 0.763 . . . . 0.0 109.98 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -71.14 -41.4 70.52 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.959 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.587 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 0.6 OUTLIER -65.36 -34.12 77.56 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.143 177.116 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.679 HG23 ' O ' ' B' ' 12' ' ' SER . 54.5 t -63.29 -42.26 95.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.218 0.533 . . . . 0.0 109.991 175.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -61.94 -42.12 98.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.867 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.76 -40.93 63.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.451 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' B' ' 15' ' ' SER . 4.5 tmtm? -53.4 -73.04 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.54 0.736 . . . . 0.0 112.186 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.541 HD22 HG11 ' B' ' 72' ' ' VAL . 17.4 mt -52.29 -29.87 25.37 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -84.41 74.23 10.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.193 0.52 . . . . 0.0 111.023 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -133.24 -79.48 0.48 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.203 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.21 34.83 2.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.943 -176.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.513 ' HA ' ' HA2' ' B' ' 46' ' ' GLY . 0.9 OUTLIER -122.79 -168.98 1.84 Allowed 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 173.466 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' B' ' 45' ' ' TYR . . . -54.26 137.24 41.79 Favored Glycine 0 N--CA 1.45 -0.41 0 O-C-N 123.961 0.788 . . . . 0.0 111.619 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.463 ' HD2' ' H ' ' B' ' 44' ' ' GLY . 0.0 OUTLIER -87.49 112.12 21.88 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 121.397 0.618 . . . . 0.0 109.911 -170.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.463 HD13 ' O ' ' B' ' 27' ' ' LEU . 0.0 OUTLIER -134.29 143.52 47.79 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.267 177.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 49.3 m -104.03 111.55 24.17 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.879 -173.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -77.5 152.79 33.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.596 0.713 . . . . 0.0 109.932 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 0.3 OUTLIER -144.27 145.48 32.05 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.29 175.303 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 43.6 mtt -112.86 133.1 55.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.072 0.463 . . . . 0.0 111.864 -165.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ASN . . . . . 0.507 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 4.3 t30 -146.11 59.22 1.23 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 47.73 -99.58 0.02 OUTLIER Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.895 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.695 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 8.1 p30 -83.39 16.57 2.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.41 -0.395 . . . . 0.0 111.493 -176.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.507 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 79.6 mt-30 -134.87 146.38 49.18 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.393 0.616 . . . . 0.0 110.735 171.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.511 ' HB3' ' HB ' ' B' ' 84' ' ' ILE . 3.2 tm? -122.39 127.96 50.36 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.558 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.482 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 16.7 mtmt -126.33 146.6 49.97 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -174.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -161.63 151.19 16.46 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -176.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 11.8 p -126.88 142.2 51.61 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 58.9 p -136.75 150.29 48.31 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -167.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 22.7 t -139.56 153.46 47.43 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.707 171.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -115.36 9.39 15.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -170.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.72 -59.84 4.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.814 0.816 . . . . 0.0 110.451 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.463 ' H ' ' HD2' ' B' ' 26' ' ' LYS . . . -91.68 61.28 2.77 Favored Glycine 0 C--N 1.309 -0.927 0 CA-C-N 114.59 -1.187 . . . . 0.0 110.89 175.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.58 ' HA ' ' HA2' ' B' ' 25' ' ' GLY . 0.1 OUTLIER -70.1 -161.91 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.079 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.66 ' H ' HG22 ' B' ' 71' ' ' THR . . . -62.14 107.44 1.58 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.27 -0.49 . . . . 0.0 112.23 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 22.2 mm -85.46 -69.74 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 CA-C-O 122.307 1.051 . . . . 0.0 109.817 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.44 ' C ' ' H ' ' B' ' 50' ' ' GLU . 6.8 m -104.62 -153.82 0.49 Allowed 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 113.634 -1.621 . . . . 0.0 109.391 -176.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 67.76 -12.53 0.29 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.992 0.917 . . . . 0.0 112.432 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' B' ' 48' ' ' SER . 44.7 mt-10 49.77 -105.2 0.16 Allowed 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.839 0.856 . . . . 0.0 111.994 -175.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -129.65 110.71 12.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.586 ' HB2' ' OE1' ' B' ' 68' ' ' GLU . 66.2 mttm -118.19 134.82 54.67 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 170.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -98.17 110.58 23.14 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.551 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 37.5 p-90 -149.38 168.18 24.11 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.444 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.9 156.86 25.68 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.408 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.417 HD12 ' CD2' ' B' ' 64' ' ' TYR . 21.8 mt -108.42 147.68 13.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.683 ' CE1' ' HD3' ' B' ' 62' ' ' LYS . 71.5 m-85 -130.46 139.9 50.54 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -169.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.463 HG23 ' HB ' ' B' ' 63' ' ' VAL . 13.6 t -131.35 138.34 53.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 4.5 m120 64.54 5.26 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.99 0.806 . . . . 0.0 109.238 -174.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.91 17.49 47.64 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.737 -172.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 7.8 mt-10 -120.5 174.56 6.47 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.683 ' HD3' ' CE1' ' B' ' 57' ' ' PHE . 0.0 OUTLIER -67.6 167.82 12.31 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.26 173.382 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.463 ' HB ' HG23 ' B' ' 58' ' ' VAL . 8.6 p -153.77 -15.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.781 164.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.652 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.5 OUTLIER -160.05 124.2 3.74 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.049 -170.29 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 28.1 m -131.94 131.11 42.35 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.797 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.512 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.1 OUTLIER -160.94 -176.55 5.57 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 122.531 1.158 . . . . 0.0 112.312 -174.113 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -133.21 149.67 52.0 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 112.272 -2.24 . . . . 0.0 108.626 173.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' GLU . . . . . 0.586 ' OE1' ' HB2' ' B' ' 52' ' ' LYS . 1.3 mp0 -52.04 -51.03 60.14 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.941 0.401 . . . . 0.0 111.57 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.562 ' O ' HG23 ' B' ' 71' ' ' THR . 88.8 tttt -69.13 -22.95 63.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.602 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.6 t -68.74 -17.06 63.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 174.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.66 HG22 ' H ' ' B' ' 46' ' ' GLY . 30.2 p 56.26 106.15 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.344 1.058 . . . . 0.0 112.865 172.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.541 HG11 HD22 ' B' ' 20' ' ' LEU . 9.5 m -62.7 -10.3 5.24 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.861 -171.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.46 -55.21 31.33 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.463 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -67.79 -36.9 81.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.416 0.627 . . . . 0.0 110.9 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' B' ' 66' ' ' PHE . 1.9 mt -68.53 -49.19 67.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.75 -177.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.421 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 22.9 t -58.81 -29.75 67.09 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.979 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -49.66 -52.23 32.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.893 0.854 . . . . 0.0 109.614 173.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.685 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 0.4 OUTLIER -72.7 -39.66 66.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.945 178.041 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.652 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.1 mm -56.96 -33.25 41.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.12 0.486 . . . . 0.0 112.26 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.511 HD21 ' HB3' ' B' ' 38' ' ' ALA . 7.3 m-80 -61.85 -16.93 54.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.685 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 20.7 pttm -85.05 -7.31 59.17 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.906 0.384 . . . . 0.0 110.469 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.53 HD23 ' HA ' ' B' ' 79' ' ' ILE . 2.5 mm? -69.61 -16.09 63.32 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -174.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 51.7 58.72 5.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.336 -171.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.801 ' H ' HD12 ' B' ' 84' ' ' ILE . 5.2 mp -55.99 148.29 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.517 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.695 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 67.5 mttm -116.8 -167.73 1.34 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.269 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.555 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -142.35 111.24 0.66 Allowed Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.131 -177.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.442 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 16.6 tpp -151.22 -73.43 0.15 Allowed 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 88' ' ' TYR . . . . . 0.442 ' N ' ' HG3' ' B' ' 87' ' ' MET . 32.8 t80 -125.77 97.15 5.03 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 22.9 mm -96.35 126.35 49.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.834 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -121.67 169.77 10.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.115 0.484 . . . . 0.0 110.784 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.538 HD11 HG22 ' B' ' 16' ' ' VAL . 23.6 mm -149.14 121.72 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.768 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.551 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 48.2 pttt -168.83 173.53 7.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.251 0.548 . . . . 0.0 111.452 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.53 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.0 OUTLIER -95.8 149.81 21.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.281 175.746 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.546 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.7 pt . . . . . 0 C--N 1.313 -0.999 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.255 -175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' MET . . . . . 0.661 ' O ' HG12 ' B' ' 13' ' ' ILE . 86.8 mmm . . . . . 0 C--O 1.222 -0.351 0 CA-C-O 121.236 0.541 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -52.51 -23.26 5.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.794 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.535 ' O ' HG23 ' B' ' 16' ' ' VAL . 5.3 m -68.39 -17.07 64.14 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.909 -174.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.661 HG12 ' O ' ' B' ' 10' ' ' MET . 14.2 mm -49.21 -65.08 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.449 0.642 . . . . 0.0 111.26 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -78.3 -25.63 46.66 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.555 -177.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.433 ' HB2' ' HA ' ' B' ' 12' ' ' SER . 23.7 m -67.7 -33.33 74.68 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.003 -176.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.535 HG23 ' O ' ' B' ' 12' ' ' SER . 71.5 t -67.84 -42.47 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.5 0.667 . . . . 0.0 109.478 176.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ASN . . . . . 0.637 ' OD1' HD22 ' B' ' 29' ' ' LEU . 4.1 t30 -59.08 -58.71 7.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.264 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.39 -12.15 60.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.857 -177.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' B' ' 16' ' ' VAL . 14.2 tppt? -78.24 -50.19 12.34 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.5 0.667 . . . . 0.0 111.059 173.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.465 HD21 ' HZ2' ' B' ' 54' ' ' TRP . 82.1 mt -80.1 -22.81 41.78 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.202 -178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -116.14 93.14 4.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.433 0.635 . . . . 0.0 110.643 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -138.59 -70.41 0.42 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.222 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.56 49.14 0.77 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -127.96 -138.47 0.24 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.437 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -76.31 163.36 52.95 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.688 ' HE3' ' OG ' ' B' ' 41' ' ' SER . 0.0 OUTLIER -70.26 150.6 46.23 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.221 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.546 ' HA ' ' O ' ' B' ' 39' ' ' THR . 16.5 tp -149.06 123.76 9.84 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -173.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 16.1 m -106.85 96.74 6.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.298 0.57 . . . . 0.0 111.468 -177.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.637 HD22 ' OD1' ' B' ' 17' ' ' ASN . 0.2 OUTLIER -68.5 147.92 51.31 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.266 1.426 . . . . 0.0 114.496 -167.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 11.4 p -155.18 152.97 30.03 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.138 171.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 61.3 mtt -115.01 149.16 37.86 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -166.67 120.28 1.05 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.181 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.1 -116.78 9.55 Favored Glycine 0 CA--C 1.506 -0.481 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.879 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.446 ' HA ' ' CD1' ' B' ' 13' ' ' ILE . 20.6 m120 -121.33 22.98 10.63 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 172.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.604 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 49.6 mt-30 -86.35 160.96 18.94 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.311 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' B' ' 36' ' ' LEU . 1.1 tm? -128.69 98.96 5.16 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 169.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.463 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 6.0 mtmp? -97.2 146.37 25.15 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.531 -177.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -173.36 142.91 1.03 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -93.02 159.12 15.44 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 177.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.486 ' OG ' ' HA2' ' B' ' 73' ' ' GLY . 11.6 p -149.92 151.06 32.8 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.592 -170.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.688 ' OG ' ' HE3' ' B' ' 26' ' ' LYS . 0.1 OUTLIER -129.83 140.79 50.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.986 177.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -94.5 41.49 1.09 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.905 -170.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.7 -60.08 3.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.244 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.68 -35.87 3.66 Favored Glycine 0 C--N 1.316 -0.572 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.737 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.437 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 23.7 p90 49.21 -166.35 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.871 1.268 . . . . 0.0 113.98 177.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.7 97.57 1.49 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.602 -175.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.484 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -108.92 -55.92 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.386 0.612 . . . . 0.0 109.74 175.079 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.9 m -39.31 -57.09 1.43 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.523 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -80.38 4.67 17.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.985 -173.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 50.47 -98.03 0.05 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.694 0.797 . . . . 0.0 112.331 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -142.46 113.37 7.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.395 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 94.6 mttt -138.13 143.36 40.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.284 175.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.419 ' HB3' ' OD1' ' B' ' 67' ' ' ASN . 0.4 OUTLIER -112.87 117.9 33.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.176 0.513 . . . . 0.0 110.715 177.108 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.628 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 48.9 p-90 -131.45 164.43 25.76 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -125.19 148.69 16.88 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.472 -173.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.456 ' C ' HG12 ' B' ' 63' ' ' VAL . 7.7 mt -100.41 150.33 5.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 170.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.783 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 74.9 m-85 -129.97 138.65 50.95 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.202 -174.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' B' ' 61' ' ' GLU . 13.5 p -121.9 131.72 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.33 7.98 3.2 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.251 0.548 . . . . 0.0 109.697 -174.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.57 -17.09 40.06 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.242 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 0.6 OUTLIER -91.5 170.21 10.14 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 123.185 0.594 . . . . 0.0 110.105 -177.098 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.432 ' HA ' ' CD1' ' B' ' 57' ' ' PHE . 5.4 tppp? -55.74 158.24 3.71 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.915 0.388 . . . . 0.0 110.007 172.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.456 HG12 ' C ' ' B' ' 56' ' ' ILE . 10.0 p -144.91 -18.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 168.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.558 ' CE2' HG23 ' B' ' 75' ' ' ILE . 1.6 t80 -171.08 153.04 3.63 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.71 -175.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.531 HG23 ' CD1' ' B' ' 94' ' ' ILE . 80.0 m -138.6 135.76 35.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.521 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.722 ' CD2' HD13 ' B' ' 75' ' ' ILE . 23.8 p90 -168.55 158.53 9.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.795 0.807 . . . . 0.0 111.521 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 5.6 m120 -113.61 151.58 31.51 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.02 -1.445 . . . . 0.0 112.001 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -61.91 -42.5 99.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.529 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.489 ' O ' HG23 ' B' ' 71' ' ' THR . 22.0 tptp -59.98 -36.12 76.46 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.02 0.914 . . . . 0.0 110.175 176.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' B' ' 67' ' ' ASN . 58.5 m -70.37 -10.33 58.75 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.264 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.489 HG23 ' O ' ' B' ' 69' ' ' LYS . 8.2 p 65.08 124.02 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 126.134 1.774 . . . . 0.0 113.209 170.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.662 ' HA ' HD12 ' B' ' 75' ' ' ILE . 3.6 m -64.57 -5.56 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.097 -173.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' GLY . . . . . 0.486 ' HA2' ' OG ' ' B' ' 40' ' ' SER . . . -67.28 -55.16 16.81 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.432 -0.413 . . . . 0.0 113.228 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -73.17 -23.38 60.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 122.048 0.928 . . . . 0.0 109.09 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.722 HD13 ' CD2' ' B' ' 66' ' ' PHE . 68.0 mt -68.79 -54.84 18.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 113.904 -1.498 . . . . 0.0 112.745 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 18.2 t -54.57 -37.82 65.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.901 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -50.85 -49.43 58.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.982 0.896 . . . . 0.0 110.599 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.533 ' HA ' ' HG2' ' B' ' 81' ' ' LYS . 72.1 m-20 -64.9 -46.89 79.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.912 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.457 HG12 ' CD2' ' B' ' 64' ' ' TYR . 66.3 mt -51.96 -37.53 21.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.325 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.456 ' OD1' ' HA ' ' B' ' 37' ' ' LYS . 32.5 m-20 -75.07 -38.49 61.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.383 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.533 ' HG2' ' HA ' ' B' ' 78' ' ' ASP . 6.4 ptpp? -75.47 -21.31 58.18 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.222 -176.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.438 HD23 ' O ' ' B' ' 78' ' ' ASP . 1.7 mm? -63.9 -22.01 66.73 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.869 0.366 . . . . 0.0 110.154 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 45.35 64.79 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.697 -171.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.604 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 55.6 mt -62.89 149.89 9.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.21 -175.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.437 ' NZ ' ' HB3' ' B' ' 85' ' ' LYS . 7.7 mtpm? -90.18 179.42 5.92 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.827 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -133.68 113.25 1.18 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 119.693 -1.241 . . . . 0.0 112.466 -176.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 17.8 ttt -154.31 -77.09 0.11 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 123.076 0.55 . . . . 0.0 109.909 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -132.34 81.86 1.98 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.217 0.532 . . . . 0.0 109.668 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.783 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.1 mp -87.72 125.51 41.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.853 178.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -108.83 177.97 4.61 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.356 0.598 . . . . 0.0 110.7 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.628 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 57.5 mt -149.74 110.04 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.632 -178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -167.87 166.67 13.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.273 0.559 . . . . 0.0 112.102 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.63 148.84 26.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.467 -174.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.531 ' CD1' HG23 ' B' ' 65' ' ' THR . 4.2 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.408 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' MET . . . . . 0.585 ' SD ' ' HA ' ' B' ' 88' ' ' TYR . 82.5 mtp . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.82 0.343 . . . . 0.0 111.585 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -57.38 -30.55 64.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.168 0.508 . . . . 0.0 110.888 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.585 ' O ' HG23 ' B' ' 16' ' ' VAL . 1.3 p -63.94 -30.94 71.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.909 -174.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mm -53.79 -45.49 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.858 0.837 . . . . 0.0 110.113 177.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -82.89 -29.99 28.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.976 -177.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' B' ' 12' ' ' SER . 21.8 t -71.5 -27.38 63.18 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.602 -175.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.585 HG23 ' O ' ' B' ' 12' ' ' SER . 87.4 t -58.44 -42.89 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.446 0.641 . . . . 0.0 109.704 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' ASN . . . . . 0.406 ' OD1' HD13 ' B' ' 29' ' ' LEU . 55.9 t30 -63.87 -45.54 88.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.866 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.8 -28.5 62.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.619 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -68.37 -53.08 26.38 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.167 0.508 . . . . 0.0 111.398 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 94.3 mt -73.0 -27.82 62.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.655 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -90.41 75.97 6.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.369 0.604 . . . . 0.0 110.593 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -135.89 62.95 1.61 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.491 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.91 54.48 4.14 Favored Glycine 0 C--N 1.317 -0.5 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.64 ' HB3' ' CD2' ' B' ' 45' ' ' TYR . 33.2 mmtp -137.15 -152.51 0.44 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.223 -0.488 . . . . 0.0 110.396 -174.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' B' ' 45' ' ' TYR . . . -78.69 -177.27 48.87 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 176.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.498 ' HE2' ' HB2' ' B' ' 41' ' ' SER . 4.3 mppt? -88.57 127.9 35.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 117.292 0.546 . . . . 0.0 111.02 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.44 HD22 HG21 ' B' ' 72' ' ' VAL . 13.4 tp -156.03 110.93 2.9 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 19.5 m -108.7 108.86 19.87 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.535 -176.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.539 HD23 HD11 ' B' ' 36' ' ' LEU . 10.2 mp -86.04 158.73 19.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.606 0.717 . . . . 0.0 110.738 176.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.564 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 20.3 m -135.81 140.29 44.12 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.919 173.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -100.59 125.65 46.99 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.792 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -139.59 58.66 1.61 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.43 -95.61 0.01 OUTLIER Glycine 0 C--N 1.335 0.506 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.028 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 14.2 m120 -88.09 15.72 7.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.481 -0.359 . . . . 0.0 111.044 -176.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 16.8 mt-30 -139.95 142.97 36.34 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.558 0.694 . . . . 0.0 110.931 173.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.539 HD11 HD23 ' B' ' 29' ' ' LEU . 32.4 tp -113.58 120.78 42.12 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.818 173.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.564 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 6.6 mmmm -114.48 150.31 35.0 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -174.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.404 ' HB2' ' HG ' ' B' ' 29' ' ' LEU . . . -163.55 143.35 8.49 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 2.8 p -120.86 151.79 39.22 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.4 t -142.89 150.07 39.32 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.126 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.498 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . 5.7 m -126.12 149.77 48.7 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.424 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -82.76 47.9 1.26 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.266 -170.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.49 -3.71 29.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.786 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.37 70.34 1.35 Allowed Glycine 0 CA--C 1.485 -1.808 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.262 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.64 ' CD2' ' HB3' ' B' ' 24' ' ' LYS . 0.8 OUTLIER -65.59 148.86 51.04 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 161.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.583 ' N ' ' CD1' ' B' ' 45' ' ' TYR . . . 109.17 58.86 0.53 Allowed Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -176.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 3.9 mm -85.84 -69.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.521 0.677 . . . . 0.0 109.702 -172.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.2 m -151.8 -130.32 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.021 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.467 ' O ' ' HE2' ' B' ' 52' ' ' LYS . 84.5 m-85 64.23 27.63 13.9 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.004 0.522 . . . . 0.0 111.503 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 43.63 -106.47 0.09 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.593 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.5 ' HB3' HD21 ' B' ' 67' ' ' ASN . 6.9 m-20 -144.48 119.4 9.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.089 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.467 ' HE2' ' O ' ' B' ' 49' ' ' TYR . 65.7 mmtt -119.26 122.74 42.62 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -107.64 127.24 53.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.149 0.499 . . . . 0.0 111.058 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.693 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 37.2 p-90 -142.41 161.38 38.2 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.891 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.1 151.94 16.89 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.899 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.491 ' O ' HG12 ' B' ' 63' ' ' VAL . 7.5 mt -102.74 141.03 19.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 172.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.69 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 64.0 m-85 -121.81 140.85 51.86 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.539 HG12 ' HB ' ' B' ' 63' ' ' VAL . 8.4 p -131.72 142.5 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.414 ' ND2' ' SD ' ' B' ' 87' ' ' MET . 10.1 m120 68.72 -2.81 1.57 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -169.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.76 -1.75 61.74 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -170.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 58' ' ' VAL . 16.5 mt-10 -100.36 172.0 7.41 Favored 'General case' 0 C--O 1.199 -1.587 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.594 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 11.1 ttmt -67.09 168.3 10.4 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 119.009 0.822 . . . . 0.0 109.948 175.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.539 ' HB ' HG12 ' B' ' 58' ' ' VAL . 7.6 p -148.49 -20.33 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.618 170.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.418 ' CD2' HG12 ' B' ' 79' ' ' ILE . 4.5 t80 -169.1 146.14 3.58 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.997 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.531 HG23 ' CD1' ' B' ' 94' ' ' ILE . 54.9 m -130.17 134.07 47.04 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.257 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.644 ' CD2' HG21 ' B' ' 75' ' ' ILE . 9.0 p90 -165.48 153.04 10.77 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.672 0.749 . . . . 0.0 109.939 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.5 HD21 ' HB3' ' B' ' 51' ' ' ASP . 23.2 t-20 -99.2 159.73 14.78 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.885 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' GLU . . . . . 0.456 ' CG ' ' HB2' ' B' ' 52' ' ' LYS . 10.2 mm-40 -60.92 -63.15 1.4 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.278 0.561 . . . . 0.0 109.954 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -66.37 -5.17 9.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.184 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.5 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 1.4 t -68.37 -3.14 10.11 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.417 0.627 . . . . 0.0 109.762 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.417 ' O ' HG13 ' B' ' 75' ' ' ILE . 31.9 p 62.17 102.97 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.308 1.443 . . . . 0.0 111.55 174.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.658 ' HA ' HD12 ' B' ' 75' ' ' ILE . 5.4 m -66.79 -4.43 2.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.151 -168.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.68 -48.12 80.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.443 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -78.78 -25.9 44.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.496 0.665 . . . . 0.0 109.777 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' B' ' 72' ' ' VAL . 24.5 mt -66.29 -44.97 90.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.299 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 28.9 t -53.73 -36.52 62.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.351 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -50.04 -54.61 19.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.792 0.806 . . . . 0.0 110.54 174.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.518 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 27.3 m-20 -63.89 -48.07 78.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.904 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' B' ' 64' ' ' TYR . 43.7 mt -54.69 -37.29 39.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.104 0.478 . . . . 0.0 111.48 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -63.98 -43.29 96.17 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.106 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 59.1 pttt -76.05 -31.1 58.64 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.054 -176.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.58 -26.31 67.89 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 65.6 t30 40.44 72.19 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 O-C-N 124.583 1.177 . . . . 0.0 110.839 -172.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.732 ' H ' HD12 ' B' ' 84' ' ' ILE . 3.1 mp -57.18 137.16 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.908 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 30.4 mmtp -90.61 -169.41 2.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.409 -177.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.49 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -136.65 113.92 1.1 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.256 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.414 ' SD ' ' ND2' ' B' ' 59' ' ' ASN . 3.1 ptp -167.43 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.637 0.375 . . . . 0.0 110.604 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 88' ' ' TYR . . . . . 0.585 ' HA ' ' SD ' ' B' ' 10' ' ' MET . 21.7 t80 -124.8 88.32 2.87 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.69 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 34.1 mm -93.75 133.35 35.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.29 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 24.1 mt-10 -125.38 155.61 40.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.142 0.496 . . . . 0.0 111.636 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.693 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 86.8 mt -131.15 118.21 40.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.453 176.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -171.69 154.19 3.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.12 0.486 . . . . 0.0 111.894 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.504 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 5.1 pm0 -64.76 149.48 49.19 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.268 175.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.531 ' CD1' HG23 ' B' ' 65' ' ' THR . 3.3 pt . . . . . 0 C--N 1.312 -1.026 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.304 -173.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' MET . . . . . 0.489 ' SD ' HG12 ' B' ' 89' ' ' ILE . 62.1 mtm . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.941 0.4 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -70.56 -26.88 63.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.692 0.758 . . . . 0.0 109.966 171.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 14.8 m -68.4 -10.14 53.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.642 -174.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.429 HG23 ' HG2' ' B' ' 31' ' ' MET . 28.5 mm -49.58 -52.34 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-O 121.089 0.471 . . . . 0.0 111.579 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -102.65 -38.3 7.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.865 -174.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.644 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 16.0 m -57.94 -41.86 83.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.945 -174.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.67 -45.13 75.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.964 0.411 . . . . 0.0 110.448 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -43.61 98.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.161 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.12 -26.19 52.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.24 -176.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.644 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -64.79 -46.29 82.68 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 121.092 0.472 . . . . 0.0 111.715 178.325 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 9.1 mt -87.05 -31.77 20.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.058 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -92.35 81.02 4.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.277 0.56 . . . . 0.0 110.176 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -122.35 -83.22 0.66 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.315 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.32 34.34 2.32 Favored Glycine 0 CA--C 1.508 -0.378 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -114.29 -147.26 0.41 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.072 -0.564 . . . . 0.0 109.591 -175.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' B' ' 45' ' ' TYR . . . -72.45 167.69 53.22 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.673 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.497 ' HE2' ' HB2' ' B' ' 41' ' ' SER . 2.1 mppt? -80.04 130.03 34.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.781 0.324 . . . . 0.0 110.943 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.476 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 26.6 tp -149.84 92.75 1.94 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 20.3 m -88.61 107.7 19.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.974 -175.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.476 ' CD1' ' HG ' ' B' ' 27' ' ' LEU . 9.3 mp -90.26 162.68 15.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.751 0.786 . . . . 0.0 111.548 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.6 p -156.0 144.68 20.26 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.718 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' MET . . . . . 0.429 ' HG2' HG23 ' B' ' 13' ' ' ILE . 0.6 OUTLIER -106.91 139.45 41.29 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.924 0.392 . . . . 0.0 111.232 -173.616 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 32' ' ' ASN . . . . . 0.532 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 2.5 t30 -142.29 57.4 1.46 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 170.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' GLY . . . . . 0.481 ' O ' ' HA3' ' B' ' 86' ' ' GLY . . . 45.44 -95.01 0.01 OUTLIER Glycine 0 C--N 1.333 0.403 0 O-C-N 123.806 0.691 . . . . 0.0 113.075 -175.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.706 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 2.4 p-10 -80.61 10.82 4.31 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.814 0.446 . . . . 0.0 112.17 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.669 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 75.1 mt-30 -132.98 147.81 52.27 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.366 0.603 . . . . 0.0 110.544 165.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.47 116.05 19.82 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -116.99 138.78 51.34 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.614 -172.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -158.66 139.12 12.53 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.115 0.484 . . . . 0.0 111.521 -177.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 13.8 p -115.9 138.35 51.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.612 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.3 p -123.43 142.47 50.95 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.172 0.51 . . . . 0.0 111.551 -174.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.497 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . 2.5 m -117.82 143.97 45.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.618 175.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -99.5 44.0 1.04 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.823 -168.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.42 -32.19 68.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.103 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.72 63.72 0.03 OUTLIER Glycine 0 CA--C 1.49 -1.482 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.287 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.773 ' CD1' ' HA ' ' B' ' 71' ' ' THR . 2.5 t80 -69.42 152.87 44.39 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 161.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.586 ' N ' ' CD1' ' B' ' 45' ' ' TYR . . . 106.38 57.18 0.63 Allowed Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 5.6 mm -79.33 -69.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.606 -0.797 . . . . 0.0 110.3 -171.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 69.1 m -152.46 -106.19 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.202 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.46 ' O ' ' HG2' ' B' ' 52' ' ' LYS . 64.9 m-85 58.94 20.66 8.37 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.083 0.553 . . . . 0.0 112.15 177.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 46.57 -95.12 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.83 0.706 . . . . 0.0 110.503 -171.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.479 ' HB3' HD21 ' B' ' 67' ' ' ASN . 9.3 m-20 -149.38 110.51 4.38 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 169.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' B' ' 49' ' ' TYR . 72.3 mmtt -121.13 122.29 39.7 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -113.52 130.58 56.31 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.298 0.571 . . . . 0.0 110.988 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.498 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 26.7 p-90 -141.0 168.45 19.76 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.695 176.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.56 145.13 16.79 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.706 -174.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.529 HD12 ' CD2' ' B' ' 64' ' ' TYR . 26.4 mt -106.76 141.73 21.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 171.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.711 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 63.5 m-85 -123.33 143.04 50.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.722 -174.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.625 HG12 ' HB ' ' B' ' 63' ' ' VAL . 10.4 p -128.0 136.89 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.476 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.3 m-80 61.69 11.04 3.71 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.989 0.515 . . . . 0.0 109.626 -172.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.51 0.64 66.96 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.278 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' B' ' 58' ' ' VAL . 15.7 mt-10 -106.8 176.27 5.23 Favored 'General case' 0 C--O 1.199 -1.597 0 C-N-CA 123.521 0.728 . . . . 0.0 109.139 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.503 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.4 tppp? -66.08 162.42 19.61 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 119.092 0.86 . . . . 0.0 109.949 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.625 ' HB ' HG12 ' B' ' 58' ' ' VAL . 7.8 p -153.42 -18.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.918 0.389 . . . . 0.0 110.371 167.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.686 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.8 OUTLIER -160.78 126.41 3.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 110.359 -172.806 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.3 m -134.23 126.64 30.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.48 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.572 ' HB2' HD13 ' B' ' 75' ' ' ILE . 0.7 OUTLIER -169.38 152.35 4.83 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.124 0.964 . . . . 0.0 112.467 -174.873 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.479 HD21 ' HB3' ' B' ' 51' ' ' ASP . 17.3 t-20 -92.61 153.98 18.67 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.233 -1.803 . . . . 0.0 109.956 174.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 68' ' ' GLU . . . . . 0.42 ' HA ' ' OH ' ' B' ' 45' ' ' TYR . 22.6 mm-40 -75.86 -3.68 36.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.192 0.52 . . . . 0.0 111.782 -174.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -111.43 -7.5 14.35 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.896 0.379 . . . . 0.0 111.431 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 1.3 t -73.92 -3.63 30.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.396 0.617 . . . . 0.0 111.688 -173.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.773 ' HA ' ' CD1' ' B' ' 45' ' ' TYR . 13.3 p 64.75 98.5 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.742 1.217 . . . . 0.0 111.444 173.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.518 ' HA ' HD12 ' B' ' 75' ' ' ILE . 7.7 m -66.64 -12.37 14.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.63 -169.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.24 -41.42 98.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.933 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -82.8 -30.76 28.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.206 0.527 . . . . 0.0 110.523 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.572 HD13 ' HB2' ' B' ' 66' ' ' PHE . 1.3 mt -75.62 -53.44 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.657 -176.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 22.5 t -58.38 -29.13 65.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.3 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -48.12 -54.74 12.23 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.778 0.799 . . . . 0.0 110.391 172.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 10.3 m-20 -69.36 -49.51 54.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.262 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.686 HG13 ' CE1' ' B' ' 64' ' ' TYR . 46.7 mm -52.29 -37.11 22.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -70.06 -20.78 63.21 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 46.9 pttt -83.26 -1.54 53.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.192 0.52 . . . . 0.0 109.986 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 3.7 mm? -77.46 -5.31 49.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.832 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 55.9 t30 51.38 63.51 2.21 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.427 -171.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.669 ' O ' ' HA ' ' B' ' 35' ' ' GLN . 48.2 mt -55.23 145.3 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.069 -172.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.706 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 50.3 mtmt -114.78 -176.94 3.01 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.779 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.498 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -142.0 113.11 0.79 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.844 -0.694 . . . . 0.0 111.725 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 12.2 tpp -150.25 -70.74 0.18 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 120.832 0.348 . . . . 0.0 110.221 178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -129.29 87.16 2.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.711 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 46.1 mm -85.9 132.51 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.213 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 33.9 mt-10 -119.2 145.06 46.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.495 173.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.49 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 44.8 mm -129.14 112.06 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.502 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.522 ' HE2' ' CE2' ' B' ' 57' ' ' PHE . 45.3 pttt -166.83 166.83 15.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.041 0.448 . . . . 0.0 111.819 -174.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -94.11 149.17 21.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.157 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.497 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.7 pt . . . . . 0 C--O 1.25 1.13 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.061 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 21.8 mmt . . . . . 0 N--CA 1.443 -0.782 0 CA-C-O 122.074 0.94 . . . . 0.0 113.359 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.07 -26.43 67.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.963 175.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.431 ' O ' HG23 ' B' ' 16' ' ' VAL . 49.1 m -67.16 -22.56 65.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.922 -174.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.555 HG21 ' HG3' ' B' ' 31' ' ' MET . 2.1 mm -60.41 -43.46 94.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.925 0.869 . . . . 0.0 109.61 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -66.51 -33.72 76.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.978 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 4.2 m -65.22 -44.43 88.29 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.941 176.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.431 HG23 ' O ' ' B' ' 12' ' ' SER . 91.9 t -61.0 -43.59 96.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.152 0.501 . . . . 0.0 110.111 176.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' ASN . . . . . 0.469 ' OD1' ' HB2' ' B' ' 29' ' ' LEU . 0.2 OUTLIER -56.02 -41.66 75.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.233 -179.454 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.39 -37.48 37.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.149 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -59.88 -43.64 94.65 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 122.86 0.464 . . . . 0.0 111.688 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.485 HD21 ' HE1' ' B' ' 54' ' ' TRP . 81.1 mt -83.66 28.6 0.56 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.896 -175.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -104.01 29.64 5.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.804 0.812 . . . . 0.0 108.954 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -119.33 57.52 0.89 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.317 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' B' ' 25' ' ' GLY . . . 163.28 47.2 0.02 OUTLIER Glycine 0 CA--C 1.503 -0.667 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.717 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.401 ' HB2' ' N ' ' B' ' 45' ' ' TYR . 34.4 mmtp 57.06 -63.27 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 170.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.613 ' H ' ' HA ' ' B' ' 45' ' ' TYR . . . -36.87 105.64 0.04 OUTLIER Glycine 0 C--N 1.33 0.248 0 O-C-N 124.006 0.816 . . . . 0.0 113.158 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.545 ' CE ' ' HB2' ' B' ' 41' ' ' SER . 34.3 pttt -63.67 132.34 50.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.941 0.401 . . . . 0.0 111.327 -176.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' B' ' 39' ' ' THR . 8.7 tp -146.09 104.7 3.85 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.073 -173.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -98.84 115.38 28.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.486 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.469 ' HB2' ' OD1' ' B' ' 17' ' ' ASN . 11.1 mp -89.05 165.93 14.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.817 0.818 . . . . 0.0 111.547 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 68.4 m -147.55 142.24 26.67 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.186 174.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' MET . . . . . 0.555 ' HG3' HG21 ' B' ' 13' ' ' ILE . 0.1 OUTLIER -112.54 117.72 33.11 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.885 -171.242 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -140.88 59.53 1.53 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.258 172.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 49.75 -87.09 0.01 OUTLIER Glycine 0 C--N 1.339 0.71 0 O-C-N 124.305 1.003 . . . . 0.0 115.133 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -66.35 -15.33 63.19 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.853 0.461 . . . . 0.0 111.6 -174.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.401 ' CD ' ' HD3' ' B' ' 37' ' ' LYS . 5.0 pt20 -132.56 149.01 52.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.057 0.932 . . . . 0.0 112.505 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.463 HD13 HG23 ' B' ' 13' ' ' ILE . 19.0 tp -112.45 101.67 9.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.604 -1.634 . . . . 0.0 107.964 170.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.419 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 35.5 mtmt -102.58 152.41 21.21 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.008 -1.451 . . . . 0.0 108.753 -172.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.86 156.93 2.91 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 1.3 p -126.27 144.94 50.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.982 175.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 16.2 m -144.02 151.31 39.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -175.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.545 ' HB2' ' CE ' ' B' ' 26' ' ' LYS . 20.1 m -138.02 158.49 44.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.288 170.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' ASN . . . . . 0.457 ' C ' ' H ' ' B' ' 44' ' ' GLY . 48.7 m-80 -109.63 46.01 1.04 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.896 -173.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.67 22.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.658 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.612 ' O ' HD11 ' B' ' 47' ' ' ILE . . . 165.9 -49.82 0.27 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.613 ' HA ' ' H ' ' B' ' 25' ' ' GLY . 7.3 p90 53.25 -177.75 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.0 1.32 . . . . 0.0 113.856 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.511 ' C ' HD13 ' B' ' 47' ' ' ILE . . . -70.74 105.76 1.69 Allowed Glycine 0 C--N 1.337 0.604 0 CA-C-N 116.014 -0.539 . . . . 0.0 113.934 -170.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.612 HD11 ' O ' ' B' ' 44' ' ' GLY . 3.4 mm -113.13 -70.0 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.988 0.423 . . . . 0.0 110.748 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.0 m -61.85 -51.75 66.96 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.816 0.817 . . . . 0.0 110.404 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -59.86 108.81 0.81 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.929 -1.487 . . . . 0.0 109.111 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.446 ' HB2' ' H ' ' B' ' 51' ' ' ASP . 0.0 OUTLIER -81.02 -157.8 0.18 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.849 0.357 . . . . 0.0 111.195 -176.67 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.448 ' HA ' ' OD1' ' B' ' 67' ' ' ASN . 9.6 p-10 -74.88 108.9 7.92 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.228 1.013 . . . . 0.0 111.152 -173.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 44.3 mttm -122.51 125.57 46.03 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.724 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -108.16 136.02 48.53 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.899 0.38 . . . . 0.0 110.848 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.668 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 21.9 p-90 -147.89 158.87 44.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.251 171.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.44 143.77 15.22 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.224 -174.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.482 ' O ' HG12 ' B' ' 63' ' ' VAL . 6.0 mt -102.84 143.1 15.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 173.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.61 ' HB2' ' HB2' ' B' ' 90' ' ' GLU . 55.4 m-85 -124.4 140.95 52.47 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.534 -176.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.492 HG12 ' HB ' ' B' ' 63' ' ' VAL . 9.1 p -128.49 134.87 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 2.3 m120 60.91 13.32 4.42 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.95 -174.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.4 -0.88 63.88 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.631 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -104.81 172.95 6.52 Favored 'General case' 0 C--O 1.207 -1.16 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.454 ' HZ3' ' HE1' ' B' ' 57' ' ' PHE . 12.0 tppt? -61.28 164.71 5.15 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.492 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.8 p -146.91 -22.66 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 167.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.431 ' CE2' ' CG1' ' B' ' 79' ' ' ILE . 2.2 t80 -171.68 144.66 1.87 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.989 -173.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 78.2 m -133.31 128.46 35.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.649 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.763 ' HD2' HD13 ' B' ' 75' ' ' ILE . 14.3 p90 -158.96 -171.39 3.38 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.221 0.534 . . . . 0.0 110.799 -176.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.7 t-20 -151.57 144.15 24.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.317 -166.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 68' ' ' GLU . . . . . 0.467 ' OE1' ' HB2' ' B' ' 52' ' ' LYS . 2.4 mp0 -63.99 -34.25 77.57 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -78.93 -18.25 54.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.235 0.541 . . . . 0.0 110.125 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 3.1 t -71.64 -8.12 52.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.662 ' O ' HG13 ' B' ' 75' ' ' ILE . 7.5 p 65.08 112.28 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.687 -1.597 . . . . 0.0 112.372 173.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.713 ' HA ' HD12 ' B' ' 75' ' ' ILE . 2.9 m -61.02 -15.14 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.449 -170.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 73' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' B' ' 40' ' ' SER . . . -67.06 -50.49 45.89 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.288 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -75.2 -19.17 59.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.491 0.662 . . . . 0.0 109.506 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.763 HD13 ' HD2' ' B' ' 66' ' ' PHE . 49.6 mt -73.64 -53.61 17.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.015 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.401 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 43.5 t -55.87 -33.05 64.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.12 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -52.0 -48.19 64.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.126 173.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.69 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 5.7 m-20 -70.54 -41.45 72.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.131 177.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.462 HG23 HD13 ' B' ' 84' ' ' ILE . 58.2 mt -54.55 -37.74 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.0 0.429 . . . . 0.0 111.381 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -58.12 -34.57 70.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.396 177.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.69 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 18.8 pttp -85.07 -31.0 23.62 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.663 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.01 -26.75 68.42 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.778 0.323 . . . . 0.0 110.23 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 4.8 t30 42.54 69.84 0.34 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.456 -172.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.613 ' H ' HD12 ' B' ' 84' ' ' ILE . 2.6 mp -59.13 131.18 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.017 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -86.47 -170.74 3.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.842 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.95 111.66 0.67 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.348 -0.929 . . . . 0.0 112.607 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 19.3 tpp -150.08 -68.58 0.2 Allowed 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -127.96 84.83 2.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 45.5 mm -85.73 130.77 35.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.983 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.61 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 27.7 mt-10 -123.7 150.19 44.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.034 0.445 . . . . 0.0 111.526 175.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.668 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 83.6 mt -129.74 125.61 61.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.491 176.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.477 ' HE3' ' CE2' ' B' ' 57' ' ' PHE . 14.9 pttp -167.57 164.97 14.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.131 0.491 . . . . 0.0 111.504 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -95.47 134.59 38.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.125 -174.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.569 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.2 pt . . . . . 0 C--O 1.247 0.938 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.682 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' MET . . . . . 0.698 ' SD ' ' HA ' ' B' ' 34' ' ' ASN . 75.2 mtm . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -56.75 -32.31 65.45 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.994 0.902 . . . . 0.0 110.044 173.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.567 ' O ' HG23 ' B' ' 16' ' ' VAL . 3.4 m -69.76 -30.75 68.41 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.253 -175.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.423 ' CG1' ' HB3' ' B' ' 10' ' ' MET . 11.3 mm -68.97 -35.86 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.914 -172.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -69.02 -32.17 71.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.085 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 32.8 t -69.48 -35.13 75.29 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.016 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.567 HG23 ' O ' ' B' ' 12' ' ' SER . 15.7 t -64.22 -42.47 95.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.691 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -57.59 -38.18 74.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.227 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.13 -40.05 32.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.216 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -65.13 -57.04 9.59 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.439 0.696 . . . . 0.0 112.455 -176.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.532 HD21 ' HZ2' ' B' ' 54' ' ' TRP . 43.6 mt -68.75 -31.39 70.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.703 -175.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.84 61.05 5.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.284 0.564 . . . . 0.0 110.529 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -121.59 -86.73 0.65 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.082 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.82 51.06 0.84 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.75 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.526 ' HE2' ' O ' ' B' ' 68' ' ' GLU . 31.5 mmtp -114.16 -161.43 0.77 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.403 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -73.01 -175.48 29.05 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.139 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.823 ' O ' ' HA ' ' B' ' 40' ' ' SER . 16.4 ptpt -67.76 105.15 1.84 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 174.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.592 ' HA ' ' O ' ' B' ' 39' ' ' THR . 17.8 tp -119.24 128.17 53.93 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.442 -162.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 67.3 m -117.87 126.05 51.65 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.164 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.57 HD12 HD21 ' B' ' 36' ' ' LEU . 1.7 mm? -104.83 147.88 27.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.117 0.484 . . . . 0.0 110.343 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 11.3 p -142.67 150.2 39.87 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.199 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 73.7 mtp -114.39 136.33 53.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.093 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -144.34 115.98 8.17 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.15 -107.28 2.05 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.698 ' HA ' ' SD ' ' B' ' 10' ' ' MET . 2.6 m-20 -123.67 14.83 9.44 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.495 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 75.1 mt-30 -78.48 162.07 26.62 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.304 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.57 HD21 HD12 ' B' ' 29' ' ' LEU . 6.1 tt -133.15 123.15 25.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.347 168.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -118.59 143.88 46.49 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.528 ' HB1' HD11 ' B' ' 27' ' ' LEU . . . -139.81 143.96 37.09 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.062 -0.655 . . . . 0.0 112.333 -170.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.592 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 8.6 p -128.02 141.63 51.46 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.105 175.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.823 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 21.2 p -153.13 145.25 23.81 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.713 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.441 ' HB2' ' CG ' ' B' ' 26' ' ' LYS . 16.9 m -113.18 167.16 10.78 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.367 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -78.88 47.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.194 -172.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.62 -59.82 2.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.015 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.505 ' O ' HD11 ' B' ' 47' ' ' ILE . . . -154.7 55.26 0.42 Allowed Glycine 0 C--N 1.313 -0.746 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.764 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.595 ' O ' HG13 ' B' ' 47' ' ' ILE . 41.4 p90 -77.63 160.16 28.71 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -172.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' B' ' 69' ' ' LYS . . . 14.87 76.5 0.01 OUTLIER Glycine 0 C--N 1.337 0.636 0 O-C-N 125.269 1.606 . . . . 0.0 116.498 168.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.595 HG13 ' O ' ' B' ' 45' ' ' TYR . 1.3 mp -106.75 -72.34 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-O 122.204 1.002 . . . . 0.0 111.684 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -88.33 -152.99 0.23 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.56 -1.655 . . . . 0.0 111.374 -170.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.51 ' O ' ' HE3' ' B' ' 52' ' ' LYS . 64.5 m-85 70.85 6.98 6.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.746 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 56.47 -81.36 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 124.245 0.966 . . . . 0.0 111.674 -175.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -167.28 110.43 0.68 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.51 ' HE3' ' O ' ' B' ' 49' ' ' TYR . 31.9 mmtp -129.61 124.09 32.89 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -104.34 128.13 52.1 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.548 ' HA ' HG12 ' B' ' 94' ' ' ILE . 50.0 p-90 -144.7 157.28 44.25 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -126.34 150.6 17.75 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.334 -170.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.636 HD12 ' CD2' ' B' ' 64' ' ' TYR . 28.6 mt -106.57 149.93 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 169.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.706 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 84.3 m-85 -131.52 142.69 50.0 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -169.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.609 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.9 p -131.67 140.51 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.425 ' HA ' ' SD ' ' B' ' 87' ' ' MET . 7.1 m120 66.76 0.11 1.79 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -170.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.22 0.24 59.88 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.37 -172.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 12.5 mt-10 -102.78 176.1 5.27 Favored 'General case' 0 C--O 1.201 -1.491 0 C-N-CA 123.716 0.806 . . . . 0.0 109.254 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.1 tppp? -62.37 160.37 13.5 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 118.633 0.651 . . . . 0.0 110.395 175.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.609 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.5 p -152.97 -15.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.507 168.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.636 ' CD2' HD12 ' B' ' 56' ' ' ILE . 0.8 OUTLIER -160.43 126.19 4.01 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -172.321 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 23.9 m -134.51 126.32 29.12 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.189 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.55 ' CB ' HD13 ' B' ' 75' ' ' ILE . 3.9 p90 -166.96 -175.16 2.93 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.533 0.682 . . . . 0.0 110.424 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 10.0 t-20 -128.77 168.27 16.11 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.093 -170.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 68' ' ' GLU . . . . . 0.526 ' O ' ' HE2' ' B' ' 24' ' ' LYS . 8.9 mm-40 -85.81 -11.08 54.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.871 0.367 . . . . 0.0 110.955 -177.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.487 ' O ' ' HA3' ' B' ' 46' ' ' GLY . 51.1 tttm -100.78 -26.1 13.9 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.505 ' OG ' HD11 ' B' ' 75' ' ' ILE . 21.5 t -63.88 152.07 40.76 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.811 0.815 . . . . 0.0 108.989 174.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.449 ' O ' HG13 ' B' ' 75' ' ' ILE . 0.1 OUTLIER -99.26 109.59 22.22 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.113 -173.75 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.583 ' HA ' HD12 ' B' ' 75' ' ' ILE . 3.6 m -67.33 -14.47 18.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.425 -167.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.54 -47.96 88.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.675 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -74.42 -32.84 62.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.045 0.45 . . . . 0.0 110.609 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' B' ' 72' ' ' VAL . 1.4 mt -70.33 -51.33 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.127 0.489 . . . . 0.0 110.274 -177.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 16.6 t -61.94 -28.77 69.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.563 -176.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -50.67 -53.5 30.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.527 0.679 . . . . 0.0 110.268 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.753 ' O ' ' HG3' ' B' ' 81' ' ' LYS . 0.8 OUTLIER -69.29 -43.07 74.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.099 179.13 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.558 HG13 ' CE1' ' B' ' 64' ' ' TYR . 42.8 mm -51.77 -37.98 21.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.266 0.555 . . . . 0.0 111.718 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -66.27 -28.42 68.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.326 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.753 ' HG3' ' O ' ' B' ' 78' ' ' ASP . 0.0 OUTLIER -84.6 -0.43 53.23 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.758 -176.582 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 3.1 mm? -72.78 -11.84 60.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.232 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 62.6 t30 50.61 58.97 4.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.634 -172.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.495 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 68.9 mt -61.59 150.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.375 -173.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.434 ' O ' HG22 ' B' ' 84' ' ' ILE . 64.8 mttm -103.26 -178.53 3.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.381 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -139.62 115.3 1.08 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.795 -1.193 . . . . 0.0 113.805 -177.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.425 ' SD ' ' HA ' ' B' ' 59' ' ' ASN . 1.7 pmm? -165.25 -57.64 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 175.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 88' ' ' TYR . . . . . 0.424 ' N ' ' HG2' ' B' ' 87' ' ' MET . 15.7 t80 -129.31 83.23 2.13 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 121.611 -0.681 . . . . 0.0 109.778 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.706 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 23.4 mm -92.21 121.9 43.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.222 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -109.14 171.54 7.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.985 0.421 . . . . 0.0 109.933 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.525 HG12 ' HB3' ' B' ' 12' ' ' SER . 30.4 mm -152.94 115.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.677 -175.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -169.18 165.79 10.93 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.177 0.513 . . . . 0.0 111.875 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.484 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 3.1 pp0? -82.76 143.61 30.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.854 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' B' ' 54' ' ' TRP . 6.2 pt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.868 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.455 -0.183 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -47.44 -32.47 5.11 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.52 ' CB ' ' HB ' ' B' ' 89' ' ' ILE . 12.2 m -65.49 -27.23 68.34 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.99 -173.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mm -67.4 -47.06 82.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 122.079 0.942 . . . . 0.0 109.392 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -59.23 -32.6 70.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.285 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 9.9 t -68.51 -42.28 78.79 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.801 177.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.484 HG23 ' O ' ' B' ' 12' ' ' SER . 97.7 t -55.26 -42.75 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.128 0.49 . . . . 0.0 110.379 177.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -56.73 -45.66 81.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.758 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.92 -38.9 52.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.237 -175.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' B' ' 15' ' ' SER . 24.1 mmmt -78.5 -8.26 58.36 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -172.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.422 HD21 ' CZ ' ' B' ' 66' ' ' PHE . 15.6 mt -91.63 23.43 3.54 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' ASN . . . . . 0.494 ' CG ' ' H ' ' B' ' 22' ' ' LYS . 20.3 p-10 -88.73 -79.34 0.31 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 171.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.494 ' H ' ' CG ' ' B' ' 21' ' ' ASN . 28.7 mtpp 48.61 34.01 4.65 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 169.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 146.8 -92.38 0.15 Allowed Glycine 0 N--CA 1.439 -1.167 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.472 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.58 ' HD2' ' CD1' ' B' ' 47' ' ' ILE . 58.0 mttm -152.84 -141.75 0.11 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -171.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.663 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . 68.05 111.75 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.8 -173.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' B' ' 40' ' ' SER . 0.3 OUTLIER -63.0 115.44 4.41 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 173.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.521 HD22 ' CG2' ' B' ' 72' ' ' VAL . 4.0 tp -152.85 105.08 2.91 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 72.4 m -97.76 113.92 25.81 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.344 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.412 ' N ' HD22 ' B' ' 29' ' ' LEU . 2.8 mm? -86.75 159.85 19.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.477 0.656 . . . . 0.0 110.59 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.555 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 0.1 OUTLIER -151.11 147.66 27.34 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.313 173.52 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 58.8 mtm -118.81 141.09 48.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.149 0.5 . . . . 0.0 111.839 -168.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' ASN . . . . . 0.532 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 49.6 t30 -150.55 60.48 0.95 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.405 173.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.78 -92.83 0.01 OUTLIER Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.2 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.35 -18.17 57.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.774 -0.213 . . . . 0.0 111.328 -177.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.532 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 68.5 mt-30 -101.53 147.0 26.9 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.666 0.746 . . . . 0.0 111.422 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.19 104.81 9.4 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.506 174.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.555 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 8.1 mmmm -102.56 142.73 33.25 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -172.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -162.92 145.1 10.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -174.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 7.9 p -122.13 143.18 49.7 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 172.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 20.3 m -137.15 155.45 49.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.45 0.643 . . . . 0.0 112.256 -173.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.431 ' HB3' ' CB ' ' B' ' 26' ' ' LYS . 32.5 t -137.87 154.53 49.47 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.618 176.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -105.93 37.05 2.35 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.924 -170.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.23 23.12 0.29 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.591 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.45 -56.71 0.41 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.728 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.663 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 14.8 p90 47.58 -161.88 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.48 1.112 . . . . 0.0 113.784 175.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.601 ' HA2' ' OH ' ' B' ' 49' ' ' TYR . . . -69.07 104.7 1.31 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 116.34 -0.391 . . . . 0.0 113.358 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.58 ' CD1' ' HD2' ' B' ' 24' ' ' LYS . 2.1 mp -100.28 -71.33 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 122.11 0.957 . . . . 0.0 110.685 179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 18.4 m -99.75 -118.65 0.15 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.036 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.601 ' OH ' ' HA2' ' B' ' 46' ' ' GLY . 0.1 OUTLIER 38.46 45.86 0.89 Allowed 'General case' 0 N--CA 1.472 0.625 0 O-C-N 123.693 0.621 . . . . 0.0 111.226 -171.315 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 48.55 -94.5 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.836 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -174.41 109.85 0.14 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.638 ' HB2' ' OE2' ' B' ' 68' ' ' GLU . 47.4 mmtt -123.26 136.84 54.9 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -174.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -120.1 140.32 51.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.799 0.333 . . . . 0.0 111.344 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.624 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 22.2 p-90 -156.23 172.02 19.19 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.505 172.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.7 147.07 19.0 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.661 -173.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 25.0 mt -107.14 146.32 13.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 170.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.639 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 60.3 m-85 -126.63 143.89 51.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.426 -174.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.603 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.1 p -129.68 136.43 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 m120 59.13 14.93 3.77 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.118 0.567 . . . . 0.0 109.842 -174.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.37 -1.5 66.95 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.496 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 14.6 mt-10 -105.86 177.5 4.83 Favored 'General case' 0 C--O 1.205 -1.266 0 C-N-CA 123.644 0.778 . . . . 0.0 109.162 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.2 tppp? -66.14 163.04 18.43 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 172.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.603 ' HB ' HG12 ' B' ' 58' ' ' VAL . 11.3 p -151.48 -21.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.104 0.478 . . . . 0.0 109.877 167.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.687 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.6 OUTLIER -161.31 123.46 3.02 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.163 0.506 . . . . 0.0 110.845 -171.773 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 8.6 m -129.48 129.4 44.55 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.421 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.475 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.0 OUTLIER -153.01 -176.7 5.88 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 122.261 1.029 . . . . 0.0 111.875 -176.0 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.753 ' ND2' ' H ' ' B' ' 69' ' ' LYS . 5.4 t30 -147.28 149.09 32.19 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 112.897 -1.956 . . . . 0.0 108.365 -176.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 68' ' ' GLU . . . . . 0.638 ' OE2' ' HB2' ' B' ' 52' ' ' LYS . 0.4 OUTLIER -66.48 -21.1 66.18 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -172.207 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.753 ' H ' ' ND2' ' B' ' 67' ' ' ASN . 85.4 tttt -95.88 -20.91 18.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.226 0.536 . . . . 0.0 110.011 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 6.7 t -69.88 -23.63 63.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.674 174.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.587 HG21 ' CD1' ' B' ' 45' ' ' TYR . 19.2 p 61.87 107.13 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.313 1.045 . . . . 0.0 111.878 174.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.629 ' HA ' HD12 ' B' ' 75' ' ' ILE . 6.0 m -64.41 -16.47 19.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.606 -169.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.07 -48.5 82.48 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.269 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -75.43 -28.91 59.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.285 0.564 . . . . 0.0 110.572 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' B' ' 72' ' ' VAL . 2.9 mt -73.0 -47.83 46.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.595 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 42.1 m -52.08 -35.43 47.61 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.041 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -48.51 -58.26 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.788 0.804 . . . . 0.0 110.336 172.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.548 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 7.1 m-20 -70.31 -35.9 73.97 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.572 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.687 HG13 ' CE1' ' B' ' 64' ' ' TYR . 41.5 mm -58.81 -25.54 29.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.571 0.7 . . . . 0.0 111.729 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -69.18 4.54 1.59 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.406 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 0.1 OUTLIER -105.17 -0.61 26.36 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.132 0.492 . . . . 0.0 110.446 176.134 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' B' ' 79' ' ' ILE . 2.4 mm? -79.56 -4.46 51.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.999 -169.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 53.13 58.85 4.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -170.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.447 HD11 HG22 ' B' ' 79' ' ' ILE . 59.8 mt -56.84 155.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.121 -175.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -134.86 -171.69 2.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.882 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -149.47 112.7 0.57 Allowed Glycine 0 C--N 1.309 -0.945 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.463 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.456 ' HG2' ' N ' ' B' ' 88' ' ' TYR . 16.0 ttt -160.29 -76.3 0.06 Allowed 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 88' ' ' TYR . . . . . 0.456 ' N ' ' HG2' ' B' ' 87' ' ' MET . 49.7 t80 -120.11 94.05 4.26 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.639 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 22.3 mm -96.32 130.52 44.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.672 -177.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 51.3 mm-40 -123.94 154.99 38.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.4 . . . . 0.0 111.528 177.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.567 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 72.2 mt -137.54 126.25 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.646 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.624 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 49.6 pttt -172.62 167.27 5.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.064 0.459 . . . . 0.0 111.262 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.519 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.1 OUTLIER -96.77 151.67 19.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.427 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.559 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.9 pt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.038 -0.982 . . . . 0.0 111.038 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' MET . . . . . 0.418 ' O ' HG13 ' B' ' 13' ' ' ILE . 25.8 mmt . . . . . 0 C--O 1.226 -0.183 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -40.25 -19.89 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.42 1.488 . . . . 0.0 114.092 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.43 ' O ' HG23 ' B' ' 16' ' ' VAL . 39.1 t -60.09 -7.3 1.76 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.569 0.747 . . . . 0.0 112.325 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.468 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.6 OUTLIER -47.91 -62.27 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.347 0 CA-C-O 121.224 0.535 . . . . 0.0 111.916 -176.064 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -106.67 -20.77 13.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.792 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 30.9 t -53.61 -38.35 63.93 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.164 -175.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 12' ' ' SER . 90.1 t -57.19 -41.93 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 111.211 -176.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' ASN . . . . . 0.436 ' HA ' HD22 ' B' ' 29' ' ' LEU . 59.5 t30 -67.05 -41.53 86.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.668 -176.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.07 -38.9 56.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.0 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 6.4 mmpt? -57.88 -66.22 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.501 HD21 ' CZ ' ' B' ' 66' ' ' PHE . 75.3 mt -59.1 -23.02 61.72 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.269 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -86.74 79.8 8.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.713 0.768 . . . . 0.0 110.711 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' B' ' 19' ' ' LYS . 29.7 mtpp -119.14 37.3 4.17 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.97 177.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.65 59.5 3.48 Favored Glycine 0 CA--C 1.505 -0.59 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.402 ' HE2' ' HB2' ' B' ' 22' ' ' LYS . 70.8 mmtt -125.45 -163.44 1.2 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -177.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.446 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -53.54 139.94 34.26 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.175 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.713 ' O ' ' HA ' ' B' ' 40' ' ' SER . 43.1 mtmt -61.76 107.9 0.91 Allowed 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 117.036 0.418 . . . . 0.0 109.96 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' B' ' 39' ' ' THR . 36.7 tp -125.41 122.58 37.14 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.853 -167.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 18.2 m -101.61 101.9 12.52 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.542 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.499 ' N ' HD12 ' B' ' 29' ' ' LEU . 4.9 mp -90.69 150.94 21.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 122.02 0.914 . . . . 0.0 112.485 -170.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 34.3 p -146.65 149.8 34.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.778 -1.555 . . . . 0.0 107.893 173.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 78.3 mtp -120.74 160.85 22.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.244 0.545 . . . . 0.0 111.811 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -159.09 104.94 1.72 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.599 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.91 -97.59 0.74 Allowed Glycine 0 CA--C 1.504 -0.604 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -169.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -137.17 19.77 2.98 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 168.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -77.68 155.14 31.52 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.927 175.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.472 HD21 HD23 ' B' ' 29' ' ' LEU . 2.0 tm? -126.45 116.99 21.99 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.18 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -120.97 133.01 55.26 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.726 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -162.82 150.44 13.56 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -170.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.62 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 18.4 p -112.14 148.11 34.69 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.713 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 7.7 p -134.34 146.47 49.97 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -170.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' B' ' 26' ' ' LYS . 47.3 t -118.82 165.26 14.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.399 167.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -113.93 18.72 17.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.165 0.507 . . . . 0.0 111.238 -172.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.75 -61.45 2.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.181 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.54 53.94 0.56 Allowed Glycine 0 C--N 1.311 -0.807 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.985 -176.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.446 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 0.1 OUTLIER -63.65 -165.69 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.03 0.532 . . . . 0.0 112.192 -177.679 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.559 ' H ' HG22 ' B' ' 71' ' ' THR . . . -70.33 106.66 1.9 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.154 175.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 4.7 mm -64.0 -68.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.974 0.416 . . . . 0.0 110.173 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.0 m -123.28 -90.79 0.56 Allowed 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.18 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 56.15 33.91 22.91 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 122.761 0.424 . . . . 0.0 111.332 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 34.02 -109.62 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.727 -1.124 . . . . 0.0 113.111 -175.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -150.65 110.52 4.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.828 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.428 ' HB2' ' HG2' ' B' ' 68' ' ' GLU . 54.2 mttm -131.53 135.16 46.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -111.5 136.09 51.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.846 0.355 . . . . 0.0 110.156 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.678 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 48.0 p-90 -151.2 166.99 29.19 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 172.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.71 159.4 26.86 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 119.989 -1.1 . . . . 0.0 113.711 -170.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 13.3 mt -105.7 142.85 17.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 171.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.58 ' CE1' ' HG3' ' B' ' 62' ' ' LYS . 48.8 m-85 -126.23 131.29 51.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.998 -0.092 . . . . 0.0 110.756 -177.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.618 HG12 ' HB ' ' B' ' 63' ' ' VAL . 12.2 p -116.26 133.86 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.276 -177.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.408 ' HA ' ' H ' ' B' ' 88' ' ' TYR . 3.6 m120 65.78 5.01 3.15 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.719 0.808 . . . . 0.0 110.263 -177.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.61 11.9 56.4 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.829 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 14.8 mt-10 -110.25 173.7 6.21 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 171.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.58 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 24.9 ttmt -76.49 168.77 19.48 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 119.427 1.012 . . . . 0.0 108.971 173.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.618 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.4 p -151.47 -19.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.804 171.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.643 ' CD2' HD11 ' B' ' 79' ' ' ILE . 0.0 OUTLIER -163.33 153.21 15.4 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.588 -175.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 27.6 m -149.97 130.03 13.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.308 177.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.661 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -145.11 -176.76 5.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.724 0.773 . . . . 0.0 110.769 -178.803 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 67' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -136.22 160.2 39.41 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.156 -1.384 . . . . 0.0 110.219 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 68' ' ' GLU . . . . . 0.428 ' HG2' ' HB2' ' B' ' 52' ' ' LYS . 62.2 mm-40 -61.15 -44.25 97.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.865 0.364 . . . . 0.0 111.724 -177.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.557 ' O ' HG23 ' B' ' 71' ' ' THR . 50.3 tptt -80.86 -19.76 43.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.838 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 8.7 t -69.1 -18.38 63.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.402 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.559 HG22 ' H ' ' B' ' 46' ' ' GLY . 41.0 p 56.27 105.93 0.01 OUTLIER 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.304 1.041 . . . . 0.0 113.332 170.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.581 ' HA ' HD12 ' B' ' 75' ' ' ILE . 11.1 m -57.65 -15.12 3.67 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-N 114.556 -1.202 . . . . 0.0 113.265 -171.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.58 -52.3 46.26 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.979 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -76.45 -32.68 58.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.354 0.597 . . . . 0.0 109.976 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.661 HD13 ' HB3' ' B' ' 66' ' ' PHE . 1.9 mt -72.03 -53.93 18.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.604 -173.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.8 m -69.75 -14.08 62.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.52 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -61.93 -42.24 98.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.768 0.794 . . . . 0.0 109.459 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 4.3 m-20 -68.95 -32.46 72.07 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.529 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.643 HD11 ' CD2' ' B' ' 64' ' ' TYR . 17.7 mm -55.67 -26.35 19.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -54.85 -27.26 40.96 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.296 173.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 19.8 pttm -104.11 -6.14 21.37 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -172.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' B' ' 79' ' ' ILE . 2.8 mm? -70.97 -18.3 62.62 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 122.126 -0.359 . . . . 0.0 111.815 -173.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 61.0 t30 45.97 55.69 6.8 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.972 0.795 . . . . 0.0 110.63 -171.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.485 HG22 ' O ' ' B' ' 85' ' ' LYS . 83.1 mt -59.81 145.5 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.171 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.485 ' O ' HG22 ' B' ' 84' ' ' ILE . 62.3 mttp -89.88 178.27 6.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.32 176.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -134.33 112.58 1.06 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.474 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.24 -79.73 0.09 Allowed 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 88' ' ' TYR . . . . . 0.408 ' H ' ' HA ' ' B' ' 59' ' ' ASN . 25.5 t80 -122.33 88.07 2.87 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 28.0 mm -90.83 128.66 42.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.912 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.58 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 33.8 mt-10 -117.52 144.73 44.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.588 173.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.413 HG21 ' HG3' ' B' ' 19' ' ' LYS . 2.5 mt -134.75 102.81 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.678 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 48.0 pttt -154.65 178.01 10.59 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -169.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.445 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 21.1 mm-40 -99.01 146.8 25.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.163 -176.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.642 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.9 pt . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.305 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 15.0 mmt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.362 0.601 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -66.5 -28.26 68.43 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.956 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 24.2 m -71.45 -21.12 62.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.712 -175.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.411 ' H ' HG12 ' B' ' 13' ' ' ILE . 3.8 mm -61.93 -47.4 93.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 122.07 0.938 . . . . 0.0 109.196 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -63.69 -38.39 90.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.405 -177.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -62.2 -44.27 96.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.934 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.96 -48.0 91.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.096 0.474 . . . . 0.0 110.329 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -60.11 -37.05 78.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.882 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' ASP . . . . . 0.677 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.2 OUTLIER -71.32 -57.47 4.43 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.377 176.799 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -55.59 -49.96 71.38 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.059 0.944 . . . . 0.0 112.85 -173.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.424 HD22 HG11 ' B' ' 72' ' ' VAL . 47.2 mt -71.17 -21.06 62.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.963 -175.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -91.94 -99.55 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.677 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 30.6 mtpp 49.9 25.79 1.74 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.67 11.22 60.84 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.933 178.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -96.25 -129.08 0.16 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 175.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.547 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -66.87 107.29 1.94 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 173.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.746 ' O ' ' HA ' ' B' ' 40' ' ' SER . 34.9 mtmt -66.97 90.08 0.18 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.846 0.314 . . . . 0.0 111.846 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 47.1 tp -108.47 93.14 4.37 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 21.0 m -81.24 105.47 12.46 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.264 -176.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.41 165.24 22.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.946 0.879 . . . . 0.0 111.601 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 49.1 m -146.49 144.35 29.58 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.363 174.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 33.9 mtt -114.26 124.1 51.19 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.817 0.341 . . . . 0.0 110.945 -170.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -144.83 60.04 1.32 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.662 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' GLY . . . . . 0.406 ' O ' ' HA3' ' B' ' 86' ' ' GLY . . . 49.55 -102.9 0.07 OUTLIER Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.248 -0.887 . . . . 0.0 113.861 178.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 4.6 m-20 -79.44 19.37 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.271 0.229 . . . . 0.0 111.435 -176.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 42.9 mt-30 -139.13 146.28 40.45 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.317 0.58 . . . . 0.0 110.472 172.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' B' ' 36' ' ' LEU . 1.4 tm? -129.05 116.66 19.64 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 176.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.489 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 16.1 mtpt -118.09 148.87 41.86 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -172.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -170.58 145.6 2.58 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -176.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 19.5 p -122.68 141.62 51.57 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.548 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.746 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 24.1 t -122.53 147.51 46.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.363 0.601 . . . . 0.0 112.163 -174.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' B' ' 26' ' ' LYS . 46.8 t -131.67 160.85 34.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.813 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' B' ' 44' ' ' GLY . 51.1 m-80 -114.1 32.84 5.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.115 -171.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.526 ' HB3' ' HE2' ' B' ' 26' ' ' LYS . . . -72.96 22.46 0.07 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.306 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' B' ' 42' ' ' ASN . . . 165.34 -43.97 0.29 Allowed Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.547 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 37.1 p90 46.04 -160.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.355 1.062 . . . . 0.0 113.013 -175.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.55 99.39 0.73 Allowed Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.842 -0.694 . . . . 0.0 114.17 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.06 -54.73 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.1 0.476 . . . . 0.0 109.782 170.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -37.93 -57.97 0.98 Allowed 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.285 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -103.81 112.91 26.08 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' B' ' 69' ' ' LYS . 30.5 mt-10 -67.75 -48.38 66.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.616 -170.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -167.22 111.93 0.72 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.443 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -132.39 142.18 49.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.848 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.59 113.87 26.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.535 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 29.1 p-90 -154.12 165.7 35.38 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.345 176.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.12 150.45 20.19 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.844 -174.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.459 HD12 ' CD2' ' B' ' 64' ' ' TYR . 24.3 mt -106.35 150.41 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 172.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 70.7 m-85 -131.9 139.43 48.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.128 -172.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.578 HG12 ' HB ' ' B' ' 63' ' ' VAL . 8.6 p -125.17 133.39 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 m120 64.12 5.88 2.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.859 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.87 -12.21 38.16 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.435 -176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' B' ' 58' ' ' VAL . 0.2 OUTLIER -100.17 177.22 5.13 Favored 'General case' 0 C--O 1.202 -1.421 0 C-N-CA 123.713 0.805 . . . . 0.0 109.938 -176.708 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.47 ' HD2' ' OG1' ' B' ' 65' ' ' THR . 13.1 tppt? -61.44 159.45 12.74 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 118.279 0.491 . . . . 0.0 110.485 174.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.578 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.1 p -153.7 -14.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.262 0.553 . . . . 0.0 110.389 167.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.786 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -161.14 133.99 6.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.184 -173.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.47 ' OG1' ' HD2' ' B' ' 62' ' ' LYS . 16.4 m -142.18 126.0 17.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.02 177.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.682 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -166.16 -177.8 4.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 122.567 1.175 . . . . 0.0 112.29 -174.26 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -136.83 145.9 45.0 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 112.349 -2.205 . . . . 0.0 108.736 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.3 -29.3 65.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.186 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.442 ' O ' HG23 ' B' ' 71' ' ' THR . 28.2 ttpp -80.99 -25.94 36.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.99 0.424 . . . . 0.0 110.599 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 9.8 t -68.05 -31.64 71.42 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 174.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.465 ' O ' HG13 ' B' ' 75' ' ' ILE . 11.1 p 62.77 125.08 0.01 OUTLIER 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.548 1.139 . . . . 0.0 112.614 174.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.501 ' HA ' HD12 ' B' ' 75' ' ' ILE . 11.6 m -63.92 -10.75 8.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.356 -168.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.92 -56.31 23.57 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.663 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -76.48 -31.28 57.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.39 0.614 . . . . 0.0 110.265 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.682 HD13 ' HB3' ' B' ' 66' ' ' PHE . 2.8 mt -67.93 -46.24 82.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.649 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 38.2 t -59.16 -32.71 70.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.693 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -49.04 -52.42 25.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.66 0.743 . . . . 0.0 110.286 176.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 30.3 m-20 -67.7 -47.32 69.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.018 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.786 HG13 ' CE1' ' B' ' 64' ' ' TYR . 46.2 mm -55.16 -30.75 24.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.262 0.553 . . . . 0.0 112.065 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -58.6 -20.01 43.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.269 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 0.0 OUTLIER -94.56 -4.0 48.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 0.0 111.058 -175.909 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.1 mm? -70.5 -16.26 62.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.99 -173.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 58.9 t30 50.84 57.64 6.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.461 -171.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' B' ' 35' ' ' GLN . 48.9 mt -57.63 144.08 10.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.94 -174.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 30.3 mtmm -109.03 -168.58 1.36 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.112 175.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' B' ' 33' ' ' GLY . . . -146.25 113.58 0.69 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.925 -177.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 37.4 ttp -157.34 -74.09 0.09 Allowed 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 116.639 0.22 . . . . 0.0 110.458 173.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -117.32 94.24 4.48 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.181 0.515 . . . . 0.0 109.694 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.571 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 20.4 mm -93.57 134.66 30.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.384 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -122.89 173.49 7.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.369 0.604 . . . . 0.0 110.937 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.535 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 92.1 mt -152.22 118.85 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.759 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 30.7 pttt -171.26 168.3 6.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.175 0.512 . . . . 0.0 111.768 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.462 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 2.4 pt20 -99.39 150.51 22.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.154 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.2 pt . . . . . 0 C--N 1.308 -1.203 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.972 -174.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' MET . . . . . 0.466 ' O ' ' HE1' ' B' ' 31' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.277 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -36.83 -22.97 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.638 1.975 . . . . 0.0 115.825 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 15.2 m -60.33 -12.5 9.31 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 122.441 0.296 . . . . 0.0 111.792 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.451 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -53.52 -50.36 49.87 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-O 121.732 0.777 . . . . 0.0 109.849 -178.082 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 14' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' B' ' 18' ' ' ASP . 19.8 m120 -106.82 -60.6 1.65 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.274 -175.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 5.5 m -58.24 -64.49 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.393 -170.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 67.9 t -62.94 -40.5 89.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.449 . . . . 0.0 110.701 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -56.83 -47.14 81.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.827 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' ASP . . . . . 0.755 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.1 OUTLIER -75.02 -40.54 60.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.273 -178.039 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -52.49 -35.18 52.27 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.016 0.527 . . . . 0.0 112.027 -176.764 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.22 -42.24 11.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.273 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' B' ' 18' ' ' ASP . 4.3 p-10 -80.45 -2.41 45.7 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.755 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 29.2 mtpp -73.37 -74.29 0.18 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.753 0.311 . . . . 0.0 111.565 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.17 15.93 59.83 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.822 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.575 ' NZ ' ' HA ' ' B' ' 68' ' ' GLU . 26.0 mtpt -129.29 -160.23 1.02 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.168 0.509 . . . . 0.0 110.224 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.492 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -66.03 139.24 38.03 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 173.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' B' ' 40' ' ' SER . 60.3 mttt -62.28 133.91 55.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -175.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.507 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 29.6 tp -141.56 96.57 3.0 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 41.9 m -86.63 126.83 34.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.789 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.507 ' CD1' ' HG ' ' B' ' 27' ' ' LEU . 10.4 mp -107.07 163.75 12.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 122.327 1.06 . . . . 0.0 112.758 -174.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.453 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 3.1 p -160.22 146.06 15.33 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 112.878 -1.965 . . . . 0.0 107.073 171.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 31' ' ' MET . . . . . 0.466 ' HE1' ' O ' ' B' ' 10' ' ' MET . 52.9 mtm -128.67 145.61 51.11 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.582 -172.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' ASN . . . . . 0.438 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 44.1 t-20 -138.02 61.21 1.6 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.47 -96.82 0.12 Allowed Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.54 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -87.19 25.77 1.31 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.913 0.387 . . . . 0.0 110.791 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.438 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 65.8 mt-30 -137.31 144.82 42.8 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 121.465 0.65 . . . . 0.0 110.627 172.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.421 ' HB3' HD13 ' B' ' 84' ' ' ILE . 3.7 tt -126.25 105.17 8.64 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.248 -1.342 . . . . 0.0 107.645 175.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.453 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 6.0 mmmm -102.62 138.27 39.74 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -173.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -156.56 147.47 21.95 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -172.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -124.27 155.22 39.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.09 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 6.7 p -135.85 157.52 46.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -172.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' B' ' 26' ' ' LYS . 22.8 t -136.43 154.45 50.78 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.776 174.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -115.96 30.39 7.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.812 -171.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.41 ' HB3' ' HE3' ' B' ' 26' ' ' LYS . . . -75.61 23.2 0.12 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -175.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.59 -24.26 0.36 Allowed Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.777 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.524 ' HB2' ' HB ' ' B' ' 71' ' ' THR . 52.6 p90 45.37 -156.6 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.167 0.987 . . . . 0.0 113.032 -176.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' B' ' 24' ' ' LYS . . . -69.52 102.98 1.02 Allowed Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.666 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.79 -64.19 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.037 0.446 . . . . 0.0 110.619 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 60.1 m -48.5 -53.66 17.24 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.152 -175.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.555 ' CB ' ' HB3' ' B' ' 68' ' ' GLU . 4.4 m-30 -78.39 127.25 31.93 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.768 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -84.25 -168.62 2.23 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.942 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -60.71 108.63 0.87 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.716 0.77 . . . . 0.0 111.325 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 54.3 mtmt -150.24 140.78 22.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.443 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.54 123.93 40.19 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.993 0.425 . . . . 0.0 111.485 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.526 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 28.1 p-90 -143.33 169.7 17.16 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.085 177.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.16 148.59 20.0 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.126 -173.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 13.5 mt -105.66 150.66 8.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 171.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.675 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 84.3 m-85 -130.56 139.48 50.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -171.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.507 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.2 p -126.58 134.32 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 4.4 m120 66.86 -2.32 1.15 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.641 -173.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' B' ' 58' ' ' VAL . . . 108.18 -6.3 34.4 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.552 -172.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -94.47 176.45 6.29 Favored 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 123.896 0.878 . . . . 0.0 109.193 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.431 ' HD3' ' CE1' ' B' ' 57' ' ' PHE . 7.8 tppt? -66.91 161.99 22.81 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.507 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.8 p -153.48 -11.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.08 0.467 . . . . 0.0 110.219 168.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.676 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -160.58 132.39 5.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.547 -175.879 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 54.9 m -139.01 124.39 19.26 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.288 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.724 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -164.84 155.6 14.43 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.505 1.145 . . . . 0.0 111.869 -174.667 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 10.7 t-20 -93.41 153.49 18.47 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.038 -1.892 . . . . 0.0 108.352 169.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 68' ' ' GLU . . . . . 0.575 ' HA ' ' NZ ' ' B' ' 24' ' ' LYS . 7.1 mm-40 -80.63 -4.48 54.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.025 0.44 . . . . 0.0 111.229 -177.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -97.23 -30.66 12.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.497 ' OG ' HD11 ' B' ' 75' ' ' ILE . 23.2 t -60.57 152.49 26.03 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.062 172.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' B' ' 45' ' ' TYR . 0.1 OUTLIER -103.22 115.79 31.24 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.112 -174.837 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.62 ' HA ' HD12 ' B' ' 75' ' ' ILE . 14.3 m -68.98 -12.48 16.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.246 -167.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.29 -46.05 94.72 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.485 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -69.13 -31.78 70.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.439 0.638 . . . . 0.0 110.271 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.724 HD13 ' HB3' ' B' ' 66' ' ' PHE . 3.8 mt -74.64 -45.89 43.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.294 -176.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 22.6 t -54.13 -34.45 60.35 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.533 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -51.89 -57.0 10.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.232 173.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.769 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 11.3 m-20 -65.9 -36.53 83.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.676 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.676 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.4 mm -61.98 -33.07 56.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.38 0.609 . . . . 0.0 111.519 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -74.66 1.77 11.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.553 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.769 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 56.6 pttt -110.44 5.62 21.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.39 . . . . 0.0 110.864 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 32.8 mt -86.75 9.35 19.2 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.149 -174.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 63.7 t30 53.15 57.44 6.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -170.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.421 HD13 ' HB3' ' B' ' 36' ' ' LEU . 76.6 mt -45.23 146.12 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.597 -175.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' B' ' 85' ' ' LYS . 38.5 mtpt -127.63 -171.77 2.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.387 177.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -157.0 113.61 0.57 Allowed Glycine 0 N--CA 1.45 -0.396 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.47 ' HG2' ' N ' ' B' ' 88' ' ' TYR . 15.9 ttt -156.4 -75.7 0.1 Allowed 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 117.057 0.429 . . . . 0.0 110.967 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 88' ' ' TYR . . . . . 0.47 ' N ' ' HG2' ' B' ' 87' ' ' MET . 60.8 t80 -122.31 101.81 7.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 28.3 mm -96.25 126.28 48.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.402 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -109.9 171.92 7.16 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 62.2 mt -149.48 107.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.148 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 47.7 pttt -157.45 179.81 8.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.098 0.475 . . . . 0.0 111.687 -177.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 1.5 pt20 -105.13 145.25 30.82 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.93 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.485 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.1 pt . . . . . 0 C--O 1.247 0.926 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.135 -174.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' MET . . . . . 0.545 ' O ' HG12 ' B' ' 13' ' ' ILE . 39.7 tpp . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -35.39 -41.85 0.19 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 5.4 m -65.52 -19.29 65.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.174 -169.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.545 HG12 ' O ' ' B' ' 10' ' ' MET . 7.7 mm -59.85 -39.59 80.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 122.198 0.999 . . . . 0.0 109.423 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -76.7 -28.01 55.7 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.22 -175.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.639 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 12.1 m -63.11 -41.93 99.45 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.821 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.552 HG13 HD13 ' B' ' 56' ' ' ILE . 63.9 t -52.7 -44.07 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.508 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -65.25 -41.56 94.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.477 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.49 -29.15 62.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.634 -178.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' B' ' 15' ' ' SER . 27.4 mmmt -71.16 -20.16 62.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.661 0.743 . . . . 0.0 111.387 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.537 HD22 HG11 ' B' ' 72' ' ' VAL . 67.1 mt -108.39 -28.15 9.55 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.416 -175.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -80.43 69.96 7.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.372 0.606 . . . . 0.0 110.104 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -133.45 33.87 3.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.954 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.28 48.85 5.49 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -130.94 -152.37 0.51 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' B' ' 45' ' ' TYR . . . -60.3 125.94 40.06 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 171.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.49 ' CB ' ' HB3' ' B' ' 41' ' ' SER . 29.7 mtpp -80.63 130.71 35.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.598 0.714 . . . . 0.0 111.276 -171.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 21.9 tp -150.26 101.57 3.0 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.11 -173.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 15.4 p -85.8 104.09 15.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.933 -174.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 60.0 mt -88.64 151.34 22.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.593 0.711 . . . . 0.0 111.31 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 71.2 m -140.49 143.9 35.73 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.748 175.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' MET . . . . . 0.47 ' SD ' HG22 ' B' ' 13' ' ' ILE . 5.1 mmt -106.79 120.46 42.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.795 0.331 . . . . 0.0 110.845 -167.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' ASN . . . . . 0.454 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 18.3 t-20 -134.29 58.97 1.75 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.267 0.556 . . . . 0.0 109.513 177.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.45 -99.76 0.03 OUTLIER Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.301 -0.863 . . . . 0.0 114.016 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -78.92 4.77 13.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.36 -0.42 . . . . 0.0 111.104 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.454 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 37.7 mt-30 -129.98 147.71 51.76 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.673 0.749 . . . . 0.0 110.579 174.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' B' ' 84' ' ' ILE . 1.4 tt -124.11 106.62 10.49 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.354 -1.294 . . . . 0.0 107.615 174.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.472 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 12.2 mmmm -96.92 153.15 18.07 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.505 -170.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -164.93 152.49 11.36 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.774 -171.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.25 171.71 12.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 169.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 16.3 p -131.78 149.95 52.31 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.189 -0.605 . . . . 0.0 111.381 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.49 ' HB3' ' CB ' ' B' ' 26' ' ' LYS . 31.1 t -130.1 155.96 45.33 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.449 0.642 . . . . 0.0 110.791 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -114.61 33.23 5.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.8 -162.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.31 -33.34 67.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.047 0.927 . . . . 0.0 110.181 172.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.33 -121.62 1.03 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 113.923 -1.489 . . . . 0.0 110.37 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.478 ' HB2' ' CG2' ' B' ' 71' ' ' THR . 9.2 p90 -177.92 -166.63 0.12 Allowed 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 120.774 0.321 . . . . 0.0 111.743 -178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.413 ' H ' HG22 ' B' ' 71' ' ' THR . . . -76.75 122.76 6.4 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.053 -176.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.419 ' H ' HD12 ' B' ' 47' ' ' ILE . 1.2 mp -107.04 -61.25 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 CA-C-O 122.36 1.076 . . . . 0.0 109.058 175.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 2.4 m -57.32 167.67 0.9 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 112.483 -2.144 . . . . 0.0 112.05 -174.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 74.49 10.29 4.2 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.391 -1.731 . . . . 0.0 111.46 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 48.65 -108.95 0.29 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.507 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -130.79 111.66 12.33 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.787 0.803 . . . . 0.0 110.42 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 94.1 mttt -134.07 138.12 45.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.121 176.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -112.47 132.84 54.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.078 0.466 . . . . 0.0 110.665 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.514 ' HA ' HG12 ' B' ' 94' ' ' ILE . 27.6 p-90 -141.88 173.05 11.87 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.016 176.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.65 139.35 10.87 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.567 -173.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.56 HD12 ' CD2' ' B' ' 64' ' ' TYR . 28.3 mt -104.86 151.34 7.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 169.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.721 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 74.9 m-85 -130.45 145.34 51.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -172.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.627 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.1 p -135.98 140.98 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.575 ' ND2' HG13 ' B' ' 58' ' ' VAL . 8.6 m-80 66.52 3.17 2.76 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -172.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.9 4.11 65.38 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.352 -172.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 3.9 mm-40 -105.84 176.51 5.14 Favored 'General case' 0 C--O 1.202 -1.433 0 C-N-CA 123.618 0.767 . . . . 0.0 109.209 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.502 ' HE3' ' CE1' ' B' ' 57' ' ' PHE . 0.0 OUTLIER -68.26 161.59 26.92 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.493 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.627 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.6 p -153.79 -12.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.909 0.385 . . . . 0.0 110.698 170.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.82 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.2 OUTLIER -159.52 128.76 5.3 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.207 -173.3 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 26.5 m -137.72 124.81 21.52 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.546 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.505 ' HB2' HD13 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -173.47 151.77 2.02 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 122.042 0.925 . . . . 0.0 112.078 -167.404 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 5.4 m120 -97.97 153.04 18.64 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.562 -1.653 . . . . 0.0 110.58 174.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -58.24 -48.06 81.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.806 0.336 . . . . 0.0 111.125 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.589 ' O ' HG23 ' B' ' 71' ' ' THR . 41.4 ttmt -72.59 -16.74 61.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.298 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.6 t -72.31 -15.08 61.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.589 HG23 ' O ' ' B' ' 69' ' ' LYS . 21.4 p 56.17 113.11 0.01 OUTLIER 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.653 1.181 . . . . 0.0 113.756 169.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.537 HG11 HD22 ' B' ' 20' ' ' LEU . 5.4 m -62.33 -14.54 12.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.16 -171.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.67 -48.96 63.27 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.404 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 74' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 77.0 m-20 -83.81 -36.29 23.62 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.451 0.643 . . . . 0.0 110.578 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.505 HD13 ' HB2' ' B' ' 66' ' ' PHE . 2.8 mt -64.89 -48.37 84.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.176 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.503 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 14.4 t -66.69 -21.13 66.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.153 -177.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 77' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' B' ' 74' ' ' ASN . 0.9 OUTLIER -52.58 -41.32 63.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 171.772 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.659 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 4.7 m-20 -72.6 -52.77 14.06 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.794 172.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.82 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 51.5 mm -47.42 -38.09 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -59.31 -30.51 68.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 45.2 pttt -73.86 -20.97 60.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.978 0.418 . . . . 0.0 110.062 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 4.3 mm? -68.66 -18.51 64.29 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.845 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 66.0 t30 39.77 69.07 0.33 Allowed 'General case' 0 C--O 1.235 0.321 0 O-C-N 124.154 0.909 . . . . 0.0 110.21 -171.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.705 ' H ' HD12 ' B' ' 84' ' ' ILE . 3.9 mp -50.23 143.91 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.614 -174.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -98.1 -178.19 3.98 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.841 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -136.75 113.68 1.07 Allowed Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.315 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.496 ' SD ' ' HA ' ' B' ' 59' ' ' ASN . 1.7 pmm? -170.21 -58.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.406 0.282 . . . . 0.0 110.907 171.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 88' ' ' TYR . . . . . 0.417 ' N ' ' HG2' ' B' ' 87' ' ' MET . 14.2 t80 -130.27 81.25 2.0 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.38 0.536 . . . . 0.0 109.85 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.721 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.3 mp -99.41 120.5 48.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.731 178.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -106.35 176.44 5.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.372 0.606 . . . . 0.0 110.442 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.472 HD11 HG22 ' B' ' 16' ' ' VAL . 30.4 mm -151.87 116.3 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.569 -174.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 40.6 pttt -168.05 159.48 11.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.094 0.473 . . . . 0.0 111.943 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.4 OUTLIER -83.27 152.31 25.22 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.014 172.297 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.514 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.4 pt . . . . . 0 C--N 1.311 -1.066 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.179 -171.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.565 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -41.58 -40.48 1.89 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.54 ' O ' HG23 ' B' ' 16' ' ' VAL . 31.8 m -74.02 -20.95 60.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.212 -172.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.479 HG22 ' SD ' ' B' ' 31' ' ' MET . 10.7 mm -58.85 -44.31 90.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 121.933 0.873 . . . . 0.0 109.284 175.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.9 -36.07 72.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.051 -176.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 19.4 t -63.81 -44.9 91.92 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.098 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.54 HG23 ' O ' ' B' ' 12' ' ' SER . 70.3 t -57.29 -47.62 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.802 0.334 . . . . 0.0 110.457 176.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -54.21 -50.56 66.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.864 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.09 -38.74 72.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.215 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -60.17 -52.13 66.65 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.514 0.673 . . . . 0.0 111.496 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.591 HD22 HG11 ' B' ' 72' ' ' VAL . 77.3 mt -75.5 -12.75 60.3 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.026 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -118.32 79.48 1.38 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.204 0.526 . . . . 0.0 111.253 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.499 ' HD3' ' OH ' ' B' ' 49' ' ' TYR . 30.1 mtpp -134.76 30.46 3.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.141 0.496 . . . . 0.0 110.667 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.17 45.18 1.91 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.1 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.52 ' HD2' ' OG ' ' B' ' 48' ' ' SER . 12.7 mmtp -90.4 -145.55 0.18 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' B' ' 45' ' ' TYR . . . -74.96 -146.24 1.28 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.74 173.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' B' ' 41' ' ' SER . 2.6 mtmp? -90.35 110.69 21.76 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -177.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.5 tp -158.75 134.33 8.72 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.611 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 74.0 p -131.24 98.77 4.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.041 0.448 . . . . 0.0 111.195 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.487 HD23 ' HB2' ' B' ' 38' ' ' ALA . 31.6 mt -83.47 151.39 25.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.416 0.627 . . . . 0.0 111.043 -177.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 54.3 m -148.43 144.69 27.6 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.624 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' MET . . . . . 0.479 ' SD ' HG22 ' B' ' 13' ' ' ILE . 57.8 mtm -109.0 130.45 55.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.92 0.391 . . . . 0.0 111.094 -173.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 2.9 t-20 -137.97 60.12 1.63 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.362 176.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 51.96 -96.95 0.02 OUTLIER Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.232 -0.894 . . . . 0.0 113.433 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -78.92 -0.58 31.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.726 0.298 . . . . 0.0 111.415 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 37.7 mt-30 -125.32 148.9 48.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.805 0.812 . . . . 0.0 111.441 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' B' ' 36' ' ' LEU . 1.3 tm? -128.7 106.84 9.21 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.383 -1.28 . . . . 0.0 107.612 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -107.38 149.21 28.13 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.521 -170.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -170.23 151.61 3.92 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.067 0.229 . . . . 0.0 111.461 -177.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 3.3 p -120.9 138.18 54.23 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 168.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.618 ' CB ' ' HA3' ' B' ' 73' ' ' GLY . 29.6 t -148.26 154.54 40.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.272 0.558 . . . . 0.0 111.431 -170.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.499 ' HB3' ' HE3' ' B' ' 26' ' ' LYS . 47.5 t -144.0 155.51 44.05 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.086 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -90.32 -6.3 55.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.845 -169.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.1 -20.47 65.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.222 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.446 ' O ' ' HA2' ' B' ' 25' ' ' GLY . . . -106.27 -4.21 38.12 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.471 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.636 ' O ' ' HA3' ' B' ' 25' ' ' GLY . 0.0 OUTLIER 78.48 -168.83 0.05 OUTLIER 'General case' 0 C--N 1.342 0.248 0 C-N-CA 123.65 0.78 . . . . 0.0 112.506 179.168 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.47 46.56 0.83 Allowed Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 167.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -44.73 -69.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.252 0.621 . . . . 0.0 110.567 -174.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.52 ' OG ' ' HD2' ' B' ' 24' ' ' LYS . 9.5 m 60.95 -88.58 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.666 172.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.499 ' OH ' ' HD3' ' B' ' 22' ' ' LYS . 59.3 m-85 -140.56 69.42 1.35 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -173.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 51.95 -94.82 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.369 -176.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -156.28 109.82 2.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.522 -0.763 . . . . 0.0 108.942 171.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 59.3 mttm -141.43 142.9 33.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.072 -175.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.516 ' HB3' ' ND2' ' B' ' 67' ' ' ASN . 0.7 OUTLIER -114.27 124.32 51.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.307 0.575 . . . . 0.0 111.856 -176.946 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.635 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 17.0 p-90 -133.88 171.68 13.84 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.948 174.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.5 143.04 14.35 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.585 -175.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.655 HD12 ' CD2' ' B' ' 64' ' ' TYR . 22.3 mt -108.49 143.33 19.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 173.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 46.8 m-85 -125.58 143.06 51.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.65 -174.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' B' ' 61' ' ' GLU . 9.6 p -128.79 143.41 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.421 ' OD1' HG13 ' B' ' 58' ' ' VAL . 2.4 m120 59.07 14.4 3.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -171.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.35 -1.56 82.33 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.628 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' B' ' 58' ' ' VAL . 13.5 mt-10 -105.12 160.03 15.38 Favored 'General case' 0 C--O 1.192 -1.973 0 C-N-CA 123.887 0.875 . . . . 0.0 109.268 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.604 ' HE2' ' CE2' ' B' ' 57' ' ' PHE . 1.2 tttm -61.89 164.08 6.86 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 118.233 0.469 . . . . 0.0 110.766 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.408 ' O ' HD12 ' B' ' 79' ' ' ILE . 0.0 OUTLIER -156.53 0.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.17 164.9 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.715 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -157.67 131.96 8.29 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.209 -0.597 . . . . 0.0 111.101 -173.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 29.6 m -142.85 119.0 10.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.208 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.54 ' CB ' HD13 ' B' ' 75' ' ' ILE . 25.4 p90 -171.29 156.41 4.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.058 0.933 . . . . 0.0 112.646 -172.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 19.7 m-80 -100.76 150.78 22.43 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.214 167.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 68' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' B' ' 48' ' ' SER . 36.3 mm-40 -58.73 -40.15 82.93 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.153 0.501 . . . . 0.0 110.92 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -65.01 -17.64 64.61 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.63 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 4.9 t -78.74 -0.59 30.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.603 178.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.444 ' O ' HG13 ' B' ' 75' ' ' ILE . 32.5 p 56.69 97.57 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.721 1.208 . . . . 0.0 112.093 176.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.651 ' HA ' HD12 ' B' ' 75' ' ' ILE . 2.5 m -57.96 -22.42 18.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.716 -170.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 73' ' ' GLY . . . . . 0.618 ' HA3' ' CB ' ' B' ' 40' ' ' SER . . . -62.03 -47.94 86.63 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.477 -178.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 74' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 77.2 m-20 -66.8 -37.73 85.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.451 0.643 . . . . 0.0 109.825 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.651 HD12 ' HA ' ' B' ' 72' ' ' VAL . 3.0 mt -67.06 -42.42 88.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.131 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 30.8 t -51.02 -39.93 56.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.54 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 77' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' B' ' 74' ' ' ASN . 0.7 OUTLIER -56.77 -40.67 76.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.887 176.788 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.78 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 24.0 m-20 -75.47 -40.67 57.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.124 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.715 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.9 mm -63.32 -32.14 55.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.325 0.583 . . . . 0.0 111.261 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.22 -11.03 56.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.593 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.78 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 20.4 pttp -95.93 3.12 53.82 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.543 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' B' ' 79' ' ' ILE . 24.2 mt -85.94 2.72 45.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.173 -176.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 52.66 62.21 2.8 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -169.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 62.1 mt -53.57 151.3 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.18 -174.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -125.08 176.19 6.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.403 176.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -139.36 112.75 0.86 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 173.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.414 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 8.2 tpt -153.7 -82.58 0.08 Allowed 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 117.024 0.412 . . . . 0.0 110.365 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 88' ' ' TYR . . . . . 0.414 ' N ' ' HG3' ' B' ' 87' ' ' MET . 23.2 t80 -109.08 94.68 5.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.646 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 34.0 mm -98.94 122.63 50.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.037 -173.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.572 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 54.1 mm-40 -116.54 148.21 41.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.428 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.635 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 77.9 mt -127.89 127.74 68.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.592 176.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.504 ' HE3' ' CE1' ' B' ' 57' ' ' PHE . 14.3 pttp -174.53 152.46 1.69 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.03 0.443 . . . . 0.0 111.476 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.4 OUTLIER -80.09 144.44 33.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.234 -179.47 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.452 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.4 pt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.197 -174.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 85.1 mmm . . . . . 0 CA--C 1.522 -0.109 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 11' ' ' ASN . . . . . 0.421 ' HA ' ' CD1' ' B' ' 13' ' ' ILE . 83.0 m-20 -46.12 -10.81 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.046 1.738 . . . . 0.0 114.956 -178.355 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.434 ' HA ' HG23 ' B' ' 16' ' ' VAL . 32.7 t -56.58 -15.49 4.47 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 122.842 0.457 . . . . 0.0 111.596 177.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.459 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.3 OUTLIER -50.68 -59.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 121.411 0.624 . . . . 0.0 111.27 -176.254 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -106.44 -49.11 3.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.015 -176.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 5.9 m -55.93 -53.45 56.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.825 -173.796 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.434 HG23 ' HA ' ' B' ' 12' ' ' SER . 80.2 t -72.8 -33.11 42.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.918 -177.019 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 17' ' ' ASN . . . . . 0.655 ' HA ' HD12 ' B' ' 29' ' ' LEU . 0.2 OUTLIER -59.79 -42.82 94.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.953 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.14 -37.88 61.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.056 178.406 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.1 OUTLIER -61.36 -40.83 95.74 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 122.9 0.48 . . . . 0.0 111.606 -179.717 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.528 HD21 ' HZ2' ' B' ' 54' ' ' TRP . 71.3 mt -80.03 -31.7 39.55 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.845 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -96.47 53.19 1.28 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.356 0.598 . . . . 0.0 110.44 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' B' ' 19' ' ' LYS . 30.6 mtpp -89.91 -51.95 5.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.139 0.495 . . . . 0.0 110.358 177.197 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.42 68.14 0.22 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 -178.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -124.28 -156.82 0.74 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.502 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -72.56 -171.08 17.68 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 175.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.714 ' O ' ' HA ' ' B' ' 40' ' ' SER . 0.0 OUTLIER -72.97 88.74 1.39 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 117.702 0.751 . . . . 0.0 109.345 176.236 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' B' ' 39' ' ' THR . 15.9 tp -105.94 127.4 53.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.035 -172.091 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 63.4 m -125.89 114.67 18.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.048 178.328 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.655 HD12 ' HA ' ' B' ' 17' ' ' ASN . 24.7 mt -89.26 156.18 18.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.439 0.638 . . . . 0.0 110.776 178.119 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.579 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 63.7 m -145.33 153.74 41.58 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.691 172.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 80.8 mtp -120.79 141.29 50.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.195 0.522 . . . . 0.0 111.857 -176.384 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -145.12 113.15 6.45 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.56 -104.55 1.09 Allowed Glycine 0 CA--C 1.507 -0.419 0 C-N-CA 119.465 -1.35 . . . . 0.0 109.769 -169.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -132.86 25.0 4.32 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.604 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 22.5 mt-30 -80.01 156.71 27.03 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.227 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.442 HD21 HD22 ' B' ' 29' ' ' LEU . 4.9 tt -110.31 110.31 21.08 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.977 -1.011 . . . . 0.0 108.514 173.208 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.579 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 22.4 mmmt -106.22 148.36 28.01 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.393 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -161.64 146.04 12.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.306 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 10.4 p -129.22 144.29 51.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.146 172.772 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.714 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 46.8 m -154.84 152.85 30.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.404 0.621 . . . . 0.0 112.292 -177.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.617 ' HB2' ' CD ' ' B' ' 26' ' ' LYS . 1.3 m -118.89 152.2 36.72 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 167.306 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 42' ' ' ASN . . . . . 0.527 ' HA ' ' HB3' ' B' ' 45' ' ' TYR . 15.0 m120 -112.56 35.16 3.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.134 0.493 . . . . 0.0 111.821 -165.353 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.81 -61.37 1.8 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.801 0.81 . . . . 0.0 110.414 173.835 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.96 62.23 0.43 Allowed Glycine 0 C--N 1.311 -0.812 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 174.666 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.601 ' HB2' HG21 ' B' ' 71' ' ' THR . 41.6 p90 -71.54 -149.68 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -173.112 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.23 92.16 1.37 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.563 -177.564 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.466 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -105.32 -57.2 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.029 0.442 . . . . 0.0 110.28 179.476 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -39.37 -58.72 1.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.318 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -91.3 101.3 14.0 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.081 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -76.7 -82.08 0.08 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.351 -176.386 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -110.99 108.75 18.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.876 0.846 . . . . 0.0 112.068 -176.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 55.4 mttm -141.23 121.59 14.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 165.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -110.12 121.3 44.93 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.61 0.719 . . . . 0.0 111.556 -174.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.589 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 28.7 p-90 -141.68 162.06 36.4 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.492 175.56 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.15 147.14 16.82 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.864 -173.323 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.614 HD12 ' CD2' ' B' ' 64' ' ' TYR . 29.0 mt -107.08 148.31 11.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 170.157 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.73 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 75.7 m-85 -127.61 144.46 51.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.263 -171.255 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.533 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.9 p -131.41 135.37 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.532 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.0 m-80 61.85 10.13 3.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.016 -176.061 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.87 -2.43 55.57 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 -177.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -107.43 176.93 4.99 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.4 tppp? -63.27 161.22 14.21 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 173.076 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.533 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.8 p -153.17 -13.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.946 0.403 . . . . 0.0 110.376 168.528 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.718 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.2 OUTLIER -160.07 128.71 4.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.016 0.436 . . . . 0.0 110.536 -172.66 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 55.0 m -139.74 123.99 17.93 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.391 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.503 ' CB ' HD13 ' B' ' 75' ' ' ILE . 19.9 p90 -171.46 157.49 4.88 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 122.012 0.91 . . . . 0.0 112.023 -172.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 24.5 m-80 -105.4 162.46 13.43 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 113.474 -1.694 . . . . 0.0 110.193 172.226 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -61.38 -48.11 82.73 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -174.715 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.567 ' O ' HG23 ' B' ' 71' ' ' THR . 41.7 ttmt -61.88 -24.52 66.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.951 0.405 . . . . 0.0 112.036 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 11.5 t -67.09 -20.46 65.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.285 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.601 HG21 ' HB2' ' B' ' 45' ' ' TYR . 9.9 p 60.56 111.72 0.02 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.633 1.173 . . . . 0.0 112.113 175.231 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.505 ' HA ' HD12 ' B' ' 75' ' ' ILE . 1.7 m -61.18 -28.42 43.74 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.961 -167.252 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.11 -49.08 57.29 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.179 -176.39 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 74' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 58.1 m-80 -67.72 -42.79 81.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.622 0.725 . . . . 0.0 110.221 179.037 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' B' ' 72' ' ' VAL . 1.8 mt -64.21 -41.75 93.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.601 -176.099 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 74.5 m -53.69 -36.01 61.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.344 179.256 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 77' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' B' ' 74' ' ' ASN . 39.0 m-20 -57.69 -38.01 74.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.989 0.423 . . . . 0.0 111.066 177.568 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.557 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 13.9 m-20 -73.83 -51.3 16.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.741 174.572 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.718 HG13 ' CE1' ' B' ' 64' ' ' TYR . 44.5 mm -56.08 -35.52 41.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.469 -178.373 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -11.28 59.68 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.318 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.557 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 15.5 ptmt -92.19 4.58 52.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.373 0.606 . . . . 0.0 110.135 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -81.47 -1.51 46.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.411 -175.292 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 63.5 t30 52.07 47.28 25.08 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.702 0.763 . . . . 0.0 109.66 -173.157 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.623 HD11 HG22 ' B' ' 79' ' ' ILE . 94.2 mt -55.12 127.69 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.682 -1.144 . . . . 0.0 113.233 -171.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -92.1 -164.35 1.17 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.582 178.145 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -151.16 119.69 1.02 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.13 -178.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 22.8 ptm -176.76 -56.73 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.616 0.208 . . . . 0.0 111.472 177.699 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -128.1 80.58 1.97 Allowed 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.816 -0.552 . . . . 0.0 110.013 177.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.73 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.3 mp -98.53 128.86 49.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.37 175.831 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -114.66 171.37 7.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.082 0.467 . . . . 0.0 110.058 175.226 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.589 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 38.9 mm -142.15 109.55 2.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.594 -178.634 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -168.27 151.87 5.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.426 0.632 . . . . 0.0 112.344 -174.604 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 2.0 pp0? -61.95 148.21 44.44 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.637 172.475 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' B' ' 54' ' ' TRP . 2.0 pt . . . . . 0 C--N 1.311 -1.075 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.028 -176.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 10' ' ' MET . . . . . 0.487 ' HG3' HD21 ' B' ' 34' ' ' ASN . 85.8 mmm . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.46 0.648 . . . . 0.0 111.94 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -77.02 -15.77 59.52 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.254 175.628 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.447 ' HA ' HD11 ' B' ' 91' ' ' ILE . 11.6 m -65.94 -10.28 37.55 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.35 -176.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.445 HG12 ' O ' ' B' ' 10' ' ' MET . 27.9 mm -58.48 -59.81 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.508 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -106.74 -36.36 6.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.644 -175.301 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.607 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 22.5 t -56.98 -41.83 79.1 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.907 -171.324 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.57 -38.95 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.85 0.357 . . . . 0.0 111.089 -176.251 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 17' ' ' ASN . . . . . 0.411 ' ND2' HD13 ' B' ' 29' ' ' LEU . 34.0 t-20 -59.13 -55.14 38.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.102 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.12 -40.11 82.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.516 -178.914 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' B' ' 15' ' ' SER . 8.5 tmtm? -49.21 -67.33 0.27 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.652 0.781 . . . . 0.0 111.71 177.824 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.585 ' C ' ' H ' ' B' ' 22' ' ' LYS . 16.2 mt -51.88 -67.01 0.29 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.729 175.805 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 21' ' ' ASN . . . . . 0.449 ' OD1' ' HE2' ' B' ' 49' ' ' TYR . 2.8 t-20 65.25 -19.4 0.09 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.935 0.894 . . . . 0.0 110.609 -168.301 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.585 ' H ' ' C ' ' B' ' 20' ' ' LEU . 31.0 mtpp 83.37 -34.62 0.07 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 159.939 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.673 ' HA2' ' CE1' ' B' ' 49' ' ' TYR . . . 95.93 79.72 1.48 Allowed Glycine 0 C--O 1.208 -1.521 0 C-N-CA 119.074 -1.536 . . . . 0.0 110.078 -166.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 64.62 -59.75 0.22 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 173.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' B' ' 23' ' ' GLY . . . -33.05 108.27 0.03 OUTLIER Glycine 0 CA--C 1.52 0.354 0 O-C-N 124.071 0.857 . . . . 0.0 113.892 179.08 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.5 ' HE3' ' HB2' ' B' ' 41' ' ' SER . 0.1 OUTLIER -77.84 153.18 32.97 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.825 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.465 HD22 ' CD ' ' B' ' 22' ' ' LYS . 1.3 pt? -163.45 170.28 17.61 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 118.291 0.496 . . . . 0.0 111.5 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 20.7 m -127.87 114.0 16.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.694 178.608 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.411 HD13 ' ND2' ' B' ' 17' ' ' ASN . 9.7 mp -83.87 158.63 21.57 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 122.038 0.923 . . . . 0.0 112.408 -179.003 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.9 p -150.4 154.8 38.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.409 178.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 29.7 mtt -122.82 138.55 54.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.654 0.264 . . . . 0.0 111.628 -168.867 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -152.09 108.09 3.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.458 177.133 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.45 -92.87 0.52 Allowed Glycine 0 CA--C 1.505 -0.534 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -176.146 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.502 ' HB2' ' CA ' ' B' ' 86' ' ' GLY . 0.4 OUTLIER -135.7 8.09 3.29 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.574 0.702 . . . . 0.0 109.311 171.585 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.525 ' OE1' ' HA ' ' B' ' 83' ' ' ASN . 49.6 mt-30 -77.94 149.82 34.11 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.23 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' B' ' 36' ' ' LEU . 12.8 tp -125.84 93.28 3.79 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.206 177.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -96.52 150.61 20.44 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.695 -171.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -165.52 158.34 15.66 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.249 -0.58 . . . . 0.0 112.219 -174.456 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 14.3 p -124.84 137.62 54.29 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.854 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 18.2 t -121.16 154.68 35.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.078 0.466 . . . . 0.0 111.484 -170.38 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.5 ' HB2' ' HE3' ' B' ' 26' ' ' LYS . 14.9 m -121.92 158.53 28.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.606 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -82.59 54.24 2.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.623 -172.223 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.75 22.44 0.6 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.973 177.219 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.518 ' O ' HD11 ' B' ' 47' ' ' ILE . . . 132.56 -47.73 1.0 Allowed Glycine 0 C--O 1.222 -0.615 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.992 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.444 ' O ' HG12 ' B' ' 47' ' ' ILE . 1.2 p90 59.15 177.38 0.08 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.455 1.102 . . . . 0.0 113.224 177.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.443 ' C ' HD13 ' B' ' 47' ' ' ILE . . . -47.64 92.03 0.01 OUTLIER Glycine 0 C--N 1.336 0.533 0 N-CA-C 114.864 0.706 . . . . 0.0 114.864 -176.425 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.518 HD11 ' O ' ' B' ' 44' ' ' GLY . 6.5 mm -109.8 -71.8 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.575 0.702 . . . . 0.0 110.625 175.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.2 p -97.45 -126.9 0.15 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.543 -178.742 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.673 ' CE1' ' HA2' ' B' ' 23' ' ' GLY . 7.1 m-85 63.91 20.29 12.14 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.206 0.526 . . . . 0.0 110.32 178.074 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 52.7 -161.17 0.11 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.621 -176.18 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -109.21 108.94 19.75 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.748 0.785 . . . . 0.0 109.435 173.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.509 ' HE3' ' O ' ' B' ' 49' ' ' TYR . 43.8 mttt -105.13 120.79 42.39 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.811 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -115.15 113.93 24.61 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.069 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.522 ' HA ' HG12 ' B' ' 94' ' ' ILE . 36.1 p-90 -148.04 164.93 32.32 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.3 -176.818 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -126.55 152.75 18.5 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.835 -176.019 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.429 ' O ' HG12 ' B' ' 63' ' ' VAL . 10.3 mt -102.18 146.81 9.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 169.631 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.7 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 83.0 m-85 -125.94 143.75 50.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.482 -172.011 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.512 HG12 ' HB ' ' B' ' 63' ' ' VAL . 10.3 p -130.7 135.24 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.381 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.497 ' HA ' ' HG3' ' B' ' 87' ' ' MET . 3.8 m120 65.74 4.62 2.97 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.72 -176.179 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.03 -0.17 51.44 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.019 -176.133 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -108.47 176.06 5.25 Favored 'General case' 0 C--O 1.203 -1.355 0 C-N-CA 123.346 0.658 . . . . 0.0 109.46 -179.346 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.496 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.5 tppp? -62.44 161.2 12.13 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 173.121 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.512 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.3 p -146.58 -22.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 166.718 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -162.21 142.5 10.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.475 -175.457 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.446 HG23 ' CD1' ' B' ' 94' ' ' ILE . 28.1 m -136.07 127.25 28.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.775 179.325 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.643 ' CD2' HG21 ' B' ' 75' ' ' ILE . 21.5 p90 -163.04 -166.95 1.37 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.07 0.462 . . . . 0.0 111.032 -177.612 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.74 ' O ' ' HB3' ' B' ' 70' ' ' SER . 22.9 t-20 -153.95 158.52 40.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.816 -173.122 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 68' ' ' GLU . . . . . 0.452 ' CD ' ' HD2' ' B' ' 52' ' ' LYS . 8.0 mm-40 -60.28 -56.62 19.24 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.385 0.612 . . . . 0.0 111.234 -178.328 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.583 ' C ' ' H ' ' B' ' 71' ' ' THR . 37.2 ttpt -65.8 -11.69 48.13 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.687 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 70' ' ' SER . . . . . 0.74 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 9.7 t -67.22 2.22 1.72 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.227 1.013 . . . . 0.0 109.283 170.253 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.583 ' H ' ' C ' ' B' ' 69' ' ' LYS . 37.6 p 59.61 80.28 0.2 Allowed 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.02 -1.9 . . . . 0.0 110.56 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.797 ' HA ' ' CG1' ' B' ' 75' ' ' ILE . 17.9 m -68.24 -4.67 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.772 -170.202 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.43 -37.18 94.22 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 119.806 -1.188 . . . . 0.0 110.201 174.653 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 74' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 42.7 m-20 -80.28 -36.21 34.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.219 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.797 ' CG1' ' HA ' ' B' ' 72' ' ' VAL . 24.2 mm -51.64 -54.27 13.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.458 176.628 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 58.8 m -55.55 -37.44 67.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.124 177.512 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 77' ' ' ASN . . . . . 0.465 ' HA ' ' ND2' ' B' ' 80' ' ' ASN . 49.0 m-20 -64.76 -38.67 91.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.205 0.526 . . . . 0.0 111.044 177.342 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.71 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 5.9 m-20 -65.78 -40.58 92.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.899 176.167 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.523 HG13 ' O ' ' B' ' 75' ' ' ILE . 63.8 mt -57.68 -30.75 37.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.121 0.486 . . . . 0.0 110.869 178.736 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' B' ' 77' ' ' ASN . 82.0 m-20 -62.02 -22.48 65.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.46 176.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.71 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 12.1 ptmm? -105.44 -11.47 16.41 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -175.212 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.24 -23.87 67.46 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.801 0.334 . . . . 0.0 110.863 -175.136 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 83' ' ' ASN . . . . . 0.525 ' HA ' ' OE1' ' B' ' 35' ' ' GLN . 23.6 t-20 45.75 62.79 2.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.059 -170.334 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.456 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 72.7 mt -64.5 142.66 16.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.125 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.44 ' H ' HG21 ' B' ' 58' ' ' VAL . 66.2 mttm -86.64 178.37 7.07 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.822 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.502 ' CA ' ' HB2' ' B' ' 34' ' ' ASN . . . -135.02 114.44 1.25 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 119.73 -1.224 . . . . 0.0 113.318 -175.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.497 ' HG3' ' HA ' ' B' ' 59' ' ' ASN . 22.8 ptp -175.07 -55.2 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.49 0.316 . . . . 0.0 110.795 177.001 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -139.6 80.7 1.79 Allowed 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.557 -0.714 . . . . 0.0 110.123 174.671 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.7 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.0 mp -94.63 126.67 47.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.061 174.861 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -109.32 175.63 5.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.26 0.552 . . . . 0.0 110.433 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.447 HD11 ' HA ' ' B' ' 12' ' ' SER . 5.7 mt -147.75 102.0 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.676 -177.246 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 45.1 pttt -164.42 165.77 21.21 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.266 -173.48 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.4 OUTLIER -73.84 159.49 32.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.781 178.998 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.522 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.0 pt . . . . . 0 C--N 1.31 -1.124 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.714 -177.176 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 10' ' ' MET . . . . . 0.452 ' SD ' ' HA ' ' B' ' 88' ' ' TYR . 80.6 mtp . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.811 0.339 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -64.16 -32.03 73.45 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.128 0.49 . . . . 0.0 110.53 176.486 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.538 ' O ' HG23 ' B' ' 16' ' ' VAL . 13.3 m -68.81 -20.89 64.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.847 -171.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 mm -51.22 -52.4 19.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 121.901 0.857 . . . . 0.0 110.672 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -75.75 -33.76 60.24 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.5 -175.029 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -64.59 -41.08 96.48 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.878 179.376 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.538 HG23 ' O ' ' B' ' 12' ' ' SER . 94.4 t -61.49 -45.22 99.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.963 0.411 . . . . 0.0 110.163 178.142 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -42.14 99.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.524 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -33.9 68.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.866 0.365 . . . . 0.0 111.359 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -68.17 -48.79 64.34 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 123.348 0.659 . . . . 0.0 111.952 -178.436 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.445 HD22 HG11 ' B' ' 72' ' ' VAL . 63.6 mt -77.81 -7.95 57.34 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.383 -176.697 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 21' ' ' ASN . . . . . 0.426 ' CG ' ' H ' ' B' ' 22' ' ' LYS . 61.2 t30 -99.73 -161.87 0.9 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.217 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.426 ' H ' ' CG ' ' B' ' 21' ' ' ASN . 53.4 mtpt 52.2 37.03 20.79 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.749 -175.014 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -134.17 41.28 1.48 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.55 -174.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.411 ' HD2' HD11 ' B' ' 47' ' ' ILE . 67.3 mttm 71.2 -67.05 0.27 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.04 0.536 . . . . 0.0 111.843 174.124 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' B' ' 45' ' ' TYR . . . -55.92 121.66 24.27 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 174.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' B' ' 40' ' ' SER . 43.2 mttm -61.5 135.41 57.66 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.194 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' B' ' 39' ' ' THR . 22.2 tp -158.94 110.93 2.17 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 121.175 0.512 . . . . 0.0 110.499 -176.358 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 55.2 m -116.32 114.08 23.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.772 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 9.2 mp -95.55 163.42 13.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.85 0.833 . . . . 0.0 111.701 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.418 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 1.4 p -157.81 147.38 19.98 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.104 171.133 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 66.0 mtp -130.02 117.06 19.46 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.512 0.673 . . . . 0.0 110.943 -177.535 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -98.83 61.57 1.3 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.316 -178.865 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.41 -88.61 0.13 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.471 -178.071 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' B' ' 84' ' ' ILE . 2.9 m-20 -94.0 16.48 14.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.786 0.327 . . . . 0.0 111.008 -177.397 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -132.12 151.24 51.89 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.261 0.553 . . . . 0.0 111.501 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tt -124.75 112.68 17.01 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.681 176.573 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.418 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 1.5 mtpm? -112.31 149.11 32.86 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -176.24 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -167.73 142.05 3.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.924 0.392 . . . . 0.0 111.759 -178.562 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 1.7 p -119.55 142.2 48.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.354 173.377 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 3.5 p -140.86 156.14 46.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.235 0.541 . . . . 0.0 112.39 -172.174 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 15.7 m -141.27 158.69 43.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.06 176.063 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -95.25 46.47 1.11 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.531 0.681 . . . . 0.0 110.768 -167.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.61 23.85 0.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.759 -1.11 . . . . 0.0 112.533 178.374 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.31 -41.01 1.53 Allowed Glycine 0 CA--C 1.51 -0.252 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.487 ' HA ' ' HA3' ' B' ' 25' ' ' GLY . 21.8 p90 51.26 -165.31 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.92 1.288 . . . . 0.0 114.138 173.757 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' B' ' 68' ' ' GLU . . . -75.95 110.43 3.04 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.867 -175.179 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.411 HD11 ' HD2' ' B' ' 24' ' ' LYS . 0.2 OUTLIER -120.65 -69.19 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-O 121.243 0.544 . . . . 0.0 111.233 177.315 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 66.9 m -119.78 -75.26 0.59 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.81 -170.363 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.454 ' O ' ' HE3' ' B' ' 52' ' ' LYS . 0.1 OUTLIER -68.17 -22.27 64.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.522 0.677 . . . . 0.0 109.875 -176.899 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.496 ' CD ' ' H ' ' B' ' 50' ' ' GLU . 22.1 mp0 -73.25 -62.6 1.42 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.996 174.171 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 51' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' B' ' 68' ' ' GLU . 6.9 t70 -44.92 108.23 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.242 -1.799 . . . . 0.0 112.497 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.704 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 98.7 mttt -150.12 161.15 42.93 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.047 176.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.407 ' HB3' ' OD1' ' B' ' 67' ' ' ASN . 3.5 p30 -109.45 119.64 40.05 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.452 0.644 . . . . 0.0 111.277 -178.677 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.561 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 6.4 p-90 -154.62 171.62 19.18 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.647 176.43 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.5 141.58 12.82 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.666 -178.061 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.679 HD12 ' CD2' ' B' ' 64' ' ' TYR . 17.7 mt -104.72 147.64 10.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 172.286 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.75 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 71.7 m-85 -127.05 143.62 51.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 -171.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.579 HG12 ' HB ' ' B' ' 63' ' ' VAL . 8.9 p -129.94 134.73 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.493 ' ND2' HG13 ' B' ' 58' ' ' VAL . 2.0 m-80 63.06 10.27 4.37 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.034 0.534 . . . . 0.0 109.885 -174.719 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.3 -1.7 64.79 Favored Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.099 -174.891 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -102.8 176.89 5.01 Favored 'General case' 0 C--O 1.207 -1.144 0 C-N-CA 123.558 0.743 . . . . 0.0 109.042 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 4.9 tppp? -66.69 161.24 23.86 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.395 0.543 . . . . 0.0 109.537 174.05 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.579 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.7 p -153.87 -13.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.196 0.522 . . . . 0.0 110.284 166.388 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.787 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -160.87 140.12 10.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.247 -171.128 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 96.1 m -157.33 121.23 4.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.563 ' CB ' HD13 ' B' ' 75' ' ' ILE . 15.6 p90 -174.9 161.27 2.98 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.938 0.875 . . . . 0.0 111.855 -168.705 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.704 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 2.2 m120 -109.09 138.2 45.81 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.184 -1.826 . . . . 0.0 108.215 166.756 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 68' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' B' ' 51' ' ' ASP . 20.2 mp0 -61.91 -12.81 19.8 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.627 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -69.12 -29.79 67.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.394 0.616 . . . . 0.0 109.863 172.872 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 39.1 t -70.58 -16.46 62.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.822 173.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 71' ' ' THR . . . . . . . . . . . . . 13.5 p 61.74 116.03 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.216 1.407 . . . . 0.0 112.095 178.23 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.565 ' HA ' HD12 ' B' ' 75' ' ' ILE . 3.0 m -59.85 -24.92 30.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.628 -169.308 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.93 -46.08 69.61 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.738 -178.555 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -72.66 -34.35 67.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.313 0.578 . . . . 0.0 110.436 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' B' ' 72' ' ' VAL . 1.7 mt -72.24 -45.85 59.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.968 -176.122 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 48.3 m -54.37 -33.08 58.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.53 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -53.13 -53.65 47.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.066 174.581 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' B' ' 81' ' ' LYS . 10.9 m-20 -69.57 -44.34 71.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.747 -179.407 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.787 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.2 mm -57.96 -32.19 42.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.348 0.594 . . . . 0.0 112.024 -178.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -65.15 -17.23 64.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.047 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' B' ' 78' ' ' ASP . 13.2 tppt? -91.63 -5.32 54.07 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.769 0.795 . . . . 0.0 109.917 -176.769 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.2 mm? -72.69 -12.59 61.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.354 -176.21 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 55.92 71.27 0.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.964 -168.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.457 ' O ' ' HB3' ' B' ' 34' ' ' ASN . 59.6 mt -64.52 157.8 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.437 -175.397 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -121.18 -175.51 3.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.183 175.718 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.02 113.44 0.75 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.661 175.272 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.82 -63.48 0.09 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.607 0.241 . . . . 0.0 111.02 -178.598 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 88' ' ' TYR . . . . . 0.452 ' HA ' ' SD ' ' B' ' 10' ' ' MET . 25.3 t80 -141.34 90.95 2.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.19 0.519 . . . . 0.0 109.892 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.75 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.1 mp -90.8 132.4 35.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.494 178.02 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -118.28 175.12 5.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.11 0.481 . . . . 0.0 110.496 177.67 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.561 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 82.1 mt -147.76 124.76 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.664 -176.703 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 41.5 pttt -177.57 160.46 1.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 0.0 111.209 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.541 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.9 OUTLIER -80.82 164.54 22.62 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.539 0.685 . . . . 0.0 110.958 177.45 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.522 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.4 pt . . . . . 0 C--N 1.309 -1.17 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.243 -173.307 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 8.2 tmm? . . . . . 0 CA--C 1.545 0.774 0 CA-C-O 121.744 0.783 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' B' B ' 11' ' ' ASN . . . . . 0.536 ' HA ' ' SD ' ' B' ' 31' ' ' MET . 9.1 t30 -61.62 -43.4 98.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.815 -175.819 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 9.9 m -69.16 -15.45 63.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.216 0.532 . . . . 0.0 110.387 -172.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -75.19 -43.49 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.57 0.7 . . . . 0.0 110.448 178.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -71.66 -14.74 62.13 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.935 -175.094 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 15' ' ' SER . . . . . 0.63 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 78.4 p -48.29 -40.53 25.25 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 123.444 0.465 . . . . 0.0 110.875 -179.679 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 49.8 t -69.61 -40.24 79.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.399 0.619 . . . . 0.0 110.166 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 17' ' ' ASN . . . . . 0.419 ' HA ' ' CD1' ' B' ' 20' ' ' LEU . 26.7 t-20 -64.83 -37.12 86.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.281 176.603 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.03 -29.27 69.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.275 174.781 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.63 ' HG2' ' O ' ' B' ' 15' ' ' SER . 24.6 mmmt -73.15 -11.6 60.59 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.183 0.516 . . . . 0.0 111.388 176.599 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.524 ' O ' ' HD3' ' B' ' 24' ' ' LYS . 39.7 mt -80.39 -18.59 48.49 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.663 0.744 . . . . 0.0 109.342 176.641 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 21' ' ' ASN . . . . . 0.475 ' OD1' ' HA ' ' B' ' 26' ' ' LYS . 62.9 t30 -92.39 58.19 3.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.985 -176.738 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -123.45 -91.85 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.492 178.561 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.16 34.64 5.24 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 177.223 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.604 ' HA ' ' C ' ' B' ' 45' ' ' TYR . 27.6 mtpt -133.07 -164.63 1.5 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.434 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.565 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -64.07 145.14 49.51 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.329 -0.939 . . . . 0.0 110.996 178.481 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.554 ' CE ' ' HB2' ' B' ' 41' ' ' SER . 13.9 ttpt -80.5 136.34 36.28 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -174.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.441 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 19.3 tp -154.03 107.67 2.96 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.869 -178.079 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -110.18 103.89 12.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.213 -176.483 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.804 HD22 ' H ' ' B' ' 29' ' ' LEU . 0.0 OUTLIER -82.02 156.92 24.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.827 0.822 . . . . 0.0 112.516 -177.702 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 53.9 m -129.8 144.11 51.14 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.355 -1.293 . . . . 0.0 107.517 164.34 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 31' ' ' MET . . . . . 0.536 ' SD ' ' HA ' ' B' ' 11' ' ' ASN . 40.7 mtt -111.24 127.53 55.64 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.675 -167.566 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 32' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 64.3 t30 -137.16 59.47 1.68 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.736 175.562 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 47.97 -93.68 0.01 OUTLIER Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.99 178.266 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.658 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 8.1 p30 -79.76 4.89 14.98 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 122.592 0.357 . . . . 0.0 111.299 -176.691 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 79.4 mt-30 -129.82 144.56 51.37 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.592 0.711 . . . . 0.0 111.017 172.584 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.453 ' CB ' ' HB ' ' B' ' 84' ' ' ILE . 0.9 OUTLIER -118.34 105.22 11.51 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.184 175.549 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 37' ' ' LYS . . . . . 0.461 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 0.0 OUTLIER -99.91 151.92 20.76 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -175.702 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.04 164.21 4.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.456 0.571 . . . . 0.0 112.498 -177.323 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 2.9 p -128.35 141.03 51.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.211 168.735 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -142.58 147.5 35.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.091 0.472 . . . . 0.0 111.615 -175.201 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.554 ' HB2' ' CE ' ' B' ' 26' ' ' LYS . 24.1 m -159.31 169.57 23.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.53 178.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 42' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' B' ' 44' ' ' GLY . 44.6 m-80 -91.73 49.18 1.53 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.102 -176.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.403 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . . . -68.96 22.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.025 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.491 ' O ' ' HD1' ' B' ' 45' ' ' TYR . . . 161.43 -63.37 0.28 Allowed Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.006 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.767 ' CD2' HG21 ' B' ' 71' ' ' THR . 0.0 OUTLIER 70.29 161.86 0.23 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.955 0.902 . . . . 0.0 111.852 -179.489 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.567 ' H ' ' CG2' ' B' ' 71' ' ' THR . . . -63.18 113.1 5.56 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 116.157 -0.474 . . . . 0.0 114.043 -166.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 11.4 mm -95.76 -67.61 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.273 0.558 . . . . 0.0 110.604 177.788 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 59.3 m -67.12 -52.67 38.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.073 -176.283 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -42.27 124.41 2.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.334 -178.892 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -74.91 -172.68 1.67 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.282 177.054 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.66 108.09 14.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.471 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 50.0 mttm -139.69 130.57 26.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.442 -178.214 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -108.79 135.6 49.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.999 0.428 . . . . 0.0 111.551 -177.702 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.617 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 37.5 p-90 -154.49 169.26 24.21 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.947 175.43 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.8 152.81 21.44 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.702 -172.44 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.532 HD12 ' CD2' ' B' ' 64' ' ' TYR . 30.0 mt -113.31 142.63 25.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 173.302 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.617 ' CE1' ' HG3' ' B' ' 62' ' ' LYS . 58.9 m-85 -127.68 140.73 51.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.408 -171.427 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' B' ' 61' ' ' GLU . 10.8 p -123.77 134.47 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.835 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 3.6 m120 63.46 4.57 1.79 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.254 0.622 . . . . 0.0 110.263 -176.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.56 -7.58 39.55 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.09 -174.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 33.1 mt-10 -98.54 175.87 5.86 Favored 'General case' 0 C--O 1.197 -1.708 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.043 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.617 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 14.4 ttmt -79.96 169.84 17.31 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 119.282 0.946 . . . . 0.0 109.929 176.323 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.2 -12.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.046 165.409 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.564 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.7 OUTLIER -159.67 123.93 3.84 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.791 -168.808 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.1 m -134.2 120.86 20.57 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.437 179.116 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.554 ' HB2' HD13 ' B' ' 75' ' ' ILE . 2.2 p90 -160.65 -178.63 7.0 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.563 1.173 . . . . 0.0 112.795 -174.529 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 67' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 16.3 t-20 -130.25 156.24 44.95 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.652 -176.597 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -70.41 -27.87 64.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.857 0.36 . . . . 0.0 110.985 -177.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.536 ' O ' HG23 ' B' ' 71' ' ' THR . 40.7 ttmt -86.6 -22.27 26.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.97 177.144 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 8.8 t -71.71 -20.29 61.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.397 173.737 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 71' ' ' THR . . . . . 0.767 HG21 ' CD2' ' B' ' 45' ' ' TYR . 35.6 p 58.46 113.69 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.4 1.08 . . . . 0.0 113.759 168.073 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.473 HG12 ' CE2' ' B' ' 66' ' ' PHE . 1.8 m -59.53 -15.99 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.21 -168.853 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.03 -50.66 64.06 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.506 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -75.69 -35.1 60.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.553 0.692 . . . . 0.0 110.461 179.463 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' B' ' 66' ' ' PHE . 1.5 mt -74.66 -51.08 23.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.184 -171.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 8.5 t -64.14 -26.8 68.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.256 -175.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -48.61 -48.93 38.91 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.925 0.869 . . . . 0.0 109.636 171.701 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.661 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 0.3 OUTLIER -71.63 -42.15 67.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.315 177.514 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.564 HG13 ' CE1' ' B' ' 64' ' ' TYR . 36.0 mm -57.92 -33.75 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.029 0.442 . . . . 0.0 111.898 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -60.04 -21.91 61.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.067 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 21.4 pttm -86.5 -7.79 58.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.839 0.352 . . . . 0.0 110.633 -178.425 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.4 mm? -71.11 -16.2 62.55 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.699 -176.184 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 t30 46.67 61.55 2.74 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 124.148 0.905 . . . . 0.0 109.624 -170.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.592 ' H ' HD12 ' B' ' 84' ' ' ILE . 3.6 mp -57.09 141.08 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.079 -176.373 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 51.5 mtpt -95.91 -175.01 3.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.846 178.203 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.415 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -139.47 114.54 1.01 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 178.553 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.14 -74.76 0.08 Allowed 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -121.21 84.7 2.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.767 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 25.7 mm -86.64 129.77 37.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.63 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.617 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 12.9 mm-40 -123.38 146.34 48.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.742 177.108 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.617 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 47.2 mt -135.01 120.5 30.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.394 177.114 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 26.8 pttt -172.76 171.21 4.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.969 0.414 . . . . 0.0 111.921 -174.174 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.423 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 15.7 mm-40 -84.62 151.52 24.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.842 179.415 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.599 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.8 pt . . . . . 0 C--N 1.313 -1.017 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.327 -174.615 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 46.1 tpp . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.388 0.137 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' B' B ' 11' ' ' ASN . . . . . 0.45 ' C ' HD12 ' B' ' 13' ' ' ILE . 1.6 m-20 -41.16 -20.41 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.165 1.786 . . . . 0.0 114.239 -176.497 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -63.75 -5.2 3.83 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.992 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.479 ' HA ' ' HB2' ' B' ' 31' ' ' MET . 0.2 OUTLIER -49.03 -52.99 8.79 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-O 122.003 0.906 . . . . 0.0 110.007 179.361 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 14' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' B' ' 18' ' ' ASP . 35.0 m-80 -88.41 -32.53 18.28 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.616 -175.536 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 3.1 m -59.51 -43.62 93.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.769 0.319 . . . . 0.0 111.424 -177.861 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.88 -41.18 60.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.27 0.557 . . . . 0.0 109.765 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 17' ' ' ASN . . . . . 0.576 ' O ' ' HB2' ' B' ' 21' ' ' ASN . 49.2 t30 -65.69 -45.88 81.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.972 -177.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 18' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' B' ' 14' ' ' ASN . 0.2 OUTLIER -67.85 -34.46 76.73 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.173 0.511 . . . . 0.0 110.729 -176.36 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -57.75 -59.91 4.5 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.192 178.373 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 49.1 mt -94.37 26.52 3.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.292 -177.577 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 21' ' ' ASN . . . . . 0.576 ' HB2' ' O ' ' B' ' 17' ' ' ASN . 27.5 t-20 -91.87 -37.86 12.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.264 0.554 . . . . 0.0 110.375 177.029 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -91.61 42.64 1.11 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.952 -178.033 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' B' ' 24' ' ' LYS . . . -85.82 -6.94 82.0 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.811 -177.673 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.478 ' HE3' ' CE1' ' B' ' 49' ' ' TYR . 86.7 mttt 72.53 -55.88 0.66 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.443 0.697 . . . . 0.0 110.801 -177.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' B' ' 45' ' ' TYR . . . -61.76 147.49 48.26 Favored Glycine 0 C--N 1.314 -0.678 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 167.234 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.531 ' CB ' ' HB3' ' B' ' 41' ' ' SER . 82.1 mttt -83.97 119.41 24.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.456 1.128 . . . . 0.0 111.105 -168.275 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 20.1 tp -158.06 118.79 3.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 28' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 57.8 m -114.55 112.27 22.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.31 -175.454 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 9.5 mp -98.09 165.65 11.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.659 0.742 . . . . 0.0 111.842 -178.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.3 p -160.47 141.44 11.97 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.808 171.485 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 31' ' ' MET . . . . . 0.703 ' SD ' HD23 ' B' ' 36' ' ' LEU . 82.0 mmm -108.47 136.38 48.19 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.65 0.262 . . . . 0.0 110.528 -175.136 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -137.08 61.33 1.63 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.153 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 55.43 -100.09 0.08 OUTLIER Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.194 177.723 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 34' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 20.9 m120 -75.81 -0.56 21.51 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.636 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -133.66 150.99 51.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.833 0.825 . . . . 0.0 112.253 175.205 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.703 HD23 ' SD ' ' B' ' 31' ' ' MET . 2.3 tm? -118.73 132.18 56.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.833 170.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -127.63 136.62 51.89 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.146 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.549 ' HB3' HD21 ' B' ' 80' ' ' ASN . . . -162.92 157.54 21.27 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.03 0.443 . . . . 0.0 111.761 -175.102 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.98 152.96 46.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.508 177.328 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 24.1 p -127.82 150.37 49.86 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.76 0.314 . . . . 0.0 110.702 -178.694 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.531 ' HB3' ' CB ' ' B' ' 26' ' ' LYS . 41.9 t -126.69 163.98 22.3 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.594 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -72.02 55.18 0.29 Allowed 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 125.243 1.589 . . . . 0.0 113.48 -154.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.456 ' HB3' ' H ' ' B' ' 26' ' ' LYS . . . -97.68 -18.32 18.93 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.911 169.247 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.12 -52.74 2.17 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.198 -0.91 . . . . 0.0 113.358 177.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.612 ' O ' ' HA3' ' B' ' 25' ' ' GLY . 5.4 m-85 -75.85 173.52 11.07 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.823 0.82 . . . . 0.0 112.638 -175.846 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.83 33.44 0.44 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 176.683 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.473 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -55.36 -45.09 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-N 114.178 -1.011 . . . . 0.0 111.803 -173.506 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.2 t 71.24 -91.33 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.168 -172.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.539 ' HB2' ' CE ' ' B' ' 52' ' ' LYS . 29.4 m-85 -140.78 126.93 19.61 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.457 0.473 . . . . 0.0 110.757 174.104 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 35.96 -109.97 0.06 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.287 1.035 . . . . 0.0 112.89 -174.509 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -132.85 132.63 42.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.19 0.519 . . . . 0.0 109.955 176.344 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.539 ' CE ' ' HB2' ' B' ' 49' ' ' TYR . 75.4 mttt -137.84 130.6 29.86 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.458 179.481 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -117.28 118.75 33.14 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.173 0.511 . . . . 0.0 109.782 175.271 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 54' ' ' TRP . . . . . 0.645 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 37.5 p-90 -143.95 170.52 15.76 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.374 -177.118 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.37 150.89 20.63 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.292 -175.234 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 11.4 mt -102.81 142.7 16.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 173.159 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 57' ' ' PHE . . . . . 0.6 ' HB2' ' HB2' ' B' ' 90' ' ' GLU . 46.7 m-85 -124.81 134.17 52.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.978 -177.322 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.558 HG12 ' HB ' ' B' ' 63' ' ' VAL . 9.3 p -126.43 137.89 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -178.796 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.436 ' HA ' ' HG3' ' B' ' 87' ' ' MET . 5.3 m120 65.86 3.09 2.41 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -172.141 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.419 ' N ' ' HB3' ' B' ' 88' ' ' TYR . . . 103.36 -12.63 54.85 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.912 -174.819 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 1.4 mp0 -91.01 170.28 10.18 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 123.663 0.785 . . . . 0.0 108.885 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 62' ' ' LYS . . . . . 0.561 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 17.4 ttmt -68.2 169.28 10.65 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 172.505 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.558 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.7 p -153.53 -13.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.297 170.722 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.5 ' CE2' HG23 ' B' ' 75' ' ' ILE . 0.3 OUTLIER -164.58 136.43 4.5 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.863 -176.347 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -128.43 127.19 42.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.515 173.35 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 66' ' ' PHE . . . . . 0.663 ' CE2' HG21 ' B' ' 75' ' ' ILE . 27.2 p90 -166.88 154.83 9.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.676 0.75 . . . . 0.0 111.074 -176.311 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -101.76 161.01 13.97 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.386 173.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 68' ' ' GLU . . . . . 0.499 ' CG ' ' HB2' ' B' ' 52' ' ' LYS . 4.7 mm-40 -73.37 -36.83 66.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.491 0.662 . . . . 0.0 109.952 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -59.72 -25.58 64.93 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.781 177.26 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.4 t -68.17 -10.4 53.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.343 -178.658 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 71' ' ' THR . . . . . . . . . . . . . 31.6 p 75.47 94.38 0.07 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 112.479 -2.146 . . . . 0.0 110.763 177.81 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.75 ' HA ' ' CG1' ' B' ' 75' ' ' ILE . 19.7 m -67.86 -8.56 9.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.328 -171.806 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.99 -37.14 94.47 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.236 176.517 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -82.14 -29.13 31.79 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.671 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 75' ' ' ILE . . . . . 0.75 ' CG1' ' HA ' ' B' ' 72' ' ' VAL . 30.2 mm -57.92 -60.56 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.959 174.429 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 76' ' ' SER . . . . . 0.429 ' HA ' HD12 ' B' ' 79' ' ' ILE . 18.9 t -61.77 -32.55 72.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.377 -177.462 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 77' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' B' ' 80' ' ' ASN . 64.8 t30 -51.96 -49.94 62.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.947 174.681 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 78' ' ' ASP . . . . . 0.68 ' O ' ' HG3' ' B' ' 81' ' ' LYS . 0.4 OUTLIER -73.47 -34.8 65.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.188 178.471 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.572 HG13 ' O ' ' B' ' 75' ' ' ILE . 57.0 mt -56.13 -34.79 39.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.253 0.549 . . . . 0.0 110.453 176.53 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 80' ' ' ASN . . . . . 0.549 HD21 ' HB3' ' B' ' 38' ' ' ALA . 10.1 m-80 -56.91 -28.08 61.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.156 177.426 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 81' ' ' LYS . . . . . 0.68 ' HG3' ' O ' ' B' ' 78' ' ' ASP . 1.1 pptp? -97.44 -5.59 35.81 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -171.212 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 31.0 mt -68.45 -21.69 64.63 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 122.0 -0.438 . . . . 0.0 110.392 -174.273 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 50.59 64.73 1.7 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.505 -166.438 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.549 HD12 ' HB2' ' B' ' 36' ' ' LEU . 70.2 mt -59.82 157.5 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.592 -172.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.465 ' O ' HG22 ' B' ' 84' ' ' ILE . 22.0 mmmt -100.82 -169.35 1.69 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.211 0.529 . . . . 0.0 110.14 175.825 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -151.53 113.27 0.57 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.192 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 87' ' ' MET . . . . . 0.436 ' HG3' ' HA ' ' B' ' 59' ' ' ASN . 18.0 ptp -174.42 -54.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 122.53 0.332 . . . . 0.0 110.248 177.636 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 88' ' ' TYR . . . . . 0.419 ' HB3' ' N ' ' B' ' 60' ' ' GLY . 6.8 t80 -134.03 79.56 1.82 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.655 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 34.1 mm -94.49 114.92 32.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.171 177.373 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.6 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 31.7 mm-40 -110.17 146.53 35.37 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.051 0.453 . . . . 0.0 111.432 179.232 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.645 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 5.2 mp -131.68 107.24 12.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.839 178.198 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 92' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 16.4 pttp -167.9 172.65 8.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.943 0.401 . . . . 0.0 111.433 -172.364 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.409 ' H ' ' HG3' ' B' ' 93' ' ' GLN . 0.4 OUTLIER -69.47 165.03 21.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.528 174.987 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 94' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' B' ' 54' ' ' TRP . 2.3 pt . . . . . 0 C--O 1.25 1.131 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.401 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 p30 . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -126.12 152.99 45.18 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.967 0.413 . . . . 0.0 110.762 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -67.47 -2.73 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.51 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -78.18 -13.3 59.92 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.297 0.57 . . . . 0.0 110.231 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.6 -169.57 0.88 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.184 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.416 ' H ' HD12 ' B' ' 6' ' ' LEU . 5.0 mp -79.37 22.22 0.44 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.086 -177.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -63.74 -69.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.793 0.33 . . . . 0.0 110.356 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -81.87 -24.32 35.83 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.805 0.812 . . . . 0.0 110.09 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.96 65.5 3.5 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.474 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 79.1 mmm -81.5 117.78 22.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.994 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -58.4 -23.59 57.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.745 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 13.3 m -65.7 -29.88 70.48 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.932 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 9.6 mm -62.74 -41.66 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 121.856 0.836 . . . . 0.0 109.436 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -70.72 -34.49 71.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.877 -174.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.573 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 17.6 m -67.73 -45.95 73.55 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.216 177.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.48 -44.59 96.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.968 0.413 . . . . 0.0 110.329 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -52.29 -49.98 63.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.953 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -18.07 47.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.24 -174.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -78.55 -49.86 12.58 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 120.984 0.421 . . . . 0.0 111.859 176.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.563 HD22 HG11 ' B' ' 72' ' ' VAL . 67.5 mt -72.89 -43.41 62.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.295 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -85.56 74.4 10.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.641 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -131.38 -77.4 0.52 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.672 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.35 46.13 1.13 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.414 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -117.19 -140.74 0.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.687 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -85.7 170.78 44.43 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.848 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.529 ' HE2' ' HB2' ' B' ' 41' ' ' SER . 4.9 ttpt -61.84 127.09 29.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' B' ' 39' ' ' THR . 11.6 tp -158.04 115.46 2.96 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 120.957 0.408 . . . . 0.0 110.693 -169.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 69.3 m -107.74 114.14 27.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.054 177.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.459 HD13 ' HB2' ' B' ' 38' ' ' ALA . 3.1 mm? -86.4 154.94 20.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.542 0.687 . . . . 0.0 111.166 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.97 154.47 41.3 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.545 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 54.1 mtt -119.88 144.73 47.24 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.118 0.485 . . . . 0.0 111.898 -171.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -154.42 108.32 2.95 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.09 -111.66 4.18 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -168.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.539 ' HB2' ' HA2' ' B' ' 86' ' ' GLY . 13.8 m120 -123.48 19.58 9.63 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 168.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -72.55 154.71 40.67 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.401 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 20.3 tp -112.44 92.03 3.87 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.172 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -89.52 151.75 21.8 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.459 ' HB2' HD13 ' B' ' 29' ' ' LEU . . . -170.65 155.53 4.91 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -171.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 11.0 p -123.27 140.18 53.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.207 168.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 27.1 t -142.18 153.13 43.8 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.767 0.794 . . . . 0.0 112.753 -172.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.529 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . 10.2 m -133.0 168.39 18.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.754 176.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -112.07 36.46 3.33 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.478 0.656 . . . . 0.0 109.94 -170.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.7 22.28 0.1 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.86 -1.064 . . . . 0.0 113.376 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.46 -44.11 0.53 Allowed Glycine 0 C--O 1.229 -0.186 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.532 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.687 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 44.4 p90 46.98 -152.51 0.08 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.22 1.008 . . . . 0.0 113.469 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.474 ' H ' ' CG2' ' B' ' 71' ' ' THR . . . -81.75 99.74 2.02 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.444 -173.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.463 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -112.52 -54.53 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.509 0.671 . . . . 0.0 109.266 172.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -42.87 -55.7 3.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.154 -1.384 . . . . 0.0 111.939 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -79.21 121.12 24.65 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.96 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -65.76 -83.92 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.814 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -146.63 112.37 5.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.508 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 79.6 mttt -139.21 136.23 34.79 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -125.41 128.14 47.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.51 0.671 . . . . 0.0 111.934 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.553 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 30.5 p-90 -147.73 177.15 9.54 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.266 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.26 151.16 22.05 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.973 -174.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' B' ' 64' ' ' TYR . 19.0 mt -110.26 141.61 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 174.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 60.9 m-85 -125.36 139.45 53.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.795 -173.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.574 HG13 ' ND2' ' B' ' 59' ' ' ASN . 7.4 p -126.37 137.38 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.642 ' HA ' ' CG ' ' B' ' 87' ' ' MET . 2.9 m-80 63.11 6.24 2.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.33 0.652 . . . . 0.0 110.171 -175.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.3 -5.45 55.41 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.94 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' B' ' 58' ' ' VAL . 22.1 mt-10 -100.2 174.45 6.14 Favored 'General case' 0 C--O 1.193 -1.873 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.504 ' HE3' ' CE1' ' B' ' 57' ' ' PHE . 10.7 tttt -80.88 169.97 16.87 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.02 -3.22 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.717 165.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.781 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -158.16 130.83 7.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.437 -172.434 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 25.3 m -137.68 125.68 22.78 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.448 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.549 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.1 OUTLIER -160.91 154.2 21.68 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 122.709 1.242 . . . . 0.0 113.239 -175.219 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 19.1 t-20 -107.93 152.1 24.9 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.364 -2.198 . . . . 0.0 107.777 166.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -64.27 -24.29 67.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.572 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.573 ' O ' HG23 ' B' ' 71' ' ' THR . 4.4 ttmp? -82.8 -26.09 32.1 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.027 0.441 . . . . 0.0 110.948 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 6.6 t -69.93 -22.3 63.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.573 HG23 ' O ' ' B' ' 69' ' ' LYS . 11.9 p 60.28 115.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.326 1.05 . . . . 0.0 112.558 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.563 HG11 HD22 ' B' ' 20' ' ' LEU . 10.0 m -61.52 -11.74 5.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.82 -172.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.56 -52.6 51.52 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.192 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -72.01 -32.57 67.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.584 0.707 . . . . 0.0 110.213 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.549 HD13 ' HB3' ' B' ' 66' ' ' PHE . 2.9 mt -73.19 -48.35 43.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.606 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.8 t -50.87 -36.75 39.59 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.239 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -51.21 -55.81 16.11 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.838 0.828 . . . . 0.0 109.744 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.748 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 24.2 m-20 -69.68 -39.7 76.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.046 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.781 HG13 ' CE1' ' B' ' 64' ' ' TYR . 42.6 mm -57.88 -30.91 39.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.378 0.609 . . . . 0.0 111.881 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -73.53 2.4 7.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.618 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.748 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 45.3 pttt -109.49 8.06 25.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.259 0.552 . . . . 0.0 109.937 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' B' ' 79' ' ' ILE . 2.3 mm? -77.36 -6.82 54.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.606 -175.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 56.2 65.03 1.53 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -167.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 54.1 mt -67.75 149.56 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.092 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.614 ' HB2' HD21 ' B' ' 59' ' ' ASN . 63.2 mttm -129.68 -159.71 0.98 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.932 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.539 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -160.29 126.77 1.67 Allowed Glycine 0 C--N 1.318 -0.426 0 C-N-CA 120.005 -1.093 . . . . 0.0 114.434 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.642 ' CG ' ' HA ' ' B' ' 59' ' ' ASN . 21.1 ptp -176.72 -52.11 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 122.782 0.433 . . . . 0.0 111.166 168.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' TYR . . . . . 0.51 ' N ' ' HG3' ' B' ' 87' ' ' MET . 60.7 t80 -127.37 99.08 5.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.917 -0.49 . . . . 0.0 109.883 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 41.1 mm -96.53 137.18 25.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.233 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 6.5 mm-40 -128.88 153.93 47.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.035 0.445 . . . . 0.0 111.494 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.553 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 51.5 mt -131.9 114.29 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.323 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 62.6 pttt -166.7 162.24 16.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.06 0.457 . . . . 0.0 112.157 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.45 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -80.82 163.97 23.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.106 175.277 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.55 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.3 pt . . . . . 0 C--O 1.245 0.85 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.892 -172.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.966 0.412 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.53 ' HB3' ' OE1' ' B' ' 8' ' ' GLU . 3.9 m-20 -80.25 -25.51 39.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.177 -175.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -75.16 -17.58 60.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.892 0.377 . . . . 0.0 110.877 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -99.84 -20.42 16.19 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.143 0.497 . . . . 0.0 110.323 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.43 125.11 25.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.977 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 61.2 mt -71.69 -3.43 21.75 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.761 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -62.8 -49.2 75.9 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.95 172.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.53 ' OE1' ' HB3' ' B' ' 2' ' ' ASN . 26.0 mt-10 -92.42 -33.65 14.46 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.393 0.616 . . . . 0.0 110.714 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -85.95 107.1 17.59 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.184 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -62.91 135.8 57.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.4 0.619 . . . . 0.0 110.678 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -56.35 -24.66 45.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.943 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.507 ' O ' HG23 ' B' ' 16' ' ' VAL . 5.4 m -63.52 -33.02 74.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.569 -178.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.448 HD11 HG13 ' B' ' 89' ' ' ILE . 12.6 mm -62.74 -43.28 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.624 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' B' ' 17' ' ' ASN . 1.3 m120 -71.93 -39.94 69.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.834 -175.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.603 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 23.8 m -61.33 -49.39 77.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.705 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.507 HG23 ' O ' ' B' ' 12' ' ' SER . 61.2 t -65.2 -38.93 83.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 110.436 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' B' ' 14' ' ' ASN . 12.2 t30 -49.97 -45.96 51.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.905 175.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.2 OUTLIER -82.75 -41.54 19.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.384 -179.322 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.603 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -58.55 -52.66 64.7 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 123.419 0.688 . . . . 0.0 112.761 -175.472 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.426 HD21 ' HZ2' ' B' ' 54' ' ' TRP . 70.2 mt -73.54 -28.39 61.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.74 0.305 . . . . 0.0 110.945 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -89.46 61.32 5.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.45 0.643 . . . . 0.0 110.279 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 30.7 mtpp -129.36 -84.27 0.56 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.835 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.65 44.95 1.39 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.616 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -126.24 -159.05 0.89 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.584 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -67.96 159.04 51.41 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.466 ' HG2' ' HB2' ' B' ' 41' ' ' SER . 0.0 OUTLIER -82.07 111.01 17.82 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.708 -177.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' B' ' 39' ' ' THR . 2.3 pt? -131.57 148.74 52.64 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.604 -176.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 60.7 m -102.67 117.08 33.89 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.404 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' B' ' 38' ' ' ALA . 2.8 mm? -88.51 152.6 21.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.51 0.672 . . . . 0.0 110.787 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.1 p -150.07 151.02 32.55 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.237 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 50.7 mtt -120.13 146.21 46.19 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.858 0.361 . . . . 0.0 110.92 -175.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -154.05 116.65 4.4 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.96 -111.49 4.16 Favored Glycine 0 CA--C 1.507 -0.41 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -169.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.56 ' HB2' ' CA ' ' B' ' 86' ' ' GLY . 43.1 m-20 -130.45 37.75 3.82 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 168.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.426 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 48.1 mt-30 -92.17 161.25 14.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.241 175.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 27.4 tp -127.44 110.53 12.87 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 171.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.427 ' HA ' ' ND2' ' B' ' 80' ' ' ASN . 32.2 mtmt -113.36 148.06 36.49 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -177.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.485 ' HB2' HD13 ' B' ' 29' ' ' LEU . . . -156.89 158.16 36.18 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -172.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 4.6 p -133.35 134.68 44.07 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.929 171.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -131.1 147.82 52.66 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -167.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.466 ' HB2' ' HG2' ' B' ' 26' ' ' LYS . 2.4 m -99.75 141.7 32.21 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 167.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -103.92 32.06 4.15 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.339 -169.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.71 22.52 1.6 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.135 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.69 -36.52 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.798 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.584 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 6.8 p90 38.13 -142.02 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.475 1.11 . . . . 0.0 113.646 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.49 112.05 3.41 Favored Glycine 0 C--N 1.339 0.729 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.076 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.21 -57.41 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.005 0.431 . . . . 0.0 109.846 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.4 m -43.2 -54.81 4.29 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.346 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -97.32 120.38 37.59 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.067 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -94.98 -84.17 0.34 Allowed 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.641 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -103.96 108.35 19.66 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.749 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.52 ' HB2' ' CG ' ' B' ' 68' ' ' GLU . 93.2 mttt -150.15 134.29 17.09 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 169.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.96 126.51 51.05 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.127 0.489 . . . . 0.0 110.805 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.566 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 25.1 p-90 -145.02 159.34 43.09 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.721 176.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -122.09 147.82 17.09 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.166 -175.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.548 HD12 ' CD2' ' B' ' 64' ' ' TYR . 16.4 mt -105.11 148.76 9.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 169.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.69 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 88.9 m-85 -128.35 141.28 51.47 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -169.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.565 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.9 p -128.12 136.57 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 3.2 m120 62.43 12.82 5.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.276 -171.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.94 78.92 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.075 -174.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 17.2 mt-10 -98.25 175.31 6.12 Favored 'General case' 0 C--O 1.202 -1.429 0 C-N-CA 123.517 0.727 . . . . 0.0 109.357 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.0 tppp? -63.4 160.56 15.9 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 118.681 0.673 . . . . 0.0 109.956 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.565 ' HB ' HG12 ' B' ' 58' ' ' VAL . 7.2 p -151.47 -16.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.965 0.412 . . . . 0.0 110.168 167.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.691 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.9 OUTLIER -161.5 125.74 3.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.148 -171.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 22.7 m -131.36 129.44 41.39 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.642 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.511 ' CB ' HD13 ' B' ' 75' ' ' ILE . 7.7 p90 -167.83 153.66 7.34 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 122.186 0.993 . . . . 0.0 112.567 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.496 ' O ' ' HB3' ' B' ' 70' ' ' SER . 16.6 t-20 -99.81 153.14 19.37 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.151 -1.84 . . . . 0.0 108.962 171.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' GLU . . . . . 0.52 ' CG ' ' HB2' ' B' ' 52' ' ' LYS . 6.7 mm-40 -62.03 -45.67 92.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.969 0.349 . . . . 0.0 111.423 -176.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.522 ' O ' HG23 ' B' ' 71' ' ' THR . 86.4 tttt -64.71 -22.22 66.93 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.454 0.702 . . . . 0.0 111.547 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 6.2 t -69.44 -16.74 63.55 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.522 HG23 ' O ' ' B' ' 69' ' ' LYS . 30.2 p 59.18 107.78 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.888 1.275 . . . . 0.0 112.915 172.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.547 ' HA ' HD12 ' B' ' 75' ' ' ILE . 2.3 m -58.34 -17.85 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 114.266 -1.333 . . . . 0.0 112.635 -171.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.37 -48.97 80.75 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.682 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -74.5 -34.21 63.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.465 0.65 . . . . 0.0 110.191 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' B' ' 72' ' ' VAL . 1.9 mt -74.68 -48.45 34.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.085 -173.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 77.7 p -50.62 -48.75 57.89 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.583 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -41.62 -52.57 3.76 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.751 -1.568 . . . . 0.0 111.216 173.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.705 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 22.7 m-20 -74.28 -28.83 61.38 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.429 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.691 HG13 ' CE1' ' B' ' 64' ' ' TYR . 48.8 mm -71.88 -38.12 63.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.142 0.496 . . . . 0.0 111.199 177.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.427 ' ND2' ' HA ' ' B' ' 37' ' ' LYS . 11.3 m120 -62.88 -28.37 70.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.373 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.705 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 61.1 pttt -81.59 3.41 25.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.446 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' B' ' 79' ' ' ILE . 36.8 mt -84.77 3.89 35.45 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.726 0.298 . . . . 0.0 110.862 -177.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 58.9 t30 54.15 58.03 5.38 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -170.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.443 HD11 HG22 ' B' ' 79' ' ' ILE . 61.7 mt -52.31 149.88 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.726 -173.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -109.22 175.14 5.56 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.573 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.56 ' CA ' ' HB2' ' B' ' 34' ' ' ASN . . . -141.97 112.94 0.78 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.472 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.536 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 0.2 OUTLIER -146.1 -81.21 0.15 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 117.021 0.41 . . . . 0.0 110.595 175.536 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 88' ' ' TYR . . . . . 0.536 ' N ' ' HG3' ' B' ' 87' ' ' MET . 46.8 t80 -120.16 106.24 11.75 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.69 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 22.0 mm -101.11 130.55 50.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.092 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -122.89 178.58 4.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.188 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.566 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 95.8 mt -149.98 127.76 2.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.29 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -174.36 154.2 2.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.98 0.419 . . . . 0.0 111.615 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.3 OUTLIER -82.68 146.43 29.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.087 177.201 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.49 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.2 pt . . . . . 0 C--O 1.249 1.064 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.95 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 14.8 t70 . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.702 0.286 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -127.96 37.99 4.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.712 0.291 . . . . 0.0 110.955 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -90.64 -70.09 0.69 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.028 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -97.1 -61.93 1.33 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.095 0.474 . . . . 0.0 111.116 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.49 85.89 6.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.204 -175.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.4 -21.51 63.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.866 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' B' ' 87' ' ' MET . 31.6 mt-10 -67.13 -10.83 54.24 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -175.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -70.11 -21.57 63.1 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 122.417 1.104 . . . . 0.0 109.351 174.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.64 ' HG2' ' H ' ' B' ' 10' ' ' MET . 17.8 tt0 -128.87 -163.59 1.3 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.085 -1.87 . . . . 0.0 107.314 174.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' MET . . . . . 0.684 ' HG2' ' H ' ' B' ' 89' ' ' ILE . 15.1 tpt -158.58 138.39 12.01 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.765 -0.585 . . . . 0.0 109.736 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -54.04 -28.63 39.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.22 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.585 ' H ' ' HG3' ' B' ' 10' ' ' MET . 6.2 m -75.2 -16.63 60.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.397 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.523 HG22 ' SD ' ' B' ' 31' ' ' MET . 6.3 mm -57.45 -44.06 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 122.313 1.054 . . . . 0.0 109.03 175.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -70.32 -30.67 67.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.536 -1.666 . . . . 0.0 109.792 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.477 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 10.7 t -70.96 -38.04 72.81 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.903 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.545 HG23 ' O ' ' B' ' 12' ' ' SER . 93.3 t -51.01 -50.55 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.397 0.618 . . . . 0.0 109.816 174.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -59.02 -49.46 77.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.871 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -30.86 68.32 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -174.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' B' ' 15' ' ' SER . 10.0 mmmm -76.85 -23.65 52.7 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.464 0.649 . . . . 0.0 111.381 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.41 HD22 HG11 ' B' ' 72' ' ' VAL . 92.0 mt -97.36 -42.11 7.92 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.181 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -84.95 73.46 10.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.395 0.616 . . . . 0.0 110.184 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -116.72 -74.38 0.61 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.504 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.49 40.65 0.82 Allowed Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.741 ' HG2' ' CE1' ' B' ' 49' ' ' TYR . 44.4 mttt -110.7 -145.48 0.4 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -70.09 154.2 52.51 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' B' ' 40' ' ' SER . 0.3 OUTLIER -61.91 121.67 13.52 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.487 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.476 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 28.8 tp -148.23 97.46 2.78 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.481 0.658 . . . . 0.0 109.256 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 43.0 m -99.12 116.24 30.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.788 -175.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.476 ' CD1' ' HG ' ' B' ' 27' ' ' LEU . 10.2 mp -101.67 167.27 10.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.555 0.693 . . . . 0.0 111.838 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.5 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 1.3 p -149.38 146.26 27.4 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.802 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' MET . . . . . 0.523 ' SD ' HG22 ' B' ' 13' ' ' ILE . 5.7 mmt -105.8 118.26 36.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.562 -169.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 14.0 t-20 -133.5 60.76 1.69 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.882 0.373 . . . . 0.0 110.009 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.88 -104.11 0.12 Allowed Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.606 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.491 ' HA ' ' N ' ' B' ' 86' ' ' GLY . 17.9 m120 -85.02 23.19 1.26 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.687 -0.257 . . . . 0.0 111.07 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 35.3 mt-30 -138.73 150.84 46.58 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.437 0.636 . . . . 0.0 110.595 172.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -123.94 114.65 20.09 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.162 172.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.5 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 6.7 mmmm -110.73 137.78 47.96 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -176.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -162.28 154.2 18.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.28 0.562 . . . . 0.0 112.329 -172.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.33 146.15 51.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.389 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 33.6 p -135.67 154.98 51.11 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.004 0.431 . . . . 0.0 112.031 -175.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 28.1 t -152.95 159.37 42.94 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.152 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' B' ' 44' ' ' GLY . 51.3 m-80 -85.76 52.82 2.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.114 -174.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.21 23.22 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.856 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' B' ' 42' ' ' ASN . . . 117.39 -13.19 13.74 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.784 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.49 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 35.7 p90 45.2 -156.98 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.403 1.081 . . . . 0.0 113.136 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.424 ' H ' HG22 ' B' ' 71' ' ' THR . . . -72.63 89.97 0.55 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.91 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.55 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -91.68 -70.85 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.541 0.686 . . . . 0.0 110.509 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 m -50.34 -55.88 13.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.987 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.741 ' CE1' ' HG2' ' B' ' 24' ' ' LYS . 4.3 m-85 -61.48 109.69 1.24 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.605 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.29 -64.44 0.95 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.543 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -173.05 113.09 0.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.734 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 54.1 mtmt -138.31 145.34 41.09 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.513 ' HB3' ' OD1' ' B' ' 67' ' ' ASN . 0.5 OUTLIER -121.82 121.96 38.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.226 0.536 . . . . 0.0 111.623 -178.194 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.584 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 33.4 p-90 -140.23 173.74 11.21 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.229 174.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.98 151.79 21.12 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.907 -1.14 . . . . 0.0 113.372 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.523 HD12 ' CD2' ' B' ' 64' ' ' TYR . 18.2 mt -110.12 145.92 16.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 174.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.76 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 72.8 m-85 -128.88 143.66 50.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.282 -171.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.536 HG13 ' ND2' ' B' ' 59' ' ' ASN . 9.6 p -128.47 137.34 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.536 ' ND2' HG13 ' B' ' 58' ' ' VAL . 1.4 m-80 60.27 9.02 1.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.277 0.631 . . . . 0.0 110.494 -176.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.77 7.87 57.45 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.232 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 12.1 mt-10 -114.62 177.02 4.8 Favored 'General case' 0 C--O 1.199 -1.592 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.571 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 18.6 ttmt -78.89 169.21 18.58 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 119.303 0.956 . . . . 0.0 109.924 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.53 -14.96 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.798 164.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.679 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.5 OUTLIER -158.4 130.07 6.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.601 -167.054 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.2 m -137.96 133.3 33.54 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.218 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.458 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.0 OUTLIER -159.35 160.97 35.63 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.953 0.882 . . . . 0.0 111.21 -174.5 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.513 ' OD1' ' HB3' ' B' ' 53' ' ' ASN . 2.9 m120 -115.96 146.78 41.81 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.624 -1.626 . . . . 0.0 109.787 170.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' GLU . . . . . 0.465 ' CD ' ' HZ3' ' B' ' 24' ' ' LYS . 13.4 mm-40 -56.35 -44.27 79.92 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.614 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.538 ' O ' HG23 ' B' ' 71' ' ' THR . 35.0 ttpt -64.01 -30.09 71.19 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.611 0.72 . . . . 0.0 110.621 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 23.7 m -81.27 -3.35 52.18 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.091 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.538 HG23 ' O ' ' B' ' 69' ' ' LYS . 23.6 p 55.21 102.01 0.01 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.304 1.442 . . . . 0.0 113.474 165.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.41 HG11 HD22 ' B' ' 20' ' ' LEU . 4.2 m -62.94 -18.88 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.425 -173.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.42 -49.58 75.09 Favored Glycine 0 C--O 1.236 0.241 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.974 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -69.62 -37.52 76.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.023 0.439 . . . . 0.0 110.268 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.569 ' O ' HG12 ' B' ' 79' ' ' ILE . 2.7 mt -68.21 -46.61 80.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.609 -176.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 45.6 m -57.02 -35.5 69.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.933 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -54.74 -49.17 71.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.169 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 7.3 m-20 -70.51 -37.49 74.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.558 -1.201 . . . . 0.0 112.122 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.679 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 43.7 mm -59.02 -24.4 26.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.482 0.658 . . . . 0.0 111.443 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -59.95 -18.66 47.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.508 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 6.0 ptpp? -87.11 1.32 53.36 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.172 0.51 . . . . 0.0 110.851 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.577 HD23 ' HA ' ' B' ' 79' ' ' ILE . 2.4 mm? -81.38 -1.66 46.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.156 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 49.54 62.35 2.68 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.798 -168.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.584 HD11 HG22 ' B' ' 79' ' ' ILE . 49.0 mt -58.71 140.77 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.71 -177.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -127.37 -176.76 3.84 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.796 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.491 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -136.89 115.53 1.27 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.872 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.487 ' HA ' ' O ' ' B' ' 7' ' ' GLU . 32.7 ttm -157.79 -74.99 0.09 Allowed 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -130.77 82.51 2.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.415 0.626 . . . . 0.0 109.503 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.76 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.2 mp -87.67 136.68 22.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.518 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -122.08 171.78 8.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.888 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.509 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 32.9 mm -144.93 110.1 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.33 -174.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.584 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 16.6 pttp -161.04 173.18 15.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.291 0.567 . . . . 0.0 112.042 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.509 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 5.1 pm0 -105.49 145.79 30.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.882 -175.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.7 pt . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.95 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -100.89 -25.09 14.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.727 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLN . . . . . 0.417 ' HA ' ' HG ' ' B' ' 6' ' ' LEU . 15.8 pt20 -55.22 -42.67 73.65 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -173.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -70.62 -26.15 63.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.143 0.497 . . . . 0.0 110.775 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -107.77 26.68 10.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.24 -175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' B' ' 9' ' ' GLN . 74.9 mt -75.24 11.47 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.24 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -68.17 -62.66 1.3 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.205 0.526 . . . . 0.0 109.639 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -89.32 -33.22 16.99 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.03 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' B' ' 6' ' ' LEU . 50.6 mt-30 -85.75 119.35 25.99 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.361 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.15 174.09 7.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.958 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -60.28 -33.36 72.23 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.967 0.413 . . . . 0.0 111.805 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.431 ' O ' HG23 ' B' ' 16' ' ' VAL . 23.2 t -67.84 -8.45 36.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.031 -169.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 10.2 mm -55.41 -55.11 18.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.935 0.874 . . . . 0.0 110.12 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -77.56 -27.7 51.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.355 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 10.1 m -57.6 -47.05 83.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.116 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.431 HG23 ' O ' ' B' ' 12' ' ' SER . 76.1 t -66.46 -43.91 90.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.085 0.469 . . . . 0.0 109.978 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -54.08 -50.77 66.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.986 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.38 -43.21 64.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.648 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -57.24 -50.89 71.45 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 123.204 0.602 . . . . 0.0 111.593 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -70.69 -45.24 65.38 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.827 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -85.97 59.78 5.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.389 0.614 . . . . 0.0 111.369 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -105.23 -17.34 14.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.328 0.585 . . . . 0.0 109.914 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.83 -95.16 0.1 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.521 ' HE3' ' OE2' ' B' ' 68' ' ' GLU . 51.3 mttp 41.65 -135.1 0.29 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.688 0.795 . . . . 0.0 111.197 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.608 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -84.42 168.15 43.85 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.785 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.425 ' HE3' ' CB ' ' B' ' 41' ' ' SER . 14.7 ttpt -86.27 109.84 19.23 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -145.52 168.31 20.91 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.161 -176.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.6 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 43.9 m -125.66 107.11 10.25 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.759 -176.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.503 HD23 ' HB2' ' B' ' 38' ' ' ALA . 33.1 mt -86.87 144.91 26.78 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.569 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 9.0 p -134.78 156.69 48.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.964 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 55.0 mtm -110.04 127.99 55.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.991 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -148.89 108.33 3.96 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.04 -114.62 6.92 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.581 ' HB2' ' HA2' ' B' ' 86' ' ' GLY . 1.7 m-20 -123.9 20.03 9.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' B' ' 84' ' ' ILE . 74.5 mt-30 -74.69 158.78 32.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.528 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tt -115.93 104.01 11.18 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.391 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.569 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 4.7 mtmp? -115.59 142.63 46.47 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -158.91 156.61 29.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -175.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -130.56 134.65 47.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 170.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 44.6 t -126.33 160.07 31.41 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -164.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.425 ' CB ' ' HE3' ' B' ' 26' ' ' LYS . 35.2 t -134.4 159.97 39.41 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.007 174.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -109.25 29.63 7.35 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.276 0.56 . . . . 0.0 110.727 -171.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.03 22.4 0.09 Allowed 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.961 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.75 -38.3 0.57 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.409 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.608 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 14.4 p90 45.56 -159.48 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.471 1.108 . . . . 0.0 113.758 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.17 114.83 6.03 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.974 -0.632 . . . . 0.0 113.118 -175.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.11 -60.81 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.837 0.351 . . . . 0.0 110.815 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 m -40.66 -57.23 1.93 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.077 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.81 106.15 10.61 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.784 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -60.0 -49.22 78.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.651 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -165.32 110.77 0.91 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.985 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 71.8 mmtt -133.51 131.93 40.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -112.73 125.77 54.68 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.522 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 16.7 p-90 -152.7 166.74 31.2 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.886 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.33 142.6 13.88 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.846 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.589 HD12 ' CD2' ' B' ' 64' ' ' TYR . 23.7 mt -106.59 151.37 8.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.669 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 76.0 m-85 -132.59 140.29 48.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.277 -170.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.544 HG12 ' HB ' ' B' ' 63' ' ' VAL . 11.9 p -124.85 131.42 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.407 ' ND2' HG13 ' B' ' 58' ' ' VAL . 2.8 m-80 64.25 11.49 6.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.51 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.96 -3.74 62.55 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.348 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -103.01 177.15 4.92 Favored 'General case' 0 C--O 1.207 -1.152 0 C-N-CA 123.303 0.641 . . . . 0.0 109.642 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.438 ' HD2' ' OG1' ' B' ' 65' ' ' THR . 5.2 tppp? -63.87 158.76 21.22 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.014 175.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.544 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.8 p -153.23 -11.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.122 0.487 . . . . 0.0 110.245 165.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.819 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -161.21 136.25 7.52 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.061 0.458 . . . . 0.0 110.53 -174.329 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.438 ' OG1' ' HD2' ' B' ' 62' ' ' LYS . 84.8 m -149.25 118.47 6.81 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' B' ' 66' ' ' PHE . 0.0 OUTLIER -167.74 159.76 12.04 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.717 0.77 . . . . 0.0 111.462 -164.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 18.1 t-20 -114.04 158.8 20.74 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.915 -1.493 . . . . 0.0 109.591 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' GLU . . . . . 0.521 ' OE2' ' HE3' ' B' ' 24' ' ' LYS . 8.5 mm-40 -74.06 -34.14 63.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.004 0.43 . . . . 0.0 110.898 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.548 ' O ' HG23 ' B' ' 71' ' ' THR . 53.0 tttm -68.94 -31.69 70.76 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.049 0.928 . . . . 0.0 109.319 176.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 30.4 m -79.62 0.3 30.74 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.843 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.548 HG23 ' O ' ' B' ' 69' ' ' LYS . 20.1 p 53.64 100.58 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.436 1.494 . . . . 0.0 113.678 165.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 m -56.68 -21.77 14.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.069 -176.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.67 -54.64 35.73 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.544 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -69.4 -31.93 70.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.202 0.525 . . . . 0.0 110.172 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.513 HG13 ' O ' ' B' ' 71' ' ' THR . 2.9 mt -70.11 -42.61 79.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.239 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -58.02 -30.25 65.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.752 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -52.6 -53.32 48.31 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.767 0.794 . . . . 0.0 109.633 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.684 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 4.9 m-20 -65.1 -40.67 94.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.461 177.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.819 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 44.5 mm -54.31 -32.33 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.314 0.578 . . . . 0.0 111.817 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.461 ' OD1' ' HA ' ' B' ' 37' ' ' LYS . 90.5 m-20 -58.43 -31.22 67.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.816 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 4.6 ptpp? -83.43 -4.48 58.54 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.163 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.8 mm? -70.32 -15.83 62.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.717 0.294 . . . . 0.0 110.667 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 44.01 61.66 2.25 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.813 -171.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.442 HG22 ' O ' ' B' ' 85' ' ' LYS . 73.0 mt -60.04 146.37 10.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.362 -1.29 . . . . 0.0 112.6 -172.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.442 ' O ' HG22 ' B' ' 84' ' ' ILE . 30.0 mmmt -92.11 -166.07 1.48 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.132 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.581 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -148.55 114.16 0.66 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.808 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.464 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 6.2 tpt -152.42 -68.89 0.16 Allowed 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 122.531 0.333 . . . . 0.0 110.124 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' TYR . . . . . 0.464 ' N ' ' HG3' ' B' ' 87' ' ' MET . 5.1 t80 -143.41 106.57 4.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.072 0.463 . . . . 0.0 109.835 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.669 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 37.0 mm -91.85 130.28 41.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.04 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -121.65 169.47 10.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.793 0.33 . . . . 0.0 110.154 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.436 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 70.5 mt -146.72 130.28 9.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.24 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 39.9 pttt -165.03 159.57 18.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.124 0.488 . . . . 0.0 111.42 174.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.502 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.6 OUTLIER -106.69 138.78 42.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.863 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.2 pt . . . . . 0 C--O 1.246 0.88 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.042 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -143.92 95.55 2.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.825 0.345 . . . . 0.0 110.277 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -62.24 -20.21 64.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.479 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' B' ' 4' ' ' LYS . 3.2 tmtp? -68.7 -29.36 67.77 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.32 0.581 . . . . 0.0 109.8 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.21 -22.09 27.11 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.413 0.625 . . . . 0.0 109.937 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 80.9 mt -87.91 8.64 25.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.367 -176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.54 -33.29 75.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.309 0.576 . . . . 0.0 109.919 174.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -86.52 -63.55 1.3 Allowed 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.833 0.825 . . . . 0.0 109.897 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -82.5 74.31 9.48 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.436 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' MET . . . . . 0.426 ' O ' HG12 ' B' ' 13' ' ' ILE . 90.3 mmm -45.86 145.49 1.44 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.108 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -51.11 -27.52 8.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.865 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 5.1 m -66.6 -31.07 71.53 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.288 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.426 HG12 ' O ' ' B' ' 10' ' ' MET . 11.4 mm -63.77 -31.0 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.647 0.737 . . . . 0.0 109.888 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -92.09 -44.36 8.87 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.812 -172.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 14.5 p -70.89 -45.24 64.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.095 -178.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 91.4 t -68.51 -30.14 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.585 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -53.79 -47.17 71.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.258 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.1 OUTLIER -78.95 -42.63 26.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.619 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -58.65 -43.05 89.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.401 -176.101 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.656 HD22 HG11 ' B' ' 72' ' ' VAL . 19.7 mt -80.24 -24.24 40.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -105.62 70.93 0.89 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.818 0.342 . . . . 0.0 111.249 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 33.6 mtmt -138.31 -91.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.817 175.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.434 ' O ' ' HA2' ' B' ' 46' ' ' GLY . . . -92.93 32.42 5.64 Favored Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.567 ' N ' ' HD2' ' B' ' 24' ' ' LYS . 0.0 OUTLIER -124.27 -163.08 1.12 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 174.119 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.648 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -67.96 144.97 44.16 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.184 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.546 ' HE2' ' HB3' ' B' ' 43' ' ' ALA . 44.7 mttm -62.2 144.5 55.41 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.424 ' CD2' ' HB3' ' B' ' 40' ' ' SER . 4.0 mt -150.07 118.45 6.45 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.118 0.485 . . . . 0.0 110.91 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 14.4 m -99.06 97.97 9.04 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.338 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.496 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 10.4 mp -86.14 163.0 18.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.797 0.808 . . . . 0.0 112.094 -172.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.1 p -146.69 148.82 32.41 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.111 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 58.0 mtt -96.49 139.7 32.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.106 0.479 . . . . 0.0 111.68 -173.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ASN . . . . . 0.524 ' O ' ' HB3' ' B' ' 35' ' ' GLN . 8.6 t30 -157.15 91.92 1.22 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.833 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.98 -97.55 0.51 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -172.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -142.1 21.61 2.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.563 ' CG ' ' HG2' ' B' ' 37' ' ' LYS . 0.1 OUTLIER -85.71 158.27 20.09 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.893 -176.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tt -111.85 98.06 7.12 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.887 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.563 ' HG2' ' CG ' ' B' ' 35' ' ' GLN . 11.1 mtmt -112.1 137.17 50.53 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' B' ' 29' ' ' LEU . . . -173.4 169.96 4.3 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -170.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 5.8 p -128.17 140.34 51.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.591 170.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 74.1 p -123.66 165.41 17.26 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -169.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' B' ' 26' ' ' LYS . 32.3 t -131.62 157.98 42.26 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.481 176.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -117.04 18.31 14.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.331 -172.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.546 ' HB3' ' HE2' ' B' ' 26' ' ' LYS . . . -63.64 -21.86 66.59 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.585 ' O ' HD11 ' B' ' 47' ' ' ILE . . . -143.14 -48.6 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.099 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.648 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 3.4 p90 52.93 -164.55 0.08 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.966 1.306 . . . . 0.0 113.852 -176.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.514 ' N ' ' HD1' ' B' ' 45' ' ' TYR . . . -57.87 100.12 0.13 Allowed Glycine 0 C--N 1.342 0.88 0 N-CA-C 114.601 0.6 . . . . 0.0 114.601 -174.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.585 HD11 ' O ' ' B' ' 44' ' ' GLY . 3.8 mm -108.53 -67.81 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-O 121.59 0.71 . . . . 0.0 110.777 173.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -51.16 -62.62 1.51 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.579 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -83.48 127.01 33.37 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.772 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.69 -171.97 1.73 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.18 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -65.53 107.07 1.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.368 0.604 . . . . 0.0 109.706 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 6.4 mtmp? -145.4 128.83 16.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.621 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -102.73 124.85 49.02 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.532 0.682 . . . . 0.0 112.357 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.61 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 51.4 p-90 -141.15 163.7 32.26 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.368 169.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.82 156.8 23.02 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 119.772 -1.204 . . . . 0.0 113.317 -172.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.45 HD12 ' CD2' ' B' ' 64' ' ' TYR . 22.1 mt -111.82 137.74 43.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 174.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.726 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 46.0 m-85 -124.77 132.12 53.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.014 -174.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.531 HG13 ' ND2' ' B' ' 59' ' ' ASN . 13.4 p -112.48 136.27 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.916 177.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.531 ' ND2' HG13 ' B' ' 58' ' ' VAL . 9.9 m-80 71.04 -7.93 1.05 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.538 0.735 . . . . 0.0 110.905 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.25 5.9 39.76 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -169.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' B' ' 58' ' ' VAL . 25.9 mt-10 -106.55 165.76 11.05 Favored 'General case' 0 C--O 1.198 -1.642 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 174.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.475 ' HA ' ' CD1' ' B' ' 57' ' ' PHE . 27.8 ttmt -78.5 168.93 19.05 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.82 -10.08 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.326 165.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.649 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.5 OUTLIER -158.1 125.79 5.2 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.413 -170.169 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -134.42 132.2 39.07 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.178 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.439 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.0 OUTLIER -163.76 165.97 22.53 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 122.161 0.981 . . . . 0.0 111.162 -175.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.627 ' HB2' ' OG ' ' B' ' 70' ' ' SER . 24.5 m-80 -116.72 144.63 44.21 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.493 169.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -64.67 -15.8 61.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.824 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -92.82 -25.28 18.2 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.252 0.549 . . . . 0.0 109.846 177.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.627 ' OG ' ' HB2' ' B' ' 67' ' ' ASN . 38.2 m -76.98 -5.57 49.17 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.458 -175.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.495 HG22 ' H ' ' B' ' 46' ' ' GLY . 3.3 p 66.27 99.84 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.741 169.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.656 HG11 HD22 ' B' ' 20' ' ' LEU . 7.8 m -65.67 -13.11 14.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.45 -176.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.55 -51.95 51.28 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.1 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -67.94 -42.68 80.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.312 0.577 . . . . 0.0 110.263 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.499 ' O ' HG12 ' B' ' 79' ' ' ILE . 2.6 mt -64.97 -42.03 93.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.54 -174.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 55.7 m -59.13 -30.29 68.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.229 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' B' ' 80' ' ' ASN . 46.9 t-20 -52.39 -54.6 29.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.607 0.718 . . . . 0.0 109.388 174.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.66 -39.49 94.46 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.634 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.649 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 48.4 mm -58.67 -33.54 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 123.021 0.528 . . . . 0.0 112.085 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' B' ' 77' ' ' ASN . 5.7 m-80 -54.81 -35.89 64.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.558 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -78.46 -14.07 59.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.782 0.325 . . . . 0.0 111.111 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.7 mm? -65.56 -22.58 66.71 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.558 -173.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 55.9 t30 46.01 57.58 5.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.938 -172.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.546 ' HB ' ' HA ' ' B' ' 35' ' ' GLN . 88.6 mt -59.38 141.98 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.203 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -87.44 -164.13 1.04 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.273 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -150.35 115.26 0.7 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.027 -1.082 . . . . 0.0 113.322 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 28.4 ttp -154.06 -75.2 0.12 Allowed 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.565 0.183 . . . . 0.0 110.591 172.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' TYR . . . . . 0.53 ' H ' ' HA ' ' B' ' 59' ' ' ASN . 44.7 t80 -121.49 93.45 4.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.192 0.52 . . . . 0.0 109.925 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.726 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.0 mp -95.32 128.95 46.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.795 -177.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 43.3 mt-10 -114.15 144.36 43.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.29 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.61 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 50.0 mm -126.23 112.4 29.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.99 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -166.49 158.39 13.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.477 0.656 . . . . 0.0 112.424 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.607 ' H ' ' CD ' ' B' ' 93' ' ' GLN . 4.5 pm0 -79.27 145.99 33.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.78 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.9 pt . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.254 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ASP . . . . . 0.401 ' OD1' ' HG2' ' B' ' 3' ' ' GLN . 27.5 t70 . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -119.34 7.97 11.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLN . . . . . 0.401 ' HG2' ' OD1' ' B' ' 1' ' ' ASP . 10.9 pt20 -91.23 -34.65 14.89 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.185 177.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -82.68 -38.01 24.01 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.98 96.92 3.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.848 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 98.6 mt -79.77 21.03 0.56 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.323 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -70.98 -62.05 1.54 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.138 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -86.4 -9.61 55.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.445 0.64 . . . . 0.0 110.591 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -108.75 102.78 11.79 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.777 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' MET . . . . . 0.412 ' O ' HG13 ' B' ' 13' ' ' ILE . 98.5 mmm -95.57 137.78 34.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.964 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -37.96 -24.93 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.887 1.675 . . . . 0.0 114.848 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.52 ' O ' HG23 ' B' ' 16' ' ' VAL . 8.8 m -61.87 -9.14 6.05 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.475 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.1 OUTLIER -51.27 -58.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 CA-C-O 122.008 0.909 . . . . 0.0 110.112 -177.312 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -79.39 -27.74 41.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.204 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.62 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 15.1 m -61.11 -39.14 88.86 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.52 HG23 ' O ' ' B' ' 12' ' ' SER . 99.0 t -69.06 -45.4 80.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.27 0.557 . . . . 0.0 109.866 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -52.43 -49.02 65.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.699 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.3 -31.86 60.8 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.78 -176.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.3 OUTLIER -61.82 -44.97 95.79 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 122.812 0.445 . . . . 0.0 111.406 177.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.423 HD21 ' HZ2' ' B' ' 54' ' ' TRP . 72.5 mt -81.53 -39.27 24.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.659 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -81.48 70.82 8.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.037 0.446 . . . . 0.0 111.33 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -144.33 -72.26 0.27 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.264 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.414 ' O ' ' HA2' ' B' ' 46' ' ' GLY . . . -119.01 44.75 1.35 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.072 -176.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -111.92 -158.05 0.64 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.685 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -83.27 -166.66 40.17 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.347 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.83 ' O ' ' HA ' ' B' ' 40' ' ' SER . 44.7 mtmt -67.84 98.57 0.74 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' B' ' 39' ' ' THR . 21.0 tp -124.88 115.7 21.05 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.23 -163.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 51.4 m -105.61 105.86 16.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.387 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.422 ' N ' HD22 ' B' ' 29' ' ' LEU . 2.5 mm? -83.31 149.57 26.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.313 0.578 . . . . 0.0 110.376 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p -146.27 147.47 31.44 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.36 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 62.0 mtt -116.42 145.34 43.33 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.103 0.478 . . . . 0.0 111.796 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -160.3 105.78 1.51 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.66 -122.81 18.09 Favored Glycine 0 CA--C 1.503 -0.681 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -167.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.523 HD22 ' CG1' ' B' ' 89' ' ' ILE . 2.0 m-20 -119.31 25.2 10.27 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.497 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 48.7 mt-30 -79.42 156.34 27.95 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.74 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.404 HD21 HD12 ' B' ' 29' ' ' LEU . 1.2 tt -114.77 88.2 2.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.127 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -96.37 141.05 30.16 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -171.45 160.64 6.07 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -171.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 2.1 p -134.85 143.73 47.18 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.713 171.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.83 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 9.9 t -144.87 149.19 34.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.438 0.637 . . . . 0.0 111.965 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.473 ' CB ' ' HE3' ' B' ' 26' ' ' LYS . 6.8 m -111.98 163.83 13.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.561 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -113.08 33.78 4.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.02 -173.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.45 -1.53 30.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.032 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.63 -43.67 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.685 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 31.2 p90 43.75 -154.62 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.884 1.274 . . . . 0.0 114.281 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' B' ' 23' ' ' GLY . . . -77.11 107.94 2.48 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.681 -173.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.71 -54.92 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.338 0.589 . . . . 0.0 110.276 176.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.1 m -34.36 -57.8 0.49 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.098 -1.41 . . . . 0.0 114.323 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -75.06 -5.8 46.04 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.136 -173.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' B' ' 69' ' ' LYS . 46.3 mt-10 54.99 -92.39 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 123.498 0.499 . . . . 0.0 110.297 -168.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -136.31 110.09 8.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.589 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 33.7 mmtp -131.92 138.89 48.54 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -114.0 130.62 56.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.912 0.387 . . . . 0.0 110.053 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.51 ' HA ' HG12 ' B' ' 94' ' ' ILE . 18.5 p-90 -146.07 168.58 20.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.895 175.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -133.25 144.0 15.83 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.776 -174.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.445 HD12 ' CD2' ' B' ' 64' ' ' TYR . 15.6 mt -107.82 148.01 12.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 171.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.69 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 71.5 m-85 -129.57 136.76 50.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.51 -171.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.634 HG12 ' HB ' ' B' ' 63' ' ' VAL . 10.6 p -122.44 135.82 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 2.4 m120 60.7 14.24 4.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.389 -172.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.65 -18.3 57.52 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.458 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' B' ' 58' ' ' VAL . 0.6 OUTLIER -87.92 165.61 15.12 Favored 'General case' 0 C--O 1.194 -1.821 0 C-N-CA 123.795 0.838 . . . . 0.0 108.831 -179.026 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.607 ' HA ' ' CD1' ' B' ' 57' ' ' PHE . 2.2 tttt -65.23 164.8 12.63 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 120.529 -0.469 . . . . 0.0 109.827 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.634 ' HB ' HG12 ' B' ' 58' ' ' VAL . 7.5 p -154.5 -13.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.084 0.468 . . . . 0.0 110.481 172.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.786 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.7 OUTLIER -159.65 124.56 4.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.215 0.531 . . . . 0.0 110.913 -171.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 21.3 m -131.9 127.92 37.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.102 176.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.527 ' HB2' HD13 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -168.31 149.42 4.97 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.171 0.986 . . . . 0.0 111.872 -171.535 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.495 ' O ' ' HB3' ' B' ' 70' ' ' SER . 26.4 t-20 -103.39 146.82 27.92 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.165 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -67.59 -21.7 65.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.775 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.494 ' O ' HG23 ' B' ' 71' ' ' THR . 1.5 tmtp? -88.05 -23.28 23.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.361 0.601 . . . . 0.0 109.526 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 5.2 t -65.7 -27.31 68.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.979 172.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.494 HG23 ' O ' ' B' ' 69' ' ' LYS . 23.5 p 61.24 123.24 0.01 OUTLIER 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.004 1.322 . . . . 0.0 113.057 174.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.425 ' HB ' ' OG ' ' B' ' 76' ' ' SER . 12.3 m -62.93 -11.2 6.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 114.405 -1.271 . . . . 0.0 113.239 -170.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' GLY . . . . . 0.537 ' HA2' ' HB3' ' B' ' 40' ' ' SER . . . -56.24 -54.21 37.39 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.267 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -73.41 -35.21 65.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.263 0.554 . . . . 0.0 110.127 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' B' ' 66' ' ' PHE . 1.6 mt -74.6 -55.74 11.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.723 -172.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.433 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 49.3 m -60.48 -30.64 69.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.863 -174.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -49.5 -52.19 31.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.83 0.824 . . . . 0.0 109.658 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 5.0 m-20 -67.31 -44.66 78.66 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.363 -1.289 . . . . 0.0 111.286 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.786 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 49.3 mm -50.82 -33.12 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.28 0.562 . . . . 0.0 112.26 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.417 HD22 ' H ' ' B' ' 38' ' ' ALA . 5.1 m-20 -64.34 -29.27 70.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.919 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 49.7 pttt -81.39 -6.23 58.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.076 0.465 . . . . 0.0 110.549 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 4.2 mm? -73.57 -10.27 59.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.014 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 33.58 64.96 0.3 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.265 1.031 . . . . 0.0 111.113 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.497 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 60.3 mt -60.46 150.55 6.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 113.866 -1.516 . . . . 0.0 112.518 -170.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.426 ' O ' HG22 ' B' ' 84' ' ' ILE . 65.8 mttm -89.38 -177.16 5.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.286 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.76 112.87 0.72 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.898 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.477 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 7.6 tpt -151.87 -74.58 0.14 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.575 0.226 . . . . 0.0 110.575 176.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' TYR . . . . . 0.477 ' N ' ' HG3' ' B' ' 87' ' ' MET . 35.5 t80 -124.64 100.2 6.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.69 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 29.1 mm -100.98 120.31 50.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.732 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -111.61 -179.53 3.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.514 0.673 . . . . 0.0 110.959 174.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.472 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 83.9 mt -153.56 131.17 2.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.033 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.585 ' HE2' ' CE2' ' B' ' 57' ' ' PHE . 42.8 pttt -171.05 150.03 3.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.038 0.447 . . . . 0.0 111.3 176.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.484 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.8 OUTLIER -84.67 153.01 23.39 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.552 172.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' B' ' 54' ' ' TRP . 7.5 pt . . . . . 0 C--N 1.314 -0.957 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.089 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 120.616 0.246 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -68.47 -25.14 64.84 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -172.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -72.88 -17.11 61.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 110.424 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -90.51 -18.06 25.96 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.371 0.605 . . . . 0.0 109.521 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.9 136.82 36.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.983 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' B' ' 9' ' ' GLN . 79.8 mt -69.48 -8.45 47.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.799 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -67.62 -60.9 2.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.511 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -90.92 -6.82 53.61 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.194 0.521 . . . . 0.0 111.504 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' B' ' 6' ' ' LEU . 29.8 tt0 -123.76 83.74 2.18 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' MET . . . . . 0.511 ' O ' HG12 ' B' ' 13' ' ' ILE . 0.0 OUTLIER -108.88 -169.11 1.43 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.749 -170.193 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ASN . . . . . 0.548 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 21.4 t-20 -50.87 -24.95 3.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -176.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.505 ' HA ' ' CG2' ' B' ' 16' ' ' VAL . 20.1 m -66.72 -14.83 63.02 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.276 -0.265 . . . . 0.0 111.69 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.511 HG12 ' O ' ' B' ' 10' ' ' MET . 16.0 mm -61.44 -52.64 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.015 0.436 . . . . 0.0 110.987 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -106.74 -63.02 1.32 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.024 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.467 ' HB3' ' OD1' ' B' ' 11' ' ' ASN . 32.6 t -59.61 -60.34 4.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.071 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.505 ' CG2' ' HA ' ' B' ' 12' ' ' SER . 47.4 t -57.78 -40.52 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.872 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -58.26 -51.23 70.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.07 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.55 -34.03 58.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.59 0.233 . . . . 0.0 111.518 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 13.1 tppt? -64.01 -47.74 79.07 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.465 0.65 . . . . 0.0 110.86 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.429 HD21 ' CZ ' ' B' ' 66' ' ' PHE . 28.3 mt -67.35 -46.68 72.67 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.774 176.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -88.12 53.9 2.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.191 0.52 . . . . 0.0 111.116 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' B' ' 19' ' ' LYS . 30.5 mtpp -83.9 -25.3 30.31 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 166.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.452 ' HA3' ' OH ' ' B' ' 49' ' ' TYR . . . 165.47 -93.94 0.11 Allowed Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 114.317 -1.311 . . . . 0.0 110.356 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.57 -125.12 0.38 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.511 0.724 . . . . 0.0 110.553 -176.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.59 137.37 15.23 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.768 ' O ' ' HA ' ' B' ' 40' ' ' SER . 41.0 mtmt -61.64 100.59 0.15 Allowed 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -177.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.465 HD21 HD11 ' B' ' 29' ' ' LEU . 43.9 tp -128.46 124.03 35.16 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 120.877 0.37 . . . . 0.0 110.06 -171.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.662 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 5.2 p -105.41 100.49 10.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.445 -176.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.465 HD11 HD21 ' B' ' 27' ' ' LEU . 2.1 mm? -87.96 147.95 24.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.736 0.779 . . . . 0.0 111.439 -175.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.9 p -142.67 141.32 31.84 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.939 168.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.78 131.34 54.01 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.359 -173.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -140.2 68.35 1.36 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.97 -102.4 0.51 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.498 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' B' ' 84' ' ' ILE . 5.3 m-20 -79.28 -24.17 43.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.756 0.312 . . . . 0.0 111.043 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -94.96 147.1 23.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.958 0.885 . . . . 0.0 111.819 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 33.4 tp -128.59 99.49 5.39 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 113.973 -1.467 . . . . 0.0 107.674 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -95.82 137.81 34.36 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.983 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.662 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -160.97 156.73 25.23 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.143 -170.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.47 147.12 47.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 171.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.768 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 6.9 t -138.62 162.87 33.52 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 47.3 t -136.29 162.17 33.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.8 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -113.68 30.68 7.06 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.534 0.683 . . . . 0.0 109.619 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.18 21.45 0.13 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.112 -173.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.51 -32.66 0.58 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.731 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.555 ' CD1' HG21 ' B' ' 71' ' ' THR . 19.0 p90 44.22 -157.27 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.578 1.151 . . . . 0.0 113.365 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.422 ' N ' ' HD1' ' B' ' 45' ' ' TYR . . . -67.07 96.12 0.31 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.748 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.562 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -91.2 -71.28 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.274 0.559 . . . . 0.0 110.593 -177.311 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.4 m -62.86 -48.61 78.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.202 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.452 ' OH ' ' HA3' ' B' ' 23' ' ' GLY . 11.5 m-85 -39.52 119.45 0.95 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.699 -1.591 . . . . 0.0 112.365 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -74.58 -171.15 1.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.22 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.5 109.39 13.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.731 0.777 . . . . 0.0 109.348 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.611 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 76.4 mttt -131.87 123.61 27.85 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.409 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -111.18 118.48 36.08 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.454 0.645 . . . . 0.0 110.777 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.664 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 40.5 p-90 -143.19 166.46 24.62 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.375 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.63 147.79 18.75 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.595 -174.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.47 HD12 ' CD2' ' B' ' 64' ' ' TYR . 18.4 mt -103.9 144.82 13.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 170.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.672 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 68.4 m-85 -125.15 141.06 52.34 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.493 -174.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.61 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.3 p -126.55 134.66 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.413 ' OD1' HG13 ' B' ' 58' ' ' VAL . 5.7 m120 68.24 0.85 2.62 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.461 0.705 . . . . 0.0 109.297 -174.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.26 -0.9 50.47 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.588 -173.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -104.48 178.13 4.65 Favored 'General case' 0 C--O 1.203 -1.342 0 C-N-CA 124.018 0.927 . . . . 0.0 109.396 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.466 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.5 tppp? -65.98 161.07 22.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 118.765 0.711 . . . . 0.0 109.8 174.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.61 ' HB ' HG12 ' B' ' 58' ' ' VAL . 11.2 p -152.87 -18.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.094 0.473 . . . . 0.0 110.229 167.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.756 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.3 OUTLIER -160.66 127.95 4.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.94 0.4 . . . . 0.0 110.235 -171.396 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 6.1 m -135.16 129.09 33.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.527 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.614 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.1 OUTLIER -162.66 -176.47 5.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 122.357 1.075 . . . . 0.0 112.191 -174.773 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.9 t-20 -138.79 148.53 43.92 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 112.831 -1.986 . . . . 0.0 108.044 176.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -43.79 70.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.253 0.478 . . . . 0.0 111.79 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.489 ' O ' HG23 ' B' ' 71' ' ' THR . 58.4 mtpt -78.88 -16.26 57.27 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.853 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 3.2 t -73.28 -20.17 60.89 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.555 HG21 ' CD1' ' B' ' 45' ' ' TYR . 19.3 p 58.64 109.55 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.594 1.157 . . . . 0.0 112.533 170.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.609 ' HA ' HD12 ' B' ' 75' ' ' ILE . 11.4 m -61.43 -10.88 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.431 -169.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.75 -56.93 21.49 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.193 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -69.32 -31.31 69.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.307 0.575 . . . . 0.0 110.313 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.614 HD13 ' HB3' ' B' ' 66' ' ' PHE . 3.2 mt -70.5 -48.79 57.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.93 -177.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 34.2 t -56.38 -33.74 66.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.095 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -50.63 -54.74 20.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.695 0.76 . . . . 0.0 110.162 175.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 34.7 m-20 -64.79 -44.55 89.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.405 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.756 HG13 ' CE1' ' B' ' 64' ' ' TYR . 42.5 mm -55.47 -30.46 25.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -176.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -59.37 -25.24 64.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.7 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 16.4 ptmt -85.65 -3.36 58.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.727 0.298 . . . . 0.0 111.304 -175.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.2 mm? -73.8 -11.9 60.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.55 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 52.26 65.84 1.39 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.812 0.815 . . . . 0.0 109.068 -169.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.423 HG23 HG21 ' B' ' 63' ' ' VAL . 65.5 mt -57.49 156.54 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.504 -1.226 . . . . 0.0 111.484 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -113.66 -178.09 3.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.269 177.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.31 112.14 0.72 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.76 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.584 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 5.6 tpt -154.79 -72.7 0.12 Allowed 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 120.491 0.186 . . . . 0.0 110.873 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' TYR . . . . . 0.584 ' N ' ' HG3' ' B' ' 87' ' ' MET . 75.9 t80 -134.48 116.73 15.45 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 21.3 mm -104.96 145.21 13.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.458 -177.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.541 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 33.4 mm-40 -135.97 156.29 48.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.38 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.664 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 67.8 mt -135.13 126.21 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.738 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.418 ' HE2' ' CE2' ' B' ' 57' ' ' PHE . 49.3 pttt -175.24 153.13 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.699 0.285 . . . . 0.0 111.533 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -75.71 150.92 37.76 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.325 0.583 . . . . 0.0 111.209 175.555 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.424 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.7 pt . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.459 -0.781 . . . . 0.0 111.634 -172.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.974 0.416 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -162.6 -39.84 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.695 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -68.21 -21.47 64.85 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -172.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -76.2 -18.41 59.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.111 0.481 . . . . 0.0 110.378 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.36 20.07 11.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.212 0.529 . . . . 0.0 110.469 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 81.0 mt -107.94 22.94 15.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.691 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -59.22 -64.85 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.599 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -88.87 -26.12 21.78 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 122.206 1.003 . . . . 0.0 110.127 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -100.16 93.72 5.86 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.375 -1.739 . . . . 0.0 110.076 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' MET . . . . . 0.465 ' C ' HD13 ' B' ' 13' ' ' ILE . 77.4 mmm -75.65 -165.24 0.42 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.544 0.687 . . . . 0.0 111.643 -175.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -109.61 -18.59 13.45 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.512 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -59.39 -21.12 59.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.829 0.823 . . . . 0.0 109.668 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.555 ' H ' ' CD1' ' B' ' 13' ' ' ILE . 1.4 mp -61.91 -34.41 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.354 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -106.7 -62.92 1.33 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.709 -173.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 49.8 m -66.12 -59.93 3.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.555 -172.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 70.6 t -55.82 -46.25 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.928 0.394 . . . . 0.0 111.359 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -56.28 -46.4 79.76 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.719 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.43 -42.72 58.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.786 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -61.89 -47.47 84.84 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 123.458 0.703 . . . . 0.0 111.936 -175.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.649 HD22 HG11 ' B' ' 72' ' ' VAL . 64.0 mt -75.53 -19.48 59.32 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.778 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -104.29 79.1 1.56 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.01 0.434 . . . . 0.0 110.323 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -130.17 19.86 5.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.572 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.49 25.63 7.65 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.389 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.635 ' HG2' ' CZ ' ' B' ' 49' ' ' TYR . 43.3 mttt -98.35 -140.02 0.3 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.617 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -65.52 142.66 44.44 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 172.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' B' ' 40' ' ' SER . 47.3 mttm -61.82 132.5 53.31 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 18.0 tp -152.5 104.87 2.95 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 -174.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 20.3 m -103.52 110.91 23.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.065 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.421 ' N ' HD22 ' B' ' 29' ' ' LEU . 2.6 mm? -90.87 152.91 20.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.746 0.784 . . . . 0.0 111.894 -173.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.7 p -145.92 147.11 31.39 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.326 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 57.6 mtt -122.32 140.49 52.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.515 0.674 . . . . 0.0 112.168 -172.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ASN . . . . . 0.492 ' O ' ' HG3' ' B' ' 35' ' ' GLN . 27.1 t-20 -130.37 101.34 5.71 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 173.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.19 -99.87 1.0 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -166.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.488 ' HB2' ' HA2' ' B' ' 86' ' ' GLY . 15.3 m120 -130.6 19.26 5.18 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 171.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' B' ' 32' ' ' ASN . 76.6 mt-30 -69.75 156.0 39.68 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.243 0.544 . . . . 0.0 110.714 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.515 ' H ' HD12 ' B' ' 84' ' ' ILE . 15.4 tp -118.2 106.59 12.98 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.842 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.409 ' HA ' ' OD1' ' B' ' 80' ' ' ASN . 24.0 mtmt -116.07 139.86 49.86 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -156.35 150.82 25.65 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -168.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 8.8 p -115.46 142.42 46.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.32 170.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 32.1 p -138.09 173.07 12.02 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -170.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' B' ' 26' ' ' LYS . 30.7 t -155.19 158.61 39.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.768 174.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -116.26 28.45 8.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.785 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.73 -18.52 65.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.691 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.67 -41.01 0.05 OUTLIER Glycine 0 C--N 1.318 -0.445 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.619 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.617 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 23.1 p90 45.04 -163.49 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.957 1.303 . . . . 0.0 114.264 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.59 ' H ' HG22 ' B' ' 71' ' ' THR . . . -81.11 85.49 1.4 Allowed Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.472 ' H ' HD12 ' B' ' 47' ' ' ILE . 1.0 OUTLIER -59.42 -69.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.4 0.619 . . . . 0.0 110.293 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.1 t -115.37 -92.97 0.5 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.389 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.635 ' CZ ' ' HG2' ' B' ' 24' ' ' LYS . 72.0 m-85 55.18 41.91 31.07 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.651 0.594 . . . . 0.0 110.154 -175.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 35.64 -95.35 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.285 -1.325 . . . . 0.0 112.988 -169.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -171.14 110.74 0.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 74.6 mttt -134.37 126.29 29.3 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -175.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -114.21 126.51 55.14 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.238 0.542 . . . . 0.0 110.578 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.516 ' HA ' HG12 ' B' ' 94' ' ' ILE . 34.3 p-90 -146.64 163.58 35.4 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.734 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -126.96 148.03 17.14 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.944 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.591 HD12 ' CD2' ' B' ' 64' ' ' TYR . 30.1 mt -107.1 148.86 11.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.753 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 89.5 m-85 -128.24 146.62 50.68 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -169.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.495 HG13 ' ND2' ' B' ' 59' ' ' ASN . 8.7 p -130.85 135.9 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.495 ' ND2' HG13 ' B' ' 58' ' ' VAL . 1.7 m-80 60.73 17.58 7.74 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -173.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.39 -3.27 83.82 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.407 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' B' ' 58' ' ' VAL . 24.4 mt-10 -103.34 176.09 5.26 Favored 'General case' 0 C--O 1.2 -1.53 0 C-N-CA 123.459 0.703 . . . . 0.0 109.711 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -60.67 156.75 16.04 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 118.541 0.61 . . . . 0.0 110.616 176.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.466 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.0 p -150.75 -12.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.007 0.432 . . . . 0.0 110.368 166.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.591 ' CD2' HD12 ' B' ' 56' ' ' ILE . 0.9 OUTLIER -162.4 125.26 2.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.239 -173.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 14.2 m -132.03 127.89 37.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.68 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.485 ' HB2' HD13 ' B' ' 75' ' ' ILE . 21.2 p90 -165.45 -175.03 3.39 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 122.017 0.913 . . . . 0.0 112.166 -176.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 18.5 t-20 -138.25 163.42 31.8 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.614 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -67.01 -51.65 52.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.298 0.57 . . . . 0.0 110.847 -176.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.471 ' O ' HG23 ' B' ' 71' ' ' THR . 40.3 ttmt -70.24 -17.75 63.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.23 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 3.2 t -69.06 -10.39 57.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.1 0.476 . . . . 0.0 109.902 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.59 HG22 ' H ' ' B' ' 46' ' ' GLY . 21.2 p 60.44 94.74 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.661 1.184 . . . . 0.0 112.157 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.656 ' HA ' HD12 ' B' ' 75' ' ' ILE . 2.4 m -59.37 -21.38 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.371 -172.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.42 -47.33 76.6 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.606 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -78.61 -36.0 44.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.282 0.563 . . . . 0.0 110.169 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.656 HD12 ' HA ' ' B' ' 72' ' ' VAL . 2.4 mt -65.41 -45.63 92.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.293 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 32.2 t -64.21 -27.52 69.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.624 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -55.37 -44.23 75.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.835 0.826 . . . . 0.0 109.865 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.721 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 10.7 m-20 -69.95 -40.46 75.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.442 -1.253 . . . . 0.0 111.022 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.586 ' HA ' HD23 ' B' ' 82' ' ' LEU . 48.3 mm -58.01 -28.87 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.333 0.587 . . . . 0.0 111.832 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.409 ' OD1' ' HA ' ' B' ' 37' ' ' LYS . 83.8 m-20 -60.38 -23.16 64.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.737 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 17.0 ptmt -96.73 6.38 48.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.808 0.337 . . . . 0.0 111.245 -174.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.4 mm? -78.78 -5.08 52.42 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -175.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 41.9 52.22 4.19 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 123.871 0.732 . . . . 0.0 110.95 -171.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.515 HD12 ' H ' ' B' ' 36' ' ' LEU . 82.8 mt -52.22 147.45 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.768 -171.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.6 -164.27 1.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.119 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.488 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -154.23 113.87 0.59 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.819 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.468 ' CG ' ' HA ' ' B' ' 59' ' ' ASN . 24.6 ptp -173.47 -54.85 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.197 0.199 . . . . 0.0 111.242 175.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' TYR . . . . . 0.43 ' N ' ' HG3' ' B' ' 87' ' ' MET . 1.3 t80 -135.73 84.44 2.09 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.842 -0.536 . . . . 0.0 110.226 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.753 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.1 mp -99.4 114.1 36.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.003 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -98.73 -179.22 4.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.366 0.603 . . . . 0.0 111.355 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 41.7 mt -151.51 114.93 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.573 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -174.64 160.85 3.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.333 0.587 . . . . 0.0 112.309 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.503 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 1.5 pp0? -72.26 158.47 35.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.617 174.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.5 pt . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.899 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -143.56 -56.43 0.39 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.867 0.365 . . . . 0.0 110.955 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -76.39 -8.86 58.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.373 -174.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -83.83 -22.12 31.84 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 120.98 0.419 . . . . 0.0 110.413 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.6 83.39 4.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.875 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.3 mt -80.31 11.36 3.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.625 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -68.14 -65.84 0.64 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.838 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -81.95 -30.05 31.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.215 1.007 . . . . 0.0 110.38 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -77.47 99.67 5.74 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 113.532 -1.667 . . . . 0.0 109.952 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 26.3 mmt -83.64 151.19 25.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.46 -175.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -62.44 -24.71 67.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.776 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.679 ' O ' HG23 ' B' ' 16' ' ' VAL . 15.9 t -66.75 -25.85 66.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.045 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 11.2 mm -58.55 -38.37 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-O 121.703 0.763 . . . . 0.0 109.98 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -71.14 -41.4 70.52 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.959 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.587 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 0.6 OUTLIER -65.36 -34.12 77.56 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.143 177.116 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.679 HG23 ' O ' ' B' ' 12' ' ' SER . 54.5 t -63.29 -42.26 95.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.218 0.533 . . . . 0.0 109.991 175.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -61.94 -42.12 98.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.867 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.76 -40.93 63.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.451 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' B' ' 15' ' ' SER . 4.5 tmtm? -53.4 -73.04 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.54 0.736 . . . . 0.0 112.186 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.541 HD22 HG11 ' B' ' 72' ' ' VAL . 17.4 mt -52.29 -29.87 25.37 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -84.41 74.23 10.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.193 0.52 . . . . 0.0 111.023 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -133.24 -79.48 0.48 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.203 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.21 34.83 2.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.943 -176.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.513 ' HA ' ' HA2' ' B' ' 46' ' ' GLY . 0.9 OUTLIER -122.79 -168.98 1.84 Allowed 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 173.466 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' B' ' 45' ' ' TYR . . . -54.26 137.24 41.79 Favored Glycine 0 N--CA 1.45 -0.41 0 O-C-N 123.961 0.788 . . . . 0.0 111.619 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.463 ' HD2' ' H ' ' B' ' 44' ' ' GLY . 0.0 OUTLIER -87.49 112.12 21.88 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 121.397 0.618 . . . . 0.0 109.911 -170.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.463 HD13 ' O ' ' B' ' 27' ' ' LEU . 0.0 OUTLIER -134.29 143.52 47.79 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.267 177.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 49.3 m -104.03 111.55 24.17 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.879 -173.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -77.5 152.79 33.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.596 0.713 . . . . 0.0 109.932 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 0.3 OUTLIER -144.27 145.48 32.05 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.29 175.303 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 43.6 mtt -112.86 133.1 55.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.072 0.463 . . . . 0.0 111.864 -165.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ASN . . . . . 0.507 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 4.3 t30 -146.11 59.22 1.23 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 47.73 -99.58 0.02 OUTLIER Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.895 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.695 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 8.1 p30 -83.39 16.57 2.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.41 -0.395 . . . . 0.0 111.493 -176.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.507 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 79.6 mt-30 -134.87 146.38 49.18 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.393 0.616 . . . . 0.0 110.735 171.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.511 ' HB3' ' HB ' ' B' ' 84' ' ' ILE . 3.2 tm? -122.39 127.96 50.36 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.558 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.482 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 16.7 mtmt -126.33 146.6 49.97 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -174.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -161.63 151.19 16.46 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -176.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 11.8 p -126.88 142.2 51.61 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 58.9 p -136.75 150.29 48.31 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -167.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 22.7 t -139.56 153.46 47.43 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.707 171.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -115.36 9.39 15.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -170.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.72 -59.84 4.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.814 0.816 . . . . 0.0 110.451 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.463 ' H ' ' HD2' ' B' ' 26' ' ' LYS . . . -91.68 61.28 2.77 Favored Glycine 0 C--N 1.309 -0.927 0 CA-C-N 114.59 -1.187 . . . . 0.0 110.89 175.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.58 ' HA ' ' HA2' ' B' ' 25' ' ' GLY . 0.1 OUTLIER -70.1 -161.91 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.079 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.66 ' H ' HG22 ' B' ' 71' ' ' THR . . . -62.14 107.44 1.58 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.27 -0.49 . . . . 0.0 112.23 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 22.2 mm -85.46 -69.74 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 CA-C-O 122.307 1.051 . . . . 0.0 109.817 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.44 ' C ' ' H ' ' B' ' 50' ' ' GLU . 6.8 m -104.62 -153.82 0.49 Allowed 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 113.634 -1.621 . . . . 0.0 109.391 -176.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 67.76 -12.53 0.29 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.992 0.917 . . . . 0.0 112.432 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' B' ' 48' ' ' SER . 44.7 mt-10 49.77 -105.2 0.16 Allowed 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.839 0.856 . . . . 0.0 111.994 -175.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -129.65 110.71 12.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.586 ' HB2' ' OE1' ' B' ' 68' ' ' GLU . 66.2 mttm -118.19 134.82 54.67 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 170.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -98.17 110.58 23.14 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.551 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 37.5 p-90 -149.38 168.18 24.11 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.444 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.9 156.86 25.68 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.408 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.417 HD12 ' CD2' ' B' ' 64' ' ' TYR . 21.8 mt -108.42 147.68 13.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.683 ' CE1' ' HD3' ' B' ' 62' ' ' LYS . 71.5 m-85 -130.46 139.9 50.54 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -169.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.463 HG23 ' HB ' ' B' ' 63' ' ' VAL . 13.6 t -131.35 138.34 53.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 4.5 m120 64.54 5.26 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.99 0.806 . . . . 0.0 109.238 -174.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.91 17.49 47.64 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.737 -172.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 7.8 mt-10 -120.5 174.56 6.47 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.683 ' HD3' ' CE1' ' B' ' 57' ' ' PHE . 0.0 OUTLIER -67.6 167.82 12.31 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.26 173.382 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.463 ' HB ' HG23 ' B' ' 58' ' ' VAL . 8.6 p -153.77 -15.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.781 164.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.652 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.5 OUTLIER -160.05 124.2 3.74 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.049 -170.29 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 28.1 m -131.94 131.11 42.35 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.797 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.512 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.1 OUTLIER -160.94 -176.55 5.57 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 122.531 1.158 . . . . 0.0 112.312 -174.113 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -133.21 149.67 52.0 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 112.272 -2.24 . . . . 0.0 108.626 173.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' GLU . . . . . 0.586 ' OE1' ' HB2' ' B' ' 52' ' ' LYS . 1.3 mp0 -52.04 -51.03 60.14 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.941 0.401 . . . . 0.0 111.57 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.562 ' O ' HG23 ' B' ' 71' ' ' THR . 88.8 tttt -69.13 -22.95 63.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.602 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.6 t -68.74 -17.06 63.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 174.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.66 HG22 ' H ' ' B' ' 46' ' ' GLY . 30.2 p 56.26 106.15 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.344 1.058 . . . . 0.0 112.865 172.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.541 HG11 HD22 ' B' ' 20' ' ' LEU . 9.5 m -62.7 -10.3 5.24 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.861 -171.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.46 -55.21 31.33 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.463 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -67.79 -36.9 81.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.416 0.627 . . . . 0.0 110.9 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' B' ' 66' ' ' PHE . 1.9 mt -68.53 -49.19 67.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.75 -177.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.421 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 22.9 t -58.81 -29.75 67.09 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.979 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -49.66 -52.23 32.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.893 0.854 . . . . 0.0 109.614 173.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.685 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 0.4 OUTLIER -72.7 -39.66 66.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.945 178.041 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.652 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.1 mm -56.96 -33.25 41.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.12 0.486 . . . . 0.0 112.26 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.511 HD21 ' HB3' ' B' ' 38' ' ' ALA . 7.3 m-80 -61.85 -16.93 54.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.685 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 20.7 pttm -85.05 -7.31 59.17 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.906 0.384 . . . . 0.0 110.469 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.53 HD23 ' HA ' ' B' ' 79' ' ' ILE . 2.5 mm? -69.61 -16.09 63.32 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -174.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 51.7 58.72 5.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.336 -171.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.801 ' H ' HD12 ' B' ' 84' ' ' ILE . 5.2 mp -55.99 148.29 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.517 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.695 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 67.5 mttm -116.8 -167.73 1.34 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.269 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.555 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -142.35 111.24 0.66 Allowed Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.131 -177.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.442 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 16.6 tpp -151.22 -73.43 0.15 Allowed 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' TYR . . . . . 0.442 ' N ' ' HG3' ' B' ' 87' ' ' MET . 32.8 t80 -125.77 97.15 5.03 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 22.9 mm -96.35 126.35 49.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.834 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -121.67 169.77 10.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.115 0.484 . . . . 0.0 110.784 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.538 HD11 HG22 ' B' ' 16' ' ' VAL . 23.6 mm -149.14 121.72 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.768 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.551 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 48.2 pttt -168.83 173.53 7.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.251 0.548 . . . . 0.0 111.452 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.53 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.0 OUTLIER -95.8 149.81 21.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.281 175.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.546 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.7 pt . . . . . 0 C--N 1.313 -0.999 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.255 -175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 17.3 t70 . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -131.85 35.89 3.74 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.599 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -67.61 -16.7 64.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.399 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -76.86 -3.41 38.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.95 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.06 114.71 1.54 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.44 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 93.7 mt -71.67 -17.17 62.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.553 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -64.11 -44.76 91.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.102 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -75.48 -46.98 29.16 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.649 0.738 . . . . 0.0 110.392 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -93.14 61.81 3.44 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.625 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' MET . . . . . 0.661 ' O ' HG12 ' B' ' 13' ' ' ILE . 86.8 mmm -53.75 130.71 37.66 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.252 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -52.51 -23.26 5.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.794 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.535 ' O ' HG23 ' B' ' 16' ' ' VAL . 5.3 m -68.39 -17.07 64.14 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.909 -174.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.661 HG12 ' O ' ' B' ' 10' ' ' MET . 14.2 mm -49.21 -65.08 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.449 0.642 . . . . 0.0 111.26 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -78.3 -25.63 46.66 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.555 -177.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.433 ' HB2' ' HA ' ' B' ' 12' ' ' SER . 23.7 m -67.7 -33.33 74.68 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.003 -176.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.535 HG23 ' O ' ' B' ' 12' ' ' SER . 71.5 t -67.84 -42.47 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.5 0.667 . . . . 0.0 109.478 176.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.637 ' OD1' HD22 ' B' ' 29' ' ' LEU . 4.1 t30 -59.08 -58.71 7.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.264 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.39 -12.15 60.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.857 -177.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' B' ' 16' ' ' VAL . 14.2 tppt? -78.24 -50.19 12.34 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.5 0.667 . . . . 0.0 111.059 173.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.465 HD21 ' HZ2' ' B' ' 54' ' ' TRP . 82.1 mt -80.1 -22.81 41.78 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.202 -178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -116.14 93.14 4.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.433 0.635 . . . . 0.0 110.643 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -138.59 -70.41 0.42 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.222 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.56 49.14 0.77 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -127.96 -138.47 0.24 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.437 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -76.31 163.36 52.95 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.688 ' HE3' ' OG ' ' B' ' 41' ' ' SER . 0.0 OUTLIER -70.26 150.6 46.23 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.221 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.546 ' HA ' ' O ' ' B' ' 39' ' ' THR . 16.5 tp -149.06 123.76 9.84 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -173.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 16.1 m -106.85 96.74 6.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.298 0.57 . . . . 0.0 111.468 -177.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.637 HD22 ' OD1' ' B' ' 17' ' ' ASN . 0.2 OUTLIER -68.5 147.92 51.31 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.266 1.426 . . . . 0.0 114.496 -167.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 11.4 p -155.18 152.97 30.03 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.138 171.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 61.3 mtt -115.01 149.16 37.86 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -166.67 120.28 1.05 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.181 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.1 -116.78 9.55 Favored Glycine 0 CA--C 1.506 -0.481 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.879 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.446 ' HA ' ' CD1' ' B' ' 13' ' ' ILE . 20.6 m120 -121.33 22.98 10.63 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 172.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.604 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 49.6 mt-30 -86.35 160.96 18.94 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.311 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' B' ' 36' ' ' LEU . 1.1 tm? -128.69 98.96 5.16 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 169.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.463 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 6.0 mtmp? -97.2 146.37 25.15 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.531 -177.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -173.36 142.91 1.03 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -93.02 159.12 15.44 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 177.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.486 ' OG ' ' HA2' ' B' ' 73' ' ' GLY . 11.6 p -149.92 151.06 32.8 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.592 -170.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.688 ' OG ' ' HE3' ' B' ' 26' ' ' LYS . 0.1 OUTLIER -129.83 140.79 50.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.986 177.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -94.5 41.49 1.09 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.905 -170.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.7 -60.08 3.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.244 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.68 -35.87 3.66 Favored Glycine 0 C--N 1.316 -0.572 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.737 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.437 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 23.7 p90 49.21 -166.35 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.871 1.268 . . . . 0.0 113.98 177.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.7 97.57 1.49 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.602 -175.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.484 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -108.92 -55.92 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.386 0.612 . . . . 0.0 109.74 175.079 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.9 m -39.31 -57.09 1.43 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.523 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -80.38 4.67 17.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.985 -173.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 50.47 -98.03 0.05 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.694 0.797 . . . . 0.0 112.331 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -142.46 113.37 7.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.395 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 94.6 mttt -138.13 143.36 40.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.284 175.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.419 ' HB3' ' OD1' ' B' ' 67' ' ' ASN . 0.4 OUTLIER -112.87 117.9 33.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.176 0.513 . . . . 0.0 110.715 177.108 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.628 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 48.9 p-90 -131.45 164.43 25.76 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -125.19 148.69 16.88 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.472 -173.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.456 ' C ' HG12 ' B' ' 63' ' ' VAL . 7.7 mt -100.41 150.33 5.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 170.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.783 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 74.9 m-85 -129.97 138.65 50.95 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.202 -174.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' B' ' 61' ' ' GLU . 13.5 p -121.9 131.72 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.33 7.98 3.2 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.251 0.548 . . . . 0.0 109.697 -174.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.57 -17.09 40.06 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.242 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 0.6 OUTLIER -91.5 170.21 10.14 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 123.185 0.594 . . . . 0.0 110.105 -177.098 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.432 ' HA ' ' CD1' ' B' ' 57' ' ' PHE . 5.4 tppp? -55.74 158.24 3.71 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.915 0.388 . . . . 0.0 110.007 172.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.456 HG12 ' C ' ' B' ' 56' ' ' ILE . 10.0 p -144.91 -18.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 168.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.558 ' CE2' HG23 ' B' ' 75' ' ' ILE . 1.6 t80 -171.08 153.04 3.63 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.71 -175.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.531 HG23 ' CD1' ' B' ' 94' ' ' ILE . 80.0 m -138.6 135.76 35.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.521 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.722 ' CD2' HD13 ' B' ' 75' ' ' ILE . 23.8 p90 -168.55 158.53 9.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.795 0.807 . . . . 0.0 111.521 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 5.6 m120 -113.61 151.58 31.51 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.02 -1.445 . . . . 0.0 112.001 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -61.91 -42.5 99.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.529 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.489 ' O ' HG23 ' B' ' 71' ' ' THR . 22.0 tptp -59.98 -36.12 76.46 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.02 0.914 . . . . 0.0 110.175 176.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' B' ' 67' ' ' ASN . 58.5 m -70.37 -10.33 58.75 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.264 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.489 HG23 ' O ' ' B' ' 69' ' ' LYS . 8.2 p 65.08 124.02 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 126.134 1.774 . . . . 0.0 113.209 170.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.662 ' HA ' HD12 ' B' ' 75' ' ' ILE . 3.6 m -64.57 -5.56 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.097 -173.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' GLY . . . . . 0.486 ' HA2' ' OG ' ' B' ' 40' ' ' SER . . . -67.28 -55.16 16.81 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.432 -0.413 . . . . 0.0 113.228 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -73.17 -23.38 60.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 122.048 0.928 . . . . 0.0 109.09 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.722 HD13 ' CD2' ' B' ' 66' ' ' PHE . 68.0 mt -68.79 -54.84 18.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 113.904 -1.498 . . . . 0.0 112.745 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 18.2 t -54.57 -37.82 65.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.901 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -50.85 -49.43 58.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.982 0.896 . . . . 0.0 110.599 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.533 ' HA ' ' HG2' ' B' ' 81' ' ' LYS . 72.1 m-20 -64.9 -46.89 79.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.912 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.457 HG12 ' CD2' ' B' ' 64' ' ' TYR . 66.3 mt -51.96 -37.53 21.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.325 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.456 ' OD1' ' HA ' ' B' ' 37' ' ' LYS . 32.5 m-20 -75.07 -38.49 61.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.383 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.533 ' HG2' ' HA ' ' B' ' 78' ' ' ASP . 6.4 ptpp? -75.47 -21.31 58.18 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.222 -176.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.438 HD23 ' O ' ' B' ' 78' ' ' ASP . 1.7 mm? -63.9 -22.01 66.73 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.869 0.366 . . . . 0.0 110.154 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 45.35 64.79 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.697 -171.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.604 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 55.6 mt -62.89 149.89 9.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.21 -175.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.437 ' NZ ' ' HB3' ' B' ' 85' ' ' LYS . 7.7 mtpm? -90.18 179.42 5.92 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.827 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -133.68 113.25 1.18 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 119.693 -1.241 . . . . 0.0 112.466 -176.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 17.8 ttt -154.31 -77.09 0.11 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 123.076 0.55 . . . . 0.0 109.909 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -132.34 81.86 1.98 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.217 0.532 . . . . 0.0 109.668 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.783 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.1 mp -87.72 125.51 41.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.853 178.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -108.83 177.97 4.61 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.356 0.598 . . . . 0.0 110.7 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.628 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 57.5 mt -149.74 110.04 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.632 -178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -167.87 166.67 13.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.273 0.559 . . . . 0.0 112.102 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.63 148.84 26.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.467 -174.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.531 ' CD1' HG23 ' B' ' 65' ' ' THR . 4.2 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.408 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 121.009 0.433 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -73.63 -32.43 64.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.884 0.373 . . . . 0.0 110.537 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -66.3 -18.38 65.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.817 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -76.06 -21.61 56.58 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.314 0.578 . . . . 0.0 110.255 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.24 -7.99 54.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.565 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.588 ' HA ' ' O ' ' B' ' 9' ' ' GLN . 98.8 mt -78.4 -6.73 56.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.197 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.91 -43.31 79.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.998 0.428 . . . . 0.0 110.351 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' B' ' 9' ' ' GLN . 10.3 pt-20 -90.9 -51.36 5.39 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.846 0.831 . . . . 0.0 110.451 175.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.588 ' O ' ' HA ' ' B' ' 6' ' ' LEU . 24.5 tt0 -99.61 87.35 3.55 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.665 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' MET . . . . . 0.585 ' SD ' ' HA ' ' B' ' 88' ' ' TYR . 82.5 mtp -71.66 171.32 11.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.585 -176.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -57.38 -30.55 64.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.168 0.508 . . . . 0.0 110.888 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.585 ' O ' HG23 ' B' ' 16' ' ' VAL . 1.3 p -63.94 -30.94 71.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.909 -174.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mm -53.79 -45.49 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.858 0.837 . . . . 0.0 110.113 177.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -82.89 -29.99 28.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.976 -177.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' B' ' 12' ' ' SER . 21.8 t -71.5 -27.38 63.18 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.602 -175.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.585 HG23 ' O ' ' B' ' 12' ' ' SER . 87.4 t -58.44 -42.89 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.446 0.641 . . . . 0.0 109.704 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.406 ' OD1' HD13 ' B' ' 29' ' ' LEU . 55.9 t30 -63.87 -45.54 88.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.866 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.8 -28.5 62.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.619 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -68.37 -53.08 26.38 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.167 0.508 . . . . 0.0 111.398 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 94.3 mt -73.0 -27.82 62.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.655 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -90.41 75.97 6.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.369 0.604 . . . . 0.0 110.593 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -135.89 62.95 1.61 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.491 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.91 54.48 4.14 Favored Glycine 0 C--N 1.317 -0.5 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.64 ' HB3' ' CD2' ' B' ' 45' ' ' TYR . 33.2 mmtp -137.15 -152.51 0.44 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.223 -0.488 . . . . 0.0 110.396 -174.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' B' ' 45' ' ' TYR . . . -78.69 -177.27 48.87 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 176.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.498 ' HE2' ' HB2' ' B' ' 41' ' ' SER . 4.3 mppt? -88.57 127.9 35.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 117.292 0.546 . . . . 0.0 111.02 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.44 HD22 HG21 ' B' ' 72' ' ' VAL . 13.4 tp -156.03 110.93 2.9 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 19.5 m -108.7 108.86 19.87 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.535 -176.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.539 HD23 HD11 ' B' ' 36' ' ' LEU . 10.2 mp -86.04 158.73 19.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.606 0.717 . . . . 0.0 110.738 176.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.564 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 20.3 m -135.81 140.29 44.12 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.919 173.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -100.59 125.65 46.99 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.792 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -139.59 58.66 1.61 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' GLY . . . . . 0.414 ' HA2' ' HB2' ' B' ' 9' ' ' GLN . . . 50.43 -95.61 0.01 OUTLIER Glycine 0 C--N 1.335 0.506 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.028 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 14.2 m120 -88.09 15.72 7.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.481 -0.359 . . . . 0.0 111.044 -176.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 16.8 mt-30 -139.95 142.97 36.34 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.558 0.694 . . . . 0.0 110.931 173.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.539 HD11 HD23 ' B' ' 29' ' ' LEU . 32.4 tp -113.58 120.78 42.12 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.818 173.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.564 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 6.6 mmmm -114.48 150.31 35.0 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -174.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.404 ' HB2' ' HG ' ' B' ' 29' ' ' LEU . . . -163.55 143.35 8.49 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 2.8 p -120.86 151.79 39.22 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.4 t -142.89 150.07 39.32 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.126 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.498 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . 5.7 m -126.12 149.77 48.7 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.424 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -82.76 47.9 1.26 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.266 -170.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.49 -3.71 29.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.786 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.37 70.34 1.35 Allowed Glycine 0 CA--C 1.485 -1.808 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.262 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.64 ' CD2' ' HB3' ' B' ' 24' ' ' LYS . 0.8 OUTLIER -65.59 148.86 51.04 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 161.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.583 ' N ' ' CD1' ' B' ' 45' ' ' TYR . . . 109.17 58.86 0.53 Allowed Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -176.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 3.9 mm -85.84 -69.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.521 0.677 . . . . 0.0 109.702 -172.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.2 m -151.8 -130.32 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.021 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.467 ' O ' ' HE2' ' B' ' 52' ' ' LYS . 84.5 m-85 64.23 27.63 13.9 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.004 0.522 . . . . 0.0 111.503 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 43.63 -106.47 0.09 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.593 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.5 ' HB3' HD21 ' B' ' 67' ' ' ASN . 6.9 m-20 -144.48 119.4 9.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.089 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.467 ' HE2' ' O ' ' B' ' 49' ' ' TYR . 65.7 mmtt -119.26 122.74 42.62 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -107.64 127.24 53.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.149 0.499 . . . . 0.0 111.058 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.693 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 37.2 p-90 -142.41 161.38 38.2 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.891 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.1 151.94 16.89 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.899 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.491 ' O ' HG12 ' B' ' 63' ' ' VAL . 7.5 mt -102.74 141.03 19.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 172.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.69 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 64.0 m-85 -121.81 140.85 51.86 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.539 HG12 ' HB ' ' B' ' 63' ' ' VAL . 8.4 p -131.72 142.5 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.414 ' ND2' ' SD ' ' B' ' 87' ' ' MET . 10.1 m120 68.72 -2.81 1.57 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -169.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.76 -1.75 61.74 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -170.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 58' ' ' VAL . 16.5 mt-10 -100.36 172.0 7.41 Favored 'General case' 0 C--O 1.199 -1.587 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.594 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 11.1 ttmt -67.09 168.3 10.4 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 119.009 0.822 . . . . 0.0 109.948 175.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.539 ' HB ' HG12 ' B' ' 58' ' ' VAL . 7.6 p -148.49 -20.33 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.618 170.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.418 ' CD2' HG12 ' B' ' 79' ' ' ILE . 4.5 t80 -169.1 146.14 3.58 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.997 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.531 HG23 ' CD1' ' B' ' 94' ' ' ILE . 54.9 m -130.17 134.07 47.04 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.257 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.644 ' CD2' HG21 ' B' ' 75' ' ' ILE . 9.0 p90 -165.48 153.04 10.77 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.672 0.749 . . . . 0.0 109.939 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.5 HD21 ' HB3' ' B' ' 51' ' ' ASP . 23.2 t-20 -99.2 159.73 14.78 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.885 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' GLU . . . . . 0.456 ' CG ' ' HB2' ' B' ' 52' ' ' LYS . 10.2 mm-40 -60.92 -63.15 1.4 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.278 0.561 . . . . 0.0 109.954 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -66.37 -5.17 9.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.184 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.5 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 1.4 t -68.37 -3.14 10.11 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.417 0.627 . . . . 0.0 109.762 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.417 ' O ' HG13 ' B' ' 75' ' ' ILE . 31.9 p 62.17 102.97 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.308 1.443 . . . . 0.0 111.55 174.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.658 ' HA ' HD12 ' B' ' 75' ' ' ILE . 5.4 m -66.79 -4.43 2.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.151 -168.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.68 -48.12 80.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.443 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -78.78 -25.9 44.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.496 0.665 . . . . 0.0 109.777 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' B' ' 72' ' ' VAL . 24.5 mt -66.29 -44.97 90.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.299 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 28.9 t -53.73 -36.52 62.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.351 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -50.04 -54.61 19.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.792 0.806 . . . . 0.0 110.54 174.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.518 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 27.3 m-20 -63.89 -48.07 78.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.904 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' B' ' 64' ' ' TYR . 43.7 mt -54.69 -37.29 39.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.104 0.478 . . . . 0.0 111.48 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -63.98 -43.29 96.17 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.106 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 59.1 pttt -76.05 -31.1 58.64 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.054 -176.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.58 -26.31 67.89 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 65.6 t30 40.44 72.19 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 O-C-N 124.583 1.177 . . . . 0.0 110.839 -172.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.732 ' H ' HD12 ' B' ' 84' ' ' ILE . 3.1 mp -57.18 137.16 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.908 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 30.4 mmtp -90.61 -169.41 2.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.409 -177.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.49 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -136.65 113.92 1.1 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.256 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.414 ' SD ' ' ND2' ' B' ' 59' ' ' ASN . 3.1 ptp -167.43 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.637 0.375 . . . . 0.0 110.604 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 88' ' ' TYR . . . . . 0.585 ' HA ' ' SD ' ' B' ' 10' ' ' MET . 21.7 t80 -124.8 88.32 2.87 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.69 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 34.1 mm -93.75 133.35 35.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.29 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 24.1 mt-10 -125.38 155.61 40.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.142 0.496 . . . . 0.0 111.636 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.693 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 86.8 mt -131.15 118.21 40.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.453 176.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -171.69 154.19 3.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.12 0.486 . . . . 0.0 111.894 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.504 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 5.1 pm0 -64.76 149.48 49.19 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.268 175.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.531 ' CD1' HG23 ' B' ' 65' ' ' THR . 3.3 pt . . . . . 0 C--N 1.312 -1.026 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.304 -173.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -162.86 108.24 1.14 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -77.18 -29.45 54.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -174.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' B' ' 4' ' ' LYS . 25.3 tptp -87.0 5.8 35.53 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.5 0.667 . . . . 0.0 110.574 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.533 ' HB1' ' HG3' ' B' ' 7' ' ' GLU . . . -53.84 129.7 34.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.616 -175.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 83.0 mt -98.98 10.48 41.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.827 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.533 ' HG3' ' HB1' ' B' ' 5' ' ' ALA . 0.0 OUTLIER -70.3 -30.58 67.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.154 173.44 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.494 ' HG3' ' HG2' ' B' ' 9' ' ' GLN . 15.2 pt-20 -96.03 -37.71 10.52 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.926 0.87 . . . . 0.0 109.928 175.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.494 ' HG2' ' HG3' ' B' ' 8' ' ' GLU . 85.5 mm-40 -93.98 71.28 4.02 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.338 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' MET . . . . . 0.489 ' SD ' HG12 ' B' ' 89' ' ' ILE . 62.1 mtm -94.18 168.93 10.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.101 -177.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -70.56 -26.88 63.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.692 0.758 . . . . 0.0 109.966 171.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 14.8 m -68.4 -10.14 53.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.642 -174.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.429 HG23 ' HG2' ' B' ' 31' ' ' MET . 28.5 mm -49.58 -52.34 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-O 121.089 0.471 . . . . 0.0 111.579 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -102.65 -38.3 7.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.865 -174.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.644 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 16.0 m -57.94 -41.86 83.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.945 -174.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.67 -45.13 75.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.964 0.411 . . . . 0.0 110.448 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -43.61 98.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.161 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.12 -26.19 52.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.24 -176.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.644 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -64.79 -46.29 82.68 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 121.092 0.472 . . . . 0.0 111.715 178.325 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 9.1 mt -87.05 -31.77 20.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.058 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -92.35 81.02 4.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.277 0.56 . . . . 0.0 110.176 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -122.35 -83.22 0.66 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.315 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.32 34.34 2.32 Favored Glycine 0 CA--C 1.508 -0.378 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -114.29 -147.26 0.41 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.072 -0.564 . . . . 0.0 109.591 -175.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' B' ' 45' ' ' TYR . . . -72.45 167.69 53.22 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.673 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.497 ' HE2' ' HB2' ' B' ' 41' ' ' SER . 2.1 mppt? -80.04 130.03 34.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.781 0.324 . . . . 0.0 110.943 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.476 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 26.6 tp -149.84 92.75 1.94 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 20.3 m -88.61 107.7 19.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.974 -175.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.476 ' CD1' ' HG ' ' B' ' 27' ' ' LEU . 9.3 mp -90.26 162.68 15.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.751 0.786 . . . . 0.0 111.548 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.6 p -156.0 144.68 20.26 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.718 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' MET . . . . . 0.429 ' HG2' HG23 ' B' ' 13' ' ' ILE . 0.6 OUTLIER -106.91 139.45 41.29 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.924 0.392 . . . . 0.0 111.232 -173.616 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 32' ' ' ASN . . . . . 0.532 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 2.5 t30 -142.29 57.4 1.46 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 170.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' GLY . . . . . 0.481 ' O ' ' HA3' ' B' ' 86' ' ' GLY . . . 45.44 -95.01 0.01 OUTLIER Glycine 0 C--N 1.333 0.403 0 O-C-N 123.806 0.691 . . . . 0.0 113.075 -175.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.706 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 2.4 p-10 -80.61 10.82 4.31 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.814 0.446 . . . . 0.0 112.17 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.669 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 75.1 mt-30 -132.98 147.81 52.27 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.366 0.603 . . . . 0.0 110.544 165.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.47 116.05 19.82 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -116.99 138.78 51.34 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.614 -172.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -158.66 139.12 12.53 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.115 0.484 . . . . 0.0 111.521 -177.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 13.8 p -115.9 138.35 51.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.612 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.3 p -123.43 142.47 50.95 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.172 0.51 . . . . 0.0 111.551 -174.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.497 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . 2.5 m -117.82 143.97 45.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.618 175.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -99.5 44.0 1.04 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.823 -168.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.42 -32.19 68.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.103 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.72 63.72 0.03 OUTLIER Glycine 0 CA--C 1.49 -1.482 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.287 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.773 ' CD1' ' HA ' ' B' ' 71' ' ' THR . 2.5 t80 -69.42 152.87 44.39 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 161.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.586 ' N ' ' CD1' ' B' ' 45' ' ' TYR . . . 106.38 57.18 0.63 Allowed Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 5.6 mm -79.33 -69.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.606 -0.797 . . . . 0.0 110.3 -171.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 69.1 m -152.46 -106.19 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.202 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.46 ' O ' ' HG2' ' B' ' 52' ' ' LYS . 64.9 m-85 58.94 20.66 8.37 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.083 0.553 . . . . 0.0 112.15 177.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 46.57 -95.12 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.83 0.706 . . . . 0.0 110.503 -171.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.479 ' HB3' HD21 ' B' ' 67' ' ' ASN . 9.3 m-20 -149.38 110.51 4.38 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 169.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' B' ' 49' ' ' TYR . 72.3 mmtt -121.13 122.29 39.7 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -113.52 130.58 56.31 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.298 0.571 . . . . 0.0 110.988 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.498 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 26.7 p-90 -141.0 168.45 19.76 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.695 176.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.56 145.13 16.79 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.706 -174.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.529 HD12 ' CD2' ' B' ' 64' ' ' TYR . 26.4 mt -106.76 141.73 21.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 171.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.711 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 63.5 m-85 -123.33 143.04 50.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.722 -174.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.625 HG12 ' HB ' ' B' ' 63' ' ' VAL . 10.4 p -128.0 136.89 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.476 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.3 m-80 61.69 11.04 3.71 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.989 0.515 . . . . 0.0 109.626 -172.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.51 0.64 66.96 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.278 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' B' ' 58' ' ' VAL . 15.7 mt-10 -106.8 176.27 5.23 Favored 'General case' 0 C--O 1.199 -1.597 0 C-N-CA 123.521 0.728 . . . . 0.0 109.139 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.503 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.4 tppp? -66.08 162.42 19.61 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 119.092 0.86 . . . . 0.0 109.949 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.625 ' HB ' HG12 ' B' ' 58' ' ' VAL . 7.8 p -153.42 -18.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.918 0.389 . . . . 0.0 110.371 167.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.686 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.8 OUTLIER -160.78 126.41 3.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 110.359 -172.806 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.3 m -134.23 126.64 30.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.48 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.572 ' HB2' HD13 ' B' ' 75' ' ' ILE . 0.7 OUTLIER -169.38 152.35 4.83 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.124 0.964 . . . . 0.0 112.467 -174.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.479 HD21 ' HB3' ' B' ' 51' ' ' ASP . 17.3 t-20 -92.61 153.98 18.67 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.233 -1.803 . . . . 0.0 109.956 174.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' GLU . . . . . 0.42 ' HA ' ' OH ' ' B' ' 45' ' ' TYR . 22.6 mm-40 -75.86 -3.68 36.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.192 0.52 . . . . 0.0 111.782 -174.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -111.43 -7.5 14.35 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.896 0.379 . . . . 0.0 111.431 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 1.3 t -73.92 -3.63 30.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.396 0.617 . . . . 0.0 111.688 -173.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.773 ' HA ' ' CD1' ' B' ' 45' ' ' TYR . 13.3 p 64.75 98.5 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.742 1.217 . . . . 0.0 111.444 173.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.518 ' HA ' HD12 ' B' ' 75' ' ' ILE . 7.7 m -66.64 -12.37 14.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.63 -169.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.24 -41.42 98.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.933 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -82.8 -30.76 28.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.206 0.527 . . . . 0.0 110.523 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.572 HD13 ' HB2' ' B' ' 66' ' ' PHE . 1.3 mt -75.62 -53.44 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.657 -176.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 22.5 t -58.38 -29.13 65.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.3 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -48.12 -54.74 12.23 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.778 0.799 . . . . 0.0 110.391 172.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 10.3 m-20 -69.36 -49.51 54.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.262 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.686 HG13 ' CE1' ' B' ' 64' ' ' TYR . 46.7 mm -52.29 -37.11 22.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -70.06 -20.78 63.21 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 46.9 pttt -83.26 -1.54 53.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.192 0.52 . . . . 0.0 109.986 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 3.7 mm? -77.46 -5.31 49.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.832 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 55.9 t30 51.38 63.51 2.21 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.427 -171.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.669 ' O ' ' HA ' ' B' ' 35' ' ' GLN . 48.2 mt -55.23 145.3 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.069 -172.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.706 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 50.3 mtmt -114.78 -176.94 3.01 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.779 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.498 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -142.0 113.11 0.79 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.844 -0.694 . . . . 0.0 111.725 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.512 ' HA ' ' HB2' ' B' ' 7' ' ' GLU . 12.2 tpp -150.25 -70.74 0.18 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 120.832 0.348 . . . . 0.0 110.221 178.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -129.29 87.16 2.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.711 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 46.1 mm -85.9 132.51 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.213 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 33.9 mt-10 -119.2 145.06 46.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.495 173.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.49 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 44.8 mm -129.14 112.06 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.502 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.522 ' HE2' ' CE2' ' B' ' 57' ' ' PHE . 45.3 pttt -166.83 166.83 15.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.041 0.448 . . . . 0.0 111.819 -174.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -94.11 149.17 21.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.157 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.497 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.7 pt . . . . . 0 C--O 1.25 1.13 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.061 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ASP . . . . . 0.438 ' OD1' ' HB2' ' B' ' 4' ' ' LYS . 11.1 t70 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.777 0.322 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 10.4 t30 73.33 -45.25 0.61 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.986 0.915 . . . . 0.0 112.998 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -72.44 -13.01 61.34 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.438 ' HB2' ' OD1' ' B' ' 1' ' ' ASP . 14.1 tptp -73.84 -8.15 54.95 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 120.931 0.396 . . . . 0.0 110.885 173.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.536 ' HA ' HE22 ' B' ' 9' ' ' GLN . . . -81.44 96.58 7.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.589 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.473 ' H ' HD12 ' B' ' 6' ' ' LEU . 5.1 mp -71.68 -95.65 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.44 177.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -116.44 -76.19 0.57 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.467 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 21.6 mt-10 -121.6 3.32 10.15 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -173.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.617 ' O ' HG13 ' B' ' 13' ' ' ILE . 2.1 pm0 -75.47 -14.73 60.45 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.26 -175.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 21.8 mmt 63.54 113.75 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.547 1.139 . . . . 0.0 113.359 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' ASN . . . . . 0.519 ' HB2' ' HB2' ' B' ' 5' ' ' ALA . 0.2 OUTLIER -61.07 -26.43 67.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.963 175.725 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.431 ' O ' HG23 ' B' ' 16' ' ' VAL . 49.1 m -67.16 -22.56 65.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.922 -174.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.617 HG13 ' O ' ' B' ' 9' ' ' GLN . 2.1 mm -60.41 -43.46 94.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.925 0.869 . . . . 0.0 109.61 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -66.51 -33.72 76.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.978 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 4.2 m -65.22 -44.43 88.29 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.941 176.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.431 HG23 ' O ' ' B' ' 12' ' ' SER . 91.9 t -61.0 -43.59 96.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.152 0.501 . . . . 0.0 110.111 176.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.469 ' OD1' ' HB2' ' B' ' 29' ' ' LEU . 0.2 OUTLIER -56.02 -41.66 75.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.233 -179.454 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.39 -37.48 37.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.149 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -59.88 -43.64 94.65 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 122.86 0.464 . . . . 0.0 111.688 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.485 HD21 ' HE1' ' B' ' 54' ' ' TRP . 81.1 mt -83.66 28.6 0.56 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.896 -175.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -104.01 29.64 5.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.804 0.812 . . . . 0.0 108.954 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -119.33 57.52 0.89 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.317 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' B' ' 25' ' ' GLY . . . 163.28 47.2 0.02 OUTLIER Glycine 0 CA--C 1.503 -0.667 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.717 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.401 ' HB2' ' N ' ' B' ' 45' ' ' TYR . 34.4 mmtp 57.06 -63.27 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 170.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.613 ' H ' ' HA ' ' B' ' 45' ' ' TYR . . . -36.87 105.64 0.04 OUTLIER Glycine 0 C--N 1.33 0.248 0 O-C-N 124.006 0.816 . . . . 0.0 113.158 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.545 ' CE ' ' HB2' ' B' ' 41' ' ' SER . 34.3 pttt -63.67 132.34 50.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.941 0.401 . . . . 0.0 111.327 -176.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' B' ' 39' ' ' THR . 8.7 tp -146.09 104.7 3.85 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.073 -173.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -98.84 115.38 28.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.486 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.469 ' HB2' ' OD1' ' B' ' 17' ' ' ASN . 11.1 mp -89.05 165.93 14.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.817 0.818 . . . . 0.0 111.547 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 68.4 m -147.55 142.24 26.67 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.186 174.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' MET . . . . . 0.555 ' HG3' HG21 ' B' ' 13' ' ' ILE . 0.1 OUTLIER -112.54 117.72 33.11 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.885 -171.242 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -140.88 59.53 1.53 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.258 172.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' B' ' 8' ' ' GLU . . . 49.75 -87.09 0.01 OUTLIER Glycine 0 C--N 1.339 0.71 0 O-C-N 124.305 1.003 . . . . 0.0 115.133 173.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -66.35 -15.33 63.19 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.853 0.461 . . . . 0.0 111.6 -174.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.401 ' CD ' ' HD3' ' B' ' 37' ' ' LYS . 5.0 pt20 -132.56 149.01 52.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.057 0.932 . . . . 0.0 112.505 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.463 HD13 HG23 ' B' ' 13' ' ' ILE . 19.0 tp -112.45 101.67 9.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.604 -1.634 . . . . 0.0 107.964 170.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.419 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 35.5 mtmt -102.58 152.41 21.21 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.008 -1.451 . . . . 0.0 108.753 -172.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.86 156.93 2.91 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 1.3 p -126.27 144.94 50.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.982 175.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 16.2 m -144.02 151.31 39.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -175.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.545 ' HB2' ' CE ' ' B' ' 26' ' ' LYS . 20.1 m -138.02 158.49 44.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.288 170.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ASN . . . . . 0.457 ' C ' ' H ' ' B' ' 44' ' ' GLY . 48.7 m-80 -109.63 46.01 1.04 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.896 -173.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.67 22.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.658 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.612 ' O ' HD11 ' B' ' 47' ' ' ILE . . . 165.9 -49.82 0.27 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.613 ' HA ' ' H ' ' B' ' 25' ' ' GLY . 7.3 p90 53.25 -177.75 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.0 1.32 . . . . 0.0 113.856 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.511 ' C ' HD13 ' B' ' 47' ' ' ILE . . . -70.74 105.76 1.69 Allowed Glycine 0 C--N 1.337 0.604 0 CA-C-N 116.014 -0.539 . . . . 0.0 113.934 -170.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.612 HD11 ' O ' ' B' ' 44' ' ' GLY . 3.4 mm -113.13 -70.0 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.988 0.423 . . . . 0.0 110.748 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.0 m -61.85 -51.75 66.96 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.816 0.817 . . . . 0.0 110.404 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -59.86 108.81 0.81 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.929 -1.487 . . . . 0.0 109.111 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.446 ' HB2' ' H ' ' B' ' 51' ' ' ASP . 0.0 OUTLIER -81.02 -157.8 0.18 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.849 0.357 . . . . 0.0 111.195 -176.67 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.448 ' HA ' ' OD1' ' B' ' 67' ' ' ASN . 9.6 p-10 -74.88 108.9 7.92 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.228 1.013 . . . . 0.0 111.152 -173.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 44.3 mttm -122.51 125.57 46.03 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.724 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -108.16 136.02 48.53 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.899 0.38 . . . . 0.0 110.848 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.668 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 21.9 p-90 -147.89 158.87 44.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.251 171.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.44 143.77 15.22 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.224 -174.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.482 ' O ' HG12 ' B' ' 63' ' ' VAL . 6.0 mt -102.84 143.1 15.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 173.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.61 ' HB2' ' HB2' ' B' ' 90' ' ' GLU . 55.4 m-85 -124.4 140.95 52.47 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.534 -176.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.492 HG12 ' HB ' ' B' ' 63' ' ' VAL . 9.1 p -128.49 134.87 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 2.3 m120 60.91 13.32 4.42 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.95 -174.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.4 -0.88 63.88 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.631 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -104.81 172.95 6.52 Favored 'General case' 0 C--O 1.207 -1.16 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.454 ' HZ3' ' HE1' ' B' ' 57' ' ' PHE . 12.0 tppt? -61.28 164.71 5.15 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.492 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.8 p -146.91 -22.66 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 167.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.431 ' CE2' ' CG1' ' B' ' 79' ' ' ILE . 2.2 t80 -171.68 144.66 1.87 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.989 -173.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 78.2 m -133.31 128.46 35.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.649 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.763 ' HD2' HD13 ' B' ' 75' ' ' ILE . 14.3 p90 -158.96 -171.39 3.38 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.221 0.534 . . . . 0.0 110.799 -176.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.7 t-20 -151.57 144.15 24.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.317 -166.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' GLU . . . . . 0.467 ' OE1' ' HB2' ' B' ' 52' ' ' LYS . 2.4 mp0 -63.99 -34.25 77.57 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -78.93 -18.25 54.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.235 0.541 . . . . 0.0 110.125 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 3.1 t -71.64 -8.12 52.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.662 ' O ' HG13 ' B' ' 75' ' ' ILE . 7.5 p 65.08 112.28 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.687 -1.597 . . . . 0.0 112.372 173.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.713 ' HA ' HD12 ' B' ' 75' ' ' ILE . 2.9 m -61.02 -15.14 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.449 -170.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 73' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' B' ' 40' ' ' SER . . . -67.06 -50.49 45.89 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.288 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -75.2 -19.17 59.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.491 0.662 . . . . 0.0 109.506 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.763 HD13 ' HD2' ' B' ' 66' ' ' PHE . 49.6 mt -73.64 -53.61 17.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.015 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.401 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 43.5 t -55.87 -33.05 64.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.12 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -52.0 -48.19 64.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.126 173.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.69 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 5.7 m-20 -70.54 -41.45 72.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.131 177.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.462 HG23 HD13 ' B' ' 84' ' ' ILE . 58.2 mt -54.55 -37.74 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.0 0.429 . . . . 0.0 111.381 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -58.12 -34.57 70.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.396 177.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.69 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 18.8 pttp -85.07 -31.0 23.62 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.663 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.01 -26.75 68.42 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.778 0.323 . . . . 0.0 110.23 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 4.8 t30 42.54 69.84 0.34 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.456 -172.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.613 ' H ' HD12 ' B' ' 84' ' ' ILE . 2.6 mp -59.13 131.18 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.017 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -86.47 -170.74 3.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.842 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.95 111.66 0.67 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.348 -0.929 . . . . 0.0 112.607 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 19.3 tpp -150.08 -68.58 0.2 Allowed 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -127.96 84.83 2.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 45.5 mm -85.73 130.77 35.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.983 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.61 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 27.7 mt-10 -123.7 150.19 44.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.034 0.445 . . . . 0.0 111.526 175.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.668 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 83.6 mt -129.74 125.61 61.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.491 176.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.477 ' HE3' ' CE2' ' B' ' 57' ' ' PHE . 14.9 pttp -167.57 164.97 14.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.131 0.491 . . . . 0.0 111.504 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -95.47 134.59 38.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.125 -174.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.569 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.2 pt . . . . . 0 C--O 1.247 0.938 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.682 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' B' ' 2' ' ' ASN . 7.0 p-10 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' B' ' 1' ' ' ASP . 28.8 t-20 68.45 94.27 0.07 Allowed 'General case' 0 C--O 1.227 -0.104 0 O-C-N 123.588 0.555 . . . . 0.0 109.872 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -60.92 -18.96 59.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.186 -175.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.599 ' HD3' ' O ' ' B' ' 4' ' ' LYS . 4.3 tmtp? -70.8 -17.45 62.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.404 0.621 . . . . 0.0 109.698 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.2 168.54 19.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.274 0.559 . . . . 0.0 110.524 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' B' ' 11' ' ' ASN . 70.3 mt -84.31 -4.16 58.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.59 -173.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -53.62 -54.67 34.3 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.241 0.543 . . . . 0.0 110.159 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -74.59 -38.0 62.74 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.543 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.25 73.2 8.09 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.297 -174.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' MET . . . . . 0.698 ' SD ' ' HA ' ' B' ' 34' ' ' ASN . 75.2 mtm 43.72 31.95 0.52 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 161.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' ASN . . . . . 0.515 ' HB2' ' HB3' ' B' ' 6' ' ' LEU . 21.8 t-20 -56.75 -32.31 65.45 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.994 0.902 . . . . 0.0 110.044 173.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.567 ' O ' HG23 ' B' ' 16' ' ' VAL . 3.4 m -69.76 -30.75 68.41 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.253 -175.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.423 ' CG1' ' HB3' ' B' ' 10' ' ' MET . 11.3 mm -68.97 -35.86 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.914 -172.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -69.02 -32.17 71.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.085 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 32.8 t -69.48 -35.13 75.29 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.016 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.567 HG23 ' O ' ' B' ' 12' ' ' SER . 15.7 t -64.22 -42.47 95.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.691 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -57.59 -38.18 74.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.227 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.13 -40.05 32.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.216 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -65.13 -57.04 9.59 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.439 0.696 . . . . 0.0 112.455 -176.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.532 HD21 ' HZ2' ' B' ' 54' ' ' TRP . 43.6 mt -68.75 -31.39 70.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.703 -175.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.84 61.05 5.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.284 0.564 . . . . 0.0 110.529 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -121.59 -86.73 0.65 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.082 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.82 51.06 0.84 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.75 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.526 ' HE2' ' O ' ' B' ' 68' ' ' GLU . 31.5 mmtp -114.16 -161.43 0.77 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.403 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -73.01 -175.48 29.05 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.139 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.823 ' O ' ' HA ' ' B' ' 40' ' ' SER . 16.4 ptpt -67.76 105.15 1.84 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 174.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.592 ' HA ' ' O ' ' B' ' 39' ' ' THR . 17.8 tp -119.24 128.17 53.93 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.442 -162.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 67.3 m -117.87 126.05 51.65 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.164 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.57 HD12 HD21 ' B' ' 36' ' ' LEU . 1.7 mm? -104.83 147.88 27.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.117 0.484 . . . . 0.0 110.343 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 11.3 p -142.67 150.2 39.87 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.199 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 73.7 mtp -114.39 136.33 53.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.093 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -144.34 115.98 8.17 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.15 -107.28 2.05 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.698 ' HA ' ' SD ' ' B' ' 10' ' ' MET . 2.6 m-20 -123.67 14.83 9.44 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.495 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 75.1 mt-30 -78.48 162.07 26.62 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.304 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.57 HD21 HD12 ' B' ' 29' ' ' LEU . 6.1 tt -133.15 123.15 25.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.347 168.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -118.59 143.88 46.49 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.528 ' HB1' HD11 ' B' ' 27' ' ' LEU . . . -139.81 143.96 37.09 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.062 -0.655 . . . . 0.0 112.333 -170.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.592 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 8.6 p -128.02 141.63 51.46 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.105 175.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.823 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 21.2 p -153.13 145.25 23.81 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.713 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.441 ' HB2' ' CG ' ' B' ' 26' ' ' LYS . 16.9 m -113.18 167.16 10.78 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.367 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -78.88 47.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.194 -172.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.62 -59.82 2.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.015 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.505 ' O ' HD11 ' B' ' 47' ' ' ILE . . . -154.7 55.26 0.42 Allowed Glycine 0 C--N 1.313 -0.746 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.764 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.595 ' O ' HG13 ' B' ' 47' ' ' ILE . 41.4 p90 -77.63 160.16 28.71 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -172.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' B' ' 69' ' ' LYS . . . 14.87 76.5 0.01 OUTLIER Glycine 0 C--N 1.337 0.636 0 O-C-N 125.269 1.606 . . . . 0.0 116.498 168.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.595 HG13 ' O ' ' B' ' 45' ' ' TYR . 1.3 mp -106.75 -72.34 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-O 122.204 1.002 . . . . 0.0 111.684 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -88.33 -152.99 0.23 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.56 -1.655 . . . . 0.0 111.374 -170.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.51 ' O ' ' HE3' ' B' ' 52' ' ' LYS . 64.5 m-85 70.85 6.98 6.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.746 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 56.47 -81.36 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 124.245 0.966 . . . . 0.0 111.674 -175.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -167.28 110.43 0.68 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.51 ' HE3' ' O ' ' B' ' 49' ' ' TYR . 31.9 mmtp -129.61 124.09 32.89 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -104.34 128.13 52.1 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.548 ' HA ' HG12 ' B' ' 94' ' ' ILE . 50.0 p-90 -144.7 157.28 44.25 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -126.34 150.6 17.75 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.334 -170.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.636 HD12 ' CD2' ' B' ' 64' ' ' TYR . 28.6 mt -106.57 149.93 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 169.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.706 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 84.3 m-85 -131.52 142.69 50.0 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -169.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.609 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.9 p -131.67 140.51 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.425 ' HA ' ' SD ' ' B' ' 87' ' ' MET . 7.1 m120 66.76 0.11 1.79 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -170.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.22 0.24 59.88 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.37 -172.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 12.5 mt-10 -102.78 176.1 5.27 Favored 'General case' 0 C--O 1.201 -1.491 0 C-N-CA 123.716 0.806 . . . . 0.0 109.254 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.1 tppp? -62.37 160.37 13.5 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 118.633 0.651 . . . . 0.0 110.395 175.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.609 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.5 p -152.97 -15.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.507 168.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.636 ' CD2' HD12 ' B' ' 56' ' ' ILE . 0.8 OUTLIER -160.43 126.19 4.01 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -172.321 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 23.9 m -134.51 126.32 29.12 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.189 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.55 ' CB ' HD13 ' B' ' 75' ' ' ILE . 3.9 p90 -166.96 -175.16 2.93 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.533 0.682 . . . . 0.0 110.424 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 10.0 t-20 -128.77 168.27 16.11 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.093 -170.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' GLU . . . . . 0.526 ' O ' ' HE2' ' B' ' 24' ' ' LYS . 8.9 mm-40 -85.81 -11.08 54.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.871 0.367 . . . . 0.0 110.955 -177.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.487 ' O ' ' HA3' ' B' ' 46' ' ' GLY . 51.1 tttm -100.78 -26.1 13.9 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.505 ' OG ' HD11 ' B' ' 75' ' ' ILE . 21.5 t -63.88 152.07 40.76 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.811 0.815 . . . . 0.0 108.989 174.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.449 ' O ' HG13 ' B' ' 75' ' ' ILE . 0.1 OUTLIER -99.26 109.59 22.22 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.113 -173.75 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.583 ' HA ' HD12 ' B' ' 75' ' ' ILE . 3.6 m -67.33 -14.47 18.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.425 -167.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.54 -47.96 88.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.675 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -74.42 -32.84 62.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.045 0.45 . . . . 0.0 110.609 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' B' ' 72' ' ' VAL . 1.4 mt -70.33 -51.33 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.127 0.489 . . . . 0.0 110.274 -177.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 16.6 t -61.94 -28.77 69.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.563 -176.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -50.67 -53.5 30.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.527 0.679 . . . . 0.0 110.268 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.753 ' O ' ' HG3' ' B' ' 81' ' ' LYS . 0.8 OUTLIER -69.29 -43.07 74.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.099 179.13 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.558 HG13 ' CE1' ' B' ' 64' ' ' TYR . 42.8 mm -51.77 -37.98 21.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.266 0.555 . . . . 0.0 111.718 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -66.27 -28.42 68.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.326 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.753 ' HG3' ' O ' ' B' ' 78' ' ' ASP . 0.0 OUTLIER -84.6 -0.43 53.23 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.758 -176.582 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 3.1 mm? -72.78 -11.84 60.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.232 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 62.6 t30 50.61 58.97 4.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.634 -172.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.495 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 68.9 mt -61.59 150.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.375 -173.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.434 ' O ' HG22 ' B' ' 84' ' ' ILE . 64.8 mttm -103.26 -178.53 3.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.381 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -139.62 115.3 1.08 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.795 -1.193 . . . . 0.0 113.805 -177.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.425 ' SD ' ' HA ' ' B' ' 59' ' ' ASN . 1.7 pmm? -165.25 -57.64 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 175.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 88' ' ' TYR . . . . . 0.424 ' N ' ' HG2' ' B' ' 87' ' ' MET . 15.7 t80 -129.31 83.23 2.13 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 121.611 -0.681 . . . . 0.0 109.778 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.706 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 23.4 mm -92.21 121.9 43.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.222 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -109.14 171.54 7.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.985 0.421 . . . . 0.0 109.933 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.525 HG12 ' HB3' ' B' ' 12' ' ' SER . 30.4 mm -152.94 115.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.677 -175.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -169.18 165.79 10.93 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.177 0.513 . . . . 0.0 111.875 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.484 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 3.1 pp0? -82.76 143.61 30.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.854 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' B' ' 54' ' ' TRP . 6.2 pt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.868 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -149.65 106.06 3.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.927 0.394 . . . . 0.0 111.138 -175.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' GLN . . . . . 0.474 ' HB3' ' O ' ' B' ' 31' ' ' MET . 8.6 pt20 -95.53 -1.58 50.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.544 175.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.95 -29.43 58.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.817 -177.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.88 98.72 0.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.337 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' B' ' 9' ' ' GLN . 91.0 mt -68.56 -15.15 63.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.051 -173.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -71.93 -44.93 62.82 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.325 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -81.5 -32.26 32.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.597 0.713 . . . . 0.0 110.885 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.63 ' OE1' ' HB ' ' B' ' 13' ' ' ILE . 0.4 OUTLIER -119.07 84.72 2.24 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.753 -177.801 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -83.35 166.67 18.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.555 -174.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -47.44 -32.47 5.11 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.52 ' CB ' ' HB ' ' B' ' 89' ' ' ILE . 12.2 m -65.49 -27.23 68.34 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.99 -173.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.63 ' HB ' ' OE1' ' B' ' 9' ' ' GLN . 3.3 mm -67.4 -47.06 82.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 122.079 0.942 . . . . 0.0 109.392 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' ASN . . . . . 0.412 ' ND2' ' H ' ' B' ' 14' ' ' ASN . 11.2 m-80 -59.23 -32.6 70.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.285 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 9.9 t -68.51 -42.28 78.79 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.801 177.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.484 HG23 ' O ' ' B' ' 12' ' ' SER . 97.7 t -55.26 -42.75 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.128 0.49 . . . . 0.0 110.379 177.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -56.73 -45.66 81.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.758 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.92 -38.9 52.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.237 -175.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' B' ' 15' ' ' SER . 24.1 mmmt -78.5 -8.26 58.36 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -172.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.422 HD21 ' CZ ' ' B' ' 66' ' ' PHE . 15.6 mt -91.63 23.43 3.54 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ASN . . . . . 0.494 ' CG ' ' H ' ' B' ' 22' ' ' LYS . 20.3 p-10 -88.73 -79.34 0.31 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 171.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.494 ' H ' ' CG ' ' B' ' 21' ' ' ASN . 28.7 mtpp 48.61 34.01 4.65 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 169.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 146.8 -92.38 0.15 Allowed Glycine 0 N--CA 1.439 -1.167 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.472 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.58 ' HD2' ' CD1' ' B' ' 47' ' ' ILE . 58.0 mttm -152.84 -141.75 0.11 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -171.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.663 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . 68.05 111.75 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.8 -173.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' B' ' 40' ' ' SER . 0.3 OUTLIER -63.0 115.44 4.41 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 173.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.521 HD22 ' CG2' ' B' ' 72' ' ' VAL . 4.0 tp -152.85 105.08 2.91 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 72.4 m -97.76 113.92 25.81 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.344 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.412 ' N ' HD22 ' B' ' 29' ' ' LEU . 2.8 mm? -86.75 159.85 19.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.477 0.656 . . . . 0.0 110.59 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.555 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 0.1 OUTLIER -151.11 147.66 27.34 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.313 173.52 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 31' ' ' MET . . . . . 0.474 ' O ' ' HB3' ' B' ' 3' ' ' GLN . 58.8 mtm -118.81 141.09 48.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.149 0.5 . . . . 0.0 111.839 -168.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' ASN . . . . . 0.532 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 49.6 t30 -150.55 60.48 0.95 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.405 173.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.78 -92.83 0.01 OUTLIER Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.2 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.35 -18.17 57.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.774 -0.213 . . . . 0.0 111.328 -177.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.532 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 68.5 mt-30 -101.53 147.0 26.9 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.666 0.746 . . . . 0.0 111.422 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.19 104.81 9.4 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.506 174.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.555 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 8.1 mmmm -102.56 142.73 33.25 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -172.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -162.92 145.1 10.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -174.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 7.9 p -122.13 143.18 49.7 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 172.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 20.3 m -137.15 155.45 49.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.45 0.643 . . . . 0.0 112.256 -173.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.431 ' HB3' ' CB ' ' B' ' 26' ' ' LYS . 32.5 t -137.87 154.53 49.47 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.618 176.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -105.93 37.05 2.35 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.924 -170.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.23 23.12 0.29 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.591 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.45 -56.71 0.41 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.728 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.663 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 14.8 p90 47.58 -161.88 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.48 1.112 . . . . 0.0 113.784 175.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.601 ' HA2' ' OH ' ' B' ' 49' ' ' TYR . . . -69.07 104.7 1.31 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 116.34 -0.391 . . . . 0.0 113.358 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.58 ' CD1' ' HD2' ' B' ' 24' ' ' LYS . 2.1 mp -100.28 -71.33 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 122.11 0.957 . . . . 0.0 110.685 179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 18.4 m -99.75 -118.65 0.15 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.036 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.601 ' OH ' ' HA2' ' B' ' 46' ' ' GLY . 0.1 OUTLIER 38.46 45.86 0.89 Allowed 'General case' 0 N--CA 1.472 0.625 0 O-C-N 123.693 0.621 . . . . 0.0 111.226 -171.315 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 48.55 -94.5 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.836 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -174.41 109.85 0.14 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.638 ' HB2' ' OE2' ' B' ' 68' ' ' GLU . 47.4 mmtt -123.26 136.84 54.9 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -174.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -120.1 140.32 51.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.799 0.333 . . . . 0.0 111.344 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.624 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 22.2 p-90 -156.23 172.02 19.19 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.505 172.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.7 147.07 19.0 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.661 -173.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 25.0 mt -107.14 146.32 13.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 170.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.639 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 60.3 m-85 -126.63 143.89 51.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.426 -174.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.603 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.1 p -129.68 136.43 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 m120 59.13 14.93 3.77 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.118 0.567 . . . . 0.0 109.842 -174.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.37 -1.5 66.95 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.496 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 14.6 mt-10 -105.86 177.5 4.83 Favored 'General case' 0 C--O 1.205 -1.266 0 C-N-CA 123.644 0.778 . . . . 0.0 109.162 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.2 tppp? -66.14 163.04 18.43 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 172.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.603 ' HB ' HG12 ' B' ' 58' ' ' VAL . 11.3 p -151.48 -21.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.104 0.478 . . . . 0.0 109.877 167.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.687 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.6 OUTLIER -161.31 123.46 3.02 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.163 0.506 . . . . 0.0 110.845 -171.773 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 8.6 m -129.48 129.4 44.55 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.421 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.475 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.0 OUTLIER -153.01 -176.7 5.88 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 122.261 1.029 . . . . 0.0 111.875 -176.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.753 ' ND2' ' H ' ' B' ' 69' ' ' LYS . 5.4 t30 -147.28 149.09 32.19 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 112.897 -1.956 . . . . 0.0 108.365 -176.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' GLU . . . . . 0.638 ' OE2' ' HB2' ' B' ' 52' ' ' LYS . 0.4 OUTLIER -66.48 -21.1 66.18 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -172.207 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.753 ' H ' ' ND2' ' B' ' 67' ' ' ASN . 85.4 tttt -95.88 -20.91 18.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.226 0.536 . . . . 0.0 110.011 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 6.7 t -69.88 -23.63 63.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.674 174.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.587 HG21 ' CD1' ' B' ' 45' ' ' TYR . 19.2 p 61.87 107.13 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.313 1.045 . . . . 0.0 111.878 174.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.629 ' HA ' HD12 ' B' ' 75' ' ' ILE . 6.0 m -64.41 -16.47 19.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.606 -169.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.07 -48.5 82.48 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.269 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -75.43 -28.91 59.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.285 0.564 . . . . 0.0 110.572 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' B' ' 72' ' ' VAL . 2.9 mt -73.0 -47.83 46.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.595 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 42.1 m -52.08 -35.43 47.61 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.041 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -48.51 -58.26 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.788 0.804 . . . . 0.0 110.336 172.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.548 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 7.1 m-20 -70.31 -35.9 73.97 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.572 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.687 HG13 ' CE1' ' B' ' 64' ' ' TYR . 41.5 mm -58.81 -25.54 29.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.571 0.7 . . . . 0.0 111.729 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -69.18 4.54 1.59 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.406 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 0.1 OUTLIER -105.17 -0.61 26.36 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.132 0.492 . . . . 0.0 110.446 176.134 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' B' ' 79' ' ' ILE . 2.4 mm? -79.56 -4.46 51.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.999 -169.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 53.13 58.85 4.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -170.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.447 HD11 HG22 ' B' ' 79' ' ' ILE . 59.8 mt -56.84 155.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.121 -175.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -134.86 -171.69 2.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.882 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -149.47 112.7 0.57 Allowed Glycine 0 C--N 1.309 -0.945 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.463 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.456 ' HG2' ' N ' ' B' ' 88' ' ' TYR . 16.0 ttt -160.29 -76.3 0.06 Allowed 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 88' ' ' TYR . . . . . 0.456 ' N ' ' HG2' ' B' ' 87' ' ' MET . 49.7 t80 -120.11 94.05 4.26 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.639 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 22.3 mm -96.32 130.52 44.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.672 -177.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 51.3 mm-40 -123.94 154.99 38.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.4 . . . . 0.0 111.528 177.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.567 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 72.2 mt -137.54 126.25 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.646 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.624 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 49.6 pttt -172.62 167.27 5.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.064 0.459 . . . . 0.0 111.262 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.519 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.1 OUTLIER -96.77 151.67 19.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.427 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.559 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.9 pt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.038 -0.982 . . . . 0.0 111.038 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.545 0.212 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -76.74 -30.55 56.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.848 0.356 . . . . 0.0 111.484 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -63.41 -15.61 58.11 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.768 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -72.76 -18.98 61.45 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.032 0.444 . . . . 0.0 110.946 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.82 11.08 30.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.063 0.459 . . . . 0.0 110.587 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 75.2 mt -118.42 21.9 12.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.46 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -40.33 75.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.418 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -87.48 -30.44 20.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 122.098 0.952 . . . . 0.0 110.149 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -81.27 68.97 7.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.772 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' MET . . . . . 0.418 ' O ' HG13 ' B' ' 13' ' ' ILE . 25.8 mmt -66.12 138.04 57.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.884 176.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -40.25 -19.89 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.42 1.488 . . . . 0.0 114.092 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.43 ' O ' HG23 ' B' ' 16' ' ' VAL . 39.1 t -60.09 -7.3 1.76 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.569 0.747 . . . . 0.0 112.325 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.468 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.6 OUTLIER -47.91 -62.27 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.347 0 CA-C-O 121.224 0.535 . . . . 0.0 111.916 -176.064 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -106.67 -20.77 13.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.792 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 30.9 t -53.61 -38.35 63.93 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.164 -175.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 12' ' ' SER . 90.1 t -57.19 -41.93 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 111.211 -176.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.436 ' HA ' HD22 ' B' ' 29' ' ' LEU . 59.5 t30 -67.05 -41.53 86.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.668 -176.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.07 -38.9 56.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.0 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 6.4 mmpt? -57.88 -66.22 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.501 HD21 ' CZ ' ' B' ' 66' ' ' PHE . 75.3 mt -59.1 -23.02 61.72 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.269 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -86.74 79.8 8.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.713 0.768 . . . . 0.0 110.711 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' B' ' 19' ' ' LYS . 29.7 mtpp -119.14 37.3 4.17 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.97 177.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.65 59.5 3.48 Favored Glycine 0 CA--C 1.505 -0.59 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.402 ' HE2' ' HB2' ' B' ' 22' ' ' LYS . 70.8 mmtt -125.45 -163.44 1.2 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -177.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.446 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -53.54 139.94 34.26 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.175 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.713 ' O ' ' HA ' ' B' ' 40' ' ' SER . 43.1 mtmt -61.76 107.9 0.91 Allowed 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 117.036 0.418 . . . . 0.0 109.96 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' B' ' 39' ' ' THR . 36.7 tp -125.41 122.58 37.14 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.853 -167.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 18.2 m -101.61 101.9 12.52 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.542 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.499 ' N ' HD12 ' B' ' 29' ' ' LEU . 4.9 mp -90.69 150.94 21.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 122.02 0.914 . . . . 0.0 112.485 -170.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 34.3 p -146.65 149.8 34.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.778 -1.555 . . . . 0.0 107.893 173.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 78.3 mtp -120.74 160.85 22.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.244 0.545 . . . . 0.0 111.811 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -159.09 104.94 1.72 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.599 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.91 -97.59 0.74 Allowed Glycine 0 CA--C 1.504 -0.604 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -169.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -137.17 19.77 2.98 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 168.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -77.68 155.14 31.52 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.927 175.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.472 HD21 HD23 ' B' ' 29' ' ' LEU . 2.0 tm? -126.45 116.99 21.99 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.18 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -120.97 133.01 55.26 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.726 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -162.82 150.44 13.56 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -170.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.62 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 18.4 p -112.14 148.11 34.69 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.713 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 7.7 p -134.34 146.47 49.97 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -170.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' B' ' 26' ' ' LYS . 47.3 t -118.82 165.26 14.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.399 167.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -113.93 18.72 17.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.165 0.507 . . . . 0.0 111.238 -172.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.75 -61.45 2.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.181 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.54 53.94 0.56 Allowed Glycine 0 C--N 1.311 -0.807 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.985 -176.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.446 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 0.1 OUTLIER -63.65 -165.69 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.03 0.532 . . . . 0.0 112.192 -177.679 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.559 ' H ' HG22 ' B' ' 71' ' ' THR . . . -70.33 106.66 1.9 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.154 175.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 4.7 mm -64.0 -68.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.974 0.416 . . . . 0.0 110.173 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.0 m -123.28 -90.79 0.56 Allowed 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.18 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 56.15 33.91 22.91 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 122.761 0.424 . . . . 0.0 111.332 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 34.02 -109.62 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.727 -1.124 . . . . 0.0 113.111 -175.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -150.65 110.52 4.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.828 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.428 ' HB2' ' HG2' ' B' ' 68' ' ' GLU . 54.2 mttm -131.53 135.16 46.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -111.5 136.09 51.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.846 0.355 . . . . 0.0 110.156 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.678 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 48.0 p-90 -151.2 166.99 29.19 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 172.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.71 159.4 26.86 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 119.989 -1.1 . . . . 0.0 113.711 -170.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 13.3 mt -105.7 142.85 17.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 171.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.58 ' CE1' ' HG3' ' B' ' 62' ' ' LYS . 48.8 m-85 -126.23 131.29 51.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.998 -0.092 . . . . 0.0 110.756 -177.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.618 HG12 ' HB ' ' B' ' 63' ' ' VAL . 12.2 p -116.26 133.86 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.276 -177.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.408 ' HA ' ' H ' ' B' ' 88' ' ' TYR . 3.6 m120 65.78 5.01 3.15 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.719 0.808 . . . . 0.0 110.263 -177.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.61 11.9 56.4 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.829 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 14.8 mt-10 -110.25 173.7 6.21 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 171.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.58 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 24.9 ttmt -76.49 168.77 19.48 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 119.427 1.012 . . . . 0.0 108.971 173.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.618 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.4 p -151.47 -19.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.804 171.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.643 ' CD2' HD11 ' B' ' 79' ' ' ILE . 0.0 OUTLIER -163.33 153.21 15.4 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.588 -175.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 27.6 m -149.97 130.03 13.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.308 177.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.661 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -145.11 -176.76 5.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.724 0.773 . . . . 0.0 110.769 -178.803 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 67' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -136.22 160.2 39.41 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.156 -1.384 . . . . 0.0 110.219 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 68' ' ' GLU . . . . . 0.428 ' HG2' ' HB2' ' B' ' 52' ' ' LYS . 62.2 mm-40 -61.15 -44.25 97.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.865 0.364 . . . . 0.0 111.724 -177.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.557 ' O ' HG23 ' B' ' 71' ' ' THR . 50.3 tptt -80.86 -19.76 43.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.838 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 8.7 t -69.1 -18.38 63.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.402 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.559 HG22 ' H ' ' B' ' 46' ' ' GLY . 41.0 p 56.27 105.93 0.01 OUTLIER 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.304 1.041 . . . . 0.0 113.332 170.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.581 ' HA ' HD12 ' B' ' 75' ' ' ILE . 11.1 m -57.65 -15.12 3.67 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-N 114.556 -1.202 . . . . 0.0 113.265 -171.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.58 -52.3 46.26 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.979 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -76.45 -32.68 58.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.354 0.597 . . . . 0.0 109.976 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.661 HD13 ' HB3' ' B' ' 66' ' ' PHE . 1.9 mt -72.03 -53.93 18.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.604 -173.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.8 m -69.75 -14.08 62.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.52 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -61.93 -42.24 98.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.768 0.794 . . . . 0.0 109.459 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 4.3 m-20 -68.95 -32.46 72.07 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.529 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.643 HD11 ' CD2' ' B' ' 64' ' ' TYR . 17.7 mm -55.67 -26.35 19.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -54.85 -27.26 40.96 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.296 173.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 19.8 pttm -104.11 -6.14 21.37 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -172.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' B' ' 79' ' ' ILE . 2.8 mm? -70.97 -18.3 62.62 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 122.126 -0.359 . . . . 0.0 111.815 -173.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 61.0 t30 45.97 55.69 6.8 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.972 0.795 . . . . 0.0 110.63 -171.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.485 HG22 ' O ' ' B' ' 85' ' ' LYS . 83.1 mt -59.81 145.5 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.171 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.485 ' O ' HG22 ' B' ' 84' ' ' ILE . 62.3 mttp -89.88 178.27 6.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.32 176.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -134.33 112.58 1.06 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.474 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.24 -79.73 0.09 Allowed 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 88' ' ' TYR . . . . . 0.408 ' H ' ' HA ' ' B' ' 59' ' ' ASN . 25.5 t80 -122.33 88.07 2.87 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 28.0 mm -90.83 128.66 42.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.912 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.58 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 33.8 mt-10 -117.52 144.73 44.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.588 173.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.413 HG21 ' HG3' ' B' ' 19' ' ' LYS . 2.5 mt -134.75 102.81 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.678 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 48.0 pttt -154.65 178.01 10.59 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -169.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.445 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 21.1 mm-40 -99.01 146.8 25.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.163 -176.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.642 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.9 pt . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.305 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.635 0.255 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -78.27 -39.54 39.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.761 0.315 . . . . 0.0 111.007 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' GLN . . . . . 0.401 ' HA ' ' OE1' ' B' ' 3' ' ' GLN . 15.6 mm-40 -83.54 -19.44 35.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.319 0.58 . . . . 0.0 110.214 178.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -93.64 9.4 37.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.023 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.04 83.71 0.33 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.825 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.89 21.22 14.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.498 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.56 -63.74 1.2 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.733 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -98.22 1.23 47.09 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 121.413 0.625 . . . . 0.0 110.512 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -130.26 76.92 1.75 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.367 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 15.0 mmt -71.64 150.52 44.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.362 0.601 . . . . 0.0 111.283 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -66.5 -28.26 68.43 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.956 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 24.2 m -71.45 -21.12 62.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.712 -175.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.411 ' H ' HG12 ' B' ' 13' ' ' ILE . 3.8 mm -61.93 -47.4 93.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 122.07 0.938 . . . . 0.0 109.196 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' ASN . . . . . 0.4 ' H ' ' ND2' ' B' ' 14' ' ' ASN . 8.4 m-80 -63.69 -38.39 90.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.405 -177.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -62.2 -44.27 96.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.934 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.96 -48.0 91.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.096 0.474 . . . . 0.0 110.329 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -60.11 -37.05 78.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.882 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' ASP . . . . . 0.677 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.2 OUTLIER -71.32 -57.47 4.43 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.377 176.799 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -55.59 -49.96 71.38 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.059 0.944 . . . . 0.0 112.85 -173.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.424 HD22 HG11 ' B' ' 72' ' ' VAL . 47.2 mt -71.17 -21.06 62.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.963 -175.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -91.94 -99.55 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.677 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 30.6 mtpp 49.9 25.79 1.74 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.67 11.22 60.84 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.933 178.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -96.25 -129.08 0.16 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 175.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.547 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -66.87 107.29 1.94 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 173.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.746 ' O ' ' HA ' ' B' ' 40' ' ' SER . 34.9 mtmt -66.97 90.08 0.18 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.846 0.314 . . . . 0.0 111.846 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 47.1 tp -108.47 93.14 4.37 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 21.0 m -81.24 105.47 12.46 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.264 -176.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.41 165.24 22.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.946 0.879 . . . . 0.0 111.601 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 49.1 m -146.49 144.35 29.58 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.363 174.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 33.9 mtt -114.26 124.1 51.19 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.817 0.341 . . . . 0.0 110.945 -170.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -144.83 60.04 1.32 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.662 176.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' GLY . . . . . 0.406 ' O ' ' HA3' ' B' ' 86' ' ' GLY . . . 49.55 -102.9 0.07 OUTLIER Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.248 -0.887 . . . . 0.0 113.861 178.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 4.6 m-20 -79.44 19.37 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.271 0.229 . . . . 0.0 111.435 -176.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 42.9 mt-30 -139.13 146.28 40.45 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.317 0.58 . . . . 0.0 110.472 172.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' B' ' 36' ' ' LEU . 1.4 tm? -129.05 116.66 19.64 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 176.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.489 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 16.1 mtpt -118.09 148.87 41.86 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -172.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -170.58 145.6 2.58 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -176.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 19.5 p -122.68 141.62 51.57 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.548 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.746 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 24.1 t -122.53 147.51 46.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.363 0.601 . . . . 0.0 112.163 -174.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' B' ' 26' ' ' LYS . 46.8 t -131.67 160.85 34.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.813 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' B' ' 44' ' ' GLY . 51.1 m-80 -114.1 32.84 5.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.115 -171.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.526 ' HB3' ' HE2' ' B' ' 26' ' ' LYS . . . -72.96 22.46 0.07 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.306 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' B' ' 42' ' ' ASN . . . 165.34 -43.97 0.29 Allowed Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.547 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 37.1 p90 46.04 -160.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.355 1.062 . . . . 0.0 113.013 -175.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.55 99.39 0.73 Allowed Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.842 -0.694 . . . . 0.0 114.17 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.06 -54.73 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.1 0.476 . . . . 0.0 109.782 170.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -37.93 -57.97 0.98 Allowed 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.285 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -103.81 112.91 26.08 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' B' ' 69' ' ' LYS . 30.5 mt-10 -67.75 -48.38 66.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.616 -170.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -167.22 111.93 0.72 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.443 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -132.39 142.18 49.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.848 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.59 113.87 26.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.535 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 29.1 p-90 -154.12 165.7 35.38 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.345 176.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.12 150.45 20.19 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.844 -174.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.459 HD12 ' CD2' ' B' ' 64' ' ' TYR . 24.3 mt -106.35 150.41 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 172.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 70.7 m-85 -131.9 139.43 48.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.128 -172.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.578 HG12 ' HB ' ' B' ' 63' ' ' VAL . 8.6 p -125.17 133.39 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 m120 64.12 5.88 2.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.859 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.87 -12.21 38.16 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.435 -176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' B' ' 58' ' ' VAL . 0.2 OUTLIER -100.17 177.22 5.13 Favored 'General case' 0 C--O 1.202 -1.421 0 C-N-CA 123.713 0.805 . . . . 0.0 109.938 -176.708 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.47 ' HD2' ' OG1' ' B' ' 65' ' ' THR . 13.1 tppt? -61.44 159.45 12.74 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 118.279 0.491 . . . . 0.0 110.485 174.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.578 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.1 p -153.7 -14.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.262 0.553 . . . . 0.0 110.389 167.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.786 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -161.14 133.99 6.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.184 -173.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.47 ' OG1' ' HD2' ' B' ' 62' ' ' LYS . 16.4 m -142.18 126.0 17.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.02 177.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.682 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -166.16 -177.8 4.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 122.567 1.175 . . . . 0.0 112.29 -174.26 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -136.83 145.9 45.0 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 112.349 -2.205 . . . . 0.0 108.736 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.3 -29.3 65.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.186 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.442 ' O ' HG23 ' B' ' 71' ' ' THR . 28.2 ttpp -80.99 -25.94 36.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.99 0.424 . . . . 0.0 110.599 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 9.8 t -68.05 -31.64 71.42 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 174.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.465 ' O ' HG13 ' B' ' 75' ' ' ILE . 11.1 p 62.77 125.08 0.01 OUTLIER 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.548 1.139 . . . . 0.0 112.614 174.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.501 ' HA ' HD12 ' B' ' 75' ' ' ILE . 11.6 m -63.92 -10.75 8.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.356 -168.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.92 -56.31 23.57 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.663 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -76.48 -31.28 57.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.39 0.614 . . . . 0.0 110.265 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.682 HD13 ' HB3' ' B' ' 66' ' ' PHE . 2.8 mt -67.93 -46.24 82.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.649 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 38.2 t -59.16 -32.71 70.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.693 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -49.04 -52.42 25.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.66 0.743 . . . . 0.0 110.286 176.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 30.3 m-20 -67.7 -47.32 69.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.018 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.786 HG13 ' CE1' ' B' ' 64' ' ' TYR . 46.2 mm -55.16 -30.75 24.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.262 0.553 . . . . 0.0 112.065 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -58.6 -20.01 43.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.269 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 0.0 OUTLIER -94.56 -4.0 48.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 0.0 111.058 -175.909 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.1 mm? -70.5 -16.26 62.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.99 -173.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 58.9 t30 50.84 57.64 6.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.461 -171.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' B' ' 35' ' ' GLN . 48.9 mt -57.63 144.08 10.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.94 -174.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 30.3 mtmm -109.03 -168.58 1.36 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.112 175.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' B' ' 33' ' ' GLY . . . -146.25 113.58 0.69 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.925 -177.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 37.4 ttp -157.34 -74.09 0.09 Allowed 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 116.639 0.22 . . . . 0.0 110.458 173.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -117.32 94.24 4.48 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.181 0.515 . . . . 0.0 109.694 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.571 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 20.4 mm -93.57 134.66 30.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.384 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -122.89 173.49 7.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.369 0.604 . . . . 0.0 110.937 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.535 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 92.1 mt -152.22 118.85 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.759 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 30.7 pttt -171.26 168.3 6.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.175 0.512 . . . . 0.0 111.768 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.462 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 2.4 pt20 -99.39 150.51 22.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.154 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.2 pt . . . . . 0 C--N 1.308 -1.203 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.972 -174.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' B' ' 4' ' ' LYS . 3.6 m-20 . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -61.64 -53.66 53.17 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -170.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' GLN . . . . . 0.408 ' O ' ' HG ' ' B' ' 6' ' ' LEU . 11.9 pt20 -74.15 -15.59 61.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.848 0.356 . . . . 0.0 111.793 -176.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.471 ' HB3' ' HB3' ' B' ' 1' ' ' ASP . 55.3 tptt -85.93 -21.75 27.77 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.248 0.547 . . . . 0.0 110.44 175.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.456 ' O ' ' HG2' ' B' ' 9' ' ' GLN . . . -108.5 42.84 1.32 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.085 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 3' ' ' GLN . 67.4 mt -71.84 -3.41 22.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.855 0.36 . . . . 0.0 111.465 -176.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -82.5 -37.02 25.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.005 0.431 . . . . 0.0 110.212 171.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.88 -20.47 49.4 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.714 0.769 . . . . 0.0 110.713 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' B' ' 5' ' ' ALA . 17.7 pt20 -128.4 68.05 1.37 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.439 172.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.75 171.02 15.05 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.625 -1.171 . . . . 0.0 112.115 -173.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -36.83 -22.97 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.638 1.975 . . . . 0.0 115.825 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 15.2 m -60.33 -12.5 9.31 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 122.441 0.296 . . . . 0.0 111.792 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.451 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -53.52 -50.36 49.87 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-O 121.732 0.777 . . . . 0.0 109.849 -178.082 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 14' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' B' ' 18' ' ' ASP . 19.8 m120 -106.82 -60.6 1.65 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.274 -175.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 5.5 m -58.24 -64.49 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.393 -170.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 67.9 t -62.94 -40.5 89.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.449 . . . . 0.0 110.701 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -56.83 -47.14 81.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.827 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' ASP . . . . . 0.755 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.1 OUTLIER -75.02 -40.54 60.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.273 -178.039 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -52.49 -35.18 52.27 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.016 0.527 . . . . 0.0 112.027 -176.764 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.22 -42.24 11.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.273 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' B' ' 18' ' ' ASP . 4.3 p-10 -80.45 -2.41 45.7 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.755 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 29.2 mtpp -73.37 -74.29 0.18 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.753 0.311 . . . . 0.0 111.565 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.17 15.93 59.83 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.822 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.575 ' NZ ' ' HA ' ' B' ' 68' ' ' GLU . 26.0 mtpt -129.29 -160.23 1.02 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.168 0.509 . . . . 0.0 110.224 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.492 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -66.03 139.24 38.03 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 173.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' B' ' 40' ' ' SER . 60.3 mttt -62.28 133.91 55.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -175.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.507 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 29.6 tp -141.56 96.57 3.0 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 41.9 m -86.63 126.83 34.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.789 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.507 ' CD1' ' HG ' ' B' ' 27' ' ' LEU . 10.4 mp -107.07 163.75 12.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 122.327 1.06 . . . . 0.0 112.758 -174.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.453 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 3.1 p -160.22 146.06 15.33 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 112.878 -1.965 . . . . 0.0 107.073 171.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 31' ' ' MET . . . . . 0.439 ' HB2' ' HE3' ' B' ' 31' ' ' MET . 52.9 mtm -128.67 145.61 51.11 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.582 -172.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' ASN . . . . . 0.438 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 44.1 t-20 -138.02 61.21 1.6 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.47 -96.82 0.12 Allowed Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.54 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -87.19 25.77 1.31 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.913 0.387 . . . . 0.0 110.791 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.438 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 65.8 mt-30 -137.31 144.82 42.8 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 121.465 0.65 . . . . 0.0 110.627 172.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.421 ' HB3' HD13 ' B' ' 84' ' ' ILE . 3.7 tt -126.25 105.17 8.64 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.248 -1.342 . . . . 0.0 107.645 175.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.453 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 6.0 mmmm -102.62 138.27 39.74 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -173.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -156.56 147.47 21.95 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -172.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -124.27 155.22 39.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.09 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 6.7 p -135.85 157.52 46.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -172.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' B' ' 26' ' ' LYS . 22.8 t -136.43 154.45 50.78 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.776 174.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -115.96 30.39 7.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.812 -171.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.41 ' HB3' ' HE3' ' B' ' 26' ' ' LYS . . . -75.61 23.2 0.12 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -175.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.59 -24.26 0.36 Allowed Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.777 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.524 ' HB2' ' HB ' ' B' ' 71' ' ' THR . 52.6 p90 45.37 -156.6 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.167 0.987 . . . . 0.0 113.032 -176.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' B' ' 24' ' ' LYS . . . -69.52 102.98 1.02 Allowed Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.666 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.79 -64.19 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.037 0.446 . . . . 0.0 110.619 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 60.1 m -48.5 -53.66 17.24 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.152 -175.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.555 ' CB ' ' HB3' ' B' ' 68' ' ' GLU . 4.4 m-30 -78.39 127.25 31.93 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.768 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -84.25 -168.62 2.23 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.942 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -60.71 108.63 0.87 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.716 0.77 . . . . 0.0 111.325 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 54.3 mtmt -150.24 140.78 22.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.443 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.54 123.93 40.19 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.993 0.425 . . . . 0.0 111.485 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.526 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 28.1 p-90 -143.33 169.7 17.16 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.085 177.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.16 148.59 20.0 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.126 -173.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 13.5 mt -105.66 150.66 8.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 171.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.675 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 84.3 m-85 -130.56 139.48 50.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -171.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.507 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.2 p -126.58 134.32 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 4.4 m120 66.86 -2.32 1.15 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.641 -173.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' B' ' 58' ' ' VAL . . . 108.18 -6.3 34.4 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.552 -172.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -94.47 176.45 6.29 Favored 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 123.896 0.878 . . . . 0.0 109.193 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.431 ' HD3' ' CE1' ' B' ' 57' ' ' PHE . 7.8 tppt? -66.91 161.99 22.81 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.507 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.8 p -153.48 -11.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.08 0.467 . . . . 0.0 110.219 168.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.676 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -160.58 132.39 5.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.547 -175.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 54.9 m -139.01 124.39 19.26 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.288 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.724 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -164.84 155.6 14.43 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.505 1.145 . . . . 0.0 111.869 -174.667 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 10.7 t-20 -93.41 153.49 18.47 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.038 -1.892 . . . . 0.0 108.352 169.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 68' ' ' GLU . . . . . 0.575 ' HA ' ' NZ ' ' B' ' 24' ' ' LYS . 7.1 mm-40 -80.63 -4.48 54.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.025 0.44 . . . . 0.0 111.229 -177.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -97.23 -30.66 12.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.497 ' OG ' HD11 ' B' ' 75' ' ' ILE . 23.2 t -60.57 152.49 26.03 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.062 172.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' B' ' 45' ' ' TYR . 0.1 OUTLIER -103.22 115.79 31.24 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.112 -174.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.62 ' HA ' HD12 ' B' ' 75' ' ' ILE . 14.3 m -68.98 -12.48 16.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.246 -167.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.29 -46.05 94.72 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.485 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -69.13 -31.78 70.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.439 0.638 . . . . 0.0 110.271 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.724 HD13 ' HB3' ' B' ' 66' ' ' PHE . 3.8 mt -74.64 -45.89 43.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.294 -176.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 22.6 t -54.13 -34.45 60.35 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.533 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -51.89 -57.0 10.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.232 173.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.769 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 11.3 m-20 -65.9 -36.53 83.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.676 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.676 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.4 mm -61.98 -33.07 56.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.38 0.609 . . . . 0.0 111.519 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -74.66 1.77 11.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.553 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.769 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 56.6 pttt -110.44 5.62 21.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.39 . . . . 0.0 110.864 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 32.8 mt -86.75 9.35 19.2 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.149 -174.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 63.7 t30 53.15 57.44 6.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -170.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.421 HD13 ' HB3' ' B' ' 36' ' ' LEU . 76.6 mt -45.23 146.12 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.597 -175.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' B' ' 85' ' ' LYS . 38.5 mtpt -127.63 -171.77 2.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.387 177.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -157.0 113.61 0.57 Allowed Glycine 0 N--CA 1.45 -0.396 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.47 ' HG2' ' N ' ' B' ' 88' ' ' TYR . 15.9 ttt -156.4 -75.7 0.1 Allowed 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 117.057 0.429 . . . . 0.0 110.967 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 88' ' ' TYR . . . . . 0.47 ' N ' ' HG2' ' B' ' 87' ' ' MET . 60.8 t80 -122.31 101.81 7.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 28.3 mm -96.25 126.28 48.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.402 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -109.9 171.92 7.16 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 62.2 mt -149.48 107.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.148 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 47.7 pttt -157.45 179.81 8.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.098 0.475 . . . . 0.0 111.687 -177.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 1.5 pt20 -105.13 145.25 30.82 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.93 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.485 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.1 pt . . . . . 0 C--O 1.247 0.926 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.135 -174.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.472 ' O ' ' HG ' ' B' ' 6' ' ' LEU . 24.4 t-20 -92.38 113.32 25.57 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.19 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -87.5 10.09 18.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.927 -176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.624 ' HB3' ' OD1' ' B' ' 11' ' ' ASN . 11.5 mmtp -98.26 -65.71 0.95 Allowed 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.033 0.444 . . . . 0.0 110.318 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.0 80.47 1.32 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.838 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.549 ' H ' HD12 ' B' ' 6' ' ' LEU . 4.8 mp -74.36 -98.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.074 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -87.98 -76.26 0.39 Allowed 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.692 -175.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -114.25 4.17 15.38 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.018 0.437 . . . . 0.0 111.252 -176.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.562 ' HB3' ' HA2' ' B' ' 33' ' ' GLY . 10.6 pt20 -98.4 155.06 17.42 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.501 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' MET . . . . . 0.545 ' O ' HG12 ' B' ' 13' ' ' ILE . 39.7 tpp -119.12 146.92 44.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.943 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' ASN . . . . . 0.624 ' OD1' ' HB3' ' B' ' 4' ' ' LYS . 42.2 m-20 -35.39 -41.85 0.19 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 5.4 m -65.52 -19.29 65.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.174 -169.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.545 HG12 ' O ' ' B' ' 10' ' ' MET . 7.7 mm -59.85 -39.59 80.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 122.198 0.999 . . . . 0.0 109.423 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -76.7 -28.01 55.7 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.22 -175.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.639 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 12.1 m -63.11 -41.93 99.45 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.821 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.552 HG13 HD13 ' B' ' 56' ' ' ILE . 63.9 t -52.7 -44.07 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.508 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -65.25 -41.56 94.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.477 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.49 -29.15 62.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.634 -178.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' B' ' 15' ' ' SER . 27.4 mmmt -71.16 -20.16 62.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.661 0.743 . . . . 0.0 111.387 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.537 HD22 HG11 ' B' ' 72' ' ' VAL . 67.1 mt -108.39 -28.15 9.55 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.416 -175.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -80.43 69.96 7.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.372 0.606 . . . . 0.0 110.104 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -133.45 33.87 3.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.954 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.28 48.85 5.49 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -130.94 -152.37 0.51 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' B' ' 45' ' ' TYR . . . -60.3 125.94 40.06 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 171.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.49 ' CB ' ' HB3' ' B' ' 41' ' ' SER . 29.7 mtpp -80.63 130.71 35.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.598 0.714 . . . . 0.0 111.276 -171.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 21.9 tp -150.26 101.57 3.0 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.11 -173.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 15.4 p -85.8 104.09 15.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.933 -174.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 60.0 mt -88.64 151.34 22.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.593 0.711 . . . . 0.0 111.31 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 71.2 m -140.49 143.9 35.73 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.748 175.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' MET . . . . . 0.47 ' SD ' HG22 ' B' ' 13' ' ' ILE . 5.1 mmt -106.79 120.46 42.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.795 0.331 . . . . 0.0 110.845 -167.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' ASN . . . . . 0.454 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 18.3 t-20 -134.29 58.97 1.75 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.267 0.556 . . . . 0.0 109.513 177.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' GLY . . . . . 0.562 ' HA2' ' HB3' ' B' ' 9' ' ' GLN . . . 50.45 -99.76 0.03 OUTLIER Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.301 -0.863 . . . . 0.0 114.016 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -78.92 4.77 13.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.36 -0.42 . . . . 0.0 111.104 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.454 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 37.7 mt-30 -129.98 147.71 51.76 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.673 0.749 . . . . 0.0 110.579 174.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' B' ' 84' ' ' ILE . 1.4 tt -124.11 106.62 10.49 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.354 -1.294 . . . . 0.0 107.615 174.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.472 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 12.2 mmmm -96.92 153.15 18.07 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.505 -170.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -164.93 152.49 11.36 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.774 -171.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.25 171.71 12.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 169.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 16.3 p -131.78 149.95 52.31 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.189 -0.605 . . . . 0.0 111.381 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.49 ' HB3' ' CB ' ' B' ' 26' ' ' LYS . 31.1 t -130.1 155.96 45.33 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.449 0.642 . . . . 0.0 110.791 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -114.61 33.23 5.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.8 -162.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.31 -33.34 67.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.047 0.927 . . . . 0.0 110.181 172.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.33 -121.62 1.03 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 113.923 -1.489 . . . . 0.0 110.37 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.478 ' HB2' ' CG2' ' B' ' 71' ' ' THR . 9.2 p90 -177.92 -166.63 0.12 Allowed 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 120.774 0.321 . . . . 0.0 111.743 -178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.413 ' H ' HG22 ' B' ' 71' ' ' THR . . . -76.75 122.76 6.4 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.053 -176.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.419 ' H ' HD12 ' B' ' 47' ' ' ILE . 1.2 mp -107.04 -61.25 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 CA-C-O 122.36 1.076 . . . . 0.0 109.058 175.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 2.4 m -57.32 167.67 0.9 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 112.483 -2.144 . . . . 0.0 112.05 -174.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 74.49 10.29 4.2 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.391 -1.731 . . . . 0.0 111.46 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 48.65 -108.95 0.29 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.507 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -130.79 111.66 12.33 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.787 0.803 . . . . 0.0 110.42 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 94.1 mttt -134.07 138.12 45.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.121 176.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -112.47 132.84 54.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.078 0.466 . . . . 0.0 110.665 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.514 ' HA ' HG12 ' B' ' 94' ' ' ILE . 27.6 p-90 -141.88 173.05 11.87 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.016 176.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.65 139.35 10.87 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.567 -173.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.56 HD12 ' CD2' ' B' ' 64' ' ' TYR . 28.3 mt -104.86 151.34 7.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 169.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.721 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 74.9 m-85 -130.45 145.34 51.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -172.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.627 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.1 p -135.98 140.98 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.575 ' ND2' HG13 ' B' ' 58' ' ' VAL . 8.6 m-80 66.52 3.17 2.76 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -172.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.9 4.11 65.38 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.352 -172.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 3.9 mm-40 -105.84 176.51 5.14 Favored 'General case' 0 C--O 1.202 -1.433 0 C-N-CA 123.618 0.767 . . . . 0.0 109.209 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.502 ' HE3' ' CE1' ' B' ' 57' ' ' PHE . 0.0 OUTLIER -68.26 161.59 26.92 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.493 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.627 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.6 p -153.79 -12.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.909 0.385 . . . . 0.0 110.698 170.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.82 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.2 OUTLIER -159.52 128.76 5.3 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.207 -173.3 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 26.5 m -137.72 124.81 21.52 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.546 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.505 ' HB2' HD13 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -173.47 151.77 2.02 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 122.042 0.925 . . . . 0.0 112.078 -167.404 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 5.4 m120 -97.97 153.04 18.64 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.562 -1.653 . . . . 0.0 110.58 174.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -58.24 -48.06 81.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.806 0.336 . . . . 0.0 111.125 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.589 ' O ' HG23 ' B' ' 71' ' ' THR . 41.4 ttmt -72.59 -16.74 61.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.298 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.6 t -72.31 -15.08 61.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.589 HG23 ' O ' ' B' ' 69' ' ' LYS . 21.4 p 56.17 113.11 0.01 OUTLIER 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.653 1.181 . . . . 0.0 113.756 169.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.537 HG11 HD22 ' B' ' 20' ' ' LEU . 5.4 m -62.33 -14.54 12.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.16 -171.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.67 -48.96 63.27 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.404 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 74' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 77.0 m-20 -83.81 -36.29 23.62 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.451 0.643 . . . . 0.0 110.578 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.505 HD13 ' HB2' ' B' ' 66' ' ' PHE . 2.8 mt -64.89 -48.37 84.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.176 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.503 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 14.4 t -66.69 -21.13 66.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.153 -177.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 77' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' B' ' 74' ' ' ASN . 0.9 OUTLIER -52.58 -41.32 63.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 171.772 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.659 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 4.7 m-20 -72.6 -52.77 14.06 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.794 172.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.82 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 51.5 mm -47.42 -38.09 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -59.31 -30.51 68.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 45.2 pttt -73.86 -20.97 60.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.978 0.418 . . . . 0.0 110.062 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 4.3 mm? -68.66 -18.51 64.29 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.845 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 66.0 t30 39.77 69.07 0.33 Allowed 'General case' 0 C--O 1.235 0.321 0 O-C-N 124.154 0.909 . . . . 0.0 110.21 -171.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.705 ' H ' HD12 ' B' ' 84' ' ' ILE . 3.9 mp -50.23 143.91 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.614 -174.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -98.1 -178.19 3.98 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.841 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -136.75 113.68 1.07 Allowed Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.315 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.496 ' SD ' ' HA ' ' B' ' 59' ' ' ASN . 1.7 pmm? -170.21 -58.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.406 0.282 . . . . 0.0 110.907 171.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 88' ' ' TYR . . . . . 0.417 ' N ' ' HG2' ' B' ' 87' ' ' MET . 14.2 t80 -130.27 81.25 2.0 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.38 0.536 . . . . 0.0 109.85 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.721 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.3 mp -99.41 120.5 48.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.731 178.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -106.35 176.44 5.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.372 0.606 . . . . 0.0 110.442 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.472 HD11 HG22 ' B' ' 16' ' ' VAL . 30.4 mm -151.87 116.3 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.569 -174.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 40.6 pttt -168.05 159.48 11.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.094 0.473 . . . . 0.0 111.943 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.4 OUTLIER -83.27 152.31 25.22 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.014 172.297 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.514 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.4 pt . . . . . 0 C--N 1.311 -1.066 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.179 -171.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 121.276 0.56 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -85.39 98.67 10.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.112 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' GLN . . . . . 0.402 ' HA ' ' HG ' ' B' ' 6' ' ' LEU . 0.5 OUTLIER -66.8 -26.44 66.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.339 -175.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -76.2 -19.16 58.66 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.016 0.436 . . . . 0.0 110.607 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.2 17.14 23.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.531 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.402 ' HG ' ' HA ' ' B' ' 3' ' ' GLN . 78.4 mt -64.17 -8.32 11.96 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -56.52 -55.14 37.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.984 174.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -94.99 -27.69 15.52 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.404 0.621 . . . . 0.0 110.881 176.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -80.37 67.4 6.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.827 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -68.61 142.63 55.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.497 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -41.58 -40.48 1.89 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.54 ' O ' HG23 ' B' ' 16' ' ' VAL . 31.8 m -74.02 -20.95 60.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.212 -172.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.479 HG22 ' SD ' ' B' ' 31' ' ' MET . 10.7 mm -58.85 -44.31 90.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 121.933 0.873 . . . . 0.0 109.284 175.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.9 -36.07 72.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.051 -176.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 19.4 t -63.81 -44.9 91.92 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.098 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.54 HG23 ' O ' ' B' ' 12' ' ' SER . 70.3 t -57.29 -47.62 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.802 0.334 . . . . 0.0 110.457 176.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -54.21 -50.56 66.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.864 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.09 -38.74 72.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.215 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -60.17 -52.13 66.65 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.514 0.673 . . . . 0.0 111.496 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.591 HD22 HG11 ' B' ' 72' ' ' VAL . 77.3 mt -75.5 -12.75 60.3 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.026 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -118.32 79.48 1.38 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.204 0.526 . . . . 0.0 111.253 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.499 ' HD3' ' OH ' ' B' ' 49' ' ' TYR . 30.1 mtpp -134.76 30.46 3.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.141 0.496 . . . . 0.0 110.667 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.17 45.18 1.91 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.1 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.52 ' HD2' ' OG ' ' B' ' 48' ' ' SER . 12.7 mmtp -90.4 -145.55 0.18 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' B' ' 45' ' ' TYR . . . -74.96 -146.24 1.28 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.74 173.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' B' ' 41' ' ' SER . 2.6 mtmp? -90.35 110.69 21.76 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -177.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.5 tp -158.75 134.33 8.72 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.611 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 74.0 p -131.24 98.77 4.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.041 0.448 . . . . 0.0 111.195 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.487 HD23 ' HB2' ' B' ' 38' ' ' ALA . 31.6 mt -83.47 151.39 25.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.416 0.627 . . . . 0.0 111.043 -177.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 54.3 m -148.43 144.69 27.6 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.624 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' MET . . . . . 0.479 ' SD ' HG22 ' B' ' 13' ' ' ILE . 57.8 mtm -109.0 130.45 55.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.92 0.391 . . . . 0.0 111.094 -173.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 2.9 t-20 -137.97 60.12 1.63 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.362 176.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 51.96 -96.95 0.02 OUTLIER Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.232 -0.894 . . . . 0.0 113.433 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -78.92 -0.58 31.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.726 0.298 . . . . 0.0 111.415 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 37.7 mt-30 -125.32 148.9 48.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.805 0.812 . . . . 0.0 111.441 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' B' ' 36' ' ' LEU . 1.3 tm? -128.7 106.84 9.21 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.383 -1.28 . . . . 0.0 107.612 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -107.38 149.21 28.13 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.521 -170.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -170.23 151.61 3.92 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.067 0.229 . . . . 0.0 111.461 -177.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 3.3 p -120.9 138.18 54.23 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 168.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.618 ' CB ' ' HA3' ' B' ' 73' ' ' GLY . 29.6 t -148.26 154.54 40.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.272 0.558 . . . . 0.0 111.431 -170.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.499 ' HB3' ' HE3' ' B' ' 26' ' ' LYS . 47.5 t -144.0 155.51 44.05 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.086 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -90.32 -6.3 55.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.845 -169.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.1 -20.47 65.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.222 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.446 ' O ' ' HA2' ' B' ' 25' ' ' GLY . . . -106.27 -4.21 38.12 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.471 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.636 ' O ' ' HA3' ' B' ' 25' ' ' GLY . 0.0 OUTLIER 78.48 -168.83 0.05 OUTLIER 'General case' 0 C--N 1.342 0.248 0 C-N-CA 123.65 0.78 . . . . 0.0 112.506 179.168 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.47 46.56 0.83 Allowed Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 167.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -44.73 -69.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.252 0.621 . . . . 0.0 110.567 -174.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.52 ' OG ' ' HD2' ' B' ' 24' ' ' LYS . 9.5 m 60.95 -88.58 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.666 172.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.499 ' OH ' ' HD3' ' B' ' 22' ' ' LYS . 59.3 m-85 -140.56 69.42 1.35 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -173.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 51.95 -94.82 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.369 -176.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -156.28 109.82 2.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.522 -0.763 . . . . 0.0 108.942 171.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 59.3 mttm -141.43 142.9 33.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.072 -175.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.516 ' HB3' ' ND2' ' B' ' 67' ' ' ASN . 0.7 OUTLIER -114.27 124.32 51.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.307 0.575 . . . . 0.0 111.856 -176.946 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.635 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 17.0 p-90 -133.88 171.68 13.84 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.948 174.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.5 143.04 14.35 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.585 -175.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.655 HD12 ' CD2' ' B' ' 64' ' ' TYR . 22.3 mt -108.49 143.33 19.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 173.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 46.8 m-85 -125.58 143.06 51.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.65 -174.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' B' ' 61' ' ' GLU . 9.6 p -128.79 143.41 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.421 ' OD1' HG13 ' B' ' 58' ' ' VAL . 2.4 m120 59.07 14.4 3.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -171.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.35 -1.56 82.33 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.628 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' B' ' 58' ' ' VAL . 13.5 mt-10 -105.12 160.03 15.38 Favored 'General case' 0 C--O 1.192 -1.973 0 C-N-CA 123.887 0.875 . . . . 0.0 109.268 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.604 ' HE2' ' CE2' ' B' ' 57' ' ' PHE . 1.2 tttm -61.89 164.08 6.86 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 118.233 0.469 . . . . 0.0 110.766 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.408 ' O ' HD12 ' B' ' 79' ' ' ILE . 0.0 OUTLIER -156.53 0.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.17 164.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.715 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -157.67 131.96 8.29 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.209 -0.597 . . . . 0.0 111.101 -173.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 29.6 m -142.85 119.0 10.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.208 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.54 ' CB ' HD13 ' B' ' 75' ' ' ILE . 25.4 p90 -171.29 156.41 4.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.058 0.933 . . . . 0.0 112.646 -172.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 19.7 m-80 -100.76 150.78 22.43 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.214 167.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 68' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' B' ' 48' ' ' SER . 36.3 mm-40 -58.73 -40.15 82.93 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.153 0.501 . . . . 0.0 110.92 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -65.01 -17.64 64.61 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.63 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 4.9 t -78.74 -0.59 30.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.603 178.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.444 ' O ' HG13 ' B' ' 75' ' ' ILE . 32.5 p 56.69 97.57 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.721 1.208 . . . . 0.0 112.093 176.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.651 ' HA ' HD12 ' B' ' 75' ' ' ILE . 2.5 m -57.96 -22.42 18.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.716 -170.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 73' ' ' GLY . . . . . 0.618 ' HA3' ' CB ' ' B' ' 40' ' ' SER . . . -62.03 -47.94 86.63 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.477 -178.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 74' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 77.2 m-20 -66.8 -37.73 85.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.451 0.643 . . . . 0.0 109.825 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.651 HD12 ' HA ' ' B' ' 72' ' ' VAL . 3.0 mt -67.06 -42.42 88.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.131 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 30.8 t -51.02 -39.93 56.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.54 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 77' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' B' ' 74' ' ' ASN . 0.7 OUTLIER -56.77 -40.67 76.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.887 176.788 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.78 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 24.0 m-20 -75.47 -40.67 57.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.124 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.715 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.9 mm -63.32 -32.14 55.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.325 0.583 . . . . 0.0 111.261 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.22 -11.03 56.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.593 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.78 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 20.4 pttp -95.93 3.12 53.82 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.543 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' B' ' 79' ' ' ILE . 24.2 mt -85.94 2.72 45.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.173 -176.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 52.66 62.21 2.8 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -169.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 62.1 mt -53.57 151.3 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.18 -174.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -125.08 176.19 6.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.403 176.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -139.36 112.75 0.86 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 173.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.414 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 8.2 tpt -153.7 -82.58 0.08 Allowed 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 117.024 0.412 . . . . 0.0 110.365 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 88' ' ' TYR . . . . . 0.414 ' N ' ' HG3' ' B' ' 87' ' ' MET . 23.2 t80 -109.08 94.68 5.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.646 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 34.0 mm -98.94 122.63 50.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.037 -173.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.572 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 54.1 mm-40 -116.54 148.21 41.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.428 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.635 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 77.9 mt -127.89 127.74 68.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.592 176.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.504 ' HE3' ' CE1' ' B' ' 57' ' ' PHE . 14.3 pttp -174.53 152.46 1.69 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.03 0.443 . . . . 0.0 111.476 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.4 OUTLIER -80.09 144.44 33.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.234 -179.47 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.452 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.4 pt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.197 -174.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 47.7 t30 70.39 -58.97 0.53 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.525 0.73 . . . . 0.0 111.755 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -72.85 -2.92 22.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.813 0.34 . . . . 0.0 111.712 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -84.95 -36.63 21.26 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.07 0.462 . . . . 0.0 109.781 177.66 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.93 60.37 4.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.414 -177.564 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 92.8 mt -96.68 21.06 9.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.379 177.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' B' ' 10' ' ' MET . 29.9 mt-10 -65.24 -56.65 11.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.968 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -80.4 -1.77 42.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.219 0.533 . . . . 0.0 111.213 -178.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -128.86 57.84 1.61 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.705 177.549 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 10' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' B' ' 7' ' ' GLU . 85.1 mmm -59.26 139.26 57.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.182 -175.287 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 11' ' ' ASN . . . . . 0.421 ' HA ' ' CD1' ' B' ' 13' ' ' ILE . 83.0 m-20 -46.12 -10.81 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.046 1.738 . . . . 0.0 114.956 -178.355 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.434 ' HA ' HG23 ' B' ' 16' ' ' VAL . 32.7 t -56.58 -15.49 4.47 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 122.842 0.457 . . . . 0.0 111.596 177.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.459 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.3 OUTLIER -50.68 -59.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 121.411 0.624 . . . . 0.0 111.27 -176.254 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -106.44 -49.11 3.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.015 -176.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 5.9 m -55.93 -53.45 56.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.825 -173.796 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.434 HG23 ' HA ' ' B' ' 12' ' ' SER . 80.2 t -72.8 -33.11 42.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.918 -177.019 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.655 ' HA ' HD12 ' B' ' 29' ' ' LEU . 0.2 OUTLIER -59.79 -42.82 94.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.953 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.14 -37.88 61.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.056 178.406 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.1 OUTLIER -61.36 -40.83 95.74 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 122.9 0.48 . . . . 0.0 111.606 -179.717 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.528 HD21 ' HZ2' ' B' ' 54' ' ' TRP . 71.3 mt -80.03 -31.7 39.55 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.845 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -96.47 53.19 1.28 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.356 0.598 . . . . 0.0 110.44 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' B' ' 19' ' ' LYS . 30.6 mtpp -89.91 -51.95 5.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.139 0.495 . . . . 0.0 110.358 177.197 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.42 68.14 0.22 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 -178.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -124.28 -156.82 0.74 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.502 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -72.56 -171.08 17.68 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 175.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.714 ' O ' ' HA ' ' B' ' 40' ' ' SER . 0.0 OUTLIER -72.97 88.74 1.39 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 117.702 0.751 . . . . 0.0 109.345 176.236 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' B' ' 39' ' ' THR . 15.9 tp -105.94 127.4 53.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.035 -172.091 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 63.4 m -125.89 114.67 18.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.048 178.328 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.655 HD12 ' HA ' ' B' ' 17' ' ' ASN . 24.7 mt -89.26 156.18 18.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.439 0.638 . . . . 0.0 110.776 178.119 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.579 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 63.7 m -145.33 153.74 41.58 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.691 172.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 80.8 mtp -120.79 141.29 50.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.195 0.522 . . . . 0.0 111.857 -176.384 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -145.12 113.15 6.45 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.56 -104.55 1.09 Allowed Glycine 0 CA--C 1.507 -0.419 0 C-N-CA 119.465 -1.35 . . . . 0.0 109.769 -169.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -132.86 25.0 4.32 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.604 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 22.5 mt-30 -80.01 156.71 27.03 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.227 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.442 HD21 HD22 ' B' ' 29' ' ' LEU . 4.9 tt -110.31 110.31 21.08 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.977 -1.011 . . . . 0.0 108.514 173.208 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.579 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 22.4 mmmt -106.22 148.36 28.01 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.393 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -161.64 146.04 12.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.306 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 10.4 p -129.22 144.29 51.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.146 172.772 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.714 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 46.8 m -154.84 152.85 30.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.404 0.621 . . . . 0.0 112.292 -177.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.617 ' HB2' ' CD ' ' B' ' 26' ' ' LYS . 1.3 m -118.89 152.2 36.72 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 167.306 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 42' ' ' ASN . . . . . 0.527 ' HA ' ' HB3' ' B' ' 45' ' ' TYR . 15.0 m120 -112.56 35.16 3.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.134 0.493 . . . . 0.0 111.821 -165.353 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.81 -61.37 1.8 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.801 0.81 . . . . 0.0 110.414 173.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.96 62.23 0.43 Allowed Glycine 0 C--N 1.311 -0.812 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 174.666 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.601 ' HB2' HG21 ' B' ' 71' ' ' THR . 41.6 p90 -71.54 -149.68 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -173.112 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.23 92.16 1.37 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.563 -177.564 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.466 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -105.32 -57.2 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.029 0.442 . . . . 0.0 110.28 179.476 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -39.37 -58.72 1.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.318 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -91.3 101.3 14.0 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.081 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -76.7 -82.08 0.08 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.351 -176.386 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -110.99 108.75 18.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.876 0.846 . . . . 0.0 112.068 -176.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 55.4 mttm -141.23 121.59 14.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 165.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -110.12 121.3 44.93 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.61 0.719 . . . . 0.0 111.556 -174.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.589 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 28.7 p-90 -141.68 162.06 36.4 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.492 175.56 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.15 147.14 16.82 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.864 -173.323 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.614 HD12 ' CD2' ' B' ' 64' ' ' TYR . 29.0 mt -107.08 148.31 11.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 170.157 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.73 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 75.7 m-85 -127.61 144.46 51.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.263 -171.255 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.533 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.9 p -131.41 135.37 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.532 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.0 m-80 61.85 10.13 3.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.016 -176.061 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.87 -2.43 55.57 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 -177.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -107.43 176.93 4.99 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.4 tppp? -63.27 161.22 14.21 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 173.076 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.533 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.8 p -153.17 -13.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.946 0.403 . . . . 0.0 110.376 168.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.718 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.2 OUTLIER -160.07 128.71 4.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.016 0.436 . . . . 0.0 110.536 -172.66 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 55.0 m -139.74 123.99 17.93 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.391 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.503 ' CB ' HD13 ' B' ' 75' ' ' ILE . 19.9 p90 -171.46 157.49 4.88 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 122.012 0.91 . . . . 0.0 112.023 -172.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 24.5 m-80 -105.4 162.46 13.43 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 113.474 -1.694 . . . . 0.0 110.193 172.226 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -61.38 -48.11 82.73 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -174.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.567 ' O ' HG23 ' B' ' 71' ' ' THR . 41.7 ttmt -61.88 -24.52 66.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.951 0.405 . . . . 0.0 112.036 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 11.5 t -67.09 -20.46 65.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.285 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.601 HG21 ' HB2' ' B' ' 45' ' ' TYR . 9.9 p 60.56 111.72 0.02 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.633 1.173 . . . . 0.0 112.113 175.231 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.505 ' HA ' HD12 ' B' ' 75' ' ' ILE . 1.7 m -61.18 -28.42 43.74 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.961 -167.252 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.11 -49.08 57.29 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.179 -176.39 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 74' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 58.1 m-80 -67.72 -42.79 81.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.622 0.725 . . . . 0.0 110.221 179.037 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' B' ' 72' ' ' VAL . 1.8 mt -64.21 -41.75 93.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.601 -176.099 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 74.5 m -53.69 -36.01 61.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.344 179.256 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 77' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' B' ' 74' ' ' ASN . 39.0 m-20 -57.69 -38.01 74.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.989 0.423 . . . . 0.0 111.066 177.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.557 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 13.9 m-20 -73.83 -51.3 16.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.741 174.572 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.718 HG13 ' CE1' ' B' ' 64' ' ' TYR . 44.5 mm -56.08 -35.52 41.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.469 -178.373 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -11.28 59.68 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.318 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.557 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 15.5 ptmt -92.19 4.58 52.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.373 0.606 . . . . 0.0 110.135 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -81.47 -1.51 46.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.411 -175.292 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 63.5 t30 52.07 47.28 25.08 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.702 0.763 . . . . 0.0 109.66 -173.157 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.623 HD11 HG22 ' B' ' 79' ' ' ILE . 94.2 mt -55.12 127.69 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.682 -1.144 . . . . 0.0 113.233 -171.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -92.1 -164.35 1.17 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.582 178.145 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -151.16 119.69 1.02 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.13 -178.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 22.8 ptm -176.76 -56.73 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.616 0.208 . . . . 0.0 111.472 177.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -128.1 80.58 1.97 Allowed 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.816 -0.552 . . . . 0.0 110.013 177.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.73 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.3 mp -98.53 128.86 49.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.37 175.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -114.66 171.37 7.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.082 0.467 . . . . 0.0 110.058 175.226 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.589 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 38.9 mm -142.15 109.55 2.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.594 -178.634 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -168.27 151.87 5.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.426 0.632 . . . . 0.0 112.344 -174.604 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 2.0 pp0? -61.95 148.21 44.44 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.637 172.475 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' B' ' 54' ' ' TRP . 2.0 pt . . . . . 0 C--N 1.311 -1.075 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.028 -176.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 34.7 t70 . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 121.252 0.548 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -147.19 158.11 43.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.205 0.526 . . . . 0.0 110.488 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -66.55 -22.33 66.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.542 -172.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' B' ' 7' ' ' GLU . 28.2 tptp -68.72 -27.69 66.17 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 120.902 0.382 . . . . 0.0 111.225 -177.498 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.22 2.24 56.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.253 0.549 . . . . 0.0 110.288 178.306 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt -117.96 23.28 11.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.043 -178.086 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' B' ' 4' ' ' LYS . 32.7 mt-10 -61.28 -52.44 64.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.862 178.368 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -87.61 -21.06 25.56 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.238 0.542 . . . . 0.0 111.508 -179.418 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -105.17 93.26 4.59 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.569 177.111 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 10' ' ' MET . . . . . 0.487 ' HG3' HD21 ' B' ' 34' ' ' ASN . 85.8 mmm -62.41 129.67 41.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.46 0.648 . . . . 0.0 111.94 -174.074 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -77.02 -15.77 59.52 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.254 175.628 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.447 ' HA ' HD11 ' B' ' 91' ' ' ILE . 11.6 m -65.94 -10.28 37.55 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.35 -176.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.445 HG12 ' O ' ' B' ' 10' ' ' MET . 27.9 mm -58.48 -59.81 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.508 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -106.74 -36.36 6.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.644 -175.301 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.607 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 22.5 t -56.98 -41.83 79.1 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.907 -171.324 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.57 -38.95 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.85 0.357 . . . . 0.0 111.089 -176.251 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.411 ' ND2' HD13 ' B' ' 29' ' ' LEU . 34.0 t-20 -59.13 -55.14 38.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.102 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.12 -40.11 82.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.516 -178.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' B' ' 15' ' ' SER . 8.5 tmtm? -49.21 -67.33 0.27 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.652 0.781 . . . . 0.0 111.71 177.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.585 ' C ' ' H ' ' B' ' 22' ' ' LYS . 16.2 mt -51.88 -67.01 0.29 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.729 175.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 21' ' ' ASN . . . . . 0.449 ' OD1' ' HE2' ' B' ' 49' ' ' TYR . 2.8 t-20 65.25 -19.4 0.09 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.935 0.894 . . . . 0.0 110.609 -168.301 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.585 ' H ' ' C ' ' B' ' 20' ' ' LEU . 31.0 mtpp 83.37 -34.62 0.07 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 159.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.673 ' HA2' ' CE1' ' B' ' 49' ' ' TYR . . . 95.93 79.72 1.48 Allowed Glycine 0 C--O 1.208 -1.521 0 C-N-CA 119.074 -1.536 . . . . 0.0 110.078 -166.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 64.62 -59.75 0.22 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 173.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' B' ' 23' ' ' GLY . . . -33.05 108.27 0.03 OUTLIER Glycine 0 CA--C 1.52 0.354 0 O-C-N 124.071 0.857 . . . . 0.0 113.892 179.08 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.5 ' HE3' ' HB2' ' B' ' 41' ' ' SER . 0.1 OUTLIER -77.84 153.18 32.97 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.825 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.465 HD22 ' CD ' ' B' ' 22' ' ' LYS . 1.3 pt? -163.45 170.28 17.61 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 118.291 0.496 . . . . 0.0 111.5 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 20.7 m -127.87 114.0 16.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.694 178.608 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.411 HD13 ' ND2' ' B' ' 17' ' ' ASN . 9.7 mp -83.87 158.63 21.57 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 122.038 0.923 . . . . 0.0 112.408 -179.003 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.9 p -150.4 154.8 38.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.409 178.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 29.7 mtt -122.82 138.55 54.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.654 0.264 . . . . 0.0 111.628 -168.867 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -152.09 108.09 3.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.458 177.133 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.45 -92.87 0.52 Allowed Glycine 0 CA--C 1.505 -0.534 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -176.146 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.502 ' HB2' ' CA ' ' B' ' 86' ' ' GLY . 0.4 OUTLIER -135.7 8.09 3.29 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.574 0.702 . . . . 0.0 109.311 171.585 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.525 ' OE1' ' HA ' ' B' ' 83' ' ' ASN . 49.6 mt-30 -77.94 149.82 34.11 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.23 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' B' ' 36' ' ' LEU . 12.8 tp -125.84 93.28 3.79 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.206 177.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -96.52 150.61 20.44 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.695 -171.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -165.52 158.34 15.66 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.249 -0.58 . . . . 0.0 112.219 -174.456 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 14.3 p -124.84 137.62 54.29 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.854 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 18.2 t -121.16 154.68 35.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.078 0.466 . . . . 0.0 111.484 -170.38 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.5 ' HB2' ' HE3' ' B' ' 26' ' ' LYS . 14.9 m -121.92 158.53 28.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.606 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -82.59 54.24 2.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.623 -172.223 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.75 22.44 0.6 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.973 177.219 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.518 ' O ' HD11 ' B' ' 47' ' ' ILE . . . 132.56 -47.73 1.0 Allowed Glycine 0 C--O 1.222 -0.615 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.992 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.444 ' O ' HG12 ' B' ' 47' ' ' ILE . 1.2 p90 59.15 177.38 0.08 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.455 1.102 . . . . 0.0 113.224 177.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.443 ' C ' HD13 ' B' ' 47' ' ' ILE . . . -47.64 92.03 0.01 OUTLIER Glycine 0 C--N 1.336 0.533 0 N-CA-C 114.864 0.706 . . . . 0.0 114.864 -176.425 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.518 HD11 ' O ' ' B' ' 44' ' ' GLY . 6.5 mm -109.8 -71.8 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.575 0.702 . . . . 0.0 110.625 175.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.2 p -97.45 -126.9 0.15 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.543 -178.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.673 ' CE1' ' HA2' ' B' ' 23' ' ' GLY . 7.1 m-85 63.91 20.29 12.14 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.206 0.526 . . . . 0.0 110.32 178.074 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 52.7 -161.17 0.11 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.621 -176.18 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -109.21 108.94 19.75 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.748 0.785 . . . . 0.0 109.435 173.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.509 ' HE3' ' O ' ' B' ' 49' ' ' TYR . 43.8 mttt -105.13 120.79 42.39 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -115.15 113.93 24.61 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.069 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.522 ' HA ' HG12 ' B' ' 94' ' ' ILE . 36.1 p-90 -148.04 164.93 32.32 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.3 -176.818 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -126.55 152.75 18.5 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.835 -176.019 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.429 ' O ' HG12 ' B' ' 63' ' ' VAL . 10.3 mt -102.18 146.81 9.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 169.631 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.7 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 83.0 m-85 -125.94 143.75 50.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.482 -172.011 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.512 HG12 ' HB ' ' B' ' 63' ' ' VAL . 10.3 p -130.7 135.24 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.381 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.497 ' HA ' ' HG3' ' B' ' 87' ' ' MET . 3.8 m120 65.74 4.62 2.97 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.72 -176.179 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.03 -0.17 51.44 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.019 -176.133 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -108.47 176.06 5.25 Favored 'General case' 0 C--O 1.203 -1.355 0 C-N-CA 123.346 0.658 . . . . 0.0 109.46 -179.346 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.496 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.5 tppp? -62.44 161.2 12.13 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 173.121 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.512 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.3 p -146.58 -22.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 166.718 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -162.21 142.5 10.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.475 -175.457 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.446 HG23 ' CD1' ' B' ' 94' ' ' ILE . 28.1 m -136.07 127.25 28.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.775 179.325 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.643 ' CD2' HG21 ' B' ' 75' ' ' ILE . 21.5 p90 -163.04 -166.95 1.37 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.07 0.462 . . . . 0.0 111.032 -177.612 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.74 ' O ' ' HB3' ' B' ' 70' ' ' SER . 22.9 t-20 -153.95 158.52 40.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.816 -173.122 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 68' ' ' GLU . . . . . 0.452 ' CD ' ' HD2' ' B' ' 52' ' ' LYS . 8.0 mm-40 -60.28 -56.62 19.24 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.385 0.612 . . . . 0.0 111.234 -178.328 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.583 ' C ' ' H ' ' B' ' 71' ' ' THR . 37.2 ttpt -65.8 -11.69 48.13 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.687 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 70' ' ' SER . . . . . 0.74 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 9.7 t -67.22 2.22 1.72 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.227 1.013 . . . . 0.0 109.283 170.253 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.583 ' H ' ' C ' ' B' ' 69' ' ' LYS . 37.6 p 59.61 80.28 0.2 Allowed 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.02 -1.9 . . . . 0.0 110.56 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.797 ' HA ' ' CG1' ' B' ' 75' ' ' ILE . 17.9 m -68.24 -4.67 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.772 -170.202 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.43 -37.18 94.22 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 119.806 -1.188 . . . . 0.0 110.201 174.653 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 74' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 42.7 m-20 -80.28 -36.21 34.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.219 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.797 ' CG1' ' HA ' ' B' ' 72' ' ' VAL . 24.2 mm -51.64 -54.27 13.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.458 176.628 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 58.8 m -55.55 -37.44 67.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.124 177.512 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 77' ' ' ASN . . . . . 0.465 ' HA ' ' ND2' ' B' ' 80' ' ' ASN . 49.0 m-20 -64.76 -38.67 91.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.205 0.526 . . . . 0.0 111.044 177.342 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.71 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 5.9 m-20 -65.78 -40.58 92.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.899 176.167 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.523 HG13 ' O ' ' B' ' 75' ' ' ILE . 63.8 mt -57.68 -30.75 37.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.121 0.486 . . . . 0.0 110.869 178.736 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' B' ' 77' ' ' ASN . 82.0 m-20 -62.02 -22.48 65.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.46 176.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.71 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 12.1 ptmm? -105.44 -11.47 16.41 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -175.212 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.24 -23.87 67.46 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.801 0.334 . . . . 0.0 110.863 -175.136 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 83' ' ' ASN . . . . . 0.525 ' HA ' ' OE1' ' B' ' 35' ' ' GLN . 23.6 t-20 45.75 62.79 2.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.059 -170.334 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.456 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 72.7 mt -64.5 142.66 16.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.125 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.44 ' H ' HG21 ' B' ' 58' ' ' VAL . 66.2 mttm -86.64 178.37 7.07 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.822 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.502 ' CA ' ' HB2' ' B' ' 34' ' ' ASN . . . -135.02 114.44 1.25 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 119.73 -1.224 . . . . 0.0 113.318 -175.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.497 ' HG3' ' HA ' ' B' ' 59' ' ' ASN . 22.8 ptp -175.07 -55.2 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.49 0.316 . . . . 0.0 110.795 177.001 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -139.6 80.7 1.79 Allowed 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.557 -0.714 . . . . 0.0 110.123 174.671 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.7 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.0 mp -94.63 126.67 47.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.061 174.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -109.32 175.63 5.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.26 0.552 . . . . 0.0 110.433 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.447 HD11 ' HA ' ' B' ' 12' ' ' SER . 5.7 mt -147.75 102.0 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.676 -177.246 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 45.1 pttt -164.42 165.77 21.21 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.266 -173.48 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.4 OUTLIER -73.84 159.49 32.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.781 178.998 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.522 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.0 pt . . . . . 0 C--N 1.31 -1.124 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.714 -177.176 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -70.49 -24.54 62.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.863 178.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -70.86 -11.93 61.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.301 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' B' ' 4' ' ' LYS . 6.5 tmtm? -73.22 -27.16 61.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.412 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.36 91.61 6.84 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.534 178.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.47 -5.15 43.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.105 -178.244 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -72.85 -43.08 63.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.493 174.491 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -81.76 -55.02 4.9 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.815 0.817 . . . . 0.0 110.222 175.576 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -88.69 75.31 8.25 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.577 178.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 10' ' ' MET . . . . . 0.452 ' SD ' ' HA ' ' B' ' 88' ' ' TYR . 80.6 mtp -74.01 179.68 4.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.219 -178.15 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -64.16 -32.03 73.45 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.128 0.49 . . . . 0.0 110.53 176.486 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.538 ' O ' HG23 ' B' ' 16' ' ' VAL . 13.3 m -68.81 -20.89 64.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.847 -171.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 mm -51.22 -52.4 19.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 121.901 0.857 . . . . 0.0 110.672 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -75.75 -33.76 60.24 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.5 -175.029 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -64.59 -41.08 96.48 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.878 179.376 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.538 HG23 ' O ' ' B' ' 12' ' ' SER . 94.4 t -61.49 -45.22 99.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.963 0.411 . . . . 0.0 110.163 178.142 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -42.14 99.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.524 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -33.9 68.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.866 0.365 . . . . 0.0 111.359 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -68.17 -48.79 64.34 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 123.348 0.659 . . . . 0.0 111.952 -178.436 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.445 HD22 HG11 ' B' ' 72' ' ' VAL . 63.6 mt -77.81 -7.95 57.34 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.383 -176.697 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 21' ' ' ASN . . . . . 0.426 ' CG ' ' H ' ' B' ' 22' ' ' LYS . 61.2 t30 -99.73 -161.87 0.9 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.217 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.426 ' H ' ' CG ' ' B' ' 21' ' ' ASN . 53.4 mtpt 52.2 37.03 20.79 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.749 -175.014 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -134.17 41.28 1.48 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.55 -174.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.411 ' HD2' HD11 ' B' ' 47' ' ' ILE . 67.3 mttm 71.2 -67.05 0.27 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.04 0.536 . . . . 0.0 111.843 174.124 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' B' ' 45' ' ' TYR . . . -55.92 121.66 24.27 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 174.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' B' ' 40' ' ' SER . 43.2 mttm -61.5 135.41 57.66 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.194 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' B' ' 39' ' ' THR . 22.2 tp -158.94 110.93 2.17 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 121.175 0.512 . . . . 0.0 110.499 -176.358 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 55.2 m -116.32 114.08 23.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.772 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 9.2 mp -95.55 163.42 13.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.85 0.833 . . . . 0.0 111.701 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.418 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 1.4 p -157.81 147.38 19.98 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.104 171.133 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 66.0 mtp -130.02 117.06 19.46 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.512 0.673 . . . . 0.0 110.943 -177.535 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -98.83 61.57 1.3 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.316 -178.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.41 -88.61 0.13 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.471 -178.071 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' B' ' 84' ' ' ILE . 2.9 m-20 -94.0 16.48 14.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.786 0.327 . . . . 0.0 111.008 -177.397 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -132.12 151.24 51.89 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.261 0.553 . . . . 0.0 111.501 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tt -124.75 112.68 17.01 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.681 176.573 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.418 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 1.5 mtpm? -112.31 149.11 32.86 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -176.24 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -167.73 142.05 3.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.924 0.392 . . . . 0.0 111.759 -178.562 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 1.7 p -119.55 142.2 48.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.354 173.377 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 3.5 p -140.86 156.14 46.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.235 0.541 . . . . 0.0 112.39 -172.174 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 15.7 m -141.27 158.69 43.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.06 176.063 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -95.25 46.47 1.11 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.531 0.681 . . . . 0.0 110.768 -167.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.61 23.85 0.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.759 -1.11 . . . . 0.0 112.533 178.374 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.31 -41.01 1.53 Allowed Glycine 0 CA--C 1.51 -0.252 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.487 ' HA ' ' HA3' ' B' ' 25' ' ' GLY . 21.8 p90 51.26 -165.31 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.92 1.288 . . . . 0.0 114.138 173.757 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' B' ' 68' ' ' GLU . . . -75.95 110.43 3.04 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.867 -175.179 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.411 HD11 ' HD2' ' B' ' 24' ' ' LYS . 0.2 OUTLIER -120.65 -69.19 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-O 121.243 0.544 . . . . 0.0 111.233 177.315 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 66.9 m -119.78 -75.26 0.59 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.81 -170.363 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.454 ' O ' ' HE3' ' B' ' 52' ' ' LYS . 0.1 OUTLIER -68.17 -22.27 64.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.522 0.677 . . . . 0.0 109.875 -176.899 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.496 ' CD ' ' H ' ' B' ' 50' ' ' GLU . 22.1 mp0 -73.25 -62.6 1.42 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.996 174.171 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' B' ' 68' ' ' GLU . 6.9 t70 -44.92 108.23 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.242 -1.799 . . . . 0.0 112.497 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.704 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 98.7 mttt -150.12 161.15 42.93 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.047 176.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.407 ' HB3' ' OD1' ' B' ' 67' ' ' ASN . 3.5 p30 -109.45 119.64 40.05 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.452 0.644 . . . . 0.0 111.277 -178.677 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.561 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 6.4 p-90 -154.62 171.62 19.18 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.647 176.43 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.5 141.58 12.82 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.666 -178.061 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.679 HD12 ' CD2' ' B' ' 64' ' ' TYR . 17.7 mt -104.72 147.64 10.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 172.286 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.75 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 71.7 m-85 -127.05 143.62 51.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 -171.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.579 HG12 ' HB ' ' B' ' 63' ' ' VAL . 8.9 p -129.94 134.73 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.493 ' ND2' HG13 ' B' ' 58' ' ' VAL . 2.0 m-80 63.06 10.27 4.37 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.034 0.534 . . . . 0.0 109.885 -174.719 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.3 -1.7 64.79 Favored Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.099 -174.891 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -102.8 176.89 5.01 Favored 'General case' 0 C--O 1.207 -1.144 0 C-N-CA 123.558 0.743 . . . . 0.0 109.042 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 4.9 tppp? -66.69 161.24 23.86 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.395 0.543 . . . . 0.0 109.537 174.05 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.579 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.7 p -153.87 -13.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.196 0.522 . . . . 0.0 110.284 166.388 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.787 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -160.87 140.12 10.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.247 -171.128 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 96.1 m -157.33 121.23 4.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.563 ' CB ' HD13 ' B' ' 75' ' ' ILE . 15.6 p90 -174.9 161.27 2.98 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.938 0.875 . . . . 0.0 111.855 -168.705 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.704 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 2.2 m120 -109.09 138.2 45.81 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.184 -1.826 . . . . 0.0 108.215 166.756 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 68' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' B' ' 51' ' ' ASP . 20.2 mp0 -61.91 -12.81 19.8 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.627 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -69.12 -29.79 67.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.394 0.616 . . . . 0.0 109.863 172.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 39.1 t -70.58 -16.46 62.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.822 173.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 71' ' ' THR . . . . . . . . . . . . . 13.5 p 61.74 116.03 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.216 1.407 . . . . 0.0 112.095 178.23 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.565 ' HA ' HD12 ' B' ' 75' ' ' ILE . 3.0 m -59.85 -24.92 30.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.628 -169.308 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.93 -46.08 69.61 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.738 -178.555 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -72.66 -34.35 67.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.313 0.578 . . . . 0.0 110.436 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' B' ' 72' ' ' VAL . 1.7 mt -72.24 -45.85 59.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.968 -176.122 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 48.3 m -54.37 -33.08 58.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.53 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -53.13 -53.65 47.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.066 174.581 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' B' ' 81' ' ' LYS . 10.9 m-20 -69.57 -44.34 71.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.747 -179.407 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.787 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.2 mm -57.96 -32.19 42.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.348 0.594 . . . . 0.0 112.024 -178.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -65.15 -17.23 64.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.047 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' B' ' 78' ' ' ASP . 13.2 tppt? -91.63 -5.32 54.07 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.769 0.795 . . . . 0.0 109.917 -176.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.2 mm? -72.69 -12.59 61.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.354 -176.21 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 55.92 71.27 0.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.964 -168.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.457 ' O ' ' HB3' ' B' ' 34' ' ' ASN . 59.6 mt -64.52 157.8 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.437 -175.397 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -121.18 -175.51 3.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.183 175.718 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.02 113.44 0.75 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.661 175.272 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.82 -63.48 0.09 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.607 0.241 . . . . 0.0 111.02 -178.598 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 88' ' ' TYR . . . . . 0.452 ' HA ' ' SD ' ' B' ' 10' ' ' MET . 25.3 t80 -141.34 90.95 2.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.19 0.519 . . . . 0.0 109.892 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.75 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.1 mp -90.8 132.4 35.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.494 178.02 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -118.28 175.12 5.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.11 0.481 . . . . 0.0 110.496 177.67 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.561 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 82.1 mt -147.76 124.76 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.664 -176.703 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 41.5 pttt -177.57 160.46 1.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 0.0 111.209 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.541 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.9 OUTLIER -80.82 164.54 22.62 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.539 0.685 . . . . 0.0 110.958 177.45 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.522 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.4 pt . . . . . 0 C--N 1.309 -1.17 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.243 -173.307 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.752 0.311 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -94.86 148.26 22.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.831 -176.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -81.35 4.85 19.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -173.667 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -72.14 -61.49 1.77 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.384 0.611 . . . . 0.0 109.737 174.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.97 96.23 10.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.151 178.136 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.91 -21.68 66.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.712 -178.466 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -62.93 -49.16 75.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.552 175.241 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.99 -2.1 42.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.279 0.562 . . . . 0.0 110.796 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.611 ' HG2' ' H ' ' B' ' 11' ' ' ASN . 20.6 tt0 -92.47 -72.51 0.59 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.239 175.449 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 8.2 tmm? 61.53 6.73 1.58 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.744 0.783 . . . . 0.0 111.414 176.81 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 11' ' ' ASN . . . . . 0.611 ' H ' ' HG2' ' B' ' 9' ' ' GLN . 9.1 t30 -61.62 -43.4 98.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.815 -175.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 9.9 m -69.16 -15.45 63.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.216 0.532 . . . . 0.0 110.387 -172.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -75.19 -43.49 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.57 0.7 . . . . 0.0 110.448 178.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -71.66 -14.74 62.13 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.935 -175.094 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.63 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 78.4 p -48.29 -40.53 25.25 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 123.444 0.465 . . . . 0.0 110.875 -179.679 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 49.8 t -69.61 -40.24 79.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.399 0.619 . . . . 0.0 110.166 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.419 ' HA ' ' CD1' ' B' ' 20' ' ' LEU . 26.7 t-20 -64.83 -37.12 86.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.281 176.603 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.03 -29.27 69.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.275 174.781 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.63 ' HG2' ' O ' ' B' ' 15' ' ' SER . 24.6 mmmt -73.15 -11.6 60.59 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.183 0.516 . . . . 0.0 111.388 176.599 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.524 ' O ' ' HD3' ' B' ' 24' ' ' LYS . 39.7 mt -80.39 -18.59 48.49 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.663 0.744 . . . . 0.0 109.342 176.641 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 21' ' ' ASN . . . . . 0.475 ' OD1' ' HA ' ' B' ' 26' ' ' LYS . 62.9 t30 -92.39 58.19 3.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.985 -176.738 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -123.45 -91.85 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.492 178.561 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.16 34.64 5.24 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 177.223 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.604 ' HA ' ' C ' ' B' ' 45' ' ' TYR . 27.6 mtpt -133.07 -164.63 1.5 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.434 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.565 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -64.07 145.14 49.51 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.329 -0.939 . . . . 0.0 110.996 178.481 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.554 ' CE ' ' HB2' ' B' ' 41' ' ' SER . 13.9 ttpt -80.5 136.34 36.28 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -174.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.441 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 19.3 tp -154.03 107.67 2.96 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.869 -178.079 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -110.18 103.89 12.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.213 -176.483 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.804 HD22 ' H ' ' B' ' 29' ' ' LEU . 0.0 OUTLIER -82.02 156.92 24.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.827 0.822 . . . . 0.0 112.516 -177.702 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 53.9 m -129.8 144.11 51.14 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.355 -1.293 . . . . 0.0 107.517 164.34 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 31' ' ' MET . . . . . 0.536 ' SD ' ' HA ' ' B' ' 11' ' ' ASN . 40.7 mtt -111.24 127.53 55.64 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.675 -167.566 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 32' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 64.3 t30 -137.16 59.47 1.68 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.736 175.562 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 47.97 -93.68 0.01 OUTLIER Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.99 178.266 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.658 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 8.1 p30 -79.76 4.89 14.98 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 122.592 0.357 . . . . 0.0 111.299 -176.691 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 79.4 mt-30 -129.82 144.56 51.37 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.592 0.711 . . . . 0.0 111.017 172.584 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.453 ' CB ' ' HB ' ' B' ' 84' ' ' ILE . 0.9 OUTLIER -118.34 105.22 11.51 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.184 175.549 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 37' ' ' LYS . . . . . 0.461 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 0.0 OUTLIER -99.91 151.92 20.76 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -175.702 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.04 164.21 4.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.456 0.571 . . . . 0.0 112.498 -177.323 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 2.9 p -128.35 141.03 51.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.211 168.735 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -142.58 147.5 35.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.091 0.472 . . . . 0.0 111.615 -175.201 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.554 ' HB2' ' CE ' ' B' ' 26' ' ' LYS . 24.1 m -159.31 169.57 23.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.53 178.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 42' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' B' ' 44' ' ' GLY . 44.6 m-80 -91.73 49.18 1.53 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.102 -176.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.403 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . . . -68.96 22.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.025 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.491 ' O ' ' HD1' ' B' ' 45' ' ' TYR . . . 161.43 -63.37 0.28 Allowed Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.006 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.767 ' CD2' HG21 ' B' ' 71' ' ' THR . 0.0 OUTLIER 70.29 161.86 0.23 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.955 0.902 . . . . 0.0 111.852 -179.489 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.567 ' H ' ' CG2' ' B' ' 71' ' ' THR . . . -63.18 113.1 5.56 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 116.157 -0.474 . . . . 0.0 114.043 -166.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 11.4 mm -95.76 -67.61 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.273 0.558 . . . . 0.0 110.604 177.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 59.3 m -67.12 -52.67 38.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.073 -176.283 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -42.27 124.41 2.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.334 -178.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -74.91 -172.68 1.67 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.282 177.054 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.66 108.09 14.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.471 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 50.0 mttm -139.69 130.57 26.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.442 -178.214 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -108.79 135.6 49.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.999 0.428 . . . . 0.0 111.551 -177.702 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.617 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 37.5 p-90 -154.49 169.26 24.21 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.947 175.43 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.8 152.81 21.44 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.702 -172.44 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.532 HD12 ' CD2' ' B' ' 64' ' ' TYR . 30.0 mt -113.31 142.63 25.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 173.302 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.617 ' CE1' ' HG3' ' B' ' 62' ' ' LYS . 58.9 m-85 -127.68 140.73 51.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.408 -171.427 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' B' ' 61' ' ' GLU . 10.8 p -123.77 134.47 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 3.6 m120 63.46 4.57 1.79 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.254 0.622 . . . . 0.0 110.263 -176.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.56 -7.58 39.55 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.09 -174.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 33.1 mt-10 -98.54 175.87 5.86 Favored 'General case' 0 C--O 1.197 -1.708 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.043 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.617 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 14.4 ttmt -79.96 169.84 17.31 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 119.282 0.946 . . . . 0.0 109.929 176.323 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.2 -12.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.046 165.409 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.564 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.7 OUTLIER -159.67 123.93 3.84 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.791 -168.808 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.1 m -134.2 120.86 20.57 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.437 179.116 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.554 ' HB2' HD13 ' B' ' 75' ' ' ILE . 2.2 p90 -160.65 -178.63 7.0 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.563 1.173 . . . . 0.0 112.795 -174.529 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 67' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 16.3 t-20 -130.25 156.24 44.95 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.652 -176.597 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -70.41 -27.87 64.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.857 0.36 . . . . 0.0 110.985 -177.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.536 ' O ' HG23 ' B' ' 71' ' ' THR . 40.7 ttmt -86.6 -22.27 26.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.97 177.144 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 8.8 t -71.71 -20.29 61.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.397 173.737 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 71' ' ' THR . . . . . 0.767 HG21 ' CD2' ' B' ' 45' ' ' TYR . 35.6 p 58.46 113.69 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.4 1.08 . . . . 0.0 113.759 168.073 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.473 HG12 ' CE2' ' B' ' 66' ' ' PHE . 1.8 m -59.53 -15.99 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.21 -168.853 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.03 -50.66 64.06 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.506 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -75.69 -35.1 60.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.553 0.692 . . . . 0.0 110.461 179.463 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' B' ' 66' ' ' PHE . 1.5 mt -74.66 -51.08 23.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.184 -171.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 8.5 t -64.14 -26.8 68.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.256 -175.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -48.61 -48.93 38.91 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.925 0.869 . . . . 0.0 109.636 171.701 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.661 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 0.3 OUTLIER -71.63 -42.15 67.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.315 177.514 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.564 HG13 ' CE1' ' B' ' 64' ' ' TYR . 36.0 mm -57.92 -33.75 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.029 0.442 . . . . 0.0 111.898 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -60.04 -21.91 61.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.067 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 21.4 pttm -86.5 -7.79 58.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.839 0.352 . . . . 0.0 110.633 -178.425 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.4 mm? -71.11 -16.2 62.55 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.699 -176.184 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 t30 46.67 61.55 2.74 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 124.148 0.905 . . . . 0.0 109.624 -170.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.592 ' H ' HD12 ' B' ' 84' ' ' ILE . 3.6 mp -57.09 141.08 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.079 -176.373 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 51.5 mtpt -95.91 -175.01 3.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.846 178.203 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.415 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -139.47 114.54 1.01 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 178.553 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.14 -74.76 0.08 Allowed 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -121.21 84.7 2.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.767 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 25.7 mm -86.64 129.77 37.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.63 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.617 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 12.9 mm-40 -123.38 146.34 48.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.742 177.108 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.617 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 47.2 mt -135.01 120.5 30.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.394 177.114 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 26.8 pttt -172.76 171.21 4.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.969 0.414 . . . . 0.0 111.921 -174.174 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.423 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 15.7 mm-40 -84.62 151.52 24.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.842 179.415 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.599 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.8 pt . . . . . 0 C--N 1.313 -1.017 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.327 -174.615 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.851 0.358 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -140.49 82.78 1.87 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.183 0.516 . . . . 0.0 109.958 -178.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -80.43 -4.71 54.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.99 -176.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.504 ' NZ ' ' HB2' ' B' ' 4' ' ' LYS . 0.0 OUTLIER -69.3 -29.03 66.8 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.471 0.653 . . . . 0.0 109.408 173.52 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.429 ' HB1' ' HG3' ' B' ' 7' ' ' GLU . . . -82.32 113.95 20.46 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.19 177.515 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 82.9 mt -98.06 24.74 6.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.232 -176.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.429 ' HG3' ' HB1' ' B' ' 5' ' ' ALA . 31.1 mt-10 -53.07 -57.84 9.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.674 -176.405 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -95.26 -26.35 15.98 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.601 0.715 . . . . 0.0 110.425 176.032 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.442 ' HG2' HG12 ' B' ' 13' ' ' ILE . 49.5 tt0 -93.8 69.99 4.04 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.012 -178.524 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 46.1 tpp -59.97 143.58 51.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.19 -178.239 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 11' ' ' ASN . . . . . 0.45 ' C ' HD12 ' B' ' 13' ' ' ILE . 1.6 m-20 -41.16 -20.41 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.165 1.786 . . . . 0.0 114.239 -176.497 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -63.75 -5.2 3.83 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.992 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.479 ' HA ' ' HB2' ' B' ' 31' ' ' MET . 0.2 OUTLIER -49.03 -52.99 8.79 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-O 122.003 0.906 . . . . 0.0 110.007 179.361 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 14' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' B' ' 18' ' ' ASP . 35.0 m-80 -88.41 -32.53 18.28 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.616 -175.536 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 3.1 m -59.51 -43.62 93.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.769 0.319 . . . . 0.0 111.424 -177.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.88 -41.18 60.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.27 0.557 . . . . 0.0 109.765 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.576 ' O ' ' HB2' ' B' ' 21' ' ' ASN . 49.2 t30 -65.69 -45.88 81.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.972 -177.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 18' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' B' ' 14' ' ' ASN . 0.2 OUTLIER -67.85 -34.46 76.73 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.173 0.511 . . . . 0.0 110.729 -176.36 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -57.75 -59.91 4.5 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.192 178.373 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 49.1 mt -94.37 26.52 3.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.292 -177.577 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 21' ' ' ASN . . . . . 0.576 ' HB2' ' O ' ' B' ' 17' ' ' ASN . 27.5 t-20 -91.87 -37.86 12.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.264 0.554 . . . . 0.0 110.375 177.029 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -91.61 42.64 1.11 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.952 -178.033 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' B' ' 24' ' ' LYS . . . -85.82 -6.94 82.0 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.811 -177.673 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.478 ' HE3' ' CE1' ' B' ' 49' ' ' TYR . 86.7 mttt 72.53 -55.88 0.66 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.443 0.697 . . . . 0.0 110.801 -177.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' B' ' 45' ' ' TYR . . . -61.76 147.49 48.26 Favored Glycine 0 C--N 1.314 -0.678 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 167.234 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.531 ' CB ' ' HB3' ' B' ' 41' ' ' SER . 82.1 mttt -83.97 119.41 24.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.456 1.128 . . . . 0.0 111.105 -168.275 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 20.1 tp -158.06 118.79 3.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 28' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 57.8 m -114.55 112.27 22.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.31 -175.454 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 9.5 mp -98.09 165.65 11.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.659 0.742 . . . . 0.0 111.842 -178.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.3 p -160.47 141.44 11.97 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.808 171.485 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 31' ' ' MET . . . . . 0.703 ' SD ' HD23 ' B' ' 36' ' ' LEU . 82.0 mmm -108.47 136.38 48.19 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.65 0.262 . . . . 0.0 110.528 -175.136 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -137.08 61.33 1.63 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.153 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 55.43 -100.09 0.08 OUTLIER Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.194 177.723 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 34' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 20.9 m120 -75.81 -0.56 21.51 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.636 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -133.66 150.99 51.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.833 0.825 . . . . 0.0 112.253 175.205 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.703 HD23 ' SD ' ' B' ' 31' ' ' MET . 2.3 tm? -118.73 132.18 56.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.833 170.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -127.63 136.62 51.89 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.146 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.549 ' HB3' HD21 ' B' ' 80' ' ' ASN . . . -162.92 157.54 21.27 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.03 0.443 . . . . 0.0 111.761 -175.102 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.98 152.96 46.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.508 177.328 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 24.1 p -127.82 150.37 49.86 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.76 0.314 . . . . 0.0 110.702 -178.694 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.531 ' HB3' ' CB ' ' B' ' 26' ' ' LYS . 41.9 t -126.69 163.98 22.3 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.594 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -72.02 55.18 0.29 Allowed 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 125.243 1.589 . . . . 0.0 113.48 -154.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.456 ' HB3' ' H ' ' B' ' 26' ' ' LYS . . . -97.68 -18.32 18.93 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.911 169.247 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.12 -52.74 2.17 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.198 -0.91 . . . . 0.0 113.358 177.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.612 ' O ' ' HA3' ' B' ' 25' ' ' GLY . 5.4 m-85 -75.85 173.52 11.07 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.823 0.82 . . . . 0.0 112.638 -175.846 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.83 33.44 0.44 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 176.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.473 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -55.36 -45.09 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-N 114.178 -1.011 . . . . 0.0 111.803 -173.506 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.2 t 71.24 -91.33 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.168 -172.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.539 ' HB2' ' CE ' ' B' ' 52' ' ' LYS . 29.4 m-85 -140.78 126.93 19.61 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.457 0.473 . . . . 0.0 110.757 174.104 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 35.96 -109.97 0.06 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.287 1.035 . . . . 0.0 112.89 -174.509 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -132.85 132.63 42.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.19 0.519 . . . . 0.0 109.955 176.344 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.539 ' CE ' ' HB2' ' B' ' 49' ' ' TYR . 75.4 mttt -137.84 130.6 29.86 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.458 179.481 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -117.28 118.75 33.14 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.173 0.511 . . . . 0.0 109.782 175.271 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.645 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 37.5 p-90 -143.95 170.52 15.76 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.374 -177.118 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.37 150.89 20.63 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.292 -175.234 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 11.4 mt -102.81 142.7 16.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 173.159 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 57' ' ' PHE . . . . . 0.6 ' HB2' ' HB2' ' B' ' 90' ' ' GLU . 46.7 m-85 -124.81 134.17 52.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.978 -177.322 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.558 HG12 ' HB ' ' B' ' 63' ' ' VAL . 9.3 p -126.43 137.89 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -178.796 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.436 ' HA ' ' HG3' ' B' ' 87' ' ' MET . 5.3 m120 65.86 3.09 2.41 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -172.141 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.419 ' N ' ' HB3' ' B' ' 88' ' ' TYR . . . 103.36 -12.63 54.85 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.912 -174.819 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 1.4 mp0 -91.01 170.28 10.18 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 123.663 0.785 . . . . 0.0 108.885 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.561 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 17.4 ttmt -68.2 169.28 10.65 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 172.505 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.558 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.7 p -153.53 -13.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.297 170.722 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.5 ' CE2' HG23 ' B' ' 75' ' ' ILE . 0.3 OUTLIER -164.58 136.43 4.5 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.863 -176.347 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -128.43 127.19 42.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.515 173.35 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 66' ' ' PHE . . . . . 0.663 ' CE2' HG21 ' B' ' 75' ' ' ILE . 27.2 p90 -166.88 154.83 9.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.676 0.75 . . . . 0.0 111.074 -176.311 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -101.76 161.01 13.97 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.386 173.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 68' ' ' GLU . . . . . 0.499 ' CG ' ' HB2' ' B' ' 52' ' ' LYS . 4.7 mm-40 -73.37 -36.83 66.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.491 0.662 . . . . 0.0 109.952 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -59.72 -25.58 64.93 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.781 177.26 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.4 t -68.17 -10.4 53.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.343 -178.658 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 71' ' ' THR . . . . . . . . . . . . . 31.6 p 75.47 94.38 0.07 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 112.479 -2.146 . . . . 0.0 110.763 177.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.75 ' HA ' ' CG1' ' B' ' 75' ' ' ILE . 19.7 m -67.86 -8.56 9.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.328 -171.806 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.99 -37.14 94.47 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.236 176.517 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -82.14 -29.13 31.79 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.671 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 75' ' ' ILE . . . . . 0.75 ' CG1' ' HA ' ' B' ' 72' ' ' VAL . 30.2 mm -57.92 -60.56 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.959 174.429 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 76' ' ' SER . . . . . 0.429 ' HA ' HD12 ' B' ' 79' ' ' ILE . 18.9 t -61.77 -32.55 72.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.377 -177.462 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 77' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' B' ' 80' ' ' ASN . 64.8 t30 -51.96 -49.94 62.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.947 174.681 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 78' ' ' ASP . . . . . 0.68 ' O ' ' HG3' ' B' ' 81' ' ' LYS . 0.4 OUTLIER -73.47 -34.8 65.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.188 178.471 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.572 HG13 ' O ' ' B' ' 75' ' ' ILE . 57.0 mt -56.13 -34.79 39.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.253 0.549 . . . . 0.0 110.453 176.53 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 80' ' ' ASN . . . . . 0.549 HD21 ' HB3' ' B' ' 38' ' ' ALA . 10.1 m-80 -56.91 -28.08 61.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.156 177.426 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 81' ' ' LYS . . . . . 0.68 ' HG3' ' O ' ' B' ' 78' ' ' ASP . 1.1 pptp? -97.44 -5.59 35.81 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -171.212 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 31.0 mt -68.45 -21.69 64.63 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 122.0 -0.438 . . . . 0.0 110.392 -174.273 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 50.59 64.73 1.7 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.505 -166.438 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.549 HD12 ' HB2' ' B' ' 36' ' ' LEU . 70.2 mt -59.82 157.5 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.592 -172.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.465 ' O ' HG22 ' B' ' 84' ' ' ILE . 22.0 mmmt -100.82 -169.35 1.69 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.211 0.529 . . . . 0.0 110.14 175.825 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -151.53 113.27 0.57 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.192 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.436 ' HG3' ' HA ' ' B' ' 59' ' ' ASN . 18.0 ptp -174.42 -54.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 122.53 0.332 . . . . 0.0 110.248 177.636 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 88' ' ' TYR . . . . . 0.419 ' HB3' ' N ' ' B' ' 60' ' ' GLY . 6.8 t80 -134.03 79.56 1.82 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.655 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 34.1 mm -94.49 114.92 32.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.171 177.373 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.6 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 31.7 mm-40 -110.17 146.53 35.37 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.051 0.453 . . . . 0.0 111.432 179.232 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.645 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 5.2 mp -131.68 107.24 12.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.839 178.198 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 92' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 16.4 pttp -167.9 172.65 8.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.943 0.401 . . . . 0.0 111.433 -172.364 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.409 ' H ' ' HG3' ' B' ' 93' ' ' GLN . 0.4 OUTLIER -69.47 165.03 21.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.528 174.987 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 94' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' B' ' 54' ' ' TRP . 2.3 pt . . . . . 0 C--O 1.25 1.131 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.401 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 79.1 mmm . . . . . 0 N--CA 1.45 -0.456 0 CA-C-O 120.978 0.418 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -58.4 -23.59 57.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.745 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 13.3 m -65.7 -29.88 70.48 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.932 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 9.6 mm -62.74 -41.66 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 121.856 0.836 . . . . 0.0 109.436 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -70.72 -34.49 71.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.877 -174.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.573 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 17.6 m -67.73 -45.95 73.55 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.216 177.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.48 -44.59 96.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.968 0.413 . . . . 0.0 110.329 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.517 ' ND2' HD23 ' B' ' 29' ' ' LEU . 2.1 t-20 -52.29 -49.98 63.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.953 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -18.07 47.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.24 -174.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -78.55 -49.86 12.58 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 120.984 0.421 . . . . 0.0 111.859 176.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.563 HD22 HG11 ' B' ' 72' ' ' VAL . 67.5 mt -72.89 -43.41 62.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.295 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -85.56 74.4 10.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.641 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -131.38 -77.4 0.52 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.672 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.35 46.13 1.13 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.414 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -117.19 -140.74 0.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.687 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -85.7 170.78 44.43 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.848 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.529 ' HE2' ' HB2' ' B' ' 41' ' ' SER . 4.9 ttpt -61.84 127.09 29.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' B' ' 39' ' ' THR . 11.6 tp -158.04 115.46 2.96 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 120.957 0.408 . . . . 0.0 110.693 -169.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 69.3 m -107.74 114.14 27.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.054 177.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.517 HD23 ' ND2' ' B' ' 17' ' ' ASN . 3.1 mm? -86.4 154.94 20.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.542 0.687 . . . . 0.0 111.166 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.97 154.47 41.3 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.545 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 54.1 mtt -119.88 144.73 47.24 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.118 0.485 . . . . 0.0 111.898 -171.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -154.42 108.32 2.95 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.09 -111.66 4.18 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -168.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.539 ' HB2' ' HA2' ' B' ' 86' ' ' GLY . 13.8 m120 -123.48 19.58 9.63 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 168.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -72.55 154.71 40.67 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.401 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 20.3 tp -112.44 92.03 3.87 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.172 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -89.52 151.75 21.8 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.459 ' HB2' HD13 ' B' ' 29' ' ' LEU . . . -170.65 155.53 4.91 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -171.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 11.0 p -123.27 140.18 53.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.207 168.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 27.1 t -142.18 153.13 43.8 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.767 0.794 . . . . 0.0 112.753 -172.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.529 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . 10.2 m -133.0 168.39 18.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.754 176.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -112.07 36.46 3.33 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.478 0.656 . . . . 0.0 109.94 -170.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.7 22.28 0.1 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.86 -1.064 . . . . 0.0 113.376 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.46 -44.11 0.53 Allowed Glycine 0 C--O 1.229 -0.186 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.532 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.687 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 44.4 p90 46.98 -152.51 0.08 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.22 1.008 . . . . 0.0 113.469 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.474 ' H ' ' CG2' ' B' ' 71' ' ' THR . . . -81.75 99.74 2.02 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.444 -173.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.463 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -112.52 -54.53 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.509 0.671 . . . . 0.0 109.266 172.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -42.87 -55.7 3.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.154 -1.384 . . . . 0.0 111.939 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -79.21 121.12 24.65 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.96 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -65.76 -83.92 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.814 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -146.63 112.37 5.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.508 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 79.6 mttt -139.21 136.23 34.79 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -125.41 128.14 47.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.51 0.671 . . . . 0.0 111.934 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.553 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 30.5 p-90 -147.73 177.15 9.54 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.266 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.26 151.16 22.05 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.973 -174.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' B' ' 64' ' ' TYR . 19.0 mt -110.26 141.61 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 174.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 60.9 m-85 -125.36 139.45 53.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.795 -173.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.574 HG13 ' ND2' ' B' ' 59' ' ' ASN . 7.4 p -126.37 137.38 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.642 ' HA ' ' CG ' ' B' ' 87' ' ' MET . 2.9 m-80 63.11 6.24 2.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.33 0.652 . . . . 0.0 110.171 -175.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.3 -5.45 55.41 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.94 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' B' ' 58' ' ' VAL . 22.1 mt-10 -100.2 174.45 6.14 Favored 'General case' 0 C--O 1.193 -1.873 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.504 ' HE3' ' CE1' ' B' ' 57' ' ' PHE . 10.7 tttt -80.88 169.97 16.87 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.02 -3.22 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.717 165.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.781 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -158.16 130.83 7.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.437 -172.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 25.3 m -137.68 125.68 22.78 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.448 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.549 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.1 OUTLIER -160.91 154.2 21.68 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 122.709 1.242 . . . . 0.0 113.239 -175.219 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 19.1 t-20 -107.93 152.1 24.9 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.364 -2.198 . . . . 0.0 107.777 166.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -64.27 -24.29 67.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.572 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.573 ' O ' HG23 ' B' ' 71' ' ' THR . 4.4 ttmp? -82.8 -26.09 32.1 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.027 0.441 . . . . 0.0 110.948 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 6.6 t -69.93 -22.3 63.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.573 HG23 ' O ' ' B' ' 69' ' ' LYS . 11.9 p 60.28 115.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.326 1.05 . . . . 0.0 112.558 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.563 HG11 HD22 ' B' ' 20' ' ' LEU . 10.0 m -61.52 -11.74 5.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.82 -172.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.56 -52.6 51.52 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.192 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -72.01 -32.57 67.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.584 0.707 . . . . 0.0 110.213 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.549 HD13 ' HB3' ' B' ' 66' ' ' PHE . 2.9 mt -73.19 -48.35 43.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.606 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.8 t -50.87 -36.75 39.59 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.239 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -51.21 -55.81 16.11 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.838 0.828 . . . . 0.0 109.744 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.748 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 24.2 m-20 -69.68 -39.7 76.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.046 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.781 HG13 ' CE1' ' B' ' 64' ' ' TYR . 42.6 mm -57.88 -30.91 39.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.378 0.609 . . . . 0.0 111.881 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -73.53 2.4 7.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.618 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.748 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 45.3 pttt -109.49 8.06 25.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.259 0.552 . . . . 0.0 109.937 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' B' ' 79' ' ' ILE . 2.3 mm? -77.36 -6.82 54.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.606 -175.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 56.2 65.03 1.53 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -167.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 54.1 mt -67.75 149.56 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.092 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.614 ' HB2' HD21 ' B' ' 59' ' ' ASN . 63.2 mttm -129.68 -159.71 0.98 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.932 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.539 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -160.29 126.77 1.67 Allowed Glycine 0 C--N 1.318 -0.426 0 C-N-CA 120.005 -1.093 . . . . 0.0 114.434 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.642 ' CG ' ' HA ' ' B' ' 59' ' ' ASN . 21.1 ptp -176.72 -52.11 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 122.782 0.433 . . . . 0.0 111.166 168.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . 0.51 ' N ' ' HG3' ' B' ' 87' ' ' MET . 60.7 t80 -127.37 99.08 5.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.917 -0.49 . . . . 0.0 109.883 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 41.1 mm -96.53 137.18 25.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.233 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 6.5 mm-40 -128.88 153.93 47.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.035 0.445 . . . . 0.0 111.494 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.553 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 51.5 mt -131.9 114.29 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.323 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 62.6 pttt -166.7 162.24 16.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.06 0.457 . . . . 0.0 112.157 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.45 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -80.82 163.97 23.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.106 175.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.55 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.3 pt . . . . . 0 C--O 1.245 0.85 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.892 -172.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 121.4 0.619 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -56.35 -24.66 45.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.943 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.507 ' O ' HG23 ' B' ' 16' ' ' VAL . 5.4 m -63.52 -33.02 74.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.569 -178.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.448 HD11 HG13 ' B' ' 89' ' ' ILE . 12.6 mm -62.74 -43.28 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.624 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' B' ' 17' ' ' ASN . 1.3 m120 -71.93 -39.94 69.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.834 -175.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.603 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 23.8 m -61.33 -49.39 77.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.705 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.507 HG23 ' O ' ' B' ' 12' ' ' SER . 61.2 t -65.2 -38.93 83.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 110.436 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.433 HD22 ' HG ' ' B' ' 29' ' ' LEU . 1.9 t-20 -49.97 -45.96 51.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.905 175.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.2 OUTLIER -82.75 -41.54 19.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.384 -179.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.603 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -58.55 -52.66 64.7 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 123.419 0.688 . . . . 0.0 112.761 -175.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.426 HD21 ' HZ2' ' B' ' 54' ' ' TRP . 70.2 mt -73.54 -28.39 61.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.74 0.305 . . . . 0.0 110.945 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -89.46 61.32 5.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.45 0.643 . . . . 0.0 110.279 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 30.7 mtpp -129.36 -84.27 0.56 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.835 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.65 44.95 1.39 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.616 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -126.24 -159.05 0.89 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.584 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -67.96 159.04 51.41 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.466 ' HG2' ' HB2' ' B' ' 41' ' ' SER . 0.0 OUTLIER -82.07 111.01 17.82 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.708 -177.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' B' ' 39' ' ' THR . 2.3 pt? -131.57 148.74 52.64 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.604 -176.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 60.7 m -102.67 117.08 33.89 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.404 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' B' ' 38' ' ' ALA . 2.8 mm? -88.51 152.6 21.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.51 0.672 . . . . 0.0 110.787 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.1 p -150.07 151.02 32.55 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.237 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 50.7 mtt -120.13 146.21 46.19 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.858 0.361 . . . . 0.0 110.92 -175.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -154.05 116.65 4.4 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.96 -111.49 4.16 Favored Glycine 0 CA--C 1.507 -0.41 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -169.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.56 ' HB2' ' CA ' ' B' ' 86' ' ' GLY . 43.1 m-20 -130.45 37.75 3.82 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 168.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.426 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 48.1 mt-30 -92.17 161.25 14.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.241 175.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 27.4 tp -127.44 110.53 12.87 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 171.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.427 ' HA ' ' ND2' ' B' ' 80' ' ' ASN . 32.2 mtmt -113.36 148.06 36.49 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -177.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.485 ' HB2' HD13 ' B' ' 29' ' ' LEU . . . -156.89 158.16 36.18 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -172.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 4.6 p -133.35 134.68 44.07 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.929 171.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -131.1 147.82 52.66 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -167.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.466 ' HB2' ' HG2' ' B' ' 26' ' ' LYS . 2.4 m -99.75 141.7 32.21 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 167.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -103.92 32.06 4.15 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.339 -169.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.71 22.52 1.6 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.135 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.69 -36.52 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.798 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.584 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 6.8 p90 38.13 -142.02 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.475 1.11 . . . . 0.0 113.646 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.49 112.05 3.41 Favored Glycine 0 C--N 1.339 0.729 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.076 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.21 -57.41 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.005 0.431 . . . . 0.0 109.846 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.4 m -43.2 -54.81 4.29 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.346 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -97.32 120.38 37.59 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.067 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -94.98 -84.17 0.34 Allowed 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.641 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -103.96 108.35 19.66 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.749 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.52 ' HB2' ' CG ' ' B' ' 68' ' ' GLU . 93.2 mttt -150.15 134.29 17.09 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 169.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.96 126.51 51.05 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.127 0.489 . . . . 0.0 110.805 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.566 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 25.1 p-90 -145.02 159.34 43.09 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.721 176.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -122.09 147.82 17.09 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.166 -175.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.548 HD12 ' CD2' ' B' ' 64' ' ' TYR . 16.4 mt -105.11 148.76 9.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 169.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.69 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 88.9 m-85 -128.35 141.28 51.47 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -169.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.565 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.9 p -128.12 136.57 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.501 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.3 m-80 62.43 12.82 5.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.276 -171.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.94 78.92 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.075 -174.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 17.2 mt-10 -98.25 175.31 6.12 Favored 'General case' 0 C--O 1.202 -1.429 0 C-N-CA 123.517 0.727 . . . . 0.0 109.357 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.0 tppp? -63.4 160.56 15.9 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 118.681 0.673 . . . . 0.0 109.956 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.565 ' HB ' HG12 ' B' ' 58' ' ' VAL . 7.2 p -151.47 -16.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.965 0.412 . . . . 0.0 110.168 167.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.691 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.9 OUTLIER -161.5 125.74 3.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.148 -171.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 22.7 m -131.36 129.44 41.39 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.642 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.511 ' CB ' HD13 ' B' ' 75' ' ' ILE . 7.7 p90 -167.83 153.66 7.34 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 122.186 0.993 . . . . 0.0 112.567 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.496 ' O ' ' HB3' ' B' ' 70' ' ' SER . 16.6 t-20 -99.81 153.14 19.37 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.151 -1.84 . . . . 0.0 108.962 171.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . 0.52 ' CG ' ' HB2' ' B' ' 52' ' ' LYS . 6.7 mm-40 -62.03 -45.67 92.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.969 0.349 . . . . 0.0 111.423 -176.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.522 ' O ' HG23 ' B' ' 71' ' ' THR . 86.4 tttt -64.71 -22.22 66.93 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.454 0.702 . . . . 0.0 111.547 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 6.2 t -69.44 -16.74 63.55 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.522 HG23 ' O ' ' B' ' 69' ' ' LYS . 30.2 p 59.18 107.78 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.888 1.275 . . . . 0.0 112.915 172.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.547 ' HA ' HD12 ' B' ' 75' ' ' ILE . 2.3 m -58.34 -17.85 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 114.266 -1.333 . . . . 0.0 112.635 -171.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.37 -48.97 80.75 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.682 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -74.5 -34.21 63.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.465 0.65 . . . . 0.0 110.191 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' B' ' 72' ' ' VAL . 1.9 mt -74.68 -48.45 34.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.085 -173.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 77.7 p -50.62 -48.75 57.89 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.583 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -41.62 -52.57 3.76 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.751 -1.568 . . . . 0.0 111.216 173.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.705 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 22.7 m-20 -74.28 -28.83 61.38 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.429 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.691 HG13 ' CE1' ' B' ' 64' ' ' TYR . 48.8 mm -71.88 -38.12 63.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.142 0.496 . . . . 0.0 111.199 177.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.427 ' ND2' ' HA ' ' B' ' 37' ' ' LYS . 11.3 m120 -62.88 -28.37 70.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.373 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.705 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 61.1 pttt -81.59 3.41 25.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.446 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' B' ' 79' ' ' ILE . 36.8 mt -84.77 3.89 35.45 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.726 0.298 . . . . 0.0 110.862 -177.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 58.9 t30 54.15 58.03 5.38 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -170.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.443 HD11 HG22 ' B' ' 79' ' ' ILE . 61.7 mt -52.31 149.88 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.726 -173.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -109.22 175.14 5.56 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.573 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.56 ' CA ' ' HB2' ' B' ' 34' ' ' ASN . . . -141.97 112.94 0.78 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.472 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.536 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 0.2 OUTLIER -146.1 -81.21 0.15 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 117.021 0.41 . . . . 0.0 110.595 175.536 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . 0.536 ' N ' ' HG3' ' B' ' 87' ' ' MET . 46.8 t80 -120.16 106.24 11.75 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.69 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 22.0 mm -101.11 130.55 50.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.092 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -122.89 178.58 4.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.188 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.566 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 95.8 mt -149.98 127.76 2.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.29 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -174.36 154.2 2.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.98 0.419 . . . . 0.0 111.615 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.597 ' NE2' ' H ' ' B' ' 93' ' ' GLN . 0.7 OUTLIER -82.68 146.43 29.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.087 177.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.49 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.2 pt . . . . . 0 C--O 1.249 1.064 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.95 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . 0.684 ' HG2' ' H ' ' B' ' 89' ' ' ILE . 15.1 tpt . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -54.04 -28.63 39.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.22 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.585 ' H ' ' HG3' ' B' ' 10' ' ' MET . 6.2 m -75.2 -16.63 60.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.397 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.523 HG22 ' SD ' ' B' ' 31' ' ' MET . 6.3 mm -57.45 -44.06 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 122.313 1.054 . . . . 0.0 109.03 175.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -70.32 -30.67 67.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.536 -1.666 . . . . 0.0 109.792 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.477 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 10.7 t -70.96 -38.04 72.81 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.903 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.545 HG23 ' O ' ' B' ' 12' ' ' SER . 93.3 t -51.01 -50.55 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.397 0.618 . . . . 0.0 109.816 174.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -59.02 -49.46 77.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.871 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -30.86 68.32 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -174.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' B' ' 15' ' ' SER . 10.0 mmmm -76.85 -23.65 52.7 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.464 0.649 . . . . 0.0 111.381 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.41 HD22 HG11 ' B' ' 72' ' ' VAL . 92.0 mt -97.36 -42.11 7.92 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.181 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -84.95 73.46 10.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.395 0.616 . . . . 0.0 110.184 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -116.72 -74.38 0.61 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.504 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.49 40.65 0.82 Allowed Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.741 ' HG2' ' CE1' ' B' ' 49' ' ' TYR . 44.4 mttt -110.7 -145.48 0.4 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -70.09 154.2 52.51 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' B' ' 40' ' ' SER . 0.3 OUTLIER -61.91 121.67 13.52 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.476 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 28.8 tp -148.23 97.46 2.78 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.481 0.658 . . . . 0.0 109.256 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 43.0 m -99.12 116.24 30.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.788 -175.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.476 ' CD1' ' HG ' ' B' ' 27' ' ' LEU . 10.2 mp -101.67 167.27 10.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.555 0.693 . . . . 0.0 111.838 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.5 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 1.3 p -149.38 146.26 27.4 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.802 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . 0.523 ' SD ' HG22 ' B' ' 13' ' ' ILE . 5.7 mmt -105.8 118.26 36.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.562 -169.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 4.0 t30 -133.5 60.76 1.69 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.882 0.373 . . . . 0.0 110.009 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.88 -104.11 0.12 Allowed Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.606 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.491 ' HA ' ' N ' ' B' ' 86' ' ' GLY . 17.9 m120 -85.02 23.19 1.26 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.687 -0.257 . . . . 0.0 111.07 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 35.3 mt-30 -138.73 150.84 46.58 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.437 0.636 . . . . 0.0 110.595 172.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -123.94 114.65 20.09 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.162 172.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.5 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 6.7 mmmm -110.73 137.78 47.96 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -176.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -162.28 154.2 18.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.28 0.562 . . . . 0.0 112.329 -172.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.33 146.15 51.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.389 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 33.6 p -135.67 154.98 51.11 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.004 0.431 . . . . 0.0 112.031 -175.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 28.1 t -152.95 159.37 42.94 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.152 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' B' ' 44' ' ' GLY . 51.3 m-80 -85.76 52.82 2.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.114 -174.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.21 23.22 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.856 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' B' ' 42' ' ' ASN . . . 117.39 -13.19 13.74 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.784 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.49 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 35.7 p90 45.2 -156.98 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.403 1.081 . . . . 0.0 113.136 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.424 ' H ' HG22 ' B' ' 71' ' ' THR . . . -72.63 89.97 0.55 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.91 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.55 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -91.68 -70.85 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.541 0.686 . . . . 0.0 110.509 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 m -50.34 -55.88 13.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.987 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.741 ' CE1' ' HG2' ' B' ' 24' ' ' LYS . 4.3 m-85 -61.48 109.69 1.24 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.605 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.29 -64.44 0.95 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.543 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -173.05 113.09 0.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.734 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 54.1 mtmt -138.31 145.34 41.09 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.513 ' HB3' ' OD1' ' B' ' 67' ' ' ASN . 0.5 OUTLIER -121.82 121.96 38.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.226 0.536 . . . . 0.0 111.623 -178.194 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.584 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 33.4 p-90 -140.23 173.74 11.21 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.229 174.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.98 151.79 21.12 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.907 -1.14 . . . . 0.0 113.372 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.523 HD12 ' CD2' ' B' ' 64' ' ' TYR . 18.2 mt -110.12 145.92 16.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 174.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.76 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 72.8 m-85 -128.88 143.66 50.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.282 -171.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.536 HG13 ' ND2' ' B' ' 59' ' ' ASN . 9.6 p -128.47 137.34 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.536 ' ND2' HG13 ' B' ' 58' ' ' VAL . 1.4 m-80 60.27 9.02 1.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.277 0.631 . . . . 0.0 110.494 -176.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.77 7.87 57.45 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.232 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 12.1 mt-10 -114.62 177.02 4.8 Favored 'General case' 0 C--O 1.199 -1.592 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.571 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 18.6 ttmt -78.89 169.21 18.58 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 119.303 0.956 . . . . 0.0 109.924 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.53 -14.96 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.798 164.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.679 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.5 OUTLIER -158.4 130.07 6.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.601 -167.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.2 m -137.96 133.3 33.54 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.218 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.458 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.0 OUTLIER -159.35 160.97 35.63 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.953 0.882 . . . . 0.0 111.21 -174.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.513 ' OD1' ' HB3' ' B' ' 53' ' ' ASN . 2.9 m120 -115.96 146.78 41.81 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.624 -1.626 . . . . 0.0 109.787 170.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . 0.465 ' CD ' ' HZ3' ' B' ' 24' ' ' LYS . 13.4 mm-40 -56.35 -44.27 79.92 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.614 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.538 ' O ' HG23 ' B' ' 71' ' ' THR . 35.0 ttpt -64.01 -30.09 71.19 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.611 0.72 . . . . 0.0 110.621 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 23.7 m -81.27 -3.35 52.18 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.091 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.538 HG23 ' O ' ' B' ' 69' ' ' LYS . 23.6 p 55.21 102.01 0.01 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.304 1.442 . . . . 0.0 113.474 165.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.41 HG11 HD22 ' B' ' 20' ' ' LEU . 4.2 m -62.94 -18.88 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.425 -173.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.42 -49.58 75.09 Favored Glycine 0 C--O 1.236 0.241 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.974 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -69.62 -37.52 76.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.023 0.439 . . . . 0.0 110.268 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.569 ' O ' HG12 ' B' ' 79' ' ' ILE . 2.7 mt -68.21 -46.61 80.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.609 -176.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 45.6 m -57.02 -35.5 69.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.933 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -54.74 -49.17 71.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.169 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 7.3 m-20 -70.51 -37.49 74.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.558 -1.201 . . . . 0.0 112.122 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.679 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 43.7 mm -59.02 -24.4 26.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.482 0.658 . . . . 0.0 111.443 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -59.95 -18.66 47.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.508 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 6.0 ptpp? -87.11 1.32 53.36 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.172 0.51 . . . . 0.0 110.851 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.577 HD23 ' HA ' ' B' ' 79' ' ' ILE . 2.4 mm? -81.38 -1.66 46.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.156 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 49.54 62.35 2.68 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.798 -168.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.584 HD11 HG22 ' B' ' 79' ' ' ILE . 49.0 mt -58.71 140.77 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.71 -177.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -127.37 -176.76 3.84 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.796 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.491 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -136.89 115.53 1.27 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.872 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 32.7 ttm -157.79 -74.99 0.09 Allowed 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -130.77 82.51 2.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.415 0.626 . . . . 0.0 109.503 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.76 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.2 mp -87.67 136.68 22.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.518 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -122.08 171.78 8.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.888 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.509 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 32.9 mm -144.93 110.1 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.33 -174.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.584 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 16.6 pttp -161.04 173.18 15.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.291 0.567 . . . . 0.0 112.042 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.563 ' NE2' ' H ' ' B' ' 93' ' ' GLN . 0.0 OUTLIER -105.49 145.79 30.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.882 -175.03 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.7 pt . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.95 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -60.28 -33.36 72.23 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.967 0.413 . . . . 0.0 111.805 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.431 ' O ' HG23 ' B' ' 16' ' ' VAL . 23.2 t -67.84 -8.45 36.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.031 -169.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 10.2 mm -55.41 -55.11 18.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.935 0.874 . . . . 0.0 110.12 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -77.56 -27.7 51.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.355 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 10.1 m -57.6 -47.05 83.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.116 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.431 HG23 ' O ' ' B' ' 12' ' ' SER . 76.1 t -66.46 -43.91 90.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.085 0.469 . . . . 0.0 109.978 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.588 HD22 HD12 ' B' ' 29' ' ' LEU . 3.8 t-20 -54.08 -50.77 66.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.986 178.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.38 -43.21 64.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.648 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -57.24 -50.89 71.45 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 123.204 0.602 . . . . 0.0 111.593 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -70.69 -45.24 65.38 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.827 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -85.97 59.78 5.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.389 0.614 . . . . 0.0 111.369 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -105.23 -17.34 14.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.328 0.585 . . . . 0.0 109.914 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.83 -95.16 0.1 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.521 ' HE3' ' OE2' ' B' ' 68' ' ' GLU . 51.3 mttp 41.65 -135.1 0.29 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.688 0.795 . . . . 0.0 111.197 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.608 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -84.42 168.15 43.85 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.785 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.425 ' HE3' ' CB ' ' B' ' 41' ' ' SER . 14.7 ttpt -86.27 109.84 19.23 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -145.52 168.31 20.91 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.161 -176.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.6 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 43.9 m -125.66 107.11 10.25 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.759 -176.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.588 HD12 HD22 ' B' ' 17' ' ' ASN . 33.1 mt -86.87 144.91 26.78 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.569 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 9.0 p -134.78 156.69 48.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.964 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 55.0 mtm -110.04 127.99 55.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.991 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -148.89 108.33 3.96 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.04 -114.62 6.92 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.581 ' HB2' ' HA2' ' B' ' 86' ' ' GLY . 1.7 m-20 -123.9 20.03 9.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' B' ' 84' ' ' ILE . 25.0 mt-30 -74.69 158.78 32.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.528 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tt -115.93 104.01 11.18 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.391 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.569 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 4.7 mtmp? -115.59 142.63 46.47 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -158.91 156.61 29.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -175.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -130.56 134.65 47.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 170.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 44.6 t -126.33 160.07 31.41 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -164.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.425 ' CB ' ' HE3' ' B' ' 26' ' ' LYS . 35.2 t -134.4 159.97 39.41 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.007 174.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -109.25 29.63 7.35 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.276 0.56 . . . . 0.0 110.727 -171.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.03 22.4 0.09 Allowed 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.961 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.75 -38.3 0.57 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.409 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.608 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 14.4 p90 45.56 -159.48 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.471 1.108 . . . . 0.0 113.758 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.17 114.83 6.03 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.974 -0.632 . . . . 0.0 113.118 -175.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.11 -60.81 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.837 0.351 . . . . 0.0 110.815 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 m -40.66 -57.23 1.93 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.077 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.81 106.15 10.61 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.784 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -60.0 -49.22 78.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.651 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -165.32 110.77 0.91 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.985 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 71.8 mmtt -133.51 131.93 40.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -112.73 125.77 54.68 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.522 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 16.7 p-90 -152.7 166.74 31.2 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.886 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.33 142.6 13.88 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.846 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.589 HD12 ' CD2' ' B' ' 64' ' ' TYR . 23.7 mt -106.59 151.37 8.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.669 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 76.0 m-85 -132.59 140.29 48.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.277 -170.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.544 HG12 ' HB ' ' B' ' 63' ' ' VAL . 11.9 p -124.85 131.42 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.407 ' ND2' HG13 ' B' ' 58' ' ' VAL . 2.8 m-80 64.25 11.49 6.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.51 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.96 -3.74 62.55 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.348 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -103.01 177.15 4.92 Favored 'General case' 0 C--O 1.207 -1.152 0 C-N-CA 123.303 0.641 . . . . 0.0 109.642 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.438 ' HD2' ' OG1' ' B' ' 65' ' ' THR . 5.2 tppp? -63.87 158.76 21.22 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.014 175.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.544 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.8 p -153.23 -11.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.122 0.487 . . . . 0.0 110.245 165.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.819 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -161.21 136.25 7.52 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.061 0.458 . . . . 0.0 110.53 -174.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.438 ' OG1' ' HD2' ' B' ' 62' ' ' LYS . 84.8 m -149.25 118.47 6.81 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' B' ' 66' ' ' PHE . 0.0 OUTLIER -167.74 159.76 12.04 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.717 0.77 . . . . 0.0 111.462 -164.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 18.1 t-20 -114.04 158.8 20.74 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.915 -1.493 . . . . 0.0 109.591 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . 0.521 ' OE2' ' HE3' ' B' ' 24' ' ' LYS . 8.5 mm-40 -74.06 -34.14 63.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.004 0.43 . . . . 0.0 110.898 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.548 ' O ' HG23 ' B' ' 71' ' ' THR . 53.0 tttm -68.94 -31.69 70.76 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.049 0.928 . . . . 0.0 109.319 176.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 30.4 m -79.62 0.3 30.74 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.843 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.548 HG23 ' O ' ' B' ' 69' ' ' LYS . 20.1 p 53.64 100.58 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.436 1.494 . . . . 0.0 113.678 165.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 m -56.68 -21.77 14.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.069 -176.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.67 -54.64 35.73 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.544 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -69.4 -31.93 70.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.202 0.525 . . . . 0.0 110.172 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.513 HG13 ' O ' ' B' ' 71' ' ' THR . 2.9 mt -70.11 -42.61 79.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.239 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -58.02 -30.25 65.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.752 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -52.6 -53.32 48.31 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.767 0.794 . . . . 0.0 109.633 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.684 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 4.9 m-20 -65.1 -40.67 94.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.461 177.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.819 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 44.5 mm -54.31 -32.33 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.314 0.578 . . . . 0.0 111.817 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.461 ' OD1' ' HA ' ' B' ' 37' ' ' LYS . 90.5 m-20 -58.43 -31.22 67.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.816 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 4.6 ptpp? -83.43 -4.48 58.54 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.163 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.8 mm? -70.32 -15.83 62.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.717 0.294 . . . . 0.0 110.667 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 44.01 61.66 2.25 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.813 -171.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.442 HG22 ' O ' ' B' ' 85' ' ' LYS . 73.0 mt -60.04 146.37 10.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.362 -1.29 . . . . 0.0 112.6 -172.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.442 ' O ' HG22 ' B' ' 84' ' ' ILE . 30.0 mmmt -92.11 -166.07 1.48 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.132 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.581 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -148.55 114.16 0.66 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.808 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.464 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 6.2 tpt -152.42 -68.89 0.16 Allowed 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 122.531 0.333 . . . . 0.0 110.124 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . 0.464 ' N ' ' HG3' ' B' ' 87' ' ' MET . 5.1 t80 -143.41 106.57 4.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.072 0.463 . . . . 0.0 109.835 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.669 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 37.0 mm -91.85 130.28 41.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.04 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -121.65 169.47 10.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.793 0.33 . . . . 0.0 110.154 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.436 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 70.5 mt -146.72 130.28 9.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.24 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 39.9 pttt -165.03 159.57 18.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.124 0.488 . . . . 0.0 111.42 174.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.502 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -106.69 138.78 42.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.863 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.2 pt . . . . . 0 C--O 1.246 0.88 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.042 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . 0.426 ' O ' HG12 ' B' ' 13' ' ' ILE . 90.3 mmm . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 121.672 0.748 . . . . 0.0 112.108 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -51.11 -27.52 8.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.865 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 5.1 m -66.6 -31.07 71.53 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.288 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.426 HG12 ' O ' ' B' ' 10' ' ' MET . 11.4 mm -63.77 -31.0 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.647 0.737 . . . . 0.0 109.888 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -92.09 -44.36 8.87 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.812 -172.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 14.5 p -70.89 -45.24 64.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.095 -178.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 91.4 t -68.51 -30.14 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.585 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -53.79 -47.17 71.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.258 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.1 OUTLIER -78.95 -42.63 26.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.619 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -58.65 -43.05 89.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.401 -176.101 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.656 HD22 HG11 ' B' ' 72' ' ' VAL . 19.7 mt -80.24 -24.24 40.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -105.62 70.93 0.89 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.818 0.342 . . . . 0.0 111.249 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 33.6 mtmt -138.31 -91.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.817 175.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.434 ' O ' ' HA2' ' B' ' 46' ' ' GLY . . . -92.93 32.42 5.64 Favored Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.567 ' N ' ' HD2' ' B' ' 24' ' ' LYS . 0.0 OUTLIER -124.27 -163.08 1.12 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 174.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.648 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -67.96 144.97 44.16 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.184 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.546 ' HE2' ' HB3' ' B' ' 43' ' ' ALA . 44.7 mttm -62.2 144.5 55.41 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.424 ' CD2' ' HB3' ' B' ' 40' ' ' SER . 4.0 mt -150.07 118.45 6.45 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.118 0.485 . . . . 0.0 110.91 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 14.4 m -99.06 97.97 9.04 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.338 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.496 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 10.4 mp -86.14 163.0 18.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.797 0.808 . . . . 0.0 112.094 -172.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.1 p -146.69 148.82 32.41 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.111 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 58.0 mtt -96.49 139.7 32.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.106 0.479 . . . . 0.0 111.68 -173.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . 0.524 ' O ' ' HB3' ' B' ' 35' ' ' GLN . 8.6 t30 -157.15 91.92 1.22 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.833 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.98 -97.55 0.51 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -172.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -142.1 21.61 2.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.563 ' CG ' ' HG2' ' B' ' 37' ' ' LYS . 0.0 OUTLIER -85.71 158.27 20.09 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.893 -176.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tt -111.85 98.06 7.12 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.887 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.563 ' HG2' ' CG ' ' B' ' 35' ' ' GLN . 11.1 mtmt -112.1 137.17 50.53 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' B' ' 29' ' ' LEU . . . -173.4 169.96 4.3 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -170.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 5.8 p -128.17 140.34 51.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.591 170.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 74.1 p -123.66 165.41 17.26 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -169.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' B' ' 26' ' ' LYS . 32.3 t -131.62 157.98 42.26 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.481 176.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -117.04 18.31 14.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.331 -172.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.546 ' HB3' ' HE2' ' B' ' 26' ' ' LYS . . . -63.64 -21.86 66.59 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.585 ' O ' HD11 ' B' ' 47' ' ' ILE . . . -143.14 -48.6 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.099 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.648 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 3.4 p90 52.93 -164.55 0.08 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.966 1.306 . . . . 0.0 113.852 -176.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.514 ' N ' ' HD1' ' B' ' 45' ' ' TYR . . . -57.87 100.12 0.13 Allowed Glycine 0 C--N 1.342 0.88 0 N-CA-C 114.601 0.6 . . . . 0.0 114.601 -174.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.585 HD11 ' O ' ' B' ' 44' ' ' GLY . 3.8 mm -108.53 -67.81 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-O 121.59 0.71 . . . . 0.0 110.777 173.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -51.16 -62.62 1.51 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.579 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -83.48 127.01 33.37 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.772 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.69 -171.97 1.73 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.18 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -65.53 107.07 1.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.368 0.604 . . . . 0.0 109.706 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 6.4 mtmp? -145.4 128.83 16.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.621 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -102.73 124.85 49.02 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.532 0.682 . . . . 0.0 112.357 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.61 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 51.4 p-90 -141.15 163.7 32.26 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.368 169.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.82 156.8 23.02 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 119.772 -1.204 . . . . 0.0 113.317 -172.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.45 HD12 ' CD2' ' B' ' 64' ' ' TYR . 22.1 mt -111.82 137.74 43.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 174.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.726 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 46.0 m-85 -124.77 132.12 53.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.014 -174.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.531 HG13 ' ND2' ' B' ' 59' ' ' ASN . 13.4 p -112.48 136.27 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.916 177.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.531 ' ND2' HG13 ' B' ' 58' ' ' VAL . 9.9 m-80 71.04 -7.93 1.05 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.538 0.735 . . . . 0.0 110.905 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.25 5.9 39.76 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -169.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' B' ' 58' ' ' VAL . 25.9 mt-10 -106.55 165.76 11.05 Favored 'General case' 0 C--O 1.198 -1.642 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 174.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.475 ' HA ' ' CD1' ' B' ' 57' ' ' PHE . 27.8 ttmt -78.5 168.93 19.05 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.82 -10.08 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.326 165.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.649 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.5 OUTLIER -158.1 125.79 5.2 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.413 -170.169 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -134.42 132.2 39.07 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.178 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.439 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.0 OUTLIER -163.76 165.97 22.53 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 122.161 0.981 . . . . 0.0 111.162 -175.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.627 ' HB2' ' OG ' ' B' ' 70' ' ' SER . 12.0 m120 -116.72 144.63 44.21 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.493 169.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -64.67 -15.8 61.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.824 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -92.82 -25.28 18.2 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.252 0.549 . . . . 0.0 109.846 177.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.627 ' OG ' ' HB2' ' B' ' 67' ' ' ASN . 38.2 m -76.98 -5.57 49.17 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.458 -175.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.495 HG22 ' H ' ' B' ' 46' ' ' GLY . 3.3 p 66.27 99.84 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.741 169.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.656 HG11 HD22 ' B' ' 20' ' ' LEU . 7.8 m -65.67 -13.11 14.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.45 -176.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.55 -51.95 51.28 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.1 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -67.94 -42.68 80.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.312 0.577 . . . . 0.0 110.263 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.499 ' O ' HG12 ' B' ' 79' ' ' ILE . 2.6 mt -64.97 -42.03 93.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.54 -174.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 55.7 m -59.13 -30.29 68.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.229 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' B' ' 80' ' ' ASN . 46.9 t-20 -52.39 -54.6 29.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.607 0.718 . . . . 0.0 109.388 174.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.66 -39.49 94.46 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.634 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.649 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 48.4 mm -58.67 -33.54 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 123.021 0.528 . . . . 0.0 112.085 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' B' ' 77' ' ' ASN . 5.7 m-80 -54.81 -35.89 64.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.558 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -78.46 -14.07 59.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.782 0.325 . . . . 0.0 111.111 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.7 mm? -65.56 -22.58 66.71 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.558 -173.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 55.9 t30 46.01 57.58 5.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.938 -172.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.546 ' HB ' ' HA ' ' B' ' 35' ' ' GLN . 88.6 mt -59.38 141.98 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.203 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -87.44 -164.13 1.04 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.273 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -150.35 115.26 0.7 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.027 -1.082 . . . . 0.0 113.322 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 28.4 ttp -154.06 -75.2 0.12 Allowed 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.565 0.183 . . . . 0.0 110.591 172.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . 0.53 ' H ' ' HA ' ' B' ' 59' ' ' ASN . 44.7 t80 -121.49 93.45 4.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.192 0.52 . . . . 0.0 109.925 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.726 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.0 mp -95.32 128.95 46.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.795 -177.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 43.3 mt-10 -114.15 144.36 43.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.29 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.61 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 50.0 mm -126.23 112.4 29.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.99 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -166.49 158.39 13.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.477 0.656 . . . . 0.0 112.424 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.607 ' H ' ' CD ' ' B' ' 93' ' ' GLN . 4.5 pm0 -79.27 145.99 33.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.78 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.9 pt . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.254 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . 0.412 ' O ' HG13 ' B' ' 13' ' ' ILE . 98.5 mmm . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -37.96 -24.93 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.887 1.675 . . . . 0.0 114.848 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.52 ' O ' HG23 ' B' ' 16' ' ' VAL . 8.8 m -61.87 -9.14 6.05 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.475 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.1 OUTLIER -51.27 -58.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 CA-C-O 122.008 0.909 . . . . 0.0 110.112 -177.312 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -79.39 -27.74 41.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.204 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.62 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 15.1 m -61.11 -39.14 88.86 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.52 HG23 ' O ' ' B' ' 12' ' ' SER . 99.0 t -69.06 -45.4 80.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.27 0.557 . . . . 0.0 109.866 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -52.43 -49.02 65.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.699 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.3 -31.86 60.8 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.78 -176.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.3 OUTLIER -61.82 -44.97 95.79 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 122.812 0.445 . . . . 0.0 111.406 177.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.423 HD21 ' HZ2' ' B' ' 54' ' ' TRP . 72.5 mt -81.53 -39.27 24.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.659 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -81.48 70.82 8.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.037 0.446 . . . . 0.0 111.33 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -144.33 -72.26 0.27 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.264 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.414 ' O ' ' HA2' ' B' ' 46' ' ' GLY . . . -119.01 44.75 1.35 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.072 -176.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -111.92 -158.05 0.64 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.685 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -83.27 -166.66 40.17 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.347 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.83 ' O ' ' HA ' ' B' ' 40' ' ' SER . 44.7 mtmt -67.84 98.57 0.74 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' B' ' 39' ' ' THR . 21.0 tp -124.88 115.7 21.05 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.23 -163.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 51.4 m -105.61 105.86 16.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.387 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.422 ' N ' HD22 ' B' ' 29' ' ' LEU . 2.5 mm? -83.31 149.57 26.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.313 0.578 . . . . 0.0 110.376 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p -146.27 147.47 31.44 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.36 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 62.0 mtt -116.42 145.34 43.33 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.103 0.478 . . . . 0.0 111.796 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -160.3 105.78 1.51 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.66 -122.81 18.09 Favored Glycine 0 CA--C 1.503 -0.681 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -167.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.523 HD22 ' CG1' ' B' ' 89' ' ' ILE . 2.0 m-20 -119.31 25.2 10.27 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.497 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 48.7 mt-30 -79.42 156.34 27.95 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.74 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.404 HD21 HD12 ' B' ' 29' ' ' LEU . 1.2 tt -114.77 88.2 2.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.127 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.474 ' HA ' ' ND2' ' B' ' 80' ' ' ASN . 27.4 mtpt -96.37 141.05 30.16 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -171.45 160.64 6.07 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -171.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 2.1 p -134.85 143.73 47.18 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.713 171.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.83 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 9.9 t -144.87 149.19 34.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.438 0.637 . . . . 0.0 111.965 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.473 ' CB ' ' HE3' ' B' ' 26' ' ' LYS . 6.8 m -111.98 163.83 13.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.561 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -113.08 33.78 4.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.02 -173.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.45 -1.53 30.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.032 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.63 -43.67 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.685 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 31.2 p90 43.75 -154.62 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.884 1.274 . . . . 0.0 114.281 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' B' ' 23' ' ' GLY . . . -77.11 107.94 2.48 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.681 -173.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.71 -54.92 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.338 0.589 . . . . 0.0 110.276 176.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.1 m -34.36 -57.8 0.49 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.098 -1.41 . . . . 0.0 114.323 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -75.06 -5.8 46.04 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.136 -173.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' B' ' 69' ' ' LYS . 46.3 mt-10 54.99 -92.39 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 123.498 0.499 . . . . 0.0 110.297 -168.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -136.31 110.09 8.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.589 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 33.7 mmtp -131.92 138.89 48.54 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -114.0 130.62 56.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.912 0.387 . . . . 0.0 110.053 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.51 ' HA ' HG12 ' B' ' 94' ' ' ILE . 18.5 p-90 -146.07 168.58 20.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.895 175.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -133.25 144.0 15.83 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.776 -174.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.445 HD12 ' CD2' ' B' ' 64' ' ' TYR . 15.6 mt -107.82 148.01 12.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 171.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.69 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 71.5 m-85 -129.57 136.76 50.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.51 -171.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.634 HG12 ' HB ' ' B' ' 63' ' ' VAL . 10.6 p -122.44 135.82 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.424 ' ND2' HG13 ' B' ' 58' ' ' VAL . 2.1 m-80 60.7 14.24 4.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.389 -172.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.65 -18.3 57.52 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.458 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' B' ' 58' ' ' VAL . 0.6 OUTLIER -87.92 165.61 15.12 Favored 'General case' 0 C--O 1.194 -1.821 0 C-N-CA 123.795 0.838 . . . . 0.0 108.831 -179.026 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.607 ' HA ' ' CD1' ' B' ' 57' ' ' PHE . 2.2 tttt -65.23 164.8 12.63 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 120.529 -0.469 . . . . 0.0 109.827 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.634 ' HB ' HG12 ' B' ' 58' ' ' VAL . 7.5 p -154.5 -13.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.084 0.468 . . . . 0.0 110.481 172.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.786 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.7 OUTLIER -159.65 124.56 4.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.215 0.531 . . . . 0.0 110.913 -171.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 21.3 m -131.9 127.92 37.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.102 176.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.527 ' HB2' HD13 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -168.31 149.42 4.97 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.171 0.986 . . . . 0.0 111.872 -171.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.495 ' O ' ' HB3' ' B' ' 70' ' ' SER . 26.4 t-20 -103.39 146.82 27.92 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.165 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -67.59 -21.7 65.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.775 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.494 ' O ' HG23 ' B' ' 71' ' ' THR . 1.5 tmtp? -88.05 -23.28 23.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.361 0.601 . . . . 0.0 109.526 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 5.2 t -65.7 -27.31 68.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.979 172.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.494 HG23 ' O ' ' B' ' 69' ' ' LYS . 23.5 p 61.24 123.24 0.01 OUTLIER 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.004 1.322 . . . . 0.0 113.057 174.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.425 ' HB ' ' OG ' ' B' ' 76' ' ' SER . 12.3 m -62.93 -11.2 6.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 114.405 -1.271 . . . . 0.0 113.239 -170.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . 0.537 ' HA2' ' HB3' ' B' ' 40' ' ' SER . . . -56.24 -54.21 37.39 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.267 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -73.41 -35.21 65.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.263 0.554 . . . . 0.0 110.127 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' B' ' 66' ' ' PHE . 1.6 mt -74.6 -55.74 11.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.723 -172.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.433 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 49.3 m -60.48 -30.64 69.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.863 -174.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -49.5 -52.19 31.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.83 0.824 . . . . 0.0 109.658 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 5.0 m-20 -67.31 -44.66 78.66 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.363 -1.289 . . . . 0.0 111.286 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.786 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 49.3 mm -50.82 -33.12 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.28 0.562 . . . . 0.0 112.26 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.474 ' ND2' ' HA ' ' B' ' 37' ' ' LYS . 0.9 OUTLIER -64.34 -29.27 70.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.919 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 49.7 pttt -81.39 -6.23 58.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.076 0.465 . . . . 0.0 110.549 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 4.2 mm? -73.57 -10.27 59.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.014 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 33.58 64.96 0.3 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.265 1.031 . . . . 0.0 111.113 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.497 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 60.3 mt -60.46 150.55 6.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 113.866 -1.516 . . . . 0.0 112.518 -170.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.426 ' O ' HG22 ' B' ' 84' ' ' ILE . 65.8 mttm -89.38 -177.16 5.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.286 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.76 112.87 0.72 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.898 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.477 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 7.6 tpt -151.87 -74.58 0.14 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.575 0.226 . . . . 0.0 110.575 176.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . 0.477 ' N ' ' HG3' ' B' ' 87' ' ' MET . 35.5 t80 -124.64 100.2 6.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.69 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 29.1 mm -100.98 120.31 50.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.732 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -111.61 -179.53 3.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.514 0.673 . . . . 0.0 110.959 174.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.472 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 83.9 mt -153.56 131.17 2.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.033 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.585 ' HE2' ' CE2' ' B' ' 57' ' ' PHE . 42.8 pttt -171.05 150.03 3.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.038 0.447 . . . . 0.0 111.3 176.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.484 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.8 OUTLIER -84.67 153.01 23.39 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.552 172.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' B' ' 54' ' ' TRP . 7.5 pt . . . . . 0 C--N 1.314 -0.957 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.089 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . 0.511 ' O ' HG12 ' B' ' 13' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . 0.548 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 21.4 t-20 -50.87 -24.95 3.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -176.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.505 ' HA ' ' CG2' ' B' ' 16' ' ' VAL . 20.1 m -66.72 -14.83 63.02 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.276 -0.265 . . . . 0.0 111.69 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.511 HG12 ' O ' ' B' ' 10' ' ' MET . 16.0 mm -61.44 -52.64 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.015 0.436 . . . . 0.0 110.987 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -106.74 -63.02 1.32 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.024 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.467 ' HB3' ' OD1' ' B' ' 11' ' ' ASN . 32.6 t -59.61 -60.34 4.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.071 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.505 ' CG2' ' HA ' ' B' ' 12' ' ' SER . 47.4 t -57.78 -40.52 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.872 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.26 -51.23 70.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.07 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.55 -34.03 58.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.59 0.233 . . . . 0.0 111.518 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 13.1 tppt? -64.01 -47.74 79.07 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.465 0.65 . . . . 0.0 110.86 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.429 HD21 ' CZ ' ' B' ' 66' ' ' PHE . 28.3 mt -67.35 -46.68 72.67 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.774 176.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -88.12 53.9 2.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.191 0.52 . . . . 0.0 111.116 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' B' ' 19' ' ' LYS . 30.5 mtpp -83.9 -25.3 30.31 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 166.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.452 ' HA3' ' OH ' ' B' ' 49' ' ' TYR . . . 165.47 -93.94 0.11 Allowed Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 114.317 -1.311 . . . . 0.0 110.356 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.57 -125.12 0.38 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.511 0.724 . . . . 0.0 110.553 -176.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.59 137.37 15.23 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.768 ' O ' ' HA ' ' B' ' 40' ' ' SER . 41.0 mtmt -61.64 100.59 0.15 Allowed 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -177.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.465 HD21 HD11 ' B' ' 29' ' ' LEU . 43.9 tp -128.46 124.03 35.16 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 120.877 0.37 . . . . 0.0 110.06 -171.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.662 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 5.2 p -105.41 100.49 10.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.445 -176.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.465 HD11 HD21 ' B' ' 27' ' ' LEU . 2.1 mm? -87.96 147.95 24.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.736 0.779 . . . . 0.0 111.439 -175.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.9 p -142.67 141.32 31.84 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.939 168.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.78 131.34 54.01 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.359 -173.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -140.2 68.35 1.36 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.97 -102.4 0.51 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.498 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' B' ' 84' ' ' ILE . 5.3 m-20 -79.28 -24.17 43.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.756 0.312 . . . . 0.0 111.043 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -94.96 147.1 23.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.958 0.885 . . . . 0.0 111.819 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 33.4 tp -128.59 99.49 5.39 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 113.973 -1.467 . . . . 0.0 107.674 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -95.82 137.81 34.36 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.983 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.662 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -160.97 156.73 25.23 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.143 -170.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.47 147.12 47.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 171.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.768 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 6.9 t -138.62 162.87 33.52 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 47.3 t -136.29 162.17 33.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.8 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -113.68 30.68 7.06 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.534 0.683 . . . . 0.0 109.619 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.18 21.45 0.13 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.112 -173.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.51 -32.66 0.58 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.731 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.555 ' CD1' HG21 ' B' ' 71' ' ' THR . 19.0 p90 44.22 -157.27 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.578 1.151 . . . . 0.0 113.365 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.422 ' N ' ' HD1' ' B' ' 45' ' ' TYR . . . -67.07 96.12 0.31 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.748 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.562 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -91.2 -71.28 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.274 0.559 . . . . 0.0 110.593 -177.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.4 m -62.86 -48.61 78.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.202 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.452 ' OH ' ' HA3' ' B' ' 23' ' ' GLY . 11.5 m-85 -39.52 119.45 0.95 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.699 -1.591 . . . . 0.0 112.365 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -74.58 -171.15 1.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.22 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.5 109.39 13.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.731 0.777 . . . . 0.0 109.348 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.611 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 76.4 mttt -131.87 123.61 27.85 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.409 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.454 HD22 HG13 ' B' ' 94' ' ' ILE . 1.2 p-10 -111.18 118.48 36.08 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.454 0.645 . . . . 0.0 110.777 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.664 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 40.5 p-90 -143.19 166.46 24.62 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.375 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.63 147.79 18.75 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.595 -174.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.47 HD12 ' CD2' ' B' ' 64' ' ' TYR . 18.4 mt -103.9 144.82 13.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 170.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.672 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 68.4 m-85 -125.15 141.06 52.34 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.493 -174.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.61 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.3 p -126.55 134.66 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.563 ' ND2' HG13 ' B' ' 58' ' ' VAL . 6.3 m-80 68.24 0.85 2.62 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.461 0.705 . . . . 0.0 109.297 -174.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.26 -0.9 50.47 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.588 -173.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -104.48 178.13 4.65 Favored 'General case' 0 C--O 1.203 -1.342 0 C-N-CA 124.018 0.927 . . . . 0.0 109.396 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.466 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.5 tppp? -65.98 161.07 22.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 118.765 0.711 . . . . 0.0 109.8 174.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.61 ' HB ' HG12 ' B' ' 58' ' ' VAL . 11.2 p -152.87 -18.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.094 0.473 . . . . 0.0 110.229 167.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.756 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.3 OUTLIER -160.66 127.95 4.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.94 0.4 . . . . 0.0 110.235 -171.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 6.1 m -135.16 129.09 33.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.527 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.614 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.1 OUTLIER -162.66 -176.47 5.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 122.357 1.075 . . . . 0.0 112.191 -174.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.9 t-20 -138.79 148.53 43.92 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 112.831 -1.986 . . . . 0.0 108.044 176.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -43.79 70.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.253 0.478 . . . . 0.0 111.79 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.489 ' O ' HG23 ' B' ' 71' ' ' THR . 58.4 mtpt -78.88 -16.26 57.27 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.853 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 3.2 t -73.28 -20.17 60.89 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.555 HG21 ' CD1' ' B' ' 45' ' ' TYR . 19.3 p 58.64 109.55 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.594 1.157 . . . . 0.0 112.533 170.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.609 ' HA ' HD12 ' B' ' 75' ' ' ILE . 11.4 m -61.43 -10.88 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.431 -169.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.75 -56.93 21.49 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.193 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -69.32 -31.31 69.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.307 0.575 . . . . 0.0 110.313 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.614 HD13 ' HB3' ' B' ' 66' ' ' PHE . 3.2 mt -70.5 -48.79 57.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.93 -177.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 34.2 t -56.38 -33.74 66.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.095 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -50.63 -54.74 20.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.695 0.76 . . . . 0.0 110.162 175.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 34.7 m-20 -64.79 -44.55 89.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.405 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.756 HG13 ' CE1' ' B' ' 64' ' ' TYR . 42.5 mm -55.47 -30.46 25.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -176.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -59.37 -25.24 64.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.7 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 16.4 ptmt -85.65 -3.36 58.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.727 0.298 . . . . 0.0 111.304 -175.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.2 mm? -73.8 -11.9 60.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.55 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 52.26 65.84 1.39 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.812 0.815 . . . . 0.0 109.068 -169.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.423 HG23 HG21 ' B' ' 63' ' ' VAL . 65.5 mt -57.49 156.54 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.504 -1.226 . . . . 0.0 111.484 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.461 ' HB2' HD21 ' B' ' 59' ' ' ASN . 86.7 mttt -113.66 -178.09 3.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.269 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.31 112.14 0.72 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.76 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.584 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 5.6 tpt -154.79 -72.7 0.12 Allowed 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 120.491 0.186 . . . . 0.0 110.873 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . 0.584 ' N ' ' HG3' ' B' ' 87' ' ' MET . 75.9 t80 -134.48 116.73 15.45 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 21.3 mm -104.96 145.21 13.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.458 -177.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.541 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 33.4 mm-40 -135.97 156.29 48.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.38 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.664 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 67.8 mt -135.13 126.21 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.738 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.418 ' HE2' ' CE2' ' B' ' 57' ' ' PHE . 49.3 pttt -175.24 153.13 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.699 0.285 . . . . 0.0 111.533 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -75.71 150.92 37.76 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.325 0.583 . . . . 0.0 111.209 175.555 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.454 HG13 HD22 ' B' ' 53' ' ' ASN . 4.7 pt . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.459 -0.781 . . . . 0.0 111.634 -172.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . 0.465 ' C ' HD13 ' B' ' 13' ' ' ILE . 77.4 mmm . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 121.544 0.687 . . . . 0.0 111.643 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -109.61 -18.59 13.45 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.512 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -59.39 -21.12 59.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.829 0.823 . . . . 0.0 109.668 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.555 ' H ' ' CD1' ' B' ' 13' ' ' ILE . 1.4 mp -61.91 -34.41 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.354 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -106.7 -62.92 1.33 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.709 -173.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 49.8 m -66.12 -59.93 3.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.555 -172.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 70.6 t -55.82 -46.25 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.928 0.394 . . . . 0.0 111.359 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -56.28 -46.4 79.76 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.719 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.43 -42.72 58.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.786 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -61.89 -47.47 84.84 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 123.458 0.703 . . . . 0.0 111.936 -175.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.649 HD22 HG11 ' B' ' 72' ' ' VAL . 64.0 mt -75.53 -19.48 59.32 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.778 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -104.29 79.1 1.56 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.01 0.434 . . . . 0.0 110.323 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -130.17 19.86 5.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.572 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.49 25.63 7.65 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.389 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.635 ' HG2' ' CZ ' ' B' ' 49' ' ' TYR . 43.3 mttt -98.35 -140.02 0.3 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.617 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -65.52 142.66 44.44 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 172.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' B' ' 40' ' ' SER . 47.3 mttm -61.82 132.5 53.31 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 18.0 tp -152.5 104.87 2.95 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 -174.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 20.3 m -103.52 110.91 23.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.065 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.421 ' N ' HD22 ' B' ' 29' ' ' LEU . 2.6 mm? -90.87 152.91 20.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.746 0.784 . . . . 0.0 111.894 -173.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.7 p -145.92 147.11 31.39 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.326 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 57.6 mtt -122.32 140.49 52.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.515 0.674 . . . . 0.0 112.168 -172.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . 0.492 ' O ' ' HG3' ' B' ' 35' ' ' GLN . 6.7 t30 -130.37 101.34 5.71 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 173.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.19 -99.87 1.0 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -166.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.488 ' HB2' ' HA2' ' B' ' 86' ' ' GLY . 15.3 m120 -130.6 19.26 5.18 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 171.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' B' ' 32' ' ' ASN . 24.7 mt-30 -69.75 156.0 39.68 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.243 0.544 . . . . 0.0 110.714 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.515 ' H ' HD12 ' B' ' 84' ' ' ILE . 15.4 tp -118.2 106.59 12.98 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.842 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.409 ' HA ' ' OD1' ' B' ' 80' ' ' ASN . 24.0 mtmt -116.07 139.86 49.86 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -156.35 150.82 25.65 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -168.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 8.8 p -115.46 142.42 46.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.32 170.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 32.1 p -138.09 173.07 12.02 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -170.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' B' ' 26' ' ' LYS . 30.7 t -155.19 158.61 39.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.768 174.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -116.26 28.45 8.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.785 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.73 -18.52 65.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.691 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.67 -41.01 0.05 OUTLIER Glycine 0 C--N 1.318 -0.445 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.619 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.617 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 23.1 p90 45.04 -163.49 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.957 1.303 . . . . 0.0 114.264 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.59 ' H ' HG22 ' B' ' 71' ' ' THR . . . -81.11 85.49 1.4 Allowed Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.472 ' H ' HD12 ' B' ' 47' ' ' ILE . 1.0 OUTLIER -59.42 -69.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.4 0.619 . . . . 0.0 110.293 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.1 t -115.37 -92.97 0.5 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.389 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.635 ' CZ ' ' HG2' ' B' ' 24' ' ' LYS . 72.0 m-85 55.18 41.91 31.07 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.651 0.594 . . . . 0.0 110.154 -175.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 35.64 -95.35 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.285 -1.325 . . . . 0.0 112.988 -169.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -171.14 110.74 0.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 74.6 mttt -134.37 126.29 29.3 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -175.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -114.21 126.51 55.14 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.238 0.542 . . . . 0.0 110.578 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.516 ' HA ' HG12 ' B' ' 94' ' ' ILE . 34.3 p-90 -146.64 163.58 35.4 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.734 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -126.96 148.03 17.14 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.944 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.591 HD12 ' CD2' ' B' ' 64' ' ' TYR . 30.1 mt -107.1 148.86 11.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.753 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 89.5 m-85 -128.24 146.62 50.68 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -169.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.495 HG13 ' ND2' ' B' ' 59' ' ' ASN . 8.7 p -130.85 135.9 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.495 ' ND2' HG13 ' B' ' 58' ' ' VAL . 1.7 m-80 60.73 17.58 7.74 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -173.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.39 -3.27 83.82 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.407 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' B' ' 58' ' ' VAL . 24.4 mt-10 -103.34 176.09 5.26 Favored 'General case' 0 C--O 1.2 -1.53 0 C-N-CA 123.459 0.703 . . . . 0.0 109.711 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -60.67 156.75 16.04 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 118.541 0.61 . . . . 0.0 110.616 176.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.466 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.0 p -150.75 -12.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.007 0.432 . . . . 0.0 110.368 166.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.591 ' CD2' HD12 ' B' ' 56' ' ' ILE . 0.9 OUTLIER -162.4 125.26 2.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.239 -173.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 14.2 m -132.03 127.89 37.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.68 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.485 ' HB2' HD13 ' B' ' 75' ' ' ILE . 21.2 p90 -165.45 -175.03 3.39 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 122.017 0.913 . . . . 0.0 112.166 -176.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 18.5 t-20 -138.25 163.42 31.8 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.614 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -67.01 -51.65 52.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.298 0.57 . . . . 0.0 110.847 -176.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.471 ' O ' HG23 ' B' ' 71' ' ' THR . 40.3 ttmt -70.24 -17.75 63.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.23 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 3.2 t -69.06 -10.39 57.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.1 0.476 . . . . 0.0 109.902 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.59 HG22 ' H ' ' B' ' 46' ' ' GLY . 21.2 p 60.44 94.74 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.661 1.184 . . . . 0.0 112.157 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.656 ' HA ' HD12 ' B' ' 75' ' ' ILE . 2.4 m -59.37 -21.38 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.371 -172.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.42 -47.33 76.6 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.606 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -78.61 -36.0 44.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.282 0.563 . . . . 0.0 110.169 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.656 HD12 ' HA ' ' B' ' 72' ' ' VAL . 2.4 mt -65.41 -45.63 92.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.293 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 32.2 t -64.21 -27.52 69.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.624 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -55.37 -44.23 75.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.835 0.826 . . . . 0.0 109.865 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.721 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 10.7 m-20 -69.95 -40.46 75.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.442 -1.253 . . . . 0.0 111.022 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.586 ' HA ' HD23 ' B' ' 82' ' ' LEU . 48.3 mm -58.01 -28.87 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.333 0.587 . . . . 0.0 111.832 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.409 ' OD1' ' HA ' ' B' ' 37' ' ' LYS . 83.8 m-20 -60.38 -23.16 64.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.737 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 17.0 ptmt -96.73 6.38 48.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.808 0.337 . . . . 0.0 111.245 -174.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.4 mm? -78.78 -5.08 52.42 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -175.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 41.9 52.22 4.19 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 123.871 0.732 . . . . 0.0 110.95 -171.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.515 HD12 ' H ' ' B' ' 36' ' ' LEU . 82.8 mt -52.22 147.45 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.768 -171.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.6 -164.27 1.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.119 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.488 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -154.23 113.87 0.59 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.819 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.468 ' CG ' ' HA ' ' B' ' 59' ' ' ASN . 24.6 ptp -173.47 -54.85 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.197 0.199 . . . . 0.0 111.242 175.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . 0.43 ' N ' ' HG3' ' B' ' 87' ' ' MET . 1.3 t80 -135.73 84.44 2.09 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.842 -0.536 . . . . 0.0 110.226 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.753 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.1 mp -99.4 114.1 36.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.003 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -98.73 -179.22 4.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.366 0.603 . . . . 0.0 111.355 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 41.7 mt -151.51 114.93 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.573 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -174.64 160.85 3.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.333 0.587 . . . . 0.0 112.309 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.503 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 1.5 pp0? -72.26 158.47 35.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.617 174.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.5 pt . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.899 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 121.261 0.553 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -62.44 -24.71 67.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.776 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.679 ' O ' HG23 ' B' ' 16' ' ' VAL . 15.9 t -66.75 -25.85 66.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.045 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 11.2 mm -58.55 -38.37 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-O 121.703 0.763 . . . . 0.0 109.98 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -71.14 -41.4 70.52 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.959 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.587 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 0.6 OUTLIER -65.36 -34.12 77.56 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.143 177.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.679 HG23 ' O ' ' B' ' 12' ' ' SER . 54.5 t -63.29 -42.26 95.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.218 0.533 . . . . 0.0 109.991 175.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.622 HD22 HD23 ' B' ' 29' ' ' LEU . 2.5 t-20 -61.94 -42.12 98.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.867 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.76 -40.93 63.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.451 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' B' ' 15' ' ' SER . 4.5 tmtm? -53.4 -73.04 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.54 0.736 . . . . 0.0 112.186 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.541 HD22 HG11 ' B' ' 72' ' ' VAL . 17.4 mt -52.29 -29.87 25.37 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -84.41 74.23 10.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.193 0.52 . . . . 0.0 111.023 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -133.24 -79.48 0.48 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.203 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.21 34.83 2.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.943 -176.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.513 ' HA ' ' HA2' ' B' ' 46' ' ' GLY . 0.9 OUTLIER -122.79 -168.98 1.84 Allowed 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 173.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' B' ' 45' ' ' TYR . . . -54.26 137.24 41.79 Favored Glycine 0 N--CA 1.45 -0.41 0 O-C-N 123.961 0.788 . . . . 0.0 111.619 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.463 ' HD2' ' H ' ' B' ' 44' ' ' GLY . 0.0 OUTLIER -87.49 112.12 21.88 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 121.397 0.618 . . . . 0.0 109.911 -170.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.463 HD13 ' O ' ' B' ' 27' ' ' LEU . 0.0 OUTLIER -134.29 143.52 47.79 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.267 177.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 49.3 m -104.03 111.55 24.17 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.879 -173.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.622 HD23 HD22 ' B' ' 17' ' ' ASN . 3.1 mm? -77.5 152.79 33.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.596 0.713 . . . . 0.0 109.932 176.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 0.3 OUTLIER -144.27 145.48 32.05 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.29 175.303 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 43.6 mtt -112.86 133.1 55.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.072 0.463 . . . . 0.0 111.864 -165.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . 0.507 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 4.3 t30 -146.11 59.22 1.23 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 47.73 -99.58 0.02 OUTLIER Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.895 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.695 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 8.1 p30 -83.39 16.57 2.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.41 -0.395 . . . . 0.0 111.493 -176.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.507 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 19.5 mt-30 -134.87 146.38 49.18 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.393 0.616 . . . . 0.0 110.735 171.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.511 ' HB3' ' HB ' ' B' ' 84' ' ' ILE . 3.2 tm? -122.39 127.96 50.36 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.558 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.482 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 16.7 mtmt -126.33 146.6 49.97 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -174.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -161.63 151.19 16.46 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -176.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 11.8 p -126.88 142.2 51.61 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 58.9 p -136.75 150.29 48.31 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -167.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 22.7 t -139.56 153.46 47.43 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.707 171.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -115.36 9.39 15.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -170.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.72 -59.84 4.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.814 0.816 . . . . 0.0 110.451 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.463 ' H ' ' HD2' ' B' ' 26' ' ' LYS . . . -91.68 61.28 2.77 Favored Glycine 0 C--N 1.309 -0.927 0 CA-C-N 114.59 -1.187 . . . . 0.0 110.89 175.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.58 ' HA ' ' HA2' ' B' ' 25' ' ' GLY . 0.1 OUTLIER -70.1 -161.91 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.079 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.66 ' H ' HG22 ' B' ' 71' ' ' THR . . . -62.14 107.44 1.58 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.27 -0.49 . . . . 0.0 112.23 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 22.2 mm -85.46 -69.74 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 CA-C-O 122.307 1.051 . . . . 0.0 109.817 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.44 ' C ' ' H ' ' B' ' 50' ' ' GLU . 6.8 m -104.62 -153.82 0.49 Allowed 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 113.634 -1.621 . . . . 0.0 109.391 -176.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 67.76 -12.53 0.29 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.992 0.917 . . . . 0.0 112.432 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' B' ' 48' ' ' SER . 44.7 mt-10 49.77 -105.2 0.16 Allowed 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.839 0.856 . . . . 0.0 111.994 -175.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -129.65 110.71 12.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.586 ' HB2' ' OE1' ' B' ' 68' ' ' GLU . 66.2 mttm -118.19 134.82 54.67 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 170.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -98.17 110.58 23.14 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.551 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 37.5 p-90 -149.38 168.18 24.11 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.444 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.9 156.86 25.68 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.408 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.417 HD12 ' CD2' ' B' ' 64' ' ' TYR . 21.8 mt -108.42 147.68 13.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.683 ' CE1' ' HD3' ' B' ' 62' ' ' LYS . 71.5 m-85 -130.46 139.9 50.54 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -169.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.463 HG23 ' HB ' ' B' ' 63' ' ' VAL . 13.6 t -131.35 138.34 53.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 64.54 5.26 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.99 0.806 . . . . 0.0 109.238 -174.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.91 17.49 47.64 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.737 -172.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 7.8 mt-10 -120.5 174.56 6.47 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.683 ' HD3' ' CE1' ' B' ' 57' ' ' PHE . 0.0 OUTLIER -67.6 167.82 12.31 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.26 173.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.463 ' HB ' HG23 ' B' ' 58' ' ' VAL . 8.6 p -153.77 -15.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.781 164.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.652 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.5 OUTLIER -160.05 124.2 3.74 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.049 -170.29 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 28.1 m -131.94 131.11 42.35 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.797 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.512 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.1 OUTLIER -160.94 -176.55 5.57 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 122.531 1.158 . . . . 0.0 112.312 -174.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -133.21 149.67 52.0 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 112.272 -2.24 . . . . 0.0 108.626 173.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . 0.586 ' OE1' ' HB2' ' B' ' 52' ' ' LYS . 1.3 mp0 -52.04 -51.03 60.14 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.941 0.401 . . . . 0.0 111.57 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.562 ' O ' HG23 ' B' ' 71' ' ' THR . 88.8 tttt -69.13 -22.95 63.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.602 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.6 t -68.74 -17.06 63.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 174.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.66 HG22 ' H ' ' B' ' 46' ' ' GLY . 30.2 p 56.26 106.15 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.344 1.058 . . . . 0.0 112.865 172.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.541 HG11 HD22 ' B' ' 20' ' ' LEU . 9.5 m -62.7 -10.3 5.24 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.861 -171.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.46 -55.21 31.33 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.463 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -67.79 -36.9 81.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.416 0.627 . . . . 0.0 110.9 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' B' ' 66' ' ' PHE . 1.9 mt -68.53 -49.19 67.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.75 -177.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.421 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 22.9 t -58.81 -29.75 67.09 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.979 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -49.66 -52.23 32.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.893 0.854 . . . . 0.0 109.614 173.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.685 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 0.4 OUTLIER -72.7 -39.66 66.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.945 178.041 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.652 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.1 mm -56.96 -33.25 41.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.12 0.486 . . . . 0.0 112.26 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.511 HD21 ' HB3' ' B' ' 38' ' ' ALA . 7.3 m-80 -61.85 -16.93 54.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.685 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 20.7 pttm -85.05 -7.31 59.17 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.906 0.384 . . . . 0.0 110.469 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.53 HD23 ' HA ' ' B' ' 79' ' ' ILE . 2.5 mm? -69.61 -16.09 63.32 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -174.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 51.7 58.72 5.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.336 -171.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.801 ' H ' HD12 ' B' ' 84' ' ' ILE . 5.2 mp -55.99 148.29 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.517 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.695 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 67.5 mttm -116.8 -167.73 1.34 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.269 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.555 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -142.35 111.24 0.66 Allowed Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.131 -177.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.442 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 16.6 tpp -151.22 -73.43 0.15 Allowed 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . 0.442 ' N ' ' HG3' ' B' ' 87' ' ' MET . 32.8 t80 -125.77 97.15 5.03 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 22.9 mm -96.35 126.35 49.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.834 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -121.67 169.77 10.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.115 0.484 . . . . 0.0 110.784 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.538 HD11 HG22 ' B' ' 16' ' ' VAL . 23.6 mm -149.14 121.72 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.768 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.551 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 48.2 pttt -168.83 173.53 7.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.251 0.548 . . . . 0.0 111.452 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.576 ' NE2' ' H ' ' B' ' 93' ' ' GLN . 0.5 OUTLIER -95.8 149.81 21.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.281 175.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.546 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.7 pt . . . . . 0 C--N 1.313 -0.999 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.255 -175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . 0.661 ' O ' HG12 ' B' ' 13' ' ' ILE . 86.8 mmm . . . . . 0 C--O 1.222 -0.351 0 CA-C-O 121.236 0.541 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -52.51 -23.26 5.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.794 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.535 ' O ' HG23 ' B' ' 16' ' ' VAL . 5.3 m -68.39 -17.07 64.14 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.909 -174.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.661 HG12 ' O ' ' B' ' 10' ' ' MET . 14.2 mm -49.21 -65.08 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.449 0.642 . . . . 0.0 111.26 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -78.3 -25.63 46.66 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.555 -177.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.433 ' HB2' ' HA ' ' B' ' 12' ' ' SER . 23.7 m -67.7 -33.33 74.68 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.003 -176.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.535 HG23 ' O ' ' B' ' 12' ' ' SER . 71.5 t -67.84 -42.47 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.5 0.667 . . . . 0.0 109.478 176.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.787 ' ND2' HD22 ' B' ' 29' ' ' LEU . 12.4 t-20 -59.08 -58.71 7.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.264 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.39 -12.15 60.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.857 -177.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' B' ' 16' ' ' VAL . 14.2 tppt? -78.24 -50.19 12.34 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.5 0.667 . . . . 0.0 111.059 173.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.465 HD21 ' HZ2' ' B' ' 54' ' ' TRP . 82.1 mt -80.1 -22.81 41.78 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.202 -178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -116.14 93.14 4.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.433 0.635 . . . . 0.0 110.643 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -138.59 -70.41 0.42 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.222 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.56 49.14 0.77 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -127.96 -138.47 0.24 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.437 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -76.31 163.36 52.95 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.688 ' HE3' ' OG ' ' B' ' 41' ' ' SER . 0.0 OUTLIER -70.26 150.6 46.23 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.221 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.546 ' HA ' ' O ' ' B' ' 39' ' ' THR . 16.5 tp -149.06 123.76 9.84 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -173.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 16.1 m -106.85 96.74 6.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.298 0.57 . . . . 0.0 111.468 -177.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.787 HD22 ' ND2' ' B' ' 17' ' ' ASN . 0.2 OUTLIER -68.5 147.92 51.31 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.266 1.426 . . . . 0.0 114.496 -167.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 11.4 p -155.18 152.97 30.03 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.138 171.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 61.3 mtt -115.01 149.16 37.86 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -166.67 120.28 1.05 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.181 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.1 -116.78 9.55 Favored Glycine 0 CA--C 1.506 -0.481 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.879 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.446 ' HA ' ' CD1' ' B' ' 13' ' ' ILE . 20.6 m120 -121.33 22.98 10.63 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 172.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.604 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 49.6 mt-30 -86.35 160.96 18.94 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.311 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' B' ' 36' ' ' LEU . 1.1 tm? -128.69 98.96 5.16 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 169.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.594 ' HA ' ' ND2' ' B' ' 80' ' ' ASN . 6.0 mtmp? -97.2 146.37 25.15 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.531 -177.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -173.36 142.91 1.03 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -93.02 159.12 15.44 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 177.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.486 ' OG ' ' HA2' ' B' ' 73' ' ' GLY . 11.6 p -149.92 151.06 32.8 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.592 -170.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.688 ' OG ' ' HE3' ' B' ' 26' ' ' LYS . 0.1 OUTLIER -129.83 140.79 50.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.986 177.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -94.5 41.49 1.09 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.905 -170.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.7 -60.08 3.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.244 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.68 -35.87 3.66 Favored Glycine 0 C--N 1.316 -0.572 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.737 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.437 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 23.7 p90 49.21 -166.35 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.871 1.268 . . . . 0.0 113.98 177.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.7 97.57 1.49 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.602 -175.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.484 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -108.92 -55.92 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.386 0.612 . . . . 0.0 109.74 175.079 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.9 m -39.31 -57.09 1.43 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.523 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -80.38 4.67 17.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.985 -173.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 50.47 -98.03 0.05 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.694 0.797 . . . . 0.0 112.331 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -142.46 113.37 7.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.395 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 94.6 mttt -138.13 143.36 40.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.284 175.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.419 ' HB3' ' OD1' ' B' ' 67' ' ' ASN . 0.4 OUTLIER -112.87 117.9 33.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.176 0.513 . . . . 0.0 110.715 177.108 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.628 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 48.9 p-90 -131.45 164.43 25.76 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -125.19 148.69 16.88 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.472 -173.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.456 ' C ' HG12 ' B' ' 63' ' ' VAL . 7.7 mt -100.41 150.33 5.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 170.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.783 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 74.9 m-85 -129.97 138.65 50.95 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.202 -174.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' B' ' 61' ' ' GLU . 13.5 p -121.9 131.72 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 63.33 7.98 3.2 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.251 0.548 . . . . 0.0 109.697 -174.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.57 -17.09 40.06 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.242 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 0.6 OUTLIER -91.5 170.21 10.14 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 123.185 0.594 . . . . 0.0 110.105 -177.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.432 ' HA ' ' CD1' ' B' ' 57' ' ' PHE . 5.4 tppp? -55.74 158.24 3.71 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.915 0.388 . . . . 0.0 110.007 172.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.456 HG12 ' C ' ' B' ' 56' ' ' ILE . 10.0 p -144.91 -18.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 168.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.558 ' CE2' HG23 ' B' ' 75' ' ' ILE . 1.6 t80 -171.08 153.04 3.63 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.71 -175.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.531 HG23 ' CD1' ' B' ' 94' ' ' ILE . 80.0 m -138.6 135.76 35.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.521 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.722 ' CD2' HD13 ' B' ' 75' ' ' ILE . 23.8 p90 -168.55 158.53 9.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.795 0.807 . . . . 0.0 111.521 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 5.6 m120 -113.61 151.58 31.51 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.02 -1.445 . . . . 0.0 112.001 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -61.91 -42.5 99.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.529 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.489 ' O ' HG23 ' B' ' 71' ' ' THR . 22.0 tptp -59.98 -36.12 76.46 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.02 0.914 . . . . 0.0 110.175 176.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' B' ' 67' ' ' ASN . 58.5 m -70.37 -10.33 58.75 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.264 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.489 HG23 ' O ' ' B' ' 69' ' ' LYS . 8.2 p 65.08 124.02 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 126.134 1.774 . . . . 0.0 113.209 170.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.662 ' HA ' HD12 ' B' ' 75' ' ' ILE . 3.6 m -64.57 -5.56 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.097 -173.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . 0.486 ' HA2' ' OG ' ' B' ' 40' ' ' SER . . . -67.28 -55.16 16.81 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.432 -0.413 . . . . 0.0 113.228 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -73.17 -23.38 60.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 122.048 0.928 . . . . 0.0 109.09 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.722 HD13 ' CD2' ' B' ' 66' ' ' PHE . 68.0 mt -68.79 -54.84 18.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 113.904 -1.498 . . . . 0.0 112.745 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 18.2 t -54.57 -37.82 65.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.901 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -50.85 -49.43 58.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.982 0.896 . . . . 0.0 110.599 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.533 ' HA ' ' HG2' ' B' ' 81' ' ' LYS . 72.1 m-20 -64.9 -46.89 79.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.912 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.457 HG12 ' CD2' ' B' ' 64' ' ' TYR . 66.3 mt -51.96 -37.53 21.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.325 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.594 ' ND2' ' HA ' ' B' ' 37' ' ' LYS . 7.3 m120 -75.07 -38.49 61.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.383 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.533 ' HG2' ' HA ' ' B' ' 78' ' ' ASP . 6.4 ptpp? -75.47 -21.31 58.18 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.222 -176.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.438 HD23 ' O ' ' B' ' 78' ' ' ASP . 1.7 mm? -63.9 -22.01 66.73 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.869 0.366 . . . . 0.0 110.154 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 45.35 64.79 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.697 -171.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.604 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 55.6 mt -62.89 149.89 9.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.21 -175.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.437 ' NZ ' ' HB3' ' B' ' 85' ' ' LYS . 7.7 mtpm? -90.18 179.42 5.92 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.827 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -133.68 113.25 1.18 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 119.693 -1.241 . . . . 0.0 112.466 -176.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 17.8 ttt -154.31 -77.09 0.11 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 123.076 0.55 . . . . 0.0 109.909 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -132.34 81.86 1.98 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.217 0.532 . . . . 0.0 109.668 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.783 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.1 mp -87.72 125.51 41.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.853 178.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -108.83 177.97 4.61 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.356 0.598 . . . . 0.0 110.7 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.628 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 57.5 mt -149.74 110.04 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.632 -178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -167.87 166.67 13.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.273 0.559 . . . . 0.0 112.102 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -84.63 148.84 26.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.467 -174.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.531 ' CD1' HG23 ' B' ' 65' ' ' THR . 4.2 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.408 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . 0.585 ' SD ' ' HA ' ' B' ' 88' ' ' TYR . 82.5 mtp . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.82 0.343 . . . . 0.0 111.585 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -57.38 -30.55 64.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.168 0.508 . . . . 0.0 110.888 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.585 ' O ' HG23 ' B' ' 16' ' ' VAL . 1.3 p -63.94 -30.94 71.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.909 -174.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mm -53.79 -45.49 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.858 0.837 . . . . 0.0 110.113 177.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -82.89 -29.99 28.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.976 -177.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' B' ' 12' ' ' SER . 21.8 t -71.5 -27.38 63.18 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.602 -175.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.585 HG23 ' O ' ' B' ' 12' ' ' SER . 87.4 t -58.44 -42.89 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.446 0.641 . . . . 0.0 109.704 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.406 ' OD1' HD13 ' B' ' 29' ' ' LEU . 55.9 t30 -63.87 -45.54 88.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.866 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.8 -28.5 62.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.619 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -68.37 -53.08 26.38 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.167 0.508 . . . . 0.0 111.398 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 94.3 mt -73.0 -27.82 62.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.655 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -90.41 75.97 6.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.369 0.604 . . . . 0.0 110.593 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -135.89 62.95 1.61 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.491 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.91 54.48 4.14 Favored Glycine 0 C--N 1.317 -0.5 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.64 ' HB3' ' CD2' ' B' ' 45' ' ' TYR . 33.2 mmtp -137.15 -152.51 0.44 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.223 -0.488 . . . . 0.0 110.396 -174.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' B' ' 45' ' ' TYR . . . -78.69 -177.27 48.87 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 176.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.498 ' HE2' ' HB2' ' B' ' 41' ' ' SER . 4.3 mppt? -88.57 127.9 35.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 117.292 0.546 . . . . 0.0 111.02 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.44 HD22 HG21 ' B' ' 72' ' ' VAL . 13.4 tp -156.03 110.93 2.9 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 19.5 m -108.7 108.86 19.87 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.535 -176.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.539 HD23 HD11 ' B' ' 36' ' ' LEU . 10.2 mp -86.04 158.73 19.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.606 0.717 . . . . 0.0 110.738 176.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.564 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 20.3 m -135.81 140.29 44.12 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.919 173.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -100.59 125.65 46.99 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.792 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.59 58.66 1.61 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.43 -95.61 0.01 OUTLIER Glycine 0 C--N 1.335 0.506 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.028 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 14.2 m120 -88.09 15.72 7.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.481 -0.359 . . . . 0.0 111.044 -176.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 16.8 mt-30 -139.95 142.97 36.34 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.558 0.694 . . . . 0.0 110.931 173.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.539 HD11 HD23 ' B' ' 29' ' ' LEU . 32.4 tp -113.58 120.78 42.12 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.818 173.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.564 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 6.6 mmmm -114.48 150.31 35.0 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -174.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.404 ' HB2' ' HG ' ' B' ' 29' ' ' LEU . . . -163.55 143.35 8.49 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 2.8 p -120.86 151.79 39.22 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.4 t -142.89 150.07 39.32 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.126 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.498 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . 5.7 m -126.12 149.77 48.7 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.424 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -82.76 47.9 1.26 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.266 -170.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.49 -3.71 29.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.786 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.37 70.34 1.35 Allowed Glycine 0 CA--C 1.485 -1.808 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.262 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.64 ' CD2' ' HB3' ' B' ' 24' ' ' LYS . 0.8 OUTLIER -65.59 148.86 51.04 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 161.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.583 ' N ' ' CD1' ' B' ' 45' ' ' TYR . . . 109.17 58.86 0.53 Allowed Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -176.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 3.9 mm -85.84 -69.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.521 0.677 . . . . 0.0 109.702 -172.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.2 m -151.8 -130.32 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.021 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.467 ' O ' ' HE2' ' B' ' 52' ' ' LYS . 84.5 m-85 64.23 27.63 13.9 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.004 0.522 . . . . 0.0 111.503 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 43.63 -106.47 0.09 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.593 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.5 ' HB3' HD21 ' B' ' 67' ' ' ASN . 6.9 m-20 -144.48 119.4 9.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.089 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.467 ' HE2' ' O ' ' B' ' 49' ' ' TYR . 65.7 mmtt -119.26 122.74 42.62 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -107.64 127.24 53.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.149 0.499 . . . . 0.0 111.058 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.693 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 37.2 p-90 -142.41 161.38 38.2 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.891 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.1 151.94 16.89 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.899 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.491 ' O ' HG12 ' B' ' 63' ' ' VAL . 7.5 mt -102.74 141.03 19.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 172.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.69 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 64.0 m-85 -121.81 140.85 51.86 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.539 HG12 ' HB ' ' B' ' 63' ' ' VAL . 8.4 p -131.72 142.5 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.516 HD22 HG13 ' B' ' 58' ' ' VAL . 14.3 m-80 68.72 -2.81 1.57 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -169.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.76 -1.75 61.74 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -170.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 58' ' ' VAL . 16.5 mt-10 -100.36 172.0 7.41 Favored 'General case' 0 C--O 1.199 -1.587 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.594 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 11.1 ttmt -67.09 168.3 10.4 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 119.009 0.822 . . . . 0.0 109.948 175.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.539 ' HB ' HG12 ' B' ' 58' ' ' VAL . 7.6 p -148.49 -20.33 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.618 170.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.418 ' CD2' HG12 ' B' ' 79' ' ' ILE . 4.5 t80 -169.1 146.14 3.58 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.997 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.531 HG23 ' CD1' ' B' ' 94' ' ' ILE . 54.9 m -130.17 134.07 47.04 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.257 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.644 ' CD2' HG21 ' B' ' 75' ' ' ILE . 9.0 p90 -165.48 153.04 10.77 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.672 0.749 . . . . 0.0 109.939 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.5 HD21 ' HB3' ' B' ' 51' ' ' ASP . 23.2 t-20 -99.2 159.73 14.78 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.885 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . 0.456 ' CG ' ' HB2' ' B' ' 52' ' ' LYS . 10.2 mm-40 -60.92 -63.15 1.4 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.278 0.561 . . . . 0.0 109.954 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -66.37 -5.17 9.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.184 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.5 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 1.4 t -68.37 -3.14 10.11 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.417 0.627 . . . . 0.0 109.762 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.417 ' O ' HG13 ' B' ' 75' ' ' ILE . 31.9 p 62.17 102.97 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.308 1.443 . . . . 0.0 111.55 174.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.658 ' HA ' HD12 ' B' ' 75' ' ' ILE . 5.4 m -66.79 -4.43 2.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.151 -168.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.68 -48.12 80.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.443 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -78.78 -25.9 44.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.496 0.665 . . . . 0.0 109.777 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' B' ' 72' ' ' VAL . 24.5 mt -66.29 -44.97 90.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.299 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 28.9 t -53.73 -36.52 62.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.351 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -50.04 -54.61 19.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.792 0.806 . . . . 0.0 110.54 174.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.518 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 27.3 m-20 -63.89 -48.07 78.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.904 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' B' ' 64' ' ' TYR . 43.7 mt -54.69 -37.29 39.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.104 0.478 . . . . 0.0 111.48 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.98 -43.29 96.17 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.106 176.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 59.1 pttt -76.05 -31.1 58.64 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.054 -176.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.58 -26.31 67.89 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 65.6 t30 40.44 72.19 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 O-C-N 124.583 1.177 . . . . 0.0 110.839 -172.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.732 ' H ' HD12 ' B' ' 84' ' ' ILE . 3.1 mp -57.18 137.16 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.908 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 30.4 mmtp -90.61 -169.41 2.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.409 -177.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.49 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -136.65 113.92 1.1 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.256 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 3.1 ptp -167.43 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.637 0.375 . . . . 0.0 110.604 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . 0.585 ' HA ' ' SD ' ' B' ' 10' ' ' MET . 21.7 t80 -124.8 88.32 2.87 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.69 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 34.1 mm -93.75 133.35 35.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.29 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 24.1 mt-10 -125.38 155.61 40.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.142 0.496 . . . . 0.0 111.636 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.693 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 86.8 mt -131.15 118.21 40.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.453 176.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -171.69 154.19 3.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.12 0.486 . . . . 0.0 111.894 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.504 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 5.1 pm0 -64.76 149.48 49.19 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.268 175.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.531 ' CD1' HG23 ' B' ' 65' ' ' THR . 3.3 pt . . . . . 0 C--N 1.312 -1.026 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.304 -173.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . 0.489 ' SD ' HG12 ' B' ' 89' ' ' ILE . 62.1 mtm . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.941 0.4 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -70.56 -26.88 63.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.692 0.758 . . . . 0.0 109.966 171.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 14.8 m -68.4 -10.14 53.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.642 -174.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.429 HG23 ' HG2' ' B' ' 31' ' ' MET . 28.5 mm -49.58 -52.34 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-O 121.089 0.471 . . . . 0.0 111.579 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -102.65 -38.3 7.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.865 -174.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.644 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 16.0 m -57.94 -41.86 83.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.945 -174.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.67 -45.13 75.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.964 0.411 . . . . 0.0 110.448 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -43.61 98.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.161 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.12 -26.19 52.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.24 -176.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.644 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -64.79 -46.29 82.68 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 121.092 0.472 . . . . 0.0 111.715 178.325 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 9.1 mt -87.05 -31.77 20.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.058 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -92.35 81.02 4.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.277 0.56 . . . . 0.0 110.176 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -122.35 -83.22 0.66 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.315 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.32 34.34 2.32 Favored Glycine 0 CA--C 1.508 -0.378 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -114.29 -147.26 0.41 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.072 -0.564 . . . . 0.0 109.591 -175.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' B' ' 45' ' ' TYR . . . -72.45 167.69 53.22 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.673 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.497 ' HE2' ' HB2' ' B' ' 41' ' ' SER . 2.1 mppt? -80.04 130.03 34.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.781 0.324 . . . . 0.0 110.943 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.476 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 26.6 tp -149.84 92.75 1.94 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 20.3 m -88.61 107.7 19.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.974 -175.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.476 ' CD1' ' HG ' ' B' ' 27' ' ' LEU . 9.3 mp -90.26 162.68 15.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.751 0.786 . . . . 0.0 111.548 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.6 p -156.0 144.68 20.26 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.718 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . 0.429 ' HG2' HG23 ' B' ' 13' ' ' ILE . 0.6 OUTLIER -106.91 139.45 41.29 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.924 0.392 . . . . 0.0 111.232 -173.616 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . 0.532 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 2.5 t30 -142.29 57.4 1.46 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 170.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . 0.481 ' O ' ' HA3' ' B' ' 86' ' ' GLY . . . 45.44 -95.01 0.01 OUTLIER Glycine 0 C--N 1.333 0.403 0 O-C-N 123.806 0.691 . . . . 0.0 113.075 -175.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.706 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 4.6 p30 -80.61 10.82 4.31 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.814 0.446 . . . . 0.0 112.17 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.669 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 21.0 mt-30 -132.98 147.81 52.27 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.366 0.603 . . . . 0.0 110.544 165.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.47 116.05 19.82 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -116.99 138.78 51.34 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.614 -172.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -158.66 139.12 12.53 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.115 0.484 . . . . 0.0 111.521 -177.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 13.8 p -115.9 138.35 51.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.612 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.3 p -123.43 142.47 50.95 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.172 0.51 . . . . 0.0 111.551 -174.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.497 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . 2.5 m -117.82 143.97 45.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.618 175.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -99.5 44.0 1.04 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.823 -168.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.42 -32.19 68.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.103 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.72 63.72 0.03 OUTLIER Glycine 0 CA--C 1.49 -1.482 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.287 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.773 ' CD1' ' HA ' ' B' ' 71' ' ' THR . 2.5 t80 -69.42 152.87 44.39 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 161.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.586 ' N ' ' CD1' ' B' ' 45' ' ' TYR . . . 106.38 57.18 0.63 Allowed Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 5.6 mm -79.33 -69.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.606 -0.797 . . . . 0.0 110.3 -171.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 69.1 m -152.46 -106.19 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.202 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.46 ' O ' ' HG2' ' B' ' 52' ' ' LYS . 64.9 m-85 58.94 20.66 8.37 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.083 0.553 . . . . 0.0 112.15 177.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 46.57 -95.12 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.83 0.706 . . . . 0.0 110.503 -171.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.479 ' HB3' HD21 ' B' ' 67' ' ' ASN . 9.3 m-20 -149.38 110.51 4.38 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 169.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' B' ' 49' ' ' TYR . 72.3 mmtt -121.13 122.29 39.7 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -113.52 130.58 56.31 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.298 0.571 . . . . 0.0 110.988 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.498 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 26.7 p-90 -141.0 168.45 19.76 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.695 176.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.56 145.13 16.79 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.706 -174.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.529 HD12 ' CD2' ' B' ' 64' ' ' TYR . 26.4 mt -106.76 141.73 21.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 171.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.711 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 63.5 m-85 -123.33 143.04 50.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.722 -174.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.625 HG12 ' HB ' ' B' ' 63' ' ' VAL . 10.4 p -128.0 136.89 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.476 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.3 m-80 61.69 11.04 3.71 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.989 0.515 . . . . 0.0 109.626 -172.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.51 0.64 66.96 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.278 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' B' ' 58' ' ' VAL . 15.7 mt-10 -106.8 176.27 5.23 Favored 'General case' 0 C--O 1.199 -1.597 0 C-N-CA 123.521 0.728 . . . . 0.0 109.139 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.503 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.4 tppp? -66.08 162.42 19.61 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 119.092 0.86 . . . . 0.0 109.949 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.625 ' HB ' HG12 ' B' ' 58' ' ' VAL . 7.8 p -153.42 -18.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.918 0.389 . . . . 0.0 110.371 167.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.686 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.8 OUTLIER -160.78 126.41 3.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 110.359 -172.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.3 m -134.23 126.64 30.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.48 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.572 ' HB2' HD13 ' B' ' 75' ' ' ILE . 0.7 OUTLIER -169.38 152.35 4.83 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.124 0.964 . . . . 0.0 112.467 -174.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.479 HD21 ' HB3' ' B' ' 51' ' ' ASP . 17.3 t-20 -92.61 153.98 18.67 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.233 -1.803 . . . . 0.0 109.956 174.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . 0.42 ' HA ' ' OH ' ' B' ' 45' ' ' TYR . 22.6 mm-40 -75.86 -3.68 36.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.192 0.52 . . . . 0.0 111.782 -174.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -111.43 -7.5 14.35 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.896 0.379 . . . . 0.0 111.431 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 1.3 t -73.92 -3.63 30.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.396 0.617 . . . . 0.0 111.688 -173.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.773 ' HA ' ' CD1' ' B' ' 45' ' ' TYR . 13.3 p 64.75 98.5 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.742 1.217 . . . . 0.0 111.444 173.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.518 ' HA ' HD12 ' B' ' 75' ' ' ILE . 7.7 m -66.64 -12.37 14.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.63 -169.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.24 -41.42 98.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.933 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -82.8 -30.76 28.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.206 0.527 . . . . 0.0 110.523 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.572 HD13 ' HB2' ' B' ' 66' ' ' PHE . 1.3 mt -75.62 -53.44 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.657 -176.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 22.5 t -58.38 -29.13 65.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.3 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -48.12 -54.74 12.23 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.778 0.799 . . . . 0.0 110.391 172.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 10.3 m-20 -69.36 -49.51 54.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.262 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.686 HG13 ' CE1' ' B' ' 64' ' ' TYR . 46.7 mm -52.29 -37.11 22.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -70.06 -20.78 63.21 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 46.9 pttt -83.26 -1.54 53.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.192 0.52 . . . . 0.0 109.986 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 3.7 mm? -77.46 -5.31 49.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.832 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 55.9 t30 51.38 63.51 2.21 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.427 -171.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.669 ' O ' ' HA ' ' B' ' 35' ' ' GLN . 48.2 mt -55.23 145.3 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.069 -172.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.706 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 50.3 mtmt -114.78 -176.94 3.01 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.779 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.498 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -142.0 113.11 0.79 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.844 -0.694 . . . . 0.0 111.725 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 12.2 tpp -150.25 -70.74 0.18 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 120.832 0.348 . . . . 0.0 110.221 178.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -129.29 87.16 2.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.711 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 46.1 mm -85.9 132.51 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.213 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 33.9 mt-10 -119.2 145.06 46.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.495 173.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.49 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 44.8 mm -129.14 112.06 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.502 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.522 ' HE2' ' CE2' ' B' ' 57' ' ' PHE . 45.3 pttt -166.83 166.83 15.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.041 0.448 . . . . 0.0 111.819 -174.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -94.11 149.17 21.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.157 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.497 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.7 pt . . . . . 0 C--O 1.25 1.13 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.061 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 21.8 mmt . . . . . 0 N--CA 1.443 -0.782 0 CA-C-O 122.074 0.94 . . . . 0.0 113.359 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.07 -26.43 67.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.963 175.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.431 ' O ' HG23 ' B' ' 16' ' ' VAL . 49.1 m -67.16 -22.56 65.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.922 -174.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.555 HG21 ' HG3' ' B' ' 31' ' ' MET . 2.1 mm -60.41 -43.46 94.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.925 0.869 . . . . 0.0 109.61 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -66.51 -33.72 76.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.978 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 4.2 m -65.22 -44.43 88.29 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.941 176.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.431 HG23 ' O ' ' B' ' 12' ' ' SER . 91.9 t -61.0 -43.59 96.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.152 0.501 . . . . 0.0 110.111 176.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.469 ' OD1' ' HB2' ' B' ' 29' ' ' LEU . 0.2 OUTLIER -56.02 -41.66 75.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.233 -179.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.39 -37.48 37.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.149 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -59.88 -43.64 94.65 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 122.86 0.464 . . . . 0.0 111.688 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.485 HD21 ' HE1' ' B' ' 54' ' ' TRP . 81.1 mt -83.66 28.6 0.56 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.896 -175.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -104.01 29.64 5.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.804 0.812 . . . . 0.0 108.954 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -119.33 57.52 0.89 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.317 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' B' ' 25' ' ' GLY . . . 163.28 47.2 0.02 OUTLIER Glycine 0 CA--C 1.503 -0.667 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.717 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.401 ' HB2' ' N ' ' B' ' 45' ' ' TYR . 34.4 mmtp 57.06 -63.27 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 170.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.613 ' H ' ' HA ' ' B' ' 45' ' ' TYR . . . -36.87 105.64 0.04 OUTLIER Glycine 0 C--N 1.33 0.248 0 O-C-N 124.006 0.816 . . . . 0.0 113.158 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.545 ' CE ' ' HB2' ' B' ' 41' ' ' SER . 34.3 pttt -63.67 132.34 50.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.941 0.401 . . . . 0.0 111.327 -176.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' B' ' 39' ' ' THR . 8.7 tp -146.09 104.7 3.85 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.073 -173.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -98.84 115.38 28.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.486 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.469 ' HB2' ' OD1' ' B' ' 17' ' ' ASN . 11.1 mp -89.05 165.93 14.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.817 0.818 . . . . 0.0 111.547 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 68.4 m -147.55 142.24 26.67 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.186 174.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . 0.555 ' HG3' HG21 ' B' ' 13' ' ' ILE . 0.1 OUTLIER -112.54 117.72 33.11 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.885 -171.242 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . 0.512 HD22 ' NE2' ' B' ' 35' ' ' GLN . 59.9 t30 -140.88 59.53 1.53 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.258 172.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 49.75 -87.09 0.01 OUTLIER Glycine 0 C--N 1.339 0.71 0 O-C-N 124.305 1.003 . . . . 0.0 115.133 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -66.35 -15.33 63.19 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.853 0.461 . . . . 0.0 111.6 -174.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.512 ' NE2' HD22 ' B' ' 32' ' ' ASN . 14.1 pt20 -132.56 149.01 52.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.057 0.932 . . . . 0.0 112.505 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.463 HD13 HG23 ' B' ' 13' ' ' ILE . 19.0 tp -112.45 101.67 9.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.604 -1.634 . . . . 0.0 107.964 170.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.419 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 35.5 mtmt -102.58 152.41 21.21 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.008 -1.451 . . . . 0.0 108.753 -172.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.86 156.93 2.91 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 1.3 p -126.27 144.94 50.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.982 175.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 16.2 m -144.02 151.31 39.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -175.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.545 ' HB2' ' CE ' ' B' ' 26' ' ' LYS . 20.1 m -138.02 158.49 44.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.288 170.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . 0.457 ' C ' ' H ' ' B' ' 44' ' ' GLY . 48.7 m-80 -109.63 46.01 1.04 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.896 -173.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.67 22.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.658 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.612 ' O ' HD11 ' B' ' 47' ' ' ILE . . . 165.9 -49.82 0.27 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.613 ' HA ' ' H ' ' B' ' 25' ' ' GLY . 7.3 p90 53.25 -177.75 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.0 1.32 . . . . 0.0 113.856 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.511 ' C ' HD13 ' B' ' 47' ' ' ILE . . . -70.74 105.76 1.69 Allowed Glycine 0 C--N 1.337 0.604 0 CA-C-N 116.014 -0.539 . . . . 0.0 113.934 -170.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.612 HD11 ' O ' ' B' ' 44' ' ' GLY . 3.4 mm -113.13 -70.0 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.988 0.423 . . . . 0.0 110.748 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.0 m -61.85 -51.75 66.96 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.816 0.817 . . . . 0.0 110.404 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -59.86 108.81 0.81 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.929 -1.487 . . . . 0.0 109.111 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.446 ' HB2' ' H ' ' B' ' 51' ' ' ASP . 0.0 OUTLIER -81.02 -157.8 0.18 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.849 0.357 . . . . 0.0 111.195 -176.67 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.448 ' HA ' ' OD1' ' B' ' 67' ' ' ASN . 9.6 p-10 -74.88 108.9 7.92 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.228 1.013 . . . . 0.0 111.152 -173.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 44.3 mttm -122.51 125.57 46.03 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.724 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -108.16 136.02 48.53 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.899 0.38 . . . . 0.0 110.848 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.668 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 21.9 p-90 -147.89 158.87 44.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.251 171.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.44 143.77 15.22 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.224 -174.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.482 ' O ' HG12 ' B' ' 63' ' ' VAL . 6.0 mt -102.84 143.1 15.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 173.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.61 ' HB2' ' HB2' ' B' ' 90' ' ' GLU . 55.4 m-85 -124.4 140.95 52.47 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.534 -176.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.492 HG12 ' HB ' ' B' ' 63' ' ' VAL . 9.1 p -128.49 134.87 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.44 ' ND2' HG13 ' B' ' 58' ' ' VAL . 2.1 m-80 60.91 13.32 4.42 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.95 -174.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.4 -0.88 63.88 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.631 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -104.81 172.95 6.52 Favored 'General case' 0 C--O 1.207 -1.16 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.454 ' HZ3' ' HE1' ' B' ' 57' ' ' PHE . 12.0 tppt? -61.28 164.71 5.15 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.492 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.8 p -146.91 -22.66 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 167.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.431 ' CE2' ' CG1' ' B' ' 79' ' ' ILE . 2.2 t80 -171.68 144.66 1.87 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.989 -173.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 78.2 m -133.31 128.46 35.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.649 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.763 ' HD2' HD13 ' B' ' 75' ' ' ILE . 14.3 p90 -158.96 -171.39 3.38 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.221 0.534 . . . . 0.0 110.799 -176.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.7 t-20 -151.57 144.15 24.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.317 -166.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . 0.467 ' OE1' ' HB2' ' B' ' 52' ' ' LYS . 2.4 mp0 -63.99 -34.25 77.57 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -78.93 -18.25 54.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.235 0.541 . . . . 0.0 110.125 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 3.1 t -71.64 -8.12 52.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.662 ' O ' HG13 ' B' ' 75' ' ' ILE . 7.5 p 65.08 112.28 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.687 -1.597 . . . . 0.0 112.372 173.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.713 ' HA ' HD12 ' B' ' 75' ' ' ILE . 2.9 m -61.02 -15.14 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.449 -170.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' B' ' 40' ' ' SER . . . -67.06 -50.49 45.89 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.288 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -75.2 -19.17 59.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.491 0.662 . . . . 0.0 109.506 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.763 HD13 ' HD2' ' B' ' 66' ' ' PHE . 49.6 mt -73.64 -53.61 17.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.015 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.401 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 43.5 t -55.87 -33.05 64.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.12 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -52.0 -48.19 64.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.126 173.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.69 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 5.7 m-20 -70.54 -41.45 72.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.131 177.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.462 HG23 HD13 ' B' ' 84' ' ' ILE . 58.2 mt -54.55 -37.74 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.0 0.429 . . . . 0.0 111.381 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -58.12 -34.57 70.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.396 177.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.69 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 18.8 pttp -85.07 -31.0 23.62 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.663 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.01 -26.75 68.42 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.778 0.323 . . . . 0.0 110.23 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 4.8 t30 42.54 69.84 0.34 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.456 -172.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.613 ' H ' HD12 ' B' ' 84' ' ' ILE . 2.6 mp -59.13 131.18 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.017 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -86.47 -170.74 3.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.842 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.95 111.66 0.67 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.348 -0.929 . . . . 0.0 112.607 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 19.3 tpp -150.08 -68.58 0.2 Allowed 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -127.96 84.83 2.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 45.5 mm -85.73 130.77 35.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.983 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.61 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 27.7 mt-10 -123.7 150.19 44.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.034 0.445 . . . . 0.0 111.526 175.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.668 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 83.6 mt -129.74 125.61 61.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.491 176.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.477 ' HE3' ' CE2' ' B' ' 57' ' ' PHE . 14.9 pttp -167.57 164.97 14.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.131 0.491 . . . . 0.0 111.504 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -95.47 134.59 38.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.125 -174.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.569 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.2 pt . . . . . 0 C--O 1.247 0.938 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.682 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . 0.698 ' SD ' ' HA ' ' B' ' 34' ' ' ASN . 75.2 mtm . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -56.75 -32.31 65.45 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.994 0.902 . . . . 0.0 110.044 173.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.567 ' O ' HG23 ' B' ' 16' ' ' VAL . 3.4 m -69.76 -30.75 68.41 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.253 -175.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.423 ' CG1' ' HB3' ' B' ' 10' ' ' MET . 11.3 mm -68.97 -35.86 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.914 -172.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . 0.658 HD22 ' N ' ' B' ' 14' ' ' ASN . 0.7 OUTLIER -69.02 -32.17 71.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.085 -178.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 32.8 t -69.48 -35.13 75.29 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.016 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.567 HG23 ' O ' ' B' ' 12' ' ' SER . 15.7 t -64.22 -42.47 95.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.691 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.475 HD22 HD23 ' B' ' 29' ' ' LEU . 5.2 t-20 -57.59 -38.18 74.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.227 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.13 -40.05 32.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.216 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -65.13 -57.04 9.59 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.439 0.696 . . . . 0.0 112.455 -176.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.532 HD21 ' HZ2' ' B' ' 54' ' ' TRP . 43.6 mt -68.75 -31.39 70.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.703 -175.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.84 61.05 5.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.284 0.564 . . . . 0.0 110.529 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -121.59 -86.73 0.65 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.082 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.82 51.06 0.84 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.75 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.526 ' HE2' ' O ' ' B' ' 68' ' ' GLU . 31.5 mmtp -114.16 -161.43 0.77 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.403 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -73.01 -175.48 29.05 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.139 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.823 ' O ' ' HA ' ' B' ' 40' ' ' SER . 16.4 ptpt -67.76 105.15 1.84 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 174.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.592 ' HA ' ' O ' ' B' ' 39' ' ' THR . 17.8 tp -119.24 128.17 53.93 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.442 -162.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 67.3 m -117.87 126.05 51.65 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.164 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.57 HD12 HD21 ' B' ' 36' ' ' LEU . 1.7 mm? -104.83 147.88 27.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.117 0.484 . . . . 0.0 110.343 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 11.3 p -142.67 150.2 39.87 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.199 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 73.7 mtp -114.39 136.33 53.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.093 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -144.34 115.98 8.17 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.15 -107.28 2.05 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.698 ' HA ' ' SD ' ' B' ' 10' ' ' MET . 2.6 m-20 -123.67 14.83 9.44 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.495 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 75.1 mt-30 -78.48 162.07 26.62 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.304 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.57 HD21 HD12 ' B' ' 29' ' ' LEU . 6.1 tt -133.15 123.15 25.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.347 168.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -118.59 143.88 46.49 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.528 ' HB1' HD11 ' B' ' 27' ' ' LEU . . . -139.81 143.96 37.09 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.062 -0.655 . . . . 0.0 112.333 -170.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.592 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 8.6 p -128.02 141.63 51.46 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.105 175.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.823 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 21.2 p -153.13 145.25 23.81 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.713 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.441 ' HB2' ' CG ' ' B' ' 26' ' ' LYS . 16.9 m -113.18 167.16 10.78 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.367 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -78.88 47.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.194 -172.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.62 -59.82 2.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.015 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.505 ' O ' HD11 ' B' ' 47' ' ' ILE . . . -154.7 55.26 0.42 Allowed Glycine 0 C--N 1.313 -0.746 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.764 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.595 ' O ' HG13 ' B' ' 47' ' ' ILE . 41.4 p90 -77.63 160.16 28.71 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -172.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' B' ' 69' ' ' LYS . . . 14.87 76.5 0.01 OUTLIER Glycine 0 C--N 1.337 0.636 0 O-C-N 125.269 1.606 . . . . 0.0 116.498 168.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.595 HG13 ' O ' ' B' ' 45' ' ' TYR . 1.3 mp -106.75 -72.34 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-O 122.204 1.002 . . . . 0.0 111.684 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -88.33 -152.99 0.23 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.56 -1.655 . . . . 0.0 111.374 -170.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.51 ' O ' ' HE3' ' B' ' 52' ' ' LYS . 64.5 m-85 70.85 6.98 6.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.746 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 56.47 -81.36 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 124.245 0.966 . . . . 0.0 111.674 -175.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -167.28 110.43 0.68 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.51 ' HE3' ' O ' ' B' ' 49' ' ' TYR . 31.9 mmtp -129.61 124.09 32.89 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -104.34 128.13 52.1 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.548 ' HA ' HG12 ' B' ' 94' ' ' ILE . 50.0 p-90 -144.7 157.28 44.25 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -126.34 150.6 17.75 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.334 -170.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.636 HD12 ' CD2' ' B' ' 64' ' ' TYR . 28.6 mt -106.57 149.93 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 169.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.706 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 84.3 m-85 -131.52 142.69 50.0 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -169.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.609 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.9 p -131.67 140.51 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.543 ' ND2' HG13 ' B' ' 58' ' ' VAL . 8.7 m-80 66.76 0.11 1.79 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -170.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.22 0.24 59.88 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.37 -172.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 12.5 mt-10 -102.78 176.1 5.27 Favored 'General case' 0 C--O 1.201 -1.491 0 C-N-CA 123.716 0.806 . . . . 0.0 109.254 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.1 tppp? -62.37 160.37 13.5 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 118.633 0.651 . . . . 0.0 110.395 175.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.609 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.5 p -152.97 -15.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.507 168.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.636 ' CD2' HD12 ' B' ' 56' ' ' ILE . 0.8 OUTLIER -160.43 126.19 4.01 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -172.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 23.9 m -134.51 126.32 29.12 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.189 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.55 ' CB ' HD13 ' B' ' 75' ' ' ILE . 3.9 p90 -166.96 -175.16 2.93 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.533 0.682 . . . . 0.0 110.424 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 10.0 t-20 -128.77 168.27 16.11 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.093 -170.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . 0.526 ' O ' ' HE2' ' B' ' 24' ' ' LYS . 8.9 mm-40 -85.81 -11.08 54.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.871 0.367 . . . . 0.0 110.955 -177.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.487 ' O ' ' HA3' ' B' ' 46' ' ' GLY . 51.1 tttm -100.78 -26.1 13.9 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.505 ' OG ' HD11 ' B' ' 75' ' ' ILE . 21.5 t -63.88 152.07 40.76 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.811 0.815 . . . . 0.0 108.989 174.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.449 ' O ' HG13 ' B' ' 75' ' ' ILE . 0.1 OUTLIER -99.26 109.59 22.22 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.113 -173.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.583 ' HA ' HD12 ' B' ' 75' ' ' ILE . 3.6 m -67.33 -14.47 18.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.425 -167.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.54 -47.96 88.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.675 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -74.42 -32.84 62.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.045 0.45 . . . . 0.0 110.609 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' B' ' 72' ' ' VAL . 1.4 mt -70.33 -51.33 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.127 0.489 . . . . 0.0 110.274 -177.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 16.6 t -61.94 -28.77 69.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.563 -176.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -50.67 -53.5 30.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.527 0.679 . . . . 0.0 110.268 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.753 ' O ' ' HG3' ' B' ' 81' ' ' LYS . 0.8 OUTLIER -69.29 -43.07 74.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.099 179.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.558 HG13 ' CE1' ' B' ' 64' ' ' TYR . 42.8 mm -51.77 -37.98 21.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.266 0.555 . . . . 0.0 111.718 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -66.27 -28.42 68.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.326 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.753 ' HG3' ' O ' ' B' ' 78' ' ' ASP . 0.0 OUTLIER -84.6 -0.43 53.23 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.758 -176.582 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 3.1 mm? -72.78 -11.84 60.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.232 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 62.6 t30 50.61 58.97 4.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.634 -172.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.495 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 68.9 mt -61.59 150.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.375 -173.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.434 ' O ' HG22 ' B' ' 84' ' ' ILE . 64.8 mttm -103.26 -178.53 3.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.381 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -139.62 115.3 1.08 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.795 -1.193 . . . . 0.0 113.805 -177.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.425 ' SD ' ' HA ' ' B' ' 59' ' ' ASN . 1.7 pmm? -165.25 -57.64 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 175.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . 0.424 ' N ' ' HG2' ' B' ' 87' ' ' MET . 15.7 t80 -129.31 83.23 2.13 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 121.611 -0.681 . . . . 0.0 109.778 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.706 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 23.4 mm -92.21 121.9 43.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.222 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -109.14 171.54 7.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.985 0.421 . . . . 0.0 109.933 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.525 HG12 ' HB3' ' B' ' 12' ' ' SER . 30.4 mm -152.94 115.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.677 -175.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -169.18 165.79 10.93 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.177 0.513 . . . . 0.0 111.875 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.484 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 3.1 pp0? -82.76 143.61 30.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.854 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' B' ' 54' ' ' TRP . 6.2 pt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.868 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.455 -0.183 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -47.44 -32.47 5.11 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.52 ' CB ' ' HB ' ' B' ' 89' ' ' ILE . 12.2 m -65.49 -27.23 68.34 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.99 -173.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mm -67.4 -47.06 82.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 122.079 0.942 . . . . 0.0 109.392 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . 0.412 ' ND2' ' H ' ' B' ' 14' ' ' ASN . 11.2 m-80 -59.23 -32.6 70.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.285 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 9.9 t -68.51 -42.28 78.79 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.801 177.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.484 HG23 ' O ' ' B' ' 12' ' ' SER . 97.7 t -55.26 -42.75 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.128 0.49 . . . . 0.0 110.379 177.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.503 ' ND2' ' HB2' ' B' ' 29' ' ' LEU . 2.3 t-20 -56.73 -45.66 81.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.758 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.92 -38.9 52.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.237 -175.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' B' ' 15' ' ' SER . 24.1 mmmt -78.5 -8.26 58.36 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -172.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.422 HD21 ' CZ ' ' B' ' 66' ' ' PHE . 15.6 mt -91.63 23.43 3.54 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . 0.494 ' CG ' ' H ' ' B' ' 22' ' ' LYS . 20.3 p-10 -88.73 -79.34 0.31 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 171.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.494 ' H ' ' CG ' ' B' ' 21' ' ' ASN . 28.7 mtpp 48.61 34.01 4.65 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 169.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 146.8 -92.38 0.15 Allowed Glycine 0 N--CA 1.439 -1.167 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.472 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.58 ' HD2' ' CD1' ' B' ' 47' ' ' ILE . 58.0 mttm -152.84 -141.75 0.11 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -171.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.663 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . 68.05 111.75 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.8 -173.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' B' ' 40' ' ' SER . 0.3 OUTLIER -63.0 115.44 4.41 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 173.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.521 HD22 ' CG2' ' B' ' 72' ' ' VAL . 4.0 tp -152.85 105.08 2.91 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 72.4 m -97.76 113.92 25.81 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.344 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.503 ' HB2' ' ND2' ' B' ' 17' ' ' ASN . 2.8 mm? -86.75 159.85 19.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.477 0.656 . . . . 0.0 110.59 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.555 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 0.1 OUTLIER -151.11 147.66 27.34 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.313 173.52 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 58.8 mtm -118.81 141.09 48.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.149 0.5 . . . . 0.0 111.839 -168.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . 0.532 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 49.6 t30 -150.55 60.48 0.95 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.405 173.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.78 -92.83 0.01 OUTLIER Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.2 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.35 -18.17 57.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.774 -0.213 . . . . 0.0 111.328 -177.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.532 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 68.5 mt-30 -101.53 147.0 26.9 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.666 0.746 . . . . 0.0 111.422 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.19 104.81 9.4 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.506 174.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.555 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 8.1 mmmm -102.56 142.73 33.25 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -172.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -162.92 145.1 10.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -174.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 7.9 p -122.13 143.18 49.7 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 172.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 20.3 m -137.15 155.45 49.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.45 0.643 . . . . 0.0 112.256 -173.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.431 ' HB3' ' CB ' ' B' ' 26' ' ' LYS . 32.5 t -137.87 154.53 49.47 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.618 176.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -105.93 37.05 2.35 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.924 -170.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.23 23.12 0.29 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.591 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.45 -56.71 0.41 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.728 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.663 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 14.8 p90 47.58 -161.88 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.48 1.112 . . . . 0.0 113.784 175.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.601 ' HA2' ' OH ' ' B' ' 49' ' ' TYR . . . -69.07 104.7 1.31 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 116.34 -0.391 . . . . 0.0 113.358 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.58 ' CD1' ' HD2' ' B' ' 24' ' ' LYS . 2.1 mp -100.28 -71.33 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 122.11 0.957 . . . . 0.0 110.685 179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 18.4 m -99.75 -118.65 0.15 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.036 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.601 ' OH ' ' HA2' ' B' ' 46' ' ' GLY . 0.1 OUTLIER 38.46 45.86 0.89 Allowed 'General case' 0 N--CA 1.472 0.625 0 O-C-N 123.693 0.621 . . . . 0.0 111.226 -171.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 48.55 -94.5 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.836 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.426 ' CG ' HD21 ' B' ' 67' ' ' ASN . 18.1 t70 -174.41 109.85 0.14 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -177.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.638 ' HB2' ' OE2' ' B' ' 68' ' ' GLU . 47.4 mmtt -123.26 136.84 54.9 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -174.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.454 ' CG ' HD22 ' B' ' 67' ' ' ASN . 47.2 m-80 -120.1 140.32 51.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.799 0.333 . . . . 0.0 111.344 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.624 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 22.2 p-90 -156.23 172.02 19.19 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.505 172.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.7 147.07 19.0 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.661 -173.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 25.0 mt -107.14 146.32 13.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 170.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.639 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 60.3 m-85 -126.63 143.89 51.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.426 -174.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.603 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.1 p -129.68 136.43 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.522 ' ND2' HG13 ' B' ' 58' ' ' VAL . 1.6 m-80 59.13 14.93 3.77 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.118 0.567 . . . . 0.0 109.842 -174.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.37 -1.5 66.95 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.496 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 14.6 mt-10 -105.86 177.5 4.83 Favored 'General case' 0 C--O 1.205 -1.266 0 C-N-CA 123.644 0.778 . . . . 0.0 109.162 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.2 tppp? -66.14 163.04 18.43 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 172.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.603 ' HB ' HG12 ' B' ' 58' ' ' VAL . 11.3 p -151.48 -21.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.104 0.478 . . . . 0.0 109.877 167.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.687 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.6 OUTLIER -161.31 123.46 3.02 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.163 0.506 . . . . 0.0 110.845 -171.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 8.6 m -129.48 129.4 44.55 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.421 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.475 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.0 OUTLIER -153.01 -176.7 5.88 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 122.261 1.029 . . . . 0.0 111.875 -176.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.454 HD22 ' CG ' ' B' ' 53' ' ' ASN . 23.9 t-20 -147.28 149.09 32.19 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 112.897 -1.956 . . . . 0.0 108.365 -176.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . 0.638 ' OE2' ' HB2' ' B' ' 52' ' ' LYS . 0.4 OUTLIER -66.48 -21.1 66.18 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -172.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.443 ' O ' HG23 ' B' ' 71' ' ' THR . 85.4 tttt -95.88 -20.91 18.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.226 0.536 . . . . 0.0 110.011 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 6.7 t -69.88 -23.63 63.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.674 174.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.587 HG21 ' CD1' ' B' ' 45' ' ' TYR . 19.2 p 61.87 107.13 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.313 1.045 . . . . 0.0 111.878 174.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.629 ' HA ' HD12 ' B' ' 75' ' ' ILE . 6.0 m -64.41 -16.47 19.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.606 -169.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.07 -48.5 82.48 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.269 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -75.43 -28.91 59.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.285 0.564 . . . . 0.0 110.572 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' B' ' 72' ' ' VAL . 2.9 mt -73.0 -47.83 46.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.595 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 42.1 m -52.08 -35.43 47.61 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.041 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -48.51 -58.26 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.788 0.804 . . . . 0.0 110.336 172.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.548 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 7.1 m-20 -70.31 -35.9 73.97 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.572 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.687 HG13 ' CE1' ' B' ' 64' ' ' TYR . 41.5 mm -58.81 -25.54 29.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.571 0.7 . . . . 0.0 111.729 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -69.18 4.54 1.59 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.406 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 0.1 OUTLIER -105.17 -0.61 26.36 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.132 0.492 . . . . 0.0 110.446 176.134 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' B' ' 79' ' ' ILE . 2.4 mm? -79.56 -4.46 51.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.999 -169.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . 0.423 ' C ' HD22 ' B' ' 83' ' ' ASN . 0.2 OUTLIER 53.13 58.85 4.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -170.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.447 HD11 HG22 ' B' ' 79' ' ' ILE . 59.8 mt -56.84 155.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.121 -175.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -134.86 -171.69 2.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.882 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -149.47 112.7 0.57 Allowed Glycine 0 C--N 1.309 -0.945 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.463 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.456 ' HG2' ' N ' ' B' ' 88' ' ' TYR . 16.0 ttt -160.29 -76.3 0.06 Allowed 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . 0.456 ' N ' ' HG2' ' B' ' 87' ' ' MET . 49.7 t80 -120.11 94.05 4.26 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.639 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 22.3 mm -96.32 130.52 44.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.672 -177.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 51.3 mm-40 -123.94 154.99 38.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.4 . . . . 0.0 111.528 177.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.567 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 72.2 mt -137.54 126.25 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.646 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.624 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 49.6 pttt -172.62 167.27 5.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.064 0.459 . . . . 0.0 111.262 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.725 ' NE2' ' H ' ' B' ' 93' ' ' GLN . 0.6 OUTLIER -96.77 151.67 19.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.427 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.559 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.9 pt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.038 -0.982 . . . . 0.0 111.038 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . 0.418 ' O ' HG13 ' B' ' 13' ' ' ILE . 25.8 mmt . . . . . 0 C--O 1.226 -0.183 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -40.25 -19.89 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.42 1.488 . . . . 0.0 114.092 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.43 ' O ' HG23 ' B' ' 16' ' ' VAL . 39.1 t -60.09 -7.3 1.76 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.569 0.747 . . . . 0.0 112.325 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.468 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.6 OUTLIER -47.91 -62.27 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.347 0 CA-C-O 121.224 0.535 . . . . 0.0 111.916 -176.064 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -106.67 -20.77 13.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.792 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 30.9 t -53.61 -38.35 63.93 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.164 -175.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 12' ' ' SER . 90.1 t -57.19 -41.93 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 111.211 -176.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.436 ' HA ' HD22 ' B' ' 29' ' ' LEU . 4.9 t-20 -67.05 -41.53 86.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.668 -176.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.07 -38.9 56.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.0 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 6.4 mmpt? -57.88 -66.22 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.501 HD21 ' CZ ' ' B' ' 66' ' ' PHE . 75.3 mt -59.1 -23.02 61.72 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.269 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -86.74 79.8 8.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.713 0.768 . . . . 0.0 110.711 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' B' ' 19' ' ' LYS . 29.7 mtpp -119.14 37.3 4.17 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.97 177.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.65 59.5 3.48 Favored Glycine 0 CA--C 1.505 -0.59 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.402 ' HE2' ' HB2' ' B' ' 22' ' ' LYS . 70.8 mmtt -125.45 -163.44 1.2 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -177.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.446 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -53.54 139.94 34.26 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.175 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.713 ' O ' ' HA ' ' B' ' 40' ' ' SER . 43.1 mtmt -61.76 107.9 0.91 Allowed 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 117.036 0.418 . . . . 0.0 109.96 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' B' ' 39' ' ' THR . 36.7 tp -125.41 122.58 37.14 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.853 -167.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 18.2 m -101.61 101.9 12.52 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.542 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.499 ' N ' HD12 ' B' ' 29' ' ' LEU . 4.9 mp -90.69 150.94 21.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 122.02 0.914 . . . . 0.0 112.485 -170.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 34.3 p -146.65 149.8 34.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.778 -1.555 . . . . 0.0 107.893 173.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 78.3 mtp -120.74 160.85 22.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.244 0.545 . . . . 0.0 111.811 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -159.09 104.94 1.72 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.599 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.91 -97.59 0.74 Allowed Glycine 0 CA--C 1.504 -0.604 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -169.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -137.17 19.77 2.98 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 168.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -77.68 155.14 31.52 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.927 175.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.472 HD21 HD23 ' B' ' 29' ' ' LEU . 2.0 tm? -126.45 116.99 21.99 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.18 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -120.97 133.01 55.26 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.726 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -162.82 150.44 13.56 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -170.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.62 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 18.4 p -112.14 148.11 34.69 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.713 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 7.7 p -134.34 146.47 49.97 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -170.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' B' ' 26' ' ' LYS . 47.3 t -118.82 165.26 14.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.399 167.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -113.93 18.72 17.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.165 0.507 . . . . 0.0 111.238 -172.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.75 -61.45 2.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.181 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.54 53.94 0.56 Allowed Glycine 0 C--N 1.311 -0.807 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.985 -176.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.446 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 0.1 OUTLIER -63.65 -165.69 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.03 0.532 . . . . 0.0 112.192 -177.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.559 ' H ' HG22 ' B' ' 71' ' ' THR . . . -70.33 106.66 1.9 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.154 175.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 4.7 mm -64.0 -68.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.974 0.416 . . . . 0.0 110.173 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.0 m -123.28 -90.79 0.56 Allowed 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.18 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 56.15 33.91 22.91 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 122.761 0.424 . . . . 0.0 111.332 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 34.02 -109.62 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.727 -1.124 . . . . 0.0 113.111 -175.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -150.65 110.52 4.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.828 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.428 ' HB2' ' HG2' ' B' ' 68' ' ' GLU . 54.2 mttm -131.53 135.16 46.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.529 HD22 ' N ' ' B' ' 53' ' ' ASN . 0.8 OUTLIER -111.5 136.09 51.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.846 0.355 . . . . 0.0 110.156 -179.446 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.678 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 48.0 p-90 -151.2 166.99 29.19 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 172.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.71 159.4 26.86 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 119.989 -1.1 . . . . 0.0 113.711 -170.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 13.3 mt -105.7 142.85 17.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 171.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.58 ' CE1' ' HG3' ' B' ' 62' ' ' LYS . 48.8 m-85 -126.23 131.29 51.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.998 -0.092 . . . . 0.0 110.756 -177.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.618 HG12 ' HB ' ' B' ' 63' ' ' VAL . 12.2 p -116.26 133.86 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.276 -177.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.431 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.8 m-80 65.78 5.01 3.15 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.719 0.808 . . . . 0.0 110.263 -177.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.61 11.9 56.4 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.829 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 14.8 mt-10 -110.25 173.7 6.21 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 171.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.58 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 24.9 ttmt -76.49 168.77 19.48 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 119.427 1.012 . . . . 0.0 108.971 173.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.618 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.4 p -151.47 -19.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.804 171.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.643 ' CD2' HD11 ' B' ' 79' ' ' ILE . 0.0 OUTLIER -163.33 153.21 15.4 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.588 -175.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 27.6 m -149.97 130.03 13.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.308 177.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.661 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -145.11 -176.76 5.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.724 0.773 . . . . 0.0 110.769 -178.803 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.45 HD22 ' ND2' ' B' ' 53' ' ' ASN . 24.6 t-20 -136.22 160.2 39.41 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.156 -1.384 . . . . 0.0 110.219 -175.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . 0.428 ' HG2' ' HB2' ' B' ' 52' ' ' LYS . 62.2 mm-40 -61.15 -44.25 97.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.865 0.364 . . . . 0.0 111.724 -177.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.557 ' O ' HG23 ' B' ' 71' ' ' THR . 50.3 tptt -80.86 -19.76 43.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.838 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 8.7 t -69.1 -18.38 63.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.402 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.559 HG22 ' H ' ' B' ' 46' ' ' GLY . 41.0 p 56.27 105.93 0.01 OUTLIER 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.304 1.041 . . . . 0.0 113.332 170.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.581 ' HA ' HD12 ' B' ' 75' ' ' ILE . 11.1 m -57.65 -15.12 3.67 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-N 114.556 -1.202 . . . . 0.0 113.265 -171.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.58 -52.3 46.26 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.979 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -76.45 -32.68 58.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.354 0.597 . . . . 0.0 109.976 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.661 HD13 ' HB3' ' B' ' 66' ' ' PHE . 1.9 mt -72.03 -53.93 18.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.604 -173.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.8 m -69.75 -14.08 62.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.52 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -61.93 -42.24 98.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.768 0.794 . . . . 0.0 109.459 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 4.3 m-20 -68.95 -32.46 72.07 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.529 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.643 HD11 ' CD2' ' B' ' 64' ' ' TYR . 17.7 mm -55.67 -26.35 19.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -54.85 -27.26 40.96 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.296 173.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 19.8 pttm -104.11 -6.14 21.37 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -172.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' B' ' 79' ' ' ILE . 2.8 mm? -70.97 -18.3 62.62 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 122.126 -0.359 . . . . 0.0 111.815 -173.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 61.0 t30 45.97 55.69 6.8 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.972 0.795 . . . . 0.0 110.63 -171.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.485 HG22 ' O ' ' B' ' 85' ' ' LYS . 83.1 mt -59.81 145.5 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.171 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.485 ' O ' HG22 ' B' ' 84' ' ' ILE . 62.3 mttp -89.88 178.27 6.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.32 176.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -134.33 112.58 1.06 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.474 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.24 -79.73 0.09 Allowed 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . 0.408 ' H ' ' HA ' ' B' ' 59' ' ' ASN . 25.5 t80 -122.33 88.07 2.87 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 28.0 mm -90.83 128.66 42.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.912 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.58 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 33.8 mt-10 -117.52 144.73 44.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.588 173.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.413 HG21 ' HG3' ' B' ' 19' ' ' LYS . 2.5 mt -134.75 102.81 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.678 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 48.0 pttt -154.65 178.01 10.59 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -169.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.445 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 21.1 mm-40 -99.01 146.8 25.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.163 -176.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.642 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.9 pt . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.305 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 15.0 mmt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.362 0.601 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -66.5 -28.26 68.43 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.956 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 24.2 m -71.45 -21.12 62.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.712 -175.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.411 ' H ' HG12 ' B' ' 13' ' ' ILE . 3.8 mm -61.93 -47.4 93.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 122.07 0.938 . . . . 0.0 109.196 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . 0.4 ' H ' ' ND2' ' B' ' 14' ' ' ASN . 8.4 m-80 -63.69 -38.39 90.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.405 -177.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -62.2 -44.27 96.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.934 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.96 -48.0 91.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.096 0.474 . . . . 0.0 110.329 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -60.11 -37.05 78.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.882 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . 0.677 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.2 OUTLIER -71.32 -57.47 4.43 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.377 176.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -55.59 -49.96 71.38 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.059 0.944 . . . . 0.0 112.85 -173.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.424 HD22 HG11 ' B' ' 72' ' ' VAL . 47.2 mt -71.17 -21.06 62.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.963 -175.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -91.94 -99.55 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.677 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 30.6 mtpp 49.9 25.79 1.74 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.67 11.22 60.84 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.933 178.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -96.25 -129.08 0.16 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 175.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.547 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -66.87 107.29 1.94 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 173.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.746 ' O ' ' HA ' ' B' ' 40' ' ' SER . 34.9 mtmt -66.97 90.08 0.18 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.846 0.314 . . . . 0.0 111.846 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 47.1 tp -108.47 93.14 4.37 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 21.0 m -81.24 105.47 12.46 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.264 -176.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.41 165.24 22.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.946 0.879 . . . . 0.0 111.601 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 49.1 m -146.49 144.35 29.58 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.363 174.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 33.9 mtt -114.26 124.1 51.19 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.817 0.341 . . . . 0.0 110.945 -170.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.83 60.04 1.32 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.662 176.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . 0.406 ' O ' ' HA3' ' B' ' 86' ' ' GLY . . . 49.55 -102.9 0.07 OUTLIER Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.248 -0.887 . . . . 0.0 113.861 178.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 4.6 m-20 -79.44 19.37 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.271 0.229 . . . . 0.0 111.435 -176.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 42.9 mt-30 -139.13 146.28 40.45 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.317 0.58 . . . . 0.0 110.472 172.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' B' ' 36' ' ' LEU . 1.4 tm? -129.05 116.66 19.64 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 176.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.489 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 16.1 mtpt -118.09 148.87 41.86 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -172.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -170.58 145.6 2.58 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -176.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 19.5 p -122.68 141.62 51.57 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.548 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.746 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 24.1 t -122.53 147.51 46.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.363 0.601 . . . . 0.0 112.163 -174.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' B' ' 26' ' ' LYS . 46.8 t -131.67 160.85 34.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.813 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' B' ' 44' ' ' GLY . 51.1 m-80 -114.1 32.84 5.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.115 -171.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.526 ' HB3' ' HE2' ' B' ' 26' ' ' LYS . . . -72.96 22.46 0.07 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.306 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' B' ' 42' ' ' ASN . . . 165.34 -43.97 0.29 Allowed Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.547 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 37.1 p90 46.04 -160.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.355 1.062 . . . . 0.0 113.013 -175.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.55 99.39 0.73 Allowed Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.842 -0.694 . . . . 0.0 114.17 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.06 -54.73 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.1 0.476 . . . . 0.0 109.782 170.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -37.93 -57.97 0.98 Allowed 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.285 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -103.81 112.91 26.08 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' B' ' 69' ' ' LYS . 30.5 mt-10 -67.75 -48.38 66.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.616 -170.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -167.22 111.93 0.72 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.443 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -132.39 142.18 49.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.848 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.59 113.87 26.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.535 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 29.1 p-90 -154.12 165.7 35.38 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.345 176.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.12 150.45 20.19 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.844 -174.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.459 HD12 ' CD2' ' B' ' 64' ' ' TYR . 24.3 mt -106.35 150.41 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 172.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 70.7 m-85 -131.9 139.43 48.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.128 -172.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.578 HG12 ' HB ' ' B' ' 63' ' ' VAL . 8.6 p -125.17 133.39 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.488 HD22 HG13 ' B' ' 58' ' ' VAL . 5.4 m-80 64.12 5.88 2.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.859 -175.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.87 -12.21 38.16 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.435 -176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' B' ' 58' ' ' VAL . 0.2 OUTLIER -100.17 177.22 5.13 Favored 'General case' 0 C--O 1.202 -1.421 0 C-N-CA 123.713 0.805 . . . . 0.0 109.938 -176.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.47 ' HD2' ' OG1' ' B' ' 65' ' ' THR . 13.1 tppt? -61.44 159.45 12.74 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 118.279 0.491 . . . . 0.0 110.485 174.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.578 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.1 p -153.7 -14.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.262 0.553 . . . . 0.0 110.389 167.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.786 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -161.14 133.99 6.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.184 -173.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.47 ' OG1' ' HD2' ' B' ' 62' ' ' LYS . 16.4 m -142.18 126.0 17.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.02 177.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.682 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -166.16 -177.8 4.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 122.567 1.175 . . . . 0.0 112.29 -174.26 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -136.83 145.9 45.0 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 112.349 -2.205 . . . . 0.0 108.736 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.3 -29.3 65.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.186 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.442 ' O ' HG23 ' B' ' 71' ' ' THR . 28.2 ttpp -80.99 -25.94 36.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.99 0.424 . . . . 0.0 110.599 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 9.8 t -68.05 -31.64 71.42 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 174.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.465 ' O ' HG13 ' B' ' 75' ' ' ILE . 11.1 p 62.77 125.08 0.01 OUTLIER 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.548 1.139 . . . . 0.0 112.614 174.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.501 ' HA ' HD12 ' B' ' 75' ' ' ILE . 11.6 m -63.92 -10.75 8.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.356 -168.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.92 -56.31 23.57 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.663 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -76.48 -31.28 57.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.39 0.614 . . . . 0.0 110.265 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.682 HD13 ' HB3' ' B' ' 66' ' ' PHE . 2.8 mt -67.93 -46.24 82.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.649 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 38.2 t -59.16 -32.71 70.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.693 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -49.04 -52.42 25.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.66 0.743 . . . . 0.0 110.286 176.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 30.3 m-20 -67.7 -47.32 69.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.018 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.786 HG13 ' CE1' ' B' ' 64' ' ' TYR . 46.2 mm -55.16 -30.75 24.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.262 0.553 . . . . 0.0 112.065 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -58.6 -20.01 43.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.269 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 0.0 OUTLIER -94.56 -4.0 48.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 0.0 111.058 -175.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.1 mm? -70.5 -16.26 62.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.99 -173.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 58.9 t30 50.84 57.64 6.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.461 -171.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' B' ' 35' ' ' GLN . 48.9 mt -57.63 144.08 10.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.94 -174.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 30.3 mtmm -109.03 -168.58 1.36 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.112 175.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' B' ' 33' ' ' GLY . . . -146.25 113.58 0.69 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.925 -177.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 37.4 ttp -157.34 -74.09 0.09 Allowed 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 116.639 0.22 . . . . 0.0 110.458 173.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -117.32 94.24 4.48 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.181 0.515 . . . . 0.0 109.694 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.571 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 20.4 mm -93.57 134.66 30.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.384 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -122.89 173.49 7.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.369 0.604 . . . . 0.0 110.937 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.535 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 92.1 mt -152.22 118.85 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.759 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 30.7 pttt -171.26 168.3 6.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.175 0.512 . . . . 0.0 111.768 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.462 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 2.4 pt20 -99.39 150.51 22.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.154 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.2 pt . . . . . 0 C--N 1.308 -1.203 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.972 -174.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . 0.466 ' O ' ' HE1' ' B' ' 31' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.277 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -36.83 -22.97 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.638 1.975 . . . . 0.0 115.825 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 15.2 m -60.33 -12.5 9.31 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 122.441 0.296 . . . . 0.0 111.792 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.451 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -53.52 -50.36 49.87 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-O 121.732 0.777 . . . . 0.0 109.849 -178.082 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' B' ' 18' ' ' ASP . 40.0 m-80 -106.82 -60.6 1.65 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.274 -175.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 5.5 m -58.24 -64.49 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.393 -170.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 67.9 t -62.94 -40.5 89.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.449 . . . . 0.0 110.701 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -56.83 -47.14 81.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.827 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . 0.755 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.1 OUTLIER -75.02 -40.54 60.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.273 -178.039 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -52.49 -35.18 52.27 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.016 0.527 . . . . 0.0 112.027 -176.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.22 -42.24 11.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.273 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' B' ' 18' ' ' ASP . 4.3 p-10 -80.45 -2.41 45.7 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.755 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 29.2 mtpp -73.37 -74.29 0.18 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.753 0.311 . . . . 0.0 111.565 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.17 15.93 59.83 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.822 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.575 ' NZ ' ' HA ' ' B' ' 68' ' ' GLU . 26.0 mtpt -129.29 -160.23 1.02 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.168 0.509 . . . . 0.0 110.224 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.492 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -66.03 139.24 38.03 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 173.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' B' ' 40' ' ' SER . 60.3 mttt -62.28 133.91 55.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -175.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.507 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 29.6 tp -141.56 96.57 3.0 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 41.9 m -86.63 126.83 34.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.789 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.507 ' CD1' ' HG ' ' B' ' 27' ' ' LEU . 10.4 mp -107.07 163.75 12.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 122.327 1.06 . . . . 0.0 112.758 -174.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.453 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 3.1 p -160.22 146.06 15.33 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 112.878 -1.965 . . . . 0.0 107.073 171.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . 0.466 ' HE1' ' O ' ' B' ' 10' ' ' MET . 52.9 mtm -128.67 145.61 51.11 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.582 -172.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . 0.457 ' C ' HD22 ' B' ' 32' ' ' ASN . 0.2 OUTLIER -138.02 61.21 1.6 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.47 -96.82 0.12 Allowed Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.54 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -87.19 25.77 1.31 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.913 0.387 . . . . 0.0 110.791 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.438 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 14.8 mt-30 -137.31 144.82 42.8 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 121.465 0.65 . . . . 0.0 110.627 172.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.421 ' HB3' HD13 ' B' ' 84' ' ' ILE . 3.7 tt -126.25 105.17 8.64 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.248 -1.342 . . . . 0.0 107.645 175.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.453 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 6.0 mmmm -102.62 138.27 39.74 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -173.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -156.56 147.47 21.95 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -172.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -124.27 155.22 39.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.09 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 6.7 p -135.85 157.52 46.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -172.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' B' ' 26' ' ' LYS . 22.8 t -136.43 154.45 50.78 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.776 174.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -115.96 30.39 7.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.812 -171.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.41 ' HB3' ' HE3' ' B' ' 26' ' ' LYS . . . -75.61 23.2 0.12 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -175.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.59 -24.26 0.36 Allowed Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.777 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.524 ' HB2' ' HB ' ' B' ' 71' ' ' THR . 52.6 p90 45.37 -156.6 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.167 0.987 . . . . 0.0 113.032 -176.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' B' ' 24' ' ' LYS . . . -69.52 102.98 1.02 Allowed Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.666 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.79 -64.19 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.037 0.446 . . . . 0.0 110.619 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 60.1 m -48.5 -53.66 17.24 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.152 -175.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.555 ' CB ' ' HB3' ' B' ' 68' ' ' GLU . 4.4 m-30 -78.39 127.25 31.93 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.768 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -84.25 -168.62 2.23 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.942 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -60.71 108.63 0.87 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.716 0.77 . . . . 0.0 111.325 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 54.3 mtmt -150.24 140.78 22.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.443 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.54 123.93 40.19 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.993 0.425 . . . . 0.0 111.485 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.526 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 28.1 p-90 -143.33 169.7 17.16 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.085 177.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.16 148.59 20.0 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.126 -173.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 13.5 mt -105.66 150.66 8.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 171.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.675 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 84.3 m-85 -130.56 139.48 50.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -171.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.517 HG13 ' ND2' ' B' ' 59' ' ' ASN . 7.2 p -126.58 134.32 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.517 ' ND2' HG13 ' B' ' 58' ' ' VAL . 4.5 m-80 66.86 -2.32 1.15 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.641 -173.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' B' ' 58' ' ' VAL . . . 108.18 -6.3 34.4 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.552 -172.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -94.47 176.45 6.29 Favored 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 123.896 0.878 . . . . 0.0 109.193 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.431 ' HD3' ' CE1' ' B' ' 57' ' ' PHE . 7.8 tppt? -66.91 161.99 22.81 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.507 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.8 p -153.48 -11.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.08 0.467 . . . . 0.0 110.219 168.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.676 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -160.58 132.39 5.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.547 -175.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 54.9 m -139.01 124.39 19.26 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.288 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.724 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -164.84 155.6 14.43 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.505 1.145 . . . . 0.0 111.869 -174.667 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 10.7 t-20 -93.41 153.49 18.47 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.038 -1.892 . . . . 0.0 108.352 169.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . 0.575 ' HA ' ' NZ ' ' B' ' 24' ' ' LYS . 7.1 mm-40 -80.63 -4.48 54.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.025 0.44 . . . . 0.0 111.229 -177.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -97.23 -30.66 12.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.497 ' OG ' HD11 ' B' ' 75' ' ' ILE . 23.2 t -60.57 152.49 26.03 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.062 172.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' B' ' 45' ' ' TYR . 0.1 OUTLIER -103.22 115.79 31.24 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.112 -174.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.62 ' HA ' HD12 ' B' ' 75' ' ' ILE . 14.3 m -68.98 -12.48 16.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.246 -167.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.29 -46.05 94.72 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.485 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -69.13 -31.78 70.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.439 0.638 . . . . 0.0 110.271 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.724 HD13 ' HB3' ' B' ' 66' ' ' PHE . 3.8 mt -74.64 -45.89 43.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.294 -176.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 22.6 t -54.13 -34.45 60.35 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.533 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -51.89 -57.0 10.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.232 173.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.769 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 11.3 m-20 -65.9 -36.53 83.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.676 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.676 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.4 mm -61.98 -33.07 56.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.38 0.609 . . . . 0.0 111.519 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -74.66 1.77 11.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.553 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.769 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 56.6 pttt -110.44 5.62 21.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.39 . . . . 0.0 110.864 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 32.8 mt -86.75 9.35 19.2 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.149 -174.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 63.7 t30 53.15 57.44 6.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -170.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.421 HD13 ' HB3' ' B' ' 36' ' ' LEU . 76.6 mt -45.23 146.12 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.597 -175.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.421 ' HB2' HD21 ' B' ' 59' ' ' ASN . 38.5 mtpt -127.63 -171.77 2.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.387 177.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -157.0 113.61 0.57 Allowed Glycine 0 N--CA 1.45 -0.396 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.47 ' HG2' ' N ' ' B' ' 88' ' ' TYR . 15.9 ttt -156.4 -75.7 0.1 Allowed 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 117.057 0.429 . . . . 0.0 110.967 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . 0.47 ' N ' ' HG2' ' B' ' 87' ' ' MET . 60.8 t80 -122.31 101.81 7.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 28.3 mm -96.25 126.28 48.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.402 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -109.9 171.92 7.16 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 62.2 mt -149.48 107.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.148 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 47.7 pttt -157.45 179.81 8.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.098 0.475 . . . . 0.0 111.687 -177.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 1.5 pt20 -105.13 145.25 30.82 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.93 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.485 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.1 pt . . . . . 0 C--O 1.247 0.926 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.135 -174.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . 0.545 ' O ' HG12 ' B' ' 13' ' ' ILE . 39.7 tpp . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -35.39 -41.85 0.19 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 5.4 m -65.52 -19.29 65.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.174 -169.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.545 HG12 ' O ' ' B' ' 10' ' ' MET . 7.7 mm -59.85 -39.59 80.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 122.198 0.999 . . . . 0.0 109.423 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -76.7 -28.01 55.7 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.22 -175.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.639 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 12.1 m -63.11 -41.93 99.45 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.821 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.552 HG13 HD13 ' B' ' 56' ' ' ILE . 63.9 t -52.7 -44.07 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.508 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -65.25 -41.56 94.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.477 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.49 -29.15 62.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.634 -178.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' B' ' 15' ' ' SER . 27.4 mmmt -71.16 -20.16 62.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.661 0.743 . . . . 0.0 111.387 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.537 HD22 HG11 ' B' ' 72' ' ' VAL . 67.1 mt -108.39 -28.15 9.55 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.416 -175.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -80.43 69.96 7.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.372 0.606 . . . . 0.0 110.104 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -133.45 33.87 3.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.954 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.28 48.85 5.49 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -130.94 -152.37 0.51 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' B' ' 45' ' ' TYR . . . -60.3 125.94 40.06 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 171.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.49 ' CB ' ' HB3' ' B' ' 41' ' ' SER . 29.7 mtpp -80.63 130.71 35.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.598 0.714 . . . . 0.0 111.276 -171.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 21.9 tp -150.26 101.57 3.0 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.11 -173.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 15.4 p -85.8 104.09 15.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.933 -174.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 60.0 mt -88.64 151.34 22.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.593 0.711 . . . . 0.0 111.31 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 71.2 m -140.49 143.9 35.73 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.748 175.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . 0.47 ' SD ' HG22 ' B' ' 13' ' ' ILE . 5.1 mmt -106.79 120.46 42.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.795 0.331 . . . . 0.0 110.845 -167.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . 0.454 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 18.3 t-20 -134.29 58.97 1.75 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.267 0.556 . . . . 0.0 109.513 177.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.45 -99.76 0.03 OUTLIER Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.301 -0.863 . . . . 0.0 114.016 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -78.92 4.77 13.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.36 -0.42 . . . . 0.0 111.104 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.454 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 37.7 mt-30 -129.98 147.71 51.76 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.673 0.749 . . . . 0.0 110.579 174.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' B' ' 84' ' ' ILE . 1.4 tt -124.11 106.62 10.49 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.354 -1.294 . . . . 0.0 107.615 174.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.472 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 12.2 mmmm -96.92 153.15 18.07 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.505 -170.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -164.93 152.49 11.36 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.774 -171.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.25 171.71 12.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 169.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 16.3 p -131.78 149.95 52.31 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.189 -0.605 . . . . 0.0 111.381 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.49 ' HB3' ' CB ' ' B' ' 26' ' ' LYS . 31.1 t -130.1 155.96 45.33 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.449 0.642 . . . . 0.0 110.791 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -114.61 33.23 5.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.8 -162.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.31 -33.34 67.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.047 0.927 . . . . 0.0 110.181 172.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.33 -121.62 1.03 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 113.923 -1.489 . . . . 0.0 110.37 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.478 ' HB2' ' CG2' ' B' ' 71' ' ' THR . 9.2 p90 -177.92 -166.63 0.12 Allowed 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 120.774 0.321 . . . . 0.0 111.743 -178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.413 ' H ' HG22 ' B' ' 71' ' ' THR . . . -76.75 122.76 6.4 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.053 -176.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.419 ' H ' HD12 ' B' ' 47' ' ' ILE . 1.2 mp -107.04 -61.25 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 CA-C-O 122.36 1.076 . . . . 0.0 109.058 175.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 2.4 m -57.32 167.67 0.9 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 112.483 -2.144 . . . . 0.0 112.05 -174.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 74.49 10.29 4.2 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.391 -1.731 . . . . 0.0 111.46 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 48.65 -108.95 0.29 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.507 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -130.79 111.66 12.33 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.787 0.803 . . . . 0.0 110.42 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 94.1 mttt -134.07 138.12 45.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.121 176.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -112.47 132.84 54.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.078 0.466 . . . . 0.0 110.665 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.514 ' HA ' HG12 ' B' ' 94' ' ' ILE . 27.6 p-90 -141.88 173.05 11.87 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.016 176.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.65 139.35 10.87 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.567 -173.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.56 HD12 ' CD2' ' B' ' 64' ' ' TYR . 28.3 mt -104.86 151.34 7.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 169.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.721 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 74.9 m-85 -130.45 145.34 51.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -172.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.627 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.1 p -135.98 140.98 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.575 ' ND2' HG13 ' B' ' 58' ' ' VAL . 8.6 m-80 66.52 3.17 2.76 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -172.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.9 4.11 65.38 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.352 -172.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 3.9 mm-40 -105.84 176.51 5.14 Favored 'General case' 0 C--O 1.202 -1.433 0 C-N-CA 123.618 0.767 . . . . 0.0 109.209 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.502 ' HE3' ' CE1' ' B' ' 57' ' ' PHE . 0.0 OUTLIER -68.26 161.59 26.92 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.493 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.627 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.6 p -153.79 -12.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.909 0.385 . . . . 0.0 110.698 170.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.82 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.2 OUTLIER -159.52 128.76 5.3 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.207 -173.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 26.5 m -137.72 124.81 21.52 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.546 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.505 ' HB2' HD13 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -173.47 151.77 2.02 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 122.042 0.925 . . . . 0.0 112.078 -167.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 5.4 m120 -97.97 153.04 18.64 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.562 -1.653 . . . . 0.0 110.58 174.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -58.24 -48.06 81.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.806 0.336 . . . . 0.0 111.125 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.589 ' O ' HG23 ' B' ' 71' ' ' THR . 41.4 ttmt -72.59 -16.74 61.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.298 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.6 t -72.31 -15.08 61.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.589 HG23 ' O ' ' B' ' 69' ' ' LYS . 21.4 p 56.17 113.11 0.01 OUTLIER 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.653 1.181 . . . . 0.0 113.756 169.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.537 HG11 HD22 ' B' ' 20' ' ' LEU . 5.4 m -62.33 -14.54 12.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.16 -171.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.67 -48.96 63.27 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.404 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 77.0 m-20 -83.81 -36.29 23.62 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.451 0.643 . . . . 0.0 110.578 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.505 HD13 ' HB2' ' B' ' 66' ' ' PHE . 2.8 mt -64.89 -48.37 84.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.176 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.503 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 14.4 t -66.69 -21.13 66.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.153 -177.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' B' ' 74' ' ' ASN . 0.9 OUTLIER -52.58 -41.32 63.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 171.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.659 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 4.7 m-20 -72.6 -52.77 14.06 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.794 172.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.82 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 51.5 mm -47.42 -38.09 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -59.31 -30.51 68.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 45.2 pttt -73.86 -20.97 60.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.978 0.418 . . . . 0.0 110.062 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 4.3 mm? -68.66 -18.51 64.29 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.845 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 66.0 t30 39.77 69.07 0.33 Allowed 'General case' 0 C--O 1.235 0.321 0 O-C-N 124.154 0.909 . . . . 0.0 110.21 -171.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.705 ' H ' HD12 ' B' ' 84' ' ' ILE . 3.9 mp -50.23 143.91 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.614 -174.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -98.1 -178.19 3.98 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.841 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -136.75 113.68 1.07 Allowed Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.315 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.496 ' SD ' ' HA ' ' B' ' 59' ' ' ASN . 1.7 pmm? -170.21 -58.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.406 0.282 . . . . 0.0 110.907 171.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . 0.417 ' N ' ' HG2' ' B' ' 87' ' ' MET . 14.2 t80 -130.27 81.25 2.0 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.38 0.536 . . . . 0.0 109.85 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.721 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.3 mp -99.41 120.5 48.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.731 178.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -106.35 176.44 5.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.372 0.606 . . . . 0.0 110.442 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.472 HD11 HG22 ' B' ' 16' ' ' VAL . 30.4 mm -151.87 116.3 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.569 -174.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 40.6 pttt -168.05 159.48 11.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.094 0.473 . . . . 0.0 111.943 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.626 ' NE2' ' H ' ' B' ' 93' ' ' GLN . 0.7 OUTLIER -83.27 152.31 25.22 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.014 172.297 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.514 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.4 pt . . . . . 0 C--N 1.311 -1.066 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.179 -171.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.565 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -41.58 -40.48 1.89 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.54 ' O ' HG23 ' B' ' 16' ' ' VAL . 31.8 m -74.02 -20.95 60.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.212 -172.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.479 HG22 ' SD ' ' B' ' 31' ' ' MET . 10.7 mm -58.85 -44.31 90.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 121.933 0.873 . . . . 0.0 109.284 175.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.9 -36.07 72.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.051 -176.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 19.4 t -63.81 -44.9 91.92 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.098 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.54 HG23 ' O ' ' B' ' 12' ' ' SER . 70.3 t -57.29 -47.62 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.802 0.334 . . . . 0.0 110.457 176.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' B' ' 29' ' ' LEU . 2.4 t-20 -54.21 -50.56 66.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.864 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.09 -38.74 72.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.215 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -60.17 -52.13 66.65 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.514 0.673 . . . . 0.0 111.496 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.591 HD22 HG11 ' B' ' 72' ' ' VAL . 77.3 mt -75.5 -12.75 60.3 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.026 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -118.32 79.48 1.38 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.204 0.526 . . . . 0.0 111.253 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.499 ' HD3' ' OH ' ' B' ' 49' ' ' TYR . 30.1 mtpp -134.76 30.46 3.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.141 0.496 . . . . 0.0 110.667 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.17 45.18 1.91 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.1 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.52 ' HD2' ' OG ' ' B' ' 48' ' ' SER . 12.7 mmtp -90.4 -145.55 0.18 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' B' ' 45' ' ' TYR . . . -74.96 -146.24 1.28 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.74 173.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' B' ' 41' ' ' SER . 2.6 mtmp? -90.35 110.69 21.76 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -177.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.5 tp -158.75 134.33 8.72 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.611 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 74.0 p -131.24 98.77 4.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.041 0.448 . . . . 0.0 111.195 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.487 HD23 ' HB2' ' B' ' 38' ' ' ALA . 31.6 mt -83.47 151.39 25.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.416 0.627 . . . . 0.0 111.043 -177.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 54.3 m -148.43 144.69 27.6 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.624 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . 0.479 ' SD ' HG22 ' B' ' 13' ' ' ILE . 57.8 mtm -109.0 130.45 55.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.92 0.391 . . . . 0.0 111.094 -173.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 2.9 t-20 -137.97 60.12 1.63 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.362 176.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 51.96 -96.95 0.02 OUTLIER Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.232 -0.894 . . . . 0.0 113.433 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -78.92 -0.58 31.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.726 0.298 . . . . 0.0 111.415 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 37.7 mt-30 -125.32 148.9 48.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.805 0.812 . . . . 0.0 111.441 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' B' ' 36' ' ' LEU . 1.3 tm? -128.7 106.84 9.21 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.383 -1.28 . . . . 0.0 107.612 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -107.38 149.21 28.13 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.521 -170.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -170.23 151.61 3.92 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.067 0.229 . . . . 0.0 111.461 -177.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 3.3 p -120.9 138.18 54.23 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 168.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.618 ' CB ' ' HA3' ' B' ' 73' ' ' GLY . 29.6 t -148.26 154.54 40.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.272 0.558 . . . . 0.0 111.431 -170.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.499 ' HB3' ' HE3' ' B' ' 26' ' ' LYS . 47.5 t -144.0 155.51 44.05 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.086 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -90.32 -6.3 55.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.845 -169.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.1 -20.47 65.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.222 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.446 ' O ' ' HA2' ' B' ' 25' ' ' GLY . . . -106.27 -4.21 38.12 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.471 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.636 ' O ' ' HA3' ' B' ' 25' ' ' GLY . 0.0 OUTLIER 78.48 -168.83 0.05 OUTLIER 'General case' 0 C--N 1.342 0.248 0 C-N-CA 123.65 0.78 . . . . 0.0 112.506 179.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.47 46.56 0.83 Allowed Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 167.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -44.73 -69.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.252 0.621 . . . . 0.0 110.567 -174.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.52 ' OG ' ' HD2' ' B' ' 24' ' ' LYS . 9.5 m 60.95 -88.58 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.666 172.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.499 ' OH ' ' HD3' ' B' ' 22' ' ' LYS . 59.3 m-85 -140.56 69.42 1.35 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -173.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 51.95 -94.82 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.369 -176.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -156.28 109.82 2.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.522 -0.763 . . . . 0.0 108.942 171.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 59.3 mttm -141.43 142.9 33.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.072 -175.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.563 HD22 HG13 ' B' ' 94' ' ' ILE . 1.0 OUTLIER -114.27 124.32 51.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.307 0.575 . . . . 0.0 111.856 -176.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.635 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 17.0 p-90 -133.88 171.68 13.84 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.948 174.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.5 143.04 14.35 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.585 -175.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.655 HD12 ' CD2' ' B' ' 64' ' ' TYR . 22.3 mt -108.49 143.33 19.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 173.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 46.8 m-85 -125.58 143.06 51.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.65 -174.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.576 HG13 ' ND2' ' B' ' 59' ' ' ASN . 9.6 p -128.79 143.41 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.576 ' ND2' HG13 ' B' ' 58' ' ' VAL . 2.0 m-80 59.07 14.4 3.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -171.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.35 -1.56 82.33 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.628 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' B' ' 58' ' ' VAL . 13.5 mt-10 -105.12 160.03 15.38 Favored 'General case' 0 C--O 1.192 -1.973 0 C-N-CA 123.887 0.875 . . . . 0.0 109.268 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.604 ' HE2' ' CE2' ' B' ' 57' ' ' PHE . 1.2 tttm -61.89 164.08 6.86 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 118.233 0.469 . . . . 0.0 110.766 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.408 ' O ' HD12 ' B' ' 79' ' ' ILE . 0.0 OUTLIER -156.53 0.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.17 164.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.715 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -157.67 131.96 8.29 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.209 -0.597 . . . . 0.0 111.101 -173.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 29.6 m -142.85 119.0 10.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.208 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.54 ' CB ' HD13 ' B' ' 75' ' ' ILE . 25.4 p90 -171.29 156.41 4.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.058 0.933 . . . . 0.0 112.646 -172.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 8.2 m120 -100.76 150.78 22.43 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.214 167.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' B' ' 48' ' ' SER . 36.3 mm-40 -58.73 -40.15 82.93 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.153 0.501 . . . . 0.0 110.92 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -65.01 -17.64 64.61 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.63 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 4.9 t -78.74 -0.59 30.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.603 178.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.444 ' O ' HG13 ' B' ' 75' ' ' ILE . 32.5 p 56.69 97.57 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.721 1.208 . . . . 0.0 112.093 176.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.651 ' HA ' HD12 ' B' ' 75' ' ' ILE . 2.5 m -57.96 -22.42 18.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.716 -170.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . 0.618 ' HA3' ' CB ' ' B' ' 40' ' ' SER . . . -62.03 -47.94 86.63 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.477 -178.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 77.2 m-20 -66.8 -37.73 85.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.451 0.643 . . . . 0.0 109.825 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.651 HD12 ' HA ' ' B' ' 72' ' ' VAL . 3.0 mt -67.06 -42.42 88.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.131 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 30.8 t -51.02 -39.93 56.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.54 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' B' ' 74' ' ' ASN . 0.7 OUTLIER -56.77 -40.67 76.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.887 176.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.78 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 24.0 m-20 -75.47 -40.67 57.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.124 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.715 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.9 mm -63.32 -32.14 55.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.325 0.583 . . . . 0.0 111.261 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.22 -11.03 56.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.593 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.78 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 20.4 pttp -95.93 3.12 53.82 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.543 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' B' ' 79' ' ' ILE . 24.2 mt -85.94 2.72 45.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.173 -176.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 52.66 62.21 2.8 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -169.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 62.1 mt -53.57 151.3 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.18 -174.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -125.08 176.19 6.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.403 176.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -139.36 112.75 0.86 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 173.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.414 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 8.2 tpt -153.7 -82.58 0.08 Allowed 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 117.024 0.412 . . . . 0.0 110.365 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . 0.414 ' N ' ' HG3' ' B' ' 87' ' ' MET . 23.2 t80 -109.08 94.68 5.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.646 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 34.0 mm -98.94 122.63 50.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.037 -173.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.572 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 54.1 mm-40 -116.54 148.21 41.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.428 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.635 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 77.9 mt -127.89 127.74 68.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.592 176.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.504 ' HE3' ' CE1' ' B' ' 57' ' ' PHE . 14.3 pttp -174.53 152.46 1.69 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.03 0.443 . . . . 0.0 111.476 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.538 ' NE2' ' H ' ' B' ' 93' ' ' GLN . 0.5 OUTLIER -80.09 144.44 33.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.234 -179.47 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.563 HG13 HD22 ' B' ' 53' ' ' ASN . 4.4 pt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.197 -174.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 85.1 mmm . . . . . 0 CA--C 1.522 -0.109 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . 0.421 ' HA ' ' CD1' ' B' ' 13' ' ' ILE . 83.0 m-20 -46.12 -10.81 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.046 1.738 . . . . 0.0 114.956 -178.355 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.434 ' HA ' HG23 ' B' ' 16' ' ' VAL . 32.7 t -56.58 -15.49 4.47 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 122.842 0.457 . . . . 0.0 111.596 177.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.459 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.3 OUTLIER -50.68 -59.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 121.411 0.624 . . . . 0.0 111.27 -176.254 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -106.44 -49.11 3.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.015 -176.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 5.9 m -55.93 -53.45 56.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.825 -173.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.434 HG23 ' HA ' ' B' ' 12' ' ' SER . 80.2 t -72.8 -33.11 42.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.918 -177.019 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.655 ' HA ' HD12 ' B' ' 29' ' ' LEU . 0.2 OUTLIER -59.79 -42.82 94.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.953 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.14 -37.88 61.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.056 178.406 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.1 OUTLIER -61.36 -40.83 95.74 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 122.9 0.48 . . . . 0.0 111.606 -179.717 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.528 HD21 ' HZ2' ' B' ' 54' ' ' TRP . 71.3 mt -80.03 -31.7 39.55 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.845 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -96.47 53.19 1.28 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.356 0.598 . . . . 0.0 110.44 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' B' ' 19' ' ' LYS . 30.6 mtpp -89.91 -51.95 5.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.139 0.495 . . . . 0.0 110.358 177.197 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.42 68.14 0.22 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 -178.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -124.28 -156.82 0.74 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.502 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -72.56 -171.08 17.68 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 175.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.714 ' O ' ' HA ' ' B' ' 40' ' ' SER . 0.0 OUTLIER -72.97 88.74 1.39 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 117.702 0.751 . . . . 0.0 109.345 176.236 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' B' ' 39' ' ' THR . 15.9 tp -105.94 127.4 53.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.035 -172.091 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 63.4 m -125.89 114.67 18.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.048 178.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.655 HD12 ' HA ' ' B' ' 17' ' ' ASN . 24.7 mt -89.26 156.18 18.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.439 0.638 . . . . 0.0 110.776 178.119 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.579 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 63.7 m -145.33 153.74 41.58 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.691 172.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 80.8 mtp -120.79 141.29 50.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.195 0.522 . . . . 0.0 111.857 -176.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -145.12 113.15 6.45 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.56 -104.55 1.09 Allowed Glycine 0 CA--C 1.507 -0.419 0 C-N-CA 119.465 -1.35 . . . . 0.0 109.769 -169.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -132.86 25.0 4.32 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.604 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 22.5 mt-30 -80.01 156.71 27.03 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.227 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.442 HD21 HD22 ' B' ' 29' ' ' LEU . 4.9 tt -110.31 110.31 21.08 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.977 -1.011 . . . . 0.0 108.514 173.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.579 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 22.4 mmmt -106.22 148.36 28.01 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.393 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -161.64 146.04 12.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 10.4 p -129.22 144.29 51.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.146 172.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.714 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 46.8 m -154.84 152.85 30.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.404 0.621 . . . . 0.0 112.292 -177.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.617 ' HB2' ' CD ' ' B' ' 26' ' ' LYS . 1.3 m -118.89 152.2 36.72 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 167.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . 0.527 ' HA ' ' HB3' ' B' ' 45' ' ' TYR . 15.0 m120 -112.56 35.16 3.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.134 0.493 . . . . 0.0 111.821 -165.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.81 -61.37 1.8 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.801 0.81 . . . . 0.0 110.414 173.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.96 62.23 0.43 Allowed Glycine 0 C--N 1.311 -0.812 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 174.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.601 ' HB2' HG21 ' B' ' 71' ' ' THR . 41.6 p90 -71.54 -149.68 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -173.112 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.23 92.16 1.37 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.563 -177.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.466 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -105.32 -57.2 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.029 0.442 . . . . 0.0 110.28 179.476 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -39.37 -58.72 1.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.318 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -91.3 101.3 14.0 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.081 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -76.7 -82.08 0.08 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.351 -176.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -110.99 108.75 18.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.876 0.846 . . . . 0.0 112.068 -176.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 55.4 mttm -141.23 121.59 14.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 165.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -110.12 121.3 44.93 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.61 0.719 . . . . 0.0 111.556 -174.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.589 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 28.7 p-90 -141.68 162.06 36.4 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.492 175.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.15 147.14 16.82 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.864 -173.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.614 HD12 ' CD2' ' B' ' 64' ' ' TYR . 29.0 mt -107.08 148.31 11.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 170.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.73 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 75.7 m-85 -127.61 144.46 51.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.263 -171.255 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.533 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.9 p -131.41 135.37 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.532 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.0 m-80 61.85 10.13 3.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.016 -176.061 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.87 -2.43 55.57 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 -177.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -107.43 176.93 4.99 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.4 tppp? -63.27 161.22 14.21 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 173.076 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.533 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.8 p -153.17 -13.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.946 0.403 . . . . 0.0 110.376 168.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.718 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.2 OUTLIER -160.07 128.71 4.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.016 0.436 . . . . 0.0 110.536 -172.66 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 55.0 m -139.74 123.99 17.93 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.391 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.503 ' CB ' HD13 ' B' ' 75' ' ' ILE . 19.9 p90 -171.46 157.49 4.88 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 122.012 0.91 . . . . 0.0 112.023 -172.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 11.4 m120 -105.4 162.46 13.43 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 113.474 -1.694 . . . . 0.0 110.193 172.226 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -61.38 -48.11 82.73 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -174.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.567 ' O ' HG23 ' B' ' 71' ' ' THR . 41.7 ttmt -61.88 -24.52 66.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.951 0.405 . . . . 0.0 112.036 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 11.5 t -67.09 -20.46 65.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.285 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.601 HG21 ' HB2' ' B' ' 45' ' ' TYR . 9.9 p 60.56 111.72 0.02 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.633 1.173 . . . . 0.0 112.113 175.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.505 ' HA ' HD12 ' B' ' 75' ' ' ILE . 1.7 m -61.18 -28.42 43.74 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.961 -167.252 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.11 -49.08 57.29 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.179 -176.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 58.1 m-80 -67.72 -42.79 81.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.622 0.725 . . . . 0.0 110.221 179.037 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' B' ' 72' ' ' VAL . 1.8 mt -64.21 -41.75 93.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.601 -176.099 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 74.5 m -53.69 -36.01 61.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.344 179.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' B' ' 74' ' ' ASN . 39.0 m-20 -57.69 -38.01 74.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.989 0.423 . . . . 0.0 111.066 177.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.557 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 13.9 m-20 -73.83 -51.3 16.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.741 174.572 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.718 HG13 ' CE1' ' B' ' 64' ' ' TYR . 44.5 mm -56.08 -35.52 41.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.469 -178.373 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -11.28 59.68 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.557 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 15.5 ptmt -92.19 4.58 52.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.373 0.606 . . . . 0.0 110.135 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -81.47 -1.51 46.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.411 -175.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 52.07 47.28 25.08 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.702 0.763 . . . . 0.0 109.66 -173.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.623 HD11 HG22 ' B' ' 79' ' ' ILE . 94.2 mt -55.12 127.69 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.682 -1.144 . . . . 0.0 113.233 -171.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -92.1 -164.35 1.17 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.582 178.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -151.16 119.69 1.02 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.13 -178.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 22.8 ptm -176.76 -56.73 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.616 0.208 . . . . 0.0 111.472 177.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -128.1 80.58 1.97 Allowed 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.816 -0.552 . . . . 0.0 110.013 177.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.73 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.3 mp -98.53 128.86 49.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.37 175.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -114.66 171.37 7.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.082 0.467 . . . . 0.0 110.058 175.226 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.589 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 38.9 mm -142.15 109.55 2.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.594 -178.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -168.27 151.87 5.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.426 0.632 . . . . 0.0 112.344 -174.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 2.0 pp0? -61.95 148.21 44.44 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.637 172.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' B' ' 54' ' ' TRP . 2.0 pt . . . . . 0 C--N 1.311 -1.075 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.028 -176.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . 0.487 ' HG3' HD21 ' B' ' 34' ' ' ASN . 85.8 mmm . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.46 0.648 . . . . 0.0 111.94 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -77.02 -15.77 59.52 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.254 175.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.447 ' HA ' HD11 ' B' ' 91' ' ' ILE . 11.6 m -65.94 -10.28 37.55 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.35 -176.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.445 HG12 ' O ' ' B' ' 10' ' ' MET . 27.9 mm -58.48 -59.81 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.508 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -106.74 -36.36 6.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.644 -175.301 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.607 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 22.5 t -56.98 -41.83 79.1 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.907 -171.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.57 -38.95 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.85 0.357 . . . . 0.0 111.089 -176.251 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.411 ' ND2' HD13 ' B' ' 29' ' ' LEU . 34.0 t-20 -59.13 -55.14 38.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.102 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.12 -40.11 82.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.516 -178.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' B' ' 15' ' ' SER . 8.5 tmtm? -49.21 -67.33 0.27 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.652 0.781 . . . . 0.0 111.71 177.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.585 ' C ' ' H ' ' B' ' 22' ' ' LYS . 16.2 mt -51.88 -67.01 0.29 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.729 175.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . 0.449 ' OD1' ' HE2' ' B' ' 49' ' ' TYR . 2.8 t-20 65.25 -19.4 0.09 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.935 0.894 . . . . 0.0 110.609 -168.301 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.585 ' H ' ' C ' ' B' ' 20' ' ' LEU . 31.0 mtpp 83.37 -34.62 0.07 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 159.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.673 ' HA2' ' CE1' ' B' ' 49' ' ' TYR . . . 95.93 79.72 1.48 Allowed Glycine 0 C--O 1.208 -1.521 0 C-N-CA 119.074 -1.536 . . . . 0.0 110.078 -166.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 64.62 -59.75 0.22 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 173.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' B' ' 23' ' ' GLY . . . -33.05 108.27 0.03 OUTLIER Glycine 0 CA--C 1.52 0.354 0 O-C-N 124.071 0.857 . . . . 0.0 113.892 179.08 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.5 ' HE3' ' HB2' ' B' ' 41' ' ' SER . 0.1 OUTLIER -77.84 153.18 32.97 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.825 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.465 HD22 ' CD ' ' B' ' 22' ' ' LYS . 1.3 pt? -163.45 170.28 17.61 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 118.291 0.496 . . . . 0.0 111.5 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 20.7 m -127.87 114.0 16.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.694 178.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.411 HD13 ' ND2' ' B' ' 17' ' ' ASN . 9.7 mp -83.87 158.63 21.57 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 122.038 0.923 . . . . 0.0 112.408 -179.003 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.9 p -150.4 154.8 38.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.409 178.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 29.7 mtt -122.82 138.55 54.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.654 0.264 . . . . 0.0 111.628 -168.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -152.09 108.09 3.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.458 177.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.45 -92.87 0.52 Allowed Glycine 0 CA--C 1.505 -0.534 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -176.146 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.502 ' HB2' ' CA ' ' B' ' 86' ' ' GLY . 0.4 OUTLIER -135.7 8.09 3.29 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.574 0.702 . . . . 0.0 109.311 171.585 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.525 ' OE1' ' HA ' ' B' ' 83' ' ' ASN . 49.6 mt-30 -77.94 149.82 34.11 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.23 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' B' ' 36' ' ' LEU . 12.8 tp -125.84 93.28 3.79 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.206 177.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -96.52 150.61 20.44 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.695 -171.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -165.52 158.34 15.66 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.249 -0.58 . . . . 0.0 112.219 -174.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 14.3 p -124.84 137.62 54.29 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 18.2 t -121.16 154.68 35.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.078 0.466 . . . . 0.0 111.484 -170.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.5 ' HB2' ' HE3' ' B' ' 26' ' ' LYS . 14.9 m -121.92 158.53 28.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.606 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -82.59 54.24 2.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.623 -172.223 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.75 22.44 0.6 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.973 177.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.518 ' O ' HD11 ' B' ' 47' ' ' ILE . . . 132.56 -47.73 1.0 Allowed Glycine 0 C--O 1.222 -0.615 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.992 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.444 ' O ' HG12 ' B' ' 47' ' ' ILE . 1.2 p90 59.15 177.38 0.08 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.455 1.102 . . . . 0.0 113.224 177.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.443 ' C ' HD13 ' B' ' 47' ' ' ILE . . . -47.64 92.03 0.01 OUTLIER Glycine 0 C--N 1.336 0.533 0 N-CA-C 114.864 0.706 . . . . 0.0 114.864 -176.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.518 HD11 ' O ' ' B' ' 44' ' ' GLY . 6.5 mm -109.8 -71.8 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.575 0.702 . . . . 0.0 110.625 175.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.2 p -97.45 -126.9 0.15 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.543 -178.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.673 ' CE1' ' HA2' ' B' ' 23' ' ' GLY . 7.1 m-85 63.91 20.29 12.14 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.206 0.526 . . . . 0.0 110.32 178.074 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 52.7 -161.17 0.11 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.621 -176.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -109.21 108.94 19.75 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.748 0.785 . . . . 0.0 109.435 173.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.509 ' HE3' ' O ' ' B' ' 49' ' ' TYR . 43.8 mttt -105.13 120.79 42.39 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -115.15 113.93 24.61 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.522 ' HA ' HG12 ' B' ' 94' ' ' ILE . 36.1 p-90 -148.04 164.93 32.32 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.3 -176.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -126.55 152.75 18.5 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.835 -176.019 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.429 ' O ' HG12 ' B' ' 63' ' ' VAL . 10.3 mt -102.18 146.81 9.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 169.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.7 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 83.0 m-85 -125.94 143.75 50.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.482 -172.011 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.521 HG13 ' ND2' ' B' ' 59' ' ' ASN . 10.3 p -130.7 135.24 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.381 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.521 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.7 m-80 65.74 4.62 2.97 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.72 -176.179 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.03 -0.17 51.44 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.019 -176.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -108.47 176.06 5.25 Favored 'General case' 0 C--O 1.203 -1.355 0 C-N-CA 123.346 0.658 . . . . 0.0 109.46 -179.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.496 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.5 tppp? -62.44 161.2 12.13 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 173.121 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.512 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.3 p -146.58 -22.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 166.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -162.21 142.5 10.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.475 -175.457 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.446 HG23 ' CD1' ' B' ' 94' ' ' ILE . 28.1 m -136.07 127.25 28.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.775 179.325 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.643 ' CD2' HG21 ' B' ' 75' ' ' ILE . 21.5 p90 -163.04 -166.95 1.37 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.07 0.462 . . . . 0.0 111.032 -177.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.74 ' O ' ' HB3' ' B' ' 70' ' ' SER . 22.9 t-20 -153.95 158.52 40.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.816 -173.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . 0.452 ' CD ' ' HD2' ' B' ' 52' ' ' LYS . 8.0 mm-40 -60.28 -56.62 19.24 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.385 0.612 . . . . 0.0 111.234 -178.328 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.583 ' C ' ' H ' ' B' ' 71' ' ' THR . 37.2 ttpt -65.8 -11.69 48.13 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.687 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . 0.74 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 9.7 t -67.22 2.22 1.72 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.227 1.013 . . . . 0.0 109.283 170.253 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.583 ' H ' ' C ' ' B' ' 69' ' ' LYS . 37.6 p 59.61 80.28 0.2 Allowed 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.02 -1.9 . . . . 0.0 110.56 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.797 ' HA ' ' CG1' ' B' ' 75' ' ' ILE . 17.9 m -68.24 -4.67 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.772 -170.202 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.43 -37.18 94.22 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 119.806 -1.188 . . . . 0.0 110.201 174.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 42.7 m-20 -80.28 -36.21 34.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.219 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.797 ' CG1' ' HA ' ' B' ' 72' ' ' VAL . 24.2 mm -51.64 -54.27 13.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.458 176.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 58.8 m -55.55 -37.44 67.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.124 177.512 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . 0.465 ' HA ' ' ND2' ' B' ' 80' ' ' ASN . 49.0 m-20 -64.76 -38.67 91.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.205 0.526 . . . . 0.0 111.044 177.342 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.71 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 5.9 m-20 -65.78 -40.58 92.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.899 176.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.523 HG13 ' O ' ' B' ' 75' ' ' ILE . 63.8 mt -57.68 -30.75 37.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.121 0.486 . . . . 0.0 110.869 178.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' B' ' 77' ' ' ASN . 82.0 m-20 -62.02 -22.48 65.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.46 176.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.71 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 12.1 ptmm? -105.44 -11.47 16.41 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -175.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.24 -23.87 67.46 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.801 0.334 . . . . 0.0 110.863 -175.136 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . 0.525 ' HA ' ' OE1' ' B' ' 35' ' ' GLN . 23.6 t-20 45.75 62.79 2.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.059 -170.334 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.456 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 72.7 mt -64.5 142.66 16.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.125 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.44 ' H ' HG21 ' B' ' 58' ' ' VAL . 66.2 mttm -86.64 178.37 7.07 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.822 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.502 ' CA ' ' HB2' ' B' ' 34' ' ' ASN . . . -135.02 114.44 1.25 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 119.73 -1.224 . . . . 0.0 113.318 -175.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.497 ' HG3' ' HA ' ' B' ' 59' ' ' ASN . 22.8 ptp -175.07 -55.2 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.49 0.316 . . . . 0.0 110.795 177.001 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -139.6 80.7 1.79 Allowed 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.557 -0.714 . . . . 0.0 110.123 174.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.7 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.0 mp -94.63 126.67 47.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.061 174.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -109.32 175.63 5.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.26 0.552 . . . . 0.0 110.433 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.447 HD11 ' HA ' ' B' ' 12' ' ' SER . 5.7 mt -147.75 102.0 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.676 -177.246 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 45.1 pttt -164.42 165.77 21.21 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.266 -173.48 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.4 OUTLIER -73.84 159.49 32.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.781 178.998 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.522 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.0 pt . . . . . 0 C--N 1.31 -1.124 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.714 -177.176 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . 0.452 ' SD ' ' HA ' ' B' ' 88' ' ' TYR . 80.6 mtp . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.811 0.339 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -64.16 -32.03 73.45 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.128 0.49 . . . . 0.0 110.53 176.486 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.538 ' O ' HG23 ' B' ' 16' ' ' VAL . 13.3 m -68.81 -20.89 64.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.847 -171.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 mm -51.22 -52.4 19.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 121.901 0.857 . . . . 0.0 110.672 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -75.75 -33.76 60.24 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.5 -175.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -64.59 -41.08 96.48 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.878 179.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.538 HG23 ' O ' ' B' ' 12' ' ' SER . 94.4 t -61.49 -45.22 99.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.963 0.411 . . . . 0.0 110.163 178.142 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -42.14 99.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.524 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -33.9 68.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.866 0.365 . . . . 0.0 111.359 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -68.17 -48.79 64.34 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 123.348 0.659 . . . . 0.0 111.952 -178.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.445 HD22 HG11 ' B' ' 72' ' ' VAL . 63.6 mt -77.81 -7.95 57.34 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.383 -176.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . 0.426 ' CG ' ' H ' ' B' ' 22' ' ' LYS . 61.2 t30 -99.73 -161.87 0.9 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.217 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.426 ' H ' ' CG ' ' B' ' 21' ' ' ASN . 53.4 mtpt 52.2 37.03 20.79 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.749 -175.014 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -134.17 41.28 1.48 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.55 -174.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.411 ' HD2' HD11 ' B' ' 47' ' ' ILE . 67.3 mttm 71.2 -67.05 0.27 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.04 0.536 . . . . 0.0 111.843 174.124 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' B' ' 45' ' ' TYR . . . -55.92 121.66 24.27 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 174.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' B' ' 40' ' ' SER . 43.2 mttm -61.5 135.41 57.66 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.194 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' B' ' 39' ' ' THR . 22.2 tp -158.94 110.93 2.17 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 121.175 0.512 . . . . 0.0 110.499 -176.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 55.2 m -116.32 114.08 23.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.772 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 9.2 mp -95.55 163.42 13.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.85 0.833 . . . . 0.0 111.701 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.418 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 1.4 p -157.81 147.38 19.98 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.104 171.133 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 66.0 mtp -130.02 117.06 19.46 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.512 0.673 . . . . 0.0 110.943 -177.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -98.83 61.57 1.3 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.316 -178.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.41 -88.61 0.13 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.471 -178.071 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' B' ' 84' ' ' ILE . 2.9 m-20 -94.0 16.48 14.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.786 0.327 . . . . 0.0 111.008 -177.397 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -132.12 151.24 51.89 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.261 0.553 . . . . 0.0 111.501 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tt -124.75 112.68 17.01 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.681 176.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.418 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 1.5 mtpm? -112.31 149.11 32.86 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -176.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -167.73 142.05 3.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.924 0.392 . . . . 0.0 111.759 -178.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 1.7 p -119.55 142.2 48.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.354 173.377 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 3.5 p -140.86 156.14 46.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.235 0.541 . . . . 0.0 112.39 -172.174 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 15.7 m -141.27 158.69 43.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.06 176.063 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -95.25 46.47 1.11 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.531 0.681 . . . . 0.0 110.768 -167.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.61 23.85 0.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.759 -1.11 . . . . 0.0 112.533 178.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.31 -41.01 1.53 Allowed Glycine 0 CA--C 1.51 -0.252 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.487 ' HA ' ' HA3' ' B' ' 25' ' ' GLY . 21.8 p90 51.26 -165.31 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.92 1.288 . . . . 0.0 114.138 173.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' B' ' 68' ' ' GLU . . . -75.95 110.43 3.04 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.867 -175.179 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.411 HD11 ' HD2' ' B' ' 24' ' ' LYS . 0.2 OUTLIER -120.65 -69.19 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-O 121.243 0.544 . . . . 0.0 111.233 177.315 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 66.9 m -119.78 -75.26 0.59 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.81 -170.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.454 ' O ' ' HE3' ' B' ' 52' ' ' LYS . 0.1 OUTLIER -68.17 -22.27 64.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.522 0.677 . . . . 0.0 109.875 -176.899 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.496 ' CD ' ' H ' ' B' ' 50' ' ' GLU . 22.1 mp0 -73.25 -62.6 1.42 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.996 174.171 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' B' ' 68' ' ' GLU . 6.9 t70 -44.92 108.23 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.242 -1.799 . . . . 0.0 112.497 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.704 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 98.7 mttt -150.12 161.15 42.93 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.047 176.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.407 ' HB3' ' OD1' ' B' ' 67' ' ' ASN . 3.5 p-10 -109.45 119.64 40.05 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.452 0.644 . . . . 0.0 111.277 -178.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.561 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 6.4 p-90 -154.62 171.62 19.18 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.647 176.43 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.5 141.58 12.82 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.666 -178.061 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.679 HD12 ' CD2' ' B' ' 64' ' ' TYR . 17.7 mt -104.72 147.64 10.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 172.286 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.75 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 71.7 m-85 -127.05 143.62 51.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 -171.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.579 HG12 ' HB ' ' B' ' 63' ' ' VAL . 8.9 p -129.94 134.73 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.493 ' ND2' HG13 ' B' ' 58' ' ' VAL . 2.0 m-80 63.06 10.27 4.37 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.034 0.534 . . . . 0.0 109.885 -174.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.3 -1.7 64.79 Favored Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.099 -174.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -102.8 176.89 5.01 Favored 'General case' 0 C--O 1.207 -1.144 0 C-N-CA 123.558 0.743 . . . . 0.0 109.042 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 4.9 tppp? -66.69 161.24 23.86 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.395 0.543 . . . . 0.0 109.537 174.05 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.579 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.7 p -153.87 -13.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.196 0.522 . . . . 0.0 110.284 166.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.787 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -160.87 140.12 10.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.247 -171.128 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 96.1 m -157.33 121.23 4.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.563 ' CB ' HD13 ' B' ' 75' ' ' ILE . 15.6 p90 -174.9 161.27 2.98 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.938 0.875 . . . . 0.0 111.855 -168.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.704 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 2.2 m120 -109.09 138.2 45.81 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.184 -1.826 . . . . 0.0 108.215 166.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' B' ' 51' ' ' ASP . 20.2 mp0 -61.91 -12.81 19.8 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.627 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -69.12 -29.79 67.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.394 0.616 . . . . 0.0 109.863 172.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 39.1 t -70.58 -16.46 62.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.822 173.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . . . . . . . . . 13.5 p 61.74 116.03 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.216 1.407 . . . . 0.0 112.095 178.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.565 ' HA ' HD12 ' B' ' 75' ' ' ILE . 3.0 m -59.85 -24.92 30.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.628 -169.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.93 -46.08 69.61 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.738 -178.555 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -72.66 -34.35 67.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.313 0.578 . . . . 0.0 110.436 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' B' ' 72' ' ' VAL . 1.7 mt -72.24 -45.85 59.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.968 -176.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 48.3 m -54.37 -33.08 58.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.53 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -53.13 -53.65 47.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.066 174.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' B' ' 81' ' ' LYS . 10.9 m-20 -69.57 -44.34 71.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.747 -179.407 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.787 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.2 mm -57.96 -32.19 42.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.348 0.594 . . . . 0.0 112.024 -178.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -65.15 -17.23 64.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.047 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' B' ' 78' ' ' ASP . 13.2 tppt? -91.63 -5.32 54.07 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.769 0.795 . . . . 0.0 109.917 -176.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.2 mm? -72.69 -12.59 61.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.354 -176.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 55.92 71.27 0.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.964 -168.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.457 ' O ' ' HB3' ' B' ' 34' ' ' ASN . 59.6 mt -64.52 157.8 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.437 -175.397 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -121.18 -175.51 3.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.183 175.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.02 113.44 0.75 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.661 175.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.82 -63.48 0.09 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.607 0.241 . . . . 0.0 111.02 -178.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . 0.452 ' HA ' ' SD ' ' B' ' 10' ' ' MET . 25.3 t80 -141.34 90.95 2.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.19 0.519 . . . . 0.0 109.892 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.75 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.1 mp -90.8 132.4 35.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.494 178.02 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -118.28 175.12 5.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.11 0.481 . . . . 0.0 110.496 177.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.561 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 82.1 mt -147.76 124.76 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.664 -176.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 41.5 pttt -177.57 160.46 1.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 0.0 111.209 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.541 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.9 OUTLIER -80.82 164.54 22.62 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.539 0.685 . . . . 0.0 110.958 177.45 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.522 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.4 pt . . . . . 0 C--N 1.309 -1.17 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.243 -173.307 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 8.2 tmm? . . . . . 0 CA--C 1.545 0.774 0 CA-C-O 121.744 0.783 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . 0.536 ' HA ' ' SD ' ' B' ' 31' ' ' MET . 9.1 t30 -61.62 -43.4 98.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.815 -175.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 9.9 m -69.16 -15.45 63.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.216 0.532 . . . . 0.0 110.387 -172.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -75.19 -43.49 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.57 0.7 . . . . 0.0 110.448 178.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -71.66 -14.74 62.13 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.935 -175.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . 0.63 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 78.4 p -48.29 -40.53 25.25 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 123.444 0.465 . . . . 0.0 110.875 -179.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 49.8 t -69.61 -40.24 79.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.399 0.619 . . . . 0.0 110.166 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.943 HD21 HD11 ' B' ' 29' ' ' LEU . 7.6 t30 -64.83 -37.12 86.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.281 176.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.03 -29.27 69.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.275 174.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.63 ' HG2' ' O ' ' B' ' 15' ' ' SER . 24.6 mmmt -73.15 -11.6 60.59 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.183 0.516 . . . . 0.0 111.388 176.599 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.524 ' O ' ' HD3' ' B' ' 24' ' ' LYS . 39.7 mt -80.39 -18.59 48.49 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.663 0.744 . . . . 0.0 109.342 176.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . 0.475 ' OD1' ' HA ' ' B' ' 26' ' ' LYS . 62.9 t30 -92.39 58.19 3.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.985 -176.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -123.45 -91.85 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.492 178.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.16 34.64 5.24 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 177.223 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.604 ' HA ' ' C ' ' B' ' 45' ' ' TYR . 27.6 mtpt -133.07 -164.63 1.5 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.434 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.565 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -64.07 145.14 49.51 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.329 -0.939 . . . . 0.0 110.996 178.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.554 ' CE ' ' HB2' ' B' ' 41' ' ' SER . 13.9 ttpt -80.5 136.34 36.28 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -174.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.441 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 19.3 tp -154.03 107.67 2.96 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.869 -178.079 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -110.18 103.89 12.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.213 -176.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.943 HD11 HD21 ' B' ' 17' ' ' ASN . 0.0 OUTLIER -82.02 156.92 24.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.827 0.822 . . . . 0.0 112.516 -177.702 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 53.9 m -129.8 144.11 51.14 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.355 -1.293 . . . . 0.0 107.517 164.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . 0.536 ' SD ' ' HA ' ' B' ' 11' ' ' ASN . 40.7 mtt -111.24 127.53 55.64 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.675 -167.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 3.1 t-20 -137.16 59.47 1.68 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.736 175.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 47.97 -93.68 0.01 OUTLIER Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.99 178.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.658 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 8.1 p30 -79.76 4.89 14.98 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 122.592 0.357 . . . . 0.0 111.299 -176.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 18.5 mt-30 -129.82 144.56 51.37 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.592 0.711 . . . . 0.0 111.017 172.584 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.453 ' CB ' ' HB ' ' B' ' 84' ' ' ILE . 0.9 OUTLIER -118.34 105.22 11.51 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.184 175.549 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . 0.461 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 0.0 OUTLIER -99.91 151.92 20.76 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -175.702 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.04 164.21 4.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.456 0.571 . . . . 0.0 112.498 -177.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 2.9 p -128.35 141.03 51.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.211 168.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -142.58 147.5 35.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.091 0.472 . . . . 0.0 111.615 -175.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.554 ' HB2' ' CE ' ' B' ' 26' ' ' LYS . 24.1 m -159.31 169.57 23.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.53 178.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' B' ' 44' ' ' GLY . 44.6 m-80 -91.73 49.18 1.53 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.102 -176.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.403 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . . . -68.96 22.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.025 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.491 ' O ' ' HD1' ' B' ' 45' ' ' TYR . . . 161.43 -63.37 0.28 Allowed Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.006 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.767 ' CD2' HG21 ' B' ' 71' ' ' THR . 0.0 OUTLIER 70.29 161.86 0.23 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.955 0.902 . . . . 0.0 111.852 -179.489 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.567 ' H ' ' CG2' ' B' ' 71' ' ' THR . . . -63.18 113.1 5.56 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 116.157 -0.474 . . . . 0.0 114.043 -166.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 11.4 mm -95.76 -67.61 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.273 0.558 . . . . 0.0 110.604 177.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 59.3 m -67.12 -52.67 38.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.073 -176.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -42.27 124.41 2.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.334 -178.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -74.91 -172.68 1.67 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.282 177.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.66 108.09 14.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.471 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 50.0 mttm -139.69 130.57 26.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.442 -178.214 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -108.79 135.6 49.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.999 0.428 . . . . 0.0 111.551 -177.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.617 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 37.5 p-90 -154.49 169.26 24.21 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.947 175.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.8 152.81 21.44 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.702 -172.44 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.532 HD12 ' CD2' ' B' ' 64' ' ' TYR . 30.0 mt -113.31 142.63 25.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 173.302 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.617 ' CE1' ' HG3' ' B' ' 62' ' ' LYS . 58.9 m-85 -127.68 140.73 51.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.408 -171.427 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.464 HG13 ' ND2' ' B' ' 59' ' ' ASN . 10.8 p -123.77 134.47 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.464 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.4 m-80 63.46 4.57 1.79 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.254 0.622 . . . . 0.0 110.263 -176.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.56 -7.58 39.55 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.09 -174.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 33.1 mt-10 -98.54 175.87 5.86 Favored 'General case' 0 C--O 1.197 -1.708 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.043 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.617 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 14.4 ttmt -79.96 169.84 17.31 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 119.282 0.946 . . . . 0.0 109.929 176.323 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.2 -12.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.046 165.409 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.564 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.7 OUTLIER -159.67 123.93 3.84 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.791 -168.808 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.1 m -134.2 120.86 20.57 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.437 179.116 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.554 ' HB2' HD13 ' B' ' 75' ' ' ILE . 2.2 p90 -160.65 -178.63 7.0 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.563 1.173 . . . . 0.0 112.795 -174.529 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 16.3 t-20 -130.25 156.24 44.95 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.652 -176.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -70.41 -27.87 64.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.857 0.36 . . . . 0.0 110.985 -177.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.536 ' O ' HG23 ' B' ' 71' ' ' THR . 40.7 ttmt -86.6 -22.27 26.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.97 177.144 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 8.8 t -71.71 -20.29 61.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.397 173.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . 0.767 HG21 ' CD2' ' B' ' 45' ' ' TYR . 35.6 p 58.46 113.69 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.4 1.08 . . . . 0.0 113.759 168.073 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.473 HG12 ' CE2' ' B' ' 66' ' ' PHE . 1.8 m -59.53 -15.99 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.21 -168.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.03 -50.66 64.06 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.506 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -75.69 -35.1 60.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.553 0.692 . . . . 0.0 110.461 179.463 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' B' ' 66' ' ' PHE . 1.5 mt -74.66 -51.08 23.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.184 -171.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 8.5 t -64.14 -26.8 68.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.256 -175.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -48.61 -48.93 38.91 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.925 0.869 . . . . 0.0 109.636 171.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.661 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 0.3 OUTLIER -71.63 -42.15 67.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.315 177.514 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.564 HG13 ' CE1' ' B' ' 64' ' ' TYR . 36.0 mm -57.92 -33.75 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.029 0.442 . . . . 0.0 111.898 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.04 -21.91 61.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.067 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 21.4 pttm -86.5 -7.79 58.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.839 0.352 . . . . 0.0 110.633 -178.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.4 mm? -71.11 -16.2 62.55 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.699 -176.184 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 t30 46.67 61.55 2.74 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 124.148 0.905 . . . . 0.0 109.624 -170.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.592 ' H ' HD12 ' B' ' 84' ' ' ILE . 3.6 mp -57.09 141.08 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.079 -176.373 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 51.5 mtpt -95.91 -175.01 3.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.846 178.203 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.415 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -139.47 114.54 1.01 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 178.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.14 -74.76 0.08 Allowed 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -121.21 84.7 2.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 25.7 mm -86.64 129.77 37.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.63 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.617 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 12.9 mm-40 -123.38 146.34 48.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.742 177.108 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.617 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 47.2 mt -135.01 120.5 30.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.394 177.114 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 26.8 pttt -172.76 171.21 4.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.969 0.414 . . . . 0.0 111.921 -174.174 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.423 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 15.7 mm-40 -84.62 151.52 24.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.842 179.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.599 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.8 pt . . . . . 0 C--N 1.313 -1.017 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.327 -174.615 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 46.1 tpp . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.388 0.137 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . 0.45 ' C ' HD12 ' B' ' 13' ' ' ILE . 1.6 m-20 -41.16 -20.41 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.165 1.786 . . . . 0.0 114.239 -176.497 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -63.75 -5.2 3.83 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.992 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.479 ' HA ' ' HB2' ' B' ' 31' ' ' MET . 0.2 OUTLIER -49.03 -52.99 8.79 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-O 122.003 0.906 . . . . 0.0 110.007 179.361 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 14' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' B' ' 18' ' ' ASP . 35.0 m-80 -88.41 -32.53 18.28 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.616 -175.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 3.1 m -59.51 -43.62 93.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.769 0.319 . . . . 0.0 111.424 -177.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.88 -41.18 60.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.27 0.557 . . . . 0.0 109.765 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 17' ' ' ASN . . . . . 0.576 ' O ' ' HB2' ' B' ' 21' ' ' ASN . 3.0 t-20 -65.69 -45.88 81.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.972 -177.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' B' ' 14' ' ' ASN . 0.2 OUTLIER -67.85 -34.46 76.73 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.173 0.511 . . . . 0.0 110.729 -176.36 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -57.75 -59.91 4.5 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.192 178.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 49.1 mt -94.37 26.52 3.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.292 -177.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . 0.576 ' HB2' ' O ' ' B' ' 17' ' ' ASN . 27.5 t-20 -91.87 -37.86 12.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.264 0.554 . . . . 0.0 110.375 177.029 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -91.61 42.64 1.11 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.952 -178.033 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' B' ' 24' ' ' LYS . . . -85.82 -6.94 82.0 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.811 -177.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.478 ' HE3' ' CE1' ' B' ' 49' ' ' TYR . 86.7 mttt 72.53 -55.88 0.66 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.443 0.697 . . . . 0.0 110.801 -177.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' B' ' 45' ' ' TYR . . . -61.76 147.49 48.26 Favored Glycine 0 C--N 1.314 -0.678 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 167.234 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.531 ' CB ' ' HB3' ' B' ' 41' ' ' SER . 82.1 mttt -83.97 119.41 24.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.456 1.128 . . . . 0.0 111.105 -168.275 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 20.1 tp -158.06 118.79 3.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 57.8 m -114.55 112.27 22.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.31 -175.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 9.5 mp -98.09 165.65 11.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.659 0.742 . . . . 0.0 111.842 -178.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.3 p -160.47 141.44 11.97 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.808 171.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 31' ' ' MET . . . . . 0.703 ' SD ' HD23 ' B' ' 36' ' ' LEU . 82.0 mmm -108.47 136.38 48.19 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.65 0.262 . . . . 0.0 110.528 -175.136 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -137.08 61.33 1.63 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.153 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 55.43 -100.09 0.08 OUTLIER Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.194 177.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 34' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 20.9 m120 -75.81 -0.56 21.51 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -133.66 150.99 51.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.833 0.825 . . . . 0.0 112.253 175.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.703 HD23 ' SD ' ' B' ' 31' ' ' MET . 2.3 tm? -118.73 132.18 56.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.833 170.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -127.63 136.62 51.89 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.549 ' HB3' HD21 ' B' ' 80' ' ' ASN . . . -162.92 157.54 21.27 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.03 0.443 . . . . 0.0 111.761 -175.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.98 152.96 46.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.508 177.328 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 24.1 p -127.82 150.37 49.86 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.76 0.314 . . . . 0.0 110.702 -178.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.531 ' HB3' ' CB ' ' B' ' 26' ' ' LYS . 41.9 t -126.69 163.98 22.3 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.594 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -72.02 55.18 0.29 Allowed 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 125.243 1.589 . . . . 0.0 113.48 -154.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.456 ' HB3' ' H ' ' B' ' 26' ' ' LYS . . . -97.68 -18.32 18.93 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.911 169.247 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.12 -52.74 2.17 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.198 -0.91 . . . . 0.0 113.358 177.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.612 ' O ' ' HA3' ' B' ' 25' ' ' GLY . 5.4 m-85 -75.85 173.52 11.07 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.823 0.82 . . . . 0.0 112.638 -175.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.83 33.44 0.44 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 176.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.473 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -55.36 -45.09 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-N 114.178 -1.011 . . . . 0.0 111.803 -173.506 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.2 t 71.24 -91.33 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.168 -172.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.539 ' HB2' ' CE ' ' B' ' 52' ' ' LYS . 29.4 m-85 -140.78 126.93 19.61 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.457 0.473 . . . . 0.0 110.757 174.104 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 35.96 -109.97 0.06 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.287 1.035 . . . . 0.0 112.89 -174.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -132.85 132.63 42.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.19 0.519 . . . . 0.0 109.955 176.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.539 ' CE ' ' HB2' ' B' ' 49' ' ' TYR . 75.4 mttt -137.84 130.6 29.86 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.458 179.481 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -117.28 118.75 33.14 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.173 0.511 . . . . 0.0 109.782 175.271 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 54' ' ' TRP . . . . . 0.645 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 37.5 p-90 -143.95 170.52 15.76 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.374 -177.118 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.37 150.89 20.63 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.292 -175.234 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 11.4 mt -102.81 142.7 16.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 173.159 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 57' ' ' PHE . . . . . 0.6 ' HB2' ' HB2' ' B' ' 90' ' ' GLU . 46.7 m-85 -124.81 134.17 52.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.978 -177.322 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.558 HG12 ' HB ' ' B' ' 63' ' ' VAL . 9.3 p -126.43 137.89 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -178.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.495 ' ND2' HG13 ' B' ' 58' ' ' VAL . 6.0 m-80 65.86 3.09 2.41 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -172.141 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.419 ' N ' ' HB3' ' B' ' 88' ' ' TYR . . . 103.36 -12.63 54.85 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.912 -174.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 1.4 mp0 -91.01 170.28 10.18 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 123.663 0.785 . . . . 0.0 108.885 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 62' ' ' LYS . . . . . 0.561 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 17.4 ttmt -68.2 169.28 10.65 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 172.505 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.558 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.7 p -153.53 -13.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.297 170.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.5 ' CE2' HG23 ' B' ' 75' ' ' ILE . 0.3 OUTLIER -164.58 136.43 4.5 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.863 -176.347 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -128.43 127.19 42.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.515 173.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 66' ' ' PHE . . . . . 0.663 ' CE2' HG21 ' B' ' 75' ' ' ILE . 27.2 p90 -166.88 154.83 9.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.676 0.75 . . . . 0.0 111.074 -176.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -101.76 161.01 13.97 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.386 173.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 68' ' ' GLU . . . . . 0.499 ' CG ' ' HB2' ' B' ' 52' ' ' LYS . 4.7 mm-40 -73.37 -36.83 66.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.491 0.662 . . . . 0.0 109.952 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -59.72 -25.58 64.93 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.781 177.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.4 t -68.17 -10.4 53.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.343 -178.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 71' ' ' THR . . . . . . . . . . . . . 31.6 p 75.47 94.38 0.07 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 112.479 -2.146 . . . . 0.0 110.763 177.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.75 ' HA ' ' CG1' ' B' ' 75' ' ' ILE . 19.7 m -67.86 -8.56 9.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.328 -171.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.99 -37.14 94.47 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.236 176.517 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -82.14 -29.13 31.79 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 75' ' ' ILE . . . . . 0.75 ' CG1' ' HA ' ' B' ' 72' ' ' VAL . 30.2 mm -57.92 -60.56 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.959 174.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 76' ' ' SER . . . . . 0.429 ' HA ' HD12 ' B' ' 79' ' ' ILE . 18.9 t -61.77 -32.55 72.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.377 -177.462 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' B' ' 80' ' ' ASN . 64.8 t30 -51.96 -49.94 62.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.947 174.681 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 78' ' ' ASP . . . . . 0.68 ' O ' ' HG3' ' B' ' 81' ' ' LYS . 0.4 OUTLIER -73.47 -34.8 65.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.188 178.471 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.572 HG13 ' O ' ' B' ' 75' ' ' ILE . 57.0 mt -56.13 -34.79 39.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.253 0.549 . . . . 0.0 110.453 176.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 80' ' ' ASN . . . . . 0.549 HD21 ' HB3' ' B' ' 38' ' ' ALA . 10.1 m-80 -56.91 -28.08 61.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.156 177.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 81' ' ' LYS . . . . . 0.68 ' HG3' ' O ' ' B' ' 78' ' ' ASP . 1.1 pptp? -97.44 -5.59 35.81 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -171.212 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 31.0 mt -68.45 -21.69 64.63 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 122.0 -0.438 . . . . 0.0 110.392 -174.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 50.59 64.73 1.7 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.505 -166.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.549 HD12 ' HB2' ' B' ' 36' ' ' LEU . 70.2 mt -59.82 157.5 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.592 -172.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.465 ' O ' HG22 ' B' ' 84' ' ' ILE . 22.0 mmmt -100.82 -169.35 1.69 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.211 0.529 . . . . 0.0 110.14 175.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -151.53 113.27 0.57 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.192 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 87' ' ' MET . . . . . 0.436 ' HG3' ' HA ' ' B' ' 59' ' ' ASN . 18.0 ptp -174.42 -54.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 122.53 0.332 . . . . 0.0 110.248 177.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 88' ' ' TYR . . . . . 0.419 ' HB3' ' N ' ' B' ' 60' ' ' GLY . 6.8 t80 -134.03 79.56 1.82 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 34.1 mm -94.49 114.92 32.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.171 177.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.6 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 31.7 mm-40 -110.17 146.53 35.37 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.051 0.453 . . . . 0.0 111.432 179.232 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.645 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 5.2 mp -131.68 107.24 12.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.839 178.198 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 92' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 16.4 pttp -167.9 172.65 8.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.943 0.401 . . . . 0.0 111.433 -172.364 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.409 ' H ' ' HG3' ' B' ' 93' ' ' GLN . 0.4 OUTLIER -69.47 165.03 21.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.528 174.987 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 94' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' B' ' 54' ' ' TRP . 2.3 pt . . . . . 0 C--O 1.25 1.131 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.401 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 p30 . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -126.12 152.99 45.18 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.967 0.413 . . . . 0.0 110.762 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -67.47 -2.73 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.51 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -78.18 -13.3 59.92 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.297 0.57 . . . . 0.0 110.231 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.6 -169.57 0.88 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.184 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.416 ' H ' HD12 ' B' ' 6' ' ' LEU . 5.0 mp -79.37 22.22 0.44 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.086 -177.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -63.74 -69.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.793 0.33 . . . . 0.0 110.356 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -81.87 -24.32 35.83 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.805 0.812 . . . . 0.0 110.09 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.96 65.5 3.5 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.474 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 79.1 mmm -81.5 117.78 22.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.994 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -58.4 -23.59 57.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.745 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 13.3 m -65.7 -29.88 70.48 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.932 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 9.6 mm -62.74 -41.66 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 121.856 0.836 . . . . 0.0 109.436 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -70.72 -34.49 71.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.877 -174.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.573 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 17.6 m -67.73 -45.95 73.55 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.216 177.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.48 -44.59 96.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.968 0.413 . . . . 0.0 110.329 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.517 ' ND2' HD23 ' B' ' 29' ' ' LEU . 2.1 t-20 -52.29 -49.98 63.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.953 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -18.07 47.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.24 -174.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -78.55 -49.86 12.58 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 120.984 0.421 . . . . 0.0 111.859 176.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.563 HD22 HG11 ' B' ' 72' ' ' VAL . 67.5 mt -72.89 -43.41 62.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.295 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -85.56 74.4 10.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.641 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -131.38 -77.4 0.52 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.672 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -123.35 46.13 1.13 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.414 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -117.19 -140.74 0.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.687 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -85.7 170.78 44.43 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.848 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.529 ' HE2' ' HB2' ' B' ' 41' ' ' SER . 4.9 ttpt -61.84 127.09 29.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' B' ' 39' ' ' THR . 11.6 tp -158.04 115.46 2.96 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 120.957 0.408 . . . . 0.0 110.693 -169.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 69.3 m -107.74 114.14 27.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.054 177.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.517 HD23 ' ND2' ' B' ' 17' ' ' ASN . 3.1 mm? -86.4 154.94 20.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.542 0.687 . . . . 0.0 111.166 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.97 154.47 41.3 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.545 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 54.1 mtt -119.88 144.73 47.24 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.118 0.485 . . . . 0.0 111.898 -171.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -154.42 108.32 2.95 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.09 -111.66 4.18 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -168.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.539 ' HB2' ' HA2' ' B' ' 86' ' ' GLY . 13.8 m120 -123.48 19.58 9.63 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 168.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -72.55 154.71 40.67 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.401 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 20.3 tp -112.44 92.03 3.87 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.172 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -89.52 151.75 21.8 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.459 ' HB2' HD13 ' B' ' 29' ' ' LEU . . . -170.65 155.53 4.91 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -171.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 11.0 p -123.27 140.18 53.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.207 168.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 27.1 t -142.18 153.13 43.8 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.767 0.794 . . . . 0.0 112.753 -172.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.529 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . 10.2 m -133.0 168.39 18.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.754 176.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -112.07 36.46 3.33 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.478 0.656 . . . . 0.0 109.94 -170.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.7 22.28 0.1 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.86 -1.064 . . . . 0.0 113.376 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.46 -44.11 0.53 Allowed Glycine 0 C--O 1.229 -0.186 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.532 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.687 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 44.4 p90 46.98 -152.51 0.08 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.22 1.008 . . . . 0.0 113.469 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.474 ' H ' ' CG2' ' B' ' 71' ' ' THR . . . -81.75 99.74 2.02 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.444 -173.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.463 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -112.52 -54.53 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.509 0.671 . . . . 0.0 109.266 172.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -42.87 -55.7 3.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.154 -1.384 . . . . 0.0 111.939 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -79.21 121.12 24.65 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.96 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -65.76 -83.92 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.814 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -146.63 112.37 5.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.508 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 79.6 mttt -139.21 136.23 34.79 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -125.41 128.14 47.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.51 0.671 . . . . 0.0 111.934 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.553 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 30.5 p-90 -147.73 177.15 9.54 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.266 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.26 151.16 22.05 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.973 -174.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' B' ' 64' ' ' TYR . 19.0 mt -110.26 141.61 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 174.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 60.9 m-85 -125.36 139.45 53.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.795 -173.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.574 HG13 ' ND2' ' B' ' 59' ' ' ASN . 7.4 p -126.37 137.38 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.642 ' HA ' ' CG ' ' B' ' 87' ' ' MET . 2.9 m-80 63.11 6.24 2.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.33 0.652 . . . . 0.0 110.171 -175.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.3 -5.45 55.41 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.94 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' B' ' 58' ' ' VAL . 22.1 mt-10 -100.2 174.45 6.14 Favored 'General case' 0 C--O 1.193 -1.873 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.504 ' HE3' ' CE1' ' B' ' 57' ' ' PHE . 10.7 tttt -80.88 169.97 16.87 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.02 -3.22 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.717 165.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.781 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -158.16 130.83 7.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.437 -172.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 25.3 m -137.68 125.68 22.78 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.448 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.549 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.1 OUTLIER -160.91 154.2 21.68 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 122.709 1.242 . . . . 0.0 113.239 -175.219 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 19.1 t-20 -107.93 152.1 24.9 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.364 -2.198 . . . . 0.0 107.777 166.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -64.27 -24.29 67.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.572 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.573 ' O ' HG23 ' B' ' 71' ' ' THR . 4.4 ttmp? -82.8 -26.09 32.1 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.027 0.441 . . . . 0.0 110.948 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 6.6 t -69.93 -22.3 63.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.573 HG23 ' O ' ' B' ' 69' ' ' LYS . 11.9 p 60.28 115.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.326 1.05 . . . . 0.0 112.558 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.563 HG11 HD22 ' B' ' 20' ' ' LEU . 10.0 m -61.52 -11.74 5.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.82 -172.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.56 -52.6 51.52 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.192 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -72.01 -32.57 67.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.584 0.707 . . . . 0.0 110.213 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.549 HD13 ' HB3' ' B' ' 66' ' ' PHE . 2.9 mt -73.19 -48.35 43.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.606 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.8 t -50.87 -36.75 39.59 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.239 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -51.21 -55.81 16.11 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.838 0.828 . . . . 0.0 109.744 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.748 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 24.2 m-20 -69.68 -39.7 76.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.046 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.781 HG13 ' CE1' ' B' ' 64' ' ' TYR . 42.6 mm -57.88 -30.91 39.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.378 0.609 . . . . 0.0 111.881 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -73.53 2.4 7.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.618 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.748 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 45.3 pttt -109.49 8.06 25.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.259 0.552 . . . . 0.0 109.937 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' B' ' 79' ' ' ILE . 2.3 mm? -77.36 -6.82 54.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.606 -175.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 56.2 65.03 1.53 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -167.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 54.1 mt -67.75 149.56 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.092 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.614 ' HB2' HD21 ' B' ' 59' ' ' ASN . 63.2 mttm -129.68 -159.71 0.98 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.932 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.539 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -160.29 126.77 1.67 Allowed Glycine 0 C--N 1.318 -0.426 0 C-N-CA 120.005 -1.093 . . . . 0.0 114.434 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.642 ' CG ' ' HA ' ' B' ' 59' ' ' ASN . 21.1 ptp -176.72 -52.11 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 122.782 0.433 . . . . 0.0 111.166 168.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . 0.51 ' N ' ' HG3' ' B' ' 87' ' ' MET . 60.7 t80 -127.37 99.08 5.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.917 -0.49 . . . . 0.0 109.883 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 41.1 mm -96.53 137.18 25.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.233 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 6.5 mm-40 -128.88 153.93 47.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.035 0.445 . . . . 0.0 111.494 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.553 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 51.5 mt -131.9 114.29 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.323 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 62.6 pttt -166.7 162.24 16.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.06 0.457 . . . . 0.0 112.157 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.45 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -80.82 163.97 23.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.106 175.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.55 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.3 pt . . . . . 0 C--O 1.245 0.85 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.892 -172.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.966 0.412 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.53 ' HB3' ' OE1' ' B' ' 8' ' ' GLU . 3.9 m-20 -80.25 -25.51 39.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.177 -175.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -75.16 -17.58 60.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.892 0.377 . . . . 0.0 110.877 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -99.84 -20.42 16.19 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.143 0.497 . . . . 0.0 110.323 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.43 125.11 25.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.977 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 61.2 mt -71.69 -3.43 21.75 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.761 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -62.8 -49.2 75.9 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.95 172.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.53 ' OE1' ' HB3' ' B' ' 2' ' ' ASN . 26.0 mt-10 -92.42 -33.65 14.46 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.393 0.616 . . . . 0.0 110.714 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -85.95 107.1 17.59 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.184 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -62.91 135.8 57.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.4 0.619 . . . . 0.0 110.678 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -56.35 -24.66 45.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.943 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.507 ' O ' HG23 ' B' ' 16' ' ' VAL . 5.4 m -63.52 -33.02 74.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.569 -178.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.448 HD11 HG13 ' B' ' 89' ' ' ILE . 12.6 mm -62.74 -43.28 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.624 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' B' ' 17' ' ' ASN . 1.3 m120 -71.93 -39.94 69.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.834 -175.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.603 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 23.8 m -61.33 -49.39 77.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.705 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.507 HG23 ' O ' ' B' ' 12' ' ' SER . 61.2 t -65.2 -38.93 83.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 110.436 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.433 HD22 ' HG ' ' B' ' 29' ' ' LEU . 1.9 t-20 -49.97 -45.96 51.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.905 175.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.2 OUTLIER -82.75 -41.54 19.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.384 -179.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.603 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -58.55 -52.66 64.7 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 123.419 0.688 . . . . 0.0 112.761 -175.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.426 HD21 ' HZ2' ' B' ' 54' ' ' TRP . 70.2 mt -73.54 -28.39 61.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.74 0.305 . . . . 0.0 110.945 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -89.46 61.32 5.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.45 0.643 . . . . 0.0 110.279 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 30.7 mtpp -129.36 -84.27 0.56 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.835 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.65 44.95 1.39 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.616 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -126.24 -159.05 0.89 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.584 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -67.96 159.04 51.41 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.466 ' HG2' ' HB2' ' B' ' 41' ' ' SER . 0.0 OUTLIER -82.07 111.01 17.82 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.708 -177.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' B' ' 39' ' ' THR . 2.3 pt? -131.57 148.74 52.64 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.604 -176.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 60.7 m -102.67 117.08 33.89 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.404 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' B' ' 38' ' ' ALA . 2.8 mm? -88.51 152.6 21.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.51 0.672 . . . . 0.0 110.787 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.1 p -150.07 151.02 32.55 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.237 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 50.7 mtt -120.13 146.21 46.19 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.858 0.361 . . . . 0.0 110.92 -175.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -154.05 116.65 4.4 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.96 -111.49 4.16 Favored Glycine 0 CA--C 1.507 -0.41 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -169.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.56 ' HB2' ' CA ' ' B' ' 86' ' ' GLY . 43.1 m-20 -130.45 37.75 3.82 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 168.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.426 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 48.1 mt-30 -92.17 161.25 14.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.241 175.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 27.4 tp -127.44 110.53 12.87 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 171.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.427 ' HA ' ' ND2' ' B' ' 80' ' ' ASN . 32.2 mtmt -113.36 148.06 36.49 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -177.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.485 ' HB2' HD13 ' B' ' 29' ' ' LEU . . . -156.89 158.16 36.18 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -172.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 4.6 p -133.35 134.68 44.07 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.929 171.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -131.1 147.82 52.66 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -167.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.466 ' HB2' ' HG2' ' B' ' 26' ' ' LYS . 2.4 m -99.75 141.7 32.21 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 167.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -103.92 32.06 4.15 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.339 -169.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.71 22.52 1.6 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.135 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.69 -36.52 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.798 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.584 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 6.8 p90 38.13 -142.02 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.475 1.11 . . . . 0.0 113.646 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.49 112.05 3.41 Favored Glycine 0 C--N 1.339 0.729 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.076 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.21 -57.41 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 121.005 0.431 . . . . 0.0 109.846 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.4 m -43.2 -54.81 4.29 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.346 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -97.32 120.38 37.59 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.067 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -94.98 -84.17 0.34 Allowed 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.641 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -103.96 108.35 19.66 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.749 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.52 ' HB2' ' CG ' ' B' ' 68' ' ' GLU . 93.2 mttt -150.15 134.29 17.09 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 169.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.96 126.51 51.05 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.127 0.489 . . . . 0.0 110.805 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.566 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 25.1 p-90 -145.02 159.34 43.09 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.721 176.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -122.09 147.82 17.09 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.166 -175.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.548 HD12 ' CD2' ' B' ' 64' ' ' TYR . 16.4 mt -105.11 148.76 9.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 169.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.69 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 88.9 m-85 -128.35 141.28 51.47 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -169.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.565 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.9 p -128.12 136.57 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.501 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.3 m-80 62.43 12.82 5.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.276 -171.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.94 78.92 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.075 -174.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 17.2 mt-10 -98.25 175.31 6.12 Favored 'General case' 0 C--O 1.202 -1.429 0 C-N-CA 123.517 0.727 . . . . 0.0 109.357 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.0 tppp? -63.4 160.56 15.9 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 118.681 0.673 . . . . 0.0 109.956 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.565 ' HB ' HG12 ' B' ' 58' ' ' VAL . 7.2 p -151.47 -16.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.965 0.412 . . . . 0.0 110.168 167.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.691 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.9 OUTLIER -161.5 125.74 3.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.148 -171.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 22.7 m -131.36 129.44 41.39 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.642 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.511 ' CB ' HD13 ' B' ' 75' ' ' ILE . 7.7 p90 -167.83 153.66 7.34 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 122.186 0.993 . . . . 0.0 112.567 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.496 ' O ' ' HB3' ' B' ' 70' ' ' SER . 16.6 t-20 -99.81 153.14 19.37 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.151 -1.84 . . . . 0.0 108.962 171.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . 0.52 ' CG ' ' HB2' ' B' ' 52' ' ' LYS . 6.7 mm-40 -62.03 -45.67 92.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.969 0.349 . . . . 0.0 111.423 -176.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.522 ' O ' HG23 ' B' ' 71' ' ' THR . 86.4 tttt -64.71 -22.22 66.93 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.454 0.702 . . . . 0.0 111.547 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 6.2 t -69.44 -16.74 63.55 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.522 HG23 ' O ' ' B' ' 69' ' ' LYS . 30.2 p 59.18 107.78 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.888 1.275 . . . . 0.0 112.915 172.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.547 ' HA ' HD12 ' B' ' 75' ' ' ILE . 2.3 m -58.34 -17.85 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 114.266 -1.333 . . . . 0.0 112.635 -171.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.37 -48.97 80.75 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.682 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -74.5 -34.21 63.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.465 0.65 . . . . 0.0 110.191 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' B' ' 72' ' ' VAL . 1.9 mt -74.68 -48.45 34.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.085 -173.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 77.7 p -50.62 -48.75 57.89 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.583 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -41.62 -52.57 3.76 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.751 -1.568 . . . . 0.0 111.216 173.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.705 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 22.7 m-20 -74.28 -28.83 61.38 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.429 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.691 HG13 ' CE1' ' B' ' 64' ' ' TYR . 48.8 mm -71.88 -38.12 63.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.142 0.496 . . . . 0.0 111.199 177.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.427 ' ND2' ' HA ' ' B' ' 37' ' ' LYS . 11.3 m120 -62.88 -28.37 70.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.373 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.705 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 61.1 pttt -81.59 3.41 25.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.446 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' B' ' 79' ' ' ILE . 36.8 mt -84.77 3.89 35.45 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.726 0.298 . . . . 0.0 110.862 -177.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 58.9 t30 54.15 58.03 5.38 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -170.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.443 HD11 HG22 ' B' ' 79' ' ' ILE . 61.7 mt -52.31 149.88 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.726 -173.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -109.22 175.14 5.56 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.573 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.56 ' CA ' ' HB2' ' B' ' 34' ' ' ASN . . . -141.97 112.94 0.78 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.472 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.536 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 0.2 OUTLIER -146.1 -81.21 0.15 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 117.021 0.41 . . . . 0.0 110.595 175.536 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . 0.536 ' N ' ' HG3' ' B' ' 87' ' ' MET . 46.8 t80 -120.16 106.24 11.75 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.69 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 22.0 mm -101.11 130.55 50.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.092 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -122.89 178.58 4.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.188 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.566 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 95.8 mt -149.98 127.76 2.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.29 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -174.36 154.2 2.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.98 0.419 . . . . 0.0 111.615 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.597 ' NE2' ' H ' ' B' ' 93' ' ' GLN . 0.7 OUTLIER -82.68 146.43 29.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.087 177.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.49 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.2 pt . . . . . 0 C--O 1.249 1.064 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.95 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 14.8 t70 . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.702 0.286 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -127.96 37.99 4.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.712 0.291 . . . . 0.0 110.955 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -90.64 -70.09 0.69 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.028 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -97.1 -61.93 1.33 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.095 0.474 . . . . 0.0 111.116 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.49 85.89 6.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.204 -175.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.4 -21.51 63.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.866 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' B' ' 87' ' ' MET . 31.6 mt-10 -67.13 -10.83 54.24 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -175.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -70.11 -21.57 63.1 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 122.417 1.104 . . . . 0.0 109.351 174.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.64 ' HG2' ' H ' ' B' ' 10' ' ' MET . 17.8 tt0 -128.87 -163.59 1.3 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.085 -1.87 . . . . 0.0 107.314 174.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . 0.684 ' HG2' ' H ' ' B' ' 89' ' ' ILE . 15.1 tpt -158.58 138.39 12.01 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.765 -0.585 . . . . 0.0 109.736 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -54.04 -28.63 39.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.22 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.585 ' H ' ' HG3' ' B' ' 10' ' ' MET . 6.2 m -75.2 -16.63 60.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.397 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.523 HG22 ' SD ' ' B' ' 31' ' ' MET . 6.3 mm -57.45 -44.06 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 122.313 1.054 . . . . 0.0 109.03 175.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -70.32 -30.67 67.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.536 -1.666 . . . . 0.0 109.792 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.477 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 10.7 t -70.96 -38.04 72.81 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.903 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.545 HG23 ' O ' ' B' ' 12' ' ' SER . 93.3 t -51.01 -50.55 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.397 0.618 . . . . 0.0 109.816 174.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -59.02 -49.46 77.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.871 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -30.86 68.32 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -174.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' B' ' 15' ' ' SER . 10.0 mmmm -76.85 -23.65 52.7 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.464 0.649 . . . . 0.0 111.381 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.41 HD22 HG11 ' B' ' 72' ' ' VAL . 92.0 mt -97.36 -42.11 7.92 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.181 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -84.95 73.46 10.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.395 0.616 . . . . 0.0 110.184 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -116.72 -74.38 0.61 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.504 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.49 40.65 0.82 Allowed Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.741 ' HG2' ' CE1' ' B' ' 49' ' ' TYR . 44.4 mttt -110.7 -145.48 0.4 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -70.09 154.2 52.51 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' B' ' 40' ' ' SER . 0.3 OUTLIER -61.91 121.67 13.52 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.476 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 28.8 tp -148.23 97.46 2.78 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.481 0.658 . . . . 0.0 109.256 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 43.0 m -99.12 116.24 30.87 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.788 -175.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.476 ' CD1' ' HG ' ' B' ' 27' ' ' LEU . 10.2 mp -101.67 167.27 10.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.555 0.693 . . . . 0.0 111.838 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.5 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 1.3 p -149.38 146.26 27.4 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.401 -1.272 . . . . 0.0 108.802 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . 0.523 ' SD ' HG22 ' B' ' 13' ' ' ILE . 5.7 mmt -105.8 118.26 36.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.562 -169.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 4.0 t30 -133.5 60.76 1.69 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.882 0.373 . . . . 0.0 110.009 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.88 -104.11 0.12 Allowed Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.606 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.491 ' HA ' ' N ' ' B' ' 86' ' ' GLY . 17.9 m120 -85.02 23.19 1.26 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.687 -0.257 . . . . 0.0 111.07 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 35.3 mt-30 -138.73 150.84 46.58 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.437 0.636 . . . . 0.0 110.595 172.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -123.94 114.65 20.09 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.162 172.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.5 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 6.7 mmmm -110.73 137.78 47.96 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -176.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -162.28 154.2 18.77 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.28 0.562 . . . . 0.0 112.329 -172.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -129.33 146.15 51.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.389 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 33.6 p -135.67 154.98 51.11 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.004 0.431 . . . . 0.0 112.031 -175.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 28.1 t -152.95 159.37 42.94 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.152 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' B' ' 44' ' ' GLY . 51.3 m-80 -85.76 52.82 2.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.114 -174.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.21 23.22 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.856 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' B' ' 42' ' ' ASN . . . 117.39 -13.19 13.74 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.784 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.49 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 35.7 p90 45.2 -156.98 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.403 1.081 . . . . 0.0 113.136 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.424 ' H ' HG22 ' B' ' 71' ' ' THR . . . -72.63 89.97 0.55 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.91 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.55 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -91.68 -70.85 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.541 0.686 . . . . 0.0 110.509 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.9 m -50.34 -55.88 13.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.987 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.741 ' CE1' ' HG2' ' B' ' 24' ' ' LYS . 4.3 m-85 -61.48 109.69 1.24 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.605 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.29 -64.44 0.95 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.543 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -173.05 113.09 0.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.734 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 54.1 mtmt -138.31 145.34 41.09 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.513 ' HB3' ' OD1' ' B' ' 67' ' ' ASN . 0.5 OUTLIER -121.82 121.96 38.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.226 0.536 . . . . 0.0 111.623 -178.194 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.584 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 33.4 p-90 -140.23 173.74 11.21 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.229 174.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.98 151.79 21.12 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.907 -1.14 . . . . 0.0 113.372 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.523 HD12 ' CD2' ' B' ' 64' ' ' TYR . 18.2 mt -110.12 145.92 16.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 174.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.76 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 72.8 m-85 -128.88 143.66 50.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.282 -171.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.536 HG13 ' ND2' ' B' ' 59' ' ' ASN . 9.6 p -128.47 137.34 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.536 ' ND2' HG13 ' B' ' 58' ' ' VAL . 1.4 m-80 60.27 9.02 1.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.277 0.631 . . . . 0.0 110.494 -176.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.77 7.87 57.45 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.232 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 12.1 mt-10 -114.62 177.02 4.8 Favored 'General case' 0 C--O 1.199 -1.592 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.571 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 18.6 ttmt -78.89 169.21 18.58 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 119.303 0.956 . . . . 0.0 109.924 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.53 -14.96 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.798 164.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.679 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.5 OUTLIER -158.4 130.07 6.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.601 -167.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.2 m -137.96 133.3 33.54 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.218 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.458 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.0 OUTLIER -159.35 160.97 35.63 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.953 0.882 . . . . 0.0 111.21 -174.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.513 ' OD1' ' HB3' ' B' ' 53' ' ' ASN . 2.9 m120 -115.96 146.78 41.81 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.624 -1.626 . . . . 0.0 109.787 170.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . 0.465 ' CD ' ' HZ3' ' B' ' 24' ' ' LYS . 13.4 mm-40 -56.35 -44.27 79.92 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.614 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.538 ' O ' HG23 ' B' ' 71' ' ' THR . 35.0 ttpt -64.01 -30.09 71.19 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.611 0.72 . . . . 0.0 110.621 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 23.7 m -81.27 -3.35 52.18 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.091 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.538 HG23 ' O ' ' B' ' 69' ' ' LYS . 23.6 p 55.21 102.01 0.01 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.304 1.442 . . . . 0.0 113.474 165.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.41 HG11 HD22 ' B' ' 20' ' ' LEU . 4.2 m -62.94 -18.88 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.425 -173.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.42 -49.58 75.09 Favored Glycine 0 C--O 1.236 0.241 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.974 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -69.62 -37.52 76.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.023 0.439 . . . . 0.0 110.268 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.569 ' O ' HG12 ' B' ' 79' ' ' ILE . 2.7 mt -68.21 -46.61 80.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.609 -176.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 45.6 m -57.02 -35.5 69.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.933 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -54.74 -49.17 71.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.169 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 7.3 m-20 -70.51 -37.49 74.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.558 -1.201 . . . . 0.0 112.122 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.679 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 43.7 mm -59.02 -24.4 26.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.482 0.658 . . . . 0.0 111.443 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -59.95 -18.66 47.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.508 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 6.0 ptpp? -87.11 1.32 53.36 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.172 0.51 . . . . 0.0 110.851 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.577 HD23 ' HA ' ' B' ' 79' ' ' ILE . 2.4 mm? -81.38 -1.66 46.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.156 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 49.54 62.35 2.68 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.798 -168.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.584 HD11 HG22 ' B' ' 79' ' ' ILE . 49.0 mt -58.71 140.77 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.71 -177.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -127.37 -176.76 3.84 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.796 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.491 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -136.89 115.53 1.27 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.872 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.487 ' HA ' ' O ' ' B' ' 7' ' ' GLU . 32.7 ttm -157.79 -74.99 0.09 Allowed 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -130.77 82.51 2.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.415 0.626 . . . . 0.0 109.503 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.76 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.2 mp -87.67 136.68 22.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.518 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -122.08 171.78 8.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.888 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.509 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 32.9 mm -144.93 110.1 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.33 -174.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.584 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 16.6 pttp -161.04 173.18 15.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.291 0.567 . . . . 0.0 112.042 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.563 ' NE2' ' H ' ' B' ' 93' ' ' GLN . 0.0 OUTLIER -105.49 145.79 30.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.882 -175.03 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.7 pt . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.95 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -100.89 -25.09 14.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.727 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . 0.417 ' HA ' ' HG ' ' B' ' 6' ' ' LEU . 15.8 pt20 -55.22 -42.67 73.65 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -173.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -70.62 -26.15 63.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.143 0.497 . . . . 0.0 110.775 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -107.77 26.68 10.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.24 -175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' B' ' 9' ' ' GLN . 74.9 mt -75.24 11.47 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.24 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -68.17 -62.66 1.3 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.205 0.526 . . . . 0.0 109.639 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -89.32 -33.22 16.99 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.03 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' B' ' 6' ' ' LEU . 50.6 mt-30 -85.75 119.35 25.99 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.361 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.15 174.09 7.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.958 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -60.28 -33.36 72.23 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.967 0.413 . . . . 0.0 111.805 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.431 ' O ' HG23 ' B' ' 16' ' ' VAL . 23.2 t -67.84 -8.45 36.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.031 -169.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 10.2 mm -55.41 -55.11 18.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.935 0.874 . . . . 0.0 110.12 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -77.56 -27.7 51.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.355 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 10.1 m -57.6 -47.05 83.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.116 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.431 HG23 ' O ' ' B' ' 12' ' ' SER . 76.1 t -66.46 -43.91 90.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.085 0.469 . . . . 0.0 109.978 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.588 HD22 HD12 ' B' ' 29' ' ' LEU . 3.8 t-20 -54.08 -50.77 66.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.986 178.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.38 -43.21 64.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.648 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -57.24 -50.89 71.45 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 123.204 0.602 . . . . 0.0 111.593 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -70.69 -45.24 65.38 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.827 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -85.97 59.78 5.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.389 0.614 . . . . 0.0 111.369 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -105.23 -17.34 14.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.328 0.585 . . . . 0.0 109.914 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.83 -95.16 0.1 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.521 ' HE3' ' OE2' ' B' ' 68' ' ' GLU . 51.3 mttp 41.65 -135.1 0.29 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.688 0.795 . . . . 0.0 111.197 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.608 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -84.42 168.15 43.85 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.785 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.425 ' HE3' ' CB ' ' B' ' 41' ' ' SER . 14.7 ttpt -86.27 109.84 19.23 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -145.52 168.31 20.91 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.161 -176.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.6 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 43.9 m -125.66 107.11 10.25 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.759 -176.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.588 HD12 HD22 ' B' ' 17' ' ' ASN . 33.1 mt -86.87 144.91 26.78 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.569 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 9.0 p -134.78 156.69 48.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.964 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 55.0 mtm -110.04 127.99 55.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.991 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -148.89 108.33 3.96 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.04 -114.62 6.92 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.581 ' HB2' ' HA2' ' B' ' 86' ' ' GLY . 1.7 m-20 -123.9 20.03 9.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' B' ' 84' ' ' ILE . 25.0 mt-30 -74.69 158.78 32.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.528 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tt -115.93 104.01 11.18 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.391 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.569 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 4.7 mtmp? -115.59 142.63 46.47 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -158.91 156.61 29.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -175.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -130.56 134.65 47.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 170.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 44.6 t -126.33 160.07 31.41 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -164.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.425 ' CB ' ' HE3' ' B' ' 26' ' ' LYS . 35.2 t -134.4 159.97 39.41 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.007 174.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -109.25 29.63 7.35 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.276 0.56 . . . . 0.0 110.727 -171.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.03 22.4 0.09 Allowed 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.961 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.75 -38.3 0.57 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.409 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.608 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 14.4 p90 45.56 -159.48 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.471 1.108 . . . . 0.0 113.758 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.17 114.83 6.03 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.974 -0.632 . . . . 0.0 113.118 -175.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.11 -60.81 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.837 0.351 . . . . 0.0 110.815 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 m -40.66 -57.23 1.93 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.077 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.81 106.15 10.61 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.784 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -60.0 -49.22 78.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.651 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -165.32 110.77 0.91 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.985 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 71.8 mmtt -133.51 131.93 40.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -112.73 125.77 54.68 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.522 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 16.7 p-90 -152.7 166.74 31.2 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.886 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.33 142.6 13.88 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.846 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.589 HD12 ' CD2' ' B' ' 64' ' ' TYR . 23.7 mt -106.59 151.37 8.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.669 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 76.0 m-85 -132.59 140.29 48.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.277 -170.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.544 HG12 ' HB ' ' B' ' 63' ' ' VAL . 11.9 p -124.85 131.42 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.407 ' ND2' HG13 ' B' ' 58' ' ' VAL . 2.8 m-80 64.25 11.49 6.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.51 -176.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.96 -3.74 62.55 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.348 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -103.01 177.15 4.92 Favored 'General case' 0 C--O 1.207 -1.152 0 C-N-CA 123.303 0.641 . . . . 0.0 109.642 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.438 ' HD2' ' OG1' ' B' ' 65' ' ' THR . 5.2 tppp? -63.87 158.76 21.22 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.014 175.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.544 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.8 p -153.23 -11.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.122 0.487 . . . . 0.0 110.245 165.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.819 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -161.21 136.25 7.52 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.061 0.458 . . . . 0.0 110.53 -174.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.438 ' OG1' ' HD2' ' B' ' 62' ' ' LYS . 84.8 m -149.25 118.47 6.81 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' B' ' 66' ' ' PHE . 0.0 OUTLIER -167.74 159.76 12.04 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.717 0.77 . . . . 0.0 111.462 -164.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 18.1 t-20 -114.04 158.8 20.74 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.915 -1.493 . . . . 0.0 109.591 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . 0.521 ' OE2' ' HE3' ' B' ' 24' ' ' LYS . 8.5 mm-40 -74.06 -34.14 63.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.004 0.43 . . . . 0.0 110.898 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.548 ' O ' HG23 ' B' ' 71' ' ' THR . 53.0 tttm -68.94 -31.69 70.76 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.049 0.928 . . . . 0.0 109.319 176.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 30.4 m -79.62 0.3 30.74 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.843 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.548 HG23 ' O ' ' B' ' 69' ' ' LYS . 20.1 p 53.64 100.58 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.436 1.494 . . . . 0.0 113.678 165.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 m -56.68 -21.77 14.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.069 -176.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.67 -54.64 35.73 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.544 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -69.4 -31.93 70.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.202 0.525 . . . . 0.0 110.172 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.513 HG13 ' O ' ' B' ' 71' ' ' THR . 2.9 mt -70.11 -42.61 79.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.239 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -58.02 -30.25 65.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.752 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -52.6 -53.32 48.31 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.767 0.794 . . . . 0.0 109.633 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.684 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 4.9 m-20 -65.1 -40.67 94.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.461 177.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.819 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 44.5 mm -54.31 -32.33 23.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.314 0.578 . . . . 0.0 111.817 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.461 ' OD1' ' HA ' ' B' ' 37' ' ' LYS . 90.5 m-20 -58.43 -31.22 67.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.816 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 4.6 ptpp? -83.43 -4.48 58.54 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.163 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.8 mm? -70.32 -15.83 62.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.717 0.294 . . . . 0.0 110.667 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 44.01 61.66 2.25 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.813 -171.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.442 HG22 ' O ' ' B' ' 85' ' ' LYS . 73.0 mt -60.04 146.37 10.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.362 -1.29 . . . . 0.0 112.6 -172.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.442 ' O ' HG22 ' B' ' 84' ' ' ILE . 30.0 mmmt -92.11 -166.07 1.48 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.132 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.581 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -148.55 114.16 0.66 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.808 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.464 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 6.2 tpt -152.42 -68.89 0.16 Allowed 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 122.531 0.333 . . . . 0.0 110.124 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . 0.464 ' N ' ' HG3' ' B' ' 87' ' ' MET . 5.1 t80 -143.41 106.57 4.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.072 0.463 . . . . 0.0 109.835 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.669 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 37.0 mm -91.85 130.28 41.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.04 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -121.65 169.47 10.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.793 0.33 . . . . 0.0 110.154 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.436 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 70.5 mt -146.72 130.28 9.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.24 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 39.9 pttt -165.03 159.57 18.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.124 0.488 . . . . 0.0 111.42 174.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.502 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -106.69 138.78 42.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.863 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.2 pt . . . . . 0 C--O 1.246 0.88 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.042 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -143.92 95.55 2.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.825 0.345 . . . . 0.0 110.277 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -20.21 64.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.479 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' B' ' 4' ' ' LYS . 3.2 tmtp? -68.7 -29.36 67.77 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.32 0.581 . . . . 0.0 109.8 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.21 -22.09 27.11 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.413 0.625 . . . . 0.0 109.937 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 80.9 mt -87.91 8.64 25.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.367 -176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.54 -33.29 75.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.309 0.576 . . . . 0.0 109.919 174.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -86.52 -63.55 1.3 Allowed 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.833 0.825 . . . . 0.0 109.897 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.401 HE21 ' HB2' ' B' ' 9' ' ' GLN . 2.5 pt20 -82.5 74.31 9.48 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.436 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . 0.426 ' O ' HG12 ' B' ' 13' ' ' ILE . 90.3 mmm -45.86 145.49 1.44 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.108 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -51.11 -27.52 8.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.865 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 5.1 m -66.6 -31.07 71.53 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.288 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.426 HG12 ' O ' ' B' ' 10' ' ' MET . 11.4 mm -63.77 -31.0 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.647 0.737 . . . . 0.0 109.888 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -92.09 -44.36 8.87 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.812 -172.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 14.5 p -70.89 -45.24 64.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.095 -178.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 91.4 t -68.51 -30.14 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.585 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -53.79 -47.17 71.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.258 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.1 OUTLIER -78.95 -42.63 26.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.619 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -58.65 -43.05 89.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.401 -176.101 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.656 HD22 HG11 ' B' ' 72' ' ' VAL . 19.7 mt -80.24 -24.24 40.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -177.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -105.62 70.93 0.89 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.818 0.342 . . . . 0.0 111.249 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 33.6 mtmt -138.31 -91.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.817 175.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.434 ' O ' ' HA2' ' B' ' 46' ' ' GLY . . . -92.93 32.42 5.64 Favored Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.567 ' N ' ' HD2' ' B' ' 24' ' ' LYS . 0.0 OUTLIER -124.27 -163.08 1.12 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 174.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.648 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -67.96 144.97 44.16 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.184 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.546 ' HE2' ' HB3' ' B' ' 43' ' ' ALA . 44.7 mttm -62.2 144.5 55.41 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.424 ' CD2' ' HB3' ' B' ' 40' ' ' SER . 4.0 mt -150.07 118.45 6.45 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.118 0.485 . . . . 0.0 110.91 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 14.4 m -99.06 97.97 9.04 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.338 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.496 ' HA ' ' HB2' ' B' ' 38' ' ' ALA . 10.4 mp -86.14 163.0 18.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.797 0.808 . . . . 0.0 112.094 -172.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.1 p -146.69 148.82 32.41 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.111 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 58.0 mtt -96.49 139.7 32.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.106 0.479 . . . . 0.0 111.68 -173.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . 0.524 ' O ' ' HB3' ' B' ' 35' ' ' GLN . 8.6 t30 -157.15 91.92 1.22 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.833 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 68.98 -97.55 0.51 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -172.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -142.1 21.61 2.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.563 ' CG ' ' HG2' ' B' ' 37' ' ' LYS . 0.0 OUTLIER -85.71 158.27 20.09 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.893 -176.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tt -111.85 98.06 7.12 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.473 -0.785 . . . . 0.0 108.887 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.563 ' HG2' ' CG ' ' B' ' 35' ' ' GLN . 11.1 mtmt -112.1 137.17 50.53 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' B' ' 29' ' ' LEU . . . -173.4 169.96 4.3 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -170.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 5.8 p -128.17 140.34 51.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.591 170.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 74.1 p -123.66 165.41 17.26 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -169.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' B' ' 26' ' ' LYS . 32.3 t -131.62 157.98 42.26 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.481 176.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -117.04 18.31 14.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.331 -172.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.546 ' HB3' ' HE2' ' B' ' 26' ' ' LYS . . . -63.64 -21.86 66.59 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -173.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.585 ' O ' HD11 ' B' ' 47' ' ' ILE . . . -143.14 -48.6 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.099 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.648 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 3.4 p90 52.93 -164.55 0.08 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.966 1.306 . . . . 0.0 113.852 -176.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.514 ' N ' ' HD1' ' B' ' 45' ' ' TYR . . . -57.87 100.12 0.13 Allowed Glycine 0 C--N 1.342 0.88 0 N-CA-C 114.601 0.6 . . . . 0.0 114.601 -174.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.585 HD11 ' O ' ' B' ' 44' ' ' GLY . 3.8 mm -108.53 -67.81 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-O 121.59 0.71 . . . . 0.0 110.777 173.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -51.16 -62.62 1.51 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.579 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -83.48 127.01 33.37 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.772 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.69 -171.97 1.73 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.18 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -65.53 107.07 1.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.368 0.604 . . . . 0.0 109.706 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 6.4 mtmp? -145.4 128.83 16.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.621 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -102.73 124.85 49.02 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.532 0.682 . . . . 0.0 112.357 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.61 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 51.4 p-90 -141.15 163.7 32.26 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.368 169.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.82 156.8 23.02 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 119.772 -1.204 . . . . 0.0 113.317 -172.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.45 HD12 ' CD2' ' B' ' 64' ' ' TYR . 22.1 mt -111.82 137.74 43.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 174.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.726 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 46.0 m-85 -124.77 132.12 53.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.014 -174.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.531 HG13 ' ND2' ' B' ' 59' ' ' ASN . 13.4 p -112.48 136.27 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.916 177.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.531 ' ND2' HG13 ' B' ' 58' ' ' VAL . 9.9 m-80 71.04 -7.93 1.05 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.538 0.735 . . . . 0.0 110.905 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.25 5.9 39.76 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -169.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' B' ' 58' ' ' VAL . 25.9 mt-10 -106.55 165.76 11.05 Favored 'General case' 0 C--O 1.198 -1.642 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 174.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.475 ' HA ' ' CD1' ' B' ' 57' ' ' PHE . 27.8 ttmt -78.5 168.93 19.05 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.82 -10.08 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.326 165.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.649 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.5 OUTLIER -158.1 125.79 5.2 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.413 -170.169 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -134.42 132.2 39.07 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.178 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.439 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.0 OUTLIER -163.76 165.97 22.53 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 122.161 0.981 . . . . 0.0 111.162 -175.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.627 ' HB2' ' OG ' ' B' ' 70' ' ' SER . 12.0 m120 -116.72 144.63 44.21 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.493 169.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -64.67 -15.8 61.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.824 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -92.82 -25.28 18.2 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.252 0.549 . . . . 0.0 109.846 177.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.627 ' OG ' ' HB2' ' B' ' 67' ' ' ASN . 38.2 m -76.98 -5.57 49.17 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.458 -175.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.495 HG22 ' H ' ' B' ' 46' ' ' GLY . 3.3 p 66.27 99.84 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.741 169.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.656 HG11 HD22 ' B' ' 20' ' ' LEU . 7.8 m -65.67 -13.11 14.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.45 -176.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.55 -51.95 51.28 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.1 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -67.94 -42.68 80.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.312 0.577 . . . . 0.0 110.263 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.499 ' O ' HG12 ' B' ' 79' ' ' ILE . 2.6 mt -64.97 -42.03 93.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.54 -174.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 55.7 m -59.13 -30.29 68.03 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.229 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' B' ' 80' ' ' ASN . 46.9 t-20 -52.39 -54.6 29.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.607 0.718 . . . . 0.0 109.388 174.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.66 -39.49 94.46 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.634 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.649 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 48.4 mm -58.67 -33.54 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 123.021 0.528 . . . . 0.0 112.085 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' B' ' 77' ' ' ASN . 5.7 m-80 -54.81 -35.89 64.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.558 177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -78.46 -14.07 59.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.782 0.325 . . . . 0.0 111.111 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.7 mm? -65.56 -22.58 66.71 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.558 -173.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 55.9 t30 46.01 57.58 5.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.938 -172.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.546 ' HB ' ' HA ' ' B' ' 35' ' ' GLN . 88.6 mt -59.38 141.98 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.203 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -87.44 -164.13 1.04 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.273 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -150.35 115.26 0.7 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.027 -1.082 . . . . 0.0 113.322 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 28.4 ttp -154.06 -75.2 0.12 Allowed 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.565 0.183 . . . . 0.0 110.591 172.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . 0.53 ' H ' ' HA ' ' B' ' 59' ' ' ASN . 44.7 t80 -121.49 93.45 4.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.192 0.52 . . . . 0.0 109.925 -177.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.726 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.0 mp -95.32 128.95 46.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.795 -177.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 43.3 mt-10 -114.15 144.36 43.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.29 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.61 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 50.0 mm -126.23 112.4 29.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.99 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -166.49 158.39 13.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.477 0.656 . . . . 0.0 112.424 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.607 ' H ' ' CD ' ' B' ' 93' ' ' GLN . 4.5 pm0 -79.27 145.99 33.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.78 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.9 pt . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.254 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . 0.401 ' OD1' ' HG2' ' B' ' 3' ' ' GLN . 27.5 t70 . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -119.34 7.97 11.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . 0.401 ' HG2' ' OD1' ' B' ' 1' ' ' ASP . 10.9 pt20 -91.23 -34.65 14.89 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.185 177.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -82.68 -38.01 24.01 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.98 96.92 3.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.848 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 98.6 mt -79.77 21.03 0.56 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.323 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -70.98 -62.05 1.54 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.138 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -86.4 -9.61 55.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.445 0.64 . . . . 0.0 110.591 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -108.75 102.78 11.79 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.777 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . 0.412 ' O ' HG13 ' B' ' 13' ' ' ILE . 98.5 mmm -95.57 137.78 34.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.964 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -37.96 -24.93 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.887 1.675 . . . . 0.0 114.848 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.52 ' O ' HG23 ' B' ' 16' ' ' VAL . 8.8 m -61.87 -9.14 6.05 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.475 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.1 OUTLIER -51.27 -58.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 CA-C-O 122.008 0.909 . . . . 0.0 110.112 -177.312 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -79.39 -27.74 41.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.204 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.62 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 15.1 m -61.11 -39.14 88.86 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.52 HG23 ' O ' ' B' ' 12' ' ' SER . 99.0 t -69.06 -45.4 80.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.27 0.557 . . . . 0.0 109.866 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -52.43 -49.02 65.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.699 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.3 -31.86 60.8 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.78 -176.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.3 OUTLIER -61.82 -44.97 95.79 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 122.812 0.445 . . . . 0.0 111.406 177.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.423 HD21 ' HZ2' ' B' ' 54' ' ' TRP . 72.5 mt -81.53 -39.27 24.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.659 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -81.48 70.82 8.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.037 0.446 . . . . 0.0 111.33 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -144.33 -72.26 0.27 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.264 176.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.414 ' O ' ' HA2' ' B' ' 46' ' ' GLY . . . -119.01 44.75 1.35 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.072 -176.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -111.92 -158.05 0.64 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 174.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.685 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -83.27 -166.66 40.17 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.347 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.83 ' O ' ' HA ' ' B' ' 40' ' ' SER . 44.7 mtmt -67.84 98.57 0.74 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' B' ' 39' ' ' THR . 21.0 tp -124.88 115.7 21.05 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.23 -163.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 51.4 m -105.61 105.86 16.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.387 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.422 ' N ' HD22 ' B' ' 29' ' ' LEU . 2.5 mm? -83.31 149.57 26.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.313 0.578 . . . . 0.0 110.376 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p -146.27 147.47 31.44 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.36 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 62.0 mtt -116.42 145.34 43.33 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.103 0.478 . . . . 0.0 111.796 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -160.3 105.78 1.51 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.66 -122.81 18.09 Favored Glycine 0 CA--C 1.503 -0.681 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -167.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.523 HD22 ' CG1' ' B' ' 89' ' ' ILE . 2.0 m-20 -119.31 25.2 10.27 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.497 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 48.7 mt-30 -79.42 156.34 27.95 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.74 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.404 HD21 HD12 ' B' ' 29' ' ' LEU . 1.2 tt -114.77 88.2 2.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.127 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.474 ' HA ' ' ND2' ' B' ' 80' ' ' ASN . 27.4 mtpt -96.37 141.05 30.16 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -171.45 160.64 6.07 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -171.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 2.1 p -134.85 143.73 47.18 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.713 171.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.83 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 9.9 t -144.87 149.19 34.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.438 0.637 . . . . 0.0 111.965 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.473 ' CB ' ' HE3' ' B' ' 26' ' ' LYS . 6.8 m -111.98 163.83 13.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.561 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -113.08 33.78 4.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.02 -173.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.45 -1.53 30.76 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.032 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.63 -43.67 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.685 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 31.2 p90 43.75 -154.62 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.884 1.274 . . . . 0.0 114.281 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' B' ' 23' ' ' GLY . . . -77.11 107.94 2.48 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.681 -173.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.71 -54.92 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.338 0.589 . . . . 0.0 110.276 176.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.1 m -34.36 -57.8 0.49 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.098 -1.41 . . . . 0.0 114.323 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -75.06 -5.8 46.04 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.136 -173.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' B' ' 69' ' ' LYS . 46.3 mt-10 54.99 -92.39 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 123.498 0.499 . . . . 0.0 110.297 -168.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -136.31 110.09 8.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.589 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 33.7 mmtp -131.92 138.89 48.54 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -114.0 130.62 56.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.912 0.387 . . . . 0.0 110.053 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.51 ' HA ' HG12 ' B' ' 94' ' ' ILE . 18.5 p-90 -146.07 168.58 20.6 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.895 175.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -133.25 144.0 15.83 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.776 -174.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.445 HD12 ' CD2' ' B' ' 64' ' ' TYR . 15.6 mt -107.82 148.01 12.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 171.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.69 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 71.5 m-85 -129.57 136.76 50.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.51 -171.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.634 HG12 ' HB ' ' B' ' 63' ' ' VAL . 10.6 p -122.44 135.82 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.424 ' ND2' HG13 ' B' ' 58' ' ' VAL . 2.1 m-80 60.7 14.24 4.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.389 -172.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.65 -18.3 57.52 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.458 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' B' ' 58' ' ' VAL . 0.6 OUTLIER -87.92 165.61 15.12 Favored 'General case' 0 C--O 1.194 -1.821 0 C-N-CA 123.795 0.838 . . . . 0.0 108.831 -179.026 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.607 ' HA ' ' CD1' ' B' ' 57' ' ' PHE . 2.2 tttt -65.23 164.8 12.63 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 120.529 -0.469 . . . . 0.0 109.827 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.634 ' HB ' HG12 ' B' ' 58' ' ' VAL . 7.5 p -154.5 -13.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.084 0.468 . . . . 0.0 110.481 172.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.786 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.7 OUTLIER -159.65 124.56 4.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.215 0.531 . . . . 0.0 110.913 -171.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 21.3 m -131.9 127.92 37.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.102 176.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.527 ' HB2' HD13 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -168.31 149.42 4.97 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.171 0.986 . . . . 0.0 111.872 -171.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.495 ' O ' ' HB3' ' B' ' 70' ' ' SER . 26.4 t-20 -103.39 146.82 27.92 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.165 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -67.59 -21.7 65.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.775 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.494 ' O ' HG23 ' B' ' 71' ' ' THR . 1.5 tmtp? -88.05 -23.28 23.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.361 0.601 . . . . 0.0 109.526 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 5.2 t -65.7 -27.31 68.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.979 172.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.494 HG23 ' O ' ' B' ' 69' ' ' LYS . 23.5 p 61.24 123.24 0.01 OUTLIER 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.004 1.322 . . . . 0.0 113.057 174.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.425 ' HB ' ' OG ' ' B' ' 76' ' ' SER . 12.3 m -62.93 -11.2 6.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 114.405 -1.271 . . . . 0.0 113.239 -170.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . 0.537 ' HA2' ' HB3' ' B' ' 40' ' ' SER . . . -56.24 -54.21 37.39 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.267 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -73.41 -35.21 65.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.263 0.554 . . . . 0.0 110.127 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' B' ' 66' ' ' PHE . 1.6 mt -74.6 -55.74 11.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.723 -172.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.433 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 49.3 m -60.48 -30.64 69.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.863 -174.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -49.5 -52.19 31.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.83 0.824 . . . . 0.0 109.658 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 5.0 m-20 -67.31 -44.66 78.66 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.363 -1.289 . . . . 0.0 111.286 176.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.786 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 49.3 mm -50.82 -33.12 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.28 0.562 . . . . 0.0 112.26 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.474 ' ND2' ' HA ' ' B' ' 37' ' ' LYS . 0.9 OUTLIER -64.34 -29.27 70.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.919 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 49.7 pttt -81.39 -6.23 58.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.076 0.465 . . . . 0.0 110.549 -176.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 4.2 mm? -73.57 -10.27 59.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.014 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 33.58 64.96 0.3 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.265 1.031 . . . . 0.0 111.113 -172.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.497 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 60.3 mt -60.46 150.55 6.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 113.866 -1.516 . . . . 0.0 112.518 -170.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.426 ' O ' HG22 ' B' ' 84' ' ' ILE . 65.8 mttm -89.38 -177.16 5.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.286 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.76 112.87 0.72 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.898 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.477 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 7.6 tpt -151.87 -74.58 0.14 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.575 0.226 . . . . 0.0 110.575 176.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . 0.477 ' N ' ' HG3' ' B' ' 87' ' ' MET . 35.5 t80 -124.64 100.2 6.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.69 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 29.1 mm -100.98 120.31 50.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.732 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -111.61 -179.53 3.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.514 0.673 . . . . 0.0 110.959 174.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.472 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 83.9 mt -153.56 131.17 2.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.033 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.585 ' HE2' ' CE2' ' B' ' 57' ' ' PHE . 42.8 pttt -171.05 150.03 3.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.038 0.447 . . . . 0.0 111.3 176.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.484 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 0.8 OUTLIER -84.67 153.01 23.39 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.552 172.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' B' ' 54' ' ' TRP . 7.5 pt . . . . . 0 C--N 1.314 -0.957 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.089 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 120.616 0.246 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -68.47 -25.14 64.84 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -172.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -72.88 -17.11 61.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.97 0.414 . . . . 0.0 110.424 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -90.51 -18.06 25.96 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.371 0.605 . . . . 0.0 109.521 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.9 136.82 36.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.983 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' B' ' 9' ' ' GLN . 79.8 mt -69.48 -8.45 47.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.799 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -67.62 -60.9 2.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.511 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -90.92 -6.82 53.61 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.194 0.521 . . . . 0.0 111.504 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' B' ' 6' ' ' LEU . 29.8 tt0 -123.76 83.74 2.18 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . 0.511 ' O ' HG12 ' B' ' 13' ' ' ILE . 0.0 OUTLIER -108.88 -169.11 1.43 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.749 -170.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . 0.548 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 21.4 t-20 -50.87 -24.95 3.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -176.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.505 ' HA ' ' CG2' ' B' ' 16' ' ' VAL . 20.1 m -66.72 -14.83 63.02 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.276 -0.265 . . . . 0.0 111.69 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.511 HG12 ' O ' ' B' ' 10' ' ' MET . 16.0 mm -61.44 -52.64 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.015 0.436 . . . . 0.0 110.987 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -106.74 -63.02 1.32 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.024 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.467 ' HB3' ' OD1' ' B' ' 11' ' ' ASN . 32.6 t -59.61 -60.34 4.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.071 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.505 ' CG2' ' HA ' ' B' ' 12' ' ' SER . 47.4 t -57.78 -40.52 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.872 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.26 -51.23 70.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.07 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.55 -34.03 58.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.59 0.233 . . . . 0.0 111.518 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 13.1 tppt? -64.01 -47.74 79.07 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.465 0.65 . . . . 0.0 110.86 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.429 HD21 ' CZ ' ' B' ' 66' ' ' PHE . 28.3 mt -67.35 -46.68 72.67 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.774 176.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -88.12 53.9 2.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.191 0.52 . . . . 0.0 111.116 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' B' ' 19' ' ' LYS . 30.5 mtpp -83.9 -25.3 30.31 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 166.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.452 ' HA3' ' OH ' ' B' ' 49' ' ' TYR . . . 165.47 -93.94 0.11 Allowed Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 114.317 -1.311 . . . . 0.0 110.356 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.57 -125.12 0.38 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.511 0.724 . . . . 0.0 110.553 -176.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.59 137.37 15.23 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.768 ' O ' ' HA ' ' B' ' 40' ' ' SER . 41.0 mtmt -61.64 100.59 0.15 Allowed 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -177.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.465 HD21 HD11 ' B' ' 29' ' ' LEU . 43.9 tp -128.46 124.03 35.16 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 120.877 0.37 . . . . 0.0 110.06 -171.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.662 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 5.2 p -105.41 100.49 10.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.445 -176.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.465 HD11 HD21 ' B' ' 27' ' ' LEU . 2.1 mm? -87.96 147.95 24.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.736 0.779 . . . . 0.0 111.439 -175.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.9 p -142.67 141.32 31.84 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.939 168.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -106.78 131.34 54.01 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.359 -173.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -140.2 68.35 1.36 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.97 -102.4 0.51 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.498 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' B' ' 84' ' ' ILE . 5.3 m-20 -79.28 -24.17 43.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.756 0.312 . . . . 0.0 111.043 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -94.96 147.1 23.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.958 0.885 . . . . 0.0 111.819 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 33.4 tp -128.59 99.49 5.39 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 113.973 -1.467 . . . . 0.0 107.674 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -95.82 137.81 34.36 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.983 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.662 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -160.97 156.73 25.23 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.143 -170.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.47 147.12 47.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 171.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.768 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 6.9 t -138.62 162.87 33.52 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 47.3 t -136.29 162.17 33.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.8 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -113.68 30.68 7.06 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.534 0.683 . . . . 0.0 109.619 -174.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.18 21.45 0.13 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.112 -173.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 156.51 -32.66 0.58 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.731 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.555 ' CD1' HG21 ' B' ' 71' ' ' THR . 19.0 p90 44.22 -157.27 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.578 1.151 . . . . 0.0 113.365 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.422 ' N ' ' HD1' ' B' ' 45' ' ' TYR . . . -67.07 96.12 0.31 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.748 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.562 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -91.2 -71.28 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.274 0.559 . . . . 0.0 110.593 -177.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.4 m -62.86 -48.61 78.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.202 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.452 ' OH ' ' HA3' ' B' ' 23' ' ' GLY . 11.5 m-85 -39.52 119.45 0.95 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.699 -1.591 . . . . 0.0 112.365 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -74.58 -171.15 1.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.22 175.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.5 109.39 13.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.731 0.777 . . . . 0.0 109.348 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.611 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 76.4 mttt -131.87 123.61 27.85 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.409 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.454 HD22 HG13 ' B' ' 94' ' ' ILE . 1.2 p-10 -111.18 118.48 36.08 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.454 0.645 . . . . 0.0 110.777 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.664 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 40.5 p-90 -143.19 166.46 24.62 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.375 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.63 147.79 18.75 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.595 -174.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.47 HD12 ' CD2' ' B' ' 64' ' ' TYR . 18.4 mt -103.9 144.82 13.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 170.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.672 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 68.4 m-85 -125.15 141.06 52.34 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.493 -174.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.61 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.3 p -126.55 134.66 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.563 ' ND2' HG13 ' B' ' 58' ' ' VAL . 6.3 m-80 68.24 0.85 2.62 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.461 0.705 . . . . 0.0 109.297 -174.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.26 -0.9 50.47 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.588 -173.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -104.48 178.13 4.65 Favored 'General case' 0 C--O 1.203 -1.342 0 C-N-CA 124.018 0.927 . . . . 0.0 109.396 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.466 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.5 tppp? -65.98 161.07 22.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 118.765 0.711 . . . . 0.0 109.8 174.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.61 ' HB ' HG12 ' B' ' 58' ' ' VAL . 11.2 p -152.87 -18.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.094 0.473 . . . . 0.0 110.229 167.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.756 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.3 OUTLIER -160.66 127.95 4.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.94 0.4 . . . . 0.0 110.235 -171.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 6.1 m -135.16 129.09 33.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.527 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.614 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.1 OUTLIER -162.66 -176.47 5.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 122.357 1.075 . . . . 0.0 112.191 -174.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.9 t-20 -138.79 148.53 43.92 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 112.831 -1.986 . . . . 0.0 108.044 176.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -43.79 70.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.253 0.478 . . . . 0.0 111.79 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.489 ' O ' HG23 ' B' ' 71' ' ' THR . 58.4 mtpt -78.88 -16.26 57.27 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.853 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 3.2 t -73.28 -20.17 60.89 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.555 HG21 ' CD1' ' B' ' 45' ' ' TYR . 19.3 p 58.64 109.55 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.594 1.157 . . . . 0.0 112.533 170.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.609 ' HA ' HD12 ' B' ' 75' ' ' ILE . 11.4 m -61.43 -10.88 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.431 -169.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.75 -56.93 21.49 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.193 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -69.32 -31.31 69.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.307 0.575 . . . . 0.0 110.313 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.614 HD13 ' HB3' ' B' ' 66' ' ' PHE . 3.2 mt -70.5 -48.79 57.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.93 -177.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 34.2 t -56.38 -33.74 66.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.095 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -50.63 -54.74 20.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.695 0.76 . . . . 0.0 110.162 175.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 34.7 m-20 -64.79 -44.55 89.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.405 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.756 HG13 ' CE1' ' B' ' 64' ' ' TYR . 42.5 mm -55.47 -30.46 25.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -176.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -59.37 -25.24 64.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.7 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 16.4 ptmt -85.65 -3.36 58.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.727 0.298 . . . . 0.0 111.304 -175.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.2 mm? -73.8 -11.9 60.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.55 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 52.26 65.84 1.39 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.812 0.815 . . . . 0.0 109.068 -169.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.423 HG23 HG21 ' B' ' 63' ' ' VAL . 65.5 mt -57.49 156.54 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.504 -1.226 . . . . 0.0 111.484 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.461 ' HB2' HD21 ' B' ' 59' ' ' ASN . 86.7 mttt -113.66 -178.09 3.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.269 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.31 112.14 0.72 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.76 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.584 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 5.6 tpt -154.79 -72.7 0.12 Allowed 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 120.491 0.186 . . . . 0.0 110.873 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . 0.584 ' N ' ' HG3' ' B' ' 87' ' ' MET . 75.9 t80 -134.48 116.73 15.45 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 21.3 mm -104.96 145.21 13.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.458 -177.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.541 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 33.4 mm-40 -135.97 156.29 48.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.38 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.664 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 67.8 mt -135.13 126.21 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.738 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.418 ' HE2' ' CE2' ' B' ' 57' ' ' PHE . 49.3 pttt -175.24 153.13 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.699 0.285 . . . . 0.0 111.533 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -75.71 150.92 37.76 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.325 0.583 . . . . 0.0 111.209 175.555 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.454 HG13 HD22 ' B' ' 53' ' ' ASN . 4.7 pt . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.459 -0.781 . . . . 0.0 111.634 -172.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.974 0.416 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -162.6 -39.84 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.695 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -68.21 -21.47 64.85 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -172.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -76.2 -18.41 59.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.111 0.481 . . . . 0.0 110.378 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.36 20.07 11.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.212 0.529 . . . . 0.0 110.469 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 81.0 mt -107.94 22.94 15.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.691 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -59.22 -64.85 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.599 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -88.87 -26.12 21.78 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 122.206 1.003 . . . . 0.0 110.127 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -100.16 93.72 5.86 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.375 -1.739 . . . . 0.0 110.076 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . 0.465 ' C ' HD13 ' B' ' 13' ' ' ILE . 77.4 mmm -75.65 -165.24 0.42 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.544 0.687 . . . . 0.0 111.643 -175.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -109.61 -18.59 13.45 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.512 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -59.39 -21.12 59.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.829 0.823 . . . . 0.0 109.668 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.555 ' H ' ' CD1' ' B' ' 13' ' ' ILE . 1.4 mp -61.91 -34.41 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.354 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -106.7 -62.92 1.33 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.709 -173.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 49.8 m -66.12 -59.93 3.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.555 -172.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 70.6 t -55.82 -46.25 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.928 0.394 . . . . 0.0 111.359 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -56.28 -46.4 79.76 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.719 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.43 -42.72 58.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.786 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -61.89 -47.47 84.84 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 123.458 0.703 . . . . 0.0 111.936 -175.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.649 HD22 HG11 ' B' ' 72' ' ' VAL . 64.0 mt -75.53 -19.48 59.32 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.778 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -104.29 79.1 1.56 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.01 0.434 . . . . 0.0 110.323 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -130.17 19.86 5.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.572 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.49 25.63 7.65 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.389 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.635 ' HG2' ' CZ ' ' B' ' 49' ' ' TYR . 43.3 mttt -98.35 -140.02 0.3 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.617 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -65.52 142.66 44.44 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 172.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' B' ' 40' ' ' SER . 47.3 mttm -61.82 132.5 53.31 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 18.0 tp -152.5 104.87 2.95 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 -174.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 20.3 m -103.52 110.91 23.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.065 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.421 ' N ' HD22 ' B' ' 29' ' ' LEU . 2.6 mm? -90.87 152.91 20.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.746 0.784 . . . . 0.0 111.894 -173.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 2.7 p -145.92 147.11 31.39 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.324 -1.307 . . . . 0.0 108.326 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 57.6 mtt -122.32 140.49 52.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.515 0.674 . . . . 0.0 112.168 -172.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . 0.492 ' O ' ' HG3' ' B' ' 35' ' ' GLN . 6.7 t30 -130.37 101.34 5.71 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 173.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.19 -99.87 1.0 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -166.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.488 ' HB2' ' HA2' ' B' ' 86' ' ' GLY . 15.3 m120 -130.6 19.26 5.18 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 171.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' B' ' 32' ' ' ASN . 24.7 mt-30 -69.75 156.0 39.68 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.243 0.544 . . . . 0.0 110.714 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.515 ' H ' HD12 ' B' ' 84' ' ' ILE . 15.4 tp -118.2 106.59 12.98 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.842 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.409 ' HA ' ' OD1' ' B' ' 80' ' ' ASN . 24.0 mtmt -116.07 139.86 49.86 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -156.35 150.82 25.65 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -168.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 8.8 p -115.46 142.42 46.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.32 170.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 32.1 p -138.09 173.07 12.02 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -170.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.418 ' HB3' ' HD2' ' B' ' 26' ' ' LYS . 30.7 t -155.19 158.61 39.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.768 174.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -116.26 28.45 8.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.785 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.73 -18.52 65.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.691 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.67 -41.01 0.05 OUTLIER Glycine 0 C--N 1.318 -0.445 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.619 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.617 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 23.1 p90 45.04 -163.49 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.957 1.303 . . . . 0.0 114.264 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.59 ' H ' HG22 ' B' ' 71' ' ' THR . . . -81.11 85.49 1.4 Allowed Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.472 ' H ' HD12 ' B' ' 47' ' ' ILE . 1.0 OUTLIER -59.42 -69.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.4 0.619 . . . . 0.0 110.293 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.1 t -115.37 -92.97 0.5 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.389 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.635 ' CZ ' ' HG2' ' B' ' 24' ' ' LYS . 72.0 m-85 55.18 41.91 31.07 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.651 0.594 . . . . 0.0 110.154 -175.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 35.64 -95.35 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.285 -1.325 . . . . 0.0 112.988 -169.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -171.14 110.74 0.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 74.6 mttt -134.37 126.29 29.3 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -175.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -114.21 126.51 55.14 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.238 0.542 . . . . 0.0 110.578 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.516 ' HA ' HG12 ' B' ' 94' ' ' ILE . 34.3 p-90 -146.64 163.58 35.4 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.734 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -126.96 148.03 17.14 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.944 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.591 HD12 ' CD2' ' B' ' 64' ' ' TYR . 30.1 mt -107.1 148.86 11.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.753 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 89.5 m-85 -128.24 146.62 50.68 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -169.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.495 HG13 ' ND2' ' B' ' 59' ' ' ASN . 8.7 p -130.85 135.9 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.495 ' ND2' HG13 ' B' ' 58' ' ' VAL . 1.7 m-80 60.73 17.58 7.74 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -173.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.39 -3.27 83.82 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.407 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' B' ' 58' ' ' VAL . 24.4 mt-10 -103.34 176.09 5.26 Favored 'General case' 0 C--O 1.2 -1.53 0 C-N-CA 123.459 0.703 . . . . 0.0 109.711 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -60.67 156.75 16.04 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 118.541 0.61 . . . . 0.0 110.616 176.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.466 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.0 p -150.75 -12.43 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.007 0.432 . . . . 0.0 110.368 166.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.591 ' CD2' HD12 ' B' ' 56' ' ' ILE . 0.9 OUTLIER -162.4 125.26 2.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.239 -173.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 14.2 m -132.03 127.89 37.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.68 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.485 ' HB2' HD13 ' B' ' 75' ' ' ILE . 21.2 p90 -165.45 -175.03 3.39 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 122.017 0.913 . . . . 0.0 112.166 -176.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 18.5 t-20 -138.25 163.42 31.8 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.614 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -67.01 -51.65 52.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.298 0.57 . . . . 0.0 110.847 -176.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.471 ' O ' HG23 ' B' ' 71' ' ' THR . 40.3 ttmt -70.24 -17.75 63.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.23 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 3.2 t -69.06 -10.39 57.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.1 0.476 . . . . 0.0 109.902 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.59 HG22 ' H ' ' B' ' 46' ' ' GLY . 21.2 p 60.44 94.74 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.661 1.184 . . . . 0.0 112.157 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.656 ' HA ' HD12 ' B' ' 75' ' ' ILE . 2.4 m -59.37 -21.38 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.371 -172.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.42 -47.33 76.6 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.606 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -78.61 -36.0 44.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.282 0.563 . . . . 0.0 110.169 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.656 HD12 ' HA ' ' B' ' 72' ' ' VAL . 2.4 mt -65.41 -45.63 92.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.293 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 32.2 t -64.21 -27.52 69.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.624 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -55.37 -44.23 75.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.835 0.826 . . . . 0.0 109.865 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.721 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 10.7 m-20 -69.95 -40.46 75.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.442 -1.253 . . . . 0.0 111.022 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.586 ' HA ' HD23 ' B' ' 82' ' ' LEU . 48.3 mm -58.01 -28.87 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.333 0.587 . . . . 0.0 111.832 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.409 ' OD1' ' HA ' ' B' ' 37' ' ' LYS . 83.8 m-20 -60.38 -23.16 64.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.737 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 17.0 ptmt -96.73 6.38 48.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.808 0.337 . . . . 0.0 111.245 -174.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.4 mm? -78.78 -5.08 52.42 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -175.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 41.9 52.22 4.19 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 123.871 0.732 . . . . 0.0 110.95 -171.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.515 HD12 ' H ' ' B' ' 36' ' ' LEU . 82.8 mt -52.22 147.45 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.768 -171.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.6 -164.27 1.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.119 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.488 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -154.23 113.87 0.59 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.819 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.468 ' CG ' ' HA ' ' B' ' 59' ' ' ASN . 24.6 ptp -173.47 -54.85 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.197 0.199 . . . . 0.0 111.242 175.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . 0.43 ' N ' ' HG3' ' B' ' 87' ' ' MET . 1.3 t80 -135.73 84.44 2.09 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 121.842 -0.536 . . . . 0.0 110.226 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.753 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.1 mp -99.4 114.1 36.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.003 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -98.73 -179.22 4.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.366 0.603 . . . . 0.0 111.355 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 41.7 mt -151.51 114.93 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.573 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -174.64 160.85 3.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.333 0.587 . . . . 0.0 112.309 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.503 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 1.5 pp0? -72.26 158.47 35.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.617 174.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.5 pt . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.899 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -143.56 -56.43 0.39 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.867 0.365 . . . . 0.0 110.955 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -76.39 -8.86 58.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.373 -174.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -83.83 -22.12 31.84 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 120.98 0.419 . . . . 0.0 110.413 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.6 83.39 4.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.875 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.3 mt -80.31 11.36 3.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.625 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -68.14 -65.84 0.64 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.838 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -81.95 -30.05 31.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.215 1.007 . . . . 0.0 110.38 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -77.47 99.67 5.74 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 113.532 -1.667 . . . . 0.0 109.952 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 26.3 mmt -83.64 151.19 25.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.46 -175.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -62.44 -24.71 67.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.776 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.679 ' O ' HG23 ' B' ' 16' ' ' VAL . 15.9 t -66.75 -25.85 66.7 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.045 -177.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 11.2 mm -58.55 -38.37 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 CA-C-O 121.703 0.763 . . . . 0.0 109.98 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -71.14 -41.4 70.52 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.959 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.587 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 0.6 OUTLIER -65.36 -34.12 77.56 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.143 177.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.679 HG23 ' O ' ' B' ' 12' ' ' SER . 54.5 t -63.29 -42.26 95.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.218 0.533 . . . . 0.0 109.991 175.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.622 HD22 HD23 ' B' ' 29' ' ' LEU . 2.5 t-20 -61.94 -42.12 98.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.867 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.76 -40.93 63.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.451 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' B' ' 15' ' ' SER . 4.5 tmtm? -53.4 -73.04 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.54 0.736 . . . . 0.0 112.186 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.541 HD22 HG11 ' B' ' 72' ' ' VAL . 17.4 mt -52.29 -29.87 25.37 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -84.41 74.23 10.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.193 0.52 . . . . 0.0 111.023 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -133.24 -79.48 0.48 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.203 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.21 34.83 2.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.943 -176.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.513 ' HA ' ' HA2' ' B' ' 46' ' ' GLY . 0.9 OUTLIER -122.79 -168.98 1.84 Allowed 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 173.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' B' ' 45' ' ' TYR . . . -54.26 137.24 41.79 Favored Glycine 0 N--CA 1.45 -0.41 0 O-C-N 123.961 0.788 . . . . 0.0 111.619 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.463 ' HD2' ' H ' ' B' ' 44' ' ' GLY . 0.0 OUTLIER -87.49 112.12 21.88 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 121.397 0.618 . . . . 0.0 109.911 -170.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.463 HD13 ' O ' ' B' ' 27' ' ' LEU . 0.0 OUTLIER -134.29 143.52 47.79 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.267 177.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 49.3 m -104.03 111.55 24.17 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.879 -173.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.622 HD23 HD22 ' B' ' 17' ' ' ASN . 3.1 mm? -77.5 152.79 33.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.596 0.713 . . . . 0.0 109.932 176.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 0.3 OUTLIER -144.27 145.48 32.05 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.29 175.303 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 43.6 mtt -112.86 133.1 55.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.072 0.463 . . . . 0.0 111.864 -165.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . 0.507 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 4.3 t30 -146.11 59.22 1.23 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 47.73 -99.58 0.02 OUTLIER Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.103 -0.953 . . . . 0.0 113.895 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.695 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 8.1 p30 -83.39 16.57 2.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.41 -0.395 . . . . 0.0 111.493 -176.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.507 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 19.5 mt-30 -134.87 146.38 49.18 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.393 0.616 . . . . 0.0 110.735 171.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.511 ' HB3' ' HB ' ' B' ' 84' ' ' ILE . 3.2 tm? -122.39 127.96 50.36 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.558 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.482 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 16.7 mtmt -126.33 146.6 49.97 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -174.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -161.63 151.19 16.46 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -176.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 11.8 p -126.88 142.2 51.61 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 58.9 p -136.75 150.29 48.31 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -167.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 22.7 t -139.56 153.46 47.43 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.707 171.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -115.36 9.39 15.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -170.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.72 -59.84 4.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.814 0.816 . . . . 0.0 110.451 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.463 ' H ' ' HD2' ' B' ' 26' ' ' LYS . . . -91.68 61.28 2.77 Favored Glycine 0 C--N 1.309 -0.927 0 CA-C-N 114.59 -1.187 . . . . 0.0 110.89 175.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.58 ' HA ' ' HA2' ' B' ' 25' ' ' GLY . 0.1 OUTLIER -70.1 -161.91 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.079 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.66 ' H ' HG22 ' B' ' 71' ' ' THR . . . -62.14 107.44 1.58 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.27 -0.49 . . . . 0.0 112.23 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 22.2 mm -85.46 -69.74 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.718 0 CA-C-O 122.307 1.051 . . . . 0.0 109.817 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.44 ' C ' ' H ' ' B' ' 50' ' ' GLU . 6.8 m -104.62 -153.82 0.49 Allowed 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 113.634 -1.621 . . . . 0.0 109.391 -176.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 67.76 -12.53 0.29 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.992 0.917 . . . . 0.0 112.432 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' B' ' 48' ' ' SER . 44.7 mt-10 49.77 -105.2 0.16 Allowed 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.839 0.856 . . . . 0.0 111.994 -175.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -129.65 110.71 12.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.586 ' HB2' ' OE1' ' B' ' 68' ' ' GLU . 66.2 mttm -118.19 134.82 54.67 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 170.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -98.17 110.58 23.14 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.551 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 37.5 p-90 -149.38 168.18 24.11 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.444 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.9 156.86 25.68 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.408 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.417 HD12 ' CD2' ' B' ' 64' ' ' TYR . 21.8 mt -108.42 147.68 13.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.683 ' CE1' ' HD3' ' B' ' 62' ' ' LYS . 71.5 m-85 -130.46 139.9 50.54 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -169.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.463 HG23 ' HB ' ' B' ' 63' ' ' VAL . 13.6 t -131.35 138.34 53.4 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 64.54 5.26 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.99 0.806 . . . . 0.0 109.238 -174.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.91 17.49 47.64 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.737 -172.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 7.8 mt-10 -120.5 174.56 6.47 Favored 'General case' 0 C--O 1.207 -1.167 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.683 ' HD3' ' CE1' ' B' ' 57' ' ' PHE . 0.0 OUTLIER -67.6 167.82 12.31 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.26 173.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.463 ' HB ' HG23 ' B' ' 58' ' ' VAL . 8.6 p -153.77 -15.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.781 164.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.652 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.5 OUTLIER -160.05 124.2 3.74 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.049 -170.29 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 28.1 m -131.94 131.11 42.35 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.797 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.512 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.1 OUTLIER -160.94 -176.55 5.57 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 122.531 1.158 . . . . 0.0 112.312 -174.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -133.21 149.67 52.0 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 112.272 -2.24 . . . . 0.0 108.626 173.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . 0.586 ' OE1' ' HB2' ' B' ' 52' ' ' LYS . 1.3 mp0 -52.04 -51.03 60.14 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.941 0.401 . . . . 0.0 111.57 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.562 ' O ' HG23 ' B' ' 71' ' ' THR . 88.8 tttt -69.13 -22.95 63.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.602 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.6 t -68.74 -17.06 63.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 174.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.66 HG22 ' H ' ' B' ' 46' ' ' GLY . 30.2 p 56.26 106.15 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.344 1.058 . . . . 0.0 112.865 172.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.541 HG11 HD22 ' B' ' 20' ' ' LEU . 9.5 m -62.7 -10.3 5.24 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.861 -171.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.46 -55.21 31.33 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.323 -0.942 . . . . 0.0 111.463 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -67.79 -36.9 81.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.416 0.627 . . . . 0.0 110.9 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' B' ' 66' ' ' PHE . 1.9 mt -68.53 -49.19 67.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.75 -177.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.421 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 22.9 t -58.81 -29.75 67.09 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.979 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -49.66 -52.23 32.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.893 0.854 . . . . 0.0 109.614 173.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.685 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 0.4 OUTLIER -72.7 -39.66 66.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.945 178.041 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.652 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.1 mm -56.96 -33.25 41.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.12 0.486 . . . . 0.0 112.26 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.511 HD21 ' HB3' ' B' ' 38' ' ' ALA . 7.3 m-80 -61.85 -16.93 54.31 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.685 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 20.7 pttm -85.05 -7.31 59.17 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.906 0.384 . . . . 0.0 110.469 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.53 HD23 ' HA ' ' B' ' 79' ' ' ILE . 2.5 mm? -69.61 -16.09 63.32 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -174.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 51.7 58.72 5.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.336 -171.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.801 ' H ' HD12 ' B' ' 84' ' ' ILE . 5.2 mp -55.99 148.29 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.517 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.695 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 67.5 mttm -116.8 -167.73 1.34 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.269 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.555 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -142.35 111.24 0.66 Allowed Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.131 -177.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.442 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 16.6 tpp -151.22 -73.43 0.15 Allowed 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . 0.442 ' N ' ' HG3' ' B' ' 87' ' ' MET . 32.8 t80 -125.77 97.15 5.03 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 22.9 mm -96.35 126.35 49.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.834 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -121.67 169.77 10.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.115 0.484 . . . . 0.0 110.784 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.538 HD11 HG22 ' B' ' 16' ' ' VAL . 23.6 mm -149.14 121.72 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.768 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.551 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 48.2 pttt -168.83 173.53 7.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.251 0.548 . . . . 0.0 111.452 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.576 ' NE2' ' H ' ' B' ' 93' ' ' GLN . 0.5 OUTLIER -95.8 149.81 21.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.281 175.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.546 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.7 pt . . . . . 0 C--N 1.313 -0.999 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.255 -175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 17.3 t70 . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -131.85 35.89 3.74 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.599 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -67.61 -16.7 64.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.399 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -76.86 -3.41 38.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.95 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.06 114.71 1.54 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.44 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 93.7 mt -71.67 -17.17 62.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.553 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -64.11 -44.76 91.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.102 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -75.48 -46.98 29.16 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.649 0.738 . . . . 0.0 110.392 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -93.14 61.81 3.44 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.625 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . 0.661 ' O ' HG12 ' B' ' 13' ' ' ILE . 86.8 mmm -53.75 130.71 37.66 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.252 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -52.51 -23.26 5.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.794 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.535 ' O ' HG23 ' B' ' 16' ' ' VAL . 5.3 m -68.39 -17.07 64.14 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.909 -174.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.661 HG12 ' O ' ' B' ' 10' ' ' MET . 14.2 mm -49.21 -65.08 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.449 0.642 . . . . 0.0 111.26 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -78.3 -25.63 46.66 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.555 -177.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.433 ' HB2' ' HA ' ' B' ' 12' ' ' SER . 23.7 m -67.7 -33.33 74.68 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.003 -176.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.535 HG23 ' O ' ' B' ' 12' ' ' SER . 71.5 t -67.84 -42.47 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.5 0.667 . . . . 0.0 109.478 176.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.787 ' ND2' HD22 ' B' ' 29' ' ' LEU . 12.4 t-20 -59.08 -58.71 7.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.264 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.39 -12.15 60.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.857 -177.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' B' ' 16' ' ' VAL . 14.2 tppt? -78.24 -50.19 12.34 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.5 0.667 . . . . 0.0 111.059 173.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.465 HD21 ' HZ2' ' B' ' 54' ' ' TRP . 82.1 mt -80.1 -22.81 41.78 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.202 -178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -116.14 93.14 4.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.433 0.635 . . . . 0.0 110.643 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -138.59 -70.41 0.42 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.222 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.56 49.14 0.77 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -127.96 -138.47 0.24 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.437 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -76.31 163.36 52.95 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.688 ' HE3' ' OG ' ' B' ' 41' ' ' SER . 0.0 OUTLIER -70.26 150.6 46.23 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.221 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.546 ' HA ' ' O ' ' B' ' 39' ' ' THR . 16.5 tp -149.06 123.76 9.84 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -173.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 16.1 m -106.85 96.74 6.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.298 0.57 . . . . 0.0 111.468 -177.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.787 HD22 ' ND2' ' B' ' 17' ' ' ASN . 0.2 OUTLIER -68.5 147.92 51.31 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.266 1.426 . . . . 0.0 114.496 -167.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 11.4 p -155.18 152.97 30.03 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.138 171.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 61.3 mtt -115.01 149.16 37.86 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -166.67 120.28 1.05 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.181 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.1 -116.78 9.55 Favored Glycine 0 CA--C 1.506 -0.481 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.879 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.446 ' HA ' ' CD1' ' B' ' 13' ' ' ILE . 20.6 m120 -121.33 22.98 10.63 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 172.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.604 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 49.6 mt-30 -86.35 160.96 18.94 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.311 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' B' ' 36' ' ' LEU . 1.1 tm? -128.69 98.96 5.16 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 169.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.594 ' HA ' ' ND2' ' B' ' 80' ' ' ASN . 6.0 mtmp? -97.2 146.37 25.15 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.531 -177.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -173.36 142.91 1.03 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -93.02 159.12 15.44 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 177.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.486 ' OG ' ' HA2' ' B' ' 73' ' ' GLY . 11.6 p -149.92 151.06 32.8 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.592 -170.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.688 ' OG ' ' HE3' ' B' ' 26' ' ' LYS . 0.1 OUTLIER -129.83 140.79 50.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.986 177.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -94.5 41.49 1.09 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.905 -170.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.7 -60.08 3.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.244 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.68 -35.87 3.66 Favored Glycine 0 C--N 1.316 -0.572 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.737 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.437 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 23.7 p90 49.21 -166.35 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.871 1.268 . . . . 0.0 113.98 177.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.7 97.57 1.49 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.602 -175.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.484 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -108.92 -55.92 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.386 0.612 . . . . 0.0 109.74 175.079 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.9 m -39.31 -57.09 1.43 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.135 -1.393 . . . . 0.0 113.523 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -80.38 4.67 17.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.985 -173.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 50.47 -98.03 0.05 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.694 0.797 . . . . 0.0 112.331 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -142.46 113.37 7.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.395 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 94.6 mttt -138.13 143.36 40.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.284 175.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.419 ' HB3' ' OD1' ' B' ' 67' ' ' ASN . 0.4 OUTLIER -112.87 117.9 33.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.176 0.513 . . . . 0.0 110.715 177.108 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.628 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 48.9 p-90 -131.45 164.43 25.76 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -125.19 148.69 16.88 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.472 -173.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.456 ' C ' HG12 ' B' ' 63' ' ' VAL . 7.7 mt -100.41 150.33 5.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 170.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.783 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 74.9 m-85 -129.97 138.65 50.95 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.202 -174.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' B' ' 61' ' ' GLU . 13.5 p -121.9 131.72 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 63.33 7.98 3.2 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.251 0.548 . . . . 0.0 109.697 -174.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.57 -17.09 40.06 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.242 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 0.6 OUTLIER -91.5 170.21 10.14 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 123.185 0.594 . . . . 0.0 110.105 -177.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.432 ' HA ' ' CD1' ' B' ' 57' ' ' PHE . 5.4 tppp? -55.74 158.24 3.71 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.915 0.388 . . . . 0.0 110.007 172.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.456 HG12 ' C ' ' B' ' 56' ' ' ILE . 10.0 p -144.91 -18.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 168.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.558 ' CE2' HG23 ' B' ' 75' ' ' ILE . 1.6 t80 -171.08 153.04 3.63 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.71 -175.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.531 HG23 ' CD1' ' B' ' 94' ' ' ILE . 80.0 m -138.6 135.76 35.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.521 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.722 ' CD2' HD13 ' B' ' 75' ' ' ILE . 23.8 p90 -168.55 158.53 9.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.795 0.807 . . . . 0.0 111.521 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 5.6 m120 -113.61 151.58 31.51 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.02 -1.445 . . . . 0.0 112.001 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -61.91 -42.5 99.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.529 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.489 ' O ' HG23 ' B' ' 71' ' ' THR . 22.0 tptp -59.98 -36.12 76.46 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 122.02 0.914 . . . . 0.0 110.175 176.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' B' ' 67' ' ' ASN . 58.5 m -70.37 -10.33 58.75 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.264 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.489 HG23 ' O ' ' B' ' 69' ' ' LYS . 8.2 p 65.08 124.02 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 126.134 1.774 . . . . 0.0 113.209 170.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.662 ' HA ' HD12 ' B' ' 75' ' ' ILE . 3.6 m -64.57 -5.56 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.097 -173.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . 0.486 ' HA2' ' OG ' ' B' ' 40' ' ' SER . . . -67.28 -55.16 16.81 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.432 -0.413 . . . . 0.0 113.228 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -73.17 -23.38 60.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 122.048 0.928 . . . . 0.0 109.09 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.722 HD13 ' CD2' ' B' ' 66' ' ' PHE . 68.0 mt -68.79 -54.84 18.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 113.904 -1.498 . . . . 0.0 112.745 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 18.2 t -54.57 -37.82 65.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.901 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -50.85 -49.43 58.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.982 0.896 . . . . 0.0 110.599 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.533 ' HA ' ' HG2' ' B' ' 81' ' ' LYS . 72.1 m-20 -64.9 -46.89 79.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.912 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.457 HG12 ' CD2' ' B' ' 64' ' ' TYR . 66.3 mt -51.96 -37.53 21.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.325 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.594 ' ND2' ' HA ' ' B' ' 37' ' ' LYS . 7.3 m120 -75.07 -38.49 61.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.383 -178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.533 ' HG2' ' HA ' ' B' ' 78' ' ' ASP . 6.4 ptpp? -75.47 -21.31 58.18 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.222 -176.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.438 HD23 ' O ' ' B' ' 78' ' ' ASP . 1.7 mm? -63.9 -22.01 66.73 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.869 0.366 . . . . 0.0 110.154 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 45.35 64.79 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.697 -171.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.604 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 55.6 mt -62.89 149.89 9.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.21 -175.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.437 ' NZ ' ' HB3' ' B' ' 85' ' ' LYS . 7.7 mtpm? -90.18 179.42 5.92 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.827 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -133.68 113.25 1.18 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 119.693 -1.241 . . . . 0.0 112.466 -176.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 17.8 ttt -154.31 -77.09 0.11 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 123.076 0.55 . . . . 0.0 109.909 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -132.34 81.86 1.98 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.217 0.532 . . . . 0.0 109.668 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.783 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.1 mp -87.72 125.51 41.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.853 178.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -108.83 177.97 4.61 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.356 0.598 . . . . 0.0 110.7 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.628 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 57.5 mt -149.74 110.04 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.632 -178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -167.87 166.67 13.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.273 0.559 . . . . 0.0 112.102 -175.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -84.63 148.84 26.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.467 -174.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.531 ' CD1' HG23 ' B' ' 65' ' ' THR . 4.2 pt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.408 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 121.009 0.433 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -73.63 -32.43 64.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.884 0.373 . . . . 0.0 110.537 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -66.3 -18.38 65.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.817 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -76.06 -21.61 56.58 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.314 0.578 . . . . 0.0 110.255 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.24 -7.99 54.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.565 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.588 ' HA ' ' O ' ' B' ' 9' ' ' GLN . 98.8 mt -78.4 -6.73 56.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.197 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.91 -43.31 79.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.998 0.428 . . . . 0.0 110.351 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' B' ' 9' ' ' GLN . 10.3 pt-20 -90.9 -51.36 5.39 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.846 0.831 . . . . 0.0 110.451 175.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.588 ' O ' ' HA ' ' B' ' 6' ' ' LEU . 24.5 tt0 -99.61 87.35 3.55 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.665 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . 0.585 ' SD ' ' HA ' ' B' ' 88' ' ' TYR . 82.5 mtp -71.66 171.32 11.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.585 -176.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -57.38 -30.55 64.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.168 0.508 . . . . 0.0 110.888 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.585 ' O ' HG23 ' B' ' 16' ' ' VAL . 1.3 p -63.94 -30.94 71.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.909 -174.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mm -53.79 -45.49 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.858 0.837 . . . . 0.0 110.113 177.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -82.89 -29.99 28.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.976 -177.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' B' ' 12' ' ' SER . 21.8 t -71.5 -27.38 63.18 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.602 -175.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.585 HG23 ' O ' ' B' ' 12' ' ' SER . 87.4 t -58.44 -42.89 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.446 0.641 . . . . 0.0 109.704 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.406 ' OD1' HD13 ' B' ' 29' ' ' LEU . 55.9 t30 -63.87 -45.54 88.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.866 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.8 -28.5 62.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.619 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -68.37 -53.08 26.38 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.167 0.508 . . . . 0.0 111.398 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 94.3 mt -73.0 -27.82 62.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.655 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -90.41 75.97 6.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.369 0.604 . . . . 0.0 110.593 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -135.89 62.95 1.61 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.491 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.91 54.48 4.14 Favored Glycine 0 C--N 1.317 -0.5 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.64 ' HB3' ' CD2' ' B' ' 45' ' ' TYR . 33.2 mmtp -137.15 -152.51 0.44 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.223 -0.488 . . . . 0.0 110.396 -174.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' B' ' 45' ' ' TYR . . . -78.69 -177.27 48.87 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 176.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.498 ' HE2' ' HB2' ' B' ' 41' ' ' SER . 4.3 mppt? -88.57 127.9 35.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 117.292 0.546 . . . . 0.0 111.02 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.44 HD22 HG21 ' B' ' 72' ' ' VAL . 13.4 tp -156.03 110.93 2.9 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 19.5 m -108.7 108.86 19.87 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.535 -176.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.539 HD23 HD11 ' B' ' 36' ' ' LEU . 10.2 mp -86.04 158.73 19.77 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.606 0.717 . . . . 0.0 110.738 176.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.564 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 20.3 m -135.81 140.29 44.12 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.919 173.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -100.59 125.65 46.99 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.792 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.59 58.66 1.61 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . 0.414 ' HA2' ' HB2' ' B' ' 9' ' ' GLN . . . 50.43 -95.61 0.01 OUTLIER Glycine 0 C--N 1.335 0.506 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.028 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 14.2 m120 -88.09 15.72 7.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.481 -0.359 . . . . 0.0 111.044 -176.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 16.8 mt-30 -139.95 142.97 36.34 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.558 0.694 . . . . 0.0 110.931 173.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.539 HD11 HD23 ' B' ' 29' ' ' LEU . 32.4 tp -113.58 120.78 42.12 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.818 173.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.564 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 6.6 mmmm -114.48 150.31 35.0 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -174.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.404 ' HB2' ' HG ' ' B' ' 29' ' ' LEU . . . -163.55 143.35 8.49 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 2.8 p -120.86 151.79 39.22 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.4 t -142.89 150.07 39.32 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.126 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.498 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . 5.7 m -126.12 149.77 48.7 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.424 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -82.76 47.9 1.26 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.266 -170.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.49 -3.71 29.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.786 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.37 70.34 1.35 Allowed Glycine 0 CA--C 1.485 -1.808 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.262 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.64 ' CD2' ' HB3' ' B' ' 24' ' ' LYS . 0.8 OUTLIER -65.59 148.86 51.04 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 161.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.583 ' N ' ' CD1' ' B' ' 45' ' ' TYR . . . 109.17 58.86 0.53 Allowed Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -176.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 3.9 mm -85.84 -69.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.521 0.677 . . . . 0.0 109.702 -172.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.2 m -151.8 -130.32 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.021 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.467 ' O ' ' HE2' ' B' ' 52' ' ' LYS . 84.5 m-85 64.23 27.63 13.9 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.004 0.522 . . . . 0.0 111.503 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 43.63 -106.47 0.09 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.593 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.5 ' HB3' HD21 ' B' ' 67' ' ' ASN . 6.9 m-20 -144.48 119.4 9.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.089 178.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.467 ' HE2' ' O ' ' B' ' 49' ' ' TYR . 65.7 mmtt -119.26 122.74 42.62 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -107.64 127.24 53.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.149 0.499 . . . . 0.0 111.058 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.693 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 37.2 p-90 -142.41 161.38 38.2 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.891 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.1 151.94 16.89 Favored Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.899 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.491 ' O ' HG12 ' B' ' 63' ' ' VAL . 7.5 mt -102.74 141.03 19.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 172.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.69 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 64.0 m-85 -121.81 140.85 51.86 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -174.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.539 HG12 ' HB ' ' B' ' 63' ' ' VAL . 8.4 p -131.72 142.5 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.516 HD22 HG13 ' B' ' 58' ' ' VAL . 14.3 m-80 68.72 -2.81 1.57 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -169.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.76 -1.75 61.74 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -170.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' B' ' 58' ' ' VAL . 16.5 mt-10 -100.36 172.0 7.41 Favored 'General case' 0 C--O 1.199 -1.587 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.594 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 11.1 ttmt -67.09 168.3 10.4 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 119.009 0.822 . . . . 0.0 109.948 175.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.539 ' HB ' HG12 ' B' ' 58' ' ' VAL . 7.6 p -148.49 -20.33 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.618 170.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.418 ' CD2' HG12 ' B' ' 79' ' ' ILE . 4.5 t80 -169.1 146.14 3.58 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.997 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.531 HG23 ' CD1' ' B' ' 94' ' ' ILE . 54.9 m -130.17 134.07 47.04 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.257 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.644 ' CD2' HG21 ' B' ' 75' ' ' ILE . 9.0 p90 -165.48 153.04 10.77 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.672 0.749 . . . . 0.0 109.939 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.5 HD21 ' HB3' ' B' ' 51' ' ' ASP . 23.2 t-20 -99.2 159.73 14.78 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.324 -1.307 . . . . 0.0 109.885 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . 0.456 ' CG ' ' HB2' ' B' ' 52' ' ' LYS . 10.2 mm-40 -60.92 -63.15 1.4 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.278 0.561 . . . . 0.0 109.954 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -66.37 -5.17 9.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.184 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.5 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 1.4 t -68.37 -3.14 10.11 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.417 0.627 . . . . 0.0 109.762 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.417 ' O ' HG13 ' B' ' 75' ' ' ILE . 31.9 p 62.17 102.97 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.308 1.443 . . . . 0.0 111.55 174.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.658 ' HA ' HD12 ' B' ' 75' ' ' ILE . 5.4 m -66.79 -4.43 2.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.151 -168.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.68 -48.12 80.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.443 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -78.78 -25.9 44.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.496 0.665 . . . . 0.0 109.777 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' B' ' 72' ' ' VAL . 24.5 mt -66.29 -44.97 90.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.299 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 28.9 t -53.73 -36.52 62.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.351 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -50.04 -54.61 19.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.792 0.806 . . . . 0.0 110.54 174.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.518 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 27.3 m-20 -63.89 -48.07 78.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.904 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' B' ' 64' ' ' TYR . 43.7 mt -54.69 -37.29 39.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.104 0.478 . . . . 0.0 111.48 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.98 -43.29 96.17 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.106 176.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 59.1 pttt -76.05 -31.1 58.64 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.054 -176.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -61.58 -26.31 67.89 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 65.6 t30 40.44 72.19 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 O-C-N 124.583 1.177 . . . . 0.0 110.839 -172.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.732 ' H ' HD12 ' B' ' 84' ' ' ILE . 3.1 mp -57.18 137.16 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.908 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 30.4 mmtp -90.61 -169.41 2.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.409 -177.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.49 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -136.65 113.92 1.1 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.256 -176.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 3.1 ptp -167.43 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.637 0.375 . . . . 0.0 110.604 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . 0.585 ' HA ' ' SD ' ' B' ' 10' ' ' MET . 21.7 t80 -124.8 88.32 2.87 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.69 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 34.1 mm -93.75 133.35 35.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.29 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 24.1 mt-10 -125.38 155.61 40.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.142 0.496 . . . . 0.0 111.636 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.693 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 86.8 mt -131.15 118.21 40.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.453 176.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -171.69 154.19 3.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.12 0.486 . . . . 0.0 111.894 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.504 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 5.1 pm0 -64.76 149.48 49.19 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.268 175.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.531 ' CD1' HG23 ' B' ' 65' ' ' THR . 3.3 pt . . . . . 0 C--N 1.312 -1.026 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.304 -173.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -162.86 108.24 1.14 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -77.18 -29.45 54.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -174.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' B' ' 4' ' ' LYS . 25.3 tptp -87.0 5.8 35.53 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.5 0.667 . . . . 0.0 110.574 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.533 ' HB1' ' HG3' ' B' ' 7' ' ' GLU . . . -53.84 129.7 34.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.616 -175.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 83.0 mt -98.98 10.48 41.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.827 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.533 ' HG3' ' HB1' ' B' ' 5' ' ' ALA . 0.0 OUTLIER -70.3 -30.58 67.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.154 173.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.494 ' HG3' ' HG2' ' B' ' 9' ' ' GLN . 15.2 pt-20 -96.03 -37.71 10.52 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.926 0.87 . . . . 0.0 109.928 175.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.494 ' HG2' ' HG3' ' B' ' 8' ' ' GLU . 16.8 mm100 -93.98 71.28 4.02 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.338 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . 0.489 ' SD ' HG12 ' B' ' 89' ' ' ILE . 62.1 mtm -94.18 168.93 10.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.101 -177.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -70.56 -26.88 63.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.692 0.758 . . . . 0.0 109.966 171.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 14.8 m -68.4 -10.14 53.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.642 -174.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.429 HG23 ' HG2' ' B' ' 31' ' ' MET . 28.5 mm -49.58 -52.34 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-O 121.089 0.471 . . . . 0.0 111.579 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -102.65 -38.3 7.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.865 -174.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.644 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 16.0 m -57.94 -41.86 83.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.945 -174.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.67 -45.13 75.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.964 0.411 . . . . 0.0 110.448 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -43.61 98.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.161 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.12 -26.19 52.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.24 -176.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.644 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -64.79 -46.29 82.68 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 121.092 0.472 . . . . 0.0 111.715 178.325 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 9.1 mt -87.05 -31.77 20.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.058 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -92.35 81.02 4.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.277 0.56 . . . . 0.0 110.176 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -122.35 -83.22 0.66 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.315 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.32 34.34 2.32 Favored Glycine 0 CA--C 1.508 -0.378 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -114.29 -147.26 0.41 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.072 -0.564 . . . . 0.0 109.591 -175.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' B' ' 45' ' ' TYR . . . -72.45 167.69 53.22 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.673 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.497 ' HE2' ' HB2' ' B' ' 41' ' ' SER . 2.1 mppt? -80.04 130.03 34.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.781 0.324 . . . . 0.0 110.943 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.476 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 26.6 tp -149.84 92.75 1.94 Allowed 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 20.3 m -88.61 107.7 19.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.974 -175.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.476 ' CD1' ' HG ' ' B' ' 27' ' ' LEU . 9.3 mp -90.26 162.68 15.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.751 0.786 . . . . 0.0 111.548 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.6 p -156.0 144.68 20.26 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.718 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . 0.429 ' HG2' HG23 ' B' ' 13' ' ' ILE . 0.6 OUTLIER -106.91 139.45 41.29 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.924 0.392 . . . . 0.0 111.232 -173.616 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . 0.532 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 2.5 t30 -142.29 57.4 1.46 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 170.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . 0.481 ' O ' ' HA3' ' B' ' 86' ' ' GLY . . . 45.44 -95.01 0.01 OUTLIER Glycine 0 C--N 1.333 0.403 0 O-C-N 123.806 0.691 . . . . 0.0 113.075 -175.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.706 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 4.6 p30 -80.61 10.82 4.31 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.814 0.446 . . . . 0.0 112.17 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.669 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 21.0 mt-30 -132.98 147.81 52.27 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.366 0.603 . . . . 0.0 110.544 165.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.47 116.05 19.82 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -116.99 138.78 51.34 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.614 -172.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -158.66 139.12 12.53 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.115 0.484 . . . . 0.0 111.521 -177.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 13.8 p -115.9 138.35 51.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.612 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.3 p -123.43 142.47 50.95 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.172 0.51 . . . . 0.0 111.551 -174.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.497 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . 2.5 m -117.82 143.97 45.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.618 175.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -99.5 44.0 1.04 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.823 -168.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.42 -32.19 68.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.103 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.72 63.72 0.03 OUTLIER Glycine 0 CA--C 1.49 -1.482 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.287 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.773 ' CD1' ' HA ' ' B' ' 71' ' ' THR . 2.5 t80 -69.42 152.87 44.39 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 161.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.586 ' N ' ' CD1' ' B' ' 45' ' ' TYR . . . 106.38 57.18 0.63 Allowed Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 5.6 mm -79.33 -69.96 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.606 -0.797 . . . . 0.0 110.3 -171.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 69.1 m -152.46 -106.19 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.202 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.46 ' O ' ' HG2' ' B' ' 52' ' ' LYS . 64.9 m-85 58.94 20.66 8.37 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.083 0.553 . . . . 0.0 112.15 177.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 46.57 -95.12 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.83 0.706 . . . . 0.0 110.503 -171.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.479 ' HB3' HD21 ' B' ' 67' ' ' ASN . 9.3 m-20 -149.38 110.51 4.38 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 169.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' B' ' 49' ' ' TYR . 72.3 mmtt -121.13 122.29 39.7 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -113.52 130.58 56.31 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.298 0.571 . . . . 0.0 110.988 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.498 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 26.7 p-90 -141.0 168.45 19.76 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.695 176.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.56 145.13 16.79 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.706 -174.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.529 HD12 ' CD2' ' B' ' 64' ' ' TYR . 26.4 mt -106.76 141.73 21.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 171.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.711 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 63.5 m-85 -123.33 143.04 50.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.722 -174.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.625 HG12 ' HB ' ' B' ' 63' ' ' VAL . 10.4 p -128.0 136.89 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.476 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.3 m-80 61.69 11.04 3.71 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.989 0.515 . . . . 0.0 109.626 -172.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.51 0.64 66.96 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.278 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' B' ' 58' ' ' VAL . 15.7 mt-10 -106.8 176.27 5.23 Favored 'General case' 0 C--O 1.199 -1.597 0 C-N-CA 123.521 0.728 . . . . 0.0 109.139 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.503 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.4 tppp? -66.08 162.42 19.61 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 119.092 0.86 . . . . 0.0 109.949 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.625 ' HB ' HG12 ' B' ' 58' ' ' VAL . 7.8 p -153.42 -18.24 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.918 0.389 . . . . 0.0 110.371 167.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.686 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.8 OUTLIER -160.78 126.41 3.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 110.359 -172.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 9.3 m -134.23 126.64 30.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.48 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.572 ' HB2' HD13 ' B' ' 75' ' ' ILE . 0.7 OUTLIER -169.38 152.35 4.83 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.124 0.964 . . . . 0.0 112.467 -174.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.479 HD21 ' HB3' ' B' ' 51' ' ' ASP . 17.3 t-20 -92.61 153.98 18.67 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.233 -1.803 . . . . 0.0 109.956 174.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . 0.42 ' HA ' ' OH ' ' B' ' 45' ' ' TYR . 22.6 mm-40 -75.86 -3.68 36.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.192 0.52 . . . . 0.0 111.782 -174.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -111.43 -7.5 14.35 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.896 0.379 . . . . 0.0 111.431 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 1.3 t -73.92 -3.63 30.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.396 0.617 . . . . 0.0 111.688 -173.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.773 ' HA ' ' CD1' ' B' ' 45' ' ' TYR . 13.3 p 64.75 98.5 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.742 1.217 . . . . 0.0 111.444 173.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.518 ' HA ' HD12 ' B' ' 75' ' ' ILE . 7.7 m -66.64 -12.37 14.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.63 -169.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.24 -41.42 98.28 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.933 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -82.8 -30.76 28.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.206 0.527 . . . . 0.0 110.523 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.572 HD13 ' HB2' ' B' ' 66' ' ' PHE . 1.3 mt -75.62 -53.44 15.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.657 -176.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 22.5 t -58.38 -29.13 65.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.3 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -48.12 -54.74 12.23 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.778 0.799 . . . . 0.0 110.391 172.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 10.3 m-20 -69.36 -49.51 54.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.262 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.686 HG13 ' CE1' ' B' ' 64' ' ' TYR . 46.7 mm -52.29 -37.11 22.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -70.06 -20.78 63.21 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.729 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 46.9 pttt -83.26 -1.54 53.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.192 0.52 . . . . 0.0 109.986 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 3.7 mm? -77.46 -5.31 49.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.832 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 55.9 t30 51.38 63.51 2.21 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.427 -171.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.669 ' O ' ' HA ' ' B' ' 35' ' ' GLN . 48.2 mt -55.23 145.3 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.069 -172.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.706 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 50.3 mtmt -114.78 -176.94 3.01 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.779 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.498 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -142.0 113.11 0.79 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.844 -0.694 . . . . 0.0 111.725 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.512 ' HA ' ' HB2' ' B' ' 7' ' ' GLU . 12.2 tpp -150.25 -70.74 0.18 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 120.832 0.348 . . . . 0.0 110.221 178.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -129.29 87.16 2.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.711 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 46.1 mm -85.9 132.51 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.213 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 33.9 mt-10 -119.2 145.06 46.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.495 173.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.49 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 44.8 mm -129.14 112.06 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.502 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.522 ' HE2' ' CE2' ' B' ' 57' ' ' PHE . 45.3 pttt -166.83 166.83 15.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.041 0.448 . . . . 0.0 111.819 -174.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -94.11 149.17 21.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.157 -175.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.497 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.7 pt . . . . . 0 C--O 1.25 1.13 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.061 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . 0.438 ' OD1' ' HB2' ' B' ' 4' ' ' LYS . 11.1 t70 . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.777 0.322 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 10.4 t30 73.33 -45.25 0.61 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.986 0.915 . . . . 0.0 112.998 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -72.44 -13.01 61.34 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.438 ' HB2' ' OD1' ' B' ' 1' ' ' ASP . 14.1 tptp -73.84 -8.15 54.95 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 120.931 0.396 . . . . 0.0 110.885 173.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.536 ' HA ' HE22 ' B' ' 9' ' ' GLN . . . -81.44 96.58 7.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.589 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.473 ' H ' HD12 ' B' ' 6' ' ' LEU . 5.1 mp -71.68 -95.65 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.44 177.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -116.44 -76.19 0.57 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.467 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 21.6 mt-10 -121.6 3.32 10.15 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -173.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.617 ' O ' HG13 ' B' ' 13' ' ' ILE . 2.1 pm0 -75.47 -14.73 60.45 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.26 -175.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 21.8 mmt 63.54 113.75 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.547 1.139 . . . . 0.0 113.359 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . 0.519 ' HB2' ' HB2' ' B' ' 5' ' ' ALA . 0.2 OUTLIER -61.07 -26.43 67.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.963 175.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.431 ' O ' HG23 ' B' ' 16' ' ' VAL . 49.1 m -67.16 -22.56 65.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.922 -174.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.617 HG13 ' O ' ' B' ' 9' ' ' GLN . 2.1 mm -60.41 -43.46 94.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.925 0.869 . . . . 0.0 109.61 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -66.51 -33.72 76.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.978 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 4.2 m -65.22 -44.43 88.29 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.941 176.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.431 HG23 ' O ' ' B' ' 12' ' ' SER . 91.9 t -61.0 -43.59 96.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.152 0.501 . . . . 0.0 110.111 176.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.469 ' OD1' ' HB2' ' B' ' 29' ' ' LEU . 0.2 OUTLIER -56.02 -41.66 75.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.233 -179.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.39 -37.48 37.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.149 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -59.88 -43.64 94.65 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 122.86 0.464 . . . . 0.0 111.688 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.485 HD21 ' HE1' ' B' ' 54' ' ' TRP . 81.1 mt -83.66 28.6 0.56 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.896 -175.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -104.01 29.64 5.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.804 0.812 . . . . 0.0 108.954 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -119.33 57.52 0.89 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.317 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' B' ' 25' ' ' GLY . . . 163.28 47.2 0.02 OUTLIER Glycine 0 CA--C 1.503 -0.667 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.717 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.401 ' HB2' ' N ' ' B' ' 45' ' ' TYR . 34.4 mmtp 57.06 -63.27 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 170.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.613 ' H ' ' HA ' ' B' ' 45' ' ' TYR . . . -36.87 105.64 0.04 OUTLIER Glycine 0 C--N 1.33 0.248 0 O-C-N 124.006 0.816 . . . . 0.0 113.158 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.545 ' CE ' ' HB2' ' B' ' 41' ' ' SER . 34.3 pttt -63.67 132.34 50.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.941 0.401 . . . . 0.0 111.327 -176.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' B' ' 39' ' ' THR . 8.7 tp -146.09 104.7 3.85 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.073 -173.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -98.84 115.38 28.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.486 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.469 ' HB2' ' OD1' ' B' ' 17' ' ' ASN . 11.1 mp -89.05 165.93 14.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.817 0.818 . . . . 0.0 111.547 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 68.4 m -147.55 142.24 26.67 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.186 174.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . 0.555 ' HG3' HG21 ' B' ' 13' ' ' ILE . 0.1 OUTLIER -112.54 117.72 33.11 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.885 -171.242 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . 0.512 HD22 ' NE2' ' B' ' 35' ' ' GLN . 59.9 t30 -140.88 59.53 1.53 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.258 172.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' B' ' 8' ' ' GLU . . . 49.75 -87.09 0.01 OUTLIER Glycine 0 C--N 1.339 0.71 0 O-C-N 124.305 1.003 . . . . 0.0 115.133 173.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -66.35 -15.33 63.19 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.853 0.461 . . . . 0.0 111.6 -174.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.512 ' NE2' HD22 ' B' ' 32' ' ' ASN . 14.1 pt20 -132.56 149.01 52.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.057 0.932 . . . . 0.0 112.505 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.463 HD13 HG23 ' B' ' 13' ' ' ILE . 19.0 tp -112.45 101.67 9.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.604 -1.634 . . . . 0.0 107.964 170.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.419 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 35.5 mtmt -102.58 152.41 21.21 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.008 -1.451 . . . . 0.0 108.753 -172.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.86 156.93 2.91 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 1.3 p -126.27 144.94 50.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.982 175.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 16.2 m -144.02 151.31 39.52 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -175.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.545 ' HB2' ' CE ' ' B' ' 26' ' ' LYS . 20.1 m -138.02 158.49 44.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.288 170.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . 0.457 ' C ' ' H ' ' B' ' 44' ' ' GLY . 48.7 m-80 -109.63 46.01 1.04 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.896 -173.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.67 22.74 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.658 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.612 ' O ' HD11 ' B' ' 47' ' ' ILE . . . 165.9 -49.82 0.27 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.613 ' HA ' ' H ' ' B' ' 25' ' ' GLY . 7.3 p90 53.25 -177.75 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.0 1.32 . . . . 0.0 113.856 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.511 ' C ' HD13 ' B' ' 47' ' ' ILE . . . -70.74 105.76 1.69 Allowed Glycine 0 C--N 1.337 0.604 0 CA-C-N 116.014 -0.539 . . . . 0.0 113.934 -170.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.612 HD11 ' O ' ' B' ' 44' ' ' GLY . 3.4 mm -113.13 -70.0 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.988 0.423 . . . . 0.0 110.748 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.0 m -61.85 -51.75 66.96 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.816 0.817 . . . . 0.0 110.404 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -59.86 108.81 0.81 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.929 -1.487 . . . . 0.0 109.111 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.446 ' HB2' ' H ' ' B' ' 51' ' ' ASP . 0.0 OUTLIER -81.02 -157.8 0.18 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.849 0.357 . . . . 0.0 111.195 -176.67 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.448 ' HA ' ' OD1' ' B' ' 67' ' ' ASN . 9.6 p-10 -74.88 108.9 7.92 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.228 1.013 . . . . 0.0 111.152 -173.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 44.3 mttm -122.51 125.57 46.03 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.724 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -108.16 136.02 48.53 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.899 0.38 . . . . 0.0 110.848 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.668 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 21.9 p-90 -147.89 158.87 44.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.251 171.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.44 143.77 15.22 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.224 -174.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.482 ' O ' HG12 ' B' ' 63' ' ' VAL . 6.0 mt -102.84 143.1 15.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 173.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.61 ' HB2' ' HB2' ' B' ' 90' ' ' GLU . 55.4 m-85 -124.4 140.95 52.47 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.534 -176.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.492 HG12 ' HB ' ' B' ' 63' ' ' VAL . 9.1 p -128.49 134.87 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.44 ' ND2' HG13 ' B' ' 58' ' ' VAL . 2.1 m-80 60.91 13.32 4.42 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.95 -174.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.4 -0.88 63.88 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.631 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -104.81 172.95 6.52 Favored 'General case' 0 C--O 1.207 -1.16 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.454 ' HZ3' ' HE1' ' B' ' 57' ' ' PHE . 12.0 tppt? -61.28 164.71 5.15 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.492 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.8 p -146.91 -22.66 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 167.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.431 ' CE2' ' CG1' ' B' ' 79' ' ' ILE . 2.2 t80 -171.68 144.66 1.87 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.989 -173.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 78.2 m -133.31 128.46 35.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.649 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.763 ' HD2' HD13 ' B' ' 75' ' ' ILE . 14.3 p90 -158.96 -171.39 3.38 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.221 0.534 . . . . 0.0 110.799 -176.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.7 t-20 -151.57 144.15 24.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.317 -166.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . 0.467 ' OE1' ' HB2' ' B' ' 52' ' ' LYS . 2.4 mp0 -63.99 -34.25 77.57 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -78.93 -18.25 54.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.235 0.541 . . . . 0.0 110.125 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 3.1 t -71.64 -8.12 52.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.662 ' O ' HG13 ' B' ' 75' ' ' ILE . 7.5 p 65.08 112.28 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.687 -1.597 . . . . 0.0 112.372 173.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.713 ' HA ' HD12 ' B' ' 75' ' ' ILE . 2.9 m -61.02 -15.14 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.449 -170.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' B' ' 40' ' ' SER . . . -67.06 -50.49 45.89 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.288 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -75.2 -19.17 59.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.491 0.662 . . . . 0.0 109.506 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.763 HD13 ' HD2' ' B' ' 66' ' ' PHE . 49.6 mt -73.64 -53.61 17.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.015 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.401 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 43.5 t -55.87 -33.05 64.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.12 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -52.0 -48.19 64.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.126 173.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.69 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 5.7 m-20 -70.54 -41.45 72.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.131 177.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.462 HG23 HD13 ' B' ' 84' ' ' ILE . 58.2 mt -54.55 -37.74 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.0 0.429 . . . . 0.0 111.381 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -58.12 -34.57 70.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.396 177.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.69 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 18.8 pttp -85.07 -31.0 23.62 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.663 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -62.01 -26.75 68.42 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.778 0.323 . . . . 0.0 110.23 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 4.8 t30 42.54 69.84 0.34 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.456 -172.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.613 ' H ' HD12 ' B' ' 84' ' ' ILE . 2.6 mp -59.13 131.18 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.017 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -86.47 -170.74 3.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.842 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.95 111.66 0.67 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.348 -0.929 . . . . 0.0 112.607 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 19.3 tpp -150.08 -68.58 0.2 Allowed 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -127.96 84.83 2.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 45.5 mm -85.73 130.77 35.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.983 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.61 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 27.7 mt-10 -123.7 150.19 44.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.034 0.445 . . . . 0.0 111.526 175.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.668 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 83.6 mt -129.74 125.61 61.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.491 176.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.477 ' HE3' ' CE2' ' B' ' 57' ' ' PHE . 14.9 pttp -167.57 164.97 14.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.131 0.491 . . . . 0.0 111.504 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -95.47 134.59 38.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.125 -174.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.569 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.2 pt . . . . . 0 C--O 1.247 0.938 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.682 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' B' ' 2' ' ' ASN . 7.0 p-10 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' B' ' 1' ' ' ASP . 9.7 t30 68.45 94.27 0.07 Allowed 'General case' 0 C--O 1.227 -0.104 0 O-C-N 123.588 0.555 . . . . 0.0 109.872 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -60.92 -18.96 59.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.186 -175.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.599 ' HD3' ' O ' ' B' ' 4' ' ' LYS . 4.3 tmtp? -70.8 -17.45 62.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.404 0.621 . . . . 0.0 109.698 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.2 168.54 19.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.274 0.559 . . . . 0.0 110.524 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' B' ' 11' ' ' ASN . 70.3 mt -84.31 -4.16 58.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.59 -173.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -53.62 -54.67 34.3 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.241 0.543 . . . . 0.0 110.159 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -74.59 -38.0 62.74 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.543 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.486 HE21 ' HB2' ' B' ' 10' ' ' MET . 0.9 OUTLIER -89.25 73.2 8.09 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.297 -174.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . 0.698 ' SD ' ' HA ' ' B' ' 34' ' ' ASN . 75.2 mtm 43.72 31.95 0.52 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 161.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . 0.515 ' HB2' ' HB3' ' B' ' 6' ' ' LEU . 21.8 t-20 -56.75 -32.31 65.45 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.994 0.902 . . . . 0.0 110.044 173.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.567 ' O ' HG23 ' B' ' 16' ' ' VAL . 3.4 m -69.76 -30.75 68.41 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.253 -175.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.423 ' CG1' ' HB3' ' B' ' 10' ' ' MET . 11.3 mm -68.97 -35.86 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.914 -172.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . 0.658 HD22 ' N ' ' B' ' 14' ' ' ASN . 0.7 OUTLIER -69.02 -32.17 71.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.085 -178.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 32.8 t -69.48 -35.13 75.29 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.016 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.567 HG23 ' O ' ' B' ' 12' ' ' SER . 15.7 t -64.22 -42.47 95.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.691 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.475 HD22 HD23 ' B' ' 29' ' ' LEU . 5.2 t-20 -57.59 -38.18 74.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.227 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.13 -40.05 32.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.216 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -65.13 -57.04 9.59 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.439 0.696 . . . . 0.0 112.455 -176.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.532 HD21 ' HZ2' ' B' ' 54' ' ' TRP . 43.6 mt -68.75 -31.39 70.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.703 -175.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.84 61.05 5.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.284 0.564 . . . . 0.0 110.529 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -121.59 -86.73 0.65 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.082 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -124.82 51.06 0.84 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.75 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.526 ' HE2' ' O ' ' B' ' 68' ' ' GLU . 31.5 mmtp -114.16 -161.43 0.77 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.403 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -73.01 -175.48 29.05 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.139 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.823 ' O ' ' HA ' ' B' ' 40' ' ' SER . 16.4 ptpt -67.76 105.15 1.84 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 174.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.592 ' HA ' ' O ' ' B' ' 39' ' ' THR . 17.8 tp -119.24 128.17 53.93 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.964 -1.017 . . . . 0.0 111.442 -162.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 67.3 m -117.87 126.05 51.65 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.164 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.57 HD12 HD21 ' B' ' 36' ' ' LEU . 1.7 mm? -104.83 147.88 27.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.117 0.484 . . . . 0.0 110.343 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 11.3 p -142.67 150.2 39.87 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.199 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 73.7 mtp -114.39 136.33 53.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.093 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -144.34 115.98 8.17 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.15 -107.28 2.05 Favored Glycine 0 CA--C 1.504 -0.62 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.698 ' HA ' ' SD ' ' B' ' 10' ' ' MET . 2.6 m-20 -123.67 14.83 9.44 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.495 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 75.1 mt-30 -78.48 162.07 26.62 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.304 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.57 HD21 HD12 ' B' ' 29' ' ' LEU . 6.1 tt -133.15 123.15 25.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.347 168.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -118.59 143.88 46.49 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.528 ' HB1' HD11 ' B' ' 27' ' ' LEU . . . -139.81 143.96 37.09 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.062 -0.655 . . . . 0.0 112.333 -170.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.592 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 8.6 p -128.02 141.63 51.46 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.105 175.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.823 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 21.2 p -153.13 145.25 23.81 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.713 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.441 ' HB2' ' CG ' ' B' ' 26' ' ' LYS . 16.9 m -113.18 167.16 10.78 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.367 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -78.88 47.89 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.194 -172.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.62 -59.82 2.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.015 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.505 ' O ' HD11 ' B' ' 47' ' ' ILE . . . -154.7 55.26 0.42 Allowed Glycine 0 C--N 1.313 -0.746 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.764 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.595 ' O ' HG13 ' B' ' 47' ' ' ILE . 41.4 p90 -77.63 160.16 28.71 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -172.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' B' ' 69' ' ' LYS . . . 14.87 76.5 0.01 OUTLIER Glycine 0 C--N 1.337 0.636 0 O-C-N 125.269 1.606 . . . . 0.0 116.498 168.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.595 HG13 ' O ' ' B' ' 45' ' ' TYR . 1.3 mp -106.75 -72.34 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-O 122.204 1.002 . . . . 0.0 111.684 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -88.33 -152.99 0.23 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.56 -1.655 . . . . 0.0 111.374 -170.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.51 ' O ' ' HE3' ' B' ' 52' ' ' LYS . 64.5 m-85 70.85 6.98 6.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.746 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 56.47 -81.36 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 124.245 0.966 . . . . 0.0 111.674 -175.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -167.28 110.43 0.68 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.51 ' HE3' ' O ' ' B' ' 49' ' ' TYR . 31.9 mmtp -129.61 124.09 32.89 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -104.34 128.13 52.1 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.548 ' HA ' HG12 ' B' ' 94' ' ' ILE . 50.0 p-90 -144.7 157.28 44.25 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -126.34 150.6 17.75 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.334 -170.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.636 HD12 ' CD2' ' B' ' 64' ' ' TYR . 28.6 mt -106.57 149.93 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 169.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.706 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 84.3 m-85 -131.52 142.69 50.0 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -169.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.609 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.9 p -131.67 140.51 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.543 ' ND2' HG13 ' B' ' 58' ' ' VAL . 8.7 m-80 66.76 0.11 1.79 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -170.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.22 0.24 59.88 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.37 -172.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 12.5 mt-10 -102.78 176.1 5.27 Favored 'General case' 0 C--O 1.201 -1.491 0 C-N-CA 123.716 0.806 . . . . 0.0 109.254 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.1 tppp? -62.37 160.37 13.5 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 118.633 0.651 . . . . 0.0 110.395 175.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.609 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.5 p -152.97 -15.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.507 168.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.636 ' CD2' HD12 ' B' ' 56' ' ' ILE . 0.8 OUTLIER -160.43 126.19 4.01 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -172.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 23.9 m -134.51 126.32 29.12 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.189 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.55 ' CB ' HD13 ' B' ' 75' ' ' ILE . 3.9 p90 -166.96 -175.16 2.93 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.533 0.682 . . . . 0.0 110.424 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 10.0 t-20 -128.77 168.27 16.11 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.093 -170.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . 0.526 ' O ' ' HE2' ' B' ' 24' ' ' LYS . 8.9 mm-40 -85.81 -11.08 54.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.871 0.367 . . . . 0.0 110.955 -177.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.487 ' O ' ' HA3' ' B' ' 46' ' ' GLY . 51.1 tttm -100.78 -26.1 13.9 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.505 ' OG ' HD11 ' B' ' 75' ' ' ILE . 21.5 t -63.88 152.07 40.76 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.811 0.815 . . . . 0.0 108.989 174.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.449 ' O ' HG13 ' B' ' 75' ' ' ILE . 0.1 OUTLIER -99.26 109.59 22.22 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.113 -173.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.583 ' HA ' HD12 ' B' ' 75' ' ' ILE . 3.6 m -67.33 -14.47 18.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.425 -167.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.54 -47.96 88.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.675 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -74.42 -32.84 62.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.045 0.45 . . . . 0.0 110.609 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' B' ' 72' ' ' VAL . 1.4 mt -70.33 -51.33 39.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.127 0.489 . . . . 0.0 110.274 -177.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 16.6 t -61.94 -28.77 69.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.563 -176.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -50.67 -53.5 30.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.527 0.679 . . . . 0.0 110.268 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.753 ' O ' ' HG3' ' B' ' 81' ' ' LYS . 0.8 OUTLIER -69.29 -43.07 74.6 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.099 179.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.558 HG13 ' CE1' ' B' ' 64' ' ' TYR . 42.8 mm -51.77 -37.98 21.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.266 0.555 . . . . 0.0 111.718 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -66.27 -28.42 68.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.326 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.753 ' HG3' ' O ' ' B' ' 78' ' ' ASP . 0.0 OUTLIER -84.6 -0.43 53.23 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.758 -176.582 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 3.1 mm? -72.78 -11.84 60.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.232 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 62.6 t30 50.61 58.97 4.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.634 -172.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.495 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 68.9 mt -61.59 150.21 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.375 -173.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.434 ' O ' HG22 ' B' ' 84' ' ' ILE . 64.8 mttm -103.26 -178.53 3.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.381 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' B' ' 34' ' ' ASN . . . -139.62 115.3 1.08 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.795 -1.193 . . . . 0.0 113.805 -177.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.425 ' SD ' ' HA ' ' B' ' 59' ' ' ASN . 1.7 pmm? -165.25 -57.64 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 175.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . 0.424 ' N ' ' HG2' ' B' ' 87' ' ' MET . 15.7 t80 -129.31 83.23 2.13 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 121.611 -0.681 . . . . 0.0 109.778 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.706 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 23.4 mm -92.21 121.9 43.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.222 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -109.14 171.54 7.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.985 0.421 . . . . 0.0 109.933 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.525 HG12 ' HB3' ' B' ' 12' ' ' SER . 30.4 mm -152.94 115.73 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.677 -175.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -169.18 165.79 10.93 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.177 0.513 . . . . 0.0 111.875 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.484 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 3.1 pp0? -82.76 143.61 30.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.854 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' B' ' 54' ' ' TRP . 6.2 pt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.868 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -149.65 106.06 3.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.927 0.394 . . . . 0.0 111.138 -175.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . 0.474 ' HB3' ' O ' ' B' ' 31' ' ' MET . 8.6 pt20 -95.53 -1.58 50.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.544 175.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.95 -29.43 58.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.817 -177.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.88 98.72 0.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.337 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' B' ' 9' ' ' GLN . 91.0 mt -68.56 -15.15 63.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.051 -173.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -71.93 -44.93 62.82 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.325 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -81.5 -32.26 32.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.597 0.713 . . . . 0.0 110.885 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.63 ' OE1' ' HB ' ' B' ' 13' ' ' ILE . 0.4 OUTLIER -119.07 84.72 2.24 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.753 -177.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -83.35 166.67 18.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.555 -174.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -47.44 -32.47 5.11 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -176.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.52 ' CB ' ' HB ' ' B' ' 89' ' ' ILE . 12.2 m -65.49 -27.23 68.34 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.99 -173.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.63 ' HB ' ' OE1' ' B' ' 9' ' ' GLN . 3.3 mm -67.4 -47.06 82.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 122.079 0.942 . . . . 0.0 109.392 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . 0.412 ' ND2' ' H ' ' B' ' 14' ' ' ASN . 11.2 m-80 -59.23 -32.6 70.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.285 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 9.9 t -68.51 -42.28 78.79 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.801 177.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.484 HG23 ' O ' ' B' ' 12' ' ' SER . 97.7 t -55.26 -42.75 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.128 0.49 . . . . 0.0 110.379 177.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.503 ' ND2' ' HB2' ' B' ' 29' ' ' LEU . 2.3 t-20 -56.73 -45.66 81.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.758 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.92 -38.9 52.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.237 -175.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' B' ' 15' ' ' SER . 24.1 mmmt -78.5 -8.26 58.36 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -172.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.422 HD21 ' CZ ' ' B' ' 66' ' ' PHE . 15.6 mt -91.63 23.43 3.54 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . 0.494 ' CG ' ' H ' ' B' ' 22' ' ' LYS . 20.3 p-10 -88.73 -79.34 0.31 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 171.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.494 ' H ' ' CG ' ' B' ' 21' ' ' ASN . 28.7 mtpp 48.61 34.01 4.65 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 169.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 146.8 -92.38 0.15 Allowed Glycine 0 N--CA 1.439 -1.167 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.472 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.58 ' HD2' ' CD1' ' B' ' 47' ' ' ILE . 58.0 mttm -152.84 -141.75 0.11 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -171.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.663 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . 68.05 111.75 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.8 -173.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' B' ' 40' ' ' SER . 0.3 OUTLIER -63.0 115.44 4.41 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 173.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.521 HD22 ' CG2' ' B' ' 72' ' ' VAL . 4.0 tp -152.85 105.08 2.91 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 72.4 m -97.76 113.92 25.81 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.344 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.503 ' HB2' ' ND2' ' B' ' 17' ' ' ASN . 2.8 mm? -86.75 159.85 19.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.477 0.656 . . . . 0.0 110.59 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.555 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 0.1 OUTLIER -151.11 147.66 27.34 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.313 173.52 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . 0.474 ' O ' ' HB3' ' B' ' 3' ' ' GLN . 58.8 mtm -118.81 141.09 48.96 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.149 0.5 . . . . 0.0 111.839 -168.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . 0.532 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 49.6 t30 -150.55 60.48 0.95 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.405 173.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.78 -92.83 0.01 OUTLIER Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.2 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.35 -18.17 57.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.774 -0.213 . . . . 0.0 111.328 -177.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.532 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 68.5 mt-30 -101.53 147.0 26.9 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.666 0.746 . . . . 0.0 111.422 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.19 104.81 9.4 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.506 174.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.555 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 8.1 mmmm -102.56 142.73 33.25 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -172.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -162.92 145.1 10.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -174.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 7.9 p -122.13 143.18 49.7 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 172.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 20.3 m -137.15 155.45 49.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.45 0.643 . . . . 0.0 112.256 -173.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.431 ' HB3' ' CB ' ' B' ' 26' ' ' LYS . 32.5 t -137.87 154.53 49.47 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.618 176.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -105.93 37.05 2.35 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.924 -170.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.23 23.12 0.29 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.591 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 154.45 -56.71 0.41 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.728 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.663 ' HA ' ' CA ' ' B' ' 25' ' ' GLY . 14.8 p90 47.58 -161.88 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.48 1.112 . . . . 0.0 113.784 175.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.601 ' HA2' ' OH ' ' B' ' 49' ' ' TYR . . . -69.07 104.7 1.31 Allowed Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 116.34 -0.391 . . . . 0.0 113.358 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.58 ' CD1' ' HD2' ' B' ' 24' ' ' LYS . 2.1 mp -100.28 -71.33 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 122.11 0.957 . . . . 0.0 110.685 179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 18.4 m -99.75 -118.65 0.15 Allowed 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.036 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.601 ' OH ' ' HA2' ' B' ' 46' ' ' GLY . 0.1 OUTLIER 38.46 45.86 0.89 Allowed 'General case' 0 N--CA 1.472 0.625 0 O-C-N 123.693 0.621 . . . . 0.0 111.226 -171.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 48.55 -94.5 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.836 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.426 ' CG ' HD21 ' B' ' 67' ' ' ASN . 18.1 t70 -174.41 109.85 0.14 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -177.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.638 ' HB2' ' OE2' ' B' ' 68' ' ' GLU . 47.4 mmtt -123.26 136.84 54.9 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -174.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.454 ' CG ' HD22 ' B' ' 67' ' ' ASN . 47.2 m-80 -120.1 140.32 51.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.799 0.333 . . . . 0.0 111.344 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.624 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 22.2 p-90 -156.23 172.02 19.19 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.505 172.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.7 147.07 19.0 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.661 -173.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 25.0 mt -107.14 146.32 13.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 170.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.639 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 60.3 m-85 -126.63 143.89 51.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.426 -174.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.603 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.1 p -129.68 136.43 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.522 ' ND2' HG13 ' B' ' 58' ' ' VAL . 1.6 m-80 59.13 14.93 3.77 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.118 0.567 . . . . 0.0 109.842 -174.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.37 -1.5 66.95 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.496 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 14.6 mt-10 -105.86 177.5 4.83 Favored 'General case' 0 C--O 1.205 -1.266 0 C-N-CA 123.644 0.778 . . . . 0.0 109.162 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.2 tppp? -66.14 163.04 18.43 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 172.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.603 ' HB ' HG12 ' B' ' 58' ' ' VAL . 11.3 p -151.48 -21.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.104 0.478 . . . . 0.0 109.877 167.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.687 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.6 OUTLIER -161.31 123.46 3.02 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.163 0.506 . . . . 0.0 110.845 -171.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 8.6 m -129.48 129.4 44.55 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.421 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.475 ' CD2' ' CE1' ' B' ' 64' ' ' TYR . 0.0 OUTLIER -153.01 -176.7 5.88 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 122.261 1.029 . . . . 0.0 111.875 -176.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.454 HD22 ' CG ' ' B' ' 53' ' ' ASN . 23.9 t-20 -147.28 149.09 32.19 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 112.897 -1.956 . . . . 0.0 108.365 -176.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . 0.638 ' OE2' ' HB2' ' B' ' 52' ' ' LYS . 0.4 OUTLIER -66.48 -21.1 66.18 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -172.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.443 ' O ' HG23 ' B' ' 71' ' ' THR . 85.4 tttt -95.88 -20.91 18.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.226 0.536 . . . . 0.0 110.011 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 6.7 t -69.88 -23.63 63.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.674 174.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.587 HG21 ' CD1' ' B' ' 45' ' ' TYR . 19.2 p 61.87 107.13 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.313 1.045 . . . . 0.0 111.878 174.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.629 ' HA ' HD12 ' B' ' 75' ' ' ILE . 6.0 m -64.41 -16.47 19.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.606 -169.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.07 -48.5 82.48 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.269 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -75.43 -28.91 59.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.285 0.564 . . . . 0.0 110.572 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' B' ' 72' ' ' VAL . 2.9 mt -73.0 -47.83 46.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.595 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 42.1 m -52.08 -35.43 47.61 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.041 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -48.51 -58.26 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.788 0.804 . . . . 0.0 110.336 172.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.548 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 7.1 m-20 -70.31 -35.9 73.97 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.572 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.687 HG13 ' CE1' ' B' ' 64' ' ' TYR . 41.5 mm -58.81 -25.54 29.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.571 0.7 . . . . 0.0 111.729 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -69.18 4.54 1.59 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.406 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 0.1 OUTLIER -105.17 -0.61 26.36 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.132 0.492 . . . . 0.0 110.446 176.134 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' B' ' 79' ' ' ILE . 2.4 mm? -79.56 -4.46 51.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.999 -169.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . 0.423 ' C ' HD22 ' B' ' 83' ' ' ASN . 0.2 OUTLIER 53.13 58.85 4.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -170.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.447 HD11 HG22 ' B' ' 79' ' ' ILE . 59.8 mt -56.84 155.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.121 -175.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -134.86 -171.69 2.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.882 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -149.47 112.7 0.57 Allowed Glycine 0 C--N 1.309 -0.945 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.463 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.456 ' HG2' ' N ' ' B' ' 88' ' ' TYR . 16.0 ttt -160.29 -76.3 0.06 Allowed 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . 0.456 ' N ' ' HG2' ' B' ' 87' ' ' MET . 49.7 t80 -120.11 94.05 4.26 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.639 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 22.3 mm -96.32 130.52 44.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.672 -177.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 51.3 mm-40 -123.94 154.99 38.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.4 . . . . 0.0 111.528 177.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.567 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 72.2 mt -137.54 126.25 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.646 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.624 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 49.6 pttt -172.62 167.27 5.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.064 0.459 . . . . 0.0 111.262 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.725 ' NE2' ' H ' ' B' ' 93' ' ' GLN . 0.6 OUTLIER -96.77 151.67 19.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.427 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.559 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.9 pt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.038 -0.982 . . . . 0.0 111.038 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.545 0.212 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -76.74 -30.55 56.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.848 0.356 . . . . 0.0 111.484 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -63.41 -15.61 58.11 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.768 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -72.76 -18.98 61.45 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.032 0.444 . . . . 0.0 110.946 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.82 11.08 30.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.063 0.459 . . . . 0.0 110.587 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 75.2 mt -118.42 21.9 12.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.46 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -40.33 75.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.418 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -87.48 -30.44 20.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 122.098 0.952 . . . . 0.0 110.149 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -81.27 68.97 7.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.772 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . 0.418 ' O ' HG13 ' B' ' 13' ' ' ILE . 25.8 mmt -66.12 138.04 57.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.884 176.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -40.25 -19.89 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.42 1.488 . . . . 0.0 114.092 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.43 ' O ' HG23 ' B' ' 16' ' ' VAL . 39.1 t -60.09 -7.3 1.76 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.569 0.747 . . . . 0.0 112.325 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.468 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.6 OUTLIER -47.91 -62.27 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.347 0 CA-C-O 121.224 0.535 . . . . 0.0 111.916 -176.064 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -106.67 -20.77 13.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.792 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 30.9 t -53.61 -38.35 63.93 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.164 -175.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 12' ' ' SER . 90.1 t -57.19 -41.93 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 111.211 -176.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.436 ' HA ' HD22 ' B' ' 29' ' ' LEU . 4.9 t-20 -67.05 -41.53 86.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.668 -176.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.07 -38.9 56.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.0 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 6.4 mmpt? -57.88 -66.22 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.501 HD21 ' CZ ' ' B' ' 66' ' ' PHE . 75.3 mt -59.1 -23.02 61.72 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.269 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -86.74 79.8 8.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.713 0.768 . . . . 0.0 110.711 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' B' ' 19' ' ' LYS . 29.7 mtpp -119.14 37.3 4.17 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.97 177.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.65 59.5 3.48 Favored Glycine 0 CA--C 1.505 -0.59 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.402 ' HE2' ' HB2' ' B' ' 22' ' ' LYS . 70.8 mmtt -125.45 -163.44 1.2 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -177.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.446 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -53.54 139.94 34.26 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.175 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.713 ' O ' ' HA ' ' B' ' 40' ' ' SER . 43.1 mtmt -61.76 107.9 0.91 Allowed 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 117.036 0.418 . . . . 0.0 109.96 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' B' ' 39' ' ' THR . 36.7 tp -125.41 122.58 37.14 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.853 -167.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 18.2 m -101.61 101.9 12.52 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.542 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.499 ' N ' HD12 ' B' ' 29' ' ' LEU . 4.9 mp -90.69 150.94 21.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 122.02 0.914 . . . . 0.0 112.485 -170.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 34.3 p -146.65 149.8 34.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.778 -1.555 . . . . 0.0 107.893 173.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 78.3 mtp -120.74 160.85 22.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.244 0.545 . . . . 0.0 111.811 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -159.09 104.94 1.72 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.599 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.91 -97.59 0.74 Allowed Glycine 0 CA--C 1.504 -0.604 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -169.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -137.17 19.77 2.98 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 168.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -77.68 155.14 31.52 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.927 175.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.472 HD21 HD23 ' B' ' 29' ' ' LEU . 2.0 tm? -126.45 116.99 21.99 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.18 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -120.97 133.01 55.26 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.726 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -162.82 150.44 13.56 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -170.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.62 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 18.4 p -112.14 148.11 34.69 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.713 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 7.7 p -134.34 146.47 49.97 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -170.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' B' ' 26' ' ' LYS . 47.3 t -118.82 165.26 14.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.399 167.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -113.93 18.72 17.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.165 0.507 . . . . 0.0 111.238 -172.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.75 -61.45 2.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.181 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.54 53.94 0.56 Allowed Glycine 0 C--N 1.311 -0.807 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.985 -176.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.446 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 0.1 OUTLIER -63.65 -165.69 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.03 0.532 . . . . 0.0 112.192 -177.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.559 ' H ' HG22 ' B' ' 71' ' ' THR . . . -70.33 106.66 1.9 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.154 175.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 4.7 mm -64.0 -68.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.974 0.416 . . . . 0.0 110.173 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.0 m -123.28 -90.79 0.56 Allowed 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.18 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 56.15 33.91 22.91 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 122.761 0.424 . . . . 0.0 111.332 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 34.02 -109.62 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.727 -1.124 . . . . 0.0 113.111 -175.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -150.65 110.52 4.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.828 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.428 ' HB2' ' HG2' ' B' ' 68' ' ' GLU . 54.2 mttm -131.53 135.16 46.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.529 HD22 ' N ' ' B' ' 53' ' ' ASN . 0.8 OUTLIER -111.5 136.09 51.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.846 0.355 . . . . 0.0 110.156 -179.446 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.678 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 48.0 p-90 -151.2 166.99 29.19 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 172.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.71 159.4 26.86 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 119.989 -1.1 . . . . 0.0 113.711 -170.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 13.3 mt -105.7 142.85 17.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 171.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.58 ' CE1' ' HG3' ' B' ' 62' ' ' LYS . 48.8 m-85 -126.23 131.29 51.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.998 -0.092 . . . . 0.0 110.756 -177.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.618 HG12 ' HB ' ' B' ' 63' ' ' VAL . 12.2 p -116.26 133.86 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.276 -177.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.431 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.8 m-80 65.78 5.01 3.15 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.719 0.808 . . . . 0.0 110.263 -177.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.61 11.9 56.4 Favored Glycine 0 N--CA 1.433 -1.533 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.829 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 14.8 mt-10 -110.25 173.7 6.21 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 171.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.58 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 24.9 ttmt -76.49 168.77 19.48 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 119.427 1.012 . . . . 0.0 108.971 173.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.618 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.4 p -151.47 -19.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.804 171.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.643 ' CD2' HD11 ' B' ' 79' ' ' ILE . 0.0 OUTLIER -163.33 153.21 15.4 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.588 -175.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 27.6 m -149.97 130.03 13.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.308 177.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.661 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -145.11 -176.76 5.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.724 0.773 . . . . 0.0 110.769 -178.803 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.45 HD22 ' ND2' ' B' ' 53' ' ' ASN . 24.6 t-20 -136.22 160.2 39.41 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.156 -1.384 . . . . 0.0 110.219 -175.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . 0.428 ' HG2' ' HB2' ' B' ' 52' ' ' LYS . 62.2 mm-40 -61.15 -44.25 97.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.865 0.364 . . . . 0.0 111.724 -177.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.557 ' O ' HG23 ' B' ' 71' ' ' THR . 50.3 tptt -80.86 -19.76 43.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.838 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 8.7 t -69.1 -18.38 63.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.402 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.559 HG22 ' H ' ' B' ' 46' ' ' GLY . 41.0 p 56.27 105.93 0.01 OUTLIER 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.304 1.041 . . . . 0.0 113.332 170.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.581 ' HA ' HD12 ' B' ' 75' ' ' ILE . 11.1 m -57.65 -15.12 3.67 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-N 114.556 -1.202 . . . . 0.0 113.265 -171.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.58 -52.3 46.26 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.979 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -76.45 -32.68 58.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.354 0.597 . . . . 0.0 109.976 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.661 HD13 ' HB3' ' B' ' 66' ' ' PHE . 1.9 mt -72.03 -53.93 18.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.604 -173.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 21.8 m -69.75 -14.08 62.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.52 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -61.93 -42.24 98.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.768 0.794 . . . . 0.0 109.459 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 4.3 m-20 -68.95 -32.46 72.07 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.529 176.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.643 HD11 ' CD2' ' B' ' 64' ' ' TYR . 17.7 mm -55.67 -26.35 19.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -54.85 -27.26 40.96 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.296 173.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 19.8 pttm -104.11 -6.14 21.37 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -172.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' B' ' 79' ' ' ILE . 2.8 mm? -70.97 -18.3 62.62 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 122.126 -0.359 . . . . 0.0 111.815 -173.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 61.0 t30 45.97 55.69 6.8 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.972 0.795 . . . . 0.0 110.63 -171.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.485 HG22 ' O ' ' B' ' 85' ' ' LYS . 83.1 mt -59.81 145.5 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.171 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.485 ' O ' HG22 ' B' ' 84' ' ' ILE . 62.3 mttp -89.88 178.27 6.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.32 176.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -134.33 112.58 1.06 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.474 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.24 -79.73 0.09 Allowed 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . 0.408 ' H ' ' HA ' ' B' ' 59' ' ' ASN . 25.5 t80 -122.33 88.07 2.87 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 28.0 mm -90.83 128.66 42.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.912 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.58 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 33.8 mt-10 -117.52 144.73 44.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.588 173.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.413 HG21 ' HG3' ' B' ' 19' ' ' LYS . 2.5 mt -134.75 102.81 4.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.678 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 48.0 pttt -154.65 178.01 10.59 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -169.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.445 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 21.1 mm-40 -99.01 146.8 25.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.163 -176.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.642 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.9 pt . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.305 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.635 0.255 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -78.27 -39.54 39.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.761 0.315 . . . . 0.0 111.007 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . 0.401 ' HA ' ' OE1' ' B' ' 3' ' ' GLN . 15.6 mm-40 -83.54 -19.44 35.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.319 0.58 . . . . 0.0 110.214 178.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -93.64 9.4 37.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.023 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.04 83.71 0.33 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.825 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.89 21.22 14.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.498 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.56 -63.74 1.2 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.733 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -98.22 1.23 47.09 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 121.413 0.625 . . . . 0.0 110.512 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -130.26 76.92 1.75 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.367 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 15.0 mmt -71.64 150.52 44.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.362 0.601 . . . . 0.0 111.283 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -66.5 -28.26 68.43 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.956 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 24.2 m -71.45 -21.12 62.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.712 -175.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.411 ' H ' HG12 ' B' ' 13' ' ' ILE . 3.8 mm -61.93 -47.4 93.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 122.07 0.938 . . . . 0.0 109.196 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . 0.4 ' H ' ' ND2' ' B' ' 14' ' ' ASN . 8.4 m-80 -63.69 -38.39 90.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.405 -177.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -62.2 -44.27 96.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.934 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.96 -48.0 91.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.096 0.474 . . . . 0.0 110.329 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -60.11 -37.05 78.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.882 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . 0.677 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.2 OUTLIER -71.32 -57.47 4.43 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.377 176.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -55.59 -49.96 71.38 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.059 0.944 . . . . 0.0 112.85 -173.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.424 HD22 HG11 ' B' ' 72' ' ' VAL . 47.2 mt -71.17 -21.06 62.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.963 -175.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -91.94 -99.55 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.677 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 30.6 mtpp 49.9 25.79 1.74 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.67 11.22 60.84 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.933 178.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -96.25 -129.08 0.16 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 175.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.547 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -66.87 107.29 1.94 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 173.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.746 ' O ' ' HA ' ' B' ' 40' ' ' SER . 34.9 mtmt -66.97 90.08 0.18 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.846 0.314 . . . . 0.0 111.846 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 47.1 tp -108.47 93.14 4.37 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 21.0 m -81.24 105.47 12.46 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.264 -176.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.41 165.24 22.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.946 0.879 . . . . 0.0 111.601 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 49.1 m -146.49 144.35 29.58 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.363 174.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 33.9 mtt -114.26 124.1 51.19 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.817 0.341 . . . . 0.0 110.945 -170.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.83 60.04 1.32 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.662 176.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . 0.406 ' O ' ' HA3' ' B' ' 86' ' ' GLY . . . 49.55 -102.9 0.07 OUTLIER Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.248 -0.887 . . . . 0.0 113.861 178.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 4.6 m-20 -79.44 19.37 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.271 0.229 . . . . 0.0 111.435 -176.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 42.9 mt-30 -139.13 146.28 40.45 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.317 0.58 . . . . 0.0 110.472 172.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' B' ' 36' ' ' LEU . 1.4 tm? -129.05 116.66 19.64 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 176.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.489 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 16.1 mtpt -118.09 148.87 41.86 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -172.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -170.58 145.6 2.58 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -176.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 19.5 p -122.68 141.62 51.57 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.548 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.746 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 24.1 t -122.53 147.51 46.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.363 0.601 . . . . 0.0 112.163 -174.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' B' ' 26' ' ' LYS . 46.8 t -131.67 160.85 34.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.813 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' B' ' 44' ' ' GLY . 51.1 m-80 -114.1 32.84 5.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.115 -171.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.526 ' HB3' ' HE2' ' B' ' 26' ' ' LYS . . . -72.96 22.46 0.07 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.306 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' B' ' 42' ' ' ASN . . . 165.34 -43.97 0.29 Allowed Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.547 ' HA ' ' N ' ' B' ' 25' ' ' GLY . 37.1 p90 46.04 -160.94 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.355 1.062 . . . . 0.0 113.013 -175.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.55 99.39 0.73 Allowed Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.842 -0.694 . . . . 0.0 114.17 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.06 -54.73 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-O 121.1 0.476 . . . . 0.0 109.782 170.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -37.93 -57.97 0.98 Allowed 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.285 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -103.81 112.91 26.08 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 172.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' B' ' 69' ' ' LYS . 30.5 mt-10 -67.75 -48.38 66.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.616 -170.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -167.22 111.93 0.72 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.443 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -132.39 142.18 49.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.848 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.59 113.87 26.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.535 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 29.1 p-90 -154.12 165.7 35.38 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.345 176.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -135.12 150.45 20.19 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.844 -174.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.459 HD12 ' CD2' ' B' ' 64' ' ' TYR . 24.3 mt -106.35 150.41 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 172.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 70.7 m-85 -131.9 139.43 48.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.128 -172.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.578 HG12 ' HB ' ' B' ' 63' ' ' VAL . 8.6 p -125.17 133.39 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.488 HD22 HG13 ' B' ' 58' ' ' VAL . 5.4 m-80 64.12 5.88 2.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.859 -175.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.87 -12.21 38.16 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.435 -176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' B' ' 58' ' ' VAL . 0.2 OUTLIER -100.17 177.22 5.13 Favored 'General case' 0 C--O 1.202 -1.421 0 C-N-CA 123.713 0.805 . . . . 0.0 109.938 -176.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.47 ' HD2' ' OG1' ' B' ' 65' ' ' THR . 13.1 tppt? -61.44 159.45 12.74 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 118.279 0.491 . . . . 0.0 110.485 174.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.578 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.1 p -153.7 -14.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.262 0.553 . . . . 0.0 110.389 167.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.786 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -161.14 133.99 6.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.184 -173.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.47 ' OG1' ' HD2' ' B' ' 62' ' ' LYS . 16.4 m -142.18 126.0 17.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.02 177.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.682 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -166.16 -177.8 4.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 122.567 1.175 . . . . 0.0 112.29 -174.26 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -136.83 145.9 45.0 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 112.349 -2.205 . . . . 0.0 108.736 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.3 -29.3 65.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.186 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.442 ' O ' HG23 ' B' ' 71' ' ' THR . 28.2 ttpp -80.99 -25.94 36.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.99 0.424 . . . . 0.0 110.599 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 9.8 t -68.05 -31.64 71.42 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 174.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.465 ' O ' HG13 ' B' ' 75' ' ' ILE . 11.1 p 62.77 125.08 0.01 OUTLIER 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.548 1.139 . . . . 0.0 112.614 174.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.501 ' HA ' HD12 ' B' ' 75' ' ' ILE . 11.6 m -63.92 -10.75 8.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.356 -168.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.92 -56.31 23.57 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.663 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -76.48 -31.28 57.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.39 0.614 . . . . 0.0 110.265 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.682 HD13 ' HB3' ' B' ' 66' ' ' PHE . 2.8 mt -67.93 -46.24 82.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.649 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 38.2 t -59.16 -32.71 70.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.693 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -49.04 -52.42 25.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.66 0.743 . . . . 0.0 110.286 176.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 30.3 m-20 -67.7 -47.32 69.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.018 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.786 HG13 ' CE1' ' B' ' 64' ' ' TYR . 46.2 mm -55.16 -30.75 24.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.262 0.553 . . . . 0.0 112.065 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -58.6 -20.01 43.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.269 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 0.0 OUTLIER -94.56 -4.0 48.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 0.0 111.058 -175.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.1 mm? -70.5 -16.26 62.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.99 -173.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 58.9 t30 50.84 57.64 6.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.461 -171.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' B' ' 35' ' ' GLN . 48.9 mt -57.63 144.08 10.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.94 -174.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 30.3 mtmm -109.03 -168.58 1.36 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.112 175.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' B' ' 33' ' ' GLY . . . -146.25 113.58 0.69 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.925 -177.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 37.4 ttp -157.34 -74.09 0.09 Allowed 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 116.639 0.22 . . . . 0.0 110.458 173.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -117.32 94.24 4.48 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.181 0.515 . . . . 0.0 109.694 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.571 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 20.4 mm -93.57 134.66 30.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.384 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -122.89 173.49 7.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.369 0.604 . . . . 0.0 110.937 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.535 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 92.1 mt -152.22 118.85 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.759 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 30.7 pttt -171.26 168.3 6.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.175 0.512 . . . . 0.0 111.768 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.462 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 2.4 pt20 -99.39 150.51 22.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.154 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.2 pt . . . . . 0 C--N 1.308 -1.203 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.972 -174.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' B' ' 4' ' ' LYS . 3.6 m-20 . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -61.64 -53.66 53.17 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -170.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . 0.408 ' O ' ' HG ' ' B' ' 6' ' ' LEU . 11.9 pt20 -74.15 -15.59 61.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.848 0.356 . . . . 0.0 111.793 -176.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.471 ' HB3' ' HB3' ' B' ' 1' ' ' ASP . 55.3 tptt -85.93 -21.75 27.77 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.248 0.547 . . . . 0.0 110.44 175.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.456 ' O ' ' HG2' ' B' ' 9' ' ' GLN . . . -108.5 42.84 1.32 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.085 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 3' ' ' GLN . 67.4 mt -71.84 -3.41 22.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.855 0.36 . . . . 0.0 111.465 -176.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -82.5 -37.02 25.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.005 0.431 . . . . 0.0 110.212 171.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.88 -20.47 49.4 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.714 0.769 . . . . 0.0 110.713 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' B' ' 5' ' ' ALA . 17.7 pt20 -128.4 68.05 1.37 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.439 172.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.75 171.02 15.05 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.625 -1.171 . . . . 0.0 112.115 -173.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -36.83 -22.97 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.638 1.975 . . . . 0.0 115.825 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 15.2 m -60.33 -12.5 9.31 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 122.441 0.296 . . . . 0.0 111.792 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.451 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -53.52 -50.36 49.87 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-O 121.732 0.777 . . . . 0.0 109.849 -178.082 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' B' ' 18' ' ' ASP . 40.0 m-80 -106.82 -60.6 1.65 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.274 -175.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 5.5 m -58.24 -64.49 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.393 -170.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 67.9 t -62.94 -40.5 89.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.449 . . . . 0.0 110.701 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -56.83 -47.14 81.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.827 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . 0.755 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 0.1 OUTLIER -75.02 -40.54 60.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.273 -178.039 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.0 OUTLIER -52.49 -35.18 52.27 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.016 0.527 . . . . 0.0 112.027 -176.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 96.3 mt -89.22 -42.24 11.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.273 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' B' ' 18' ' ' ASP . 4.3 p-10 -80.45 -2.41 45.7 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -173.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.755 ' HG3' ' O ' ' B' ' 18' ' ' ASP . 29.2 mtpp -73.37 -74.29 0.18 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.753 0.311 . . . . 0.0 111.565 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.17 15.93 59.83 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.822 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.575 ' NZ ' ' HA ' ' B' ' 68' ' ' GLU . 26.0 mtpt -129.29 -160.23 1.02 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.168 0.509 . . . . 0.0 110.224 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.492 ' CA ' ' HA ' ' B' ' 45' ' ' TYR . . . -66.03 139.24 38.03 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 173.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' B' ' 40' ' ' SER . 60.3 mttt -62.28 133.91 55.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -175.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.507 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 29.6 tp -141.56 96.57 3.0 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 41.9 m -86.63 126.83 34.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.789 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.507 ' CD1' ' HG ' ' B' ' 27' ' ' LEU . 10.4 mp -107.07 163.75 12.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 122.327 1.06 . . . . 0.0 112.758 -174.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.453 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 3.1 p -160.22 146.06 15.33 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 112.878 -1.965 . . . . 0.0 107.073 171.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . 0.439 ' HB2' ' HE3' ' B' ' 31' ' ' MET . 52.9 mtm -128.67 145.61 51.11 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.582 -172.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . 0.457 ' C ' HD22 ' B' ' 32' ' ' ASN . 0.2 OUTLIER -138.02 61.21 1.6 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.47 -96.82 0.12 Allowed Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.54 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -87.19 25.77 1.31 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.913 0.387 . . . . 0.0 110.791 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.438 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 14.8 mt-30 -137.31 144.82 42.8 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 121.465 0.65 . . . . 0.0 110.627 172.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.421 ' HB3' HD13 ' B' ' 84' ' ' ILE . 3.7 tt -126.25 105.17 8.64 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.248 -1.342 . . . . 0.0 107.645 175.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.453 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 6.0 mmmm -102.62 138.27 39.74 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -173.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -156.56 147.47 21.95 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -172.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -124.27 155.22 39.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.09 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 6.7 p -135.85 157.52 46.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -172.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' B' ' 26' ' ' LYS . 22.8 t -136.43 154.45 50.78 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.776 174.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -115.96 30.39 7.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.812 -171.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.41 ' HB3' ' HE3' ' B' ' 26' ' ' LYS . . . -75.61 23.2 0.12 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -175.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.59 -24.26 0.36 Allowed Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.777 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.524 ' HB2' ' HB ' ' B' ' 71' ' ' THR . 52.6 p90 45.37 -156.6 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.167 0.987 . . . . 0.0 113.032 -176.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' B' ' 24' ' ' LYS . . . -69.52 102.98 1.02 Allowed Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.666 -178.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.79 -64.19 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.037 0.446 . . . . 0.0 110.619 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 60.1 m -48.5 -53.66 17.24 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.152 -175.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.555 ' CB ' ' HB3' ' B' ' 68' ' ' GLU . 4.4 m-30 -78.39 127.25 31.93 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.768 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -84.25 -168.62 2.23 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.942 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -60.71 108.63 0.87 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.716 0.77 . . . . 0.0 111.325 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 54.3 mtmt -150.24 140.78 22.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.443 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.54 123.93 40.19 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.993 0.425 . . . . 0.0 111.485 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.526 ' HB2' ' O ' ' B' ' 92' ' ' LYS . 28.1 p-90 -143.33 169.7 17.16 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.085 177.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.16 148.59 20.0 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.126 -173.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 13.5 mt -105.66 150.66 8.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 171.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.675 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 84.3 m-85 -130.56 139.48 50.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -171.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.517 HG13 ' ND2' ' B' ' 59' ' ' ASN . 7.2 p -126.58 134.32 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.517 ' ND2' HG13 ' B' ' 58' ' ' VAL . 4.5 m-80 66.86 -2.32 1.15 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.641 -173.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' B' ' 58' ' ' VAL . . . 108.18 -6.3 34.4 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.552 -172.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -94.47 176.45 6.29 Favored 'General case' 0 C--O 1.207 -1.176 0 C-N-CA 123.896 0.878 . . . . 0.0 109.193 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.431 ' HD3' ' CE1' ' B' ' 57' ' ' PHE . 7.8 tppt? -66.91 161.99 22.81 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.507 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.8 p -153.48 -11.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.08 0.467 . . . . 0.0 110.219 168.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.676 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -160.58 132.39 5.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.547 -175.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 54.9 m -139.01 124.39 19.26 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.288 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.724 ' HB3' HD13 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -164.84 155.6 14.43 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.505 1.145 . . . . 0.0 111.869 -174.667 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 10.7 t-20 -93.41 153.49 18.47 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.038 -1.892 . . . . 0.0 108.352 169.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . 0.575 ' HA ' ' NZ ' ' B' ' 24' ' ' LYS . 7.1 mm-40 -80.63 -4.48 54.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.025 0.44 . . . . 0.0 111.229 -177.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -97.23 -30.66 12.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.497 ' OG ' HD11 ' B' ' 75' ' ' ILE . 23.2 t -60.57 152.49 26.03 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.062 172.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' B' ' 45' ' ' TYR . 0.1 OUTLIER -103.22 115.79 31.24 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.112 -174.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.62 ' HA ' HD12 ' B' ' 75' ' ' ILE . 14.3 m -68.98 -12.48 16.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.246 -167.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.29 -46.05 94.72 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.485 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -69.13 -31.78 70.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.439 0.638 . . . . 0.0 110.271 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.724 HD13 ' HB3' ' B' ' 66' ' ' PHE . 3.8 mt -74.64 -45.89 43.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.294 -176.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 22.6 t -54.13 -34.45 60.35 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.533 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -51.89 -57.0 10.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.232 173.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.769 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 11.3 m-20 -65.9 -36.53 83.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.676 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.676 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.4 mm -61.98 -33.07 56.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.38 0.609 . . . . 0.0 111.519 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -74.66 1.77 11.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.553 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.769 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 56.6 pttt -110.44 5.62 21.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.39 . . . . 0.0 110.864 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 32.8 mt -86.75 9.35 19.2 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.149 -174.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 63.7 t30 53.15 57.44 6.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -170.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.421 HD13 ' HB3' ' B' ' 36' ' ' LEU . 76.6 mt -45.23 146.12 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.597 -175.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.421 ' HB2' HD21 ' B' ' 59' ' ' ASN . 38.5 mtpt -127.63 -171.77 2.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.387 177.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -157.0 113.61 0.57 Allowed Glycine 0 N--CA 1.45 -0.396 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.47 ' HG2' ' N ' ' B' ' 88' ' ' TYR . 15.9 ttt -156.4 -75.7 0.1 Allowed 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 117.057 0.429 . . . . 0.0 110.967 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . 0.47 ' N ' ' HG2' ' B' ' 87' ' ' MET . 60.8 t80 -122.31 101.81 7.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 28.3 mm -96.25 126.28 48.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.402 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -109.9 171.92 7.16 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 62.2 mt -149.48 107.49 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.148 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 47.7 pttt -157.45 179.81 8.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.098 0.475 . . . . 0.0 111.687 -177.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 1.5 pt20 -105.13 145.25 30.82 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.93 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.485 HG12 ' HA ' ' B' ' 54' ' ' TRP . 5.1 pt . . . . . 0 C--O 1.247 0.926 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.135 -174.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.472 ' O ' ' HG ' ' B' ' 6' ' ' LEU . 24.4 t-20 -92.38 113.32 25.57 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.19 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -87.5 10.09 18.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.927 -176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.624 ' HB3' ' OD1' ' B' ' 11' ' ' ASN . 11.5 mmtp -98.26 -65.71 0.95 Allowed 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.033 0.444 . . . . 0.0 110.318 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.0 80.47 1.32 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.838 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.549 ' H ' HD12 ' B' ' 6' ' ' LEU . 4.8 mp -74.36 -98.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.074 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -87.98 -76.26 0.39 Allowed 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.692 -175.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -114.25 4.17 15.38 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.018 0.437 . . . . 0.0 111.252 -176.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.562 ' HB3' ' HA2' ' B' ' 33' ' ' GLY . 16.6 pt20 -98.4 155.06 17.42 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.501 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . 0.545 ' O ' HG12 ' B' ' 13' ' ' ILE . 39.7 tpp -119.12 146.92 44.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.943 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . 0.624 ' OD1' ' HB3' ' B' ' 4' ' ' LYS . 42.2 m-20 -35.39 -41.85 0.19 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 5.4 m -65.52 -19.29 65.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.174 -169.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.545 HG12 ' O ' ' B' ' 10' ' ' MET . 7.7 mm -59.85 -39.59 80.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 122.198 0.999 . . . . 0.0 109.423 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -76.7 -28.01 55.7 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.22 -175.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.639 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 12.1 m -63.11 -41.93 99.45 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.821 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.552 HG13 HD13 ' B' ' 56' ' ' ILE . 63.9 t -52.7 -44.07 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.508 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -65.25 -41.56 94.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.477 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.49 -29.15 62.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.634 -178.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' B' ' 15' ' ' SER . 27.4 mmmt -71.16 -20.16 62.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.661 0.743 . . . . 0.0 111.387 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.537 HD22 HG11 ' B' ' 72' ' ' VAL . 67.1 mt -108.39 -28.15 9.55 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.416 -175.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -80.43 69.96 7.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.372 0.606 . . . . 0.0 110.104 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -133.45 33.87 3.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.954 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.28 48.85 5.49 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -130.94 -152.37 0.51 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -175.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' B' ' 45' ' ' TYR . . . -60.3 125.94 40.06 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 171.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.49 ' CB ' ' HB3' ' B' ' 41' ' ' SER . 29.7 mtpp -80.63 130.71 35.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.598 0.714 . . . . 0.0 111.276 -171.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 21.9 tp -150.26 101.57 3.0 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.11 -173.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 15.4 p -85.8 104.09 15.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.933 -174.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 60.0 mt -88.64 151.34 22.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.593 0.711 . . . . 0.0 111.31 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 71.2 m -140.49 143.9 35.73 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.748 175.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . 0.47 ' SD ' HG22 ' B' ' 13' ' ' ILE . 5.1 mmt -106.79 120.46 42.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.795 0.331 . . . . 0.0 110.845 -167.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . 0.454 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 18.3 t-20 -134.29 58.97 1.75 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.267 0.556 . . . . 0.0 109.513 177.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . 0.562 ' HA2' ' HB3' ' B' ' 9' ' ' GLN . . . 50.45 -99.76 0.03 OUTLIER Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.301 -0.863 . . . . 0.0 114.016 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -78.92 4.77 13.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.36 -0.42 . . . . 0.0 111.104 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.454 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 37.7 mt-30 -129.98 147.71 51.76 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.673 0.749 . . . . 0.0 110.579 174.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' B' ' 84' ' ' ILE . 1.4 tt -124.11 106.62 10.49 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.354 -1.294 . . . . 0.0 107.615 174.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.472 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 12.2 mmmm -96.92 153.15 18.07 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.505 -170.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -164.93 152.49 11.36 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.774 -171.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.25 171.71 12.99 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 169.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 16.3 p -131.78 149.95 52.31 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.189 -0.605 . . . . 0.0 111.381 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.49 ' HB3' ' CB ' ' B' ' 26' ' ' LYS . 31.1 t -130.1 155.96 45.33 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.449 0.642 . . . . 0.0 110.791 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -114.61 33.23 5.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.8 -162.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.31 -33.34 67.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.047 0.927 . . . . 0.0 110.181 172.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.33 -121.62 1.03 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 113.923 -1.489 . . . . 0.0 110.37 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.478 ' HB2' ' CG2' ' B' ' 71' ' ' THR . 9.2 p90 -177.92 -166.63 0.12 Allowed 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 120.774 0.321 . . . . 0.0 111.743 -178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.413 ' H ' HG22 ' B' ' 71' ' ' THR . . . -76.75 122.76 6.4 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.053 -176.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.419 ' H ' HD12 ' B' ' 47' ' ' ILE . 1.2 mp -107.04 -61.25 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 CA-C-O 122.36 1.076 . . . . 0.0 109.058 175.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 2.4 m -57.32 167.67 0.9 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 112.483 -2.144 . . . . 0.0 112.05 -174.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 74.49 10.29 4.2 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.391 -1.731 . . . . 0.0 111.46 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 48.65 -108.95 0.29 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.507 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -130.79 111.66 12.33 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.787 0.803 . . . . 0.0 110.42 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 94.1 mttt -134.07 138.12 45.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.121 176.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -112.47 132.84 54.86 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.078 0.466 . . . . 0.0 110.665 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.514 ' HA ' HG12 ' B' ' 94' ' ' ILE . 27.6 p-90 -141.88 173.05 11.87 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.016 176.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.65 139.35 10.87 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.567 -173.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.56 HD12 ' CD2' ' B' ' 64' ' ' TYR . 28.3 mt -104.86 151.34 7.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 169.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.721 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 74.9 m-85 -130.45 145.34 51.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -172.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.627 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.1 p -135.98 140.98 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.575 ' ND2' HG13 ' B' ' 58' ' ' VAL . 8.6 m-80 66.52 3.17 2.76 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -172.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.9 4.11 65.38 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.352 -172.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 3.9 mm-40 -105.84 176.51 5.14 Favored 'General case' 0 C--O 1.202 -1.433 0 C-N-CA 123.618 0.767 . . . . 0.0 109.209 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.502 ' HE3' ' CE1' ' B' ' 57' ' ' PHE . 0.0 OUTLIER -68.26 161.59 26.92 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.493 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.627 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.6 p -153.79 -12.02 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.909 0.385 . . . . 0.0 110.698 170.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.82 ' CZ ' HG13 ' B' ' 79' ' ' ILE . 0.2 OUTLIER -159.52 128.76 5.3 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.207 -173.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 26.5 m -137.72 124.81 21.52 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.625 -1.171 . . . . 0.0 108.546 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.505 ' HB2' HD13 ' B' ' 75' ' ' ILE . 0.0 OUTLIER -173.47 151.77 2.02 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 122.042 0.925 . . . . 0.0 112.078 -167.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 5.4 m120 -97.97 153.04 18.64 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 113.562 -1.653 . . . . 0.0 110.58 174.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -58.24 -48.06 81.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.806 0.336 . . . . 0.0 111.125 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.589 ' O ' HG23 ' B' ' 71' ' ' THR . 41.4 ttmt -72.59 -16.74 61.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.298 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.6 t -72.31 -15.08 61.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.589 HG23 ' O ' ' B' ' 69' ' ' LYS . 21.4 p 56.17 113.11 0.01 OUTLIER 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.653 1.181 . . . . 0.0 113.756 169.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.537 HG11 HD22 ' B' ' 20' ' ' LEU . 5.4 m -62.33 -14.54 12.79 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.16 -171.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.67 -48.96 63.27 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.404 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 77.0 m-20 -83.81 -36.29 23.62 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.451 0.643 . . . . 0.0 110.578 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.505 HD13 ' HB2' ' B' ' 66' ' ' PHE . 2.8 mt -64.89 -48.37 84.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.176 -178.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.503 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 14.4 t -66.69 -21.13 66.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.153 -177.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' B' ' 74' ' ' ASN . 0.9 OUTLIER -52.58 -41.32 63.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 171.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.659 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 4.7 m-20 -72.6 -52.77 14.06 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.794 172.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.82 HG13 ' CZ ' ' B' ' 64' ' ' TYR . 51.5 mm -47.42 -38.09 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -59.31 -30.51 68.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 45.2 pttt -73.86 -20.97 60.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.978 0.418 . . . . 0.0 110.062 -178.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.507 ' HB2' ' O ' ' B' ' 79' ' ' ILE . 4.3 mm? -68.66 -18.51 64.29 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.845 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 66.0 t30 39.77 69.07 0.33 Allowed 'General case' 0 C--O 1.235 0.321 0 O-C-N 124.154 0.909 . . . . 0.0 110.21 -171.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.705 ' H ' HD12 ' B' ' 84' ' ' ILE . 3.9 mp -50.23 143.91 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.614 -174.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -98.1 -178.19 3.98 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.841 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -136.75 113.68 1.07 Allowed Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.315 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.496 ' SD ' ' HA ' ' B' ' 59' ' ' ASN . 1.7 pmm? -170.21 -58.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.406 0.282 . . . . 0.0 110.907 171.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . 0.417 ' N ' ' HG2' ' B' ' 87' ' ' MET . 14.2 t80 -130.27 81.25 2.0 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.38 0.536 . . . . 0.0 109.85 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.721 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.3 mp -99.41 120.5 48.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.731 178.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -106.35 176.44 5.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.372 0.606 . . . . 0.0 110.442 176.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.472 HD11 HG22 ' B' ' 16' ' ' VAL . 30.4 mm -151.87 116.3 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.569 -174.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 40.6 pttt -168.05 159.48 11.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.094 0.473 . . . . 0.0 111.943 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.626 ' NE2' ' H ' ' B' ' 93' ' ' GLN . 0.7 OUTLIER -83.27 152.31 25.22 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.014 172.297 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.514 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.4 pt . . . . . 0 C--N 1.311 -1.066 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.179 -171.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 121.276 0.56 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -85.39 98.67 10.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.112 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . 0.402 ' HA ' ' HG ' ' B' ' 6' ' ' LEU . 0.5 OUTLIER -66.8 -26.44 66.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.339 -175.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -76.2 -19.16 58.66 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.016 0.436 . . . . 0.0 110.607 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.2 17.14 23.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.531 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.402 ' HG ' ' HA ' ' B' ' 3' ' ' GLN . 78.4 mt -64.17 -8.32 11.96 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -56.52 -55.14 37.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.984 174.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -94.99 -27.69 15.52 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.404 0.621 . . . . 0.0 110.881 176.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -80.37 67.4 6.2 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.827 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -68.61 142.63 55.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.497 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -41.58 -40.48 1.89 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.54 ' O ' HG23 ' B' ' 16' ' ' VAL . 31.8 m -74.02 -20.95 60.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.212 -172.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.479 HG22 ' SD ' ' B' ' 31' ' ' MET . 10.7 mm -58.85 -44.31 90.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 121.933 0.873 . . . . 0.0 109.284 175.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.9 -36.07 72.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.051 -176.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 19.4 t -63.81 -44.9 91.92 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.098 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.54 HG23 ' O ' ' B' ' 12' ' ' SER . 70.3 t -57.29 -47.62 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.802 0.334 . . . . 0.0 110.457 176.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' B' ' 29' ' ' LEU . 2.4 t-20 -54.21 -50.56 66.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.864 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.09 -38.74 72.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.215 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -60.17 -52.13 66.65 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.514 0.673 . . . . 0.0 111.496 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.591 HD22 HG11 ' B' ' 72' ' ' VAL . 77.3 mt -75.5 -12.75 60.3 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.026 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -118.32 79.48 1.38 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.204 0.526 . . . . 0.0 111.253 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.499 ' HD3' ' OH ' ' B' ' 49' ' ' TYR . 30.1 mtpp -134.76 30.46 3.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.141 0.496 . . . . 0.0 110.667 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.17 45.18 1.91 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.1 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.52 ' HD2' ' OG ' ' B' ' 48' ' ' SER . 12.7 mmtp -90.4 -145.55 0.18 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' B' ' 45' ' ' TYR . . . -74.96 -146.24 1.28 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.74 173.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' B' ' 41' ' ' SER . 2.6 mtmp? -90.35 110.69 21.76 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -177.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 12.5 tp -158.75 134.33 8.72 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.611 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 74.0 p -131.24 98.77 4.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.041 0.448 . . . . 0.0 111.195 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.487 HD23 ' HB2' ' B' ' 38' ' ' ALA . 31.6 mt -83.47 151.39 25.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.416 0.627 . . . . 0.0 111.043 -177.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 54.3 m -148.43 144.69 27.6 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.624 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . 0.479 ' SD ' HG22 ' B' ' 13' ' ' ILE . 57.8 mtm -109.0 130.45 55.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.92 0.391 . . . . 0.0 111.094 -173.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 2.9 t-20 -137.97 60.12 1.63 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.362 176.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 51.96 -96.95 0.02 OUTLIER Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.232 -0.894 . . . . 0.0 113.433 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -78.92 -0.58 31.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.726 0.298 . . . . 0.0 111.415 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' B' ' 32' ' ' ASN . 37.7 mt-30 -125.32 148.9 48.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.805 0.812 . . . . 0.0 111.441 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' B' ' 36' ' ' LEU . 1.3 tm? -128.7 106.84 9.21 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.383 -1.28 . . . . 0.0 107.612 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -107.38 149.21 28.13 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.521 -170.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -170.23 151.61 3.92 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.067 0.229 . . . . 0.0 111.461 -177.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 3.3 p -120.9 138.18 54.23 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 168.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.618 ' CB ' ' HA3' ' B' ' 73' ' ' GLY . 29.6 t -148.26 154.54 40.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.272 0.558 . . . . 0.0 111.431 -170.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.499 ' HB3' ' HE3' ' B' ' 26' ' ' LYS . 47.5 t -144.0 155.51 44.05 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.086 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -90.32 -6.3 55.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.845 -169.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.1 -20.47 65.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.222 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.446 ' O ' ' HA2' ' B' ' 25' ' ' GLY . . . -106.27 -4.21 38.12 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.471 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.636 ' O ' ' HA3' ' B' ' 25' ' ' GLY . 0.0 OUTLIER 78.48 -168.83 0.05 OUTLIER 'General case' 0 C--N 1.342 0.248 0 C-N-CA 123.65 0.78 . . . . 0.0 112.506 179.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.47 46.56 0.83 Allowed Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 167.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -44.73 -69.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.252 0.621 . . . . 0.0 110.567 -174.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.52 ' OG ' ' HD2' ' B' ' 24' ' ' LYS . 9.5 m 60.95 -88.58 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.666 172.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.499 ' OH ' ' HD3' ' B' ' 22' ' ' LYS . 59.3 m-85 -140.56 69.42 1.35 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -173.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 51.95 -94.82 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.369 -176.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -156.28 109.82 2.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.522 -0.763 . . . . 0.0 108.942 171.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 59.3 mttm -141.43 142.9 33.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.072 -175.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.563 HD22 HG13 ' B' ' 94' ' ' ILE . 1.0 OUTLIER -114.27 124.32 51.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.307 0.575 . . . . 0.0 111.856 -176.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.635 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 17.0 p-90 -133.88 171.68 13.84 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.948 174.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.5 143.04 14.35 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.585 -175.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.655 HD12 ' CD2' ' B' ' 64' ' ' TYR . 22.3 mt -108.49 143.33 19.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 173.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 46.8 m-85 -125.58 143.06 51.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.65 -174.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.576 HG13 ' ND2' ' B' ' 59' ' ' ASN . 9.6 p -128.79 143.41 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.576 ' ND2' HG13 ' B' ' 58' ' ' VAL . 2.0 m-80 59.07 14.4 3.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -171.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.35 -1.56 82.33 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.628 -176.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' B' ' 58' ' ' VAL . 13.5 mt-10 -105.12 160.03 15.38 Favored 'General case' 0 C--O 1.192 -1.973 0 C-N-CA 123.887 0.875 . . . . 0.0 109.268 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.604 ' HE2' ' CE2' ' B' ' 57' ' ' PHE . 1.2 tttm -61.89 164.08 6.86 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 118.233 0.469 . . . . 0.0 110.766 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.408 ' O ' HD12 ' B' ' 79' ' ' ILE . 0.0 OUTLIER -156.53 0.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.17 164.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.715 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -157.67 131.96 8.29 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.209 -0.597 . . . . 0.0 111.101 -173.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 29.6 m -142.85 119.0 10.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.208 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.54 ' CB ' HD13 ' B' ' 75' ' ' ILE . 25.4 p90 -171.29 156.41 4.63 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.058 0.933 . . . . 0.0 112.646 -172.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 8.2 m120 -100.76 150.78 22.43 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.214 167.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' B' ' 48' ' ' SER . 36.3 mm-40 -58.73 -40.15 82.93 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.153 0.501 . . . . 0.0 110.92 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -65.01 -17.64 64.61 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.63 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 4.9 t -78.74 -0.59 30.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.603 178.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.444 ' O ' HG13 ' B' ' 75' ' ' ILE . 32.5 p 56.69 97.57 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.721 1.208 . . . . 0.0 112.093 176.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.651 ' HA ' HD12 ' B' ' 75' ' ' ILE . 2.5 m -57.96 -22.42 18.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.716 -170.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . 0.618 ' HA3' ' CB ' ' B' ' 40' ' ' SER . . . -62.03 -47.94 86.63 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.477 -178.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 77.2 m-20 -66.8 -37.73 85.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.451 0.643 . . . . 0.0 109.825 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.651 HD12 ' HA ' ' B' ' 72' ' ' VAL . 3.0 mt -67.06 -42.42 88.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.131 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 30.8 t -51.02 -39.93 56.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.54 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' B' ' 74' ' ' ASN . 0.7 OUTLIER -56.77 -40.67 76.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.887 176.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.78 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 24.0 m-20 -75.47 -40.67 57.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.124 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.715 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.9 mm -63.32 -32.14 55.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.325 0.583 . . . . 0.0 111.261 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.22 -11.03 56.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.593 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.78 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 20.4 pttp -95.93 3.12 53.82 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.543 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' B' ' 79' ' ' ILE . 24.2 mt -85.94 2.72 45.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.173 -176.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 52.66 62.21 2.8 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -169.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . . 62.1 mt -53.57 151.3 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.18 -174.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -125.08 176.19 6.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.403 176.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -139.36 112.75 0.86 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 173.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.414 ' HG3' ' N ' ' B' ' 88' ' ' TYR . 8.2 tpt -153.7 -82.58 0.08 Allowed 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 117.024 0.412 . . . . 0.0 110.365 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . 0.414 ' N ' ' HG3' ' B' ' 87' ' ' MET . 23.2 t80 -109.08 94.68 5.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.646 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 34.0 mm -98.94 122.63 50.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.037 -173.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.572 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 54.1 mm-40 -116.54 148.21 41.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.428 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.635 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 77.9 mt -127.89 127.74 68.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.592 176.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.504 ' HE3' ' CE1' ' B' ' 57' ' ' PHE . 14.3 pttp -174.53 152.46 1.69 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.03 0.443 . . . . 0.0 111.476 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.538 ' NE2' ' H ' ' B' ' 93' ' ' GLN . 0.5 OUTLIER -80.09 144.44 33.12 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.234 -179.47 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.563 HG13 HD22 ' B' ' 53' ' ' ASN . 4.4 pt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.197 -174.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 47.7 t30 70.39 -58.97 0.53 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.525 0.73 . . . . 0.0 111.755 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -72.85 -2.92 22.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.813 0.34 . . . . 0.0 111.712 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -84.95 -36.63 21.26 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.07 0.462 . . . . 0.0 109.781 177.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.93 60.37 4.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.414 -177.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 92.8 mt -96.68 21.06 9.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.379 177.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' B' ' 10' ' ' MET . 29.9 mt-10 -65.24 -56.65 11.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.968 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -80.4 -1.77 42.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.219 0.533 . . . . 0.0 111.213 -178.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -128.86 57.84 1.61 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.705 177.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' B' ' 7' ' ' GLU . 85.1 mmm -59.26 139.26 57.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.182 -175.287 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . 0.421 ' HA ' ' CD1' ' B' ' 13' ' ' ILE . 83.0 m-20 -46.12 -10.81 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.046 1.738 . . . . 0.0 114.956 -178.355 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.434 ' HA ' HG23 ' B' ' 16' ' ' VAL . 32.7 t -56.58 -15.49 4.47 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 122.842 0.457 . . . . 0.0 111.596 177.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.459 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.3 OUTLIER -50.68 -59.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-O 121.411 0.624 . . . . 0.0 111.27 -176.254 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -106.44 -49.11 3.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.015 -176.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 5.9 m -55.93 -53.45 56.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.825 -173.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.434 HG23 ' HA ' ' B' ' 12' ' ' SER . 80.2 t -72.8 -33.11 42.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.918 -177.019 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.655 ' HA ' HD12 ' B' ' 29' ' ' LEU . 0.2 OUTLIER -59.79 -42.82 94.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 175.953 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.14 -37.88 61.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.056 178.406 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' B' ' 15' ' ' SER . 0.1 OUTLIER -61.36 -40.83 95.74 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 122.9 0.48 . . . . 0.0 111.606 -179.717 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.528 HD21 ' HZ2' ' B' ' 54' ' ' TRP . 71.3 mt -80.03 -31.7 39.55 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.845 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -96.47 53.19 1.28 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.356 0.598 . . . . 0.0 110.44 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' B' ' 19' ' ' LYS . 30.6 mtpp -89.91 -51.95 5.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.139 0.495 . . . . 0.0 110.358 177.197 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.42 68.14 0.22 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 -178.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -124.28 -156.82 0.74 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.502 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -72.56 -171.08 17.68 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 175.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.714 ' O ' ' HA ' ' B' ' 40' ' ' SER . 0.0 OUTLIER -72.97 88.74 1.39 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 117.702 0.751 . . . . 0.0 109.345 176.236 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' B' ' 39' ' ' THR . 15.9 tp -105.94 127.4 53.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.035 -172.091 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 63.4 m -125.89 114.67 18.84 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.048 178.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.655 HD12 ' HA ' ' B' ' 17' ' ' ASN . 24.7 mt -89.26 156.18 18.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.439 0.638 . . . . 0.0 110.776 178.119 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.579 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 63.7 m -145.33 153.74 41.58 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.691 172.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 80.8 mtp -120.79 141.29 50.65 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.195 0.522 . . . . 0.0 111.857 -176.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -145.12 113.15 6.45 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.56 -104.55 1.09 Allowed Glycine 0 CA--C 1.507 -0.419 0 C-N-CA 119.465 -1.35 . . . . 0.0 109.769 -169.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -132.86 25.0 4.32 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.604 ' HG2' ' HB ' ' B' ' 84' ' ' ILE . 22.5 mt-30 -80.01 156.71 27.03 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.227 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.442 HD21 HD22 ' B' ' 29' ' ' LEU . 4.9 tt -110.31 110.31 21.08 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.977 -1.011 . . . . 0.0 108.514 173.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.579 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 22.4 mmmt -106.22 148.36 28.01 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.393 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -161.64 146.04 12.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 10.4 p -129.22 144.29 51.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.146 172.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.714 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 46.8 m -154.84 152.85 30.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.404 0.621 . . . . 0.0 112.292 -177.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.617 ' HB2' ' CD ' ' B' ' 26' ' ' LYS . 1.3 m -118.89 152.2 36.72 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 167.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . 0.527 ' HA ' ' HB3' ' B' ' 45' ' ' TYR . 15.0 m120 -112.56 35.16 3.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.134 0.493 . . . . 0.0 111.821 -165.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.81 -61.37 1.8 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.801 0.81 . . . . 0.0 110.414 173.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.96 62.23 0.43 Allowed Glycine 0 C--N 1.311 -0.812 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 174.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.601 ' HB2' HG21 ' B' ' 71' ' ' THR . 41.6 p90 -71.54 -149.68 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -173.112 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.23 92.16 1.37 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.563 -177.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.466 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -105.32 -57.2 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.029 0.442 . . . . 0.0 110.28 179.476 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -39.37 -58.72 1.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.318 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -91.3 101.3 14.0 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.081 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -76.7 -82.08 0.08 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.351 -176.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -110.99 108.75 18.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.876 0.846 . . . . 0.0 112.068 -176.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 55.4 mttm -141.23 121.59 14.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 165.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -110.12 121.3 44.93 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.61 0.719 . . . . 0.0 111.556 -174.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.589 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 28.7 p-90 -141.68 162.06 36.4 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.492 175.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.15 147.14 16.82 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.864 -173.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.614 HD12 ' CD2' ' B' ' 64' ' ' TYR . 29.0 mt -107.08 148.31 11.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 170.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.73 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 75.7 m-85 -127.61 144.46 51.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.263 -171.255 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.533 HG12 ' HB ' ' B' ' 63' ' ' VAL . 7.9 p -131.41 135.37 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.532 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.0 m-80 61.85 10.13 3.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.016 -176.061 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.87 -2.43 55.57 Favored Glycine 0 N--CA 1.433 -1.503 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 -177.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -107.43 176.93 4.99 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.4 tppp? -63.27 161.22 14.21 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 173.076 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.533 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.8 p -153.17 -13.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.946 0.403 . . . . 0.0 110.376 168.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.718 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.2 OUTLIER -160.07 128.71 4.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.016 0.436 . . . . 0.0 110.536 -172.66 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 55.0 m -139.74 123.99 17.93 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.391 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.503 ' CB ' HD13 ' B' ' 75' ' ' ILE . 19.9 p90 -171.46 157.49 4.88 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 122.012 0.91 . . . . 0.0 112.023 -172.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 11.4 m120 -105.4 162.46 13.43 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 113.474 -1.694 . . . . 0.0 110.193 172.226 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -61.38 -48.11 82.73 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -174.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.567 ' O ' HG23 ' B' ' 71' ' ' THR . 41.7 ttmt -61.88 -24.52 66.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.951 0.405 . . . . 0.0 112.036 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 11.5 t -67.09 -20.46 65.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.285 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.601 HG21 ' HB2' ' B' ' 45' ' ' TYR . 9.9 p 60.56 111.72 0.02 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.633 1.173 . . . . 0.0 112.113 175.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.505 ' HA ' HD12 ' B' ' 75' ' ' ILE . 1.7 m -61.18 -28.42 43.74 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.961 -167.252 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.11 -49.08 57.29 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.179 -176.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 58.1 m-80 -67.72 -42.79 81.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.622 0.725 . . . . 0.0 110.221 179.037 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' B' ' 72' ' ' VAL . 1.8 mt -64.21 -41.75 93.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.601 -176.099 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 74.5 m -53.69 -36.01 61.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.344 179.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' B' ' 74' ' ' ASN . 39.0 m-20 -57.69 -38.01 74.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 120.989 0.423 . . . . 0.0 111.066 177.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.557 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 13.9 m-20 -73.83 -51.3 16.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.741 174.572 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.718 HG13 ' CE1' ' B' ' 64' ' ' TYR . 44.5 mm -56.08 -35.52 41.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.469 -178.373 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -11.28 59.68 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.557 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 15.5 ptmt -92.19 4.58 52.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.373 0.606 . . . . 0.0 110.135 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -81.47 -1.51 46.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.411 -175.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 52.07 47.28 25.08 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.702 0.763 . . . . 0.0 109.66 -173.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.623 HD11 HG22 ' B' ' 79' ' ' ILE . 94.2 mt -55.12 127.69 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.682 -1.144 . . . . 0.0 113.233 -171.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -92.1 -164.35 1.17 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.582 178.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -151.16 119.69 1.02 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.13 -178.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 22.8 ptm -176.76 -56.73 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.616 0.208 . . . . 0.0 111.472 177.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -128.1 80.58 1.97 Allowed 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.816 -0.552 . . . . 0.0 110.013 177.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.73 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.3 mp -98.53 128.86 49.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.37 175.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -114.66 171.37 7.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.082 0.467 . . . . 0.0 110.058 175.226 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.589 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 38.9 mm -142.15 109.55 2.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.594 -178.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -168.27 151.87 5.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.426 0.632 . . . . 0.0 112.344 -174.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 2.0 pp0? -61.95 148.21 44.44 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.637 172.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' B' ' 54' ' ' TRP . 2.0 pt . . . . . 0 C--N 1.311 -1.075 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.028 -176.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 34.7 t70 . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 121.252 0.548 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -147.19 158.11 43.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.205 0.526 . . . . 0.0 110.488 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -66.55 -22.33 66.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.542 -172.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' B' ' 7' ' ' GLU . 28.2 tptp -68.72 -27.69 66.17 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 120.902 0.382 . . . . 0.0 111.225 -177.498 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.22 2.24 56.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.253 0.549 . . . . 0.0 110.288 178.306 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt -117.96 23.28 11.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.043 -178.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' B' ' 4' ' ' LYS . 32.7 mt-10 -61.28 -52.44 64.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.862 178.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -87.61 -21.06 25.56 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.238 0.542 . . . . 0.0 111.508 -179.418 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -105.17 93.26 4.59 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.569 177.111 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . 0.487 ' HG3' HD21 ' B' ' 34' ' ' ASN . 85.8 mmm -62.41 129.67 41.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.46 0.648 . . . . 0.0 111.94 -174.074 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -77.02 -15.77 59.52 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.254 175.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.447 ' HA ' HD11 ' B' ' 91' ' ' ILE . 11.6 m -65.94 -10.28 37.55 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.35 -176.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.445 HG12 ' O ' ' B' ' 10' ' ' MET . 27.9 mm -58.48 -59.81 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.508 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -106.74 -36.36 6.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.644 -175.301 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.607 ' O ' ' HB2' ' B' ' 19' ' ' LYS . 22.5 t -56.98 -41.83 79.1 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.907 -171.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.57 -38.95 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.85 0.357 . . . . 0.0 111.089 -176.251 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.411 ' ND2' HD13 ' B' ' 29' ' ' LEU . 34.0 t-20 -59.13 -55.14 38.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.102 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.12 -40.11 82.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.516 -178.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' B' ' 15' ' ' SER . 8.5 tmtm? -49.21 -67.33 0.27 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.652 0.781 . . . . 0.0 111.71 177.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.585 ' C ' ' H ' ' B' ' 22' ' ' LYS . 16.2 mt -51.88 -67.01 0.29 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.729 175.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . 0.449 ' OD1' ' HE2' ' B' ' 49' ' ' TYR . 2.8 t-20 65.25 -19.4 0.09 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.935 0.894 . . . . 0.0 110.609 -168.301 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.585 ' H ' ' C ' ' B' ' 20' ' ' LEU . 31.0 mtpp 83.37 -34.62 0.07 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 159.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.673 ' HA2' ' CE1' ' B' ' 49' ' ' TYR . . . 95.93 79.72 1.48 Allowed Glycine 0 C--O 1.208 -1.521 0 C-N-CA 119.074 -1.536 . . . . 0.0 110.078 -166.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 64.62 -59.75 0.22 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 173.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' B' ' 23' ' ' GLY . . . -33.05 108.27 0.03 OUTLIER Glycine 0 CA--C 1.52 0.354 0 O-C-N 124.071 0.857 . . . . 0.0 113.892 179.08 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.5 ' HE3' ' HB2' ' B' ' 41' ' ' SER . 0.1 OUTLIER -77.84 153.18 32.97 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.825 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.465 HD22 ' CD ' ' B' ' 22' ' ' LYS . 1.3 pt? -163.45 170.28 17.61 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 118.291 0.496 . . . . 0.0 111.5 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 20.7 m -127.87 114.0 16.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.694 178.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.411 HD13 ' ND2' ' B' ' 17' ' ' ASN . 9.7 mp -83.87 158.63 21.57 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 122.038 0.923 . . . . 0.0 112.408 -179.003 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.9 p -150.4 154.8 38.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.409 178.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 29.7 mtt -122.82 138.55 54.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.654 0.264 . . . . 0.0 111.628 -168.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -152.09 108.09 3.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.458 177.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.45 -92.87 0.52 Allowed Glycine 0 CA--C 1.505 -0.534 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -176.146 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.502 ' HB2' ' CA ' ' B' ' 86' ' ' GLY . 0.4 OUTLIER -135.7 8.09 3.29 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.574 0.702 . . . . 0.0 109.311 171.585 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.525 ' OE1' ' HA ' ' B' ' 83' ' ' ASN . 49.6 mt-30 -77.94 149.82 34.11 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.23 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' B' ' 36' ' ' LEU . 12.8 tp -125.84 93.28 3.79 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.206 177.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -96.52 150.61 20.44 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.695 -171.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -165.52 158.34 15.66 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.249 -0.58 . . . . 0.0 112.219 -174.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 14.3 p -124.84 137.62 54.29 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 18.2 t -121.16 154.68 35.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.078 0.466 . . . . 0.0 111.484 -170.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.5 ' HB2' ' HE3' ' B' ' 26' ' ' LYS . 14.9 m -121.92 158.53 28.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.606 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -82.59 54.24 2.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.623 -172.223 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.75 22.44 0.6 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.973 177.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.518 ' O ' HD11 ' B' ' 47' ' ' ILE . . . 132.56 -47.73 1.0 Allowed Glycine 0 C--O 1.222 -0.615 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.992 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.444 ' O ' HG12 ' B' ' 47' ' ' ILE . 1.2 p90 59.15 177.38 0.08 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.455 1.102 . . . . 0.0 113.224 177.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.443 ' C ' HD13 ' B' ' 47' ' ' ILE . . . -47.64 92.03 0.01 OUTLIER Glycine 0 C--N 1.336 0.533 0 N-CA-C 114.864 0.706 . . . . 0.0 114.864 -176.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.518 HD11 ' O ' ' B' ' 44' ' ' GLY . 6.5 mm -109.8 -71.8 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.575 0.702 . . . . 0.0 110.625 175.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.2 p -97.45 -126.9 0.15 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.543 -178.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.673 ' CE1' ' HA2' ' B' ' 23' ' ' GLY . 7.1 m-85 63.91 20.29 12.14 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.206 0.526 . . . . 0.0 110.32 178.074 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 52.7 -161.17 0.11 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.621 -176.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -109.21 108.94 19.75 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.748 0.785 . . . . 0.0 109.435 173.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.509 ' HE3' ' O ' ' B' ' 49' ' ' TYR . 43.8 mttt -105.13 120.79 42.39 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -115.15 113.93 24.61 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.522 ' HA ' HG12 ' B' ' 94' ' ' ILE . 36.1 p-90 -148.04 164.93 32.32 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.3 -176.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -126.55 152.75 18.5 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.835 -176.019 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.429 ' O ' HG12 ' B' ' 63' ' ' VAL . 10.3 mt -102.18 146.81 9.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 169.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.7 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 83.0 m-85 -125.94 143.75 50.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.482 -172.011 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.521 HG13 ' ND2' ' B' ' 59' ' ' ASN . 10.3 p -130.7 135.24 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.381 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.521 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.7 m-80 65.74 4.62 2.97 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.72 -176.179 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.03 -0.17 51.44 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.019 -176.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -108.47 176.06 5.25 Favored 'General case' 0 C--O 1.203 -1.355 0 C-N-CA 123.346 0.658 . . . . 0.0 109.46 -179.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.496 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 5.5 tppp? -62.44 161.2 12.13 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 173.121 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.512 ' HB ' HG12 ' B' ' 58' ' ' VAL . 9.3 p -146.58 -22.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 166.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -162.21 142.5 10.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.475 -175.457 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.446 HG23 ' CD1' ' B' ' 94' ' ' ILE . 28.1 m -136.07 127.25 28.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.775 179.325 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.643 ' CD2' HG21 ' B' ' 75' ' ' ILE . 21.5 p90 -163.04 -166.95 1.37 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.07 0.462 . . . . 0.0 111.032 -177.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.74 ' O ' ' HB3' ' B' ' 70' ' ' SER . 22.9 t-20 -153.95 158.52 40.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.816 -173.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . 0.452 ' CD ' ' HD2' ' B' ' 52' ' ' LYS . 8.0 mm-40 -60.28 -56.62 19.24 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.385 0.612 . . . . 0.0 111.234 -178.328 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.583 ' C ' ' H ' ' B' ' 71' ' ' THR . 37.2 ttpt -65.8 -11.69 48.13 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.687 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . 0.74 ' HB3' ' O ' ' B' ' 67' ' ' ASN . 9.7 t -67.22 2.22 1.72 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.227 1.013 . . . . 0.0 109.283 170.253 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.583 ' H ' ' C ' ' B' ' 69' ' ' LYS . 37.6 p 59.61 80.28 0.2 Allowed 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.02 -1.9 . . . . 0.0 110.56 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.797 ' HA ' ' CG1' ' B' ' 75' ' ' ILE . 17.9 m -68.24 -4.67 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.772 -170.202 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.43 -37.18 94.22 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 119.806 -1.188 . . . . 0.0 110.201 174.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' B' ' 77' ' ' ASN . 42.7 m-20 -80.28 -36.21 34.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 176.219 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.797 ' CG1' ' HA ' ' B' ' 72' ' ' VAL . 24.2 mm -51.64 -54.27 13.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.458 176.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 58.8 m -55.55 -37.44 67.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.124 177.512 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . 0.465 ' HA ' ' ND2' ' B' ' 80' ' ' ASN . 49.0 m-20 -64.76 -38.67 91.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.205 0.526 . . . . 0.0 111.044 177.342 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.71 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 5.9 m-20 -65.78 -40.58 92.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.899 176.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.523 HG13 ' O ' ' B' ' 75' ' ' ILE . 63.8 mt -57.68 -30.75 37.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.121 0.486 . . . . 0.0 110.869 178.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' B' ' 77' ' ' ASN . 82.0 m-20 -62.02 -22.48 65.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.46 176.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.71 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 12.1 ptmm? -105.44 -11.47 16.41 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -175.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.24 -23.87 67.46 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.801 0.334 . . . . 0.0 110.863 -175.136 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . 0.525 ' HA ' ' OE1' ' B' ' 35' ' ' GLN . 23.6 t-20 45.75 62.79 2.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.059 -170.334 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.456 ' HB ' ' HG2' ' B' ' 35' ' ' GLN . 72.7 mt -64.5 142.66 16.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.125 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.44 ' H ' HG21 ' B' ' 58' ' ' VAL . 66.2 mttm -86.64 178.37 7.07 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.822 178.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.502 ' CA ' ' HB2' ' B' ' 34' ' ' ASN . . . -135.02 114.44 1.25 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 119.73 -1.224 . . . . 0.0 113.318 -175.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.497 ' HG3' ' HA ' ' B' ' 59' ' ' ASN . 22.8 ptp -175.07 -55.2 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.49 0.316 . . . . 0.0 110.795 177.001 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -139.6 80.7 1.79 Allowed 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.557 -0.714 . . . . 0.0 110.123 174.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.7 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.0 mp -94.63 126.67 47.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.061 174.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -109.32 175.63 5.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.26 0.552 . . . . 0.0 110.433 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.447 HD11 ' HA ' ' B' ' 12' ' ' SER . 5.7 mt -147.75 102.0 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.676 -177.246 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 45.1 pttt -164.42 165.77 21.21 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.266 -173.48 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.4 OUTLIER -73.84 159.49 32.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.781 178.998 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.522 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.0 pt . . . . . 0 C--N 1.31 -1.124 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.714 -177.176 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -70.49 -24.54 62.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.863 178.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -70.86 -11.93 61.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.301 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' B' ' 4' ' ' LYS . 6.5 tmtm? -73.22 -27.16 61.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.36 91.61 6.84 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.534 178.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.47 -5.15 43.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.105 -178.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -72.85 -43.08 63.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.493 174.491 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -81.76 -55.02 4.9 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.815 0.817 . . . . 0.0 110.222 175.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -88.69 75.31 8.25 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.577 178.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . 0.452 ' SD ' ' HA ' ' B' ' 88' ' ' TYR . 80.6 mtp -74.01 179.68 4.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.219 -178.15 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -64.16 -32.03 73.45 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.128 0.49 . . . . 0.0 110.53 176.486 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.538 ' O ' HG23 ' B' ' 16' ' ' VAL . 13.3 m -68.81 -20.89 64.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.847 -171.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 mm -51.22 -52.4 19.12 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 121.901 0.857 . . . . 0.0 110.672 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -75.75 -33.76 60.24 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.5 -175.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -64.59 -41.08 96.48 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.878 179.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.538 HG23 ' O ' ' B' ' 12' ' ' SER . 94.4 t -61.49 -45.22 99.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.963 0.411 . . . . 0.0 110.163 178.142 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.61 -42.14 99.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.524 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -33.9 68.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.866 0.365 . . . . 0.0 111.359 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -68.17 -48.79 64.34 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 123.348 0.659 . . . . 0.0 111.952 -178.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.445 HD22 HG11 ' B' ' 72' ' ' VAL . 63.6 mt -77.81 -7.95 57.34 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.383 -176.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . 0.426 ' CG ' ' H ' ' B' ' 22' ' ' LYS . 61.2 t30 -99.73 -161.87 0.9 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.217 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.426 ' H ' ' CG ' ' B' ' 21' ' ' ASN . 53.4 mtpt 52.2 37.03 20.79 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.749 -175.014 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -134.17 41.28 1.48 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.55 -174.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.411 ' HD2' HD11 ' B' ' 47' ' ' ILE . 67.3 mttm 71.2 -67.05 0.27 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.04 0.536 . . . . 0.0 111.843 174.124 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' B' ' 45' ' ' TYR . . . -55.92 121.66 24.27 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 174.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' B' ' 40' ' ' SER . 43.2 mttm -61.5 135.41 57.66 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.194 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' B' ' 39' ' ' THR . 22.2 tp -158.94 110.93 2.17 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 121.175 0.512 . . . . 0.0 110.499 -176.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 55.2 m -116.32 114.08 23.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.772 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 9.2 mp -95.55 163.42 13.22 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.85 0.833 . . . . 0.0 111.701 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.418 ' OG ' ' HB2' ' B' ' 37' ' ' LYS . 1.4 p -157.81 147.38 19.98 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.104 171.133 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . . . . . . . . . 66.0 mtp -130.02 117.06 19.46 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.512 0.673 . . . . 0.0 110.943 -177.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -98.83 61.57 1.3 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.316 -178.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.41 -88.61 0.13 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.471 -178.071 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' B' ' 84' ' ' ILE . 2.9 m-20 -94.0 16.48 14.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.786 0.327 . . . . 0.0 111.008 -177.397 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -132.12 151.24 51.89 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.261 0.553 . . . . 0.0 111.501 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tt -124.75 112.68 17.01 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.681 176.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.418 ' HB2' ' OG ' ' B' ' 30' ' ' SER . 1.5 mtpm? -112.31 149.11 32.86 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -176.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' B' ' 28' ' ' SER . . . -167.73 142.05 3.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.924 0.392 . . . . 0.0 111.759 -178.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 1.7 p -119.55 142.2 48.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.354 173.377 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' B' ' 26' ' ' LYS . 3.5 p -140.86 156.14 46.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.235 0.541 . . . . 0.0 112.39 -172.174 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 15.7 m -141.27 158.69 43.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.06 176.063 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -95.25 46.47 1.11 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.531 0.681 . . . . 0.0 110.768 -167.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.61 23.85 0.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.759 -1.11 . . . . 0.0 112.533 178.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.31 -41.01 1.53 Allowed Glycine 0 CA--C 1.51 -0.252 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.487 ' HA ' ' HA3' ' B' ' 25' ' ' GLY . 21.8 p90 51.26 -165.31 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.92 1.288 . . . . 0.0 114.138 173.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' B' ' 68' ' ' GLU . . . -75.95 110.43 3.04 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.867 -175.179 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.411 HD11 ' HD2' ' B' ' 24' ' ' LYS . 0.2 OUTLIER -120.65 -69.19 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-O 121.243 0.544 . . . . 0.0 111.233 177.315 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 66.9 m -119.78 -75.26 0.59 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.81 -170.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.454 ' O ' ' HE3' ' B' ' 52' ' ' LYS . 0.1 OUTLIER -68.17 -22.27 64.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.522 0.677 . . . . 0.0 109.875 -176.899 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.496 ' CD ' ' H ' ' B' ' 50' ' ' GLU . 22.1 mp0 -73.25 -62.6 1.42 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.996 174.171 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' B' ' 68' ' ' GLU . 6.9 t70 -44.92 108.23 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.242 -1.799 . . . . 0.0 112.497 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.704 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 98.7 mttt -150.12 161.15 42.93 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.047 176.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.407 ' HB3' ' OD1' ' B' ' 67' ' ' ASN . 3.5 p-10 -109.45 119.64 40.05 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.452 0.644 . . . . 0.0 111.277 -178.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.561 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 6.4 p-90 -154.62 171.62 19.18 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.647 176.43 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -130.5 141.58 12.82 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.666 -178.061 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.679 HD12 ' CD2' ' B' ' 64' ' ' TYR . 17.7 mt -104.72 147.64 10.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 172.286 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.75 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 71.7 m-85 -127.05 143.62 51.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 -171.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.579 HG12 ' HB ' ' B' ' 63' ' ' VAL . 8.9 p -129.94 134.73 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.493 ' ND2' HG13 ' B' ' 58' ' ' VAL . 2.0 m-80 63.06 10.27 4.37 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.034 0.534 . . . . 0.0 109.885 -174.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.3 -1.7 64.79 Favored Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.099 -174.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -102.8 176.89 5.01 Favored 'General case' 0 C--O 1.207 -1.144 0 C-N-CA 123.558 0.743 . . . . 0.0 109.042 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' B' ' 63' ' ' VAL . 4.9 tppp? -66.69 161.24 23.86 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.395 0.543 . . . . 0.0 109.537 174.05 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.579 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.7 p -153.87 -13.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.196 0.522 . . . . 0.0 110.284 166.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.787 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.1 OUTLIER -160.87 140.12 10.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.247 -171.128 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 96.1 m -157.33 121.23 4.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.563 ' CB ' HD13 ' B' ' 75' ' ' ILE . 15.6 p90 -174.9 161.27 2.98 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.938 0.875 . . . . 0.0 111.855 -168.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.704 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 2.2 m120 -109.09 138.2 45.81 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.184 -1.826 . . . . 0.0 108.215 166.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' B' ' 51' ' ' ASP . 20.2 mp0 -61.91 -12.81 19.8 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.627 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -69.12 -29.79 67.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.394 0.616 . . . . 0.0 109.863 172.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 39.1 t -70.58 -16.46 62.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.822 173.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . . . . . . . . . 13.5 p 61.74 116.03 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.216 1.407 . . . . 0.0 112.095 178.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.565 ' HA ' HD12 ' B' ' 75' ' ' ILE . 3.0 m -59.85 -24.92 30.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.628 -169.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.93 -46.08 69.61 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.738 -178.555 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -72.66 -34.35 67.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.313 0.578 . . . . 0.0 110.436 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' B' ' 72' ' ' VAL . 1.7 mt -72.24 -45.85 59.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.968 -176.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 48.3 m -54.37 -33.08 58.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.53 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -53.13 -53.65 47.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.066 174.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' B' ' 81' ' ' LYS . 10.9 m-20 -69.57 -44.34 71.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.747 -179.407 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.787 HG13 ' CE1' ' B' ' 64' ' ' TYR . 49.2 mm -57.96 -32.19 42.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.348 0.594 . . . . 0.0 112.024 -178.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -65.15 -17.23 64.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.047 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' B' ' 78' ' ' ASP . 13.2 tppt? -91.63 -5.32 54.07 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.769 0.795 . . . . 0.0 109.917 -176.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.2 mm? -72.69 -12.59 61.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.354 -176.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 55.92 71.27 0.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.964 -168.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.457 ' O ' ' HB3' ' B' ' 34' ' ' ASN . 59.6 mt -64.52 157.8 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.437 -175.397 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -121.18 -175.51 3.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.183 175.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.02 113.44 0.75 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.661 175.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.82 -63.48 0.09 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.607 0.241 . . . . 0.0 111.02 -178.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . 0.452 ' HA ' ' SD ' ' B' ' 10' ' ' MET . 25.3 t80 -141.34 90.95 2.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.19 0.519 . . . . 0.0 109.892 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.75 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 2.1 mp -90.8 132.4 35.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.494 178.02 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -118.28 175.12 5.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.11 0.481 . . . . 0.0 110.496 177.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.561 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 82.1 mt -147.76 124.76 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.664 -176.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 41.5 pttt -177.57 160.46 1.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 0.0 111.209 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.541 ' HA ' ' HA ' ' B' ' 54' ' ' TRP . 0.9 OUTLIER -80.82 164.54 22.62 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.539 0.685 . . . . 0.0 110.958 177.45 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.522 HG12 ' HA ' ' B' ' 54' ' ' TRP . 3.4 pt . . . . . 0 C--N 1.309 -1.17 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.243 -173.307 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.752 0.311 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -94.86 148.26 22.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.831 -176.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -81.35 4.85 19.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -173.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -72.14 -61.49 1.77 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.384 0.611 . . . . 0.0 109.737 174.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.97 96.23 10.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.151 178.136 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.91 -21.68 66.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.712 -178.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -62.93 -49.16 75.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.552 175.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.99 -2.1 42.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.279 0.562 . . . . 0.0 110.796 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.611 ' HG2' ' H ' ' B' ' 11' ' ' ASN . 20.6 tt0 -92.47 -72.51 0.59 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.239 175.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 8.2 tmm? 61.53 6.73 1.58 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.744 0.783 . . . . 0.0 111.414 176.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . 0.611 ' H ' ' HG2' ' B' ' 9' ' ' GLN . 9.1 t30 -61.62 -43.4 98.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.815 -175.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 9.9 m -69.16 -15.45 63.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.216 0.532 . . . . 0.0 110.387 -172.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -75.19 -43.49 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.57 0.7 . . . . 0.0 110.448 178.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -71.66 -14.74 62.13 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.935 -175.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.63 ' O ' ' HG2' ' B' ' 19' ' ' LYS . 78.4 p -48.29 -40.53 25.25 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 123.444 0.465 . . . . 0.0 110.875 -179.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 49.8 t -69.61 -40.24 79.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.399 0.619 . . . . 0.0 110.166 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.943 HD21 HD11 ' B' ' 29' ' ' LEU . 7.6 t30 -64.83 -37.12 86.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.281 176.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.03 -29.27 69.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.275 174.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.63 ' HG2' ' O ' ' B' ' 15' ' ' SER . 24.6 mmmt -73.15 -11.6 60.59 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.183 0.516 . . . . 0.0 111.388 176.599 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.524 ' O ' ' HD3' ' B' ' 24' ' ' LYS . 39.7 mt -80.39 -18.59 48.49 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.663 0.744 . . . . 0.0 109.342 176.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . 0.475 ' OD1' ' HA ' ' B' ' 26' ' ' LYS . 62.9 t30 -92.39 58.19 3.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.985 -176.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -123.45 -91.85 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.492 178.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.16 34.64 5.24 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 177.223 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.604 ' HA ' ' C ' ' B' ' 45' ' ' TYR . 27.6 mtpt -133.07 -164.63 1.5 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.434 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.565 ' N ' ' HA ' ' B' ' 45' ' ' TYR . . . -64.07 145.14 49.51 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.329 -0.939 . . . . 0.0 110.996 178.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.554 ' CE ' ' HB2' ' B' ' 41' ' ' SER . 13.9 ttpt -80.5 136.34 36.28 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -174.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.441 ' HG ' ' CD1' ' B' ' 29' ' ' LEU . 19.3 tp -154.03 107.67 2.96 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.869 -178.079 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -110.18 103.89 12.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.213 -176.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.943 HD11 HD21 ' B' ' 17' ' ' ASN . 0.0 OUTLIER -82.02 156.92 24.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.827 0.822 . . . . 0.0 112.516 -177.702 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' B' ' 37' ' ' LYS . 53.9 m -129.8 144.11 51.14 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.355 -1.293 . . . . 0.0 107.517 164.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . 0.536 ' SD ' ' HA ' ' B' ' 11' ' ' ASN . 40.7 mtt -111.24 127.53 55.64 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.675 -167.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' B' ' 35' ' ' GLN . 3.1 t-20 -137.16 59.47 1.68 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.736 175.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 47.97 -93.68 0.01 OUTLIER Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.99 178.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.658 ' O ' ' HA ' ' B' ' 85' ' ' LYS . 8.1 p30 -79.76 4.89 14.98 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 122.592 0.357 . . . . 0.0 111.299 -176.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 18.5 mt-30 -129.82 144.56 51.37 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.592 0.711 . . . . 0.0 111.017 172.584 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.453 ' CB ' ' HB ' ' B' ' 84' ' ' ILE . 0.9 OUTLIER -118.34 105.22 11.51 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.184 175.549 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . 0.461 ' HB2' ' HB2' ' B' ' 30' ' ' SER . 0.0 OUTLIER -99.91 151.92 20.76 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -175.702 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.04 164.21 4.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.456 0.571 . . . . 0.0 112.498 -177.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' B' ' 27' ' ' LEU . 2.9 p -128.35 141.03 51.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.211 168.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 23.3 t -142.58 147.5 35.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.091 0.472 . . . . 0.0 111.615 -175.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.554 ' HB2' ' CE ' ' B' ' 26' ' ' LYS . 24.1 m -159.31 169.57 23.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.53 178.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' B' ' 44' ' ' GLY . 44.6 m-80 -91.73 49.18 1.53 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.102 -176.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.403 ' HB2' ' HE2' ' B' ' 26' ' ' LYS . . . -68.96 22.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.025 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.491 ' O ' ' HD1' ' B' ' 45' ' ' TYR . . . 161.43 -63.37 0.28 Allowed Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.006 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.767 ' CD2' HG21 ' B' ' 71' ' ' THR . 0.0 OUTLIER 70.29 161.86 0.23 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.955 0.902 . . . . 0.0 111.852 -179.489 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.567 ' H ' ' CG2' ' B' ' 71' ' ' THR . . . -63.18 113.1 5.56 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 116.157 -0.474 . . . . 0.0 114.043 -166.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . . . . . . . . . 11.4 mm -95.76 -67.61 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.273 0.558 . . . . 0.0 110.604 177.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 59.3 m -67.12 -52.67 38.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.073 -176.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -42.27 124.41 2.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.334 -178.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -74.91 -172.68 1.67 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.282 177.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.66 108.09 14.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.471 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' B' ' 67' ' ' ASN . 50.0 mttm -139.69 130.57 26.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.442 -178.214 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -108.79 135.6 49.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.999 0.428 . . . . 0.0 111.551 -177.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.617 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 37.5 p-90 -154.49 169.26 24.21 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.947 175.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.8 152.81 21.44 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.702 -172.44 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.532 HD12 ' CD2' ' B' ' 64' ' ' TYR . 30.0 mt -113.31 142.63 25.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 173.302 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.617 ' CE1' ' HG3' ' B' ' 62' ' ' LYS . 58.9 m-85 -127.68 140.73 51.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.408 -171.427 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.464 HG13 ' ND2' ' B' ' 59' ' ' ASN . 10.8 p -123.77 134.47 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.464 ' ND2' HG13 ' B' ' 58' ' ' VAL . 3.4 m-80 63.46 4.57 1.79 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.254 0.622 . . . . 0.0 110.263 -176.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.56 -7.58 39.55 Favored Glycine 0 N--CA 1.438 -1.171 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.09 -174.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' B' ' 57' ' ' PHE . 33.1 mt-10 -98.54 175.87 5.86 Favored 'General case' 0 C--O 1.197 -1.708 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.043 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.617 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 14.4 ttmt -79.96 169.84 17.31 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 119.282 0.946 . . . . 0.0 109.929 176.323 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.2 -12.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.046 165.409 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.564 ' CE1' HG13 ' B' ' 79' ' ' ILE . 0.7 OUTLIER -159.67 123.93 3.84 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.791 -168.808 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.1 m -134.2 120.86 20.57 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.437 179.116 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.554 ' HB2' HD13 ' B' ' 75' ' ' ILE . 2.2 p90 -160.65 -178.63 7.0 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.563 1.173 . . . . 0.0 112.795 -174.529 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 16.3 t-20 -130.25 156.24 44.95 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.652 -176.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -70.41 -27.87 64.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.857 0.36 . . . . 0.0 110.985 -177.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.536 ' O ' HG23 ' B' ' 71' ' ' THR . 40.7 ttmt -86.6 -22.27 26.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.97 177.144 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 8.8 t -71.71 -20.29 61.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.397 173.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . 0.767 HG21 ' CD2' ' B' ' 45' ' ' TYR . 35.6 p 58.46 113.69 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.4 1.08 . . . . 0.0 113.759 168.073 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.473 HG12 ' CE2' ' B' ' 66' ' ' PHE . 1.8 m -59.53 -15.99 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.21 -168.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.03 -50.66 64.06 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.506 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -75.69 -35.1 60.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.553 0.692 . . . . 0.0 110.461 179.463 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' B' ' 66' ' ' PHE . 1.5 mt -74.66 -51.08 23.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.184 -171.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . . . . . . . . . 8.5 t -64.14 -26.8 68.69 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.256 -175.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -48.61 -48.93 38.91 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.925 0.869 . . . . 0.0 109.636 171.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.661 ' O ' ' HG2' ' B' ' 81' ' ' LYS . 0.3 OUTLIER -71.63 -42.15 67.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.315 177.514 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.564 HG13 ' CE1' ' B' ' 64' ' ' TYR . 36.0 mm -57.92 -33.75 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.029 0.442 . . . . 0.0 111.898 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.04 -21.91 61.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.067 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' B' ' 78' ' ' ASP . 21.4 pttm -86.5 -7.79 58.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.839 0.352 . . . . 0.0 110.633 -178.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' B' ' 79' ' ' ILE . 3.4 mm? -71.11 -16.2 62.55 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.699 -176.184 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 t30 46.67 61.55 2.74 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 124.148 0.905 . . . . 0.0 109.624 -170.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.592 ' H ' HD12 ' B' ' 84' ' ' ILE . 3.6 mp -57.09 141.08 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.079 -176.373 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' B' ' 34' ' ' ASN . 51.5 mtpt -95.91 -175.01 3.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.846 178.203 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.415 ' N ' ' HA ' ' B' ' 34' ' ' ASN . . . -139.47 114.54 1.01 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 178.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.14 -74.76 0.08 Allowed 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -121.21 84.7 2.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 176.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 25.7 mm -86.64 129.77 37.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.63 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.617 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 12.9 mm-40 -123.38 146.34 48.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.742 177.108 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.617 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 47.2 mt -135.01 120.5 30.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.394 177.114 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 26.8 pttt -172.76 171.21 4.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.969 0.414 . . . . 0.0 111.921 -174.174 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.423 ' HA ' ' CB ' ' B' ' 54' ' ' TRP . 15.7 mm-40 -84.62 151.52 24.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.842 179.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.599 HG12 ' HA ' ' B' ' 54' ' ' TRP . 4.8 pt . . . . . 0 C--N 1.313 -1.017 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.327 -174.615 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.851 0.358 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -140.49 82.78 1.87 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.183 0.516 . . . . 0.0 109.958 -178.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -80.43 -4.71 54.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.99 -176.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.504 ' NZ ' ' HB2' ' B' ' 4' ' ' LYS . 0.0 OUTLIER -69.3 -29.03 66.8 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.471 0.653 . . . . 0.0 109.408 173.52 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.429 ' HB1' ' HG3' ' B' ' 7' ' ' GLU . . . -82.32 113.95 20.46 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.19 177.515 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 82.9 mt -98.06 24.74 6.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.232 -176.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.429 ' HG3' ' HB1' ' B' ' 5' ' ' ALA . 31.1 mt-10 -53.07 -57.84 9.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.674 -176.405 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -95.26 -26.35 15.98 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.601 0.715 . . . . 0.0 110.425 176.032 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.442 ' HG2' HG12 ' B' ' 13' ' ' ILE . 49.5 tt0 -93.8 69.99 4.04 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.012 -178.524 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 10' ' ' MET . . . . . . . . . . . . . 46.1 tpp -59.97 143.58 51.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.19 -178.239 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . 0.45 ' C ' HD12 ' B' ' 13' ' ' ILE . 1.6 m-20 -41.16 -20.41 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.165 1.786 . . . . 0.0 114.239 -176.497 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -63.75 -5.2 3.83 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.992 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.479 ' HA ' ' HB2' ' B' ' 31' ' ' MET . 0.2 OUTLIER -49.03 -52.99 8.79 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-O 122.003 0.906 . . . . 0.0 110.007 179.361 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 14' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' B' ' 18' ' ' ASP . 35.0 m-80 -88.41 -32.53 18.28 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.616 -175.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . . . . . . . . . 3.1 m -59.51 -43.62 93.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.769 0.319 . . . . 0.0 111.424 -177.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.88 -41.18 60.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.27 0.557 . . . . 0.0 109.765 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.576 ' O ' ' HB2' ' B' ' 21' ' ' ASN . 3.0 t-20 -65.69 -45.88 81.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.972 -177.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' B' ' 14' ' ' ASN . 0.2 OUTLIER -67.85 -34.46 76.73 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.173 0.511 . . . . 0.0 110.729 -176.36 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -57.75 -59.91 4.5 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.192 178.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 49.1 mt -94.37 26.52 3.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.292 -177.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . 0.576 ' HB2' ' O ' ' B' ' 17' ' ' ASN . 27.5 t-20 -91.87 -37.86 12.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.264 0.554 . . . . 0.0 110.375 177.029 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -91.61 42.64 1.11 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.952 -178.033 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' B' ' 24' ' ' LYS . . . -85.82 -6.94 82.0 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.811 -177.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.478 ' HE3' ' CE1' ' B' ' 49' ' ' TYR . 86.7 mttt 72.53 -55.88 0.66 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.443 0.697 . . . . 0.0 110.801 -177.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' B' ' 45' ' ' TYR . . . -61.76 147.49 48.26 Favored Glycine 0 C--N 1.314 -0.678 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 167.234 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.531 ' CB ' ' HB3' ' B' ' 41' ' ' SER . 82.1 mttt -83.97 119.41 24.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.456 1.128 . . . . 0.0 111.105 -168.275 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 20.1 tp -158.06 118.79 3.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' B' ' 38' ' ' ALA . 57.8 m -114.55 112.27 22.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.31 -175.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 9.5 mp -98.09 165.65 11.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.659 0.742 . . . . 0.0 111.842 -178.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.3 p -160.47 141.44 11.97 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.808 171.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 31' ' ' MET . . . . . 0.703 ' SD ' HD23 ' B' ' 36' ' ' LEU . 82.0 mmm -108.47 136.38 48.19 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.65 0.262 . . . . 0.0 110.528 -175.136 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -137.08 61.33 1.63 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.153 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 55.43 -100.09 0.08 OUTLIER Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.194 177.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 34' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' B' ' 84' ' ' ILE . 20.9 m120 -75.81 -0.56 21.51 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -133.66 150.99 51.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.833 0.825 . . . . 0.0 112.253 175.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.703 HD23 ' SD ' ' B' ' 31' ' ' MET . 2.3 tm? -118.73 132.18 56.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.833 170.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -127.63 136.62 51.89 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.549 ' HB3' HD21 ' B' ' 80' ' ' ASN . . . -162.92 157.54 21.27 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.03 0.443 . . . . 0.0 111.761 -175.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.98 152.96 46.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.508 177.328 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 24.1 p -127.82 150.37 49.86 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.76 0.314 . . . . 0.0 110.702 -178.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.531 ' HB3' ' CB ' ' B' ' 26' ' ' LYS . 41.9 t -126.69 163.98 22.3 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.594 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -72.02 55.18 0.29 Allowed 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 125.243 1.589 . . . . 0.0 113.48 -154.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.456 ' HB3' ' H ' ' B' ' 26' ' ' LYS . . . -97.68 -18.32 18.93 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.911 169.247 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.12 -52.74 2.17 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.198 -0.91 . . . . 0.0 113.358 177.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.612 ' O ' ' HA3' ' B' ' 25' ' ' GLY . 5.4 m-85 -75.85 173.52 11.07 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.823 0.82 . . . . 0.0 112.638 -175.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.83 33.44 0.44 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 176.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.473 ' H ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -55.36 -45.09 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-N 114.178 -1.011 . . . . 0.0 111.803 -173.506 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.2 t 71.24 -91.33 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.495 -1.684 . . . . 0.0 108.168 -172.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.539 ' HB2' ' CE ' ' B' ' 52' ' ' LYS . 29.4 m-85 -140.78 126.93 19.61 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.457 0.473 . . . . 0.0 110.757 174.104 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 35.96 -109.97 0.06 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.287 1.035 . . . . 0.0 112.89 -174.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -132.85 132.63 42.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.19 0.519 . . . . 0.0 109.955 176.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.539 ' CE ' ' HB2' ' B' ' 49' ' ' TYR . 75.4 mttt -137.84 130.6 29.86 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.458 179.481 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -117.28 118.75 33.14 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.173 0.511 . . . . 0.0 109.782 175.271 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.645 ' CZ3' HG23 ' B' ' 91' ' ' ILE . 37.5 p-90 -143.95 170.52 15.76 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.374 -177.118 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.37 150.89 20.63 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.292 -175.234 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 11.4 mt -102.81 142.7 16.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 173.159 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 57' ' ' PHE . . . . . 0.6 ' HB2' ' HB2' ' B' ' 90' ' ' GLU . 46.7 m-85 -124.81 134.17 52.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.978 -177.322 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.558 HG12 ' HB ' ' B' ' 63' ' ' VAL . 9.3 p -126.43 137.89 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -178.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.495 ' ND2' HG13 ' B' ' 58' ' ' VAL . 6.0 m-80 65.86 3.09 2.41 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -172.141 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.419 ' N ' ' HB3' ' B' ' 88' ' ' TYR . . . 103.36 -12.63 54.85 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.912 -174.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' B' ' 57' ' ' PHE . 1.4 mp0 -91.01 170.28 10.18 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 123.663 0.785 . . . . 0.0 108.885 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.561 ' HG3' ' CE1' ' B' ' 57' ' ' PHE . 17.4 ttmt -68.2 169.28 10.65 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 172.505 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.558 ' HB ' HG12 ' B' ' 58' ' ' VAL . 8.7 p -153.53 -13.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.297 170.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.5 ' CE2' HG23 ' B' ' 75' ' ' ILE . 0.3 OUTLIER -164.58 136.43 4.5 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.863 -176.347 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 39.3 m -128.43 127.19 42.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.515 173.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 66' ' ' PHE . . . . . 0.663 ' CE2' HG21 ' B' ' 75' ' ' ILE . 27.2 p90 -166.88 154.83 9.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.676 0.75 . . . . 0.0 111.074 -176.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -101.76 161.01 13.97 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.386 173.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . 0.499 ' CG ' ' HB2' ' B' ' 52' ' ' LYS . 4.7 mm-40 -73.37 -36.83 66.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.491 0.662 . . . . 0.0 109.952 -179.612 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -59.72 -25.58 64.93 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.781 177.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 70' ' ' SER . . . . . . . . . . . . . 4.4 t -68.17 -10.4 53.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.343 -178.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 71' ' ' THR . . . . . . . . . . . . . 31.6 p 75.47 94.38 0.07 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 112.479 -2.146 . . . . 0.0 110.763 177.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.75 ' HA ' ' CG1' ' B' ' 75' ' ' ILE . 19.7 m -67.86 -8.56 9.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.328 -171.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.99 -37.14 94.47 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.236 176.517 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -82.14 -29.13 31.79 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 75' ' ' ILE . . . . . 0.75 ' CG1' ' HA ' ' B' ' 72' ' ' VAL . 30.2 mm -57.92 -60.56 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.959 174.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 76' ' ' SER . . . . . 0.429 ' HA ' HD12 ' B' ' 79' ' ' ILE . 18.9 t -61.77 -32.55 72.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.377 -177.462 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' B' ' 80' ' ' ASN . 64.8 t30 -51.96 -49.94 62.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.947 174.681 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 78' ' ' ASP . . . . . 0.68 ' O ' ' HG3' ' B' ' 81' ' ' LYS . 0.4 OUTLIER -73.47 -34.8 65.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.188 178.471 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.572 HG13 ' O ' ' B' ' 75' ' ' ILE . 57.0 mt -56.13 -34.79 39.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.253 0.549 . . . . 0.0 110.453 176.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 80' ' ' ASN . . . . . 0.549 HD21 ' HB3' ' B' ' 38' ' ' ALA . 10.1 m-80 -56.91 -28.08 61.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.156 177.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . 0.68 ' HG3' ' O ' ' B' ' 78' ' ' ASP . 1.1 pptp? -97.44 -5.59 35.81 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -171.212 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 31.0 mt -68.45 -21.69 64.63 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 122.0 -0.438 . . . . 0.0 110.392 -174.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 50.59 64.73 1.7 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.505 -166.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.549 HD12 ' HB2' ' B' ' 36' ' ' LEU . 70.2 mt -59.82 157.5 2.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.592 -172.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.465 ' O ' HG22 ' B' ' 84' ' ' ILE . 22.0 mmmt -100.82 -169.35 1.69 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.211 0.529 . . . . 0.0 110.14 175.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -151.53 113.27 0.57 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.192 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.436 ' HG3' ' HA ' ' B' ' 59' ' ' ASN . 18.0 ptp -174.42 -54.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 122.53 0.332 . . . . 0.0 110.248 177.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 88' ' ' TYR . . . . . 0.419 ' HB3' ' N ' ' B' ' 60' ' ' GLY . 6.8 t80 -134.03 79.56 1.82 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' B' ' 57' ' ' PHE . 34.1 mm -94.49 114.92 32.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.171 177.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.6 ' HB2' ' HB2' ' B' ' 57' ' ' PHE . 31.7 mm-40 -110.17 146.53 35.37 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.051 0.453 . . . . 0.0 111.432 179.232 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.645 HG23 ' CZ3' ' B' ' 54' ' ' TRP . 5.2 mp -131.68 107.24 12.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.839 178.198 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 92' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' B' ' 54' ' ' TRP . 16.4 pttp -167.9 172.65 8.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.943 0.401 . . . . 0.0 111.433 -172.364 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.409 ' H ' ' HG3' ' B' ' 93' ' ' GLN . 0.4 OUTLIER -69.47 165.03 21.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.528 174.987 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 94' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' B' ' 54' ' ' TRP . 2.3 pt . . . . . 0 C--O 1.25 1.131 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.401 -176.0 . . . . . . . . 1 1 . 1 stop_ save_